0001193125-21-329998.txt : 20211115 0001193125-21-329998.hdr.sgml : 20211115 20211115164139 ACCESSION NUMBER: 0001193125-21-329998 CONFORMED SUBMISSION TYPE: 10-Q PUBLIC DOCUMENT COUNT: 90 CONFORMED PERIOD OF REPORT: 20210930 FILED AS OF DATE: 20211115 DATE AS OF CHANGE: 20211115 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Shapeways Holdings, Inc. CENTRAL INDEX KEY: 0001784851 STANDARD INDUSTRIAL CLASSIFICATION: MISCELLANEOUS MANUFACTURING INDUSTRIES [3990] IRS NUMBER: 000000000 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 10-Q SEC ACT: 1934 Act SEC FILE NUMBER: 001-39092 FILM NUMBER: 211411687 BUSINESS ADDRESS: STREET 1: 30-02 48TH AVENUE CITY: LONG ISLAND CITY STATE: NY ZIP: 11101 BUSINESS PHONE: (646) 979-9885 MAIL ADDRESS: STREET 1: 30-02 48TH AVENUE CITY: LONG ISLAND CITY STATE: NY ZIP: 11101 FORMER COMPANY: FORMER CONFORMED NAME: Galileo Acquisition Corp. DATE OF NAME CHANGE: 20190807 10-Q 1 d216471d10q.htm 10-Q 10-Q
P0YShapeways Holdings, Inc.NY0001784851--12-312021Q3falsetrue 0001784851 2021-09-30 0001784851 2020-12-31 0001784851 2021-01-01 2021-09-30 0001784851 2020-01-01 2020-09-30 0001784851 2021-07-01 2021-09-30 0001784851 2020-07-01 2020-09-30 0001784851 2021-01-01 2021-03-31 0001784851 2021-04-01 2021-06-30 0001784851 2020-04-01 2020-06-30 0001784851 2020-01-01 2020-12-31 0001784851 2020-01-01 2020-03-31 0001784851 2020-09-30 0001784851 2021-09-29 2021-09-29 0001784851 2021-11-10 0001784851 2020-01-01 0001784851 2019-12-31 0001784851 2021-03-31 0001784851 2021-06-30 0001784851 2020-03-31 0001784851 2020-06-30 0001784851 us-gaap:FairValueInputsLevel3Member shpw:WarrantLiabilityMember us-gaap:FairValueMeasurementsRecurringMember 2021-09-30 0001784851 shpw:PrivateWarrantsMember 2021-09-30 0001784851 shpw:SponsorWarrantsMember 2021-09-30 0001784851 us-gaap:FairValueInputsLevel3Member shpw:PrivatePlacementWarrantsMember us-gaap:MeasurementInputSharePriceMember 2021-09-30 0001784851 us-gaap:FairValueInputsLevel3Member shpw:PrivatePlacementWarrantsMember us-gaap:MeasurementInputExercisePriceMember 2021-09-30 0001784851 us-gaap:FairValueInputsLevel3Member shpw:PrivatePlacementWarrantsMember us-gaap:MeasurementInputPriceVolatilityMember 2021-09-30 0001784851 us-gaap:FairValueInputsLevel3Member shpw:PrivatePlacementWarrantsMember 2021-09-30 0001784851 us-gaap:FairValueInputsLevel3Member shpw:PrivatePlacementWarrantsMember us-gaap:MeasurementInputExpectedDividendRateMember 2021-09-30 0001784851 us-gaap:FairValueInputsLevel3Member shpw:PrivatePlacementWarrantsMember shpw:MeasurementInputFairValuePerWarrantMember 2021-09-30 0001784851 us-gaap:FairValueInputsLevel3Member us-gaap:MeasurementInputExpectedTermMember shpw:PrivatePlacementWarrantsMember 2021-09-30 0001784851 shpw:RelatedPartyNoteMember srt:OfficerMember 2021-09-30 0001784851 us-gaap:MachineryAndEquipmentMember 2021-09-30 0001784851 us-gaap:ComputerEquipmentMember 2021-09-30 0001784851 us-gaap:FurnitureAndFixturesMember 2021-09-30 0001784851 us-gaap:LeaseholdImprovementsMember 2021-09-30 0001784851 shpw:EarnoutSharesMember us-gaap:FairValueMeasurementsNonrecurringMember 2021-09-30 0001784851 shpw:EarnoutSharesMember 2021-09-30 0001784851 shpw:DutchLandlordLoanMember 2021-09-30 0001784851 shpw:TermLoanMember 2021-09-30 0001784851 us-gaap:ConvertibleNotesPayableMember 2021-09-30 0001784851 shpw:PaymentProtectionProgramLoanMember 2021-09-30 0001784851 shpw:LegacyShapewaysCommonStockWarrantsMember shpw:PriorToTheBusinessCombinationMember 2021-09-30 0001784851 shpw:PublicWarrantsMember 2021-09-30 0001784851 shpw:TwoThousandTwentyOneEquityIncentivePlanMember 2021-09-30 0001784851 shpw:TwoThousandTenStockPlanMember 2021-09-30 0001784851 shpw:TradingPriceOneMember shpw:ReverseRecapitalizationMember 2021-09-30 0001784851 shpw:TradingPriceTwoMember shpw:ReverseRecapitalizationMember 2021-09-30 0001784851 shpw:PipeInvestorsMember shpw:SubscriptionAgreementMember shpw:ReverseRecapitalizationMember 2021-09-30 0001784851 shpw:PriorToMergerMember shpw:PublicWarrantsMember 2021-09-30 0001784851 shpw:ReverseRecapitalizationMember shpw:BusinessCombinationElementsToUnauditedConsolidatedStatementOfEquityMember 2021-09-30 0001784851 shpw:LegacyShapewaysMember shpw:PostBusinessCombinationMember 2021-09-30 0001784851 shpw:LegacyShapewaysMember shpw:PostBusinessCombinationMember shpw:UnpaidAndAccruedInterestMember 2021-09-30 0001784851 us-gaap:FairValueInputsLevel3Member shpw:WarrantLiabilityMember us-gaap:FairValueMeasurementsRecurringMember 2020-12-31 0001784851 us-gaap:MachineryAndEquipmentMember 2020-12-31 0001784851 us-gaap:ComputerEquipmentMember 2020-12-31 0001784851 us-gaap:FurnitureAndFixturesMember 2020-12-31 0001784851 us-gaap:LeaseholdImprovementsMember 2020-12-31 0001784851 shpw:DutchLandlordLoanMember 2020-12-31 0001784851 shpw:TermLoanMember 2020-12-31 0001784851 us-gaap:ConvertibleNotesPayableMember 2020-12-31 0001784851 shpw:PaymentProtectionProgramLoanMember 2020-12-31 0001784851 us-gaap:AdditionalPaidInCapitalMember 2021-07-01 2021-09-30 0001784851 us-gaap:CommonStockMember 2021-07-01 2021-09-30 0001784851 us-gaap:CommonStockMember us-gaap:SeriesDPreferredStockMember 2021-07-01 2021-09-30 0001784851 shpw:MajorCustomerMember us-gaap:CustomerConcentrationRiskMember us-gaap:SalesRevenueNetMember 2021-07-01 2021-09-30 0001784851 us-gaap:OtherCustomerMember us-gaap:CustomerConcentrationRiskMember us-gaap:SalesRevenueNetMember 2021-07-01 2021-09-30 0001784851 shpw:DirectSalesMember 2021-07-01 2021-09-30 0001784851 shpw:MarketPlaceSalesMember 2021-07-01 2021-09-30 0001784851 us-gaap:SoftwareAndSoftwareDevelopmentCostsMember 2021-07-01 2021-09-30 0001784851 us-gaap:TransferredAtPointInTimeMember 2021-07-01 2021-09-30 0001784851 us-gaap:TransferredOverTimeMember 2021-07-01 2021-09-30 0001784851 us-gaap:RetainedEarningsMember 2021-07-01 2021-09-30 0001784851 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2021-07-01 2021-09-30 0001784851 shpw:DutchLandlordLoanMember 2021-07-01 2021-09-30 0001784851 us-gaap:ConvertibleNotesPayableMember 2021-07-01 2021-09-30 0001784851 shpw:TermLoanMember 2021-07-01 2021-09-30 0001784851 us-gaap:AdditionalPaidInCapitalMember 2020-07-01 2020-09-30 0001784851 us-gaap:CommonStockMember 2020-07-01 2020-09-30 0001784851 shpw:MajorCustomerMember us-gaap:CustomerConcentrationRiskMember us-gaap:SalesRevenueNetMember 2020-07-01 2020-09-30 0001784851 us-gaap:OtherCustomerMember us-gaap:CustomerConcentrationRiskMember us-gaap:SalesRevenueNetMember 2020-07-01 2020-09-30 0001784851 shpw:DirectSalesMember 2020-07-01 2020-09-30 0001784851 shpw:MarketPlaceSalesMember 2020-07-01 2020-09-30 0001784851 us-gaap:SoftwareAndSoftwareDevelopmentCostsMember 2020-07-01 2020-09-30 0001784851 us-gaap:TransferredAtPointInTimeMember 2020-07-01 2020-09-30 0001784851 us-gaap:TransferredOverTimeMember 2020-07-01 2020-09-30 0001784851 us-gaap:RetainedEarningsMember 2020-07-01 2020-09-30 0001784851 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2020-07-01 2020-09-30 0001784851 shpw:DutchLandlordLoanMember 2020-07-01 2020-09-30 0001784851 us-gaap:ConvertibleNotesPayableMember 2020-07-01 2020-09-30 0001784851 shpw:TermLoanMember 2020-07-01 2020-09-30 0001784851 us-gaap:FairValueInputsLevel3Member 2021-01-01 2021-09-30 0001784851 shpw:ConvertibleNoteMember 2021-01-01 2021-09-30 0001784851 shpw:RelatedPartyNoteMember srt:OfficerMember 2021-01-01 2021-09-30 0001784851 us-gaap:SalesRevenueNetMember us-gaap:CustomerConcentrationRiskMember shpw:MajorCustomerMember 2021-01-01 2021-09-30 0001784851 us-gaap:SalesRevenueNetMember us-gaap:CustomerConcentrationRiskMember us-gaap:OtherCustomerMember 2021-01-01 2021-09-30 0001784851 us-gaap:SupplierConcentrationRiskMember us-gaap:CostOfGoodsTotalMember shpw:MajorVendorMember 2021-01-01 2021-09-30 0001784851 us-gaap:AccountsReceivableMember us-gaap:CustomerConcentrationRiskMember shpw:MajorCustomerMember 2021-01-01 2021-09-30 0001784851 us-gaap:AccountsPayableMember us-gaap:SupplierConcentrationRiskMember shpw:MajorVendorOneMember 2021-01-01 2021-09-30 0001784851 us-gaap:AccountsPayableMember us-gaap:SupplierConcentrationRiskMember shpw:MajorVendorTwoMember 2021-01-01 2021-09-30 0001784851 us-gaap:AccountsPayableMember us-gaap:SupplierConcentrationRiskMember shpw:MajorVendorThreeMember 2021-01-01 2021-09-30 0001784851 us-gaap:AccountsPayableMember us-gaap:SupplierConcentrationRiskMember shpw:MajorVendorFourMember 2021-01-01 2021-09-30 0001784851 us-gaap:CostOfGoodsTotalMember us-gaap:SupplierConcentrationRiskMember shpw:OtherVendorMember 2021-01-01 2021-09-30 0001784851 us-gaap:AccountsReceivableMember us-gaap:CustomerConcentrationRiskMember us-gaap:OtherCustomerMember 2021-01-01 2021-09-30 0001784851 us-gaap:SupplierConcentrationRiskMember us-gaap:AccountsPayableMember 2021-01-01 2021-09-30 0001784851 us-gaap:AccountsPayableMember shpw:OtherVendorMember 2021-01-01 2021-09-30 0001784851 shpw:DirectSalesMember 2021-01-01 2021-09-30 0001784851 shpw:MarketPlaceSalesMember 2021-01-01 2021-09-30 0001784851 us-gaap:SoftwareAndSoftwareDevelopmentCostsMember 2021-01-01 2021-09-30 0001784851 us-gaap:TransferredAtPointInTimeMember 2021-01-01 2021-09-30 0001784851 us-gaap:TransferredOverTimeMember 2021-01-01 2021-09-30 0001784851 us-gaap:MachineryAndEquipmentMember 2021-01-01 2021-09-30 0001784851 us-gaap:ComputerEquipmentMember 2021-01-01 2021-09-30 0001784851 us-gaap:FurnitureAndFixturesMember 2021-01-01 2021-09-30 0001784851 us-gaap:LeaseholdImprovementsMember 2021-01-01 2021-09-30 0001784851 shpw:ConvertibleNoteMember shpw:SponsorWarrantsMember 2021-01-01 2021-09-30 0001784851 srt:MinimumMember 2021-01-01 2021-09-30 0001784851 srt:MaximumMember 2021-01-01 2021-09-30 0001784851 shpw:DutchLandlordLoanMember 2021-01-01 2021-09-30 0001784851 us-gaap:ConvertibleNotesPayableMember 2021-01-01 2021-09-30 0001784851 shpw:ShapewaysIncMember shpw:PaymentProtectionProgramLoanMember 2021-01-01 2021-09-30 0001784851 shpw:TwoThousandTenStockPlanMember 2021-01-01 2021-09-30 0001784851 shpw:PaymentProtectionProgramLoanMember 2021-01-01 2021-09-30 0001784851 us-gaap:OtherIncomeMember shpw:PaymentProtectionProgramLoanMember 2021-01-01 2021-09-30 0001784851 shpw:TwoThousandTwentyOneEquityIncentivePlanMember 2021-01-01 2021-09-30 0001784851 shpw:TermLoanMember 2021-01-01 2021-09-30 0001784851 shpw:ReverseRecapitalizationMember shpw:GalileoMember 2021-01-01 2021-09-30 0001784851 shpw:ReverseRecapitalizationMember shpw:GalileoMember us-gaap:CommonStockMember 2021-01-01 2021-09-30 0001784851 shpw:ReverseRecapitalizationMember shpw:FounderAndRepresentativeSharesMember 2021-01-01 2021-09-30 0001784851 shpw:ReverseRecapitalizationMember shpw:PipeInvestmentMember 2021-01-01 2021-09-30 0001784851 shpw:ReverseRecapitalizationMember shpw:MergerAndInvestmentMember us-gaap:CommonStockMember 2021-01-01 2021-09-30 0001784851 shpw:ReverseRecapitalizationMember shpw:ShapewaysIncMember us-gaap:CommonStockMember 2021-01-01 2021-09-30 0001784851 us-gaap:CommonStockMember 2021-01-01 2021-09-30 0001784851 us-gaap:WarrantMember 2021-01-01 2021-09-30 0001784851 shpw:ReverseRecapitalizationMember shpw:BusinessCombinationElementsToUnauditedConsolidatedStatementOfEquityMember 2021-01-01 2021-09-30 0001784851 shpw:ReverseRecapitalizationMember shpw:BusinessCombinationElementsToUnauditedConsolidatedStatementOfEquityMember shpw:GalileoMember 2021-01-01 2021-09-30 0001784851 shpw:EarnoutSharesMember shpw:ReverseRecapitalizationMember shpw:GalileoMember 2021-01-01 2021-09-30 0001784851 shpw:PipeInvestorsMember shpw:SubscriptionAgreementMember shpw:ReverseRecapitalizationMember 2021-01-01 2021-09-30 0001784851 shpw:GalileoMember shpw:ReverseRecapitalizationMember shpw:BusinessCombinationElementsToUnauditedConsolidatedStatementOfCashFlowsMember 2021-01-01 2021-09-30 0001784851 shpw:ReverseRecapitalizationMember shpw:BusinessCombinationElementsToUnauditedConsolidatedStatementOfCashFlowsMember shpw:PipeInvestmentMember 2021-01-01 2021-09-30 0001784851 shpw:ReverseRecapitalizationMember shpw:BusinessCombinationElementsToUnauditedConsolidatedStatementOfCashFlowsMember 2021-01-01 2021-09-30 0001784851 shpw:ReverseRecapitalizationMember shpw:BusinessCombinationElementsToUnauditedConsolidatedStatementOfEquityMember shpw:PrivateSponsorWarrantLiabilitiesMember 2021-01-01 2021-09-30 0001784851 shpw:ShapewaysIncMember 2021-01-01 2021-09-30 0001784851 shpw:ShapewaysIncMember srt:MinimumMember 2021-01-01 2021-09-30 0001784851 us-gaap:SalesRevenueNetMember us-gaap:CustomerConcentrationRiskMember shpw:MajorCustomerMember 2020-01-01 2020-09-30 0001784851 us-gaap:CostOfGoodsTotalMember us-gaap:SupplierConcentrationRiskMember shpw:MajorVendorMember 2020-01-01 2020-09-30 0001784851 us-gaap:OtherCustomerMember us-gaap:SalesRevenueNetMember us-gaap:CustomerConcentrationRiskMember 2020-01-01 2020-09-30 0001784851 us-gaap:CostOfGoodsTotalMember us-gaap:SupplierConcentrationRiskMember shpw:OtherVendorMember 2020-01-01 2020-09-30 0001784851 shpw:DirectSalesMember 2020-01-01 2020-09-30 0001784851 shpw:MarketPlaceSalesMember 2020-01-01 2020-09-30 0001784851 us-gaap:SoftwareAndSoftwareDevelopmentCostsMember 2020-01-01 2020-09-30 0001784851 us-gaap:TransferredAtPointInTimeMember 2020-01-01 2020-09-30 0001784851 us-gaap:TransferredOverTimeMember 2020-01-01 2020-09-30 0001784851 srt:MinimumMember 2020-01-01 2020-09-30 0001784851 srt:MaximumMember 2020-01-01 2020-09-30 0001784851 shpw:DutchLandlordLoanMember 2020-01-01 2020-09-30 0001784851 us-gaap:ConvertibleNotesPayableMember 2020-01-01 2020-09-30 0001784851 shpw:PaymentProtectionProgramLoanMember 2020-01-01 2020-09-30 0001784851 shpw:TwoThousandTwentyOneEquityIncentivePlanMember 2020-01-01 2020-09-30 0001784851 shpw:TermLoanMember 2020-01-01 2020-09-30 0001784851 us-gaap:AdditionalPaidInCapitalMember 2021-04-01 2021-06-30 0001784851 us-gaap:CommonStockMember 2021-04-01 2021-06-30 0001784851 us-gaap:AdditionalPaidInCapitalMember shpw:SeriesB1PreferredStockMember 2021-04-01 2021-06-30 0001784851 shpw:SeriesB1PreferredStockMember 2021-04-01 2021-06-30 0001784851 us-gaap:CommonStockMember shpw:SeriesB1PreferredStockMember 2021-04-01 2021-06-30 0001784851 us-gaap:RetainedEarningsMember 2021-04-01 2021-06-30 0001784851 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2021-04-01 2021-06-30 0001784851 us-gaap:PreferredStockMember srt:RestatementAdjustmentMember 2021-01-01 2021-03-31 0001784851 us-gaap:CommonStockMember srt:RestatementAdjustmentMember 2021-01-01 2021-03-31 0001784851 us-gaap:AdditionalPaidInCapitalMember srt:RestatementAdjustmentMember 2021-01-01 2021-03-31 0001784851 us-gaap:AdditionalPaidInCapitalMember 2021-01-01 2021-03-31 0001784851 us-gaap:CommonStockMember 2021-01-01 2021-03-31 0001784851 us-gaap:RetainedEarningsMember 2021-01-01 2021-03-31 0001784851 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2021-01-01 2021-03-31 0001784851 srt:CumulativeEffectPeriodOfAdoptionAdjustedBalanceMember 2021-01-01 2021-03-31 0001784851 shpw:DesktopMetalMember us-gaap:SubsequentEventMember 2021-12-31 0001784851 shpw:MergerAgreementMember srt:OfficerMember shpw:RelatedPartyNoteMember 2021-09-29 2021-09-29 0001784851 us-gaap:ConvertibleNotesPayableMember 2021-09-29 2021-09-29 0001784851 us-gaap:ConvertibleNotesPayableMember us-gaap:CommonStockMember 2021-09-29 2021-09-29 0001784851 us-gaap:ConvertibleNotesPayableMember us-gaap:CommonStockMember shpw:UnpaidAndAccruedInterestMember 2021-09-29 2021-09-29 0001784851 shpw:PriorToTheBusinessCombinationMember shpw:LegacyShapewaysCommonStockWarrantsMember 2021-09-29 2021-09-29 0001784851 shpw:ShapewaysIncMember us-gaap:CommonStockMember shpw:ReverseRecapitalizationMember 2021-09-29 2021-09-29 0001784851 shpw:EarnoutSharesMember shpw:ReverseRecapitalizationMember 2021-09-29 2021-09-29 0001784851 shpw:ShapewaysIncMember shpw:ReverseRecapitalizationMember shpw:GalileoMember 2021-09-29 2021-09-29 0001784851 shpw:EarnoutRestrictedStockUnitsMember shpw:ReverseRecapitalizationMember 2021-09-29 2021-09-29 0001784851 shpw:TwoThousandTenStockPlanMember shpw:LegacyShapewaysStockOptionMember 2021-09-29 2021-09-29 0001784851 us-gaap:AccountsReceivableMember us-gaap:CustomerConcentrationRiskMember shpw:MajorCustomerMember 2020-01-01 2020-12-31 0001784851 us-gaap:AccountsPayableMember us-gaap:SupplierConcentrationRiskMember shpw:MajorVendorOneMember 2020-01-01 2020-12-31 0001784851 us-gaap:AccountsPayableMember us-gaap:SupplierConcentrationRiskMember shpw:MajorVendorTwoMember 2020-01-01 2020-12-31 0001784851 us-gaap:SupplierConcentrationRiskMember us-gaap:AccountsPayableMember shpw:MajorVendorThreeMember 2020-01-01 2020-12-31 0001784851 us-gaap:AccountsReceivableMember us-gaap:CustomerConcentrationRiskMember us-gaap:OtherCustomerMember 2020-01-01 2020-12-31 0001784851 us-gaap:SupplierConcentrationRiskMember us-gaap:AccountsPayableMember 2020-01-01 2020-12-31 0001784851 us-gaap:AccountsPayableMember shpw:OtherVendorMember us-gaap:SupplierConcentrationRiskMember 2020-01-01 2020-12-31 0001784851 us-gaap:ConvertibleNotesPayableMember 2020-01-01 2020-12-31 0001784851 srt:RestatementAdjustmentMember us-gaap:PreferredStockMember 2020-01-01 2020-03-31 0001784851 us-gaap:CommonStockMember srt:RestatementAdjustmentMember 2020-01-01 2020-03-31 0001784851 us-gaap:AdditionalPaidInCapitalMember srt:RestatementAdjustmentMember 2020-01-01 2020-03-31 0001784851 us-gaap:CommonStockMember 2020-01-01 2020-03-31 0001784851 us-gaap:AdditionalPaidInCapitalMember 2020-01-01 2020-03-31 0001784851 us-gaap:RetainedEarningsMember 2020-01-01 2020-03-31 0001784851 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2020-01-01 2020-03-31 0001784851 us-gaap:AdditionalPaidInCapitalMember 2020-04-01 2020-06-30 0001784851 us-gaap:CommonStockMember 2020-04-01 2020-06-30 0001784851 us-gaap:RetainedEarningsMember 2020-04-01 2020-06-30 0001784851 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2020-04-01 2020-06-30 0001784851 us-gaap:IPOMember 2019-10-22 2019-10-22 0001784851 us-gaap:PrivatePlacementMember shpw:PrivateWarrantsMember 2019-10-22 2019-10-22 0001784851 us-gaap:IPOMember 2019-10-22 0001784851 us-gaap:PrivatePlacementMember shpw:PrivateWarrantsMember 2019-10-22 0001784851 shpw:LegacyShapewaysPreferredStockWarrantsMember 2021-09-30 2021-09-30 0001784851 shpw:ReverseRecapitalizationMember 2021-09-30 2021-09-30 0001784851 shpw:PublicWarrantsMember 2021-09-30 2021-09-30 0001784851 shpw:RelatedPartyNoteMember srt:OfficerMember 2020-09-30 0001784851 shpw:TermLoanMember us-gaap:PrimeRateMember 2018-10-29 2018-10-29 0001784851 shpw:TermLoanMember 2018-10-29 0001784851 shpw:DutchLandlordLoanMember 2014-05-12 0001784851 us-gaap:ConvertibleNotesPayableMember 2019-06-19 0001784851 us-gaap:FairValueInputsLevel3Member shpw:PrivatePlacementWarrantsMember us-gaap:MeasurementInputSharePriceMember 2021-09-29 0001784851 us-gaap:FairValueInputsLevel3Member shpw:PrivatePlacementWarrantsMember us-gaap:MeasurementInputExercisePriceMember 2021-09-29 0001784851 us-gaap:FairValueInputsLevel3Member shpw:PrivatePlacementWarrantsMember us-gaap:MeasurementInputPriceVolatilityMember 2021-09-29 0001784851 us-gaap:FairValueInputsLevel3Member shpw:PrivatePlacementWarrantsMember 2021-09-29 0001784851 us-gaap:FairValueInputsLevel3Member shpw:PrivatePlacementWarrantsMember us-gaap:MeasurementInputExpectedDividendRateMember 2021-09-29 0001784851 us-gaap:FairValueInputsLevel3Member shpw:PrivatePlacementWarrantsMember shpw:MeasurementInputFairValuePerWarrantMember 2021-09-29 0001784851 us-gaap:FairValueInputsLevel3Member us-gaap:MeasurementInputExpectedTermMember shpw:PrivatePlacementWarrantsMember 2021-09-29 0001784851 shpw:TwoThousandTenStockPlanMember 2021-09-29 0001784851 shpw:LegacyShapewaysSeriesAOnePreferredStockMember 2021-09-29 0001784851 shpw:LegacyShapewaysSeriesATwoPreferredStockMember 2021-09-29 0001784851 shpw:LegacyShapewaysSeriesBPreferredStockMember 2021-09-29 0001784851 shpw:LegacyShapewaysSeriesBOnePreferredStockMember 2021-09-29 0001784851 shpw:LegacyShapewaysSeriesCPreferredStockMember 2021-09-29 0001784851 shpw:LegacyShapewaysSeriesDPreferredStockMember 2021-09-29 0001784851 shpw:LegacyShapewaysSeriesEPreferredStockMember 2021-09-29 0001784851 shpw:ReverseRecapitalizationMember shpw:ShapewaysIncMember us-gaap:CommonStockMember 2021-09-29 0001784851 shpw:TwoThousandTwentyOneEquityIncentivePlanMember shpw:ReverseRecapitalizationMember 2021-09-29 0001784851 shpw:ReverseRecapitalizationMember 2021-09-29 0001784851 shpw:PaymentProtectionProgramLoanMember 2020-05-04 2020-05-04 0001784851 shpw:PaymentProtectionProgramLoanMember 2020-05-04 0001784851 shpw:LegacyShapewaysCommonStockWarrantsMember shpw:ExecutingALoanAgreementMember 2013-12-18 2013-12-18 0001784851 shpw:LegacyShapewaysCommonStockWarrantsMember shpw:ExecutingALoanAgreementMember 2013-12-18 0001784851 shpw:LegacyShapewaysCommonStockWarrantsMember shpw:ExecutingALoanAgreementMember 2014-02-03 2014-02-03 0001784851 shpw:LegacyShapewaysCommonStockWarrantsMember shpw:ExecutingALoanAgreementMember 2014-02-03 0001784851 shpw:AmendedLoanAgreementMember shpw:LegacyShapewaysCommonStockWarrantsMember 2015-04-22 2015-04-22 0001784851 shpw:LegacyShapewaysCommonStockWarrantsMember shpw:AmendedLoanAgreementMember 2015-04-22 0001784851 shpw:LegacyShapewaysPreferredStockWarrantsMember shpw:LegacyShapewaysSeriesBOnePreferredStockMember 2013-03-08 2013-03-08 0001784851 shpw:LegacyShapewaysPreferredStockWarrantsMember 2013-03-08 2013-03-08 0001784851 shpw:LegacyShapewaysPreferredStockWarrantsMember 2021-05-10 2021-05-10 0001784851 shpw:LegacyShapewaysCommonStockWarrantsMember shpw:LegacyShapewaysSeriesBOnePreferredStockMember 2021-05-10 2021-05-10 0001784851 shpw:LegacyShapewaysPreferredStockWarrantsMember 2021-05-10 0001784851 shpw:LegacyShapewaysPreferredStockWarrantsMember shpw:LegacyShapewaysSeriesDPreferredStockMember 2017-06-30 2017-06-30 0001784851 shpw:LegacyShapewaysPreferredStockWarrantsMember 2017-06-30 2017-06-30 0001784851 shpw:LegacyShapewaysPreferredStockWarrantsMember 2017-06-30 0001784851 shpw:RelatedPartyNoteMember srt:OfficerMember 2012-12-31 0001784851 shpw:LegacyShapewaysPreferredStockWarrantsMember 2013-03-08 0001784851 shpw:DesktopMetalMember 2021-03-26 0001784851 shpw:DesktopMetalMember 2021-03-26 2021-03-26 0001784851 shpw:DesktopMetalMember us-gaap:SubsequentEventMember 2021-11-01 2021-11-30 0001784851 us-gaap:CommonStockMember 2021-09-30 0001784851 us-gaap:AdditionalPaidInCapitalMember 2021-09-30 0001784851 us-gaap:RetainedEarningsMember 2021-09-30 0001784851 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2021-09-30 0001784851 us-gaap:PreferredStockMember 2021-09-30 0001784851 us-gaap:PreferredStockMember 2020-09-30 0001784851 us-gaap:CommonStockMember 2020-09-30 0001784851 us-gaap:AdditionalPaidInCapitalMember 2020-09-30 0001784851 us-gaap:RetainedEarningsMember 2020-09-30 0001784851 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2020-09-30 0001784851 us-gaap:FairValueInputsLevel3Member 2020-12-31 0001784851 us-gaap:FairValueInputsLevel3Member 2021-09-30 0001784851 shpw:ReverseRecapitalizationMember shpw:PriorToBusinessCombinationMember us-gaap:CommonStockMember 2020-12-31 0001784851 shpw:ReverseRecapitalizationMember us-gaap:CommonStockMember shpw:ImmediatelyAfterBusinessCombinationMember 2021-09-30 0001784851 us-gaap:CommonStockMember 2021-06-30 0001784851 us-gaap:AdditionalPaidInCapitalMember 2021-06-30 0001784851 us-gaap:RetainedEarningsMember 2021-06-30 0001784851 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2021-06-30 0001784851 us-gaap:PreferredStockMember 2021-06-30 0001784851 us-gaap:PreferredStockMember 2020-12-31 0001784851 us-gaap:CommonStockMember 2020-12-31 0001784851 us-gaap:AdditionalPaidInCapitalMember 2020-12-31 0001784851 us-gaap:RetainedEarningsMember 2020-12-31 0001784851 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2020-12-31 0001784851 us-gaap:PreferredStockMember srt:ScenarioPreviouslyReportedMember 2020-12-31 0001784851 us-gaap:CommonStockMember srt:ScenarioPreviouslyReportedMember 2020-12-31 0001784851 us-gaap:AdditionalPaidInCapitalMember srt:ScenarioPreviouslyReportedMember 2020-12-31 0001784851 us-gaap:RetainedEarningsMember srt:ScenarioPreviouslyReportedMember 2020-12-31 0001784851 us-gaap:AccumulatedOtherComprehensiveIncomeMember srt:ScenarioPreviouslyReportedMember 2020-12-31 0001784851 srt:ScenarioPreviouslyReportedMember 2020-12-31 0001784851 us-gaap:CommonStockMember 2021-03-31 0001784851 us-gaap:AdditionalPaidInCapitalMember 2021-03-31 0001784851 us-gaap:RetainedEarningsMember 2021-03-31 0001784851 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2021-03-31 0001784851 us-gaap:PreferredStockMember 2021-03-31 0001784851 srt:CumulativeEffectPeriodOfAdoptionAdjustedBalanceMember 2020-12-31 0001784851 srt:ScenarioPreviouslyReportedMember us-gaap:PreferredStockMember 2019-12-31 0001784851 us-gaap:CommonStockMember srt:ScenarioPreviouslyReportedMember 2019-12-31 0001784851 us-gaap:AdditionalPaidInCapitalMember srt:ScenarioPreviouslyReportedMember 2019-12-31 0001784851 us-gaap:RetainedEarningsMember srt:ScenarioPreviouslyReportedMember 2019-12-31 0001784851 us-gaap:AccumulatedOtherComprehensiveIncomeMember srt:ScenarioPreviouslyReportedMember 2019-12-31 0001784851 srt:ScenarioPreviouslyReportedMember 2019-12-31 0001784851 us-gaap:CommonStockMember 2019-12-31 0001784851 us-gaap:AdditionalPaidInCapitalMember 2019-12-31 0001784851 us-gaap:RetainedEarningsMember 2019-12-31 0001784851 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2019-12-31 0001784851 us-gaap:PreferredStockMember 2019-12-31 0001784851 us-gaap:PreferredStockMember 2020-03-31 0001784851 us-gaap:CommonStockMember 2020-03-31 0001784851 us-gaap:AdditionalPaidInCapitalMember 2020-03-31 0001784851 us-gaap:RetainedEarningsMember 2020-03-31 0001784851 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2020-03-31 0001784851 us-gaap:PreferredStockMember 2020-06-30 0001784851 us-gaap:CommonStockMember 2020-06-30 0001784851 us-gaap:AdditionalPaidInCapitalMember 2020-06-30 0001784851 us-gaap:RetainedEarningsMember 2020-06-30 0001784851 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2020-06-30 iso4217:USD xbrli:shares xbrli:pure utr:Year iso4217:EUR utr:Day iso4217:USD xbrli:shares shpw:Customer shpw:Customers shpw:Vendor shpw:Vendors shpw:lease shpw:Supplychainpartners shpw:Countries shpw:Additivetechnolgies shpw:Materialsandfinishes utr:Y
 
 
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
 
 
FORM
10-Q
 
 
 
QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
For the quarterly period ended September 30, 2021
OR
 
TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
For the transition period from
    
    
    
    
to
    
    
    
    
Commission file number:
001-39092
 
 
SHAPEWAYS HOLDINGS, INC.
(Exact name of registrant as specified in its charter)
 
 
 
Delaware
 
87-2876494
(State or other jurisdiction of incorporation)
 
(I.R.S. Employer Identification No.)
30-02
48th Avenue
Long Island City, NY 11101
(Address of principal executive offices) (Zip Code)
(646)
979-9885
(Registrant’s telephone number, including area code)
 
 
Securities registered pursuant to Section 12(b) of the Act:
 
Title of each class:
 
Trading
Symbol(s)
 
Name of each exchange
on which registered:
Common Stock, par value $0.0001 per share
 
SHPW
 
New York Stock Exchange
Warrants, each whole warrant exercisable for
one share of Common Stock for $11.50 per share
 
SHPW WS
 
New York Stock Exchange
Indicate by check mark whether the registrant: (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days.    Yes  ☒    No  ☐
Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation
S-T
(§232.0405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).    Yes  ☒     No  ☐
Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a
non-accelerated
filer, a smaller reporting company, or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company,” and “emerging growth company” in Rule
12b-2
of the Exchange Act.
 
Large accelerated filer      Accelerated filer  
       
Non-accelerated filer
     Smaller reporting company  
       
         Emerging growth company  
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.  
Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b2 of the Exchange Act).    Yes  ☐    No  
As of November 10, 2021 the registrant had 48,296,484 shares of common stock outstanding.
 
 
 

SHAPEWAYS HOLDINGS, INC.
TABLE OF CONTENTS
 
  
     
     
Item 1.
 
  
     
 
 
  
 
1
 
 
 
  
 
2
 
 
 
  
 
3
 
 
 
  
 
5
 
 
 
  
 
6
 
Item 2.
 
  
 
26
 
Item 3.
 
  
 
35
 
Item 4.
 
  
 
36
 
   
  
     
     
Item 1.
 
  
 
37
 
Item 1A.
 
  
 
37
 
Item 2.
 
  
 
37
 
Item 3.
 
  
 
37
 
Item 4.
 
  
 
37
 
Item 5.
 
  
 
37
 
Item 6.
 
  
 
38
 
   
  
 
38
 

CAUTIONARY NOTE REGARDING FORWARD-LOOKING STATEMENTS
This Quarterly Report on Form 10-Q (the “Report”), including, without limitation, the section titled “Management’s Discussion and Analysis of Financial Condition and Results of Operations,” includes forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended (the “Securities Act”) and Section 21E of the Securities Exchange Act of 1934, as amended (the “Exchange Act”). All statements, other than statements of present or historical fact included in or incorporated by reference in this Report, regarding the future financial performance of Shapeways Holdings, Inc. (the “Company”), as well as the Company’s strategy, future operations, future operating results, financial position, estimated revenues, and losses, projected costs, prospects, plans and objectives of management are forward-looking statements. In some cases, you can identify forward-looking statements by terminology such as “plan,” “believe,” “expect,” “anticipate,” “intend,” “outlook,” “estimate,” “forecast,” “project,” “continue,” “could,” “may,” “might,” “possible,” “potential,” “predict,” “should,” “would,” “will,” “seek,” “target,” and other similar words and expressions, but the absence of these words does not mean that a statement is not forward-looking.
The forward-looking statements are based on information available as of the date of this Report and on the current expectations, forecasts and assumptions of the management of the Company, involve a number of judgments, risks and uncertainties and are inherently subject to changes in circumstances and their potential effects and speak only as of the date of such statements. There can be no assurance that future developments will be those that have been anticipated. These forward-looking statements involve a number of risks, uncertainties or other assumptions that may cause actual results or performance to be materially different from those expressed, contemplated or implied by these forward-looking statements. The Company cautions you that these forward-looking statements are subject to numerous risk and uncertainties, most of which are difficult to predict and many of which are beyond the control of the Company. These risks and uncertainties include, but are not limited to, those factors described in the section titled “Risk Factors” in the final joint proxy statement/consent solicitation statement/prospectus filed by Galileo Acquisition Corp. with the U.S. Securities and Exchange Commission (the “SEC”) on September 7, 2021 (the “Proxy Statement”) as well as elsewhere in this Report. Should one or more of these risks or uncertainties materialize, or should any of our assumptions prove incorrect, actual results may vary in material respects from those projected in these forward-looking statements. The Company undertakes no obligation to update or revise any forward-looking statements, whether as a result of new information, future events or otherwise, except as may be required under applicable securities laws. These risks and others described in the section titled “Risk Factors” in the Proxy Statement may not be exhaustive.
By their nature, forward-looking statements involve risks and uncertainties because they relate to events and depend on circumstances that may or may not occur in the future. Forward-looking statements are not guarantees of future performance and the Company’s actual results of operations, financial condition and liquidity, and developments in the industry in the Company operates may differ materially from those made in or suggested by the forward-looking statements contained in this Report. In addition, even if the Company’s results or operations, financial condition and liquidity, and developments in the industry in which it operates are consistent with the forward-looking statements contained in this Report, those results or developments may not be indicative of results or developments in subsequent periods.

PART 1 - FINANCIAL INFORMATION
ITEM 1. Financial Statements
SHAPEWAYS HOLDINGS, INC.
CONDENSED CONSOLIDATED BALANCE SHEETS
(in thousands, except share and per share amounts)
 
    
September 30, 2021
   
December 31, 2020
 
    
(Unaudited)
       
Assets
                
Current assets
                
Cash and cash equivalents
   $ 90,108     $ 8,564  
Restricted cash
     143       145  
Accounts receivable
     1,114       185  
Inventory
     573       727  
Promissory note due from related party
              151  
Prepaid expenses and other current assets
     1,908       1,910  
    
 
 
   
 
 
 
Total current assets
     93,846       11,682  
Property and equipment, net
     1,090       948  
Right-of-use
assets, net
     982       2,102  
Goodwill
     1,835       1,835  
Security deposits
     175       175  
    
 
 
   
 
 
 
Total assets
   $ 97,928     $ 16,742  
    
 
 
   
 
 
 
Liabilities and Stockholders’ Equity (Deficit)
                
Current liabilities
                
Accounts payable
   $ 1,168     $ 1,633  
Accrued expenses and other liabilities
     3,700       3,319  
Current portion of long-term debt
     39       8,332  
Operating lease liabilities, current
     631       1,222  
Deferred revenue
     658       753  
    
 
 
   
 
 
 
Total current liabilities
     6,196       15,259  
Operating lease liabilities, net of current portion
     499       1,094  
Warrant liabilities
     6,777           
Long-term debt
     88       2,236  
    
 
 
   
 
 
 
Total liabilities
     13,560       18,589  
    
 
 
   
 
 
 
Commitments and contingencies
           
Stockholders’ equity (deficit)
(1)
                
Preferred stock ($0.0001 par value; 10,000,000 shares authorized; none issued and outstanding as of September 30, 2021 and December 31, 2020, respectively)
                  
Common stock ($0.0001 par value; 120,000,000 shares authorized; 48,296,484 and 32,170,068 shares issued and outstanding as of September 30, 2021 and December 31, 2020, respectively)
     5       3  
Additional
paid-in
capital
     195,121       112,994  
Accumulated deficit
     (110,442     (114,567
Accumulated other comprehensive loss
     (316     (277
    
 
 
   
 
 
 
Total stockholders’ equity (deficit)
     84,368       (1,847
    
 
 
   
 
 
 
Total liabilities and stockholders’ equity (deficit)
   $ 97,928     $ 16,742  
    
 
 
   
 
 
 
 
(1)
Retroactively restated for the reverse recapitalization as described in Notes 1 and 3.
 
The accompanying notes are an integral part of these unaudited consolidated financial statements.
 
1

SHAPEWAYS HOLDINGS, INC.
CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS AND COMPREHENSIVE LOSS
(Unaudited)
(in thousands, except share and per share amounts)
 
    
Three Months Ended September 30,
   
Nine Months Ended September 30,
 
    
2021
   
2020
   
2021
   
2020
 
Revenue, net
   $ 7,716     $ 8,107     $ 25,354     $ 23,028  
Cost of revenue
     4,055       4,406       13,271       13,030  
    
 
 
   
 
 
   
 
 
   
 
 
 
Gross profit
     3,661       3,701       12,083       9,998  
Operating expenses
                                
Selling, general and administrative
     4,366       2,461       10,513       8,075  
Research and development
     1,673       1,516       4,099       4,289  
Amortization and depreciation
     33       37       100       113  
    
 
 
   
 
 
   
 
 
   
 
 
 
Total operating expenses
     6,072       4,014       14,712       12,477  
    
 
 
   
 
 
   
 
 
   
 
 
 
Loss from operations
     (2,411     (313     (2,629     (2,479
Other income (expense)
                                
Long-term debt forgiveness
                       2,000           
Interest expense
     (126     (141     (407     (444
Change in fair value of warrant liabilities
     5,088                5,088           
Interest income
     1                1           
Other income
              4       1       7  
Loss on disposal of assets
                                (4
    
 
 
   
 
 
   
 
 
   
 
 
 
Total other income (expense), net
     4,963       (137     6,683       (441
    
 
 
   
 
 
   
 
 
   
 
 
 
Income (loss) 
before income tax benefit
     2,552       (450     4,054       (2,920
Income tax benefit
                       (71     —    
    
 
 
   
 
 
   
 
 
   
 
 
 
Net
income
 
(loss)
     2,552       (450     4,125       (2,920
Deemed dividend - Earnout Shares
     (18,132              (18,132     —    
    
 
 
   
 
 
   
 
 
   
 
 
 
Net loss attributable to common stockholders
     (15,580     (450     (14,007     (2,920
    
 
 
   
 
 
   
 
 
   
 
 
 
Net
income
 
(
loss)
 
per share:
                                
Basic
   $ 0.07     $ (0.01   $ 0.11     $ (0.08
    
 
 
   
 
 
   
 
 
   
 
 
 
Diluted
   $ 0.07     $ (0.01   $ 0.11     $ (0.08
    
 
 
   
 
 
   
 
 
   
 
 
 
Net loss per share attributable to common stockholders:
                                
Basic
   $ (0.41   $ (0.01   $ (0.38   $ (0.08
    
 
 
   
 
 
   
 
 
   
 
 
 
Diluted
   $ (0.41   $ (0.01   $ (0.38   $ (0.08
    
 
 
   
 
 
   
 
 
   
 
 
 
Weighted average common shares outstanding:
(1)
                                
Basic
     37,932,345       35,787,986       37,351,244       35,660,635  
    
 
 
   
 
 
   
 
 
   
 
 
 
Diluted
     37,932,345       35,787,986       37,351,244       35,660,635  
    
 
 
   
 
 
   
 
 
   
 
 
 
Other comprehensive
(
loss
) income
                                
Foreign currency translation adjustment
     (22     65       (39     32  
Comprehensive loss
   $ (15,602   $ (385   $ (14,046   $ (2,888
    
 
 
   
 
 
   
 
 
   
 
 
 
 
(1)
Retroactively restated for the reverse recapitalization as described in Notes 1 and 3.
 
The accompanying notes are an integral part of these unaudited consolidated financial statements.
 
2

SHAPEWAYS HOLDINGS, INC.
CONDENSED CONSOLIDATED STATEMENT OF CHANGES IN STOCKHOLDERS’ EQUITY (DEFICIT)
(1)
(Unaudited)
(in thousands, except share and per share amounts)
 
    
Preferred Stock
   
Common Stock
                          
Three and Nine Months Ended September 30, 2021
  
Shares
   
Amount
   
Shares
   
Amount
    
Additional
Paid-In

Capital
   
Accumulated
Deficit
   
Accumulated Other
Comprehensive
Loss
   
Total
Stockholders’
Equity (Deficit)
 
Balance at January 1, 2021 (as previously reported)
     22,579,695     $ 2       16,211,567     $ 2      $ 112,993     $ (114,567   $ (277   $ (1,847
Retroactive application of reverse recapitalization
     (22,579,695     (2     15,972,696       1        1       —         —         —    
    
 
 
   
 
 
   
 
 
   
 
 
    
 
 
   
 
 
   
 
 
   
 
 
 
Balance at January 1, 2021 (after effect of reverse recapitalization)
            $          32,184,263     $ 3      $ 112,994     $ (114,567   $ (277   $ (1,847
Issuance of Legacy Shapeways common stock upon exercise of stock options
     —         —         35,895       —          16       —         —         16  
Stock-based compensation expense
     —         —         —         —          174       —         —         174  
Net income
     —         —         —         —          —         1,708       —         1,708  
Foreign currency translation
     —         —         —         —          —                 (9     (9
    
 
 
   
 
 
   
 
 
   
 
 
    
 
 
   
 
 
   
 
 
   
 
 
 
Balance at March 31, 2021
                       32,220,158       3        113,184       (112,859     (286     42  
Issuance of Legacy Shapeways common stock upon exercise of stock options
     —         —         63,506       —          55       —         —         55  
Issuance of Legacy Shapeways convertible Series
B-1
preferred stock resulting from exercise of warrants
     —         —         19,177       —          60       —         —         60  
Stock-based compensation expense
     —         —         —         —          171       —         —         171  
Net loss
     —         —         —         —          —         (135     —         (135
Foreign currency translation
     —         —         —         —          —         —         (8     (8
    
 
 
   
 
 
   
 
 
   
 
 
    
 
 
   
 
 
   
 
 
   
 
 
 
Balance at June 30, 2021
                       32,302,841       3        113,470       (112,994     (294     185  
Issuance of Legacy Shapeways common stock upon exercise of stock options
     —         —         1,113,029       —          481       —         —         481  
Issuance of Legacy Shapeways common stock upon conversion of convertible notes
     —         —         1,406,741       —          5,913       —         —         5,913  
Issuance of Legacy Shapeways common stock upon exercise of warrants
     —         —         212,234       —          —         —         —         —    
Issuance of Legacy Shapeways convertible Series D preferred stock upon exercise of warrants
     —         —         89,217       —          —         —         —         —    
Repurchase of Legacy Shapeways common stock
     —         —         (19,226     —          (152     —         —         (152
Effect of Merger and recapitalization, net of redemptions and issuance costs
     —         —         5,691,648       1        10,035       —         —         10,036  
Issuance of common stock pursuant to PIPE financing, net of issuance costs
     —         —         7,500,000       1        64,936       —         —         64,937  
Stock-based compensation expense
     —         —         —         —          438       —         —         438  
Net
income
     —         —         —         —          —         2,552       —         2,552  
Foreign currency translation
     —         —         —         —          —         —         (22     (22
    
 
 
   
 
 
   
 
 
   
 
 
    
 
 
   
 
 
   
 
 
   
 
 
 
Balance at September 30, 2021
            $          48,296,484     $ 5      $ 195,121     $ (110,442   $ (316   $ 84,368  
    
 
 
   
 
 
   
 
 
   
 
 
    
 
 
   
 
 
   
 
 
   
 
 
 
 
The accompanying notes are an integral part of these unaudited consolidated financial statements.
 
3

SHAPEWAYS HOLDINGS, INC.
CONDENSED CONSOLIDATED STATEMENT OF CHANGES IN STOCKHOLDERS’ EQUITY (DEFICIT)
(1)
(Unaudited)
(in thousands, except share and per share amounts)
 
    
Preferred Stock
   
Common Stock
                           
Three and Nine Months Ended September 30, 2020
  
Shares
   
Amount
   
Shares
    
Amount
    
Additional
Paid-In

Capital
    
Accumulated
Deficit
   
Accumulated Other
Comprehensive
Loss
   
Total
Stockholders’
Equity (Deficit)
 
Balance at January 1, 2020 (as previously reported)
     22,579,695     $ 2       15,894,428      $ 2      $ 112,186      $ (111,399   $ (360   $ 431  
Retroactive application of reverse recapitalization
     (22,579,695     (2     16,026,831        1        1        —         —         —    
    
 
 
   
 
 
   
 
 
    
 
 
    
 
 
    
 
 
   
 
 
   
 
 
 
Balance at January 1, 2020 (after effect of reverse recapitalization)
            $ —         31,921,259      $ 3      $ 112,187      $ (111,399   $ (360   $ 431  
Issuance of Legacy Shapeways common stock upon exercise of stock options
     —         —         994        —          —          —         —         —    
Stock-based compensation expense
     —         —         —          —          171        —         —         171  
Net loss
     —         —         —          —          —          (1,435     —         (1,435
Foreign currency translation
     —         —         —          —          —          —         (61     (61
    
 
 
   
 
 
   
 
 
    
 
 
    
 
 
    
 
 
   
 
 
   
 
 
 
Balance at March 31, 2020
                       31,922,253        3        112,358        (112,834     (421     (894
Issuance of Legacy Shapeways common stock upon exercise of stock options
     —         —         141,270        —          47        —         —         47  
Stock-based compensation expense
     —         —         —          —          190        —         —         190  
Net loss
     —         —         —          —          —          (1,035     —         (1,035
Foreign currency translation
     —         —         —          —          —          —         28       28  
    
 
 
   
 
 
   
 
 
    
 
 
    
 
 
    
 
 
   
 
 
   
 
 
 
Balance at June 30, 2020
                       32,063,523        3        112,595        (113,869     (393     (1,664
Issuance of Legacy Shapeways common stock upon exercise of stock options
     —         —         68,555        —          21        —         —         21  
Stock-based compensation expense
     —         —         —          —          183        —         —         183  
Net loss
     —         —         —          —          —          (450     —         (450
Foreign currency translation
     —         —         —          —          —          —         65       65  
    
 
 
   
 
 
   
 
 
    
 
 
    
 
 
    
 
 
   
 
 
   
 
 
 
Balance at September 30, 2020
            $          32,132,078      $ 3      $ 112,799      $ (114,319   $ (328   $ (1,845
    
 
 
   
 
 
   
 
 
    
 
 
    
 
 
    
 
 
   
 
 
   
 
 
 
 
(1)
Retroactively restated for the reverse recapitalization as described in Notes 1 and 3.
 
The accompanying notes are an integral part of these unaudited consolidated financial statements.
 
4

SHAPEWAYS HOLDINGS, INC.
CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS
(Unaudited)
(in thousands, except share and per share amounts)
 
    
Nine Months Ended September 30,
 
    
2021
   
2020
 
Cash flows from operating activities:
                
Net
income (
loss
)
   $ 4,125     $ (2,920
Adjustments to reconcile net
income (loss) to net cash used in operating activities:
                
Depreciation and amortization
     424       362  
Loss on disposal of assets
              4  
Stock-based compensation expense
     783       544  
Non-cash
lease expense
     696       1,586  
Non-cash
debt forgiveness
     (2,000         
Change in fair value of warrant liabilities
     (5,088         
Change in operating assets and liabilities:
                
Accounts receivable
     (924     (763
Inventory
     173       (102
Prepaid expenses and other assets
     83       337  
Interest on promissory note due from related party
              50  
Accounts payable
     (512     (775
Accrued expenses and other liabilities
     853       713  
Lease liabilities
     (762     (1,674
Deferred revenue
     (101     67  
Deferred rent
              (283
    
 
 
   
 
 
 
Net cash used in operating activities
     (2,250     (2,854
    
 
 
   
 
 
 
Cash flows from investing activities:
                
Purchases of property and equipment
     (125     (23
    
 
 
   
 
 
 
Net cash used in investing activities
     (125     (23
    
 
 
   
 
 
 
Cash flows from financing activities:
                
Principal payments on capital leases
              (18
Proceeds from issuance of common stock
     552       68  
Proceeds received from exercise of preferred stock warrants
     60           
Effect of Merger, net of transaction costs
     86,792       —    
Repayments of loans payable
     (3,459     (851
Proceeds from loans payable
              1,983  
    
 
 
   
 
 
 
Net cash provided by financing activities
     83,945       1,182  
    
 
 
   
 
 
 
Net change in cash and cash equivalents and restricted cash
   $ 81,570     $ (1,695
    
 
 
   
 
 
 
Effect of change in foreign currency exchange rates on cash and cash equivalents and restricted cash
     (28     8  
Cash and cash equivalents and restricted cash at beginning of period
     8,709       9,605  
    
 
 
   
 
 
 
Cash and cash equivalents and restricted cash at end of period
   $ 90,251     $ 7,918  
    
 
 
   
 
 
 
Supplemental disclosure of cash and
non-cash
transactions:
                
Cash paid for interest
   $ 88     $ 145  
    
 
 
   
 
 
 
Accrued acquisition of property and equipment
   $ 441     $     
    
 
 
   
 
 
 
Issuance of Legacy Shapeways common stock upon conversion of convertible notes
   $ 5,913     $     
    
 
 
   
 
 
 
Repurchase of Legacy Shapeways common stock
   $ (152   $     
    
 
 
   
 
 
 
 
The accompanying notes are an integral part of these unaudited consolidated financial statements.
 
5

SHAPEWAYS HOLDINGS, INC.
NOTES TO THE UNAUDITED CONDENSED CONSOLIDATED FINANCIAL STATEMENTS
(in thousands, except share and per share amounts)
Note 1. Organization
On September 29, 2021 (the “Closing” or the “Closing Date”), Galileo Acquisition Corp., a Cayman Islands exempted company (“Galileo” and after the Domestication (as defined below) “Shapeways”), a publicly-traded special purpose acquisition company, consummated the transactions described in the Agreement and Plan of Merger and Reorganization (the “Merger Agreement”) dated April 28, 2021, by and among Galileo Founders Holdings, L.P. (the “Sponsor”), Galileo Acquisition Corp., Galileo Acquisition Holdings, Inc., a Delaware corporation and wholly-owned subsidiary of Galileo (“Merger Sub”), and Shapeways, Inc., a Delaware corporation (“Legacy Shapeways”),
 
whereby Merger Sub merged with and into Legacy Shapeways, the separate corporate existence of Merger Sub ceasing and Legacy Shapeways being the surviving corporation and a wholly owned subsidiary of Shapeways (the “Merger”).
Further, on the Closing Date, as contemplated by the Merger Agreement, Galileo filed a notice of deregistration with the Cayman Islands Registrar of Companies, together with the necessary accompanying documents, and filed a certificate of incorporation and a certificate of corporate domestication with the Secretary of State of the State of Delaware, under which Galileo was domesticated and continued as a Delaware corporation (the “Domestication” and, together with the Merger, the “Business Combination”), changing its name to “Shapeways Holdings, Inc.” (the “Company” and/or “Shapeways”).
Shapeways is a leader in the large and fast-growing digital manufacturing industry combining high quality, flexible on-demand manufacturing powered by purpose-built proprietary software which enables customers to rapidly transform digital designs into physical products, globally. Shapeways makes industrial-grade additive manufacturing accessible by fully digitizing the end-to-end manufacturing process , and by providing a broad range of solutions utilizing 11 additive manufacturing technologies and more than 90 materials and finishes, with the ability to easily scale new innovation. Shapeways has delivered over 21 million parts to 1 million customers in over 160 countries.
Note 2. Summary of Significant Accounting Policies
Basis of Presentation and Principles of Consolidation
The accompanying condensed consolidated interim financial statements have been prepared in accordance with accounting principles generally accepted in the United States of America (“U.S. GAAP”) for interim financial information as defined by the Financial Accounting Standards Board (“FASB”) Accounting Standards Codification (“ASC”) and in accordance with the instruction to Form
10-Q
and Article 8 of Regulation
S-X
of the SEC. Certain information or footnote disclosures normally included in financial statements prepared in accordance with GAAP have been condensed or omitted, pursuant to the rules and regulations of the SEC for interim financial reporting. Accordingly, they do not include all the information and footnotes necessary for a complete presentation of financial position, results of operations, or cash flows. The condensed consolidated financial statements include the accounts of its wholly owned subsidiaries, Legacy Shapeways and Shapeways BV. All intercompany accounts and transactions have been eliminated in consolidation. In the opinion of management, the accompanying condensed consolidated interim financial statements include all adjustments, consisting of a normal recurring nature, which are necessary for a fair presentation of the financial position, operating results and cash flows for the periods presented. These unaudited condensed consolidated interim financial statements should be read along with the final proxy statement/prospectus as filed with the SEC on September 7, 2021.
The Business Combination has been accounted for as a reverse recapitalization, in accordance with U.S. GAAP (the “Reverse Recapitalization”). Under this method of accounting, Galileo has been treated as the “acquired” company for financial reporting purposes. Accordingly, the Business Combination has been treated as the equivalent of Legacy Shapeways issuing stock for the net assets of Galileo, accompanied by a recapitalization. The net assets of Galileo are stated at historical cost, with no goodwill or other intangible assets recorded. There has been no accounting effect or change in the carrying amount of the assets and liabilities as a result of the Business Combination.
Legacy Shapeways has been treated as the accounting acquirer based on evaluation of the following facts and circumstances with regard to the Company as of the Closing:
 
 
 
Legacy Shapeways’ directors represented the majority of the new board of directors of the Company;
 
 
 
The executive officers and senior management of Legacy Shapeways are the executive officers and senior management of the Company;
 
 
 
The assets of Legacy Shapeways represent a significant majority of the assets of the Company (excluding cash formerly held in the Galileo trust account); and
 
6

SHAPEWAYS HOLDINGS, INC.
NOTES TO THE UNAUDITED CONDENSED CONSOLIDATED FINANCIAL STATEMENTS
(in thousands, except share and per share amounts)
 
   
The business of the Company will be the continued business of Legacy Shapeways. The business of the Company will continue to focus on Legacy Shapeways’ core offerings related to the facilitation of the sale, design and manufacturing of 3D printed items.
The consolidated assets, liabilities and results of operations prior to the Reverse Recapitalization are those of Legacy Shapeways. The shares and corresponding capital amounts and losses per share, prior to the Merger, have been retroactively adjusted based on shares reflecting the conversion ratio (as defined below) established in the Merger.
Use of Estimates
The preparation of the Company’s
unaudited
condensed consolidated financial statements, in conformity with U.S. GAAP, requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the condensed consolidated financial statements and reported amounts of revenues and expenses during the reporting period. Actual results may differ from those estimates.
In March 2020, the World Health Organization declared the outbreak of a novel coronavirus
(COVID-19)
as a pandemic, which continues to spread throughout the United States. While the disruption is currently expected to be temporary, there is uncertainty around the duration. The Company has considered information available to it as of the date of issuance of these unaudited condensed consolidated financial statements and is not aware of any specific events or circumstances that would require an update to its estimates or judgements, or an adjustment to the carrying value of its assets or liabilities. The accounting estimates and other matters assessed include, but were not limited to, goodwill and other long-lived assets, warrant liabilities and revenue recognition. These estimates may change as new events occur and additional information becomes available. Actual results could differ materially from these estimates.
Functional Currency
The local currency is the functional currency for Shapeways BV’s (a
wholly
-owned subsidiary of the Company) operations outside the United States. Assets and liabilities of these operations are translated into U.S. Dollars at the exchange rate in effect at the end of each period. Income statement accounts are translated at the average exchange rate prevailing during the period. Translation adjustments arising from the use of differing exchange rates from period to period are included as a component of other comprehensive loss within stockholders’ equity (deficit). Gains and losses from foreign currency transactions are included in net loss for the period.
Cash, Cash Equivalents
and
Restricted Cash
Cash includes cash on hand and demand deposits. The Company maintains its deposits at high quality financial institutions and monitors the credit ratings of those institutions. The Company considers all highly liquid investments with original maturities of three months or less to be cash equivalents. While cash held by financial institutions may at times exceed federally insured
limits
, the Company believes that no material credit or market risk exposure exists due to the high quality of the institutions. The Company has not experienced any losses on such accounts. Restricted cash represents cash required to be held as collateral for the Company’s credit cards and security deposit for our facility in the Netherlands. Accordingly, these balances contain restrictions as to their availability and usage and are classified as restricted cash in the condensed consolidated balance sheets.
The reconciliation of cash, cash equivalents and restricted cash reported within the applicable consolidated balance sheet that sum to the total of the same such amount shown in the condensed consolidated statements of cash flows is as follows:
 
 
  
September 30, 2021
 
  
December 31, 2020
 
Cash and cash equivalents
   $ 90,108      $ 8,564  
Restricted cash
     143        145  
    
 
 
    
 
 
 
     $ 90,251      $ 8,709  
    
 
 
    
 
 
 
Accounts Receivable
Accounts receivables are recorded at the invoiced amount and are generally unsecured as they are uncollateralized. The Company provides an allowance for doubtful accounts to reduce receivables to their estimated net realizable value. Judgement is exercised in establishing allowances and estimates are based on the customers’ payment history and liquidity. Any amounts that were previously recognized as revenue and subsequently determined to be uncollectible are charged to bad debt expense included in selling, general and administrative expense in the accompanying condensed consolidated statements of operations and comprehensive loss. Given the nature and historical collectability of the Company’s accounts receivable, an allowance for doubtful accounts was not deemed necessary at September 30, 2021 and December 31, 2020.
 
7

SHAPEWAYS HOLDINGS, INC.
NOTES TO THE UNAUDITED CONDENSED CONSOLIDATED FINANCIAL STATEMENTS
(in thousands, except share and per share amounts)
 
Inventory
Inventory consists of raw materials, work in progress and finished goods at the Company’s distribution center. Raw materials are stated at the lower of cost or net realizable value, determined by the
first-in-first-out
method. Finished goods and work in progress are valued using a methodology to determine the cost of each 3D printed object using allocations for material, labor, machine time and overhead. The Company periodically reviews its inventory for slow-moving, damaged and discontinued items and provides allowances to reduce such items identified to their recoverable amounts. As of September 30, 2021 and December 31, 2020, the Company determined an allowance was not deemed necessary.
Property and Equipment, net
Property and equipment are stated at cost, less accumulated depreciation. Maintenance and repairs are charged to expense when incurred. Additions and improvements that extend the economic useful life of the asset are capitalized and depreciated over the remaining useful lives of the assets. The cost and accumulated depreciation of assets sold or retired are removed from the respective accounts, and any resulting gain or loss is reflected in current earnings. No impairment charges were recorded for the periods ended September 30, 2021 and December 31, 2020. Depreciation is recognized using the straight-line method in amounts considered to be sufficient to allocate the cost of the assets to operations over the estimated useful lives or lease terms, as follows:
 
Asset Category
  
Depreciable Life
Machinery and equipment
   5 years
Computers and IT equipment
   3 years
Furniture and fixtures
   7 years
Leasehold improvements
   **
 
**
Leasehold improvements are amortized using the straight-line method over the shorter of the lease term or estimated useful life of the asset.
Long-Lived Assets, Including Definite-Lived Intangible Assets
Intangible assets, which consist of technology, customer relationships, and trademarks, are stated at cost less accumulated amortization. Amortization is generally recorded on a straight-line basis over estimated useful lives ranging from three to eight years. The Company periodically reviews the estimated useful lives of intangible assets and adjusts when events indicate that a shorter life is appropriate. In accordance with authoritative accounting guidance, capitalization of costs to develop software begin when preliminary development efforts are successfully and completed. Costs related to the design or maintenance of
internal-use
software are expensed as incurred.
Long-lived assets, other than goodwill and other indefinite-lived intangibles, are evaluated for impairment whenever events or changes in circumstances indicate that the carrying amount of the assets may not be recoverable through the estimated undiscounted future cash flows derived from such assets.
Factors that the Company considers in deciding when to perform an impairment review include significant changes in the Company’s forecasted projections for the asset or asset group for reasons including, but not limited to, significant underperformance of a product in relation to expectations, significant changes, or planned changes in the Company’s use of the assets, significant negative industry or economic trends, and new or competing products that enter the marketplace. The impairment test is based on a comparison of the undiscounted cash flows expected to be generated from the use of the asset group. If impairment is indicated, the asset is written down by the amount by which the carrying value of the asset exceeds the related fair value of the asset with the related impairment charge recognized within the statements of operations and comprehensive loss. No impairment charges were recorded for the periods ended September 30, 2021 and December 31, 2020.
Goodwill
Goodwill, which represents the excess of purchase prices over the fair value of net assets acquired, is carried at cost. Goodwill is not amortized; rather, it is subject to a periodic assessment for impairment by applying a fair value-based test. Goodwill is evaluated for impairment on an annual basis at a level of reporting referred to as the reporting unit, and more frequently if adverse events or changes in circumstances indicate that the asset may be impaired.
Under ASC 350,
Intangibles - Goodwill and Other
,
the Company has the option to first assess the qualitative factors to determine whether it is more likely than not that the fair value of the reporting unit is less than its carrying amount as a basis for determining whether it is necessary to perform a quantitative goodwill impairment test. If the Company determines that it is more likely than not that
 
8

SHAPEWAYS HOLDINGS, INC.
NOTES TO THE UNAUDITED CONDENSED CONSOLIDATED FINANCIAL STATEMENTS
(in thousands, except share and per share amounts)
 
the fair value of a reporting unit is less than its carrying amount, then the goodwill impairment test is performed. Impairment tests are performed, at a minimum, in the fourth quarter of each year. Management uses the future discounted cash flows valuation approach to determine the fair value of reporting units and determines whether the fair value of reporting units exceeded its carrying amounts. If the fair value exceeds the carrying amount, then no impairment is recognized. If the carrying amount recorded exceeds the fair value calculated, then an impairment charge is recognized for the difference. The impairment review requires management to make judgments in determining various assumptions with respect to revenues, operating margins, growth rates and discount rates. The judgments made in determining the projected cash flows used to estimate the fair value can materially impact the Company’s financial condition and results of operations. There was no impairment of goodwill as of September 30, 2021 or December 31,
2020
.
Fair Value Measurements
The Company applies ASC 820,
Fair Value Measurement
(“ASC 820”), which establishes framework for measuring fair value and clarifies the definition of fair value within that framework. ASC 820 defines fair value as an exit price, which is the price that would be received for an asset or paid to transfer a liability in the Company’s principal or most advantageous market in an orderly transaction between market participants on the measurement date. The fair value hierarchy established in ASC 820 generally requires an entity to maximize the use of observable inputs and minimize the use of unobservable inputs when measuring fair value. Observable inputs reflect the assumptions that market participants would use in pricing the asset or liability and are developed based on market data obtained from sources independent of the reporting entity. Unobservable inputs reflect the entity’s own assumptions based on market data and the entity’s judgments about the assumptions that market participants would use in pricing the asset or liability and are to be developed based on the best information available in the circumstances.
The valuation hierarchy is composed of three levels. The classification within the valuation hierarchy is based on the lowest level of input that is significant to the fair value measurement. The levels within the valuation hierarchy are described below:
Level 1
-
Assets and liabilities with unadjusted, quoted prices listed on active market exchanges. Inputs to the fair value measurement are observable inputs, such as quoted prices in active markets for identical assets or liabilities.
Level 2
-
Inputs to the fair value measurement are determined using prices for recently traded assets and liabilities with similar underlying terms, as well as direct or indirect observable inputs, such as interest rates and yield curves that are observable at commonly quoted intervals.
Level 3
-
Inputs to the fair value measurement are unobservable inputs, such as estimates, assumptions, and valuation techniques when little or no market data exists for the assets or liabilities.
Revenue Recognition
Revenue is derived from two primary sources: a) products and services and b) software.
The Company recognizes revenue following the five-step model prescribed under ASC 606: (i) identify contract(s) with a customer; (ii) identify the performance obligation(s) in the contract; (iii) determine the transaction price; (iv) allocate the transaction price to the performance obligation(s) in the contract; and (v) recognize revenue when (or as) the Company satisfies a performance obligation. The Company only applies the five-step model to contracts when it is probable that the Company will collect the consideration it is entitled to in exchange for the products or services it transfers to the customer. These contracts have different terms based on the scope, performance obligations, and complexity of the project, which often requires us to make judgments and estimates in recognizing revenues.
Performance obligations are satisfied both at a
point
of time and over time. All revenue is recognized based on the satisfaction of the performance obligation to date (see Note 4).
Leases
The Company’s lease arrangements relate primarily to office and manufacturing space, and equipment. The Company’s leases generally have initial terms ranging from 5 to 10 years and may include renewal options and rent escalation clauses. The Company is typically required to make fixed minimum rent payments relating to its right to use an underlying leased asset. Additionally, the Company’s leases do not contain significantly restrictive covenants or residual value guarantees.
The Company determines if an arrangement is a lease at inception and classifies its leases at commencement. Operating leases are presented as
right-of-use
(“ROU”) assets and the corresponding lease liabilities are included in operating lease liabilities, current and operating lease liabilities on the Company’s condensed consolidated balance sheets. The Company does not currently maintain any finance lease
 
9

SHAPEWAYS HOLDINGS, INC.
NOTES TO THE UNAUDITED CONDENSED CONSOLIDATED FINANCIAL STATEMENTS
(in thousands, except share and per share amounts)
 
arrangements. ROU assets represent the Company’s right to use an underlying asset, and lease liabilities represent the Company’s obligation for lease payments in exchange for the ability to use the asset for the duration of the lease term. The Company does not recognize short term leases that have a term of twelve months or less as ROU assets or lease liabilities. The Company’s short-term leases are not material and do not have a material impact on its ROU assets or lease liabilities.
ROU assets and lease
liabilities
are recognized at commencement date and determined using the present value of the future minimum lease payments over the lease term. The Company uses an incremental borrowing rate based on estimated rate of interest for collateralized borrowing since the Company’s leases do not include an implicit interest rate. The estimated incremental borrowing rate considers market data, actual lease economic environment, and actual lease term at commencement date. The lease term may include options to extend when it is reasonably certain that the Company will exercise that option. ROU assets include lease payments made in advance, and excludes any incentives received or initial direct costs incurred. The Company recognizes lease expense on a straight-line basis over the lease term
The Company has lease agreements which contain both lease and
non-lease
components, which it has elected to account for as a single lease component. As such, minimum lease payments include fixed payments for
non-lease
components within a lease agreement, but exclude variable lease payments not dependent on an index or rate, such as common area maintenance, operating expenses, utilities, or other costs that are subject to fluctuation from period to period.
Stock-based Compensation
The Company recognizes stock-based compensation expense for all options and other arrangements within the scope of ASC 718,
Stock Compensation
. Stock-based compensation expense is measured at the date of grant, based on the fair value of the award, and is recognized using the straight-line method over the employee’s requisite service period. Compensation for stock-based awards with vesting conditions other than service are recognized at the time that those conditions will be achieved. Forfeitures are recognized as they are incurred.
Public and Private Common Stock Warrant Liabilities
As part of Galileo’s initial public offering, Galileo issued to third party investors 13,800,000 units, consisting of one ordinary share of Galileo and one warrant, at a price of $10.00 per unit. Each whole warrant entitles the holder to purchase one share of 
C
ommon
S
tock at an exercise price of $11.50 per share (the “Public Warrants”). Simultaneously with the closing of Galileo’s initial public offering, Galileo completed the private sale of 4,110,000 warrants to Galileo’s sponsor and EarlyBirdCapital, Inc. at a purchase price of $1.00 per warrant (the “Private Warrants”). In connection with the Business Combination, Galileo’s sponsor exercised its right to convert the aggregate outstanding principal amount of the convertible promissory note issued by Galileo into an aggregate of 500,000 Sponsor Warrants, with terms equivalents to the Private Warrants.
The Private Warrants are
identical
to the Public Warrants, except that the Private Warrants (i) will not be redeemable by the Company and (ii) may be exercised for cash or on a cashless basis, so long as they are held by the initial purchaser or any of its permitted transferees. If the Private Warrants are held by holders other than the initial purchasers or any of their permitted transferees, the Private Warrants will be redeemable by the Company and exercisable by the holders on the same basis as the Public Warrants.
The Company evaluated the Public and Private Warrants under ASC
815-40,
Derivatives and Hedging—Contracts in Entity’s Own Equity
(“ASC
815-40”),
and concluded that the Private Warrants do not meet the criteria to be classified in stockholders’ equity. Since the Private Warrants meet the definition of a derivative under ASC 815, the Company recorded these warrants as liabilities on the condensed consolidated balance sheet at fair value, with subsequent changes in their respective fair values recognized in the condensed consolidated statement of operations at each reporting date.
Research and Development Costs
Research and development expenses consist primarily of allocated personnel costs, fees paid to consultants and outside service providers, and allocations for rent and overhead. Research and development costs are expensed as incurred. Advance payments for goods and services that will be used in future research and development activities are expensed when the activity has been performed or when the goods have been received. For the three months ended September 30, 2021 and 2020, research and development costs were $1,673 and $1,516, respectively. For the nine months ended September 30, 2021 and 2020, research and development costs were $4,099 and $4,289, respectively.
 
10

SHAPEWAYS HOLDINGS, INC.
NOTES TO THE UNAUDITED CONDENSED CONSOLIDATED FINANCIAL STATEMENTS
(in thousands, except share and per share amounts)
 
Advertising
Advertising costs are expensed as incurred. For the three months ended September 30, 2021 and 2020, advertising costs were $568 and $123, respectively. For the nine months ended September 30, 2021 and 2020, advertising costs were $1,008 and $353, respectively, which are included in selling, general and administrative expense on the
 condensed
consolidated statements of operations and comprehensive loss.
Income Taxes
The Company files income tax returns in
the
U.S. federal jurisdiction and various state jurisdictions. Income taxes are accounted for under the asset and liability method. Deferred tax assets and liabilities are recognized for the estimated future tax consequences attributable to differences between the financial statement carrying amounts of existing assets and liabilities and their respective tax bases. Deferred tax assets and liabilities are measured using enacted tax rates in effect for the year in which those temporary differences are expected to be recovered or settled. Where applicable, the Company records a valuation allowance to reduce any deferred tax assets that it determines will not be realizable in the future.
The Company recognizes the benefit of an uncertain tax position that it has taken or expects to take on income tax returns it files if such tax position is more likely than not to be sustained on examination by the taxing authorities, based on the technical merits of the position. These tax benefits are measured based on the largest benefit that has a greater than 50% likelihood of being realized upon ultimate resolution. Although the Company believes that i
t
 has adequately reserved for uncertain tax positions (including interest and penalties), it can provide no assurance that the final tax outcome of these matters will not be materially different. The Company makes adjustments to these reserves in accordance with the income tax accounting guidance when facts and circumstances change, such as the closing of a tax audit or the refinement of an estimate. To the extent that the final tax outcome of these matters is different than the amounts recorded, such differences will affect the provision for income taxes in the period in which such determination is made, and could have a material impact on the Company’s financial condition and operating results. Carryforward attributes that were generated in tax years prior to those that remain open for examination may still be adjusted by relevant tax authorities upon examination if they either have been, or will be, used in a future period.
In applying the estimated annual effective tax rate approach prescribed under ASC 740,
Income Taxes,
based on present evidence and conclusions around the realizability of deferred tax assets, we determined that any deferred tax benefits related to the forecasted tax rate and pretax activity during the three and nine months ended September 30, 2021 and 2020 are neither more likely than not to be realized in the current year, nor realizable as a deferred tax asset at the end of the year. Therefore, the appropriate amount of income tax benefit to recognize related to deferred tax assets during the three and nine months ended September 30, 2021 and 2020 is zero. The Company’s effective tax rate of
(1.78)%
for the nine months ended September 30, 2021 differs from the applicable statutory tax rate primarily due to the fact that income recognized for the forgiveness of loans granted under the PPP loan program and changes in the fair value of warrant liabilities are not taxable under current U.S. tax law.
Income (Loss) per Share
In accordance with the provisions of ASC 260,
Earnings Per Share
, net income (loss) per common share is computed by dividing net income (loss) by the weighted-average shares of Common Stock outstanding during the period. Basic income (loss) per share is computed by dividing net income (loss) attributable to common stockholders by the weighted average number of shares outstanding during the period. Diluted income (loss) per share gives effect to all dilutive potential common shares outstanding during the period including stock options and warrants, using the treasury stock method, and convertible debt and convertible securities, using the
if-converted
method. During a loss period, the effect of the potential exercise of stock options and convertible debt are not considered in the diluted loss per common share calculation since the effect would be anti-dilutive.
The following outstanding shares of Common Stock equivalents were excluded from the computation of the diluted net loss per share attributable to Common Stock for the periods in which a net loss is presented because their effect would have been anti-dilutive:
 
    
Three Months Ended
September 30,
    
Nine Months Ended
September 30,
 
    
2021
    
2020
    
2021
    
2020
 
Common stock warrants
     18,410,000                  18,410,000            
Earnout Shares
     3,510,405                  3,510,405            
Included in income (loss) per common share are 
4,833,059 and 3,673,963 shares of
options
due to their nominal exercise prices as of September 30, 2021 and 2020, respectively.
Segment Information
The Company has determined that it operates and reports in one segment, which focuses on providing additive manufacturing services to customers. The Company’s operating segment is reported in a manner consistent with the internal reporting provided to the chief operating decision maker (“CODM”). The Company’s CODM has been identified as its Chief Executive Officer.
 
11

SHAPEWAYS HOLDINGS, INC.
NOTES TO THE UNAUDITED CONDENSED CONSOLIDATED FINANCIAL STATEMENTS
(in thousands, except share and per share amounts)
 
Recent Accounting Pronouncements
Accounting Pronouncements Recently Adopted
In January 2017, the FASB issued Accounting Standard Update (“ASU”)
No. 2017-04,
Intangibles—Goodwill and Other (Topic 350): Simplifying the Test for Goodwill Impairment,
which aims to simplify the subsequent measurement of goodwill by eliminating Step 2 from the goodwill impairment test. Under the new guidance, goodwill impairment will be measured as the amount by which the carrying value exceeds the fair value. The loss recognized should not exceed the total amount of goodwill allocated to the reporting unit. The standard is effective for annual and interim reporting periods beginning after December 15, 2021. Early adoption is permitted. The Company adopted ASU
2017-04
effective January 1, 2021. The adoption of this standard did not have a significant impact on the Company’s condensed consolidated financial statements.
In December 2019, the FASB issued ASU
No. 2019-12,
Income Taxes (Topic 740): Simplifying the Accounting for Income Taxes
. The purpose of Update
No. 2019-12
is to continue the FASB’s Simplification Initiative to reduce complexity in accounting standards. The amendments in Update
No. 2019-12
simplify the accounting for income taxes by removing certain exceptions related to the incremental approach for intraperiod tax allocation, the requirement to recognize or derecognize deferred tax liabilities related to equity method investments that are also foreign subsidiaries, and the methodology for calculating income taxes in an interim period. In addition to removing these exceptions, Update
No. 2019-12
also clarifies and simplifies other aspects of the accounting for income taxes. The Company adopted ASU
2019-12
effective January 1, 2021. The adoption of this standard did not have a significant impact on the Company’s condensed consolidated financial statements.
In August 2020, the FASB issued ASU
2020-06,
Debt — Debt with Conversion and Other Options (Subtopic
470-20)
and Derivatives and Hedging — Contracts in Entity’s Own Equity (Subtopic
815-40):
Accounting for Convertible Instruments and Contracts in an Entity’s Own Equity
, which simplifies the accounting for convertible instruments by removing certain separation models in Subtopic
470-20,
Debt—Debt with Conversion and Other Options, for convertible instruments and also increases information transparency by making disclosure amendments. The standard is effective for fiscal years beginning after December 15, 2023, including interim periods within those fiscal years. Early adoption is permitted, but no earlier than fiscal years beginning after December 15, 2020, including interim periods within those fiscal years. The Company adopted ASU
2020-06
effective January 1, 2021. The adoption of this standard did not have a significant impact on the Company’s condensed consolidated financial statements.
In August 2018, the FASB issued ASU
No. 2018-15,
Intangibles – Goodwill and Other –
Internal-Use
Software (Subtopic
350-40):
Customer’s Accounting for Implementation Costs Incurred in a Cloud Computing Arrangement That Is a Service Contract
, which aligns the requirements for capitalizing implementation costs incurred in a hosting arrangement that is a service contract with the requirements for capitalizing implementation costs incurred to develop or obtain
internal-use
software (and hosting arrangements that include an
internal-use
software license). The standard is effective for annual reporting periods beginning after December 15, 2020 and interim periods within annual periods beginning after December 15, 2021. Early adoption is permitted. The Company adopted ASU 2018-15 effective January 1, 2021. The adoption of this standard did not have a significant impact on the Company’s condensed consolidated financial statements.
Accounting Pronouncements Not Yet Adopted
In June 2016, the FASB issued ASU No. 2016-13, Accounting for Credit Losses (Topic 326), which requires the use of an “expected loss” model on certain types of financial instruments. The standard also amends the impairment model for available-for-sale debt securities and requires estimated credit losses to be recorded as allowances instead of reductions to amortized cost of the securities. Update No. 2016-13 is effective for annual periods beginning after December 15, 2022, including interim periods within those annual periods. Early adoption is permitted, including adoption in an interim period. The Company is currently evaluating the impact the standard will have on its condensed consolidated financial statements.
Note 3. Reverse Recapitalization
As discussed in Note 1, on September 29, 2021, Galileo closed the Business Combination with Shapeways, Inc., as a result of which Legacy Shapeways became a wholly-owned subsidiary of Galileo. While Galileo was the legal acquirer of Legacy Shapeways in the business combination, for accounting purposes, the Business Combination is treated as a Reverse Recapitalization, whereby Legacy Shapeways is deemed to be the accounting acquirer, and the historical financial statements of Legacy Shapeways became the historical financial statements of Galileo upon the closing of the Business Combination. Under this method of accounting, Galileo was treated as the “acquired” company and Legacy Shapeways is treated as the acquirer for financial reporting purposes. Accordingly, for accounting purposes, the Business Combination was treated as the equivalent of Legacy Shapeways issuing stock for the net assets of Galileo, accompanied by a recapitalization. The net assets of Galileo were stated at historical cost, with no goodwill or other intangible assets recorded.
 
12

SHAPEWAYS HOLDINGS, INC.
NOTES TO THE UNAUDITED CONSOLIDATED FINANCIAL STATEMENTS
(in thousands, except share and per share amounts)
 
At the closing of the Business Combination, (1) all outstanding shares of Legacy Shapeways’ preferred stock (including shares of Legacy Shapeways’ preferred stock issuable upon conversion of Legacy Shapeways’ convertible notes outstanding as of the Closing) and Shapeways’ common stock were converted into an aggregate of 35,104,836 shares of Common Stock of the Company, par value $0.0001 per share, representing aggregate consideration value equal to $406,000 (the “Merger Consideration”), 3,510,405
shares of which are subject to the Earnout Terms (as defined below, and such shares, the “Earnout Shares”), (2) options to purchase Legacy Shapeways’ common stock (whether vested or unvested, exercisable or unexercisable) issued pursuant to the Legacy Shapeways 2010 Stock Plan, as amended (the “2010 Stock Plan”), and outstanding immediately prior to the Closing were assumed and converted into (a) options to purchase an aggregate of
 
4,901,207
shares of Common Stock under the
2021
Equity Incentive Plan (the “Incentive Plan”) and (b) in the case of
in-the-money
options held by individuals who were service providers as of the Closing Date, an aggregate of
493,489
restricted stock units denominated in a number of shares of Common Stock (“Earnout RSUs”) granted under the Incentive Plan, which Earnout RSUs are subject to the earnout vesting and forfeiture conditions described in the Merger Agreement,
(3)
 all warrants to purchase Legacy Shapeways’ common stock and Shapeways’ preferred stock outstanding immediately prior to the Closing were exercised in full and converted into shares of Legacy Shapeways preferred stock or Legacy Shapeways common stock, as applicable, in accordance with their terms, and each such share of Legacy Shapeways preferred stock and Legacy Shapeways common stock issued upon the exercise of such warrants was converted into an aggregate of
301,750
shares of Common Stock (for the avoidance of doubt, such shares of Common Stock are included in the aggregate shares of Common Stock described in clause
(1)
 above) and
(4)
 any Legacy Shapeways
non-plan
options outstanding immediately prior to Closing were cancelled without payment in accordance with the terms described in the Merger Agreement.
At the Closing, there were 3,510,405 shares of Common Stock issued as part of the Merger Consideration (the “Stockholder Merger Consideration” and/or “Earnout Shares”) subject to vesting and forfeiture conditions (the “Earnout Terms”) based upon the
volume-weighted average
trading price of Common Stock reaching targets of $14.00 and $16.00, respectively (with 50% released at each target) for a period of 30 consecutive trading days during the three-year period after the Closing, with the portion of such shares that would otherwise be deliverable to Shapeways Stockholders at the Closing being withheld and deposited into escrow. A pro rata portion of the Stockholder Merger Consideration earnout has also been allocated to Legacy Shapeways options and warrants that, as of the Closing, have been exchanged for options and warrants (as applicable) exercisable for shares of Common Stock (as described below).
Legacy Shapeways options issued pursuant to Legacy Shapeways’ 2010 Stock Plan that were not exercised prior to the Closing have been assumed by the Company and converted, subject to certain adjustments that are described in the Merger Agreement, into options exercisable for shares of Common Stock and, in the case of
in-the-money
Legacy Shapeways options held by individuals remaining in continuous service to the Company through the Closing, a right to receive an award of restricted stock units (“RSUs”) denominated in shares of Common Stock that are subject to the Earnout Terms and to service-based vesting and forfeiture restrictions. As a result of the Closing, outstanding Legacy Shapeways Convertible Notes were converted into shares of Legacy Shapeways Preferred Stock at the election of the holders thereof, which were then converted into shares of Shapeways Common Stock prior to the Closing
Simultaneously with the execution of the Business Combination, Galileo entered into subscription agreements (collectively, the “Subscription Agreements”) pursuant to which certain investors agreed to purchase an aggregate of 7,500,000 shares of Common Stock for a purchase price of $10.00 per share and $75,000,000 in the aggregate (the “PIPE Investment”). At the Closing, the Company consummated the PIPE Investment.
The following table reconciles the elements of the Business Combination to the unaudited condensed consolidated statement of cash flows for the nine months ended September 30, 2021:
 
    
Recapitalization
 
Cash - Galileo trust and cash, net of redemption
   $ 28,115  
Cash - PIPE Investment, net of transaction costs
     75,000  
Less: transaction costs and advisory fees allocated to equity
     (16,323
    
 
 
 
Effect of Merger, net of redemption, transaction costs and advisory costs
   $ 86,792  
    
 
 
 
 
13

SHAPEWAYS HOLDINGS, INC.
NOTES TO THE UNAUDITED CONSOLIDATED FINANCIAL STATEMENTS
(in thousands, except share and per share amounts)
 
The following table reconciles the elements of the Business Combination to the unaudited condensed consolidated statement of changes in stockholders’ equity (deficit) for the three and nine months ended September 30, 2021:
 
    
Recapitalization
 
Cash - Galileo trust and cash, net of redemption
   $ 28,115  
Non-cash
net working capital assumed from Galileo
     46  
Less: fair value of Private and Sponsor Warrant liabilities
     (11,865
Less: transaction costs and advisory fees allocated to equity
     (6,260
    
 
 
 
Effect of Merger, net of redemption, transaction costs and advisory costs
   $ 10,036  
    
 
 
 
         
The following table details the number of shares of Common Stock issued immediately following the consummation of the Business Combination:
 
    
Number of Shares
 
Common stock, outstanding prior to Business Combination
     13,800,000  
Less: redemption of Galileo shares
     (11,018,352
    
 
 
 
Common stock of Galileo
     2,781,648  
Galileo founder and representative shares, net of forfeited shares
     2,910,000  
Shares issued in PIPE Investment
     7,500,000  
    
 
 
 
Merger and PIPE Investment - common stock
     13,191,648  
Legacy Shapeways shares - common stock
(1)
     35,104,836  
    
 
 
 
Total shares of common stock immediately after Business Combination
     48,296,484  
    
 
 
 
 
(1)
Includes 3,510,405 Earnout Shares
Note 4. Revenue Recognition
Under ASC 606, revenue is recognized throughout the life of the executed agreement. The Company measures revenue based on consideration specified in a contract with a customer. Furthermore, the Company recognizes revenue when a performance obligation is satisfied by transferring control of the product or service to the customer which could occur over time or at a point in time.
A performance obligation is a promise in a contract to transfer a distinct service to the customer. The transaction price of a contract is allocated to each distinct performance obligation and recognized as revenue when or as the customer receives the benefit of the performance obligation. Customers typically receive the benefit of the Company’s services as (or when) they are performed. Substantially all customer contracts provide that compensation is received for services performed to date. Taxes assessed by a governmental au
thority that are both imposed on and concurrent with a specific revenue-producing transaction, that are collected by us from a customer, are excluded from revenue.
Nature of Products and Services
The following is a description of the Company’s
products
and
services
from which the Company generates revenue, as well as the nature, timing of satisfaction of performance obligations, and significant payment terms for each:
Direct sales
The Company provides customers with an additive manufacturing service, allowing for the customer to select the specifications of the model which they wish to have printed. Shapeways prints the 3D model and ships the product directly to the customer.
The Company recognizes the sale of shop owner products through their
e-commerce
website over time using the output method. Contracts involving the sale of shop owner products through their
e-commerce
website do not include other performance obligations. As such, allocation of the transaction price was not necessary as the entire contract price is attributed to the sole performance obligation identified.
Marketplace sales
The Company provides a platform for shop owners to sell their products to customers through Shapeways’ marketplace website. Shapeways receives a 3.5% markup fee from the shop owner upon the sale of any products through the marketplace.
 
14

SHAPEWAYS HOLDINGS, INC.
NOTES TO THE UNAUDITED CONSOLIDATED FINANCIAL STATEMENTS
(in thousands, except share and per share amounts)
 
The Company handles the financial transaction, manufacturing, distribution and customer service on behalf of the shop owners. The Company is responsible for billing the customer in this arrangement and transmitting the applicable fees to the shop owner. The Company assessed whether it is responsible for providing the actual product or service as a principal, or for arranging for the product or service to be provided by the third party as an agent. Judgment is applied to determine whether the Company is the principal or the agent by evaluating whether it has control of the product or service prior to it being transferred to the customer. The principal versus agent assessment is performed at the performance obligation level. Indicators that the Company has considered include whether it has the primary responsibility for fulfilling the promise to provide the specified product or service to the customer and whether it has inventory risk prior to transferring the product or service to the customer. The Company has the responsibility to fulfill the promise to provide the specific good or service on behalf of the shop owners to the customer. In addition, the Company has inventory risk before the specific good or service is transferred to a customer. As such, the Company is deemed the principal and shall recognize revenue on a gross basis for the price it charges to the shop owner for each product or service.
The Company recognizes the sale of 3D products to customers at a point in time, specifically upon shipping the goods to the customer (FOB Origin) given the transfer of significant risks and rewards of ownership at that point in time. Contracts involving the manufacturing and delivery of 3D printed products to customers do not include other performance obligations. As such, allocation of the transaction price was not necessary as the entire contract price is attributed to the sole performance obligation identified.
Software revenue
In 2020, Shapeways launched their software under the brand of “Powered by Shapeways” to a limited set of design customers to gain feedback on product market fit. The software enables other manufacturers to leverage Shapeways’ existing end-to-end manufacturing software to scale their businesses and shift to digital manufacturing. 
For each of the performance obligations classified as software revenue, the performance obligations are satisfied evenly over the term of the contract. For contracts including performance obligations classified as software revenue, the Company identified that each performance obligation has an explicitly stated standalone selling price. As such, allocation is not necessary as the prices included in the contract are attributed to each separate performance obligation.
The following table presents our revenues disaggregated by revenue discipline:
 
    
Three Months Ended
September 30,
    
Nine Months Ended
September 30,
 
    
2021
    
2020
    
2021
    
2020
 
Major products/service lines:
                                   
Direct sales
   $ 5,985      $ 5,994      $ 19,068      $ 16,827  
Marketplace sales
     1,663        2,091        6,062        6,060  
Software
     68        22        224        141  
    
 
 
    
 
 
    
 
 
    
 
 
 
Total revenue
   $ 7,716      $ 8,107      $ 25,354      $ 23,028  
    
 
 
    
 
 
    
 
 
    
 
 
 
Timing of revenue recognition:
                                   
Products transferred at a point in time
   $ 1,663      $ 2,091      $ 6,062      $ 6,060  
Products and services transferred over time
     6,053        6,016        19,292        16,968  
    
 
 
    
 
 
    
 
 
    
 
 
 
Total revenue
   $ 7,716      $ 8,107      $ 25,354      $ 23,028  
    
 
 
    
 
 
    
 
 
    
 
 
 
Deferred Revenue
The Company records deferred revenue when cash payments are received in advance of performance.
 
15

SHAPEWAYS HOLDINGS, INC.
NOTES TO THE UNAUDITED CONSOLIDATED FINANCIAL STATEMENTS
(in thousands, except share and per share amounts)
 
Deferred revenue activity consisted of the following for the nine months ended September 30, 2021:
 
    
Deferred Revenue
 
Balance at January 1, 2021
   $ 753  
Deferred revenue recognized during period
     (25,354
Additions to deferred revenue during period
     25,259  
    
 
 
 
Balance at September 30, 2021
   $ 658  
    
 
 
 
The Company expects to satisfy its remaining performance obligations within the next twelve months. The $753 of deferred revenue as of January 1, 2021 was recognized during the nine months ended September 30, 2021. The opening balance of accounts receivable as of January 1, 2020 was $151.
Practical Expedients and Exemptions
We apply the practical expedient related to incremental costs of obtaining a contract. Although certain of our commission costs qualify for capitalization under ASC
340-40,
Contracts with customers, their amortization period is less than one year. Therefore, utilizing the practical expedient, we expense these costs as incurred.
Note 5. Inventory
Components of inventory consisted of the following:
 
    
September 30,
2021
    
December 31,
2020
 
Raw materials
   $ 418      $ 521  
Work-in-process
     40        36  
Finished goods
     115        170  
    
 
 
    
 
 
 
Total
   $ 573      $ 727  
    
 
 
    
 
 
 
Note 6. Prepaid Expenses and Other Current Assets
Prepaid expenses and other current assets consisted of the following:
 
    
September 30,
2021
    
December 31,
2020
 
Prepaid expenses
   $ 698      $ 646  
Security deposits
     259        259  
VAT receivable
     950        975  
Other current assets
     1        30  
    
 
 
    
 
 
 
Total
   $ 1,908      $ 1,910  
    
 
 
    
 
 
 
Note 7. Property and Equipment, net
Property and equipment consisted of the following:
 
    
September 30,
2021
    
December 31,
2020
 
Machinery and equipment
   $ 1,388      $ 1,430  
Computers and IT equipment
     5,631        5,193  
Furniture and fixtures
     49        50  
Leasehold improvements
     2,477        2,520  
    
 
 
    
 
 
 
       9,545        9,193  
Less: Accumulated depreciation
     (8,455      (8,245
    
 
 
    
 
 
 
Property and equipment, net
   $ 1,090      $ 948  
    
 
 
    
 
 
 
 
16

SHAPEWAYS HOLDINGS, INC.
NOTES TO THE UNAUDITED CONSOLIDATED FINANCIAL STATEMENTS
(in thousands, except share and per share amounts)
 
For the three months ended September 30, 2021 and 2020, depreciation expense totaled $146 and $115, respectively. For the nine months ended September 30, 2021 and 2020, depreciation expense totaled $424 and $362, respectively. Of these amounts, depreciation charged to cost of revenue was $113 and $78 for the three months ended September 30, 2021 and 2020, respectively, and $324 and $249 for the nine months ended September 30, 2021 and 2020, respectively.
Note 8. Accrued Expenses and Other Liabilities
Accrued expenses consisted of the following:
 
 
  
September 30,
2021
 
  
December 31,
2020
 
Accrued selling expenses
   $ 712      $ 947  
Accrued compensation
     757        876  
Interest payable
     —          612  
Taxes payable
     306        477  
Accrued transaction costs
  
 
450
 
  
 
—  
 
Accrued acquisition of property and equipment
     441        —    
Shapeways credits
     300        313  
Other
     734        94  
    
 
 
    
 
 
 
Total
   $ 3,700      $ 3,319  
    
 
 
    
 
 
 
Note 9. Commitments and Contingencies
Leases
During the
three
a
nd
nine months ended September 30, 2021, the Company maintained three leases of facilities located in the United States and the Netherlands, as well as, one lease of office equipment, under operating leases. The Company maintained one additional lease of equipment under a finance lease arrangement which expired during the nine months ended September 30, 2020. Additionally, the Company terminated one lease of office space during the nine months ended September 30, 2021.
The table below presents certain information related to the Company’s lease costs:
 
 
  
Three Months Ended
September 30,
 
  
Nine Months Ended
September 30,
 
 
  
2021
 
  
2020
 
  
2021
 
  
2020
 
Operating lease expense
   $ 144      $ 482      $ 696      $ 1,585  
Finance lease expense
     —          —          —          16  
Interest expense on finance lease liabilities
     —          —          —          1  
Short-term lease expense
     —          —          —          14  
    
 
 
    
 
 
    
 
 
    
 
 
 
Total lease cost
   $ 144      $ 482      $ 696      $ 1,616  
    
 
 
    
 
 
    
 
 
    
 
 
 
 
17

SHAPEWAYS HOLDINGS, INC.
NOTES TO THE UNAUDITED CONSOLIDATED FINANCIAL STATEMENTS
(in thousands, except share and per share amounts)
 
Right of use assets and lease liabilities for operating leases were
recorded
in the condensed consolidated balance sheets as follows:
 
    
September 30,
2021
    
December 31,
2020
 
Assets:
                 
Right-of-use
assets, net
   $ 982      $ 2,102  
    
 
 
    
 
 
 
Total lease assets
   $ 982      $ 2,102  
    
 
 
    
 
 
 
Liabilities:
                 
Current liabilities:
                 
Operating lease liabilities, current
   $ 631      $ 1,222  
Non-current
liabilities:
                 
Operating lease liabilities, net of current portion
     499      $ 1,094  
    
 
 
    
 
 
 
Total lease liability
   $ 1,130      $ 2,316  
    
 
 
    
 
 
 
The Company’s lease agreements do not state an implicit borrowing rate; therefore, an internal incremental borrowing rate was determined based on information available at the lease commencement date for the purposes of determining the present value of lease payments. The incremental borrowing rate reflects the cost to borrow on a securitized basis in each market. The weighted-average remaining lease term for operating leases was 2.05 years and the weighted-average incremental borrowing rate was 5.34% as of September 30, 2021.
Supplemental cash flow information related to the Company’s leases was as follows:
 
    
Nine Months Ended
September 30,
 
    
2021
    
2020
 
Operating cash flows from operating leases
   $ 762      $ 1,754  
Operating cash flows from finance leases
     —          1  
Financing cash flows from finance leases
     —          18  
Lease liabilities arising from obtaining
right-of-use
assets
     —          4,025  
As of September 30, 2021, future
minimum
lease payments required under operating leases are as follows:
 
Rest of 2021
   $ 167  
2022
     680  
2023
     214  
2024
     132  
2025
     1  
    
 
 
 
Total minimum lease payments
     1,194  
Less effects of discounting
     (64
    
 
 
 
Present value of future minimum lease payments
   $ 1,130  
    
 
 
 
Desktop Metal
On March 26, 2021, the Company entered into a non-binding Memorandum of Understanding (“MOU”) with Desktop Metal, pursuant to which Desktop Metal agreed to invest $20.0 million in the PIPE Investment. Upon consummation of this investment, the Company became obligated to purchase $20.0 million of equipment, materials and services from Desktop Metal. In conjunction with these obligations, the Company and Desktop Metal agreed to develop a strategic partnership. In November 2021, the Company paid $3.5 million to Desktop Metal for equipment received, and 
has a commitment to place purchase orders for another
 
$16.5 million
of equipment and materials under the MOU by or before December
3
1, 2021.
Legal Proceedings
The Company is involved in various legal proceedings which arise from time to time in the normal course of business. While the results of such matters generally cannot be predicted with certainty, management does not expect any such matters to have a material adverse effect on the Company’s condensed consolidated financial position or results of operations as of September 30, 2021 and December 31, 2020, and for the three and nine months ended September 30, 2021 and 2020.
 
18

SHAPEWAYS HOLDINGS, INC.
NOTES TO THE UNAUDITED CONDENSED CONSOLIDATED FINANCIAL STATEMENTS
(in thousands, except share and per share amounts)
 
Note 10. Borrowing Arrangements
The Company’s outstanding debt obligations consisted of the following:
 
 
  
September 30,
2021
 
  
December 31,
2020
 
Dutch Landlord Loan
   $ 127      $ 163  
Term Loan
            3,423  
Convertible Promissory Notes
               5,000  
PPP Loan
               1,982  
    
 
 
    
 
 
 
       127        10,568  
Less: current portion
     (39      (8,332
    
 
 
    
 
 
 
Long-term debt
   $ 88      $ 2,236  
    
 
 
    
 
 
 
Dutch Landlord Loan
On May 12
,
2014, the Company entered into a loan agreement with its landlord at the Eindhoven factory (the “Dutch Landlord Loan”) to advance
242 (equivalent to $280 and $297
in total at September 30, 2021 and December 31, 2020, respectively) to finance leasehold improvements
.
The Dutch Landlord Loan is unsecured and required interest-only payments until September 30, 2016, followed by monthly payments of principal and interest. Interest accrues at 8.50% per annum through the maturity date on September 30, 2024.
For the three months ended September 30, 2021 and 2020, interest expense totaled $5, respectively. For the nine months ended September 30, 2021 and 2020, interest expense totaled $14, respectively.
Term Loan
On October 29, 2018, the Company entered into a loan and security agreement (the “Term Loan”) for the principal sum of $5,000 with a maturity date of October 29, 2022. The Term Loan requires interest-only payments until October 29, 2019, followed by monthly payments of principal and interest. Interest is payable at a rate equal to the prime rate, plus 0.25% per annum. At the Closing of the Business Combination, the Company repaid and terminated the Term Loan in full. As of December 31, 2020, the interest rate was 3.50%. In connection with the Term Loan, the bank is due a $75 fee in the event of a liquidity event valuing the Company above a certain threshold.
For the three months ended September 30, 2021 and 2020, interest expense totaled $12 and $36, respectively. For the nine months ended September 30, 2021 and 2020, interest expense totaled $66 and $129, respectively.
Convertible Promissory Notes
On June 19, 2019, the Company entered into note purchase agreements (the “Convertible Promissory Notes”) with certain stockholders of the Company for the aggregate principal sum of $5,000. The Convertible Promissory Notes bear interest at a rate of 8% per annum with all principal and interest due on or before the earlier of (i) December 19, 2020; and (ii) the closing of a Qualified Equity Financing, as defined below. The Convertible Promissory Notes are automatically converted into conversion shares upon the closing of a Qualified Equity Financing. Qualified Equity Financing is defined as the next sale by the Company of preferred stock following the date of the Convertible Promissory Notes on or prior to the maturity date with the principal purpose of raising capital. In the event there is a
non-Qualified
Equity Financing, the outstanding principal and unpaid accrued interest of each note may be converted, at the written election of the holders of the Convertible Promissory Notes, into conversion shares.
Non-Qualified
Equity Financing shall mean the next sale by the Company of its equity following the date of the Convertible Promissory Notes on or prior to the maturity date with the principal purpose of raising capital which is not a Qualified Equity Financing. If the next equity financing or a corporate transaction has not occurred on or before the maturity date of the Convertible Promissory Notes, the principal and unpaid accrued interest of each outstanding note may be converted, at the written election of each holder of the Convertible Promissory Notes, into conversion shares on the date of such written election. The number of conversion shares to be issued upon conversion shall be equal to the quotient obtained by dividing (i) the outstanding principal and unpaid accrued interest due on a Convertible Promissory Note to be converted on the date of the conversion by (ii) the Conversion Price. The conversion price is defined as the Discounted Conversion Price, which is 70% of the next equity price per share. The Convertible Promissory Notes are subordinated in right of payment to all indebtedness of the Company arising under the Term Loan. At inception, the terms of the notes gave rise to a contingent beneficial conversion feature.
On December 14, 2020, the Company executed an amendment to the Convertible Promissory Notes that extended the maturity date to August 10, 2021. All other relevant terms and conditions of the Convertible Promissory Notes remain binding.
 
19

SHAPEWAYS HOLDINGS, INC.
NOTES TO THE UNAUDITED CONDENSED CONSOLIDATED FINANCIAL STATEMENTS
(in thousands, except share and per share amounts)
 
Immediately prior to the completion of the Business Combination, the Convertible Promissory Notes in the aggregate principal amount of
$5,000
were converted into
 
1,434,391
shares of common stock of Legacy Shapeways (1,189,558 shares of Common Stock post Business Combination), and the related unpaid and accrued interest totaling
 
$
913
were
 
converted into
261,884
shares of common stock of Legacy
Shapeways (217,183 shares of Common Stock post Business Combination).
For the three months ended September 30, 2021 and 2020, interest expense totaled $109 and $100, respectively. For the nine months ended September 30, 2021 and 2020, interest expense totaled $309 and $300, respectively.
Paycheck Protection Program Loan
On May 4, 2020, the Company received an unsecured loan of $1,982 under the Paycheck Protection Program (the “PPP Loan”). The Paycheck Protection Program (or “PPP”) was established under the recently enacted CARES Act and is administered by the U.S. Small Business Administration (“SBA”). On May 4, 2020, the Company entered into a promissory note with Pacific Western Bank evidencing the unsecured PPP Loan.
The PPP Loan has a maturity date of May 4, 2022 and accrues interest at an annual rate of 1.00%. To the extent the loan amount is not forgiven under the PPP, the Company is obligated to make monthly payments of principal and interest, beginning six months from the date of the note, until the maturity date. In October 2020, the PPP Flexibility Act of 2020 extended the deferral period for borrower payments on all PPP loans from six months to ten months. Interest expense totaled $18 for the nine months ended September 30, 2021. There was no interest expense incurred for the nine months ended September 30, 2020.
The CARES Act and the PPP provide a mechanism for forgiveness of up to the full amount borrowed. Under the PPP, the Company may apply for and be granted forgiveness for all or part of the PPP Loan. The amount of the loan proceeds eligible for forgiveness is based on a formula that takes into account a number of factors, including the amount of loan proceeds used by the Company during the eight-week period after the loan origination for certain purposes including payroll costs, and certain rent payments, mortgage payments, and utility payments, provided that at least 75% of the loan amount is used for eligible payroll costs. Subject to the other requirements and limitations on loan forgiveness, only loan proceeds spent on payroll and other eligible costs during the covered eight-week period will qualify for forgiveness.
As of September 30, 2021, the full principal and interest amount of $2,000 of
the PPP Loan was forgiven and recorded in other income on the condensed consolidated statement of operations and comprehensive loss. Although the PPP Loan has been forgiven as of September 30, 2021, the Company intends to repay the PPP Loan in its entirety during the fourth quarter of 2021 and will reverse the previously recognized gain on debt forgiveness when repaid.
Note 11. Stockholders’ Equity (Deficit)
The condensed consolidated statements of changes in stockholders’ equity (deficit) reflects the Business Combination as defined in Note 1 as of September 29, 2021. As Legacy Shapeways was deemed the accounting acquirer in the Business Combination with Galileo, all periods prior to the consummation date reflect the balances and activity of Legacy Shapeways. The balances as of January 1, 2021 and 2020 from the consolidated financial statements of Legacy Shapeways as of that date, share activity (convertible preferred stock, common stock, additional paid in capital, accumulated deficit, and accumulated other comprehensive loss) and per share amounts were retroactively adjusted, where applicable, using the recapitalization conversion ratio of
 0.8293
(the “Conversion Ratio”).
Common Stock
Upon closing of the Business Combination, pursuant to the terms of the Certificate of Incorporation, the Company authorized 120,000,000 shares of
C
ommon
S
tock with a par value $0.0001. The holders of
C
ommon
S
tock are entitled to one vote per share on all matters submitted to the stockholders for their vote or approval and are entitled to receive dividends, as and if declared by the Board out of legally available funds.
The Company has issued and outstanding 48,296,484 shares of
C
ommon
S
tock as of September 30, 2021.
Legacy Shapeways Common Stock Warrants
On December 18, 2013, in connection with executing a loan agreement, the Company issued warrants to purchase 40,000 shares of Legacy Shapeways common stock. The warrants had an exercise price of $1.25 per share and had an expiration date of December 18, 2023.
 
20

SHAPEWAYS HOLDINGS, INC.
NOTES TO THE UNAUDITED CONSOLIDATED FINANCIAL STATEMENTS
(in thousands, except share and per share amounts)
 
On February 3, 2014, in connection with executing a lease agreement, the Company issued warrants to purchase 248,000 shares of Legacy Shapeways common stock. The warrants had an exercise price of $1.25 per share and expired upon the latest to occur i) seven years from the original issuance date or ii) five years from the effective date of an initial public offering.
On April 22, 2015, in connection to an amended loan agreement, the Company issued warrants to purchase 13,750 shares of Legacy Shapeways common stock. The warrants had an exercise price of $1.70 per share and had an expiration date of April 22, 2025.
Immediately prior to the completion of the Business Combination, all outstanding Legacy Shapeways common stock warrants were exercised into an aggregate of 255,917
shares of Legacy Shapeways common stock (
212,234
shares of Common Stock post Business Combination).
Legacy Shapeways Convertible Preferred Stock
Immediately prior to the completion of the Business Combination, all outstanding shares of the Legacy Shapeways Series
A-1,
Series
A-2,
Series B, Series
B-1,
Series C, Series D, and Series E preferred stock converted into an aggregate of 22,579,695 shares of common stock. Each share of Legacy Shapeways convertible preferred stock was converted into one share of Legacy Shapeways common stock.
Legacy Shapeways Preferred Stock Warrants
On March 8, 2013, the Company issued warrants to purchase a total of 23,125 shares of Series
B-1
preferred stock of Legacy Shapeways. The warrants had an exercise price of $2.5946 per share and were exercisable for ten years from the date of grant. On May 10, 2021, the 23,125 warrants were exercised for 23,125 shares of Series
B-1
preferred stock of Legacy Shapeways at an exercise price of $2.5946 per share.
On June 30, 2017, in connection with executing a loan agreement, the Company issued warrants to purchase a total of 57,051 shares of Series D preferred stock of Legacy Shapeways. The warrants had an exercise price of $5.2584 per share and were exercisable for ten years from the date of grant. Immediately prior to the completion of the Business Combination, the 57,051 warrants were exercised for 107,580 shares of Legacy Shapeways common stock.
Public Warrants
Prior to the Merger, the Company had outstanding 13,800,000 Public Warrants. Each Public Warrant entitles the holder to purchase one share of
C
ommon
S
tock of the Company at an exercise price of $11.50 per share. The Public Warrants become exercisable 30 days after the Closing Date, and expire five years after the Closing Date or earlier upon redemption or liquidation.
The Company may redeem the Public Warrants as follows: in whole and not in part; at a price of $0.01 per warrant; at any time while the Public Warrants are exercisable, upon not less than 30 days’ prior written notice of redemption to each Public Warrant holder; if, and only if, the reported last sale price of the Company’s ordinary shares equals or exceeds $18.00 per share, for any 20 trading days within a
30-trading
day period ending on the third business day prior to the notice of redemption to the warrant holders; and if, and only if, there is a current registration statement in effect with respect to the ordinary shares underlying such warrants at the time of redemption and for the entire
30-day
trading period referred to above and continuing each day thereafter until the date of redemption. Certain of these conditions have not been met to redeem the Public Warrants. If the Company calls the Public Warrants for redemption, management will have the option to require all holders that wish to exercise the Public Warrants to do so on a “cashless basis,” as described in the warrant agreement.
As of September 30, 2021, there
we
re 13,800,000
Public Warrants outstanding.
Note 12. Stock-Based Compensation
2010 Stock Plan
Prior to the Business Combination, Legacy Shapeways maintained its 2010 Stock Plan (the “2010 Plan”), under which Legacy Shapeways granted statutory and
non-statutory
stock to employees, outside directors and consultants. The maximum number of shares of common stock that was issuable under the 2010 Plan was 16,942,546 shares.
In connection with the Business Combination, each Legacy Shapeways stock option that was outstanding immediately prior to Closing, whether vested or unvested, was converted into an option to acquire a number of shares of common stock (each such option, an “Exchanged Option”) equal to the product (rounded down to the nearest whole number) of (i) the number of shares of Legacy Shapeways common stock subject to such Legacy Shapeways option immediately prior to the Business Combination and (ii) 90% of the Conversion Ratio, at an exercise price per share (rounded up to the nearest whole cent) equal to (A) the exercise price per share of such Legacy Shapeways
 
21

SHAPEWAYS HOLDINGS, INC.
NOTES TO THE UNAUDITED CONDENSED CONSOLIDATED FINANCIAL STATEMENTS
(in thousands, except share and per share amounts)
 
option immediately prior to the consummation of the Business Combination, divided by (B) 90% of the Conversion Ratio. Except as specifically provided in the Business Combination Agreement, following the Business Combination, each Exchanged Option will continue to be governed by the same terms and conditions (including vesting and exercisability terms) as were applicable to the corresponding former Legacy Shapeways option immediately prior to the consummation of the Business Combination. All stock option activity was retroactively restated to reflect the Exchanged Options.
In addition, as discussed in Note 3, each holder of an
in-the-money
Legacy Shapeways option held by individuals remaining in continuous service to the Company through the Closing, was granted a right to receive an award of restricted stock units denominated in shares of common stock granted under the 2021 Plan (each, an “Earnout RSU”) equal to the product of (A) the number of shares of Legacy Shapeways common stock that were subject to the option immediately prior to Closing, multiplied by (B) ten percent
(10%)
of the Conversion
 
Ratio (rounded down to the nearest whole number of shares). The Earnout RSUs are subject to substantially the same service-based vesting conditions and acceleration provisions as applied to the Legacy Shapeways option provided that, in addition to such service-based vesting conditions, Earnout RSUs will be subject to vesting and forfeiture conditions based upon the dollar volume-weighted price of the Company’s
C
ommon
S
tock reaching certain targets (the “RSU Performance Milestones”).
If the service of the holder of an Earnout RSU terminates before the RSU Performance Milestones have been satisfied, then the portion of the Earnout RSUs for which the service-based vesting conditions has been satisfied (taking into account any acceleration provisions) shall remain outstanding and eligible to vest upon achievement of the applicable RSU Performance Milestone. Any Earnout RSUs for which the service-based vested conditions has not been satisfied as of such termination of service (taking into account any acceleration provisions) shall be forfeited and cancelled without payment. If any RSU Performance Milestone fails to be satisfied by the end of the Earnout Period, then the Earnout RSUs corresponding to such RSU Performance Milestone shall be forfeited and cancelled without payment as of the end of the Earnout Period.
Upon the Closing of the Business Combination, the outstanding and unexercised Legacy Shapeways options became options to purchase an aggregate of 4,901,207 shares of the Company’s Common Stock under the 2010 Plan at an average exercise price of $0.62 per share.
2021 Equity Incentive Plan
Upon
 the closing of the Business Combination, the Company adopted the 2021 Equity Incentive Plan (the “2021 Plan”). The 2021 Plan permits the granting of incentive stock options, restricted stock awards, other share-based awards or other cash-based awards to employees, consultants, and
non-employee
directors. As of September 30, 2021,
 
7,621,401
shares of
C
ommon
S
tock are authorized for issuance pursuant to awards under the 2021 Plan. As of September 30, 2021,
no
shares have been awarded and
7,621,401
shares remain available for issuance under the 2021 Plan.
Option Awards
The Company accounts for share-based payments pursuant to ASC 718,
Stock Compensation
and, accordingly, the Company records stock compensation expense for share-based awards based upon an assessment of the grant date fair value for stock options using the Black-Scholes option pricing model. The Company is a public company and lacks company-specific historical and implied volatility information. Therefore, it estimates its expected stock volatility based on the historical volatility of a publicly traded set of peer companies. Due to the lack of historical exercise history, the expected term of the Company’s stock options for employees has been determined utilizing the “simplified” method for awards. The risk-free interest rate is determined by reference to the U.S. Treasury yield curve. Expected dividend yield is zero based on the fact that the Company has never paid cash dividends and does not expect to pay any cash dividends in the foreseeable future.
 
22

SHAPEWAYS HOLDINGS, INC.
NOTES TO THE UNAUDITED CONDENSED CONSOLIDATED FINANCIAL STATEMENTS
(in thousands, except share and per share amounts)
 
The fair value of stock options under the Black-Scholes model requires management to make assumptions regarding projected employee stock option exercise behaviors, risk-free interest rates, volatility of the Company’s stock price and expected dividends. The Company generally recognizes stock compensation expense on the grant date and over the period of vesting or period that services will be provided. The assumptions used to estimate the fair value of stock options granted during the periods presented were as follows:
 
 
  
Three and Nine Months Ended
September 30,
 
 
  
2021
 
 
2020
 
Strike price
   $ 0.17      $ 0.37  
Expected term (in years)
     5.55 - 6.05        5.00 - 6.04  
Expected volatility
    
57.09% - 57.81
    
49.15% - 52.41
Risk-free interest rate
     0.50% - 0.57
     0.37% - 1.46
Dividend yield
                   
The following table summarizes the Company’s stock option plan and the activity:
 
    
Shares
Underlying
Options
    
Weighted
Average Exercise
Price
    
Weighted
Average
Remaining
Contractual
Term (in years)
 
Outstanding at January 1, 2021 (as previously reported)
     8,247,340      $ 0.44        6.72  
Retroactive application of reverse recapitalization
     (1,967,440                —    
    
 
 
    
 
 
    
 
 
 
Outstanding as of January 1, 2021, effect of Merger
     6,279,900      $ 0.58        6.64  
Granted
     29,420        0.36        9.82  
Forfeited
     (145,878      0.43        —    
Exercised
     (35,895      0.43        —    
    
 
 
    
 
 
    
 
 
 
Outstanding at March 31, 2021
     6,127,547      $ 0.58        6.53  
Granted
                         —    
Forfeited
     (39,309      0.44        —    
Exercised
     (63,506      0.45        —    
    
 
 
    
 
 
    
 
 
 
Outstanding at June 30, 2021
     6,024,732      $ 0.59        6.26  
Granted
                         —    
Forfeited
     (10,496      0.40        —    
Exercised
     (1,113,029      0.44        —    
    
 
 
    
 
 
    
 
 
 
Outstanding at September 30, 2021
     4,901,207      $ 0.62        6.80  
    
 
 
    
 
 
    
 
 
 
Exercisable at September 30, 2021
     4,833,059      $ 0.62        6.79  
    
 
 
    
 
 
    
 
 
 
The aggregate intrinsic value in the above table is calculated as the difference between fair value of the Company’s
C
ommon
Stock
price and the exercise price of the stock options. The weighted-average grant-date fair value per stock option granted during the nine months ended September 30, 2021 and 2020 was $0.36 and $0.50, respectively. As of September 30, 2021, approximately $193 of unrecognized compensation expense related to
non-vested
awards is expected to be recognized over the weighted average period of 1.80 years.
2021 Employee Stock Purchase Plan
Upon
 the closing of the Business Combination, the Company adopted the 2021 Employee Stock Purchase Plan (the “ESPP”). The purpose of the ESPP is to provide eligible employees with an opportunity to increase their proprietary interest in the success of the Company by purchasing Common Stock from the Company on favorable terms and to pay for such purchases through payroll deductions or other approved contributions. As of September 30, 2021, 895,721 shares of Common Stock are available for purchase under the ESPP. As of September 30, 2021, no shares have been purchased under the ESPP.
Note 13. Fair Value Measurements
Fair value measurements discussed herein are based upon certain market assumptions and pertinent information available to management as of September 30, 2021 and December 31, 2020. The carrying amounts of accounts receivable, inventory, prepaid expenses and other current assets, accounts payable, accrued expenses and other liabilities, and deferred revenue approximated fair value as they are short term in nature. The fair value of warrants issued for settlement and services are estimated based on the Black-Scholes model. The carrying value of the Company’s debt and operating lease liabilities approximated its fair value, as the obligation bears interest at rates currently available for debt with similar maturities and collateral requirements.
 
23

SHAPEWAYS HOLDINGS, INC.
NOTES TO THE UNAUDITED CONSOLIDATED FINANCIAL STATEMENTS
(in thousands, except share and per share amounts)
 
Fair Value on a Recurring Basis
The Company follows the guidance in ASC 820 for its financial assets and liabilities that are
re-measured
and reported at fair value at each reporting period, and
non-financial
assets and liabilities that are
re-measured
and reported at fair value at least annually. The estimated fair value of the warrant liabilities represent Level 3 measurements. The following table presents information about the Company’s liabilities that are measured at fair value on a recurring basis at September 30, 2021 and December 31, 2020, and indicates the fair value hierarchy of the valuation inputs the Company utilized to determine such fair value:
 
Description
  
Level
 
  
September 30,
2021
 
  
December 31,
2020
 
Liabilities:
  
     
  
     
  
     
Warrant liabilities
     3      $ 6,777      $     
Warrant Liabilities
Prior to the Business Combination, the Company had outstanding 4,110,000
warrants
(the “Private Warrant”) that were issued upon the consummation of the initial public offering of Galileo. Additionally, at the Closing, a lender holding a convertible note issued by the Company with an aggregate principal amount of $500 converted the note into 500,000 warrants (the “Sponsor Warrants”) exercisable for
C
ommon
S
tock at a purchase price of $1.00 per warrant.
The Private Warrants and Sponsor
Warrants
are identical to the Public Warrants except that the Private and Sponsor Warrants (i) are not redeemable by the Company and (ii) may be exercised for cash or on a cashless basis, so long as they are held by the initial purchaser or any of its permitted transferees. If the Private Warrants are held by someone other than the initial purchasers or their permitted transferees, the Private Warrants will be redeemable by the Company and exercisable by such holders on the same basis as the Public Warrants.
The Private and Sponsor Warrants are not indexed to the Company’s common shares in the manner contemplated by ASC
815-40-15
because the holder of the instrument is not an input into the pricing of a
fixed-for-fixed
option on equity shares. The Company classifies the Private and Sponsor Warrants as derivative liabilities in its unaudited condensed consolidated balance sheet as of September 30, 2021.
The Company utilizes a Binomial Lattice model approach to value the Private Warrants and Sponsor Warrants at each reporting period with changes in fair value recognized in the statement of operations. The estimated fair value of the warrant liabilities is determined using Level 3 inputs. Inherent in a binomial options pricing model are assumptions related to expected share-price volatility, expected life, risk-free interest rate and dividend yield. The Company estimates the volatility of its Common Stock based on historical volatility that matches the expected remaining life of the warrants. The risk-free interest rate is based on the U.S. Treasury
zero-coupon
yield curve on the grant date for a maturity similar to the expected remaining life of the warrants. The expected life of the warrants is assumed to be equivalent to their remaining contractual term. The dividend rate is based on the historical rate, which the Company anticipates to remain at zero.
The significant unobservable inputs used in the Binomial Lattice Model to measure the warrant liabilities that are categorized within Level 3 of the fair value hierarchy are as follows:
 
 
  
September 30,
2021
 
 
At Closing
(September 29, 2021)
 
Stock price on valuation date
   $ 7.70     $ 8.54  
Exercise price per share
   $ 11.50     $ 11.50  
Expected life
     5 years       5 years  
Volatility
     34.8 %
 
 
    43.9
Risk-free rate
     1.0     1.0
Dividend yield
              
    
 
 
   
 
 
 
Fair value per warrant
   $ 1.47     $ 2.57  
    
 
 
   
 
 
 
 
24

SHAPEWAYS HOLDINGS, INC.
NOTES TO THE UNAUDITED CONSOLIDATED FINANCIAL STATEMENTS
(in thousands, except share and per share amounts)
 
The following table provides a summary of changes in fair value of the Company’s Level 3 financial instruments that are measured at fair value on a recurring basis:
 
    
Warrant
Liabilities
 
Balance at December 31, 2020
   $     
Additions pursuant to Merger
     11,865  
Change in fair value
     (5,088
    
 
 
 
Balance at September 30, 2021
   $ 6,777  
    
 
 
 
As of September 30, 2021, 4,110,000 Private Warrants and 500,000 Sponsor Warrants remain outstanding, respectively.
Fair Value on a
Non-Recurring
Basis
The fair value of the Earnout Shares has been estimated using the trading price of our
C
ommon
S
tock at Closing ($7.70), discounted based on the probability of the Earnout Terms being met as determined at Closing, and thus represents a Level 2 fair value measurement as defined in ASC 820. The Earnout Shares, if achieved, would be issued to Legacy Shapeways shareholders. The Earnout Shares are a fixed number of shares to be issued to such shareholders on a pro rata basis. The fair value of the Earnout Shares were recognized as a deemed dividend. Upon closing of the Merger, the estimated fair value of the Earnout Shares was $18,132 with such amount recognized as a deemed dividend. As the Company is in an accumulated deficit position as of the measurement date, the resulting deemed dividend is recorded as a reduction of additional
paid-in
capital with a corresponding offset recorded to additional
paid-in
capital.
Note 14. Significant Concentrations
One customer accounted for approximately 22% and 23% of revenue for the three months ended September 30, 2021 and 2020, respectively. No other customers represented more than 10% of revenue for the three months ended September 30, 2021 and 2020.
One customer accounted for approximately 23% and 22% of revenue for the nine months ended September 30, 2021 and 2020, respectively. No other customers represented more than 10% of revenue for the nine months ended September 30, 2021 and 2020.
One vendor accounted for approximately 15% of purchases for the nine months ended September 30, 2021. No other vendors represented more than 10% of purchases for the nine months ended September 30, 2021 and 2020.
As of September 30, 2021 and December 31, 2020, one customer accounted for approximately 55% and 32% of accounts receivable, respectively. No other customers represented more than 10% of outstanding accounts receivable as of September 30, 2021 and December 31, 2020.
As of September 30, 2021, four vendors accounted for approximately 19%, 12%, 12%, and 11% of accounts payable. As of December 31, 2020, five vendors accounted for approximately 18%, 15%, 15%, 11% and 10% of accounts payable. No other vendors represented more than 10% of outstanding accounts payable balance as of September 30, 2021 and December 31, 2020.
Note 15. Related Party Transactions
During 2012, the Company signed a $175 promissory note (the “Related Party Note”) with an officer of the Company, bearing interest equal to the greater of (a) 0.88% per annum or (b) the
mid-term
Applicable Federal Rate under Section 1274(d) of the Internal Revenue Code in effect during the time the note is outstanding. The average interest rates for the nine months ended September 30, 2021 and 2020 were 0.84% and 0.90%, respectively. On May 12, 2020, the Related Party Note was amended to extend the maturity date such that the remainder of the principal and accrued interest be due and payable on August 10, 2021. The Related Party Note was secured by the assets of the borrower. Immediately prior to the completion of the Business Combination, the Company entered into a stock repurchase agreement with the holder of the Related Party Note to which the Company repurchased 19,226 shares of
C
ommon
S
tock held by the holder in exchange for settlement of the Related Party Note.
Note 16. Subsequent Events
The Company has evaluated all known subsequent events through November 15, 2021, which is the date these condensed consolidated financial statements were available to be issued, and has determined that no subsequent events have occurred requiring recognition or disclosure in these condensed consolidated financial statements.
 
25

Item 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations
The following discussion and analysis provides information that management believes is relevant to an assessment and understanding of our consolidated results of operations and financial condition. You should read the following discussion and analysis of financial condition and results of operations together with the accompanying unaudited condensed consolidated financial statements and the related notes to those statements of Shapeways included elsewhere in this Report and our Current Report relating to the Business Combination (as defined herein) on Form 8-K filed with the SEC on October 5, 2021. Some of the information contained in this discussion and analysis contains forward-looking statements that involve risks and uncertainties. As a result of many factors, such as those set forth in Item 1A. Risk Factors of this Report, actual results may differ materially from those anticipated in these forward-looking statements. Although we believe that the expectations reflected in the forward-looking statements are reasonable, we cannot guarantee future results, levels of activity, performance, or achievements. Except as required by law, we do not intend to update any of these forward-looking statements after the date hereof or to conform these statements to actual results or revised expectations. Unless otherwise indicated or the context otherwise requires, references in this section to “Shapeways”, the “Company”, “we”, “us”, “our”, and other similar terms refer to Shapeways Holdings, Inc.
Company Overview
On September 29, 2021, as contemplated by the Agreement and Plan of Merger and Reorganization (the “Merger Agreement”), the Company consummated the previously announced business combination (the “Business Combination”) by and among our company (formerly known as Galileo Acquisition Corp. (“Galileo”)), Shapeways, Inc., a Delaware corporation (“Legacy Shapeways”), and Galileo Acquisition Holdings Inc., a Delaware corporation and a wholly owned subsidiary of Galileo (“Merger Sub”), pursuant to which Merger Sub was merged with and into Legacy Shapeways, with Legacy Shapeways surviving the merger (the “Merger”). As a result of the Merger, and upon consummation of the Merger and other transactions contemplated by the Merger Agreement, Legacy Shapeways became a wholly-owned, direct subsidiary of Galileo. Upon closing of the Business Combination, we changed our name to Shapeways Holdings, Inc. Results of operations included within this Report pertaining to periods ending prior to the Closing of the Business Combination on September 29, 2021 are those of Legacy Shapeways.
Shapeways is a leading digital manufacturer combining high quality, flexible,
on-demand
manufacturing with purpose-built proprietary software to offer customers an
end-to-end
digital manufacturing platform on which they can rapidly transform digital designs into physical products. Shapeways’ manufacturing platform offers customers access to high quality manufacturing from start to finish through automation, innovation, and digitization. Shapeways’ proprietary software, wide selection of materials and technologies, and global supply chain lower manufacturing barriers and accelerate delivery of manufactured parts from prototypes to finished end parts.
Shapeways combines deep digital manufacturing
know-how
and software expertise to deliver high quality, flexible
on-demand
digital manufacturing to a range of customers, from project-focused engineers to large enterprises. Digital manufacturing is the complete digitization of the
end-to-end
manufacturing process that enables the transition of a digital file to a physical product. Digital manufacturing is well suited for high quality, low volume, complex manufacturing at scale using both traditional manufacturing methods as well as additive manufacturing. Additive manufacturing is well suited for low volume, complex manufacturing due its ability to “add” layer upon layer of material to form complex parts without the need for high cost molds and tooling or wasteful “subtractive” manufacturing processes.
Based in New York City, Shapeways was founded in 2008 and has two manufacturing facilities, one in Long Island City, New York and the other in Eindhoven, the Netherlands. In addition, as of September 30, 2021, Shapeways had over 50 strategic supply chain partners who provide incremental capacity and production technologies to help us scale with customer demand and support us in efficiently launching new materials and manufacturing technologies.
Shapeways supports its customers through the design,
pre-production,
manufacturing, and delivery process across a range of industries, materials, part volumes, and delivery options. Shapeways’ software is deeply integrated with our customers’ workflows and often is mission critical to their businesses. Shapeways believes its manufacturing platform is highly scalable, having delivered to date over 21 million parts to one million customers in over 160 countries. Shapeways’ platform is agnostic as to manufacturing hardware, materials, and design software providers. Today, Shapeways utilizes 11 additive manufacturing technologies to produce parts in more than 90 materials and finishes.
Shapeways uses its proprietary software to automate production that passes through the Shapeways manufacturing platform. Our software supports ordering, part analysis, manufacturing planning, preproduction, and manufacturing. This software enables Shapeways to offer high quality,
low-volume,
complex part production. In an environment increasingly focused on mass customization and speed of part delivery, Shapeways’ core competency in
low-volume,
high-mix
production at scale appeals to customers.
In 2020, Shapeways launched their software under the brand “Powered by Shapeways” to a limited set of design customers to gain feedback on product market fit. The software enables other manufacturers to leverage Shapeways’ existing
end-to-end
manufacturing software to scale their businesses and shift to digital manufacturing. Shapeways’ software offers improved customer accessibility, increased productivity, and expanded manufacturing capabilities for its customers. Shapeways recently launched the first phase of this offering more publicly under the brand “Otto”. This phase of the software offering provides a limited ordering service for additive manufacturing capabilities fulfilled by Shapeways. Further phases of this software, which are expected to be rolled out over the next two years, will include expanded ordering capabilities and additional end to end functionality to digitize manufacturing processes. Shapeways intends to further commercialize its software as part of its goal to accelerate digital transformation across the manufacturing ecosystem. Shapeways believes its software can transform manufacturers globally by easing the digital transformation by traditional manufacturers, particularly small- to
medium-sized
manufacturers that are not able to invest the capital and time necessary to digitize their processes.
 
26

Recent Developments
COVID-19
In March 2020, the World Health Organization declared the outbreak of
COVID-19
a pandemic. Shapeways business and operations have been adversely affected by the
COVID-19
pandemic, as have the businesses and operations of our customers and the markets in which they operate. The
COVID-19
pandemic has caused and continues to cause significant business and financial markets disruption worldwide and there is significant uncertainty around the duration of this disruption and its ongoing effects on our business. While we demonstrated revenue growth for the nine months ended September 30, 2021 as compared to the same period in 2020, management believes growth could have been higher if not for the
COVID-19
pandemic.
The
COVID-19
pandemic has caused us to experience several adverse impacts, including extended sales cycles to obtain new customers, delays in shipping due to closed facilities and travel limitations, reduced customer demand for our products, including lower order values and delays in collecting accounts receivable. In addition, in order to keep our manufacturing facilities operating, we have experienced an increased spend on personal protective equipment (PPE), maintaining facilities, enhanced cleaning and other costs to adhere to
COVID-19
operating rules, including a software application for checking
COVID-19
symptoms of essential personnel. Due to
COVID-19
related disruptions, we have experienced increased logistics costs, such as shipping, and certain of our major materials vendors were unable to fill our orders in a timely manner or at all. Also related to the pandemic, we repurposed our Long Island City manufacturing facility in the spring and summer of 2020 so as to be able to create PPE such as face shields, ventilator parts and hands-free door handles for our essential workers in New York City. A continued or resurgent
COVID-19
pandemic may contribute to facility closures at our facilities, third-party manufacturing partners and key suppliers, particularly in geographies that are experiencing resurgences such as India, which could cause delays and disruptions in manufacturing or otherwise affect our ability to deliver finished products to our customers in a timely manner. Disruptions in the capital markets as a result of the
COVID-19
pandemic may also adversely affect our business if these disruptions continue for a prolonged period and we need to seek additional capital.
Shapeways has taken, and will continue to take, actions to mitigate the impact of the
COVID-19
pandemic on our business. Shapeways is managing the variable portion of its cost structure to better align with revenue, including external marketing spend, which has been significantly reduced during this period of disruption, but began to increase after the first quarter of 2021. Additionally, earlier in the
COVID-19
pandemic, Shapeways had reduced hiring across all departments within Shapeways, but it has resumed hiring at projected levels. Shapeways also implemented other cost-cutting measures such as reducing discretionary spending, reducing our reliance on third-party recruiters and taking advantage of the employer tax credit provisions of the CARES Act.
Shapeways does not yet know the full extent of potential impact on our business and operations. Given the extant uncertainty, Shapeways cannot reasonably estimate the impact on our future results of operations, cash flows or financial condition.
Desktop Metal Partnership
In November 2021, as part of its existing strategic partnership with Desktop Metal, Shapeways announced it is expanding Desktop Metal system capacity and capabilities by providing customers access to these solutions at Shapeways’ ISO-9001 manufacturing facilities in both Long Island City, New York and Eindhoven, Netherlands. In addition, Desktop Metal plans to leverage Shapeways’ manufacturing capabilities and purpose-built software platform, Otto, to provide its customers with instant access to fully digitized, end-to-end 3D printing workflows.
Key Factors Affecting Operating Results
Shapeways believe that its performance and future success depend on many factors that present significant opportunities for us but also pose risks and challenges, including the following:
Commercial Launch of New Offerings
Shapeways plans to launch several new manufacturing technologies, materials, and finishes. Prior to commercialization, Shapeways must complete testing and manufacturing
ramp-up
either in house or through our network of third-party manufacturing partners. Any delays in the successful completion of these steps or the results of testing may impact Shapeways’ ability or the pace at which Shapeways will generate revenue from these offerings. Shapeways released its software offering to third-party manufacturers, which involves additional activities such as creating awareness of the new offering and ensuring the software can interoperate with systems used by potential customers.
Even if Shapeways successfully introduces these new offerings, there is no assurance that they will be accepted by the broader market.
 
27

Adoption of Our Digital Manufacturing Solutions
Shapeways believes that the market is shifting toward digitization of manufacturing and approaching an inflection point in the overall adoption of digital manufacturing solutions. Shapeways believes that it is well-positioned to take advantage of this market opportunity across an array of industries due to its platform that combines high-quality, flexible,
on-demand
manufacturing with purpose-built proprietary software. Shapeways expects that its results of operations, including revenue and gross margins, will fluctuate for the foreseeable future as businesses continue to shift away from traditional manufacturing processes towards digital manufacturing. The degree to which current and potential customers recognize the benefits of the digitization of manufacturing and the use our solutions in particular will affect our financial results.
Pricing, Product Cost and Margins
To date, the majority of Shapeways’ revenue has been generated by the manufacturing and sales of additively-manufactured end parts.
Shapeways has not generated significant revenue from its planned new offerings. Shapeways expects to further commercialize its software, which we expect will provide those software customers with an
end-to-end
software for their manufacturing operations and to expand the manufacturing capabilities that they offer to their customers.
Software and manufacturing pricing may vary due to market-specific supply and demand dynamics, customer size, and other factors. Sales of certain products, such as software, have, or are expected to have, higher gross margins than others. As a result, Shapeways’ financial performance depends, in part, on the mix of offerings Shapeways sells during a given period. In addition, Shapeways is subject to price competition, and its ability to compete in key markets will depend on the success of its investments in its offerings, on cost improvements as well as on its ability to efficiently and reliably introduce cost-effective digital manufacturing solutions for our customers.
Continued Investment and Innovation
Shapeways believes that it is a leader in digital manufacturing solutions, offering high-quality, flexible,
on-demand
manufacturing coupled with purpose-built proprietary software. Shapeways’ performance is significantly dependent on the investment we make in our software development efforts and in new digital manufacturing technologies. It is essential that Shapeways continually identifies and respond to rapidly evolving customer requirements, develop and introduce innovative new offerings, enhance existing solutions and generate customer demand for our offerings. Shapeways believes that investment in its digital manufacturing solutions will contribute to long-term revenue growth, but may adversely affect our near-term profitability.
Components of Results of Operations
Revenue
The majority of Shapeways’ revenue results from the sales of products that we manufacture for customers. Manufacturing product revenue is recognized upon shipment of the manufactured product to its customer.
During the nine months ended September 30, 2021 and 2020, approximately 24% and 26% of Shapeways’ revenue was designated as “Marketplace Sales”. This revenue is from Shapeways’ customers who sell their products that Shapeways manufactures for them through Shapeways
e-commerce
website. Sales through this channel are subject to Shapeways’ regular manufacturing fees and also a 3.5% fee on any price markup the customer includes on their product. See Note 4 to the unaudited condensed consolidated financial statements included in this Report.
Shapeways also expects to increase software revenue over time. Software revenue will be recognized (i) upon implementation for implementation fees, (ii) ratably over the term of the agreement for licensing fees, and (iii) upon order processing for the revenue-sharing component of our arrangements. To date, Shapeways has not recognized a material amount of revenue from software since this product offering has been limited to only design partners as we developed the complete product offering. In October 2021, the Company publicly launched a limited version of the software to expand our customer base.
Cost of Revenue
Shapeways’ cost of revenue consists of the cost to produce manufactured products and related services. Cost of revenue includes machine costs, material costs, rent costs, personnel costs, and other costs directly associated with manufacturing operations in Shapeways’ factories as well as amounts paid to its third-party contract manufacturers and suppliers. Shapeways’ cost of revenue also includes depreciation and amortization of equipment, cost of spare or replacement machine parts, machine service costs, shipping and handling costs, and some overhead costs. Shapeways expects cost of revenue to increase in absolute dollars in the future.
 
28

Once Shapeways commercializes its software offering and if we generate material revenue from sales of its software offering, it will separately recognize the related cost of revenue.
Gross Profit and Gross Margin
Shapeways’ gross profit and gross margin are, or may be, influenced by a number of factors, including:
 
   
Market conditions that may impact our pricing;
 
   
Product mix changes between established manufacturing product offerings and new manufacturing product offerings;
 
   
Product mix changes;
 
   
Mix changes between products we manufacture in house and through outsourced manufacturers;
 
   
Shapeways’ cost structure, including rent, materials costs, machine costs, labor rates, and other manufacturing operations costs; and
 
   
Shapeways’ level of investment in new technologies.
Research and Development
Shapeways’ research and development expenses consist primarily of employee-related personnel expenses, consulting and contractor costs, and SaaS, data center, and other technology costs. Shapeways expects research and development costs will increase on an absolute dollar basis over time as Shapeways continues to invest in our software offering.
Selling, General and Administrative
Selling, general and administrative expenses consist primarily of employee-related costs for individuals working in our sales and marketing departments, third party consultants, marketing costs such as search engine marketing and search engine optimization and other advertising costs, as well as personnel-related expenses associated with our executive, finance and accounting, legal, human resources, and supply chain functions, as well as professional fees for legal, audit, accounting and other consulting services.
Shapeways expects its sales and marketing costs will increase on an absolute-dollar basis as it expands its headcount, initiate new marketing campaigns, and launch its software offering.
Shapeways expects its general and administrative expenses will increase on an absolute-dollar basis as a result of operating as a public company, including expenses necessary to comply with the rules and regulations applicable to companies listed on a national securities exchange and related to compliance and reporting obligations pursuant to the rules and regulations of the SEC, as well as increased expenses for insurance (including director and officer insurance), investor relations, and other administrative and professional services. In addition, Shapeways expects to incur additional costs as we hire additional personnel and enhance its infrastructure to support the anticipated growth of the business.
Interest Expense
Interest expense consists primarily of interest expense associated with Shapeways’ term loan and its bridge loan. At the Closing of the Business Combination, the Company repaid and terminated the term loan in full. Immediately prior to the completion of the Business Combination, the bridge loan was converted into shares of common stock of Legacy Shapeways.
Income Tax (Benefit) Expense
Shapeways files consolidated income tax returns in the United States and in various state jurisdictions. Income taxes are accounted for under the asset and liability method. Deferred tax assets and liabilities are recognized for the estimated future tax consequences attributable to differences between the financial statement carrying amounts of existing assets and liabilities and their respective tax bases. Deferred tax assets and liabilities are measured using enacted tax rates in effect for the year in which those temporary differences are expected to be recovered or settled. Where applicable, we record a valuation allowance to reduce any deferred tax assets that it determines will not be realizable in the future.
Due to Shapeways’ cumulative losses, Shapeways maintains a valuation allowance against our U.S. and state deferred tax assets.
 
29

Results of Operations
Comparison of the Three Months Ended September 30, 2021 and 2020
Revenue
 
    
Three Months Ended September 30,
    
Change
 
(Dollars in thousands)
  
2021
    
2020
    
$
    
%
 
Revenue
   $ 7,716    $ 8,107    $ (391      (5      %  
Revenue for the three months ended September 30, 2021 and 2020 was $7.7 million and $8.1 million, respectively, representing a decrease of $0.4 million, or 5% from the prior year period. The decrease in revenue was attributable to a 16% decrease in products shipped, partially offset by a 13% increase in higher average price per product sold. Shapeways has continued to optimize our pricing algorithm and mix of technology offerings, resulting in this higher average price per product.
Cost of Revenue
 
    
Three Months Ended September 30,
    
Change
 
(Dollars in thousands)
  
2021
    
2020
    
$
    
%
 
Cost of Revenue
   $ 4,055    $ 4,406    $ (351      (8      %  
Cost of revenue for the three months ended September 30, 2021 and 2020 was $4.1 million and $4.4 million, respectively, representing a decrease of $0.4 million, or 8%.
The decrease in cost of revenue was driven primarily by a 16% decrease in part production, partially offset by an 8% increase in cost per item produced.
Selling, General and Administrative
Selling, general, and administrative (“SG&A”) expenses for the three months ended September 30, 2021 and 2020 were $4.4 million and $2.5 million, respectively, representing an increase of $1.9 million, or 77%. The increase in SG&A expenses was primarily due to increase in marketing spending, such as branding and Search Engine Marketing to drive growth, an increase in audit and other spending related to becoming a public company, and an increase in stock-based compensation due to vesting acceleration of certain executives.
Research and Development
Research and development expenses for the three months ended September 30, 2021 and 2020 were $1.7 million and $1.5 million, respectively, representing an increase of $0.2 million, or 10%. The increase in research and development expenses was primarily due to an increase in personnel cost.
Interest Expense
Interest expense for was $0.1 for the three months ended September 30, 2021 and 2020, respectively.
Change in fair value of warrant liabilities
Change in fair value of warrant liabilities increased by $5,088 million and resulted in a gain for the three months ended September 30, 2021. The increase related to the decrease in fair value of the Private and Sponsor Warrants assumed pursuant to the Merger.
Income Taxes
The Company did not record an income tax benefit for the three months ended September 30, 2021 and 2020, respectively.
 
30

Comparison of the Nine Months Ended September 30, 2021 and 2020
Revenue
 
    
Nine Months Ended September 30,
    
Change
 
(Dollars in thousands)
  
2021
    
2020
    
$        
    
%        
 
Revenue
   $ 25,354    $ 23,028    $ 2,326      10
Revenue for the nine months ended September 30, 2021 and 2020 was $25.4 million and $23.0 million, respectively, representing an increase of $2.3 million, or 10%. The increase in total revenue was primarily attributable to an 11% higher average price per product, partially offset by 1% decrease in products shipped. Shapeways has continued to optimize our pricing algorithm and mix of technology offerings, resulting in this higher average price per product.
Cost of Revenue
 
    
Nine Months Ended September 30,
    
Change
 
(Dollars in thousands)
  
2021
    
2020
    
$        
    
%        
 
Cost of Revenue
   $ 13,271    $ 13,030    $    241        2
Cost of revenue for the nine months ended September 30, 2021 and 2020 was $13.3 million and $13.0 million, respectively, representing an increase of $0.2 million, or 2%. The increase in cost of revenue was driven primarily by a 3% increase in cost per item produced, partially offset by a 1% decrease in part production.
Selling, General and Administrative
Selling, general, and administrative (“SG&A”) expenses for the nine months ended September 30, 2021 and 2020 were $10.5 million and $8.1 million, respectively, representing an increase of $2.4 million, or 30%. The increase in selling, general and administrative expenses resulted from an increase to personnel cost, marketing spend, advertising, office expense, and audit and other spending related to becoming a public company.
Research and Development
Research and development expenses for the nine months ended September 30, 2021 and 2020 were $4.1 million and $4.3 million, respectively, representing a decrease of $0.2 million, or 4%. The decrease in research and development expenses was primarily due to a decrease in rent expense.
Debt Forgiveness
Debt forgiveness for the nine months ended September 30, 2021 was $2.0 million, relating to our Payroll Protection Program (“PPP”) loan, which we expect to reverse in the period following the closing of the Business Combination when the PPP loan is repaid. We had no debt forgiveness during the nine months ended September 30, 2020.
Interest Expense
Interest expense was $0.4 for the nine months ended September 30, 2021 and 2020, respectively.
Change in fair value of warrant liabilities
Refer to discussion on change in fair value of warrant liabilities during the three months ended September 30, 2021 and 2020 above.
Income Taxes
Income tax benefit was $0.1 million for the nine months ended September 30, 2021. Shapeways received resolution of a tax assessment charge for 2019 in respect of our Dutch subsidiary, resulting in a refund during the nine months ended September 30, 2021, and we had no income tax benefit during the nine months ended September 30, 2020.
Shapeways has provided a valuation allowance for all of its deferred tax assets as a result of our historical net losses in the jurisdictions in which we operate. Shapeways continues to assess our future taxable income by jurisdiction based on its recent historical operating
 
31

results, the expected timing of reversal of temporary differences, various tax planning strategies that we may be able to enact in future periods, the impact of potential operating changes on its business and its forecast results from operations in future periods based on available information at the end of each reporting period. To the extent that Shapeways is able to reach the conclusion that deferred tax assets are realizable based on any combination of the above factors in a single, or multiple, taxing jurisdictions, a reversal of the related portion of its existing valuation allowances may occur.
Non-GAAP
Financial Information
In addition to Shapeways’ results determined in accordance with GAAP, Shapeways believes that Adjusted EBITDA, a
non-GAAP
financial measure, is useful in evaluating our operational performance. Shapeways uses this
non-GAAP
financial information to evaluate our ongoing operations and for internal planning and forecasting purposes. Shapeways believes that this
non-GAAP
financial information, when taken collectively, may be helpful to investors in assessing our operating performance.
Shapeways defines Adjusted EBITDA as net income (loss) excluding debt forgiveness, interest expense, income taxes, depreciation and amortization expense, and change in fair value of warrant liabilities. In the future, Shapeways expects to report Adjusted EBITDA with an additional adjustment for stock based compensation expense.
Shapeways believes that the use of Adjusted EBITDA provides an additional tool for investors to use in evaluating ongoing operating results and trends because it eliminates the effect of financing and capital expenditures and provides investors with a means to compare its financial measures with those of comparable companies, which may present similar
non-GAAP
financial measures to investors. However, you should be aware that when evaluating Adjusted EBITDA Shapeways may incur future expenses similar to those excluded when calculating these measures. In addition, Shapeways’ presentation of these measures should not be construed as an inference that our future results will be unaffected by unusual or
non-recurring
items.
Because of these limitations, Adjusted EBITDA should not be considered in isolation or as a substitute for performance measures calculated in accordance with GAAP. Shapeways compensates for these limitations by relying primarily on our GAAP results and using Adjusted EBITDA on a supplemental basis. You should review the reconciliation of net income (loss) to Adjusted EBITDA below and not rely on any single financial measure to evaluate Shapeways’ business.
The following table reconciles net income (loss) to Adjusted EBITDA for the three months ended September 30, 2021 and 2020 and for the nine months ended September 30, 2021 and 2020:
 
    
Three Months Ended September 30,
    
Nine Months Ended September 30,
 
(Dollars in thousands)
  
2021
    
2020
    
2021
    
2020
 
Net income (loss)
   $ 2,552      $ (450    $ 4,125      $ (2,920
Debt forgiveness
     —          —          (2,000      —    
Interest expense
     126        141        407        444  
Depreciation and amortization
     33        37        100        113  
Change in fair value of warrant liabilities
     (5,088      —          (5,088      —    
Income tax benefit
     —          —          (71      —    
    
 
 
    
 
 
    
 
 
    
 
 
 
Adjusted EBITDA
   $ (2,377    $ (272    $ (2,527    $ (2,363
    
 
 
    
 
 
    
 
 
    
 
 
 
Liquidity and Capital Resources
Shapeways has incurred a net loss in each of its annual reporting periods since its inception. As of September 30, 2021, Shapeways had $90.1 million in cash and cash equivalents and $0.1 in restricted cash. Up until the Business Combination, Shapeways primarily obtained cash to fund its operations through preferred stock offerings and debt instruments.
Since inception through closing of the Business Combination, Shapeways has received cumulative net proceeds from the sale of its preferred and common stock of approximately $110 million to fund its operations.
 
32

In October 2018, Shapeways entered into a five-year, $5.0 million term loan. Interest is calculated using the Wall Street Journal Prime rate plus 25 basis points, payable monthly in arrears. If its domestic cash falls below $2.5 million, Shapeways will be in default under the loan agreement. In connection with this loan, Shapeways is also subject to periodic reporting requirements, and the lender has a first priority lien on all assets. Repayment terms included interest only payments for 12 months. Shapeways negotiated a three-month principal payment deferment in the second quarter of 2020 due to
COVID-19.
Shapeways paid off this term loan in connection with the closing of the Business Combination.
In June 2019, Shapeways received a $5.0 million bridge loan from existing investors, which bore interest at 8% annually. The loan converted into Shapeways’ Series E Preferred Stock at a price per share equal to the Series E liquidation preference immediately prior to the closing of the Business Combination.
In May 2020, Shapeways received loan proceeds in the amount of approximately $2.0 million under the PPP. The PPP, established as part of the CARES Act, provided for loans to qualifying businesses. Although the PPP loan has been forgiven, Shapeways intends to repay the loan in its entirety in the period after the closing of the Business Combination.
In September 2021, we consummated the Business Combination which provided gross proceeds resulting from the Merger and PIPE Investment of approximately $28.1 million and $75.0 million, respectively, to Shapeways’ balance sheet, for a total of approximately $86.8 million in net proceeds after transaction costs.
Our growth strategy includes exploring strategic partnerships. On March 26, 2021, we entered into a non-binding Memorandum of Understanding (“MOU”) with Desktop Metal, pursuant to which Desktop Metal agreed to invest $20.0 million in the PIPE Investment. Upon consummation of this investment, we became obligated to purchase $20.0 million of equipment, materials and services from Desktop Metal. In conjunction with these obligations, we and Desktop Metal agreed to develop a strategic partnership. In November 2021, we paid $3.5 million to Desktop Metal for equipment received, and
has a commitment to place purchase orders for another 
$16.5 million
of equipment and materials under the 
MOU by or before December 31, 2021.
Shapeways believes that its current cash and cash equivalents will be sufficient to meet its working capital needs for the twelve months following the issuance date of its unaudited condensed consolidated financial statements included within this Report. Its ability to transition to more profitable operations is dependent upon achieving a level of revenue adequate to support its evolving cost structure. If events or circumstances occur such that Shapeways does not meet its operating plan as expected, Shapeways will be required to reduce corporate overhead or other operating expenses, which could have an adverse impact on its ability to achieve intended business objectives or obtain additional financing. If Shapeways anticipates that its actual results will differ from its operating plan, Shapeways believes it will have sufficient capabilities to enact cost savings measures to preserve capital. There can be no assurance that Shapeways will be successful in implementing its business objectives, however, Shapeways believes that external sources of funding will be available in such circumstances.
As of the date of this Report, we believe our existing cash resources are sufficient to support planned operations for the next 12 months. Shapeways expects to continue to incur net losses in connection with its ongoing activities, particularly as Shapeways invests in hiring, growth-related operating expenditures, and capital expenditures in respect of new digital manufacturing technologies. Additionally, Shapeways may engage in future acquisitions.
Cash Flow Summary for the nine months ended September 30, 2021 and 2020
The following table sets forth a summary of cash flows for the periods presented:
 
    
Nine Months Ended
September 30,
 
(Dollars in thousands)
  
2021
    
2020
 
Net cash used in operating activities
   $ (2,250    $ (2,854
Ned cash used in investing activities
     (125      (23
Net cash provided by financing activities
     83,945        1,182  
    
 
 
    
 
 
 
Net change in cash and cash equivalents and restricted cash
   $ 81,570      $ (1,695
    
 
 
    
 
 
 
Operating Activities
During the nine months ended September 30, 2021, net cash used in operating activities was $2.3 million, primarily resulting from net loss of $4.1 million, reduced by
non-cash
charges of $5.2 million, including $2.0 million of
non-cash
debt forgiveness and $5.1 million of
non-cash
change in fair value of warrant liabilities, partially offset by $0.7 million of
non-cash
lease expense, $0.8 million of stock-based compensation expense and $0.4 million of depreciation and amortization; and a decrease in operating assets and liabilities of $1.2 million.
 
33

During the nine months ended September 30, 2020, net cash used in operating activities was $2.9 million, primarily resulting from net loss of $2.9, reduced by
non-cash
charges of $2.5 million, including $1.6 million of
non-cash
lease expense, $0.5 million of stock-based compensation expense and $0.4 million of depreciation and amortization; and a decrease in operating assets and liabilities of $2.4 million.
Investing Activities
During the nine months ended September 30, 2021, net cash used in investing activities was $0.13 million resulting from the purchase of property and equipment.
During the nine months ended September 30, 2020, net cash used in investing activities $0.02 million resulting from the purchase of property and equipment.
Financing Activities
During the nine months ended September 30, 2021, net cash provided by financing activities was $83.9 million primarily resulting from the effect of the Merger, (net of transaction costs) of $86.8 million, partially offset by repayments of loans payable of $3.5 million.
During the nine months ended September 30, 2020, net cash provided by financing activities was $1.2 million resulting primarily from proceeds from loans payable of $2.0 million, partially offset by repayments of loans payable of $0.9 million.
Contractual Obligations and Commitments
See Note 9, Commitments and Contingencies, of the notes to the unaudited condensed consolidated financial statements for the nine months ended September 30, 2021 and 2020 included elsewhere in this Report for further discussion of Shapeways’ commitments and contingencies.
Off-Balance
Sheet Arrangements
Shapeways has no
off-balance
sheet arrangements and does not utilize any “structured debt,” “special purpose” or similar unconsolidated entities for liquidity or financing purposes.
Critical Accounting Policies and Significant Estimates
Shapeways’ discussion and analysis of financial condition and results of operations are based upon its unaudited condensed consolidated financial statements, which have been prepared in accordance with U.S. GAAP. Certain of Shapeways’ accounting policies require the application of judgment in selecting the appropriate assumptions for calculating financial estimates. By their nature, these judgments are subject to an inherent degree of uncertainty. Shapeways periodically evaluates the judgments and estimates used for its critical accounting policies to ensure that such judgments and estimates are reasonable for its interim and
year-end
reporting requirements. These judgments and estimates are based on its historical experience (where available), current trends and information available from other sources, as appropriate. If different conditions result from those assumptions used in its judgments, the results could be materially different from Shapeways’ estimates. Shapeways believes the following critical accounting policies requires significant judgments and estimates in the preparation of its consolidated financial statements:
Revenue Recognition
Shapeways recognizes revenue from sale of products (both direct sales and marketplace sales) upon transfer of control, which is generally at the point of shipment.
Shapeways’ software contracts with customers often include promises to transfer multiple software elements to the customer. Revenue from sale of software may be recognized over the life of the associated software contract or as services are performed, depending on the nature of the services being provided. Judgment is required to determine the separate performance obligations present in a given contract, which Shapeways has concluded are generally capable of being distinct and accounted for as separate performance obligations. Shapeways uses standalone selling price (“SSP”) to allocate revenue to each performance obligation. Significant judgment is required to determine the SSP for each distinct performance obligation in a contract.
Shapeways provides a platform for shop owners to sell their products to customers through Shapeways’ marketplace website. Shapeways receives a 3.5% markup fee from the shop owner upon the sale of any products through the marketplace. Shapeways handles the financial transaction, manufacturing, distribution and customer service on behalf of the shop owners. Shapeways is responsible for billing the customer in this arrangement and transmitting the applicable fees to the shop owner. Shapeways assesses whether it is responsible for
 
34

providing the actual product or service as a principal, or for arranging for the product or service to be provided by the third party as an agent. Judgment is applied to determine whether Shapeways is the principal or the agent by evaluating whether it has control of the product or service prior to it being transferred to the customer. The principal versus agent assessment is performed at the performance obligation level. Indicators that Shapeways considers include whether it has the primary responsibility for fulfilling the promise to provide the specified product or service to the customer and whether it has inventory risk prior to transferring the product or service to the customer. Shapeways has the responsibility to fulfill the promise to provide the specific good or service on behalf of the shop owners to the customer. In addition, Shapeways has inventory risk before the specific good or service is transferred to a customer. As such, Shapeways is deemed the principal and shall recognize revenue on a gross basis for the price it charges to the shop owner for each product or service.
Stock-Based Compensation
Shapeways has applied the fair value recognition provisions of Financial Accounting Standards Board (“FASB”) Accounting Standards Codification (“ASC”) Topic 718
Compensation-Stock Compensation
to account for the stock-based compensation for employees and
non-employees.
Shapeways recognizes compensation costs related to stock options granted to employees and
non-employees
based on estimated fair value of the award on the date of grant.
Prior to the Business Combination, the estimated fair value of Shapeways’ common shares has historically been determined by a third party appraisal. Subsequent to the Business Combination, Shapeways determines the fair value of the common stock based on the closing market price on the date of grant. Shapeways uses the Black-Scholes option pricing model to estimate the fair value of options granted which requires the use of subjective assumptions that could materially impact the estimation of fair value and related compensation expense to be recognized. One of these assumptions include the expected volatility of our stock price. Developing this assumption requires the use of judgment. Shapeways, both prior to and after the Merger, lacks historical and implied volatility information. Therefore, we estimate our expected stock volatility based on the historical volatility of representative companies from the additive manufacturing industry. Shapeways uses the simplified method as prescribed by the SEC Staff Accounting Bulletin No. 107, Share-Based Payment as Shapeways does not have sufficient historical stock option activity data to provide a reasonable basis upon which to estimate the expected term of stock options granted to employees and
non-employees.
Shapeways utilizes a dividend yield of zero based on the fact that Shapeways has never paid and are not expected to pay cash dividends. The risk-free interest rate used for each grant is an interpolated rate to match the term assumption based on the U.S. Treasury yield curve as of the valuation date.
Warrant Liabilities
We account for warrants as either equity-classified or liability-classified instruments based on an assessment of the warrant’s specific terms and applicable authoritative guidance in FASB’s ASC 480, Distinguishing Liabilities from Equity (“ASC 480”) and ASC 815, Derivatives and Hedging (“ASC 815”). The assessment considers whether the warrants are freestanding financial instruments pursuant to ASC 480, meet the definition of a liability pursuant to ASC 480, and whether the warrants meet all of the requirements for equity classification under ASC 815, including whether the warrants are indexed to the Company’s own common stock and whether the warrant holders could potentially require “net cash settlement” in a circumstance outside of the Company’s control, among other conditions for equity classification. This assessment, which requires the use of professional judgment, is conducted at the time of warrant issuance and as of each subsequent quarterly period end date while the warrants are outstanding.
For issued or modified warrants that meet all of the criteria for equity classification, the warrants are required to be recorded as a component of additional
paid-in
capital at the time of issuance. For issued or modified warrants that do not meet all the criteria for equity classification, the warrants are required to be recorded at their initial fair value on the date of issuance, and each balance sheet date thereafter. Changes in the estimated fair value of the warrants are recognized as a
non-cash
gain or loss on the statements of operations. The fair value of the Private Warrants and Sponsor Warrants were estimated using a Binomial Lattice Model.
Recent Accounting Pronouncements
Refer to Note 2 of Shapeways’ unaudited condensed consolidated financial statements found elsewhere in this Report.
Item 3. Quantitative and Qualitative Disclosures About Market Risk
Because we are a “smaller reporting company” as defined in Rule
12b-2
of the Securities Exchange Act of 1934 we are not required to provide the information under this item.
 
35

Item 4. Controls and Procedures
(a) Evaluation of Disclosure Controls and Procedures
We maintain disclosure controls and procedures that are designed to ensure that information required to be disclosed in our reports filed under the Securities Exchange Act of 1934, as amended, is recorded, processed, summarized and reported within the time periods specified in the SEC’s rules and forms, and that such information is accumulated and communicated to our management, including our Chief Executive Officer and Chief Financial Officer or persons performing similar functions, to allow for timely decisions regarding required disclosure.
In accordance with Rules
13a-15(b)
under the Exchange Act, we carried out an evaluation, under the supervision and with the participation of our management, including our Chief Executive Officer and Chief Financial Officer, of the effectiveness of our disclosure controls and procedures as of September 30, 2021, which is the end of the three-month period covered by this Quarterly Report on Form
10-Q.
Based on this evaluation, our Chief Executive Officer and Chief Financial Officer have concluded that during the period covered by this Report, our disclosure controls and procedures were effective at a reasonable assurance level and, accordingly, provided reasonable assurance that the information required to be disclosed by us in reports filed under the Exchange Act is recorded, processed, summarized and reported within the time periods specified in the SEC’s rules and forms.
(b) Changes in Internal Control Over Financial Reporting
During the fiscal quarter ended September 30, 2021, we completed the Business Combination with Galileo, and the internal controls of Shapeways, Inc. became our internal controls. We are engaged in the process of the design and implementation of our internal control over financial reporting (as defined in Rules
13a-15(f)
and
15d-15(f)
under the Exchange Act) in a manner commensurate with the scale of our operations subsequent to the Business Combination.
There have been no other changes in our internal control over financial reporting during the fiscal quarter ended September 30, 2021, that has materially affected, or is reasonably likely to materially affect, our internal control over financial reporting.
 
36

Part II - Other Information
Item 1. Legal Proceedings
The Company is involved in various legal proceedings which arise from time to time in the normal course of business. While the results of such matters generally cannot be predicted with certainty, management does not expect any such matters to have a material adverse effect on the Company’s consolidated financial position or results of operations as of the date of this Report.
Item 1A. Risk Factors
Our Current Report on Form 8-K, filed with the SEC, on October 5, 2021, describes important risk factors that could cause our business, financial condition, results of operations and growth prospects to differ materially from those indicated or suggested by forward-looking statements made in this Quarterly Report on Form 10-Q or presented elsewhere by management from time to time. There have been no material changes in the risk factors that appear in our Current Report on Form 8-K, other than those listed below. Additional risks and uncertainties not currently known to us or that we currently deem to be immaterial may also materially and adversely affect our business.
Our actual results may be significantly different from our projections, estimates, targets, or forecasts.
Our projections, estimates, targets, and forecasts are forward-looking statements that are based on assumptions that are inherently subject to significant uncertainties and contingencies, many of which are beyond our control. In November 2021, Shapeways revised its projected revenues for 2021 from $38.0 million to a range of $32.5 to $33.5 million. While all projections, estimates, targets and forecasts are necessarily speculative, we believe that the preparation of prospective financial information involves increasingly higher levels of uncertainty the further out the projection, estimate, target, or forecast extends from the date of preparation. The assumptions and estimates underlying the projected, expected, or target results are inherently uncertain and are subject to a wide variety of significant business, economic, regulatory and competitive risks and uncertainties that could cause actual results to differ materially from those contained in such projections, estimates, targets and forecasts. Our projections, estimates, targets and forecast should not be regarded as an indication that Shapeways or its representatives, considered or consider the financial projections, estimates, targets to be a reliable prediction of future events.
Item 2. Unregistered Sales of Equity Securities and Use of Proceeds
None.
Item 3. Defaults upon Senior Securities
None.
Item 4. Mine Safety Disclosures
Not applicable.
Item 5. Other Information.
Not applicable.
 
37

Item 6. Exhibits.
 
Exhibit No.
  
Description
    3.1    Certificate of Incorporation of Shapeways Holdings, Inc. (incorporated by reference to Exhibit 3.1 to the Company’s Current Report on Form 8-K (File No. 001-39092), filed with the SEC on October 5, 2021).
    3.2    Bylaws of Shapeways Holdings, Inc. (incorporated by reference to Exhibit 3.2 to the Company’s Current Report on Form 8-K (File No. 001-39092), filed with the SEC on October 5, 2021).
    4.1    Certificate of Corporate Domestication of Galileo Acquisition Corp. (incorporated by reference to Exhibit 3.3 to the Company’s Registration Statement on Form S-1 (File No. 333-260387), filed with the SEC on October 20, 2021).
  10.1    Amendment to Share Escrow Agreement, dated as of September 29, 2021, by and among Galileo Acquisition Corp., Galileo Founders Holdings, L.P., Continental Stock Transfer & Trust Company, as escrow agent (incorporated by reference to Exhibit 10.5 to the Company’s Current Report on Form 8-K (File No. 001-39092), filed with the SEC on October 5, 2021).
  10.2    First Amendment to Registration Rights Agreement, dated September 29, 2021, by and among Galileo Acquisition Corp., Galileo Founders Holdings, L.P. and the investors party thereto (incorporated by reference to Exhibit 10.21 to the Company’s Current Report on Form 8-K (File No. 001-39092), filed with the SEC on October 5, 2021).
  10.3    Registration Rights Agreement, dated September 29, 2021, by and among Galileo Acquisition Corp. and the investors party thereto (incorporated by reference to Exhibit 10.22 to the Company’s Current Report on Form 8-K (File No. 001-39092), filed with the SEC on October 5, 2021).
  10.4    Shapeways Holdings, Inc. 2021 Equity Incentive Plan (incorporated by reference to Exhibit 10.18 to the Company’s Current Report on Form 8-K (File No. 001-39092), filed with the SEC on October 5, 2021).
  10.5    Shapeways Holdings, Inc. 2021 Employee Stock Purchase Plan (incorporated by reference to Exhibit 10.19 to the Company’s Current Report on Form 8-K (File No. 001-39092), filed with the SEC on October 5, 2021).
  10.6    Employment Agreement, dated as of July 19, 2021, by and between Shapeways Holdings, Inc. and Greg Kress (incorporated by reference to Exhibit 10.11 to the Company’s Current Report on Form 8-K (File No. 001-39092), filed with the SEC on October 5, 2021).
  10.7    Employment Agreement, dated as of July 19, 2021, by and between Shapeways Holdings, Inc. and Jennifer Walsh (incorporated by reference to Exhibit 10.12 to the Company’s Current Report on Form 8-K (File No. 001-39092), filed with the SEC on October 5, 2021).
  10.8    Employment Agreement, dated as of July 19, 2021, by and between Shapeways Holdings, Inc. and Miko Levy (incorporated by reference to Exhibit 10.13 to the Company’s Current Report on Form 8-K (File No. 001-39092), filed with the SEC on October 5, 2021).
  31.1    Certification of the Chief Executive Officer required by Rule 13a-14(a) or Rule 15d-14(a).*
  31.2    Certification of the Chief Financial Officer required by Rule 13a-14(a) or Rule 15d-14(a).*
  32.1    Certification of the Chief Executive Officer required by Rule 13a-14(b) or Rule 15d-14(b) and 18 U.S.C. 1350**
  32.2    Certification of the Chief Financial Officer required by Rule 13a-14(b) or Rule 15d-14(b) and 18 U.S.C. 1350**
  101.INS    XBRL Instance Document
  101.SCH    XBRL Taxonomy Extension Schema
  101.CAL    XBRL Taxonomy Extension Calculation Linkbase
  101.DEF    XBRL Taxonomy Extension Definition Linkbase
  101.LAB    XBRL Taxonomy Extension Label Linkbase
  101.PRE    XBRL Taxonomy Extension Presentation Linkbase
  104    Cover Page Interactive Data File (embedded within the Inline XBRL document)
 
*
Filed herewith
**
Furnished herewith
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this Report to be signed on its behalf by the undersigned, thereunto duly authorized.
 
   
Shapeways Holdings, Inc.
Dated: November 15, 2021    
By: /s/ Jennifer Walsh
    Jennifer Walsh
    Chief Financial Officer
   
(Principal Financial and Accounting Officer)
 
 
38
EX-31.1 2 d216471dex311.htm EX-31.1 EX-31.1

Exhibit 31.1

CERTIFICATION OF THE CHIEF EXECUTIVE OFFICER

PURSUANT TO RULE 13a-14(a) AND 15d-14(a),

AS ADOPTED PURSUANT TO SECTION 302 OF THE SARBANES-OXLEY ACT OF 2002

I, Greg Kress, Chief Executive Officer of Shapeways Holdings, Inc., certify that:

 

1.

I have reviewed this Quarterly Report on Form 10-Q of Shapeways Holdings, Inc. (the “Registrant”);

 

2.

Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this Quarterly Report;

 

3.

Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations, and cash flows of the Registrant as of, and for, the periods presented in this Quarterly Report;

 

4.

The Registrant’s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the Registrant and have:

 

  a.

Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the Registrant is made known to us by others within those entities, particularly during the period in which this Quarterly Report is being prepared;

 

  b.

Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

 

  c.

Evaluated the effectiveness of the Registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

 

  d.

Disclosed in this report any change in the Registrant’s internal control over financial reporting that occurred during the Registrant’s most recent fiscal quarter (the Registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the Registrant’s internal control over financial reporting; and

 

5.

The Registrant’s other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the Registrant’s auditors and the audit committee of the Registrant’s board of directors (or persons performing equivalent functions):

 

  a.

All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the Registrant’s ability to record, process, summarize and report financial information; and

 

  b.

Any fraud, whether or not material, that involves management or other employees who have a significant role in the Registrant’s internal control over financial reporting.

 

    Shapeways Holdings, Inc.
Dated: November 15, 2021    

By: /s/ Greg Kress

    Greg Kress
    Chief Executive Officer and Director
    (Principal Executive Officer)
EX-31.2 3 d216471dex312.htm EX-31.2 EX-31.2

Exhibit 31.2

CERTIFICATION OF THE CHIEF FINANCIAL OFFICER

PURSUANT TO RULE 13a-14(a) AND 15d-14(a),

AS ADOPTED PURSUANT TO SECTION 302 OF THE SARBANES-OXLEY ACT OF 2002

I, Jennifer Walsh, Chief Financial Officer of Shapeways Holdings, Inc., certify that:

 

1.

I have reviewed this Quarterly Report on Form 10-Q of Shapeways Holdings, Inc. (the “Registrant”);

 

2.

Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this Quarterly Report;

 

3.

Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations, and cash flows of the Registrant as of, and for, the periods presented in this Quarterly Report;

 

4.

The Registrant’s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the Registrant and have:

 

  a.

Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the Registrant is made known to us by others within those entities, particularly during the period in which this Quarterly Report is being prepared;

 

  b.

Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

 

  c.

Evaluated the effectiveness of the Registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

 

  d.

Disclosed in this report any change in the Registrant’s internal control over financial reporting that occurred during the Registrant’s most recent fiscal quarter (the Registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the Registrant’s internal control over financial reporting; and

 

5.

The Registrant’s other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the Registrant’s auditors and the audit committee of the Registrant’s board of directors (or persons performing equivalent functions):

 

  a.

All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the Registrant’s ability to record, process, summarize and report financial information; and

 

  b.

Any fraud, whether or not material, that involves management or other employees who have a significant role in the Registrant’s internal control over financial reporting.

 

    Shapeways Holdings, Inc.
Dated: November 15, 2021    

By: /s/ Jennifer Walsh

    Jennifer Walsh
    Chief Financial Officer
    (Principal Financial and Accounting Officer)
EX-32.1 4 d216471dex321.htm EX-32.1 EX-32.1

Exhibit 32.1

CERTIFICATION OF THE CHIEF EXECUTIVE OFFICER

PURSUANT TO 18 U.S.C. SECTION 1350,

AS ADOPTED PURSUANT TO SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

In connection with the filing of the Quarterly Report on Form 10-Q for the nine months ended September 30, 2021 (the “Report”) by Shapeways Holdings, Inc. (the “Registrant”), I, Greg Kress as Chief Executive Officer of the Registrant hereby certify pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that, to the best of my knowledge:

 

  1.

the Report fully complies with the requirements of Section 13(a) or Section 15(d) of the Securities Exchange Act of 1934, as amended; and

 

  2.

the information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Registrant.

 

    Shapeways Holdings, Inc.
Dated: November 15, 2021    

By: /s/ Greg Kress

    Greg Kress
    Chief Executive Officer and Director
    (Principal Executive Officer)
EX-32.2 5 d216471dex322.htm EX-32.2 EX-32.2

Exhibit 32.2

CERTIFICATION OF THE CHIEF FINANCIAL OFFICER

PURSUANT TO 18 U.S.C. SECTION 1350,

AS ADOPTED PURSUANT TO SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

In connection with the filing of the Quarterly Report on Form 10-Q for the nine months ended September 30, 2021 (the “Report”) by Shapeways Holdings, Inc. (the “Registrant”), I, Jennifer Walsh as Chief Financial Officer of the Registrant hereby certify pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that, to the best of my knowledge:

 

  1.

the Report fully complies with the requirements of Section 13(a) or Section 15(d) of the Securities Exchange Act of 1934, as amended; and

 

  2.

the information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Registrant.

 

    Shapeways Holdings, Inc.
Dated: November 15, 2021    

By: /s/ Jennifer Walsh

    Jennifer Walsh
    Chief Financial Officer
    (Principal Financial and Accounting Officer)
EX-101.SCH 6 shpw-20210930.xsd XBRL TAXONOMY EXTENSION SCHEMA 1001 - Document - Cover Page link:presentationLink link:definitionLink link:calculationLink 1002 - Statement - Condensed Consolidated Balance Sheets link:presentationLink link:definitionLink link:calculationLink 1003 - Statement - Condensed Consolidated Balance Sheets (Parenthetical) link:presentationLink link:definitionLink link:calculationLink 1004 - Statement - Condensed Consolidated Statements of Operations and Comprehensive Loss link:presentationLink link:definitionLink link:calculationLink 1005 - Statement - Condensed Consolidated Statements of Changes in Stockholders' Equity (Deficit) link:presentationLink link:definitionLink link:calculationLink 1006 - Statement - Condensed Consolidated Statements of Cash Flows link:presentationLink link:definitionLink link:calculationLink 1007 - Disclosure - Organization link:presentationLink link:definitionLink link:calculationLink 1008 - Disclosure - Summary of Significant Accounting Policies link:presentationLink link:definitionLink link:calculationLink 1009 - Disclosure - Reverse Recapitalization link:presentationLink link:definitionLink link:calculationLink 1010 - Disclosure - Revenue Recognition link:presentationLink link:definitionLink link:calculationLink 1011 - Disclosure - Inventory link:presentationLink link:definitionLink link:calculationLink 1012 - Disclosure - Prepaid Expenses and Other Current Assets link:presentationLink link:definitionLink link:calculationLink 1013 - Disclosure - Property and Equipment, net link:presentationLink link:definitionLink link:calculationLink 1014 - Disclosure - Accrued Expenses and Other Liabilities link:presentationLink link:definitionLink link:calculationLink 1015 - Disclosure - Commitments and Contingencies link:presentationLink link:definitionLink link:calculationLink 1016 - Disclosure - Borrowing Arrangements link:presentationLink link:definitionLink link:calculationLink 1017 - Disclosure - Stockholders' Equity (Deficit) link:presentationLink link:definitionLink link:calculationLink 1018 - Disclosure - Stock-Based Compensation link:presentationLink link:definitionLink link:calculationLink 1019 - Disclosure - Fair Value Measurements link:presentationLink link:definitionLink link:calculationLink 1020 - Disclosure - Significant Concentrations link:presentationLink link:definitionLink link:calculationLink 1021 - Disclosure - Related Party Transactions link:presentationLink link:definitionLink link:calculationLink 1022 - Disclosure - Subsequent Events link:presentationLink link:definitionLink link:calculationLink 1023 - Disclosure - Summary of Significant Accounting Policies (Policies) link:presentationLink link:definitionLink link:calculationLink 1024 - Disclosure - Summary of Significant Accounting Policies (Tables) link:presentationLink link:definitionLink link:calculationLink 1025 - Disclosure - Reverse Recapitalization (Tables) link:presentationLink link:definitionLink link:calculationLink 1026 - Disclosure - Revenue Recognition (Tables) link:presentationLink link:definitionLink link:calculationLink 1027 - Disclosure - Inventory (Tables) link:presentationLink link:definitionLink link:calculationLink 1028 - Disclosure - Prepaid Expenses and Other Current Assets (Tables) link:presentationLink link:definitionLink link:calculationLink 1029 - Disclosure - Property and Equipment, net (Tables) link:presentationLink link:definitionLink link:calculationLink 1030 - Disclosure - Accrued Expenses and Other Liabilities (Tables) link:presentationLink link:definitionLink link:calculationLink 1031 - Disclosure - Commitments and Contingencies (Tables) link:presentationLink link:definitionLink link:calculationLink 1032 - Disclosure - Borrowing Arrangements (Tables) link:presentationLink link:definitionLink link:calculationLink 1033 - Disclosure - Stock-Based Compensation (Tables) link:presentationLink link:definitionLink link:calculationLink 1034 - Disclosure - Fair Value Measurements (Tables) link:presentationLink link:definitionLink link:calculationLink 1035 - Disclosure - Organization (Details) link:presentationLink link:definitionLink link:calculationLink 1036 - Disclosure - Summary of Significant Accounting Policies (Details) link:presentationLink link:definitionLink link:calculationLink 1037 - Disclosure - Summary of Significant Accounting Policies - Summary of reconciliation of cash and cash equivalents (Details) link:presentationLink link:definitionLink link:calculationLink 1038 - Disclosure - Summary of Significant Accounting Policies - Summary of useful lives of property plant and equipment (Details) link:presentationLink link:definitionLink link:calculationLink 1039 - Disclosure - Summary of Significant Accounting Policies - Summary of common stock equivalents outstanding were excluded from computation of diluted net loss per share (Details) link:presentationLink link:definitionLink link:calculationLink 1040 - Disclosure - Reverse Recapitalization - Schedule of common stock shares issued following the consummation of merger (Details) link:presentationLink link:definitionLink link:calculationLink 1041 - Disclosure - Reverse Recapitalization - Schedule of reconciles the elements of business combination to the unaudited consolidated statement of changes in stockholders equity (Details) link:presentationLink link:definitionLink link:calculationLink 1042 - Disclosure - Reverse Recapitalization - Schedule of common stock shares issued following the consummation of business combination (Details) link:presentationLink link:definitionLink link:calculationLink 1043 - Disclosure - Reverse Recapitalization - Schedule of common stock shares issued following the consummation of business combination (Parenthetical) (Details) link:presentationLink link:definitionLink link:calculationLink 1044 - Disclosure - Reverse Recapitalization (Details) link:presentationLink link:definitionLink link:calculationLink 1045 - Disclosure - Revenue Recognition - Marketplace sales (Details) link:presentationLink link:definitionLink link:calculationLink 1046 - Disclosure - Revenue Recognition - Disaggregation of revenues (Details) link:presentationLink link:definitionLink link:calculationLink 1047 - Disclosure - Revenue Recognition - Deferred revenues (Details) link:presentationLink link:definitionLink link:calculationLink 1048 - Disclosure - Revenue Recognition - Practical expedients and exemptions (Details) link:presentationLink link:definitionLink link:calculationLink 1049 - Disclosure - Inventory (Details) link:presentationLink link:definitionLink link:calculationLink 1050 - Disclosure - Prepaid Expenses and Other Current Assets (Details) link:presentationLink link:definitionLink link:calculationLink 1051 - Disclosure - Property and Equipment, net (Details) link:presentationLink link:definitionLink link:calculationLink 1052 - Disclosure - Accrued Expenses and Other Liabilities (Details) link:presentationLink link:definitionLink link:calculationLink 1053 - Disclosure - Commitments and Contingencies - Leases (Details) link:presentationLink link:definitionLink link:calculationLink 1054 - Disclosure - Commitments and Contingencies - Company's lease costs (Details) link:presentationLink link:definitionLink link:calculationLink 1055 - Disclosure - Commitments and Contingencies - Right of use assets and lease liabilities for operating leases (Details) link:presentationLink link:definitionLink link:calculationLink 1056 - Disclosure - Commitments and Contingencies - Weighted-average (Details) link:presentationLink link:definitionLink link:calculationLink 1057 - Disclosure - Commitments and Contingencies - Supplemental cash flow (Details) link:presentationLink link:definitionLink link:calculationLink 1058 - Disclosure - Commitments and Contingencies - Future minimum lease payments (Details) link:presentationLink link:definitionLink link:calculationLink 1059 - Disclosure - Commitments and Contingencies - Additional Information (Details) link:presentationLink link:definitionLink link:calculationLink 1060 - Disclosure - Borrowing Arrangements - Term Loan (Details) link:presentationLink link:definitionLink link:calculationLink 1061 - Disclosure - Borrowing Arrangements - Dutch landlord loan (Details) link:presentationLink link:definitionLink link:calculationLink 1062 - Disclosure - Borrowing Arrangements - Outstanding debt obligations (Details) link:presentationLink link:definitionLink link:calculationLink 1063 - Disclosure - Borrowing Arrangements - Convertible promissory notes (Details) link:presentationLink link:definitionLink link:calculationLink 1064 - Disclosure - Borrowing Arrangements - Paycheck protection program loan (Details) link:presentationLink link:definitionLink link:calculationLink 1065 - Disclosure - Stockholders' Equity (Deficit) (Details) link:presentationLink link:definitionLink link:calculationLink 1066 - Disclosure - Stock-Based Compensation - Fair value of stock-based compensation (Details) link:presentationLink link:definitionLink link:calculationLink 1067 - Disclosure - Stock-Based Compensation - Stock option plan (Details) link:presentationLink link:definitionLink link:calculationLink 1068 - Disclosure - Stock-Based Compensation (Details) link:presentationLink link:definitionLink link:calculationLink 1069 - Disclosure - Fair Value Measurements - Initial measurement (Details) link:presentationLink link:definitionLink link:calculationLink 1070 - Disclosure - Fair Value Measurements - Subsequent measurement (Details) link:presentationLink link:definitionLink link:calculationLink 1071 - Disclosure - Fair Value Measurements (Details) link:presentationLink link:definitionLink link:calculationLink 1072 - Disclosure - Significant Concentrations (Details) link:presentationLink link:definitionLink link:calculationLink 1073 - Disclosure - Related Party Transactions (Details) link:presentationLink link:definitionLink link:calculationLink EX-101.CAL 7 shpw-20210930_cal.xml XBRL TAXONOMY EXTENSION CALCULATION LINKBASE EX-101.DEF 8 shpw-20210930_def.xml XBRL TAXONOMY EXTENSION DEFINITION LINKBASE EX-101.LAB 9 shpw-20210930_lab.xml XBRL TAXONOMY EXTENSION LABEL LINKBASE EX-101.PRE 10 shpw-20210930_pre.xml XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE XML 11 d216471d10q_htm.xml IDEA: XBRL DOCUMENT 0001784851 2021-09-30 0001784851 2020-12-31 0001784851 2021-01-01 2021-09-30 0001784851 2020-01-01 2020-09-30 0001784851 2021-07-01 2021-09-30 0001784851 2020-07-01 2020-09-30 0001784851 2021-01-01 2021-03-31 0001784851 2021-04-01 2021-06-30 0001784851 2020-04-01 2020-06-30 0001784851 2020-01-01 2020-12-31 0001784851 2020-01-01 2020-03-31 0001784851 2020-09-30 0001784851 2021-09-29 2021-09-29 0001784851 2021-11-10 0001784851 2020-01-01 0001784851 2019-12-31 0001784851 2021-03-31 0001784851 2021-06-30 0001784851 2020-03-31 0001784851 2020-06-30 0001784851 shpw:WarrantLiabilityMember us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember 2021-09-30 0001784851 shpw:PrivateWarrantsMember 2021-09-30 0001784851 shpw:SponsorWarrantsMember 2021-09-30 0001784851 shpw:PrivatePlacementWarrantsMember us-gaap:FairValueInputsLevel3Member us-gaap:MeasurementInputSharePriceMember 2021-09-30 0001784851 shpw:PrivatePlacementWarrantsMember us-gaap:FairValueInputsLevel3Member us-gaap:MeasurementInputExercisePriceMember 2021-09-30 0001784851 shpw:PrivatePlacementWarrantsMember us-gaap:FairValueInputsLevel3Member us-gaap:MeasurementInputPriceVolatilityMember 2021-09-30 0001784851 shpw:PrivatePlacementWarrantsMember us-gaap:FairValueInputsLevel3Member 2021-09-30 0001784851 shpw:PrivatePlacementWarrantsMember us-gaap:FairValueInputsLevel3Member us-gaap:MeasurementInputExpectedDividendRateMember 2021-09-30 0001784851 shpw:PrivatePlacementWarrantsMember us-gaap:FairValueInputsLevel3Member shpw:MeasurementInputFairValuePerWarrantMember 2021-09-30 0001784851 shpw:PrivatePlacementWarrantsMember us-gaap:FairValueInputsLevel3Member us-gaap:MeasurementInputExpectedTermMember 2021-09-30 0001784851 shpw:RelatedPartyNoteMember srt:OfficerMember 2021-09-30 0001784851 us-gaap:MachineryAndEquipmentMember 2021-09-30 0001784851 us-gaap:ComputerEquipmentMember 2021-09-30 0001784851 us-gaap:FurnitureAndFixturesMember 2021-09-30 0001784851 us-gaap:LeaseholdImprovementsMember 2021-09-30 0001784851 us-gaap:FairValueMeasurementsNonrecurringMember shpw:EarnoutSharesMember 2021-09-30 0001784851 shpw:EarnoutSharesMember 2021-09-30 0001784851 shpw:DutchLandlordLoanMember 2021-09-30 0001784851 shpw:TermLoanMember 2021-09-30 0001784851 us-gaap:ConvertibleNotesPayableMember 2021-09-30 0001784851 shpw:PaymentProtectionProgramLoanMember 2021-09-30 0001784851 shpw:LegacyShapewaysCommonStockWarrantsMember shpw:PriorToTheBusinessCombinationMember 2021-09-30 0001784851 shpw:PublicWarrantsMember 2021-09-30 0001784851 shpw:TwoThousandTwentyOneEquityIncentivePlanMember 2021-09-30 0001784851 shpw:TwoThousandTenStockPlanMember 2021-09-30 0001784851 shpw:ReverseRecapitalizationMember shpw:TradingPriceOneMember 2021-09-30 0001784851 shpw:ReverseRecapitalizationMember shpw:TradingPriceTwoMember 2021-09-30 0001784851 shpw:PipeInvestorsMember shpw:SubscriptionAgreementMember shpw:ReverseRecapitalizationMember 2021-09-30 0001784851 shpw:PublicWarrantsMember shpw:PriorToMergerMember 2021-09-30 0001784851 shpw:BusinessCombinationElementsToUnauditedConsolidatedStatementOfEquityMember shpw:ReverseRecapitalizationMember 2021-09-30 0001784851 shpw:PostBusinessCombinationMember shpw:LegacyShapewaysMember 2021-09-30 0001784851 shpw:UnpaidAndAccruedInterestMember shpw:PostBusinessCombinationMember shpw:LegacyShapewaysMember 2021-09-30 0001784851 shpw:WarrantLiabilityMember us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember 2020-12-31 0001784851 us-gaap:MachineryAndEquipmentMember 2020-12-31 0001784851 us-gaap:ComputerEquipmentMember 2020-12-31 0001784851 us-gaap:FurnitureAndFixturesMember 2020-12-31 0001784851 us-gaap:LeaseholdImprovementsMember 2020-12-31 0001784851 shpw:DutchLandlordLoanMember 2020-12-31 0001784851 shpw:TermLoanMember 2020-12-31 0001784851 us-gaap:ConvertibleNotesPayableMember 2020-12-31 0001784851 shpw:PaymentProtectionProgramLoanMember 2020-12-31 0001784851 us-gaap:AdditionalPaidInCapitalMember 2021-07-01 2021-09-30 0001784851 us-gaap:CommonStockMember 2021-07-01 2021-09-30 0001784851 us-gaap:SeriesDPreferredStockMember us-gaap:CommonStockMember 2021-07-01 2021-09-30 0001784851 shpw:MajorCustomerMember us-gaap:SalesRevenueNetMember us-gaap:CustomerConcentrationRiskMember 2021-07-01 2021-09-30 0001784851 us-gaap:OtherCustomerMember us-gaap:SalesRevenueNetMember us-gaap:CustomerConcentrationRiskMember 2021-07-01 2021-09-30 0001784851 shpw:DirectSalesMember 2021-07-01 2021-09-30 0001784851 shpw:MarketPlaceSalesMember 2021-07-01 2021-09-30 0001784851 us-gaap:SoftwareAndSoftwareDevelopmentCostsMember 2021-07-01 2021-09-30 0001784851 us-gaap:TransferredAtPointInTimeMember 2021-07-01 2021-09-30 0001784851 us-gaap:TransferredOverTimeMember 2021-07-01 2021-09-30 0001784851 us-gaap:RetainedEarningsMember 2021-07-01 2021-09-30 0001784851 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2021-07-01 2021-09-30 0001784851 shpw:DutchLandlordLoanMember 2021-07-01 2021-09-30 0001784851 us-gaap:ConvertibleNotesPayableMember 2021-07-01 2021-09-30 0001784851 shpw:TermLoanMember 2021-07-01 2021-09-30 0001784851 us-gaap:AdditionalPaidInCapitalMember 2020-07-01 2020-09-30 0001784851 us-gaap:CommonStockMember 2020-07-01 2020-09-30 0001784851 shpw:MajorCustomerMember us-gaap:SalesRevenueNetMember us-gaap:CustomerConcentrationRiskMember 2020-07-01 2020-09-30 0001784851 us-gaap:OtherCustomerMember us-gaap:SalesRevenueNetMember us-gaap:CustomerConcentrationRiskMember 2020-07-01 2020-09-30 0001784851 shpw:DirectSalesMember 2020-07-01 2020-09-30 0001784851 shpw:MarketPlaceSalesMember 2020-07-01 2020-09-30 0001784851 us-gaap:SoftwareAndSoftwareDevelopmentCostsMember 2020-07-01 2020-09-30 0001784851 us-gaap:TransferredAtPointInTimeMember 2020-07-01 2020-09-30 0001784851 us-gaap:TransferredOverTimeMember 2020-07-01 2020-09-30 0001784851 us-gaap:RetainedEarningsMember 2020-07-01 2020-09-30 0001784851 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2020-07-01 2020-09-30 0001784851 shpw:DutchLandlordLoanMember 2020-07-01 2020-09-30 0001784851 us-gaap:ConvertibleNotesPayableMember 2020-07-01 2020-09-30 0001784851 shpw:TermLoanMember 2020-07-01 2020-09-30 0001784851 us-gaap:FairValueInputsLevel3Member 2021-01-01 2021-09-30 0001784851 shpw:ConvertibleNoteMember 2021-01-01 2021-09-30 0001784851 shpw:RelatedPartyNoteMember srt:OfficerMember 2021-01-01 2021-09-30 0001784851 shpw:MajorCustomerMember us-gaap:SalesRevenueNetMember us-gaap:CustomerConcentrationRiskMember 2021-01-01 2021-09-30 0001784851 us-gaap:OtherCustomerMember us-gaap:SalesRevenueNetMember us-gaap:CustomerConcentrationRiskMember 2021-01-01 2021-09-30 0001784851 us-gaap:CostOfGoodsTotalMember us-gaap:SupplierConcentrationRiskMember shpw:MajorVendorMember 2021-01-01 2021-09-30 0001784851 shpw:MajorCustomerMember us-gaap:AccountsReceivableMember us-gaap:CustomerConcentrationRiskMember 2021-01-01 2021-09-30 0001784851 us-gaap:AccountsPayableMember us-gaap:SupplierConcentrationRiskMember shpw:MajorVendorOneMember 2021-01-01 2021-09-30 0001784851 us-gaap:AccountsPayableMember us-gaap:SupplierConcentrationRiskMember shpw:MajorVendorTwoMember 2021-01-01 2021-09-30 0001784851 us-gaap:AccountsPayableMember us-gaap:SupplierConcentrationRiskMember shpw:MajorVendorThreeMember 2021-01-01 2021-09-30 0001784851 us-gaap:AccountsPayableMember us-gaap:SupplierConcentrationRiskMember shpw:MajorVendorFourMember 2021-01-01 2021-09-30 0001784851 us-gaap:CostOfGoodsTotalMember us-gaap:SupplierConcentrationRiskMember shpw:OtherVendorMember 2021-01-01 2021-09-30 0001784851 us-gaap:OtherCustomerMember us-gaap:AccountsReceivableMember us-gaap:CustomerConcentrationRiskMember 2021-01-01 2021-09-30 0001784851 us-gaap:AccountsPayableMember us-gaap:SupplierConcentrationRiskMember 2021-01-01 2021-09-30 0001784851 us-gaap:AccountsPayableMember shpw:OtherVendorMember 2021-01-01 2021-09-30 0001784851 shpw:DirectSalesMember 2021-01-01 2021-09-30 0001784851 shpw:MarketPlaceSalesMember 2021-01-01 2021-09-30 0001784851 us-gaap:SoftwareAndSoftwareDevelopmentCostsMember 2021-01-01 2021-09-30 0001784851 us-gaap:TransferredAtPointInTimeMember 2021-01-01 2021-09-30 0001784851 us-gaap:TransferredOverTimeMember 2021-01-01 2021-09-30 0001784851 us-gaap:MachineryAndEquipmentMember 2021-01-01 2021-09-30 0001784851 us-gaap:ComputerEquipmentMember 2021-01-01 2021-09-30 0001784851 us-gaap:FurnitureAndFixturesMember 2021-01-01 2021-09-30 0001784851 us-gaap:LeaseholdImprovementsMember 2021-01-01 2021-09-30 0001784851 shpw:SponsorWarrantsMember shpw:ConvertibleNoteMember 2021-01-01 2021-09-30 0001784851 srt:MinimumMember 2021-01-01 2021-09-30 0001784851 srt:MaximumMember 2021-01-01 2021-09-30 0001784851 shpw:DutchLandlordLoanMember 2021-01-01 2021-09-30 0001784851 us-gaap:ConvertibleNotesPayableMember 2021-01-01 2021-09-30 0001784851 shpw:PaymentProtectionProgramLoanMember shpw:ShapewaysIncMember 2021-01-01 2021-09-30 0001784851 shpw:TwoThousandTenStockPlanMember 2021-01-01 2021-09-30 0001784851 shpw:PaymentProtectionProgramLoanMember 2021-01-01 2021-09-30 0001784851 us-gaap:OtherIncomeMember shpw:PaymentProtectionProgramLoanMember 2021-01-01 2021-09-30 0001784851 shpw:TwoThousandTwentyOneEquityIncentivePlanMember 2021-01-01 2021-09-30 0001784851 shpw:TermLoanMember 2021-01-01 2021-09-30 0001784851 shpw:ReverseRecapitalizationMember shpw:GalileoMember 2021-01-01 2021-09-30 0001784851 us-gaap:CommonStockMember shpw:ReverseRecapitalizationMember shpw:GalileoMember 2021-01-01 2021-09-30 0001784851 shpw:FounderAndRepresentativeSharesMember shpw:ReverseRecapitalizationMember 2021-01-01 2021-09-30 0001784851 shpw:PipeInvestmentMember shpw:ReverseRecapitalizationMember 2021-01-01 2021-09-30 0001784851 us-gaap:CommonStockMember shpw:MergerAndInvestmentMember shpw:ReverseRecapitalizationMember 2021-01-01 2021-09-30 0001784851 us-gaap:CommonStockMember shpw:ReverseRecapitalizationMember shpw:ShapewaysIncMember 2021-01-01 2021-09-30 0001784851 us-gaap:CommonStockMember 2021-01-01 2021-09-30 0001784851 us-gaap:WarrantMember 2021-01-01 2021-09-30 0001784851 shpw:BusinessCombinationElementsToUnauditedConsolidatedStatementOfEquityMember shpw:ReverseRecapitalizationMember 2021-01-01 2021-09-30 0001784851 shpw:GalileoMember shpw:BusinessCombinationElementsToUnauditedConsolidatedStatementOfEquityMember shpw:ReverseRecapitalizationMember 2021-01-01 2021-09-30 0001784851 shpw:GalileoMember shpw:EarnoutSharesMember shpw:ReverseRecapitalizationMember 2021-01-01 2021-09-30 0001784851 shpw:PipeInvestorsMember shpw:SubscriptionAgreementMember shpw:ReverseRecapitalizationMember 2021-01-01 2021-09-30 0001784851 shpw:GalileoMember shpw:BusinessCombinationElementsToUnauditedConsolidatedStatementOfCashFlowsMember shpw:ReverseRecapitalizationMember 2021-01-01 2021-09-30 0001784851 shpw:PipeInvestmentMember shpw:BusinessCombinationElementsToUnauditedConsolidatedStatementOfCashFlowsMember shpw:ReverseRecapitalizationMember 2021-01-01 2021-09-30 0001784851 shpw:BusinessCombinationElementsToUnauditedConsolidatedStatementOfCashFlowsMember shpw:ReverseRecapitalizationMember 2021-01-01 2021-09-30 0001784851 shpw:PrivateSponsorWarrantLiabilitiesMember shpw:BusinessCombinationElementsToUnauditedConsolidatedStatementOfEquityMember shpw:ReverseRecapitalizationMember 2021-01-01 2021-09-30 0001784851 shpw:ShapewaysIncMember 2021-01-01 2021-09-30 0001784851 srt:MinimumMember shpw:ShapewaysIncMember 2021-01-01 2021-09-30 0001784851 shpw:MajorCustomerMember us-gaap:SalesRevenueNetMember us-gaap:CustomerConcentrationRiskMember 2020-01-01 2020-09-30 0001784851 us-gaap:CostOfGoodsTotalMember us-gaap:SupplierConcentrationRiskMember shpw:MajorVendorMember 2020-01-01 2020-09-30 0001784851 us-gaap:OtherCustomerMember us-gaap:SalesRevenueNetMember us-gaap:CustomerConcentrationRiskMember 2020-01-01 2020-09-30 0001784851 us-gaap:CostOfGoodsTotalMember us-gaap:SupplierConcentrationRiskMember shpw:OtherVendorMember 2020-01-01 2020-09-30 0001784851 shpw:DirectSalesMember 2020-01-01 2020-09-30 0001784851 shpw:MarketPlaceSalesMember 2020-01-01 2020-09-30 0001784851 us-gaap:SoftwareAndSoftwareDevelopmentCostsMember 2020-01-01 2020-09-30 0001784851 us-gaap:TransferredAtPointInTimeMember 2020-01-01 2020-09-30 0001784851 us-gaap:TransferredOverTimeMember 2020-01-01 2020-09-30 0001784851 srt:MinimumMember 2020-01-01 2020-09-30 0001784851 srt:MaximumMember 2020-01-01 2020-09-30 0001784851 shpw:DutchLandlordLoanMember 2020-01-01 2020-09-30 0001784851 us-gaap:ConvertibleNotesPayableMember 2020-01-01 2020-09-30 0001784851 shpw:PaymentProtectionProgramLoanMember 2020-01-01 2020-09-30 0001784851 shpw:TwoThousandTwentyOneEquityIncentivePlanMember 2020-01-01 2020-09-30 0001784851 shpw:TermLoanMember 2020-01-01 2020-09-30 0001784851 us-gaap:AdditionalPaidInCapitalMember 2021-04-01 2021-06-30 0001784851 us-gaap:CommonStockMember 2021-04-01 2021-06-30 0001784851 shpw:SeriesB1PreferredStockMember us-gaap:AdditionalPaidInCapitalMember 2021-04-01 2021-06-30 0001784851 shpw:SeriesB1PreferredStockMember 2021-04-01 2021-06-30 0001784851 shpw:SeriesB1PreferredStockMember us-gaap:CommonStockMember 2021-04-01 2021-06-30 0001784851 us-gaap:RetainedEarningsMember 2021-04-01 2021-06-30 0001784851 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2021-04-01 2021-06-30 0001784851 srt:RestatementAdjustmentMember us-gaap:PreferredStockMember 2021-01-01 2021-03-31 0001784851 srt:RestatementAdjustmentMember us-gaap:CommonStockMember 2021-01-01 2021-03-31 0001784851 srt:RestatementAdjustmentMember us-gaap:AdditionalPaidInCapitalMember 2021-01-01 2021-03-31 0001784851 us-gaap:AdditionalPaidInCapitalMember 2021-01-01 2021-03-31 0001784851 us-gaap:CommonStockMember 2021-01-01 2021-03-31 0001784851 us-gaap:RetainedEarningsMember 2021-01-01 2021-03-31 0001784851 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2021-01-01 2021-03-31 0001784851 srt:CumulativeEffectPeriodOfAdoptionAdjustedBalanceMember 2021-01-01 2021-03-31 0001784851 shpw:DesktopMetalMember us-gaap:SubsequentEventMember 2021-12-31 0001784851 shpw:RelatedPartyNoteMember srt:OfficerMember shpw:MergerAgreementMember 2021-09-29 2021-09-29 0001784851 us-gaap:ConvertibleNotesPayableMember 2021-09-29 2021-09-29 0001784851 us-gaap:ConvertibleNotesPayableMember us-gaap:CommonStockMember 2021-09-29 2021-09-29 0001784851 us-gaap:ConvertibleNotesPayableMember us-gaap:CommonStockMember shpw:UnpaidAndAccruedInterestMember 2021-09-29 2021-09-29 0001784851 shpw:LegacyShapewaysCommonStockWarrantsMember shpw:PriorToTheBusinessCombinationMember 2021-09-29 2021-09-29 0001784851 us-gaap:CommonStockMember shpw:ReverseRecapitalizationMember shpw:ShapewaysIncMember 2021-09-29 2021-09-29 0001784851 shpw:EarnoutSharesMember shpw:ReverseRecapitalizationMember 2021-09-29 2021-09-29 0001784851 shpw:GalileoMember shpw:ReverseRecapitalizationMember shpw:ShapewaysIncMember 2021-09-29 2021-09-29 0001784851 shpw:EarnoutRestrictedStockUnitsMember shpw:ReverseRecapitalizationMember 2021-09-29 2021-09-29 0001784851 shpw:LegacyShapewaysStockOptionMember shpw:TwoThousandTenStockPlanMember 2021-09-29 2021-09-29 0001784851 shpw:MajorCustomerMember us-gaap:AccountsReceivableMember us-gaap:CustomerConcentrationRiskMember 2020-01-01 2020-12-31 0001784851 us-gaap:AccountsPayableMember us-gaap:SupplierConcentrationRiskMember shpw:MajorVendorOneMember 2020-01-01 2020-12-31 0001784851 us-gaap:AccountsPayableMember us-gaap:SupplierConcentrationRiskMember shpw:MajorVendorTwoMember 2020-01-01 2020-12-31 0001784851 us-gaap:AccountsPayableMember us-gaap:SupplierConcentrationRiskMember shpw:MajorVendorThreeMember 2020-01-01 2020-12-31 0001784851 us-gaap:OtherCustomerMember us-gaap:AccountsReceivableMember us-gaap:CustomerConcentrationRiskMember 2020-01-01 2020-12-31 0001784851 us-gaap:AccountsPayableMember us-gaap:SupplierConcentrationRiskMember 2020-01-01 2020-12-31 0001784851 us-gaap:AccountsPayableMember us-gaap:SupplierConcentrationRiskMember shpw:OtherVendorMember 2020-01-01 2020-12-31 0001784851 us-gaap:ConvertibleNotesPayableMember 2020-01-01 2020-12-31 0001784851 srt:RestatementAdjustmentMember us-gaap:PreferredStockMember 2020-01-01 2020-03-31 0001784851 srt:RestatementAdjustmentMember us-gaap:CommonStockMember 2020-01-01 2020-03-31 0001784851 srt:RestatementAdjustmentMember us-gaap:AdditionalPaidInCapitalMember 2020-01-01 2020-03-31 0001784851 us-gaap:CommonStockMember 2020-01-01 2020-03-31 0001784851 us-gaap:AdditionalPaidInCapitalMember 2020-01-01 2020-03-31 0001784851 us-gaap:RetainedEarningsMember 2020-01-01 2020-03-31 0001784851 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2020-01-01 2020-03-31 0001784851 us-gaap:AdditionalPaidInCapitalMember 2020-04-01 2020-06-30 0001784851 us-gaap:CommonStockMember 2020-04-01 2020-06-30 0001784851 us-gaap:RetainedEarningsMember 2020-04-01 2020-06-30 0001784851 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2020-04-01 2020-06-30 0001784851 us-gaap:IPOMember 2019-10-22 2019-10-22 0001784851 shpw:PrivateWarrantsMember us-gaap:PrivatePlacementMember 2019-10-22 2019-10-22 0001784851 us-gaap:IPOMember 2019-10-22 0001784851 shpw:PrivateWarrantsMember us-gaap:PrivatePlacementMember 2019-10-22 0001784851 shpw:LegacyShapewaysPreferredStockWarrantsMember 2021-09-30 2021-09-30 0001784851 shpw:ReverseRecapitalizationMember 2021-09-30 2021-09-30 0001784851 shpw:PublicWarrantsMember 2021-09-30 2021-09-30 0001784851 shpw:RelatedPartyNoteMember srt:OfficerMember 2020-09-30 0001784851 shpw:TermLoanMember us-gaap:PrimeRateMember 2018-10-29 2018-10-29 0001784851 shpw:TermLoanMember 2018-10-29 0001784851 shpw:DutchLandlordLoanMember 2014-05-12 0001784851 us-gaap:ConvertibleNotesPayableMember 2019-06-19 0001784851 shpw:PrivatePlacementWarrantsMember us-gaap:FairValueInputsLevel3Member us-gaap:MeasurementInputSharePriceMember 2021-09-29 0001784851 shpw:PrivatePlacementWarrantsMember us-gaap:FairValueInputsLevel3Member us-gaap:MeasurementInputExercisePriceMember 2021-09-29 0001784851 shpw:PrivatePlacementWarrantsMember us-gaap:FairValueInputsLevel3Member us-gaap:MeasurementInputPriceVolatilityMember 2021-09-29 0001784851 shpw:PrivatePlacementWarrantsMember us-gaap:FairValueInputsLevel3Member 2021-09-29 0001784851 shpw:PrivatePlacementWarrantsMember us-gaap:FairValueInputsLevel3Member us-gaap:MeasurementInputExpectedDividendRateMember 2021-09-29 0001784851 shpw:PrivatePlacementWarrantsMember us-gaap:FairValueInputsLevel3Member shpw:MeasurementInputFairValuePerWarrantMember 2021-09-29 0001784851 shpw:PrivatePlacementWarrantsMember us-gaap:FairValueInputsLevel3Member us-gaap:MeasurementInputExpectedTermMember 2021-09-29 0001784851 shpw:TwoThousandTenStockPlanMember 2021-09-29 0001784851 shpw:LegacyShapewaysSeriesAOnePreferredStockMember 2021-09-29 0001784851 shpw:LegacyShapewaysSeriesATwoPreferredStockMember 2021-09-29 0001784851 shpw:LegacyShapewaysSeriesBPreferredStockMember 2021-09-29 0001784851 shpw:LegacyShapewaysSeriesBOnePreferredStockMember 2021-09-29 0001784851 shpw:LegacyShapewaysSeriesCPreferredStockMember 2021-09-29 0001784851 shpw:LegacyShapewaysSeriesDPreferredStockMember 2021-09-29 0001784851 shpw:LegacyShapewaysSeriesEPreferredStockMember 2021-09-29 0001784851 us-gaap:CommonStockMember shpw:ReverseRecapitalizationMember shpw:ShapewaysIncMember 2021-09-29 0001784851 shpw:TwoThousandTwentyOneEquityIncentivePlanMember shpw:ReverseRecapitalizationMember 2021-09-29 0001784851 shpw:ReverseRecapitalizationMember 2021-09-29 0001784851 shpw:PaymentProtectionProgramLoanMember 2020-05-04 2020-05-04 0001784851 shpw:PaymentProtectionProgramLoanMember 2020-05-04 0001784851 shpw:LegacyShapewaysCommonStockWarrantsMember shpw:ExecutingALoanAgreementMember 2013-12-18 2013-12-18 0001784851 shpw:LegacyShapewaysCommonStockWarrantsMember shpw:ExecutingALoanAgreementMember 2013-12-18 0001784851 shpw:LegacyShapewaysCommonStockWarrantsMember shpw:ExecutingALoanAgreementMember 2014-02-03 2014-02-03 0001784851 shpw:LegacyShapewaysCommonStockWarrantsMember shpw:ExecutingALoanAgreementMember 2014-02-03 0001784851 shpw:LegacyShapewaysCommonStockWarrantsMember shpw:AmendedLoanAgreementMember 2015-04-22 2015-04-22 0001784851 shpw:LegacyShapewaysCommonStockWarrantsMember shpw:AmendedLoanAgreementMember 2015-04-22 0001784851 shpw:LegacyShapewaysSeriesBOnePreferredStockMember shpw:LegacyShapewaysPreferredStockWarrantsMember 2013-03-08 2013-03-08 0001784851 shpw:LegacyShapewaysPreferredStockWarrantsMember 2013-03-08 2013-03-08 0001784851 shpw:LegacyShapewaysPreferredStockWarrantsMember 2021-05-10 2021-05-10 0001784851 shpw:LegacyShapewaysSeriesBOnePreferredStockMember shpw:LegacyShapewaysCommonStockWarrantsMember 2021-05-10 2021-05-10 0001784851 shpw:LegacyShapewaysPreferredStockWarrantsMember 2021-05-10 0001784851 shpw:LegacyShapewaysSeriesDPreferredStockMember shpw:LegacyShapewaysPreferredStockWarrantsMember 2017-06-30 2017-06-30 0001784851 shpw:LegacyShapewaysPreferredStockWarrantsMember 2017-06-30 2017-06-30 0001784851 shpw:LegacyShapewaysPreferredStockWarrantsMember 2017-06-30 0001784851 shpw:RelatedPartyNoteMember srt:OfficerMember 2012-12-31 0001784851 shpw:LegacyShapewaysPreferredStockWarrantsMember 2013-03-08 0001784851 shpw:DesktopMetalMember 2021-03-26 0001784851 shpw:DesktopMetalMember 2021-03-26 2021-03-26 0001784851 shpw:DesktopMetalMember us-gaap:SubsequentEventMember 2021-11-01 2021-11-30 0001784851 us-gaap:CommonStockMember 2021-09-30 0001784851 us-gaap:AdditionalPaidInCapitalMember 2021-09-30 0001784851 us-gaap:RetainedEarningsMember 2021-09-30 0001784851 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2021-09-30 0001784851 us-gaap:PreferredStockMember 2021-09-30 0001784851 us-gaap:PreferredStockMember 2020-09-30 0001784851 us-gaap:CommonStockMember 2020-09-30 0001784851 us-gaap:AdditionalPaidInCapitalMember 2020-09-30 0001784851 us-gaap:RetainedEarningsMember 2020-09-30 0001784851 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2020-09-30 0001784851 us-gaap:FairValueInputsLevel3Member 2020-12-31 0001784851 us-gaap:FairValueInputsLevel3Member 2021-09-30 0001784851 us-gaap:CommonStockMember shpw:PriorToBusinessCombinationMember shpw:ReverseRecapitalizationMember 2020-12-31 0001784851 us-gaap:CommonStockMember shpw:ImmediatelyAfterBusinessCombinationMember shpw:ReverseRecapitalizationMember 2021-09-30 0001784851 us-gaap:CommonStockMember 2021-06-30 0001784851 us-gaap:AdditionalPaidInCapitalMember 2021-06-30 0001784851 us-gaap:RetainedEarningsMember 2021-06-30 0001784851 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2021-06-30 0001784851 us-gaap:PreferredStockMember 2021-06-30 0001784851 us-gaap:PreferredStockMember 2020-12-31 0001784851 us-gaap:CommonStockMember 2020-12-31 0001784851 us-gaap:AdditionalPaidInCapitalMember 2020-12-31 0001784851 us-gaap:RetainedEarningsMember 2020-12-31 0001784851 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2020-12-31 0001784851 srt:ScenarioPreviouslyReportedMember us-gaap:PreferredStockMember 2020-12-31 0001784851 srt:ScenarioPreviouslyReportedMember us-gaap:CommonStockMember 2020-12-31 0001784851 srt:ScenarioPreviouslyReportedMember us-gaap:AdditionalPaidInCapitalMember 2020-12-31 0001784851 srt:ScenarioPreviouslyReportedMember us-gaap:RetainedEarningsMember 2020-12-31 0001784851 srt:ScenarioPreviouslyReportedMember us-gaap:AccumulatedOtherComprehensiveIncomeMember 2020-12-31 0001784851 srt:ScenarioPreviouslyReportedMember 2020-12-31 0001784851 us-gaap:CommonStockMember 2021-03-31 0001784851 us-gaap:AdditionalPaidInCapitalMember 2021-03-31 0001784851 us-gaap:RetainedEarningsMember 2021-03-31 0001784851 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2021-03-31 0001784851 us-gaap:PreferredStockMember 2021-03-31 0001784851 srt:CumulativeEffectPeriodOfAdoptionAdjustedBalanceMember 2020-12-31 0001784851 srt:ScenarioPreviouslyReportedMember us-gaap:PreferredStockMember 2019-12-31 0001784851 srt:ScenarioPreviouslyReportedMember us-gaap:CommonStockMember 2019-12-31 0001784851 srt:ScenarioPreviouslyReportedMember us-gaap:AdditionalPaidInCapitalMember 2019-12-31 0001784851 srt:ScenarioPreviouslyReportedMember us-gaap:RetainedEarningsMember 2019-12-31 0001784851 srt:ScenarioPreviouslyReportedMember us-gaap:AccumulatedOtherComprehensiveIncomeMember 2019-12-31 0001784851 srt:ScenarioPreviouslyReportedMember 2019-12-31 0001784851 us-gaap:CommonStockMember 2019-12-31 0001784851 us-gaap:AdditionalPaidInCapitalMember 2019-12-31 0001784851 us-gaap:RetainedEarningsMember 2019-12-31 0001784851 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2019-12-31 0001784851 us-gaap:PreferredStockMember 2019-12-31 0001784851 us-gaap:PreferredStockMember 2020-03-31 0001784851 us-gaap:CommonStockMember 2020-03-31 0001784851 us-gaap:AdditionalPaidInCapitalMember 2020-03-31 0001784851 us-gaap:RetainedEarningsMember 2020-03-31 0001784851 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2020-03-31 0001784851 us-gaap:PreferredStockMember 2020-06-30 0001784851 us-gaap:CommonStockMember 2020-06-30 0001784851 us-gaap:AdditionalPaidInCapitalMember 2020-06-30 0001784851 us-gaap:RetainedEarningsMember 2020-06-30 0001784851 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2020-06-30 iso4217:USD shares pure utr:Year iso4217:EUR utr:Day iso4217:USD shares shpw:Customer shpw:Customers shpw:Vendor shpw:Vendors shpw:lease shpw:Supplychainpartners shpw:Countries shpw:Additivetechnolgies shpw:Materialsandfinishes utr:Y P0Y Shapeways Holdings, Inc. NY 0001784851 --12-31 2021 Q3 false true 10-Q true 2021-09-30 false 001-39092 DE 87-2876494 30-02 48th Avenue Long Island City 11101 646 979-9885 Common Stock, par value $0.0001 per share SHPW NYSE Warrants, each whole warrant exercisable for one share of Common Stock for $11.50 per share SHPW WS NYSE Yes Yes Non-accelerated Filer true true false false 48296484 90108000 8564000 143000 145000 1114000 185000 573000 727000 0 151000 1908000 1910000 93846000 11682000 1090000 948000 982000 2102000 1835000 1835000 175000 175000 97928000 16742000 1168000 1633000 3700000 3319000 39000 8332000 631000 1222000 658000 753000 6196000 15259000 499000 1094000 6777000 0 88000 2236000 13560000 18589000 0.0001 0.0001 10000000 10000000 0 0 0 0 0 0 0.0001 0.0001 120000000 120000000 48296484 48296484 32170068 32170068 5000 3000 195121000 112994000 -110442000 -114567000 -316000 -277000 84368000 -1847000 97928000 16742000 7716000 8107000 25354000 23028000 4055000 4406000 13271000 13030000 3661000 3701000 12083000 9998000 4366000 2461000 10513000 8075000 1673000 1516000 4099000 4289000 33000 37000 100000 113000 6072000 4014000 14712000 12477000 -2411000 -313000 -2629000 -2479000 0 0 2000000 0 126000 141000 407000 444000 -5088000 0 -5088000 0 1000 0 1000 0 0 4000 1000 7000 0 0 0 -4000 4963000 -137000 6683000 -441000 2552000 -450000 4054000 -2920000 0 0 -71000 2552000 -450000 4125000 -2920000 18132000 0 18132000 -15580000 -450000 -14007000 -2920000 0.07 -0.01 0.11 -0.08 0.07 -0.01 0.11 -0.08 -0.41 -0.01 -0.38 -0.08 -0.41 -0.01 -0.38 -0.08 37932345 35787986 37351244 35660635 37932345 35787986 37351244 35660635 -22000 65000 -39000 32000 -15602000 -385000 -14046000 -2888000 22579695 2000 16211567 2000 112993000 -114567000 -277000 -1847000 -22579695 -2000 15972696 1000 1000 0 0 32184263 3000 112994000 -114567000 -277000 -1847000 35895 16000 16000 174000 174000 1708000 1708000 -9000 -9000 0 0 32220158 3000 113184000 -112859000 -286000 42000 63506 55000 55000 19177 60000 60000 171000 171000 -135000 -135000 -8000 -8000 0 0 32302841 3000 113470000 -112994000 -294000 185000 1113029 481000 481000 1406741 5913000 5913000 212234 89217 -19226 152000 152000 5691648 1000 10035000 10036000 7500000 1000 64936000 64937000 438000 438000 2552000 2552000 -22000 -22000 0 0 48296484 5000 195121000 -110442000 -316000 84368000 22579695 2000 15894428 2000 112186000 -111399000 -360000 431000 -22579695 -2000 16026831 1000 1000 0 31921259 3000 112187000 -111399000 -360000 431000 994 171000 171000 -1435000 -1435000 -61000 -61000 0 0 31922253 3000 112358000 -112834000 -421000 -894000 141270 47000 47000 190000 190000 -1035000 -1035000 28000 28000 0 0 32063523 3000 112595000 -113869000 -393000 -1664000 68555 21000 21000 183000 183000 -450000 -450000 65000 65000 0 0 32132078 3000 112799000 -114319000 -328000 -1845000 4125000 -2920000 424000 362000 0 -4000 783000 544000 696000 1586000 2000000 0 -5088000 0 924000 763000 -173000 102000 -83000 -337000 0 -50000 -512000 -775000 853000 713000 -762000 -1674000 -101000 67000 0 -283000 -2250000 -2854000 125000 23000 -125000 -23000 0 18000 552000 68000 60000 0 -86792000 3459000 851000 0 1983000 83945000 1182000 81570000 -1695000 -28000 8000 8709000 9605000 90251000 7918000 88000 145000 441000 0 5913000 0 -152000 0 <div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt; text-indent: 0px;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Note 1. Organization </div></div></div></div> <div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt; text-indent: 0px;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">On September 29, 2021 (the “Closing” or the “Closing Date”), Galileo Acquisition Corp., a Cayman Islands exempted company (“Galileo” and after the Domestication (as defined below) “Shapeways”), a publicly-traded special purpose acquisition company, consummated the transactions described in the Agreement and Plan of Merger and Reorganization (the “Merger Agreement”) dated April 28, 2021, by and among Galileo Founders Holdings, L.P. (the “Sponsor”), Galileo Acquisition Corp., Galileo Acquisition Holdings, Inc., a Delaware corporation and wholly-owned subsidiary of Galileo (“Merger Sub”), and Shapeways, Inc., a Delaware corporation (“Legacy Shapeways”),<div style="display:inline;"> </div>whereby Merger Sub merged with and into Legacy Shapeways, the separate corporate existence of Merger Sub ceasing and Legacy Shapeways being the surviving corporation and a wholly owned subsidiary of Shapeways (the “Merger”). </div></div></div> <div style="letter-spacing: 0px; top: 0px; background: none;;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px; background: none; text-decoration: none;;display:inline;"> </div></div> <div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt; text-indent: 0px;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Further, on the Closing Date, as contemplated by the Merger Agreement, Galileo filed a notice of deregistration with the Cayman Islands Registrar of Companies, together with the necessary accompanying documents, and filed a certificate of incorporation and a certificate of corporate domestication with the Secretary of State of the State of Delaware, under which Galileo was domesticated and continued as a Delaware corporation (the “Domestication” and, together with the Merger, the “Business Combination”), changing its name to “Shapeways Holdings, Inc.” (the “Company” and/or “Shapeways”). </div></div></div> <div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt; text-indent: 0px;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Shapeways is a leader in the large and fast-growing digital manufacturing industry combining high quality, flexible on-demand manufacturing powered by purpose-built proprietary software which enables customers to rapidly transform digital designs into physical products, globally. Shapeways makes industrial-grade additive manufacturing accessible by fully digitizing the end-to-end manufacturing process , and by providing a broad range of solutions utilizing 11 additive manufacturing technologies and more than 90 materials and finishes, with the ability to easily scale new innovation. Shapeways has delivered over 21 million parts to 1 million customers in over 160 countries. </div></div></div> 11 90 21000000 1000000 160 <div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 18pt; margin-bottom: 0pt;"><div style="font-weight:bold;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Note 2. Summary of Significant Accounting Policies </div></div></div> <div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt; text-indent: 0px;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;"><div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">Basis of Presentation and Principles of Consolidation </div></div></div></div></div> <div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt; text-indent: 0px;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">The accompanying condensed consolidated interim financial statements have been prepared in accordance with accounting principles generally accepted in the United States of America (“U.S. GAAP”) for interim financial information as defined by the Financial Accounting Standards Board (“FASB”) Accounting Standards Codification (“ASC”) and in accordance with the instruction to Form <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">10-Q</div> and Article 8 of Regulation <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">S-X</div> of the SEC. Certain information or footnote disclosures normally included in financial statements prepared in accordance with GAAP have been condensed or omitted, pursuant to the rules and regulations of the SEC for interim financial reporting. Accordingly, they do not include all the information and footnotes necessary for a complete presentation of financial position, results of operations, or cash flows. The condensed consolidated financial statements include the accounts of its wholly owned subsidiaries, Legacy Shapeways and Shapeways BV. All intercompany accounts and transactions have been eliminated in consolidation. In the opinion of management, the accompanying condensed consolidated interim financial statements include all adjustments, consisting of a normal recurring nature, which are necessary for a fair presentation of the financial position, operating results and cash flows for the periods presented. These unaudited condensed consolidated interim financial statements should be read along with the final proxy statement/prospectus as filed with the SEC on September 7, 2021. </div></div> <div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt; text-indent: 0px;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">The Business Combination has been accounted for as a reverse recapitalization, in accordance with U.S. GAAP (the “Reverse Recapitalization”). Under this method of accounting, Galileo has been treated as the “acquired” company for financial reporting purposes. Accordingly, the Business Combination has been treated as the equivalent of Legacy Shapeways issuing stock for the net assets of Galileo, accompanied by a recapitalization. The net assets of Galileo are stated at historical cost, with no goodwill or other intangible assets recorded. There has been no accounting effect or change in the carrying amount of the assets and liabilities as a result of the Business Combination. </div></div></div> <div style="letter-spacing: 0px; top: 0px; background: none;;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px; background: none; text-decoration: none;;display:inline;"> </div></div> <div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt; text-indent: 0px;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Legacy Shapeways has been treated as the accounting acquirer based on evaluation of the following facts and circumstances with regard to the Company as of the Closing: </div></div></div> <div style="font-size: 6pt; margin-top: 0pt; margin-bottom: 0pt; text-indent: 0px;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-size: 6pt; letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></div> <table cellpadding="0" cellspacing="0" style="border: 0px currentcolor; width: 100%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px; text-indent: 0px;"> <tr style="page-break-inside: avoid;"> <td style="width: 4%;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="width: 4%; vertical-align: top;;text-align:left;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">•</div></td> <td style="width: 1%; vertical-align: top;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align: top;;text-align:left;"> <div style="text-align: left; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">Legacy Shapeways’ directors represented the majority of the new board of directors of the Company; </div></div> </td> </tr> </table> <div style="clear: both; max-height: 0px; text-indent: 0px;"/> <div style="font-size: 6pt; margin-top: 0pt; margin-bottom: 0pt; text-indent: 0px;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-size: 6pt; letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></div> <table cellpadding="0" cellspacing="0" style="border: 0px currentcolor; width: 100%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px; text-indent: 0px;"> <tr style="page-break-inside: avoid;"> <td style="width: 4%;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="width: 4%; vertical-align: top;;text-align:left;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">•</div></td> <td style="width: 1%; vertical-align: top;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align: top;;text-align:left;"> <div style="text-align: left; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">The executive officers and senior management of Legacy Shapeways are the executive officers and senior management of the Company; </div></div> </td> </tr> </table> <div style="clear: both; max-height: 0px; text-indent: 0px;"/> <div style="font-size: 6pt; margin-top: 0pt; margin-bottom: 0pt; text-indent: 0px;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-size: 6pt; letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></div> <table cellpadding="0" cellspacing="0" style="border: 0px currentcolor; width: 100%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px; text-indent: 0px;"> <tr style="page-break-inside: avoid;"> <td style="width: 4%;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="width: 4%; vertical-align: top;;text-align:left;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">•</div></td> <td style="width: 1%; vertical-align: top;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align: top;;text-align:left;"> <div style="text-align: left; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">The assets of Legacy Shapeways represent a significant majority of the assets of the Company (excluding cash formerly held in the Galileo trust account); and </div></div> </td> </tr> </table> <div style="clear: both; max-height: 0px; text-indent: 0px;"/> <div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div> <div style="font-size: 8pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-size: 8pt; letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> <table cellpadding="0" cellspacing="0" style="border: 0px currentcolor; width: 100%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;"> <tr style="page-break-inside: avoid;"> <td style="width: 4%;"> </td> <td style="width: 4%; vertical-align: top;;text-align:left;">•</td> <td style="width: 1%; vertical-align: top;"> </td> <td style="vertical-align: top;;text-align:left;"> <div style="text-align: left; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; line-height: normal;">The business of the Company will be the continued business of Legacy Shapeways. The business of the Company will continue to focus on Legacy Shapeways’ core offerings related to the facilitation of the sale, design and manufacturing of 3D printed items. </div> </td> </tr> </table> <div style="clear: both; max-height: 0px;"/> <div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt; text-indent: 0px;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">The consolidated assets, liabilities and results of operations prior to the Reverse Recapitalization are those of Legacy Shapeways. The shares and corresponding capital amounts and losses per share, prior to the Merger, have been retroactively adjusted based on shares reflecting the conversion ratio (as defined below) established in the Merger. </div></div></div> <div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"> </div> <div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 18pt; margin-bottom: 0pt;"><div style="font-weight:bold;display:inline;"><div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">Use of Estimates </div></div></div></div> <div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt; text-indent: 0px;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">The preparation of the Company’s <div style="letter-spacing: 0px; top: 0px;;display:inline;">unaudited </div>condensed consolidated financial statements, in conformity with U.S. GAAP, requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the condensed consolidated financial statements and reported amounts of revenues and expenses during the reporting period. Actual results may differ from those estimates. </div></div></div> <div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt; text-indent: 0px;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">In March 2020, the World Health Organization declared the outbreak of a novel coronavirus <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">(COVID-19)</div> as a pandemic, which continues to spread throughout the United States. While the disruption is currently expected to be temporary, there is uncertainty around the duration. The Company has considered information available to it as of the date of issuance of these unaudited condensed consolidated financial statements and is not aware of any specific events or circumstances that would require an update to its estimates or judgements, or an adjustment to the carrying value of its assets or liabilities. The accounting estimates and other matters assessed include, but were not limited to, goodwill and other long-lived assets, warrant liabilities and revenue recognition. These estimates may change as new events occur and additional information becomes available. Actual results could differ materially from these estimates. </div></div> <div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div> <div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 18pt; margin-bottom: 0pt; text-indent: 0px;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;"><div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">Functional Currency </div></div></div></div></div> <div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt; text-indent: 0px;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">The local currency is the functional currency for Shapeways BV’s (a <div style="letter-spacing: 0px; top: 0px;;display:inline;">wholly</div>-owned subsidiary of the Company) operations outside the United States. Assets and liabilities of these operations are translated into U.S. Dollars at the exchange rate in effect at the end of each period. Income statement accounts are translated at the average exchange rate prevailing during the period. Translation adjustments arising from the use of differing exchange rates from period to period are included as a component of other comprehensive loss within stockholders’ equity (deficit). Gains and losses from foreign currency transactions are included in net loss for the period. </div></div></div> <div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"> </div> <div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 18pt; margin-bottom: 0pt;"><div style="font-weight:bold;display:inline;"><div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">Cash, Cash Equivalents <div style="letter-spacing: 0px; top: 0px;;display:inline;">and </div>Restricted Cash </div></div></div></div> <div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt; text-indent: 0px;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Cash includes cash on hand and demand deposits. The Company maintains its deposits at high quality financial institutions and monitors the credit ratings of those institutions. The Company considers all highly liquid investments with original maturities of three months or less to be cash equivalents. While cash held by financial institutions may at times exceed federally insured <div style="letter-spacing: 0px; top: 0px;;display:inline;">limits</div>, the Company believes that no material credit or market risk exposure exists due to the high quality of the institutions. The Company has not experienced any losses on such accounts. Restricted cash represents cash required to be held as collateral for the Company’s credit cards and security deposit for our facility in the Netherlands. Accordingly, these balances contain restrictions as to their availability and usage and are classified as restricted cash in the condensed consolidated balance sheets. </div></div></div> <div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"> </div> <div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt; text-indent: 0px;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">The reconciliation of cash, cash equivalents and restricted cash reported within the applicable consolidated balance sheet that sum to the total of the same such amount shown in the condensed consolidated statements of cash flows is as follows:</div></div></div> <div style="font-size: 12pt; margin-top: 0pt; margin-bottom: 0pt; text-indent: 0px;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-size: 12pt; letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></div> <table cellpadding="0" cellspacing="0" style="margin: 0px auto; border: 0px currentcolor; width: 100%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px; text-indent: 0px;"> <tr style="font-size: 0px;"> <td style="width: 75%;"/> <td style="width: 8%; vertical-align: bottom;"/> <td/> <td/> <td/> <td style="width: 8%; vertical-align: bottom;"/> <td/> <td/> <td/> </tr> <tr style="font-family: Times New Roman; font-size: 8pt; page-break-inside: avoid;"> <td style="vertical-align: bottom; padding-bottom: 1pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align: bottom; padding-bottom: 1pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">  </div></td> <td colspan="2" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">September 30, 2021</div></div></div></td> <td style="vertical-align: bottom; padding-bottom: 1pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align: bottom; padding-bottom: 1pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">  </div></td> <td colspan="2" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">December 31, 2020</div></div></div></td> <td style="vertical-align: bottom; padding-bottom: 1pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> </tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);"> <td style="vertical-align: top; width: 75%;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Cash and cash equivalents</div></div> </td> <td style="vertical-align: bottom; width: 8%;">  </td> <td style="vertical-align: bottom; white-space: nowrap;">$</td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">90,108</td> <td style="vertical-align: bottom; white-space: nowrap; font-family: &quot;Times New Roman&quot;;"> </td> <td style="vertical-align: bottom; width: 8%;">  </td> <td style="vertical-align: bottom; white-space: nowrap;">$</td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">8,564</td> <td style="vertical-align: bottom; white-space: nowrap; font-family: &quot;Times New Roman&quot;;"> </td> </tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;"> <td style="vertical-align: top; width: 75%;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Restricted cash</div></div> </td> <td style="vertical-align: bottom; width: 8%;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">143</td> <td style="vertical-align: bottom; white-space: nowrap; font-family: &quot;Times New Roman&quot;;"> </td> <td style="vertical-align: bottom; width: 8%;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">145</td> <td style="vertical-align: bottom; white-space: nowrap; font-family: &quot;Times New Roman&quot;;"> </td> </tr> <tr style="font-size: 1px;"> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; width: 75%;"> </td> <td style="vertical-align: bottom; width: 8%;">  </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td> </td> <td style="vertical-align: bottom; width: 8%;">  </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td> </td> </tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);"> <td style="vertical-align: top; font-family: &quot;Times New Roman&quot;; width: 75%;"> </td> <td style="vertical-align: bottom; width: 8%;">  </td> <td style="vertical-align: bottom; white-space: nowrap;">$</td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">90,251</td> <td style="vertical-align: bottom; white-space: nowrap; font-family: &quot;Times New Roman&quot;;"> </td> <td style="vertical-align: bottom; width: 8%;">  </td> <td style="vertical-align: bottom; white-space: nowrap;">$</td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">8,709</td> <td style="vertical-align: bottom; white-space: nowrap; font-family: &quot;Times New Roman&quot;;"> </td> </tr> <tr style="font-size: 1px;"> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; width: 75%;"> </td> <td style="vertical-align: bottom; width: 8%;">  </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td> </td> <td style="vertical-align: bottom; width: 8%;">  </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td> </td> </tr> </table> <div style="clear: both; max-height: 0px; text-indent: 0px;"/> <div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 18pt; margin-bottom: 0pt;"><div style="font-weight:bold;display:inline;"><div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">Accounts Receivable </div></div></div></div> <div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt; text-indent: 0px;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Accounts receivables are recorded at the invoiced amount and are generally unsecured as they are uncollateralized. The Company provides an allowance for doubtful accounts to reduce receivables to their estimated net realizable value. Judgement is exercised in establishing allowances and estimates are based on the customers’ payment history and liquidity. Any amounts that were previously recognized as revenue and subsequently determined to be uncollectible are charged to bad debt expense included in selling, general and administrative expense in the accompanying condensed consolidated statements of operations and comprehensive loss. Given the nature and historical collectability of the Company’s accounts receivable, an allowance for doubtful accounts was not deemed necessary at September 30, 2021 and December 31, 2020. </div></div></div> <div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"> </div> <div style="font-size: 8pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-size: 8pt; letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> <div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-weight:bold;display:inline;"><div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">Inventory </div></div></div></div> <div style="font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt;">Inventory consists of raw materials, work in progress and finished goods at the Company’s distribution center. Raw materials are stated at the lower of cost or net realizable value, determined by the <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;"><div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;"><div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">first-in-first-out</div></div></div> method. Finished goods and work in progress are valued using a methodology to determine the cost of each 3D printed object using allocations for material, labor, machine time and overhead. The Company periodically reviews its inventory for slow-moving, damaged and discontinued items and provides allowances to reduce such items identified to their recoverable amounts. As of September 30, 2021 and December 31, 2020, the Company determined an allowance was not deemed necessary. </div> <div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 18pt; margin-bottom: 0pt;"><div style="font-weight:bold;display:inline;"><div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">Property and Equipment, net </div></div></div></div> <div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt; text-indent: 0px;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Property and equipment are stated at cost, less accumulated depreciation. Maintenance and repairs are charged to expense when incurred. Additions and improvements that extend the economic useful life of the asset are capitalized and depreciated over the remaining useful lives of the assets. The cost and accumulated depreciation of assets sold or retired are removed from the respective accounts, and any resulting gain or loss is reflected in current earnings. No impairment charges were recorded for the periods ended September 30, 2021 and December 31, 2020. Depreciation is recognized using the straight-line method in amounts considered to be sufficient to allocate the cost of the assets to operations over the estimated useful lives or lease terms, as follows: </div></div></div> <div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"> </div> <div style="font-size: 12pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-size: 12pt; letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> <table cellpadding="0" cellspacing="0" style="margin: 0px auto; border: 0px currentcolor; width: 100%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;"> <tr style="font-size: 0px;"> <td style="width: 82%; font-family: &quot;Times New Roman&quot;;"/> <td style="width: 11%; vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"/> <td style="font-family: &quot;Times New Roman&quot;;"/> </tr> <tr style="font-family: Times New Roman; font-size: 8pt; page-break-inside: avoid;"> <td style="vertical-align: bottom; white-space: nowrap; padding-bottom: 1pt; width: 82%;"> <div style="font-family: &quot;Times New Roman&quot;; font-size: 8pt; margin-top: 0pt; margin-bottom: 0pt; border-bottom: 1pt solid rgb(0, 0, 0); display: table-cell; line-height: normal;"><div style="font-weight:bold;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 8pt; letter-spacing: 0px; top: 0px;;display:inline;">Asset Category</div></div></div> </td> <td style="vertical-align: bottom; padding-bottom: 1pt; width: 11%;">  </td> <td style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Depreciable Life</div></div></td> </tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);"> <td style="vertical-align: top; width: 82%;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Machinery and equipment</div></div> </td> <td style="vertical-align: bottom; width: 11%;">  </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:center;">5 years</td> </tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;"> <td style="vertical-align: top; width: 82%;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Computers and IT equipment</div></div> </td> <td style="vertical-align: bottom; width: 11%;">  </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:center;">3 years</td> </tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);"> <td style="vertical-align: top; width: 82%;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Furniture and fixtures</div></div> </td> <td style="vertical-align: bottom; width: 11%;">  </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:center;">7 years</td> </tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;"> <td style="vertical-align: top; width: 82%;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Leasehold improvements</div></div> </td> <td style="vertical-align: bottom; width: 11%;">  </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:center;">*<span style="-sec-ix-hidden:hidden29104785">*</span></td> </tr> </table> <div style="font-size: 12pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-size: 12pt; letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> <table cellpadding="0" cellspacing="0" style="border: 0px currentcolor; width: 100%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;"> <tr style="page-break-inside: avoid;"> <td style="width: 4%; vertical-align: top;;text-align:left;">**</td> <td style="vertical-align: top;;text-align:left;"> <div style="text-align: left; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Leasehold improvements are amortized using the straight-line method over the shorter of the lease term or estimated useful life of the asset. </div></div> </td> </tr> </table> <div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 18pt; margin-bottom: 0pt;"><div style="font-weight:bold;display:inline;"><div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">Long-Lived Assets, Including Definite-Lived Intangible Assets </div></div></div></div> <div style="font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt;">Intangible assets, which consist of technology, customer relationships, and trademarks, are stated at cost less accumulated amortization. Amortization is generally recorded on a straight-line basis over estimated useful lives ranging from three to eight years. The Company periodically reviews the estimated useful lives of intangible assets and adjusts when events indicate that a shorter life is appropriate. In accordance with authoritative accounting guidance, capitalization of costs to develop software begin when preliminary development efforts are successfully and completed. Costs related to the design or maintenance of <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">internal-use</div> software are expensed as incurred. </div> <div style="font-family: Times New Roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Long-lived assets, other than goodwill and other indefinite-lived intangibles, are evaluated for impairment whenever events or changes in circumstances indicate that the carrying amount of the assets may not be recoverable through the estimated undiscounted future cash flows derived from such assets. </div></div> <div style="font-family: Times New Roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Factors that the Company considers in deciding when to perform an impairment review include significant changes in the Company’s forecasted projections for the asset or asset group for reasons including, but not limited to, significant underperformance of a product in relation to expectations, significant changes, or planned changes in the Company’s use of the assets, significant negative industry or economic trends, and new or competing products that enter the marketplace. The impairment test is based on a comparison of the undiscounted cash flows expected to be generated from the use of the asset group. If impairment is indicated, the asset is written down by the amount by which the carrying value of the asset exceeds the related fair value of the asset with the related impairment charge recognized within the statements of operations and comprehensive loss. No impairment charges were recorded for the periods ended September 30, 2021 and December 31, 2020. </div></div> <div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 18pt; margin-bottom: 0pt;"><div style="font-weight:bold;display:inline;"><div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">Goodwill </div></div></div></div> <div style="font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Goodwill, which represents the excess of purchase prices over the fair value of net assets acquired, is carried at cost. Goodwill is not amortized; rather, it is subject to a periodic assessment for impairment by applying a fair value-based test. Goodwill is evaluated for impairment on an annual basis at a level of reporting referred to as the reporting unit, and more frequently if adverse events or changes in circumstances indicate that the asset may be impaired. </div></div> <div style="font-family: Times New Roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;">Under ASC 350, <div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">Intangibles - Goodwill and Other</div></div>,<div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;"> </div></div>the Company has the option to first assess the qualitative factors to determine whether it is more likely than not that the fair value of the reporting unit is less than its carrying amount as a basis for determining whether it is necessary to perform a quantitative goodwill impairment test. If the Company determines that it is more likely than not that </div> <div style="font-family: Times New Roman; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">the fair value of a reporting unit is less than its carrying amount, then the goodwill impairment test is performed. Impairment tests are performed, at a minimum, in the fourth quarter of each year. Management uses the future discounted cash flows valuation approach to determine the fair value of reporting units and determines whether the fair value of reporting units exceeded its carrying amounts. If the fair value exceeds the carrying amount, then no impairment is recognized. If the carrying amount recorded exceeds the fair value calculated, then an impairment charge is recognized for the difference. The impairment review requires management to make judgments in determining various assumptions with respect to revenues, operating margins, growth rates and discount rates. The judgments made in determining the projected cash flows used to estimate the fair value can materially impact the Company’s financial condition and results of operations. There was no impairment of goodwill as of September 30, 2021 or December 31, <div style="letter-spacing: 0px; top: 0px;;display:inline;">2020</div>. </div></div> <div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 18pt; margin-bottom: 0pt;"><div style="font-weight:bold;display:inline;"><div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">Fair Value Measurements </div></div></div></div> <div style="font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt;">The Company applies ASC 820, <div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">Fair Value Measurement </div></div>(“ASC 820”), which establishes framework for measuring fair value and clarifies the definition of fair value within that framework. ASC 820 defines fair value as an exit price, which is the price that would be received for an asset or paid to transfer a liability in the Company’s principal or most advantageous market in an orderly transaction between market participants on the measurement date. The fair value hierarchy established in ASC 820 generally requires an entity to maximize the use of observable inputs and minimize the use of unobservable inputs when measuring fair value. Observable inputs reflect the assumptions that market participants would use in pricing the asset or liability and are developed based on market data obtained from sources independent of the reporting entity. Unobservable inputs reflect the entity’s own assumptions based on market data and the entity’s judgments about the assumptions that market participants would use in pricing the asset or liability and are to be developed based on the best information available in the circumstances. </div> <div style="font-family: Times New Roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">The valuation hierarchy is composed of three levels. The classification within the valuation hierarchy is based on the lowest level of input that is significant to the fair value measurement. The levels within the valuation hierarchy are described below: </div></div> <div style="font-family: Times New Roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;">Level 1 <div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">-</div></div> Assets and liabilities with unadjusted, quoted prices listed on active market exchanges. Inputs to the fair value measurement are observable inputs, such as quoted prices in active markets for identical assets or liabilities. </div> <div style="font-family: Times New Roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;">Level 2 <div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">-</div></div> Inputs to the fair value measurement are determined using prices for recently traded assets and liabilities with similar underlying terms, as well as direct or indirect observable inputs, such as interest rates and yield curves that are observable at commonly quoted intervals. </div> <div style="font-family: Times New Roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;">Level 3 <div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">-</div></div> Inputs to the fair value measurement are unobservable inputs, such as estimates, assumptions, and valuation techniques when little or no market data exists for the assets or liabilities. </div> <div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 18pt; margin-bottom: 0pt;"><div style="font-weight:bold;display:inline;"><div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">Revenue Recognition </div></div></div></div> <div style="font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Revenue is derived from two primary sources: a) products and services and b) software. </div></div> <div style="font-family: Times New Roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">The Company recognizes revenue following the five-step model prescribed under ASC 606: (i) identify contract(s) with a customer; (ii) identify the performance obligation(s) in the contract; (iii) determine the transaction price; (iv) allocate the transaction price to the performance obligation(s) in the contract; and (v) recognize revenue when (or as) the Company satisfies a performance obligation. The Company only applies the five-step model to contracts when it is probable that the Company will collect the consideration it is entitled to in exchange for the products or services it transfers to the customer. These contracts have different terms based on the scope, performance obligations, and complexity of the project, which often requires us to make judgments and estimates in recognizing revenues. </div></div> <div style="font-family: Times New Roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Performance obligations are satisfied both at a <div style="letter-spacing: 0px; top: 0px;;display:inline;">point </div>of time and over time. All revenue is recognized based on the satisfaction of the performance obligation to date (see Note 4). </div></div> <div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 18pt; margin-bottom: 0pt;"><div style="font-weight:bold;display:inline;"><div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">Leases </div></div></div></div> <div style="font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">The Company’s lease arrangements relate primarily to office and manufacturing space, and equipment. The Company’s leases generally have initial terms ranging from 5 to 10 years and may include renewal options and rent escalation clauses. The Company is typically required to make fixed minimum rent payments relating to its right to use an underlying leased asset. Additionally, the Company’s leases do not contain significantly restrictive covenants or residual value guarantees. </div></div> <div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt; text-indent: 0px;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">The Company determines if an arrangement is a lease at inception and classifies its leases at commencement. Operating leases are presented as <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;"><div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">right-of-use</div></div> (“ROU”) assets and the corresponding lease liabilities are included in operating lease liabilities, current and operating lease liabilities on the Company’s condensed consolidated balance sheets. The Company does not currently maintain any finance lease </div></div> <div style="font-family: Times New Roman; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">arrangements. ROU assets represent the Company’s right to use an underlying asset, and lease liabilities represent the Company’s obligation for lease payments in exchange for the ability to use the asset for the duration of the lease term. The Company does not recognize short term leases that have a term of twelve months or less as ROU assets or lease liabilities. The Company’s short-term leases are not material and do not have a material impact on its ROU assets or lease liabilities. </div></div> <div style="font-family: Times New Roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">ROU assets and lease <div style="letter-spacing: 0px; top: 0px;;display:inline;">liabilities </div>are recognized at commencement date and determined using the present value of the future minimum lease payments over the lease term. The Company uses an incremental borrowing rate based on estimated rate of interest for collateralized borrowing since the Company’s leases do not include an implicit interest rate. The estimated incremental borrowing rate considers market data, actual lease economic environment, and actual lease term at commencement date. The lease term may include options to extend when it is reasonably certain that the Company will exercise that option. ROU assets include lease payments made in advance, and excludes any incentives received or initial direct costs incurred. The Company recognizes lease expense on a straight-line basis over the lease term </div></div> <div style="font-family: Times New Roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;">The Company has lease agreements which contain both lease and <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">non-lease</div> components, which it has elected to account for as a single lease component. As such, minimum lease payments include fixed payments for <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">non-lease</div> components within a lease agreement, but exclude variable lease payments not dependent on an index or rate, such as common area maintenance, operating expenses, utilities, or other costs that are subject to fluctuation from period to period. </div> <div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 18pt; margin-bottom: 0pt;"><div style="font-weight:bold;display:inline;"><div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">Stock-based Compensation </div></div></div></div> <div style="font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt;">The Company recognizes stock-based compensation expense for all options and other arrangements within the scope of ASC 718, <div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">Stock Compensation</div></div>. Stock-based compensation expense is measured at the date of grant, based on the fair value of the award, and is recognized using the straight-line method over the employee’s requisite service period. Compensation for stock-based awards with vesting conditions other than service are recognized at the time that those conditions will be achieved. Forfeitures are recognized as they are incurred. </div> <div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 18pt; margin-bottom: 0pt;"><div style="font-weight:bold;display:inline;"><div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">Public and Private Common Stock Warrant Liabilities </div></div></div></div> <div style="font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">As part of Galileo’s initial public offering, Galileo issued to third party investors 13,800,000 units, consisting of one ordinary share of Galileo and one warrant, at a price of $10.00 per unit. Each whole warrant entitles the holder to purchase one share of <div style="letter-spacing: 0px; top: 0px;;display:inline;">C</div>ommon <div style="letter-spacing: 0px; top: 0px;;display:inline;">S</div>tock at an exercise price of $11.50 per share (the “Public Warrants”). Simultaneously with the closing of Galileo’s initial public offering, Galileo completed the private sale of 4,110,000 warrants to Galileo’s sponsor and EarlyBirdCapital, Inc. at a purchase price of $1.00 per warrant (the “Private Warrants”). In connection with the Business Combination, Galileo’s sponsor exercised its right to convert the aggregate outstanding principal amount of the convertible promissory note issued by Galileo into an aggregate of 500,000 Sponsor Warrants, with terms equivalents to the Private Warrants. </div></div> <div style="font-family: Times New Roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">The Private Warrants are <div style="letter-spacing: 0px; top: 0px;;display:inline;">identical</div> to the Public Warrants, except that the Private Warrants (i) will not be redeemable by the Company and (ii) may be exercised for cash or on a cashless basis, so long as they are held by the initial purchaser or any of its permitted transferees. If the Private Warrants are held by holders other than the initial purchasers or any of their permitted transferees, the Private Warrants will be redeemable by the Company and exercisable by the holders on the same basis as the Public Warrants. </div></div> <div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt; text-indent: 0px;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">The Company evaluated the Public and Private Warrants under ASC <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">815-40,</div> <div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">Derivatives and Hedging—Contracts in Entity’s Own Equity</div></div> (“ASC <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">815-40”),</div> and concluded that the Private Warrants do not meet the criteria to be classified in stockholders’ equity. Since the Private Warrants meet the definition of a derivative under ASC 815, the Company recorded these warrants as liabilities on the condensed consolidated balance sheet at fair value, with subsequent changes in their respective fair values recognized in the condensed consolidated statement of operations at each reporting date. </div></div> <div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div> <div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 18pt; margin-bottom: 0pt;"><div style="font-weight:bold;display:inline;"><div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">Research and Development Costs </div></div></div></div> <div style="font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Research and development expenses consist primarily of allocated personnel costs, fees paid to consultants and outside service providers, and allocations for rent and overhead. Research and development costs are expensed as incurred. Advance payments for goods and services that will be used in future research and development activities are expensed when the activity has been performed or when the goods have been received. For the three months ended September 30, 2021 and 2020, research and development costs were $1,673 and $1,516, respectively. For the nine months ended September 30, 2021 and 2020, research and development costs were $4,099 and $4,289, respectively. </div></div> <div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-weight:bold;display:inline;"><div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">Advertising </div></div></div></div> <div style="font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Advertising costs are expensed as incurred. For the three months ended September 30, 2021 and 2020, advertising costs were $568 and $123, respectively. For the nine months ended September 30, 2021 and 2020, advertising costs were $1,008 and $353, respectively, which are included in selling, general and administrative expense on the<div style="letter-spacing: 0px; top: 0px;;display:inline;"> condensed</div> consolidated statements of operations and comprehensive loss. </div></div> <div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 18pt; margin-bottom: 0pt; text-indent: 0px;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;"><div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">Income Taxes </div></div></div></div></div> <div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt; text-indent: 0px;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">The Company files income tax returns in <div style="letter-spacing: 0px; top: 0px;;display:inline;">the </div>U.S. federal jurisdiction and various state jurisdictions. Income taxes are accounted for under the asset and liability method. Deferred tax assets and liabilities are recognized for the estimated future tax consequences attributable to differences between the financial statement carrying amounts of existing assets and liabilities and their respective tax bases. Deferred tax assets and liabilities are measured using enacted tax rates in effect for the year in which those temporary differences are expected to be recovered or settled. Where applicable, the Company records a valuation allowance to reduce any deferred tax assets that it determines will not be realizable in the future. </div></div></div> <div style="font-family: Times New Roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">The Company recognizes the benefit of an uncertain tax position that it has taken or expects to take on income tax returns it files if such tax position is more likely than not to be sustained on examination by the taxing authorities, based on the technical merits of the position. These tax benefits are measured based on the largest benefit that has a greater than 50% likelihood of being realized upon ultimate resolution. Although the Company believes that i<div style="letter-spacing: 0px; top: 0px;;display:inline;">t</div> has adequately reserved for uncertain tax positions (including interest and penalties), it can provide no assurance that the final tax outcome of these matters will not be materially different. The Company makes adjustments to these reserves in accordance with the income tax accounting guidance when facts and circumstances change, such as the closing of a tax audit or the refinement of an estimate. To the extent that the final tax outcome of these matters is different than the amounts recorded, such differences will affect the provision for income taxes in the period in which such determination is made, and could have a material impact on the Company’s financial condition and operating results. Carryforward attributes that were generated in tax years prior to those that remain open for examination may still be adjusted by relevant tax authorities upon examination if they either have been, or will be, used in a future period.</div></div> <div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt; text-indent: 0px;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">In applying the estimated annual effective tax rate approach prescribed under ASC 740, <div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">Income Taxes,</div></div> based on present evidence and conclusions around the realizability of deferred tax assets, we determined that any deferred tax benefits related to the forecasted tax rate and pretax activity during the three and nine months ended September 30, 2021 and 2020 are neither more likely than not to be realized in the current year, nor realizable as a deferred tax asset at the end of the year. Therefore, the appropriate amount of income tax benefit to recognize related to deferred tax assets during the three and nine months ended September 30, 2021 and 2020 is zero. The Company’s effective tax rate of </div><div style="letter-spacing: 0px; top: 0px; text-indent: 0px;;display:inline;">(1.78)% <div style="letter-spacing: 0px; top: 0px;;display:inline;">for the nine months ended September 30, 2021 differs from the applicable statutory tax rate primarily due to the fact that income recognized for the forgiveness of loans granted under the PPP loan program and changes in the fair value of warrant liabilities are not taxable under current U.S. tax law.</div></div></div> <div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"> </div> <div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 18pt; margin-bottom: 0pt;"><div style="font-weight:bold;display:inline;"><div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">Income (Loss) per Share </div></div></div></div> <div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt; text-indent: 0px;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">In accordance with the provisions of ASC 260, <div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">Earnings Per Share</div></div>, net income (loss) per common share is computed by dividing net income (loss) by the weighted-average shares of Common Stock outstanding during the period. Basic income (loss) per share is computed by dividing net income (loss) attributable to common stockholders by the weighted average number of shares outstanding during the period. Diluted income (loss) per share gives effect to all dilutive potential common shares outstanding during the period including stock options and warrants, using the treasury stock method, and convertible debt and convertible securities, using the <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">if-converted</div> method. During a loss period, the effect of the potential exercise of stock options and convertible debt are not considered in the diluted loss per common share calculation since the effect would be anti-dilutive. </div></div> <div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div> <div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div> <div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt; text-indent: 0px;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">The following outstanding shares of Common Stock equivalents were excluded from the computation of the diluted net loss per share attributable to Common Stock for the periods in which a net loss is presented because their effect would have been anti-dilutive: </div></div></div> <div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"> </div> <div style="font-size: 12pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-size: 12pt; letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> <table cellpadding="0" cellspacing="0" style="margin: 0px auto; border: 0px currentcolor; width: 100%; font-family: &quot;Times New Roman&quot;; font-size: 8pt; border-collapse: collapse; border-spacing: 0px;"> <tr style="font-size: 0px;"> <td style="width: 74%;"/> <td style="width: 1%; vertical-align: bottom;"/> <td/> <td/> <td/> <td style="width: 1%; vertical-align: bottom;"/> <td/> <td/> <td/> <td style="width: 1%; vertical-align: bottom;"/> <td/> <td/> <td/> <td style="width: 1%; vertical-align: bottom;"/> <td/> <td/> <td/> </tr> <tr style="font-family: Times New Roman; font-size: 8pt; page-break-inside: avoid;"> <td style="vertical-align: bottom; padding-bottom: 1pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 1pt;">  </td> <td colspan="6" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Three Months Ended<br/> September 30,</div></div></td> <td style="vertical-align: bottom; padding-bottom: 1pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 1pt;">  </td> <td colspan="6" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Nine Months Ended<br/> September 30,</div></div></td> <td style="vertical-align: bottom; padding-bottom: 1pt;"> </td> </tr> <tr style="font-family: Times New Roman; font-size: 8pt; page-break-inside: avoid;"> <td style="vertical-align: bottom; padding-bottom: 1pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 1pt;">  </td> <td colspan="2" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">2021</div></div></td> <td style="vertical-align: bottom; padding-bottom: 1pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 1pt;">  </td> <td colspan="2" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">2020</div></div></td> <td style="vertical-align: bottom; padding-bottom: 1pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 1pt;">  </td> <td colspan="2" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">2021</div></div></td> <td style="vertical-align: bottom; padding-bottom: 1pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 1pt;">  </td> <td colspan="2" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">2020</div></div></td> <td style="vertical-align: bottom; padding-bottom: 1pt;"> </td> </tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);"> <td style="vertical-align: top; width: 74%;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Common stock warrants</div></div> </td> <td style="vertical-align: bottom; width: 1%;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">18,410,000</td> <td style="vertical-align: bottom; white-space: nowrap; font-family: &quot;Times New Roman&quot;;"> </td> <td style="vertical-align: bottom; width: 1%;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">—  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; width: 1%;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">18,410,000</td> <td style="vertical-align: bottom; white-space: nowrap; font-family: &quot;Times New Roman&quot;;"> </td> <td style="vertical-align: bottom; width: 1%;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">—  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> </tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;"> <td style="vertical-align: top; width: 74%;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Earnout Shares</div></div> </td> <td style="vertical-align: bottom; width: 1%;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">3,510,405</td> <td style="vertical-align: bottom; white-space: nowrap; font-family: &quot;Times New Roman&quot;;"> </td> <td style="vertical-align: bottom; width: 1%;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">—  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; width: 1%;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">3,510,405</td> <td style="vertical-align: bottom; white-space: nowrap; font-family: &quot;Times New Roman&quot;;"> </td> <td style="vertical-align: bottom; width: 1%;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">—  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> </tr> </table> <div style="font-family: Times New Roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px; text-indent: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">Included in income (loss) per common share are </div>4,833,059 and 3,673,963 shares of <div style="letter-spacing: 0px; top: 0px;;display:inline;">options</div> due to their nominal exercise prices as of September 30, 2021 and 2020, respectively. </div></div> <div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 18pt; margin-bottom: 0pt;"><div style="font-weight:bold;display:inline;"><div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">Segment Information </div></div></div></div> <div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt; text-indent: 0px;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">The Company has determined that it operates and reports in one segment, which focuses on providing additive manufacturing services to customers. The Company’s operating segment is reported in a manner consistent with the internal reporting provided to the chief operating decision maker (“CODM”). The Company’s CODM has been identified as its Chief Executive Officer. </div></div></div> <div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; text-indent: 0px;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;"><div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">Recent Accounting Pronouncements </div></div></div></div></div> <div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt; text-indent: 0px;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">Accounting Pronouncements Recently Adopted </div></div></div></div> <div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt; text-indent: 0px;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">In January 2017, the FASB issued Accounting Standard Update (“ASU”) <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">No. 2017-04,</div> <div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">Intangibles—Goodwill and Other (Topic 350): Simplifying the Test for Goodwill Impairment,</div></div> which aims to simplify the subsequent measurement of goodwill by eliminating Step 2 from the goodwill impairment test. Under the new guidance, goodwill impairment will be measured as the amount by which the carrying value exceeds the fair value. The loss recognized should not exceed the total amount of goodwill allocated to the reporting unit. The standard is effective for annual and interim reporting periods beginning after December 15, 2021. Early adoption is permitted. The Company adopted ASU <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">2017-04</div> effective January 1, 2021. The adoption of this standard did not have a significant impact on the Company’s condensed consolidated financial statements. </div></div> <div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div> <div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt; text-indent: 0px;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">In December 2019, the FASB issued ASU <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">No. 2019-12,</div> <div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">Income Taxes (Topic 740): Simplifying the Accounting for Income Taxes</div></div>. The purpose of Update <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">No. 2019-12</div> is to continue the FASB’s Simplification Initiative to reduce complexity in accounting standards. The amendments in Update <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">No. 2019-12</div> simplify the accounting for income taxes by removing certain exceptions related to the incremental approach for intraperiod tax allocation, the requirement to recognize or derecognize deferred tax liabilities related to equity method investments that are also foreign subsidiaries, and the methodology for calculating income taxes in an interim period. In addition to removing these exceptions, Update <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">No. 2019-12</div> also clarifies and simplifies other aspects of the accounting for income taxes. The Company adopted ASU <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">2019-12</div> effective January 1, 2021. The adoption of this standard did not have a significant impact on the Company’s condensed consolidated financial statements. </div></div> <div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div> <div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt; text-indent: 0px;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">In August 2020, the FASB issued ASU <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">2020-06,</div> <div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">Debt — Debt with Conversion and Other Options (Subtopic <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">470-20)</div> and Derivatives and Hedging — Contracts in Entity’s Own Equity (Subtopic <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">815-40):</div> Accounting for Convertible Instruments and Contracts in an Entity’s Own Equity</div></div>, which simplifies the accounting for convertible instruments by removing certain separation models in Subtopic <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">470-20,</div> Debt—Debt with Conversion and Other Options, for convertible instruments and also increases information transparency by making disclosure amendments. The standard is effective for fiscal years beginning after December 15, 2023, including interim periods within those fiscal years. Early adoption is permitted, but no earlier than fiscal years beginning after December 15, 2020, including interim periods within those fiscal years. The Company adopted ASU <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">2020-06</div> effective January 1, 2021. The adoption of this standard did not have a significant impact on the Company’s condensed consolidated financial statements. </div></div> <div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt; text-indent: 0px;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">In August 2018, the FASB issued ASU <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">No. 2018-15,</div> <div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">Intangibles – Goodwill and Other – <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">Internal-Use</div> Software (Subtopic <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">350-40):</div> Customer’s Accounting for Implementation Costs Incurred in a Cloud Computing Arrangement That Is a Service Contract</div></div>, which aligns the requirements for capitalizing implementation costs incurred in a hosting arrangement that is a service contract with the requirements for capitalizing implementation costs incurred to develop or obtain <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">internal-use</div> software (and hosting arrangements that include an <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">internal-use</div> software license). The standard is effective for annual reporting periods beginning after December 15, 2020 and interim periods within annual periods beginning after December 15, 2021. Early adoption is permitted. The Company adopted ASU 2018-15 effective January 1, 2021. The adoption of this standard did not have a significant impact on the Company’s condensed consolidated financial statements. </div></div> <div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 18pt; margin-bottom: 0pt; text-indent: 0px;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">Accounting Pronouncements Not Yet Adopted </div></div></div></div> <div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt; text-indent: 0px;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">In June 2016, the FASB issued ASU No. 2016-13, Accounting for Credit Losses (Topic 326), which requires the use of an “expected loss” model on certain types of financial instruments. The standard also amends the impairment model for available-for-sale debt securities and requires estimated credit losses to be recorded as allowances instead of reductions to amortized cost of the securities. Update No. 2016-13 is effective for annual periods beginning after December 15, 2022, including interim periods within those annual periods. Early adoption is permitted, including adoption in an interim period. The Company is currently evaluating the impact the standard will have on its condensed consolidated financial statements. </div></div></div> <div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div> <div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt; text-indent: 0px;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;"><div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">Basis of Presentation and Principles of Consolidation </div></div></div></div></div> <div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt; text-indent: 0px;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">The accompanying condensed consolidated interim financial statements have been prepared in accordance with accounting principles generally accepted in the United States of America (“U.S. GAAP”) for interim financial information as defined by the Financial Accounting Standards Board (“FASB”) Accounting Standards Codification (“ASC”) and in accordance with the instruction to Form <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">10-Q</div> and Article 8 of Regulation <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">S-X</div> of the SEC. Certain information or footnote disclosures normally included in financial statements prepared in accordance with GAAP have been condensed or omitted, pursuant to the rules and regulations of the SEC for interim financial reporting. Accordingly, they do not include all the information and footnotes necessary for a complete presentation of financial position, results of operations, or cash flows. The condensed consolidated financial statements include the accounts of its wholly owned subsidiaries, Legacy Shapeways and Shapeways BV. All intercompany accounts and transactions have been eliminated in consolidation. In the opinion of management, the accompanying condensed consolidated interim financial statements include all adjustments, consisting of a normal recurring nature, which are necessary for a fair presentation of the financial position, operating results and cash flows for the periods presented. These unaudited condensed consolidated interim financial statements should be read along with the final proxy statement/prospectus as filed with the SEC on September 7, 2021. </div></div> <div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt; text-indent: 0px;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">The Business Combination has been accounted for as a reverse recapitalization, in accordance with U.S. GAAP (the “Reverse Recapitalization”). Under this method of accounting, Galileo has been treated as the “acquired” company for financial reporting purposes. Accordingly, the Business Combination has been treated as the equivalent of Legacy Shapeways issuing stock for the net assets of Galileo, accompanied by a recapitalization. The net assets of Galileo are stated at historical cost, with no goodwill or other intangible assets recorded. There has been no accounting effect or change in the carrying amount of the assets and liabilities as a result of the Business Combination. </div></div></div> <div style="letter-spacing: 0px; top: 0px; background: none;;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px; background: none; text-decoration: none;;display:inline;"> </div></div> <div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt; text-indent: 0px;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Legacy Shapeways has been treated as the accounting acquirer based on evaluation of the following facts and circumstances with regard to the Company as of the Closing: </div></div></div> <div style="font-size: 6pt; margin-top: 0pt; margin-bottom: 0pt; text-indent: 0px;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-size: 6pt; letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></div> <table cellpadding="0" cellspacing="0" style="border: 0px currentcolor; width: 100%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px; text-indent: 0px;"> <tr style="page-break-inside: avoid;"> <td style="width: 4%;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="width: 4%; vertical-align: top;;text-align:left;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">•</div></td> <td style="width: 1%; vertical-align: top;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align: top;;text-align:left;"> <div style="text-align: left; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">Legacy Shapeways’ directors represented the majority of the new board of directors of the Company; </div></div> </td> </tr> </table> <div style="clear: both; max-height: 0px; text-indent: 0px;"/> <div style="font-size: 6pt; margin-top: 0pt; margin-bottom: 0pt; text-indent: 0px;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-size: 6pt; letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></div> <table cellpadding="0" cellspacing="0" style="border: 0px currentcolor; width: 100%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px; text-indent: 0px;"> <tr style="page-break-inside: avoid;"> <td style="width: 4%;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="width: 4%; vertical-align: top;;text-align:left;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">•</div></td> <td style="width: 1%; vertical-align: top;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align: top;;text-align:left;"> <div style="text-align: left; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">The executive officers and senior management of Legacy Shapeways are the executive officers and senior management of the Company; </div></div> </td> </tr> </table> <div style="clear: both; max-height: 0px; text-indent: 0px;"/> <div style="font-size: 6pt; margin-top: 0pt; margin-bottom: 0pt; text-indent: 0px;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-size: 6pt; letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></div> <table cellpadding="0" cellspacing="0" style="border: 0px currentcolor; width: 100%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px; text-indent: 0px;"> <tr style="page-break-inside: avoid;"> <td style="width: 4%;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="width: 4%; vertical-align: top;;text-align:left;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">•</div></td> <td style="width: 1%; vertical-align: top;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align: top;;text-align:left;"> <div style="text-align: left; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">The assets of Legacy Shapeways represent a significant majority of the assets of the Company (excluding cash formerly held in the Galileo trust account); and </div></div> </td> </tr> </table> <div style="clear: both; max-height: 0px; text-indent: 0px;"/> <div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div> <div style="font-size: 8pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-size: 8pt; letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> <table cellpadding="0" cellspacing="0" style="border: 0px currentcolor; width: 100%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;"> <tr style="page-break-inside: avoid;"> <td style="width: 4%;"> </td> <td style="width: 4%; vertical-align: top;;text-align:left;">•</td> <td style="width: 1%; vertical-align: top;"> </td> <td style="vertical-align: top;;text-align:left;"> <div style="text-align: left; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; line-height: normal;">The business of the Company will be the continued business of Legacy Shapeways. The business of the Company will continue to focus on Legacy Shapeways’ core offerings related to the facilitation of the sale, design and manufacturing of 3D printed items. </div> </td> </tr> </table> <div style="clear: both; max-height: 0px;"/> <div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt; text-indent: 0px;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">The consolidated assets, liabilities and results of operations prior to the Reverse Recapitalization are those of Legacy Shapeways. The shares and corresponding capital amounts and losses per share, prior to the Merger, have been retroactively adjusted based on shares reflecting the conversion ratio (as defined below) established in the Merger. </div></div></div> <div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"> </div> <div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 18pt; margin-bottom: 0pt;"><div style="font-weight:bold;display:inline;"><div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">Use of Estimates </div></div></div></div> <div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt; text-indent: 0px;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">The preparation of the Company’s <div style="letter-spacing: 0px; top: 0px;;display:inline;">unaudited </div>condensed consolidated financial statements, in conformity with U.S. GAAP, requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the condensed consolidated financial statements and reported amounts of revenues and expenses during the reporting period. Actual results may differ from those estimates. </div></div></div> <div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt; text-indent: 0px;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">In March 2020, the World Health Organization declared the outbreak of a novel coronavirus <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">(COVID-19)</div> as a pandemic, which continues to spread throughout the United States. While the disruption is currently expected to be temporary, there is uncertainty around the duration. The Company has considered information available to it as of the date of issuance of these unaudited condensed consolidated financial statements and is not aware of any specific events or circumstances that would require an update to its estimates or judgements, or an adjustment to the carrying value of its assets or liabilities. The accounting estimates and other matters assessed include, but were not limited to, goodwill and other long-lived assets, warrant liabilities and revenue recognition. These estimates may change as new events occur and additional information becomes available. Actual results could differ materially from these estimates. </div></div> <div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div> <div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 18pt; margin-bottom: 0pt; text-indent: 0px;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;"><div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">Functional Currency </div></div></div></div></div> <div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt; text-indent: 0px;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">The local currency is the functional currency for Shapeways BV’s (a <div style="letter-spacing: 0px; top: 0px;;display:inline;">wholly</div>-owned subsidiary of the Company) operations outside the United States. Assets and liabilities of these operations are translated into U.S. Dollars at the exchange rate in effect at the end of each period. Income statement accounts are translated at the average exchange rate prevailing during the period. Translation adjustments arising from the use of differing exchange rates from period to period are included as a component of other comprehensive loss within stockholders’ equity (deficit). Gains and losses from foreign currency transactions are included in net loss for the period. </div></div></div> <div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 18pt; margin-bottom: 0pt;"><div style="font-weight:bold;display:inline;"><div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">Cash, Cash Equivalents <div style="letter-spacing: 0px; top: 0px;;display:inline;">and </div>Restricted Cash </div></div></div></div> <div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt; text-indent: 0px;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Cash includes cash on hand and demand deposits. The Company maintains its deposits at high quality financial institutions and monitors the credit ratings of those institutions. The Company considers all highly liquid investments with original maturities of three months or less to be cash equivalents. While cash held by financial institutions may at times exceed federally insured <div style="letter-spacing: 0px; top: 0px;;display:inline;">limits</div>, the Company believes that no material credit or market risk exposure exists due to the high quality of the institutions. The Company has not experienced any losses on such accounts. Restricted cash represents cash required to be held as collateral for the Company’s credit cards and security deposit for our facility in the Netherlands. Accordingly, these balances contain restrictions as to their availability and usage and are classified as restricted cash in the condensed consolidated balance sheets. </div></div></div> <div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt; text-indent: 0px;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">The reconciliation of cash, cash equivalents and restricted cash reported within the applicable consolidated balance sheet that sum to the total of the same such amount shown in the condensed consolidated statements of cash flows is as follows:</div></div></div> <div style="font-size: 12pt; margin-top: 0pt; margin-bottom: 0pt; text-indent: 0px;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-size: 12pt; letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></div> <table cellpadding="0" cellspacing="0" style="margin: 0px auto; border: 0px currentcolor; width: 100%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px; text-indent: 0px;"> <tr style="font-size: 0px;"> <td style="width: 75%;"/> <td style="width: 8%; vertical-align: bottom;"/> <td/> <td/> <td/> <td style="width: 8%; vertical-align: bottom;"/> <td/> <td/> <td/> </tr> <tr style="font-family: Times New Roman; font-size: 8pt; page-break-inside: avoid;"> <td style="vertical-align: bottom; padding-bottom: 1pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align: bottom; padding-bottom: 1pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">  </div></td> <td colspan="2" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">September 30, 2021</div></div></div></td> <td style="vertical-align: bottom; padding-bottom: 1pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align: bottom; padding-bottom: 1pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">  </div></td> <td colspan="2" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">December 31, 2020</div></div></div></td> <td style="vertical-align: bottom; padding-bottom: 1pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> </tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);"> <td style="vertical-align: top; width: 75%;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Cash and cash equivalents</div></div> </td> <td style="vertical-align: bottom; width: 8%;">  </td> <td style="vertical-align: bottom; white-space: nowrap;">$</td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">90,108</td> <td style="vertical-align: bottom; white-space: nowrap; font-family: &quot;Times New Roman&quot;;"> </td> <td style="vertical-align: bottom; width: 8%;">  </td> <td style="vertical-align: bottom; white-space: nowrap;">$</td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">8,564</td> <td style="vertical-align: bottom; white-space: nowrap; font-family: &quot;Times New Roman&quot;;"> </td> </tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;"> <td style="vertical-align: top; width: 75%;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Restricted cash</div></div> </td> <td style="vertical-align: bottom; width: 8%;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">143</td> <td style="vertical-align: bottom; white-space: nowrap; font-family: &quot;Times New Roman&quot;;"> </td> <td style="vertical-align: bottom; width: 8%;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">145</td> <td style="vertical-align: bottom; white-space: nowrap; font-family: &quot;Times New Roman&quot;;"> </td> </tr> <tr style="font-size: 1px;"> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; width: 75%;"> </td> <td style="vertical-align: bottom; width: 8%;">  </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td> </td> <td style="vertical-align: bottom; width: 8%;">  </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td> </td> </tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);"> <td style="vertical-align: top; font-family: &quot;Times New Roman&quot;; width: 75%;"> </td> <td style="vertical-align: bottom; width: 8%;">  </td> <td style="vertical-align: bottom; white-space: nowrap;">$</td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">90,251</td> <td style="vertical-align: bottom; white-space: nowrap; font-family: &quot;Times New Roman&quot;;"> </td> <td style="vertical-align: bottom; width: 8%;">  </td> <td style="vertical-align: bottom; white-space: nowrap;">$</td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">8,709</td> <td style="vertical-align: bottom; white-space: nowrap; font-family: &quot;Times New Roman&quot;;"> </td> </tr> <tr style="font-size: 1px;"> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; width: 75%;"> </td> <td style="vertical-align: bottom; width: 8%;">  </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td> </td> <td style="vertical-align: bottom; width: 8%;">  </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td> </td> </tr> </table> <div style="clear: both; max-height: 0px; text-indent: 0px;"/> <div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt; text-indent: 0px;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">The reconciliation of cash, cash equivalents and restricted cash reported within the applicable consolidated balance sheet that sum to the total of the same such amount shown in the condensed consolidated statements of cash flows is as follows:</div></div></div> <div style="font-size: 12pt; margin-top: 0pt; margin-bottom: 0pt; text-indent: 0px;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-size: 12pt; letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></div> <table cellpadding="0" cellspacing="0" style="margin: 0px auto; border: 0px currentcolor; width: 100%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px; text-indent: 0px;"> <tr style="font-size: 0px;"> <td style="width: 75%;"/> <td style="width: 8%; vertical-align: bottom;"/> <td/> <td/> <td/> <td style="width: 8%; vertical-align: bottom;"/> <td/> <td/> <td/> </tr> <tr style="font-family: Times New Roman; font-size: 8pt; page-break-inside: avoid;"> <td style="vertical-align: bottom; padding-bottom: 1pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align: bottom; padding-bottom: 1pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">  </div></td> <td colspan="2" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">September 30, 2021</div></div></div></td> <td style="vertical-align: bottom; padding-bottom: 1pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align: bottom; padding-bottom: 1pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">  </div></td> <td colspan="2" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">December 31, 2020</div></div></div></td> <td style="vertical-align: bottom; padding-bottom: 1pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> </tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);"> <td style="vertical-align: top; width: 75%;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Cash and cash equivalents</div></div> </td> <td style="vertical-align: bottom; width: 8%;">  </td> <td style="vertical-align: bottom; white-space: nowrap;">$</td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">90,108</td> <td style="vertical-align: bottom; white-space: nowrap; font-family: &quot;Times New Roman&quot;;"> </td> <td style="vertical-align: bottom; width: 8%;">  </td> <td style="vertical-align: bottom; white-space: nowrap;">$</td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">8,564</td> <td style="vertical-align: bottom; white-space: nowrap; font-family: &quot;Times New Roman&quot;;"> </td> </tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;"> <td style="vertical-align: top; width: 75%;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Restricted cash</div></div> </td> <td style="vertical-align: bottom; width: 8%;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">143</td> <td style="vertical-align: bottom; white-space: nowrap; font-family: &quot;Times New Roman&quot;;"> </td> <td style="vertical-align: bottom; width: 8%;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">145</td> <td style="vertical-align: bottom; white-space: nowrap; font-family: &quot;Times New Roman&quot;;"> </td> </tr> <tr style="font-size: 1px;"> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; width: 75%;"> </td> <td style="vertical-align: bottom; width: 8%;">  </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td> </td> <td style="vertical-align: bottom; width: 8%;">  </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td> </td> </tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);"> <td style="vertical-align: top; font-family: &quot;Times New Roman&quot;; width: 75%;"> </td> <td style="vertical-align: bottom; width: 8%;">  </td> <td style="vertical-align: bottom; white-space: nowrap;">$</td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">90,251</td> <td style="vertical-align: bottom; white-space: nowrap; font-family: &quot;Times New Roman&quot;;"> </td> <td style="vertical-align: bottom; width: 8%;">  </td> <td style="vertical-align: bottom; white-space: nowrap;">$</td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">8,709</td> <td style="vertical-align: bottom; white-space: nowrap; font-family: &quot;Times New Roman&quot;;"> </td> </tr> <tr style="font-size: 1px;"> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; width: 75%;"> </td> <td style="vertical-align: bottom; width: 8%;">  </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td> </td> <td style="vertical-align: bottom; width: 8%;">  </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td> </td> </tr> </table> <div style="clear: both; max-height: 0px; text-indent: 0px;"/> 90108000 8564000 143000 145000 90251000 8709000 <div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 18pt; margin-bottom: 0pt;"><div style="font-weight:bold;display:inline;"><div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">Accounts Receivable </div></div></div></div> <div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt; text-indent: 0px;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Accounts receivables are recorded at the invoiced amount and are generally unsecured as they are uncollateralized. The Company provides an allowance for doubtful accounts to reduce receivables to their estimated net realizable value. Judgement is exercised in establishing allowances and estimates are based on the customers’ payment history and liquidity. Any amounts that were previously recognized as revenue and subsequently determined to be uncollectible are charged to bad debt expense included in selling, general and administrative expense in the accompanying condensed consolidated statements of operations and comprehensive loss. Given the nature and historical collectability of the Company’s accounts receivable, an allowance for doubtful accounts was not deemed necessary at September 30, 2021 and December 31, 2020. </div></div></div> <div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-weight:bold;display:inline;"><div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">Inventory </div></div></div></div> <div style="font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt;">Inventory consists of raw materials, work in progress and finished goods at the Company’s distribution center. Raw materials are stated at the lower of cost or net realizable value, determined by the <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;"><div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;"><div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">first-in-first-out</div></div></div> method. Finished goods and work in progress are valued using a methodology to determine the cost of each 3D printed object using allocations for material, labor, machine time and overhead. The Company periodically reviews its inventory for slow-moving, damaged and discontinued items and provides allowances to reduce such items identified to their recoverable amounts. As of September 30, 2021 and December 31, 2020, the Company determined an allowance was not deemed necessary. </div> <div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 18pt; margin-bottom: 0pt;"><div style="font-weight:bold;display:inline;"><div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">Property and Equipment, net </div></div></div></div> <div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt; text-indent: 0px;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Property and equipment are stated at cost, less accumulated depreciation. Maintenance and repairs are charged to expense when incurred. Additions and improvements that extend the economic useful life of the asset are capitalized and depreciated over the remaining useful lives of the assets. The cost and accumulated depreciation of assets sold or retired are removed from the respective accounts, and any resulting gain or loss is reflected in current earnings. No impairment charges were recorded for the periods ended September 30, 2021 and December 31, 2020. Depreciation is recognized using the straight-line method in amounts considered to be sufficient to allocate the cost of the assets to operations over the estimated useful lives or lease terms, as follows: </div></div></div> <div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"> </div> <div style="font-size: 12pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-size: 12pt; letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> <table cellpadding="0" cellspacing="0" style="margin: 0px auto; border: 0px currentcolor; width: 100%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;"> <tr style="font-size: 0px;"> <td style="width: 82%; font-family: &quot;Times New Roman&quot;;"/> <td style="width: 11%; vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"/> <td style="font-family: &quot;Times New Roman&quot;;"/> </tr> <tr style="font-family: Times New Roman; font-size: 8pt; page-break-inside: avoid;"> <td style="vertical-align: bottom; white-space: nowrap; padding-bottom: 1pt; width: 82%;"> <div style="font-family: &quot;Times New Roman&quot;; font-size: 8pt; margin-top: 0pt; margin-bottom: 0pt; border-bottom: 1pt solid rgb(0, 0, 0); display: table-cell; line-height: normal;"><div style="font-weight:bold;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 8pt; letter-spacing: 0px; top: 0px;;display:inline;">Asset Category</div></div></div> </td> <td style="vertical-align: bottom; padding-bottom: 1pt; width: 11%;">  </td> <td style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Depreciable Life</div></div></td> </tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);"> <td style="vertical-align: top; width: 82%;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Machinery and equipment</div></div> </td> <td style="vertical-align: bottom; width: 11%;">  </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:center;">5 years</td> </tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;"> <td style="vertical-align: top; width: 82%;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Computers and IT equipment</div></div> </td> <td style="vertical-align: bottom; width: 11%;">  </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:center;">3 years</td> </tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);"> <td style="vertical-align: top; width: 82%;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Furniture and fixtures</div></div> </td> <td style="vertical-align: bottom; width: 11%;">  </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:center;">7 years</td> </tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;"> <td style="vertical-align: top; width: 82%;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Leasehold improvements</div></div> </td> <td style="vertical-align: bottom; width: 11%;">  </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:center;">*<span style="-sec-ix-hidden:hidden29104785">*</span></td> </tr> </table> <div style="font-size: 12pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-size: 12pt; letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> <table cellpadding="0" cellspacing="0" style="border: 0px currentcolor; width: 100%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;"> <tr style="page-break-inside: avoid;"> <td style="width: 4%; vertical-align: top;;text-align:left;">**</td> <td style="vertical-align: top;;text-align:left;"> <div style="text-align: left; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Leasehold improvements are amortized using the straight-line method over the shorter of the lease term or estimated useful life of the asset. </div></div> </td> </tr> </table> 0 0 <div style="font-size: 12pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-size: 12pt; letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> <table cellpadding="0" cellspacing="0" style="margin: 0px auto; border: 0px currentcolor; width: 100%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;"> <tr style="font-size: 0px;"> <td style="width: 82%; font-family: &quot;Times New Roman&quot;;"/> <td style="width: 11%; vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"/> <td style="font-family: &quot;Times New Roman&quot;;"/> </tr> <tr style="font-family: Times New Roman; font-size: 8pt; page-break-inside: avoid;"> <td style="vertical-align: bottom; white-space: nowrap; padding-bottom: 1pt; width: 82%;"> <div style="font-family: &quot;Times New Roman&quot;; font-size: 8pt; margin-top: 0pt; margin-bottom: 0pt; border-bottom: 1pt solid rgb(0, 0, 0); display: table-cell; line-height: normal;"><div style="font-weight:bold;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 8pt; letter-spacing: 0px; top: 0px;;display:inline;">Asset Category</div></div></div> </td> <td style="vertical-align: bottom; padding-bottom: 1pt; width: 11%;">  </td> <td style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Depreciable Life</div></div></td> </tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);"> <td style="vertical-align: top; width: 82%;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Machinery and equipment</div></div> </td> <td style="vertical-align: bottom; width: 11%;">  </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:center;">5 years</td> </tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;"> <td style="vertical-align: top; width: 82%;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Computers and IT equipment</div></div> </td> <td style="vertical-align: bottom; width: 11%;">  </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:center;">3 years</td> </tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);"> <td style="vertical-align: top; width: 82%;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Furniture and fixtures</div></div> </td> <td style="vertical-align: bottom; width: 11%;">  </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:center;">7 years</td> </tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;"> <td style="vertical-align: top; width: 82%;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Leasehold improvements</div></div> </td> <td style="vertical-align: bottom; width: 11%;">  </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:center;">*<span style="-sec-ix-hidden:hidden29104785">*</span></td> </tr> </table> P5Y P3Y P7Y <div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 18pt; margin-bottom: 0pt;"><div style="font-weight:bold;display:inline;"><div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">Long-Lived Assets, Including Definite-Lived Intangible Assets </div></div></div></div> <div style="font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt;">Intangible assets, which consist of technology, customer relationships, and trademarks, are stated at cost less accumulated amortization. Amortization is generally recorded on a straight-line basis over estimated useful lives ranging from three to eight years. The Company periodically reviews the estimated useful lives of intangible assets and adjusts when events indicate that a shorter life is appropriate. In accordance with authoritative accounting guidance, capitalization of costs to develop software begin when preliminary development efforts are successfully and completed. Costs related to the design or maintenance of <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">internal-use</div> software are expensed as incurred. </div> <div style="font-family: Times New Roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Long-lived assets, other than goodwill and other indefinite-lived intangibles, are evaluated for impairment whenever events or changes in circumstances indicate that the carrying amount of the assets may not be recoverable through the estimated undiscounted future cash flows derived from such assets. </div></div> <div style="font-family: Times New Roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Factors that the Company considers in deciding when to perform an impairment review include significant changes in the Company’s forecasted projections for the asset or asset group for reasons including, but not limited to, significant underperformance of a product in relation to expectations, significant changes, or planned changes in the Company’s use of the assets, significant negative industry or economic trends, and new or competing products that enter the marketplace. The impairment test is based on a comparison of the undiscounted cash flows expected to be generated from the use of the asset group. If impairment is indicated, the asset is written down by the amount by which the carrying value of the asset exceeds the related fair value of the asset with the related impairment charge recognized within the statements of operations and comprehensive loss. No impairment charges were recorded for the periods ended September 30, 2021 and December 31, 2020. </div></div> 0 0 <div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 18pt; margin-bottom: 0pt;"><div style="font-weight:bold;display:inline;"><div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">Goodwill </div></div></div></div> <div style="font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Goodwill, which represents the excess of purchase prices over the fair value of net assets acquired, is carried at cost. Goodwill is not amortized; rather, it is subject to a periodic assessment for impairment by applying a fair value-based test. Goodwill is evaluated for impairment on an annual basis at a level of reporting referred to as the reporting unit, and more frequently if adverse events or changes in circumstances indicate that the asset may be impaired. </div></div> <div style="font-family: Times New Roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;">Under ASC 350, <div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">Intangibles - Goodwill and Other</div></div>,<div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;"> </div></div>the Company has the option to first assess the qualitative factors to determine whether it is more likely than not that the fair value of the reporting unit is less than its carrying amount as a basis for determining whether it is necessary to perform a quantitative goodwill impairment test. If the Company determines that it is more likely than not that </div> <div style="font-family: Times New Roman; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">the fair value of a reporting unit is less than its carrying amount, then the goodwill impairment test is performed. Impairment tests are performed, at a minimum, in the fourth quarter of each year. Management uses the future discounted cash flows valuation approach to determine the fair value of reporting units and determines whether the fair value of reporting units exceeded its carrying amounts. If the fair value exceeds the carrying amount, then no impairment is recognized. If the carrying amount recorded exceeds the fair value calculated, then an impairment charge is recognized for the difference. The impairment review requires management to make judgments in determining various assumptions with respect to revenues, operating margins, growth rates and discount rates. The judgments made in determining the projected cash flows used to estimate the fair value can materially impact the Company’s financial condition and results of operations. There was no impairment of goodwill as of September 30, 2021 or December 31, <div style="letter-spacing: 0px; top: 0px;;display:inline;">2020</div>. </div></div> 0 0 <div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 18pt; margin-bottom: 0pt;"><div style="font-weight:bold;display:inline;"><div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">Fair Value Measurements </div></div></div></div> <div style="font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt;">The Company applies ASC 820, <div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">Fair Value Measurement </div></div>(“ASC 820”), which establishes framework for measuring fair value and clarifies the definition of fair value within that framework. ASC 820 defines fair value as an exit price, which is the price that would be received for an asset or paid to transfer a liability in the Company’s principal or most advantageous market in an orderly transaction between market participants on the measurement date. The fair value hierarchy established in ASC 820 generally requires an entity to maximize the use of observable inputs and minimize the use of unobservable inputs when measuring fair value. Observable inputs reflect the assumptions that market participants would use in pricing the asset or liability and are developed based on market data obtained from sources independent of the reporting entity. Unobservable inputs reflect the entity’s own assumptions based on market data and the entity’s judgments about the assumptions that market participants would use in pricing the asset or liability and are to be developed based on the best information available in the circumstances. </div> <div style="font-family: Times New Roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">The valuation hierarchy is composed of three levels. The classification within the valuation hierarchy is based on the lowest level of input that is significant to the fair value measurement. The levels within the valuation hierarchy are described below: </div></div> <div style="font-family: Times New Roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;">Level 1 <div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">-</div></div> Assets and liabilities with unadjusted, quoted prices listed on active market exchanges. Inputs to the fair value measurement are observable inputs, such as quoted prices in active markets for identical assets or liabilities. </div> <div style="font-family: Times New Roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;">Level 2 <div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">-</div></div> Inputs to the fair value measurement are determined using prices for recently traded assets and liabilities with similar underlying terms, as well as direct or indirect observable inputs, such as interest rates and yield curves that are observable at commonly quoted intervals. </div> <div style="font-family: Times New Roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;">Level 3 <div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">-</div></div> Inputs to the fair value measurement are unobservable inputs, such as estimates, assumptions, and valuation techniques when little or no market data exists for the assets or liabilities. </div> <div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 18pt; margin-bottom: 0pt;"><div style="font-weight:bold;display:inline;"><div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">Revenue Recognition </div></div></div></div> <div style="font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Revenue is derived from two primary sources: a) products and services and b) software. </div></div> <div style="font-family: Times New Roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">The Company recognizes revenue following the five-step model prescribed under ASC 606: (i) identify contract(s) with a customer; (ii) identify the performance obligation(s) in the contract; (iii) determine the transaction price; (iv) allocate the transaction price to the performance obligation(s) in the contract; and (v) recognize revenue when (or as) the Company satisfies a performance obligation. The Company only applies the five-step model to contracts when it is probable that the Company will collect the consideration it is entitled to in exchange for the products or services it transfers to the customer. These contracts have different terms based on the scope, performance obligations, and complexity of the project, which often requires us to make judgments and estimates in recognizing revenues. </div></div> <div style="font-family: Times New Roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Performance obligations are satisfied both at a <div style="letter-spacing: 0px; top: 0px;;display:inline;">point </div>of time and over time. All revenue is recognized based on the satisfaction of the performance obligation to date (see Note 4). </div></div> <div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 18pt; margin-bottom: 0pt;"><div style="font-weight:bold;display:inline;"><div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">Leases </div></div></div></div> <div style="font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">The Company’s lease arrangements relate primarily to office and manufacturing space, and equipment. The Company’s leases generally have initial terms ranging from 5 to 10 years and may include renewal options and rent escalation clauses. The Company is typically required to make fixed minimum rent payments relating to its right to use an underlying leased asset. Additionally, the Company’s leases do not contain significantly restrictive covenants or residual value guarantees. </div></div> <div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt; text-indent: 0px;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">The Company determines if an arrangement is a lease at inception and classifies its leases at commencement. Operating leases are presented as <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;"><div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">right-of-use</div></div> (“ROU”) assets and the corresponding lease liabilities are included in operating lease liabilities, current and operating lease liabilities on the Company’s condensed consolidated balance sheets. The Company does not currently maintain any finance lease </div></div> <div style="font-family: Times New Roman; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">arrangements. ROU assets represent the Company’s right to use an underlying asset, and lease liabilities represent the Company’s obligation for lease payments in exchange for the ability to use the asset for the duration of the lease term. The Company does not recognize short term leases that have a term of twelve months or less as ROU assets or lease liabilities. The Company’s short-term leases are not material and do not have a material impact on its ROU assets or lease liabilities. </div></div> <div style="font-family: Times New Roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">ROU assets and lease <div style="letter-spacing: 0px; top: 0px;;display:inline;">liabilities </div>are recognized at commencement date and determined using the present value of the future minimum lease payments over the lease term. The Company uses an incremental borrowing rate based on estimated rate of interest for collateralized borrowing since the Company’s leases do not include an implicit interest rate. The estimated incremental borrowing rate considers market data, actual lease economic environment, and actual lease term at commencement date. The lease term may include options to extend when it is reasonably certain that the Company will exercise that option. ROU assets include lease payments made in advance, and excludes any incentives received or initial direct costs incurred. The Company recognizes lease expense on a straight-line basis over the lease term </div></div> <div style="font-family: Times New Roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;">The Company has lease agreements which contain both lease and <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">non-lease</div> components, which it has elected to account for as a single lease component. As such, minimum lease payments include fixed payments for <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">non-lease</div> components within a lease agreement, but exclude variable lease payments not dependent on an index or rate, such as common area maintenance, operating expenses, utilities, or other costs that are subject to fluctuation from period to period. </div> <div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 18pt; margin-bottom: 0pt;"><div style="font-weight:bold;display:inline;"><div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">Stock-based Compensation </div></div></div></div> <div style="font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt;">The Company recognizes stock-based compensation expense for all options and other arrangements within the scope of ASC 718, <div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">Stock Compensation</div></div>. Stock-based compensation expense is measured at the date of grant, based on the fair value of the award, and is recognized using the straight-line method over the employee’s requisite service period. Compensation for stock-based awards with vesting conditions other than service are recognized at the time that those conditions will be achieved. Forfeitures are recognized as they are incurred. </div> <div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 18pt; margin-bottom: 0pt;"><div style="font-weight:bold;display:inline;"><div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">Public and Private Common Stock Warrant Liabilities </div></div></div></div> <div style="font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">As part of Galileo’s initial public offering, Galileo issued to third party investors 13,800,000 units, consisting of one ordinary share of Galileo and one warrant, at a price of $10.00 per unit. Each whole warrant entitles the holder to purchase one share of <div style="letter-spacing: 0px; top: 0px;;display:inline;">C</div>ommon <div style="letter-spacing: 0px; top: 0px;;display:inline;">S</div>tock at an exercise price of $11.50 per share (the “Public Warrants”). Simultaneously with the closing of Galileo’s initial public offering, Galileo completed the private sale of 4,110,000 warrants to Galileo’s sponsor and EarlyBirdCapital, Inc. at a purchase price of $1.00 per warrant (the “Private Warrants”). In connection with the Business Combination, Galileo’s sponsor exercised its right to convert the aggregate outstanding principal amount of the convertible promissory note issued by Galileo into an aggregate of 500,000 Sponsor Warrants, with terms equivalents to the Private Warrants. </div></div> <div style="font-family: Times New Roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">The Private Warrants are <div style="letter-spacing: 0px; top: 0px;;display:inline;">identical</div> to the Public Warrants, except that the Private Warrants (i) will not be redeemable by the Company and (ii) may be exercised for cash or on a cashless basis, so long as they are held by the initial purchaser or any of its permitted transferees. If the Private Warrants are held by holders other than the initial purchasers or any of their permitted transferees, the Private Warrants will be redeemable by the Company and exercisable by the holders on the same basis as the Public Warrants. </div></div> <div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt; text-indent: 0px;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">The Company evaluated the Public and Private Warrants under ASC <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">815-40,</div> <div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">Derivatives and Hedging—Contracts in Entity’s Own Equity</div></div> (“ASC <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">815-40”),</div> and concluded that the Private Warrants do not meet the criteria to be classified in stockholders’ equity. Since the Private Warrants meet the definition of a derivative under ASC 815, the Company recorded these warrants as liabilities on the condensed consolidated balance sheet at fair value, with subsequent changes in their respective fair values recognized in the condensed consolidated statement of operations at each reporting date. </div></div> <div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div> 13800000 10.00 11.50 4110000 1.00 500000 <div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 18pt; margin-bottom: 0pt;"><div style="font-weight:bold;display:inline;"><div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">Research and Development Costs </div></div></div></div> <div style="font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Research and development expenses consist primarily of allocated personnel costs, fees paid to consultants and outside service providers, and allocations for rent and overhead. Research and development costs are expensed as incurred. Advance payments for goods and services that will be used in future research and development activities are expensed when the activity has been performed or when the goods have been received. For the three months ended September 30, 2021 and 2020, research and development costs were $1,673 and $1,516, respectively. For the nine months ended September 30, 2021 and 2020, research and development costs were $4,099 and $4,289, respectively. </div></div> 1673000 1516000 4099000 4289000 <div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-weight:bold;display:inline;"><div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">Advertising </div></div></div></div> <div style="font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Advertising costs are expensed as incurred. For the three months ended September 30, 2021 and 2020, advertising costs were $568 and $123, respectively. For the nine months ended September 30, 2021 and 2020, advertising costs were $1,008 and $353, respectively, which are included in selling, general and administrative expense on the<div style="letter-spacing: 0px; top: 0px;;display:inline;"> condensed</div> consolidated statements of operations and comprehensive loss. </div></div> 568000 123000 1008000 353000 <div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 18pt; margin-bottom: 0pt; text-indent: 0px;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;"><div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">Income Taxes </div></div></div></div></div> <div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt; text-indent: 0px;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">The Company files income tax returns in <div style="letter-spacing: 0px; top: 0px;;display:inline;">the </div>U.S. federal jurisdiction and various state jurisdictions. Income taxes are accounted for under the asset and liability method. Deferred tax assets and liabilities are recognized for the estimated future tax consequences attributable to differences between the financial statement carrying amounts of existing assets and liabilities and their respective tax bases. Deferred tax assets and liabilities are measured using enacted tax rates in effect for the year in which those temporary differences are expected to be recovered or settled. Where applicable, the Company records a valuation allowance to reduce any deferred tax assets that it determines will not be realizable in the future. </div></div></div> <div style="font-family: Times New Roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">The Company recognizes the benefit of an uncertain tax position that it has taken or expects to take on income tax returns it files if such tax position is more likely than not to be sustained on examination by the taxing authorities, based on the technical merits of the position. These tax benefits are measured based on the largest benefit that has a greater than 50% likelihood of being realized upon ultimate resolution. Although the Company believes that i<div style="letter-spacing: 0px; top: 0px;;display:inline;">t</div> has adequately reserved for uncertain tax positions (including interest and penalties), it can provide no assurance that the final tax outcome of these matters will not be materially different. The Company makes adjustments to these reserves in accordance with the income tax accounting guidance when facts and circumstances change, such as the closing of a tax audit or the refinement of an estimate. To the extent that the final tax outcome of these matters is different than the amounts recorded, such differences will affect the provision for income taxes in the period in which such determination is made, and could have a material impact on the Company’s financial condition and operating results. Carryforward attributes that were generated in tax years prior to those that remain open for examination may still be adjusted by relevant tax authorities upon examination if they either have been, or will be, used in a future period.</div></div> <div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt; text-indent: 0px;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">In applying the estimated annual effective tax rate approach prescribed under ASC 740, <div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">Income Taxes,</div></div> based on present evidence and conclusions around the realizability of deferred tax assets, we determined that any deferred tax benefits related to the forecasted tax rate and pretax activity during the three and nine months ended September 30, 2021 and 2020 are neither more likely than not to be realized in the current year, nor realizable as a deferred tax asset at the end of the year. Therefore, the appropriate amount of income tax benefit to recognize related to deferred tax assets during the three and nine months ended September 30, 2021 and 2020 is zero. The Company’s effective tax rate of </div><div style="letter-spacing: 0px; top: 0px; text-indent: 0px;;display:inline;">(1.78)% <div style="letter-spacing: 0px; top: 0px;;display:inline;">for the nine months ended September 30, 2021 differs from the applicable statutory tax rate primarily due to the fact that income recognized for the forgiveness of loans granted under the PPP loan program and changes in the fair value of warrant liabilities are not taxable under current U.S. tax law.</div></div></div> 0.50 0.0178 <div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 18pt; margin-bottom: 0pt;"><div style="font-weight:bold;display:inline;"><div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">Income (Loss) per Share </div></div></div></div> <div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt; text-indent: 0px;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">In accordance with the provisions of ASC 260, <div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">Earnings Per Share</div></div>, net income (loss) per common share is computed by dividing net income (loss) by the weighted-average shares of Common Stock outstanding during the period. Basic income (loss) per share is computed by dividing net income (loss) attributable to common stockholders by the weighted average number of shares outstanding during the period. Diluted income (loss) per share gives effect to all dilutive potential common shares outstanding during the period including stock options and warrants, using the treasury stock method, and convertible debt and convertible securities, using the <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">if-converted</div> method. During a loss period, the effect of the potential exercise of stock options and convertible debt are not considered in the diluted loss per common share calculation since the effect would be anti-dilutive. </div></div> <div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div> <div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div> <div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt; text-indent: 0px;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">The following outstanding shares of Common Stock equivalents were excluded from the computation of the diluted net loss per share attributable to Common Stock for the periods in which a net loss is presented because their effect would have been anti-dilutive: </div></div></div> <div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"> </div> <div style="font-size: 12pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-size: 12pt; letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> <table cellpadding="0" cellspacing="0" style="margin: 0px auto; border: 0px currentcolor; width: 100%; font-family: &quot;Times New Roman&quot;; font-size: 8pt; border-collapse: collapse; border-spacing: 0px;"> <tr style="font-size: 0px;"> <td style="width: 74%;"/> <td style="width: 1%; vertical-align: bottom;"/> <td/> <td/> <td/> <td style="width: 1%; vertical-align: bottom;"/> <td/> <td/> <td/> <td style="width: 1%; vertical-align: bottom;"/> <td/> <td/> <td/> <td style="width: 1%; vertical-align: bottom;"/> <td/> <td/> <td/> </tr> <tr style="font-family: Times New Roman; font-size: 8pt; page-break-inside: avoid;"> <td style="vertical-align: bottom; padding-bottom: 1pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 1pt;">  </td> <td colspan="6" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Three Months Ended<br/> September 30,</div></div></td> <td style="vertical-align: bottom; padding-bottom: 1pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 1pt;">  </td> <td colspan="6" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Nine Months Ended<br/> September 30,</div></div></td> <td style="vertical-align: bottom; padding-bottom: 1pt;"> </td> </tr> <tr style="font-family: Times New Roman; font-size: 8pt; page-break-inside: avoid;"> <td style="vertical-align: bottom; padding-bottom: 1pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 1pt;">  </td> <td colspan="2" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">2021</div></div></td> <td style="vertical-align: bottom; padding-bottom: 1pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 1pt;">  </td> <td colspan="2" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">2020</div></div></td> <td style="vertical-align: bottom; padding-bottom: 1pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 1pt;">  </td> <td colspan="2" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">2021</div></div></td> <td style="vertical-align: bottom; padding-bottom: 1pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 1pt;">  </td> <td colspan="2" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">2020</div></div></td> <td style="vertical-align: bottom; padding-bottom: 1pt;"> </td> </tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);"> <td style="vertical-align: top; width: 74%;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Common stock warrants</div></div> </td> <td style="vertical-align: bottom; width: 1%;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">18,410,000</td> <td style="vertical-align: bottom; white-space: nowrap; font-family: &quot;Times New Roman&quot;;"> </td> <td style="vertical-align: bottom; width: 1%;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">—  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; width: 1%;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">18,410,000</td> <td style="vertical-align: bottom; white-space: nowrap; font-family: &quot;Times New Roman&quot;;"> </td> <td style="vertical-align: bottom; width: 1%;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">—  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> </tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;"> <td style="vertical-align: top; width: 74%;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Earnout Shares</div></div> </td> <td style="vertical-align: bottom; width: 1%;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">3,510,405</td> <td style="vertical-align: bottom; white-space: nowrap; font-family: &quot;Times New Roman&quot;;"> </td> <td style="vertical-align: bottom; width: 1%;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">—  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; width: 1%;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">3,510,405</td> <td style="vertical-align: bottom; white-space: nowrap; font-family: &quot;Times New Roman&quot;;"> </td> <td style="vertical-align: bottom; width: 1%;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">—  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> </tr> </table> <div style="font-family: Times New Roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px; text-indent: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">Included in income (loss) per common share are </div>4,833,059 and 3,673,963 shares of <div style="letter-spacing: 0px; top: 0px;;display:inline;">options</div> due to their nominal exercise prices as of September 30, 2021 and 2020, respectively. </div></div> <div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt; text-indent: 0px;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">The following outstanding shares of Common Stock equivalents were excluded from the computation of the diluted net loss per share attributable to Common Stock for the periods in which a net loss is presented because their effect would have been anti-dilutive: </div></div></div> <div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"> </div> <div style="font-size: 12pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-size: 12pt; letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> <table cellpadding="0" cellspacing="0" style="margin: 0px auto; border: 0px currentcolor; width: 100%; font-family: &quot;Times New Roman&quot;; font-size: 8pt; border-collapse: collapse; border-spacing: 0px;"> <tr style="font-size: 0px;"> <td style="width: 74%;"/> <td style="width: 1%; vertical-align: bottom;"/> <td/> <td/> <td/> <td style="width: 1%; vertical-align: bottom;"/> <td/> <td/> <td/> <td style="width: 1%; vertical-align: bottom;"/> <td/> <td/> <td/> <td style="width: 1%; vertical-align: bottom;"/> <td/> <td/> <td/> </tr> <tr style="font-family: Times New Roman; font-size: 8pt; page-break-inside: avoid;"> <td style="vertical-align: bottom; padding-bottom: 1pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 1pt;">  </td> <td colspan="6" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Three Months Ended<br/> September 30,</div></div></td> <td style="vertical-align: bottom; padding-bottom: 1pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 1pt;">  </td> <td colspan="6" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Nine Months Ended<br/> September 30,</div></div></td> <td style="vertical-align: bottom; padding-bottom: 1pt;"> </td> </tr> <tr style="font-family: Times New Roman; font-size: 8pt; page-break-inside: avoid;"> <td style="vertical-align: bottom; padding-bottom: 1pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 1pt;">  </td> <td colspan="2" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">2021</div></div></td> <td style="vertical-align: bottom; padding-bottom: 1pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 1pt;">  </td> <td colspan="2" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">2020</div></div></td> <td style="vertical-align: bottom; padding-bottom: 1pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 1pt;">  </td> <td colspan="2" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">2021</div></div></td> <td style="vertical-align: bottom; padding-bottom: 1pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 1pt;">  </td> <td colspan="2" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">2020</div></div></td> <td style="vertical-align: bottom; padding-bottom: 1pt;"> </td> </tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);"> <td style="vertical-align: top; width: 74%;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Common stock warrants</div></div> </td> <td style="vertical-align: bottom; width: 1%;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">18,410,000</td> <td style="vertical-align: bottom; white-space: nowrap; font-family: &quot;Times New Roman&quot;;"> </td> <td style="vertical-align: bottom; width: 1%;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">—  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; width: 1%;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">18,410,000</td> <td style="vertical-align: bottom; white-space: nowrap; font-family: &quot;Times New Roman&quot;;"> </td> <td style="vertical-align: bottom; width: 1%;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">—  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> </tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;"> <td style="vertical-align: top; width: 74%;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Earnout Shares</div></div> </td> <td style="vertical-align: bottom; width: 1%;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">3,510,405</td> <td style="vertical-align: bottom; white-space: nowrap; font-family: &quot;Times New Roman&quot;;"> </td> <td style="vertical-align: bottom; width: 1%;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">—  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; width: 1%;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">3,510,405</td> <td style="vertical-align: bottom; white-space: nowrap; font-family: &quot;Times New Roman&quot;;"> </td> <td style="vertical-align: bottom; width: 1%;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">—  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> </tr> </table> 18410000000 0 18410000000 0 3510405000 0 3510405000 0 4833059 3673963 <div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 18pt; margin-bottom: 0pt;"><div style="font-weight:bold;display:inline;"><div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">Segment Information </div></div></div></div> <div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt; text-indent: 0px;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">The Company has determined that it operates and reports in one segment, which focuses on providing additive manufacturing services to customers. The Company’s operating segment is reported in a manner consistent with the internal reporting provided to the chief operating decision maker (“CODM”). The Company’s CODM has been identified as its Chief Executive Officer. </div></div></div> <div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; text-indent: 0px;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;"><div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">Recent Accounting Pronouncements </div></div></div></div></div> <div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt; text-indent: 0px;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">Accounting Pronouncements Recently Adopted </div></div></div></div> <div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt; text-indent: 0px;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">In January 2017, the FASB issued Accounting Standard Update (“ASU”) <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">No. 2017-04,</div> <div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">Intangibles—Goodwill and Other (Topic 350): Simplifying the Test for Goodwill Impairment,</div></div> which aims to simplify the subsequent measurement of goodwill by eliminating Step 2 from the goodwill impairment test. Under the new guidance, goodwill impairment will be measured as the amount by which the carrying value exceeds the fair value. The loss recognized should not exceed the total amount of goodwill allocated to the reporting unit. The standard is effective for annual and interim reporting periods beginning after December 15, 2021. Early adoption is permitted. The Company adopted ASU <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">2017-04</div> effective January 1, 2021. The adoption of this standard did not have a significant impact on the Company’s condensed consolidated financial statements. </div></div> <div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div> <div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt; text-indent: 0px;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">In December 2019, the FASB issued ASU <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">No. 2019-12,</div> <div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">Income Taxes (Topic 740): Simplifying the Accounting for Income Taxes</div></div>. The purpose of Update <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">No. 2019-12</div> is to continue the FASB’s Simplification Initiative to reduce complexity in accounting standards. The amendments in Update <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">No. 2019-12</div> simplify the accounting for income taxes by removing certain exceptions related to the incremental approach for intraperiod tax allocation, the requirement to recognize or derecognize deferred tax liabilities related to equity method investments that are also foreign subsidiaries, and the methodology for calculating income taxes in an interim period. In addition to removing these exceptions, Update <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">No. 2019-12</div> also clarifies and simplifies other aspects of the accounting for income taxes. The Company adopted ASU <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">2019-12</div> effective January 1, 2021. The adoption of this standard did not have a significant impact on the Company’s condensed consolidated financial statements. </div></div> <div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div> <div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt; text-indent: 0px;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">In August 2020, the FASB issued ASU <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">2020-06,</div> <div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">Debt — Debt with Conversion and Other Options (Subtopic <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">470-20)</div> and Derivatives and Hedging — Contracts in Entity’s Own Equity (Subtopic <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">815-40):</div> Accounting for Convertible Instruments and Contracts in an Entity’s Own Equity</div></div>, which simplifies the accounting for convertible instruments by removing certain separation models in Subtopic <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">470-20,</div> Debt—Debt with Conversion and Other Options, for convertible instruments and also increases information transparency by making disclosure amendments. The standard is effective for fiscal years beginning after December 15, 2023, including interim periods within those fiscal years. Early adoption is permitted, but no earlier than fiscal years beginning after December 15, 2020, including interim periods within those fiscal years. The Company adopted ASU <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">2020-06</div> effective January 1, 2021. The adoption of this standard did not have a significant impact on the Company’s condensed consolidated financial statements. </div></div> <div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt; text-indent: 0px;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">In August 2018, the FASB issued ASU <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">No. 2018-15,</div> <div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">Intangibles – Goodwill and Other – <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">Internal-Use</div> Software (Subtopic <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">350-40):</div> Customer’s Accounting for Implementation Costs Incurred in a Cloud Computing Arrangement That Is a Service Contract</div></div>, which aligns the requirements for capitalizing implementation costs incurred in a hosting arrangement that is a service contract with the requirements for capitalizing implementation costs incurred to develop or obtain <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">internal-use</div> software (and hosting arrangements that include an <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">internal-use</div> software license). The standard is effective for annual reporting periods beginning after December 15, 2020 and interim periods within annual periods beginning after December 15, 2021. Early adoption is permitted. The Company adopted ASU 2018-15 effective January 1, 2021. The adoption of this standard did not have a significant impact on the Company’s condensed consolidated financial statements. </div></div> <div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 18pt; margin-bottom: 0pt; text-indent: 0px;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">Accounting Pronouncements Not Yet Adopted </div></div></div></div> <div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt; text-indent: 0px;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">In June 2016, the FASB issued ASU No. 2016-13, Accounting for Credit Losses (Topic 326), which requires the use of an “expected loss” model on certain types of financial instruments. The standard also amends the impairment model for available-for-sale debt securities and requires estimated credit losses to be recorded as allowances instead of reductions to amortized cost of the securities. Update No. 2016-13 is effective for annual periods beginning after December 15, 2022, including interim periods within those annual periods. Early adoption is permitted, including adoption in an interim period. The Company is currently evaluating the impact the standard will have on its condensed consolidated financial statements. </div></div></div> <div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div> <div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 18pt; margin-bottom: 0pt; text-indent: 0px;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Note 3. Reverse Recapitalization </div></div></div></div> <div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt; text-indent: 0px;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">As discussed in Note 1, on September 29, 2021, Galileo closed the Business Combination with Shapeways, Inc., as a result of which Legacy Shapeways became a wholly-owned subsidiary of Galileo. While Galileo was the legal acquirer of Legacy Shapeways in the business combination, for accounting purposes, the Business Combination is treated as a Reverse Recapitalization, whereby Legacy Shapeways is deemed to be the accounting acquirer, and the historical financial statements of Legacy Shapeways became the historical financial statements of Galileo upon the closing of the Business Combination. Under this method of accounting, Galileo was treated as the “acquired” company and Legacy Shapeways is treated as the acquirer for financial reporting purposes. Accordingly, for accounting purposes, the Business Combination was treated as the equivalent of Legacy Shapeways issuing stock for the net assets of Galileo, accompanied by a recapitalization. The net assets of Galileo were stated at historical cost, with no goodwill or other intangible assets recorded. </div></div></div> <div style="letter-spacing: 0px; top: 0px; background: none;;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px; background: none; text-decoration: none;;display:inline;"> </div></div> <div style="font-size: 8pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-size: 8pt; letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> <div style="font-family: Times New Roman; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;">At the closing of the Business Combination, (1) all outstanding shares of Legacy Shapeways’ preferred stock (including shares of Legacy Shapeways’ preferred stock issuable upon conversion of Legacy Shapeways’ convertible notes outstanding as of the Closing) and Shapeways’ common stock were converted into an aggregate of 35,104,836 shares of Common Stock of the Company, par value $0.0001 per share, representing aggregate consideration value equal to $406,000 (the “Merger Consideration”), 3,510,405 <div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">shares of which are subject to the Earnout Terms (as defined below, and such shares, the “Earnout Shares”), (2) options to purchase Legacy Shapeways’ common stock (whether vested or unvested, exercisable or unexercisable) issued pursuant to the Legacy Shapeways 2010 Stock Plan, as amended (the “2010 Stock Plan”), and outstanding immediately prior to the Closing were assumed and converted into (a) options to purchase an aggregate of<div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></div>4,901,207<div style="font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"> shares of Common Stock under the </div>2021<div style="font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"> Equity Incentive Plan (the “Incentive Plan”) and (b) in the case of </div><div style="font-size: 10pt; white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">in-the-money</div></div><div style="font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"> options held by individuals who were service providers as of the Closing Date, an aggregate of </div>493,489<div style="font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"> restricted stock units denominated in a number of shares of Common Stock (“Earnout RSUs”) granted under the Incentive Plan, which Earnout RSUs are subject to the earnout vesting and forfeiture conditions described in the Merger Agreement, </div>(3)<div style="font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"> all warrants to purchase Legacy Shapeways’ common stock and Shapeways’ preferred stock outstanding immediately prior to the Closing were exercised in full and converted into shares of Legacy Shapeways preferred stock or Legacy Shapeways common stock, as applicable, in accordance with their terms, and each such share of Legacy Shapeways preferred stock and Legacy Shapeways common stock issued upon the exercise of such warrants was converted into an aggregate of </div>301,750<div style="font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"> shares of Common Stock (for the avoidance of doubt, such shares of Common Stock are included in the aggregate shares of Common Stock described in clause </div>(1)<div style="font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"> above) and </div>(4)<div style="font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"> any Legacy Shapeways </div><div style="font-size: 10pt; white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">non-plan</div><div style="font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"> options outstanding immediately prior to Closing were cancelled without payment in accordance with the terms described in the Merger Agreement.</div></div> <div style="font-family: Times New Roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">At the Closing, there were 3,510,405 shares of Common Stock issued as part of the Merger Consideration (the “Stockholder Merger Consideration” and/or “Earnout Shares”) subject to vesting and forfeiture conditions (the “Earnout Terms”) based upon the </div><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">volume-weighted average </div></div><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">trading price of Common Stock reaching targets of $14.00 and $16.00, respectively (with 50% released at each target) for a period of 30 consecutive trading days during the three-year period after the Closing, with the portion of such shares that would otherwise be deliverable to Shapeways Stockholders at the Closing being withheld and deposited into escrow. A pro rata portion of the Stockholder Merger Consideration earnout has also been allocated to Legacy Shapeways options and warrants that, as of the Closing, have been exchanged for options and warrants (as applicable) exercisable for shares of Common Stock (as described below). </div></div> <div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt; text-indent: 0px;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">Legacy Shapeways options issued pursuant to Legacy Shapeways’ 2010 Stock Plan that were not exercised prior to the Closing have been assumed by the Company and converted, subject to certain adjustments that are described in the Merger Agreement, into options exercisable for shares of Common Stock and, in the case of <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;"><div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">in-the-money</div></div> Legacy Shapeways options held by individuals remaining in continuous service to the Company through the Closing, a right to receive an award of restricted stock units (“RSUs”) denominated in shares of Common Stock that are subject to the Earnout Terms and to service-based vesting and forfeiture restrictions. As a result of the Closing, outstanding Legacy Shapeways Convertible Notes were converted into shares of Legacy Shapeways Preferred Stock at the election of the holders thereof, which were then converted into shares of Shapeways Common Stock prior to the Closing </div></div> <div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div> <div style="font-family: Times New Roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Simultaneously with the execution of the Business Combination, Galileo entered into subscription agreements (collectively, the “Subscription Agreements”) pursuant to which certain investors agreed to purchase an aggregate of 7,500,000 shares of Common Stock for a purchase price of $10.00 per share and $75,000,000 in the aggregate (the “PIPE Investment”). At the Closing, the Company consummated the PIPE Investment. </div></div> <div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt; text-indent: 0px;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">The following table reconciles the elements of the Business Combination to the unaudited condensed consolidated statement of cash flows for the nine months ended September 30, 2021: </div></div></div> <div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"> </div> <div style="font-size: 12pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-size: 12pt; letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> <table cellpadding="0" cellspacing="0" style="margin: 0px auto; border: 0px currentcolor; width: 100%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;"> <tr style="font-size: 0px;"> <td style="width: 89%;"/> <td style="width: 5%; vertical-align: bottom;"/> <td/> <td/> <td/> </tr> <tr style="font-family: Times New Roman; font-size: 8pt; page-break-inside: avoid;"> <td style="vertical-align: bottom; padding-bottom: 1pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 1pt;">  </td> <td colspan="2" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Recapitalization</div></div></td> <td style="vertical-align: bottom; padding-bottom: 1pt;"> </td> </tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);"> <td style="vertical-align: top; width: 89%;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Cash - Galileo trust and cash, net of redemption</div></div> </td> <td style="vertical-align: bottom; width: 5%;">  </td> <td style="vertical-align: bottom; white-space: nowrap;">$</td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">28,115</td> <td style="vertical-align: bottom; white-space: nowrap; font-family: &quot;Times New Roman&quot;;"> </td> </tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;"> <td style="vertical-align: top; width: 89%;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Cash - PIPE Investment, net of transaction costs</div></div> </td> <td style="vertical-align: bottom; width: 5%;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">75,000</td> <td style="vertical-align: bottom; white-space: nowrap; font-family: &quot;Times New Roman&quot;;"> </td> </tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);"> <td style="vertical-align: top; width: 89%;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Less: transaction costs and advisory fees allocated to equity</div></div> </td> <td style="vertical-align: bottom; width: 5%;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">(16,323</td> <td style="vertical-align: bottom; white-space: nowrap;">) </td> </tr> <tr style="font-size: 1px;"> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; width: 89%;"> </td> <td style="vertical-align: bottom; width: 5%;">  </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td> </td> </tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;"> <td style="vertical-align: top; width: 89%;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;">Effect of Merger, net of redemption, transaction costs and advisory costs</div> </td> <td style="vertical-align: bottom; width: 5%;">  </td> <td style="vertical-align: bottom; white-space: nowrap;">$</td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">86,792</td> <td style="vertical-align: bottom; white-space: nowrap; font-family: &quot;Times New Roman&quot;;"> </td> </tr> <tr style="font-size: 1px;"> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; width: 89%;"> </td> <td style="vertical-align: bottom; width: 5%;">  </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td> </td> </tr> </table> <div style="font-size: 8pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-size: 8pt; letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> <div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; text-indent: 0px;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">The following table reconciles the elements of the Business Combination to the unaudited condensed consolidated statement of changes in stockholders’ equity (deficit) for the three and nine months ended September 30, 2021: </div></div></div> <div style="letter-spacing: 0px; top: 0px; background: none;;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px; background: none; text-decoration: none;;display:inline;"> </div></div> <div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"> </div> <div style="font-size: 12pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-size: 12pt; letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> <table cellpadding="0" cellspacing="0" style="margin: 0px auto; border: 0px currentcolor; width: 100%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;"> <tr style="font-size: 0px;"> <td style="width: 89%;"/> <td style="width: 5%; vertical-align: bottom;"/> <td/> <td/> <td/></tr> <tr style="font-family: Times New Roman; font-size: 8pt; page-break-inside: avoid;"> <td style="vertical-align: bottom; padding-bottom: 1pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 1pt;">  </td> <td colspan="2" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Recapitalization</div></div></td> <td style="vertical-align: bottom; padding-bottom: 1pt;"> </td></tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);"> <td style="vertical-align: top; width: 89%;"><div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Cash - Galileo trust and cash, net of redemption</div></div></td> <td style="vertical-align: bottom; width: 5%;">  </td> <td style="vertical-align: bottom; white-space: nowrap;">$</td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">28,115</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td></tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;"> <td style="vertical-align: top; width: 89%;"><div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">Non-cash</div> net working capital assumed from Galileo</div></td> <td style="vertical-align: bottom; width: 5%;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">46</td> <td style="vertical-align: bottom; white-space: nowrap; font-family: &quot;Times New Roman&quot;;"> </td></tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);"> <td style="vertical-align: top; width: 89%;"><div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Less: fair value of Private and Sponsor Warrant liabilities</div></div></td> <td style="vertical-align: bottom; width: 5%;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">(11,865</td> <td style="vertical-align: bottom; white-space: nowrap;">) </td></tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;"> <td style="vertical-align: top; width: 89%;"><div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Less: transaction costs and advisory fees allocated to equity</div></div></td> <td style="vertical-align: bottom; width: 5%;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">(6,260</td> <td style="vertical-align: bottom; white-space: nowrap;">) </td></tr> <tr style="font-size: 1px;"> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; width: 89%;"> </td> <td style="vertical-align: bottom; width: 5%;">  </td> <td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></td> <td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></td> <td> </td></tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);"> <td style="vertical-align: top; width: 89%;"><div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;">Effect of Merger, net of redemption, transaction costs and advisory costs</div></td> <td style="vertical-align: bottom; width: 5%;">  </td> <td style="vertical-align: bottom; white-space: nowrap;">$</td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">10,036</td> <td style="vertical-align: bottom; white-space: nowrap; font-family: &quot;Times New Roman&quot;;"> </td></tr> <tr style="font-size: 1px;"> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; width: 89%;"> </td> <td style="vertical-align: bottom; width: 5%;">  </td> <td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></td> <td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></td> <td> </td></tr></table> <table cellpadding="0" cellspacing="0" style="margin: 0px auto; border: 0px currentcolor; width: 68%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;"> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);"> <td colspan="0"/></tr> <tr style="font-size: 1px;"> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"> </td> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom;"> </td> <td> </td></tr></table> <div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt; text-indent: 0px;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">The following table details the number of shares of Common Stock issued immediately following the consummation of the Business Combination: </div></div></div> <div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"> </div> <div style="font-size: 12pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-size: 12pt; letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> <table cellpadding="0" cellspacing="0" style="margin: 0px auto; border: 0px currentcolor; width: 100%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;"> <tr style="font-size: 0px;"> <td style="width: 88%;"/> <td style="width: 3%; vertical-align: bottom;"/> <td/> <td/> <td/></tr> <tr style="font-family: Times New Roman; font-size: 8pt; page-break-inside: avoid;"> <td style="vertical-align: bottom; padding-bottom: 1pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 1pt;">  </td> <td colspan="2" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Number of Shares</div></div></td> <td style="vertical-align: bottom; padding-bottom: 1pt;"> </td></tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);"> <td style="vertical-align: top; width: 88%;"><div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Common stock, outstanding prior to Business Combination</div></div></td> <td style="vertical-align: bottom; width: 3%;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">13,800,000</td> <td style="vertical-align: bottom; white-space: nowrap; font-family: &quot;Times New Roman&quot;;"> </td></tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;"> <td style="vertical-align: top; width: 88%;"><div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Less: redemption of Galileo shares</div></div></td> <td style="vertical-align: bottom; width: 3%;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">(11,018,352</td> <td style="vertical-align: bottom; white-space: nowrap;">) </td></tr> <tr style="font-size: 1px;"> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; width: 88%;"> </td> <td style="vertical-align: bottom; width: 3%;">  </td> <td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></td> <td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></td> <td> </td></tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);"> <td style="vertical-align: top; width: 88%;"><div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Common stock of Galileo</div></div></td> <td style="vertical-align: bottom; width: 3%;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">2,781,648</td> <td style="vertical-align: bottom; white-space: nowrap; font-family: &quot;Times New Roman&quot;;"> </td></tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;"> <td style="vertical-align: top; width: 88%;"><div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Galileo founder and representative shares, net of forfeited shares</div></div></td> <td style="vertical-align: bottom; width: 3%;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">2,910,000</td> <td style="vertical-align: bottom; white-space: nowrap; font-family: &quot;Times New Roman&quot;;"> </td></tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);"> <td style="vertical-align: top; width: 88%;"><div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Shares issued in PIPE Investment</div></div></td> <td style="vertical-align: bottom; width: 3%;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">7,500,000</td> <td style="vertical-align: bottom; white-space: nowrap; font-family: &quot;Times New Roman&quot;;"> </td></tr> <tr style="font-size: 1px;"> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; width: 88%;"> </td> <td style="vertical-align: bottom; width: 3%;">  </td> <td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></td> <td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></td> <td> </td></tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;"> <td style="vertical-align: top; width: 88%;"><div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Merger and PIPE Investment - common stock</div></div></td> <td style="vertical-align: bottom; width: 3%;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">13,191,648</td> <td style="vertical-align: bottom; white-space: nowrap; font-family: &quot;Times New Roman&quot;;"> </td></tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);"> <td style="vertical-align: top; width: 88%;"><div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;">Legacy Shapeways shares - common stock<div style="font-size: 85%; vertical-align: top;;display:inline;;font-size:9.4px"> (1)</div></div></td> <td style="vertical-align: bottom; width: 3%;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">35,104,836</td> <td style="vertical-align: bottom; white-space: nowrap; font-family: &quot;Times New Roman&quot;;"> </td></tr> <tr style="font-size: 1px;"> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; width: 88%;"> </td> <td style="vertical-align: bottom; width: 3%;">  </td> <td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></td> <td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></td> <td> </td></tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;"> <td style="vertical-align: top; width: 88%;"><div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Total shares of common stock immediately after Business Combination</div></div></td> <td style="vertical-align: bottom; width: 3%;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">48,296,484</td> <td style="vertical-align: bottom; white-space: nowrap; font-family: &quot;Times New Roman&quot;;"> </td></tr> <tr style="font-size: 1px;"> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; width: 88%;"> </td> <td style="vertical-align: bottom; width: 3%;">  </td> <td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></td> <td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></td> <td> </td></tr></table> <div style="font-size: 6pt; margin-top: 0pt; margin-bottom: 0pt; text-indent: 0px;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-size: 6pt; letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></div> <table cellpadding="0" cellspacing="0" style="border: 0px currentcolor; width: 100%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px; text-indent: 0px;"> <tr style="page-break-inside: avoid;"> <td style="width: 4%; vertical-align: top;;text-align:left;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">(1)</div></td> <td style="vertical-align: top; font-size: 10pt;;text-align:left;"><div style="text-align: left; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Includes 3,510,405 Earnout Shares </div></div></div></td></tr></table> 35104836 0.0001 406000000 3510405 4901207 493489 301750 3510405 14.00 16.00 P30D 7500000 10.00 75000000000 <div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt; text-indent: 0px;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">The following table reconciles the elements of the Business Combination to the unaudited condensed consolidated statement of cash flows for the nine months ended September 30, 2021: </div></div></div> <div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"> </div> <div style="font-size: 12pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-size: 12pt; letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> <table cellpadding="0" cellspacing="0" style="margin: 0px auto; border: 0px currentcolor; width: 100%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;"> <tr style="font-size: 0px;"> <td style="width: 89%;"/> <td style="width: 5%; vertical-align: bottom;"/> <td/> <td/> <td/> </tr> <tr style="font-family: Times New Roman; font-size: 8pt; page-break-inside: avoid;"> <td style="vertical-align: bottom; padding-bottom: 1pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 1pt;">  </td> <td colspan="2" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Recapitalization</div></div></td> <td style="vertical-align: bottom; padding-bottom: 1pt;"> </td> </tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);"> <td style="vertical-align: top; width: 89%;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Cash - Galileo trust and cash, net of redemption</div></div> </td> <td style="vertical-align: bottom; width: 5%;">  </td> <td style="vertical-align: bottom; white-space: nowrap;">$</td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">28,115</td> <td style="vertical-align: bottom; white-space: nowrap; font-family: &quot;Times New Roman&quot;;"> </td> </tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;"> <td style="vertical-align: top; width: 89%;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Cash - PIPE Investment, net of transaction costs</div></div> </td> <td style="vertical-align: bottom; width: 5%;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">75,000</td> <td style="vertical-align: bottom; white-space: nowrap; font-family: &quot;Times New Roman&quot;;"> </td> </tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);"> <td style="vertical-align: top; width: 89%;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Less: transaction costs and advisory fees allocated to equity</div></div> </td> <td style="vertical-align: bottom; width: 5%;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">(16,323</td> <td style="vertical-align: bottom; white-space: nowrap;">) </td> </tr> <tr style="font-size: 1px;"> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; width: 89%;"> </td> <td style="vertical-align: bottom; width: 5%;">  </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td> </td> </tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;"> <td style="vertical-align: top; width: 89%;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;">Effect of Merger, net of redemption, transaction costs and advisory costs</div> </td> <td style="vertical-align: bottom; width: 5%;">  </td> <td style="vertical-align: bottom; white-space: nowrap;">$</td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">86,792</td> <td style="vertical-align: bottom; white-space: nowrap; font-family: &quot;Times New Roman&quot;;"> </td> </tr> <tr style="font-size: 1px;"> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; width: 89%;"> </td> <td style="vertical-align: bottom; width: 5%;">  </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td> </td> </tr> </table> 28115000 75000000 16323000 86792000 <div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; text-indent: 0px;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">The following table reconciles the elements of the Business Combination to the unaudited condensed consolidated statement of changes in stockholders’ equity (deficit) for the three and nine months ended September 30, 2021: </div></div></div> <div style="letter-spacing: 0px; top: 0px; background: none;;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px; background: none; text-decoration: none;;display:inline;"> </div></div> <div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"> </div> <div style="font-size: 12pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-size: 12pt; letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> <table cellpadding="0" cellspacing="0" style="margin: 0px auto; border: 0px currentcolor; width: 100%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;"> <tr style="font-size: 0px;"> <td style="width: 89%;"/> <td style="width: 5%; vertical-align: bottom;"/> <td/> <td/> <td/></tr> <tr style="font-family: Times New Roman; font-size: 8pt; page-break-inside: avoid;"> <td style="vertical-align: bottom; padding-bottom: 1pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 1pt;">  </td> <td colspan="2" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Recapitalization</div></div></td> <td style="vertical-align: bottom; padding-bottom: 1pt;"> </td></tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);"> <td style="vertical-align: top; width: 89%;"><div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Cash - Galileo trust and cash, net of redemption</div></div></td> <td style="vertical-align: bottom; width: 5%;">  </td> <td style="vertical-align: bottom; white-space: nowrap;">$</td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">28,115</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td></tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;"> <td style="vertical-align: top; width: 89%;"><div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">Non-cash</div> net working capital assumed from Galileo</div></td> <td style="vertical-align: bottom; width: 5%;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">46</td> <td style="vertical-align: bottom; white-space: nowrap; font-family: &quot;Times New Roman&quot;;"> </td></tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);"> <td style="vertical-align: top; width: 89%;"><div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Less: fair value of Private and Sponsor Warrant liabilities</div></div></td> <td style="vertical-align: bottom; width: 5%;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">(11,865</td> <td style="vertical-align: bottom; white-space: nowrap;">) </td></tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;"> <td style="vertical-align: top; width: 89%;"><div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Less: transaction costs and advisory fees allocated to equity</div></div></td> <td style="vertical-align: bottom; width: 5%;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">(6,260</td> <td style="vertical-align: bottom; white-space: nowrap;">) </td></tr> <tr style="font-size: 1px;"> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; width: 89%;"> </td> <td style="vertical-align: bottom; width: 5%;">  </td> <td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></td> <td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></td> <td> </td></tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);"> <td style="vertical-align: top; width: 89%;"><div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;">Effect of Merger, net of redemption, transaction costs and advisory costs</div></td> <td style="vertical-align: bottom; width: 5%;">  </td> <td style="vertical-align: bottom; white-space: nowrap;">$</td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">10,036</td> <td style="vertical-align: bottom; white-space: nowrap; font-family: &quot;Times New Roman&quot;;"> </td></tr> <tr style="font-size: 1px;"> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; width: 89%;"> </td> <td style="vertical-align: bottom; width: 5%;">  </td> <td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></td> <td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></td> <td> </td></tr></table> 28115000 46000 11865000 6260000 10036000 <div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt; text-indent: 0px;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">The following table details the number of shares of Common Stock issued immediately following the consummation of the Business Combination: </div></div></div> <div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"> </div> <div style="font-size: 12pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-size: 12pt; letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> <table cellpadding="0" cellspacing="0" style="margin: 0px auto; border: 0px currentcolor; width: 100%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;"> <tr style="font-size: 0px;"> <td style="width: 88%;"/> <td style="width: 3%; vertical-align: bottom;"/> <td/> <td/> <td/></tr> <tr style="font-family: Times New Roman; font-size: 8pt; page-break-inside: avoid;"> <td style="vertical-align: bottom; padding-bottom: 1pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 1pt;">  </td> <td colspan="2" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Number of Shares</div></div></td> <td style="vertical-align: bottom; padding-bottom: 1pt;"> </td></tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);"> <td style="vertical-align: top; width: 88%;"><div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Common stock, outstanding prior to Business Combination</div></div></td> <td style="vertical-align: bottom; width: 3%;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">13,800,000</td> <td style="vertical-align: bottom; white-space: nowrap; font-family: &quot;Times New Roman&quot;;"> </td></tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;"> <td style="vertical-align: top; width: 88%;"><div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Less: redemption of Galileo shares</div></div></td> <td style="vertical-align: bottom; width: 3%;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">(11,018,352</td> <td style="vertical-align: bottom; white-space: nowrap;">) </td></tr> <tr style="font-size: 1px;"> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; width: 88%;"> </td> <td style="vertical-align: bottom; width: 3%;">  </td> <td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></td> <td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></td> <td> </td></tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);"> <td style="vertical-align: top; width: 88%;"><div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Common stock of Galileo</div></div></td> <td style="vertical-align: bottom; width: 3%;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">2,781,648</td> <td style="vertical-align: bottom; white-space: nowrap; font-family: &quot;Times New Roman&quot;;"> </td></tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;"> <td style="vertical-align: top; width: 88%;"><div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Galileo founder and representative shares, net of forfeited shares</div></div></td> <td style="vertical-align: bottom; width: 3%;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">2,910,000</td> <td style="vertical-align: bottom; white-space: nowrap; font-family: &quot;Times New Roman&quot;;"> </td></tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);"> <td style="vertical-align: top; width: 88%;"><div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Shares issued in PIPE Investment</div></div></td> <td style="vertical-align: bottom; width: 3%;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">7,500,000</td> <td style="vertical-align: bottom; white-space: nowrap; font-family: &quot;Times New Roman&quot;;"> </td></tr> <tr style="font-size: 1px;"> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; width: 88%;"> </td> <td style="vertical-align: bottom; width: 3%;">  </td> <td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></td> <td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></td> <td> </td></tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;"> <td style="vertical-align: top; width: 88%;"><div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Merger and PIPE Investment - common stock</div></div></td> <td style="vertical-align: bottom; width: 3%;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">13,191,648</td> <td style="vertical-align: bottom; white-space: nowrap; font-family: &quot;Times New Roman&quot;;"> </td></tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);"> <td style="vertical-align: top; width: 88%;"><div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;">Legacy Shapeways shares - common stock<div style="font-size: 85%; vertical-align: top;;display:inline;;font-size:9.4px"> (1)</div></div></td> <td style="vertical-align: bottom; width: 3%;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">35,104,836</td> <td style="vertical-align: bottom; white-space: nowrap; font-family: &quot;Times New Roman&quot;;"> </td></tr> <tr style="font-size: 1px;"> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; width: 88%;"> </td> <td style="vertical-align: bottom; width: 3%;">  </td> <td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></td> <td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></td> <td> </td></tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;"> <td style="vertical-align: top; width: 88%;"><div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Total shares of common stock immediately after Business Combination</div></div></td> <td style="vertical-align: bottom; width: 3%;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">48,296,484</td> <td style="vertical-align: bottom; white-space: nowrap; font-family: &quot;Times New Roman&quot;;"> </td></tr> <tr style="font-size: 1px;"> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; width: 88%;"> </td> <td style="vertical-align: bottom; width: 3%;">  </td> <td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></td> <td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></td> <td> </td></tr></table> <div style="font-size: 6pt; margin-top: 0pt; margin-bottom: 0pt; text-indent: 0px;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-size: 6pt; letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></div> <table cellpadding="0" cellspacing="0" style="border: 0px currentcolor; width: 100%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px; text-indent: 0px;"> <tr style="page-break-inside: avoid;"> <td style="width: 4%; vertical-align: top;;text-align:left;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">(1)</div></td> <td style="vertical-align: top; font-size: 10pt;;text-align:left;"><div style="text-align: left; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Includes 3,510,405 Earnout Shares </div></div></div></td></tr></table> 13800000 11018352 2781648 2910000 7500000 13191648 35104836 48296484 3510405 <div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 18pt; margin-bottom: 0pt;"><div style="font-weight:bold;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Note 4. Revenue Recognition </div></div></div> <div style="font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Under ASC 606, revenue is recognized throughout the life of the executed agreement. The Company measures revenue based on consideration specified in a contract with a customer. Furthermore, the Company recognizes revenue when a performance obligation is satisfied by transferring control of the product or service to the customer which could occur over time or at a point in time. </div></div> <div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt; text-indent: 0px;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">A performance obligation is a promise in a contract to transfer a distinct service to the customer. The transaction price of a contract is allocated to each distinct performance obligation and recognized as revenue when or as the customer receives the benefit of the performance obligation. Customers typically receive the benefit of the Company’s services as (or when) they are performed. Substantially all customer contracts provide that compensation is received for services performed to date. Taxes assessed by a governmental au </div></div></div> <div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; text-indent: 0px;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">thority that are both imposed on and concurrent with a specific revenue-producing transaction, that are collected by us from a customer, are excluded from revenue. </div></div></div> <div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"> </div> <div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 18pt; margin-bottom: 0pt;"><div style="font-weight:bold;display:inline;"><div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">Nature of Products and Services </div></div></div></div> <div style="font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">The following is a description of the Company’s <div style="letter-spacing: 0px; top: 0px;;display:inline;">products </div>and <div style="letter-spacing: 0px; top: 0px;;display:inline;">services </div>from which the Company generates revenue, as well as the nature, timing of satisfaction of performance obligations, and significant payment terms for each: </div></div> <div style="font-family: Times New Roman; font-size: 10pt; margin-top: 18pt; margin-bottom: 0pt;"><div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">Direct sales </div></div></div> <div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt; text-indent: 0px;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">The Company provides customers with an additive manufacturing service, allowing for the customer to select the specifications of the model which they wish to have printed. Shapeways prints the 3D model and ships the product directly to the customer. </div></div></div> <div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"> </div> <div style="font-family: Times New Roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;">The Company recognizes the sale of shop owner products through their <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">e-commerce</div> website over time using the output method. Contracts involving the sale of shop owner products through their <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">e-commerce</div> website do not include other performance obligations. As such, allocation of the transaction price was not necessary as the entire contract price is attributed to the sole performance obligation identified. </div> <div style="font-family: Times New Roman; font-size: 10pt; margin-top: 18pt; margin-bottom: 0pt;"><div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">Marketplace sales </div></div></div> <div style="font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">The Company provides a platform for shop owners to sell their products to customers through Shapeways’ marketplace website. Shapeways receives a 3.5% markup fee from the shop owner upon the sale of any products through the marketplace. </div></div> <div style="font-size: 8pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-size: 8pt; letter-spacing: 0px; top: 0px;;display:inline;"> </div></div><div style="font-family: Times New Roman; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">The Company handles the financial transaction, manufacturing, distribution and customer service on behalf of the shop owners. The Company is responsible for billing the customer in this arrangement and transmitting the applicable fees to the shop owner. The Company assessed whether it is responsible for providing the actual product or service as a principal, or for arranging for the product or service to be provided by the third party as an agent. Judgment is applied to determine whether the Company is the principal or the agent by evaluating whether it has control of the product or service prior to it being transferred to the customer. The principal versus agent assessment is performed at the performance obligation level. Indicators that the Company has considered include whether it has the primary responsibility for fulfilling the promise to provide the specified product or service to the customer and whether it has inventory risk prior to transferring the product or service to the customer. The Company has the responsibility to fulfill the promise to provide the specific good or service on behalf of the shop owners to the customer. In addition, the Company has inventory risk before the specific good or service is transferred to a customer. As such, the Company is deemed the principal and shall recognize revenue on a gross basis for the price it charges to the shop owner for each product or service. </div></div><div style="font-family: Times New Roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">The Company recognizes the sale of 3D products to customers at a point in time, specifically upon shipping the goods to the customer (FOB Origin) given the transfer of significant risks and rewards of ownership at that point in time. Contracts involving the manufacturing and delivery of 3D printed products to customers do not include other performance obligations. As such, allocation of the transaction price was not necessary as the entire contract price is attributed to the sole performance obligation identified. </div></div><div style="font-family: Times New Roman; font-size: 10pt; margin-top: 18pt; margin-bottom: 0pt;"><div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">Software revenue </div></div></div><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt; text-indent: 0px;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">In 2020, Shapeways launched their software under the brand of “Powered by Shapeways” to a limited set of design customers to gain feedback on product market fit. The software enables other manufacturers to leverage Shapeways’ existing end-to-end manufacturing software to scale their businesses and shift to digital manufacturing. </div></div></div><div style="font-family: Times New Roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">For each of the performance obligations classified as software revenue, the performance obligations are satisfied evenly over the term of the contract. For contracts including performance obligations classified as software revenue, the Company identified that each performance obligation has an explicitly stated standalone selling price. As such, allocation is not necessary as the prices included in the contract are attributed to each separate performance obligation. </div></div><div style="font-family: Times New Roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">The following table presents our revenues disaggregated by revenue discipline: </div></div><div style="font-size: 12pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-size: 12pt; letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> <table cellpadding="0" cellspacing="0" style="margin: 0px auto; border: 0px currentcolor; width: 100%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;"> <tr style="font-size: 0px;"> <td style="width: 74%;"/> <td style="width: 2%; vertical-align: bottom;"/> <td/> <td/> <td/> <td style="width: 2%; vertical-align: bottom;"/> <td/> <td/> <td/> <td style="width: 2%; vertical-align: bottom;"/> <td/> <td/> <td/> <td style="width: 2%; vertical-align: bottom;"/> <td/> <td/> <td/></tr> <tr style="font-family: Times New Roman; font-size: 8pt; page-break-inside: avoid;"> <td style="vertical-align: bottom; padding-bottom: 1pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 1pt;">  </td> <td colspan="6" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Three Months Ended<br/> September 30,</div></div></td> <td style="vertical-align: bottom; padding-bottom: 1pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 1pt;">  </td> <td colspan="6" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Nine Months Ended<br/> September 30,</div></div></td> <td style="vertical-align: bottom; padding-bottom: 1pt;"> </td></tr> <tr style="font-family: Times New Roman; font-size: 8pt; page-break-inside: avoid;"> <td style="vertical-align: bottom; padding-bottom: 1pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 1pt;">  </td> <td colspan="2" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">2021</div></div></td> <td style="vertical-align: bottom; padding-bottom: 1pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 1pt;">  </td> <td colspan="2" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">2020</div></div></td> <td style="vertical-align: bottom; padding-bottom: 1pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 1pt;">  </td> <td colspan="2" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">2021</div></div></td> <td style="vertical-align: bottom; padding-bottom: 1pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 1pt;">  </td> <td colspan="2" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">2020</div></div></td> <td style="vertical-align: bottom; padding-bottom: 1pt;"> </td></tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);"> <td style="vertical-align: top; width: 74%;"><div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-weight:bold;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Major products/service lines:</div></div></div></td> <td style="vertical-align: bottom; width: 2%;">  </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"> </td> <td style="vertical-align: bottom; width: 2%;">  </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"> </td> <td style="vertical-align: bottom; width: 2%;">  </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"> </td> <td style="vertical-align: bottom; width: 2%;">  </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"> </td></tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;"> <td style="vertical-align: top; width: 74%;"><div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Direct sales</div></div></td> <td style="vertical-align: bottom; width: 2%;">  </td> <td style="vertical-align: bottom; white-space: nowrap;">$</td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">5,985</td> <td style="vertical-align: bottom; white-space: nowrap; font-family: &quot;Times New Roman&quot;;"> </td> <td style="vertical-align: bottom; width: 2%;">  </td> <td style="vertical-align: bottom; white-space: nowrap;">$</td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">5,994</td> <td style="vertical-align: bottom; white-space: nowrap; font-family: &quot;Times New Roman&quot;;"> </td> <td style="vertical-align: bottom; width: 2%;">  </td> <td style="vertical-align: bottom; white-space: nowrap;">$</td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">19,068</td> <td style="vertical-align: bottom; white-space: nowrap; font-family: &quot;Times New Roman&quot;;"> </td> <td style="vertical-align: bottom; width: 2%;">  </td> <td style="vertical-align: bottom; white-space: nowrap;">$</td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">16,827</td> <td style="vertical-align: bottom; white-space: nowrap; font-family: &quot;Times New Roman&quot;;"> </td></tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);"> <td style="vertical-align: top; width: 74%;"><div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Marketplace sales</div></div></td> <td style="vertical-align: bottom; width: 2%;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">1,663</td> <td style="vertical-align: bottom; white-space: nowrap; font-family: &quot;Times New Roman&quot;;"> </td> <td style="vertical-align: bottom; width: 2%;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">2,091</td> <td style="vertical-align: bottom; white-space: nowrap; font-family: &quot;Times New Roman&quot;;"> </td> <td style="vertical-align: bottom; width: 2%;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">6,062</td> <td style="vertical-align: bottom; white-space: nowrap; font-family: &quot;Times New Roman&quot;;"> </td> <td style="vertical-align: bottom; width: 2%;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">6,060</td> <td style="vertical-align: bottom; white-space: nowrap; font-family: &quot;Times New Roman&quot;;"> </td></tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;"> <td style="vertical-align: top; width: 74%;"><div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Software</div></div></td> <td style="vertical-align: bottom; width: 2%;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">68</td> <td style="vertical-align: bottom; white-space: nowrap; font-family: &quot;Times New Roman&quot;;"> </td> <td style="vertical-align: bottom; width: 2%;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">22</td> <td style="vertical-align: bottom; white-space: nowrap; font-family: &quot;Times New Roman&quot;;"> </td> <td style="vertical-align: bottom; width: 2%;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">224</td> <td style="vertical-align: bottom; white-space: nowrap; font-family: &quot;Times New Roman&quot;;"> </td> <td style="vertical-align: bottom; width: 2%;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">141</td> <td style="vertical-align: bottom; white-space: nowrap; font-family: &quot;Times New Roman&quot;;"> </td></tr> <tr style="font-size: 1px;"> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; width: 74%;"> </td> <td style="vertical-align: bottom; width: 2%;">  </td> <td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></td> <td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></td> <td> </td> <td style="vertical-align: bottom; width: 2%;">  </td> <td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></td> <td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></td> <td> </td> <td style="vertical-align: bottom; width: 2%;">  </td> <td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></td> <td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></td> <td> </td> <td style="vertical-align: bottom; width: 2%;">  </td> <td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></td> <td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></td> <td> </td></tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);"> <td style="vertical-align: top; width: 74%;"><div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-weight:bold;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Total revenue</div></div></div></td> <td style="vertical-align: bottom; width: 2%;">  </td> <td style="vertical-align: bottom; white-space: nowrap;">$</td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">7,716</td> <td style="vertical-align: bottom; white-space: nowrap; font-family: &quot;Times New Roman&quot;;"> </td> <td style="vertical-align: bottom; width: 2%;">  </td> <td style="vertical-align: bottom; white-space: nowrap;">$</td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">8,107</td> <td style="vertical-align: bottom; white-space: nowrap; font-family: &quot;Times New Roman&quot;;"> </td> <td style="vertical-align: bottom; width: 2%;">  </td> <td style="vertical-align: bottom; white-space: nowrap;">$</td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">25,354</td> <td style="vertical-align: bottom; white-space: nowrap; font-family: &quot;Times New Roman&quot;;"> </td> <td style="vertical-align: bottom; width: 2%;">  </td> <td style="vertical-align: bottom; white-space: nowrap;">$</td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">23,028</td> <td style="vertical-align: bottom; white-space: nowrap; font-family: &quot;Times New Roman&quot;;"> </td></tr> <tr style="font-size: 1px;"> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; width: 74%;"> </td> <td style="vertical-align: bottom; width: 2%;">  </td> <td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></td> <td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></td> <td> </td> <td style="vertical-align: bottom; width: 2%;">  </td> <td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></td> <td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></td> <td> </td> <td style="vertical-align: bottom; width: 2%;">  </td> <td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></td> <td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></td> <td> </td> <td style="vertical-align: bottom; width: 2%;">  </td> <td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></td> <td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></td> <td> </td></tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;"> <td style="vertical-align: top; width: 74%;"><div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-weight:bold;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Timing of revenue recognition:</div></div></div></td> <td style="vertical-align: bottom; width: 2%;">  </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"> </td> <td style="vertical-align: bottom; width: 2%;">  </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"> </td> <td style="vertical-align: bottom; width: 2%;">  </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"> </td> <td style="vertical-align: bottom; width: 2%;">  </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"> </td></tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);"> <td style="vertical-align: top; width: 74%;"><div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Products transferred at a point in time</div></div></td> <td style="vertical-align: bottom; width: 2%;">  </td> <td style="vertical-align: bottom; white-space: nowrap;">$</td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">1,663</td> <td style="vertical-align: bottom; white-space: nowrap; font-family: &quot;Times New Roman&quot;;"> </td> <td style="vertical-align: bottom; width: 2%;">  </td> <td style="vertical-align: bottom; white-space: nowrap;">$</td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">2,091</td> <td style="vertical-align: bottom; white-space: nowrap; font-family: &quot;Times New Roman&quot;;"> </td> <td style="vertical-align: bottom; width: 2%;">  </td> <td style="vertical-align: bottom; white-space: nowrap;">$</td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">6,062</td> <td style="vertical-align: bottom; white-space: nowrap; font-family: &quot;Times New Roman&quot;;"> </td> <td style="vertical-align: bottom; width: 2%;">  </td> <td style="vertical-align: bottom; white-space: nowrap;">$</td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">6,060</td> <td style="vertical-align: bottom; white-space: nowrap; font-family: &quot;Times New Roman&quot;;"> </td></tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;"> <td style="vertical-align: top; width: 74%;"><div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Products and services transferred over time</div></div></td> <td style="vertical-align: bottom; width: 2%;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">6,053</td> <td style="vertical-align: bottom; white-space: nowrap; font-family: &quot;Times New Roman&quot;;"> </td> <td style="vertical-align: bottom; width: 2%;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">6,016</td> <td style="vertical-align: bottom; white-space: nowrap; font-family: &quot;Times New Roman&quot;;"> </td> <td style="vertical-align: bottom; width: 2%;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">19,292</td> <td style="vertical-align: bottom; white-space: nowrap; font-family: &quot;Times New Roman&quot;;"> </td> <td style="vertical-align: bottom; width: 2%;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">16,968</td> <td style="vertical-align: bottom; white-space: nowrap; font-family: &quot;Times New Roman&quot;;"> </td></tr> <tr style="font-size: 1px;"> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; width: 74%;"> </td> <td style="vertical-align: bottom; width: 2%;">  </td> <td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></td> <td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></td> <td> </td> <td style="vertical-align: bottom; width: 2%;">  </td> <td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></td> <td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></td> <td> </td> <td style="vertical-align: bottom; width: 2%;">  </td> <td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></td> <td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></td> <td> </td> <td style="vertical-align: bottom; width: 2%;">  </td> <td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></td> <td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></td> <td> </td></tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);"> <td style="vertical-align: top; width: 74%;"><div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-weight:bold;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Total revenue</div></div></div></td> <td style="vertical-align: bottom; width: 2%;">  </td> <td style="vertical-align: bottom; white-space: nowrap;">$</td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">7,716</td> <td style="vertical-align: bottom; white-space: nowrap; font-family: &quot;Times New Roman&quot;;"> </td> <td style="vertical-align: bottom; width: 2%;">  </td> <td style="vertical-align: bottom; white-space: nowrap;">$</td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">8,107</td> <td style="vertical-align: bottom; white-space: nowrap; font-family: &quot;Times New Roman&quot;;"> </td> <td style="vertical-align: bottom; width: 2%;">  </td> <td style="vertical-align: bottom; white-space: nowrap;">$</td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">25,354</td> <td style="vertical-align: bottom; white-space: nowrap; font-family: &quot;Times New Roman&quot;;"> </td> <td style="vertical-align: bottom; width: 2%;">  </td> <td style="vertical-align: bottom; white-space: nowrap;">$</td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">23,028</td> <td style="vertical-align: bottom; white-space: nowrap; font-family: &quot;Times New Roman&quot;;"> </td></tr> <tr style="font-size: 1px;"> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; width: 74%;"> </td> <td style="vertical-align: bottom; width: 2%;">  </td> <td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></td> <td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></td> <td> </td> <td style="vertical-align: bottom; width: 2%;">  </td> <td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></td> <td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></td> <td> </td> <td style="vertical-align: bottom; width: 2%;">  </td> <td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></td> <td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></td> <td> </td> <td style="vertical-align: bottom; width: 2%;">  </td> <td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></td> <td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></td> <td> </td></tr></table> <div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 18pt; margin-bottom: 0pt; text-indent: 0px;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;"><div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">Deferred Revenue </div></div></div></div></div> <div style="font-weight:bold;display:inline;"><div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;"> </div></div></div> <div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt; text-indent: 0px;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">The Company records deferred revenue when cash payments are received in advance of performance. </div></div></div> <div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"> </div> <div style="font-size: 8pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-size: 8pt; letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> <div style="font-family: Times New Roman; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Deferred revenue activity consisted of the following for the nine months ended September 30, 2021: </div></div> <div style="font-size: 12pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-size: 12pt; letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> <table cellpadding="0" cellspacing="0" style="margin: 0px auto; border: 0px currentcolor; width: 100%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;"> <tr style="font-size: 0px;"> <td style="width: 88%;"/> <td style="width: 9%; vertical-align: bottom;"/> <td/> <td/> <td/> </tr> <tr style="font-family: Times New Roman; font-size: 8pt; page-break-inside: avoid;"> <td style="vertical-align: bottom; padding-bottom: 1pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 1pt;">  </td> <td colspan="2" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Deferred Revenue</div></div></td> <td style="vertical-align: bottom; padding-bottom: 1pt;"> </td> </tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);"> <td style="vertical-align: top; width: 88%;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Balance at January 1, 2021</div></div> </td> <td style="vertical-align: bottom; width: 9%;">  </td> <td style="vertical-align: bottom; white-space: nowrap;">$</td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">753</td> <td style="vertical-align: bottom; white-space: nowrap; font-family: &quot;Times New Roman&quot;;"> </td> </tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;"> <td style="vertical-align: top; width: 88%;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Deferred revenue recognized during period</div></div> </td> <td style="vertical-align: bottom; width: 9%;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">(25,354</td> <td style="vertical-align: bottom; white-space: nowrap;">) </td> </tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);"> <td style="vertical-align: top; width: 88%;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Additions to deferred revenue during period</div></div> </td> <td style="vertical-align: bottom; width: 9%;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">25,259</td> <td style="vertical-align: bottom; white-space: nowrap; font-family: &quot;Times New Roman&quot;;"> </td> </tr> <tr style="font-size: 1px;"> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; width: 88%;"> </td> <td style="vertical-align: bottom; width: 9%;">  </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td> </td> </tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;"> <td style="vertical-align: top; width: 88%;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Balance at September 30, 2021</div></div> </td> <td style="vertical-align: bottom; width: 9%;">  </td> <td style="vertical-align: bottom; white-space: nowrap;">$</td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">658</td> <td style="vertical-align: bottom; white-space: nowrap; font-family: &quot;Times New Roman&quot;;"> </td> </tr> <tr style="font-size: 1px;"> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; width: 88%;"> </td> <td style="vertical-align: bottom; width: 9%;">  </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td> </td> </tr> </table> <div style="font-family: Times New Roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">The Company expects to satisfy its remaining performance obligations within the next twelve months. The $753 of deferred revenue as of January 1, 2021 was recognized during the nine months ended September 30, 2021. The opening balance of accounts receivable as of January 1, 2020 was $151. </div></div> <div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 18pt; margin-bottom: 0pt;"><div style="font-weight:bold;display:inline;"><div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">Practical Expedients and Exemptions </div></div></div></div> <div style="font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt;">We apply the practical expedient related to incremental costs of obtaining a contract. Although certain of our commission costs qualify for capitalization under ASC <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">340-40,</div> Contracts with customers, their amortization period is less than one year. Therefore, utilizing the <span style="-sec-ix-hidden:hidden29105085">practical expedient</span>, we expense these costs as incurred. </div> 0.035 <table cellpadding="0" cellspacing="0" style="margin: 0px auto; border: 0px currentcolor; width: 100%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;"> <tr style="font-size: 0px;"> <td style="width: 74%;"/> <td style="width: 2%; vertical-align: bottom;"/> <td/> <td/> <td/> <td style="width: 2%; vertical-align: bottom;"/> <td/> <td/> <td/> <td style="width: 2%; vertical-align: bottom;"/> <td/> <td/> <td/> <td style="width: 2%; vertical-align: bottom;"/> <td/> <td/> <td/></tr> <tr style="font-family: Times New Roman; font-size: 8pt; page-break-inside: avoid;"> <td style="vertical-align: bottom; padding-bottom: 1pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 1pt;">  </td> <td colspan="6" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Three Months Ended<br/> September 30,</div></div></td> <td style="vertical-align: bottom; padding-bottom: 1pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 1pt;">  </td> <td colspan="6" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Nine Months Ended<br/> September 30,</div></div></td> <td style="vertical-align: bottom; padding-bottom: 1pt;"> </td></tr> <tr style="font-family: Times New Roman; font-size: 8pt; page-break-inside: avoid;"> <td style="vertical-align: bottom; padding-bottom: 1pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 1pt;">  </td> <td colspan="2" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">2021</div></div></td> <td style="vertical-align: bottom; padding-bottom: 1pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 1pt;">  </td> <td colspan="2" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">2020</div></div></td> <td style="vertical-align: bottom; padding-bottom: 1pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 1pt;">  </td> <td colspan="2" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">2021</div></div></td> <td style="vertical-align: bottom; padding-bottom: 1pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 1pt;">  </td> <td colspan="2" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">2020</div></div></td> <td style="vertical-align: bottom; padding-bottom: 1pt;"> </td></tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);"> <td style="vertical-align: top; width: 74%;"><div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-weight:bold;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Major products/service lines:</div></div></div></td> <td style="vertical-align: bottom; width: 2%;">  </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"> </td> <td style="vertical-align: bottom; width: 2%;">  </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"> </td> <td style="vertical-align: bottom; width: 2%;">  </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"> </td> <td style="vertical-align: bottom; width: 2%;">  </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"> </td></tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;"> <td style="vertical-align: top; width: 74%;"><div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Direct sales</div></div></td> <td style="vertical-align: bottom; width: 2%;">  </td> <td style="vertical-align: bottom; white-space: nowrap;">$</td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">5,985</td> <td style="vertical-align: bottom; white-space: nowrap; font-family: &quot;Times New Roman&quot;;"> </td> <td style="vertical-align: bottom; width: 2%;">  </td> <td style="vertical-align: bottom; white-space: nowrap;">$</td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">5,994</td> <td style="vertical-align: bottom; white-space: nowrap; font-family: &quot;Times New Roman&quot;;"> </td> <td style="vertical-align: bottom; width: 2%;">  </td> <td style="vertical-align: bottom; white-space: nowrap;">$</td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">19,068</td> <td style="vertical-align: bottom; white-space: nowrap; font-family: &quot;Times New Roman&quot;;"> </td> <td style="vertical-align: bottom; width: 2%;">  </td> <td style="vertical-align: bottom; white-space: nowrap;">$</td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">16,827</td> <td style="vertical-align: bottom; white-space: nowrap; font-family: &quot;Times New Roman&quot;;"> </td></tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);"> <td style="vertical-align: top; width: 74%;"><div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Marketplace sales</div></div></td> <td style="vertical-align: bottom; width: 2%;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">1,663</td> <td style="vertical-align: bottom; white-space: nowrap; font-family: &quot;Times New Roman&quot;;"> </td> <td style="vertical-align: bottom; width: 2%;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">2,091</td> <td style="vertical-align: bottom; white-space: nowrap; font-family: &quot;Times New Roman&quot;;"> </td> <td style="vertical-align: bottom; width: 2%;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">6,062</td> <td style="vertical-align: bottom; white-space: nowrap; font-family: &quot;Times New Roman&quot;;"> </td> <td style="vertical-align: bottom; width: 2%;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">6,060</td> <td style="vertical-align: bottom; white-space: nowrap; font-family: &quot;Times New Roman&quot;;"> </td></tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;"> <td style="vertical-align: top; width: 74%;"><div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Software</div></div></td> <td style="vertical-align: bottom; width: 2%;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">68</td> <td style="vertical-align: bottom; white-space: nowrap; font-family: &quot;Times New Roman&quot;;"> </td> <td style="vertical-align: bottom; width: 2%;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">22</td> <td style="vertical-align: bottom; white-space: nowrap; font-family: &quot;Times New Roman&quot;;"> </td> <td style="vertical-align: bottom; width: 2%;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">224</td> <td style="vertical-align: bottom; white-space: nowrap; font-family: &quot;Times New Roman&quot;;"> </td> <td style="vertical-align: bottom; width: 2%;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">141</td> <td style="vertical-align: bottom; white-space: nowrap; font-family: &quot;Times New Roman&quot;;"> </td></tr> <tr style="font-size: 1px;"> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; width: 74%;"> </td> <td style="vertical-align: bottom; width: 2%;">  </td> <td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></td> <td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></td> <td> </td> <td style="vertical-align: bottom; width: 2%;">  </td> <td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></td> <td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></td> <td> </td> <td style="vertical-align: bottom; width: 2%;">  </td> <td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></td> <td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></td> <td> </td> <td style="vertical-align: bottom; width: 2%;">  </td> <td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></td> <td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></td> <td> </td></tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);"> <td style="vertical-align: top; width: 74%;"><div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-weight:bold;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Total revenue</div></div></div></td> <td style="vertical-align: bottom; width: 2%;">  </td> <td style="vertical-align: bottom; white-space: nowrap;">$</td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">7,716</td> <td style="vertical-align: bottom; white-space: nowrap; font-family: &quot;Times New Roman&quot;;"> </td> <td style="vertical-align: bottom; width: 2%;">  </td> <td style="vertical-align: bottom; white-space: nowrap;">$</td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">8,107</td> <td style="vertical-align: bottom; white-space: nowrap; font-family: &quot;Times New Roman&quot;;"> </td> <td style="vertical-align: bottom; width: 2%;">  </td> <td style="vertical-align: bottom; white-space: nowrap;">$</td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">25,354</td> <td style="vertical-align: bottom; white-space: nowrap; font-family: &quot;Times New Roman&quot;;"> </td> <td style="vertical-align: bottom; width: 2%;">  </td> <td style="vertical-align: bottom; white-space: nowrap;">$</td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">23,028</td> <td style="vertical-align: bottom; white-space: nowrap; font-family: &quot;Times New Roman&quot;;"> </td></tr> <tr style="font-size: 1px;"> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; width: 74%;"> </td> <td style="vertical-align: bottom; width: 2%;">  </td> <td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></td> <td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></td> <td> </td> <td style="vertical-align: bottom; width: 2%;">  </td> <td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></td> <td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></td> <td> </td> <td style="vertical-align: bottom; width: 2%;">  </td> <td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></td> <td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></td> <td> </td> <td style="vertical-align: bottom; width: 2%;">  </td> <td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></td> <td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></td> <td> </td></tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;"> <td style="vertical-align: top; width: 74%;"><div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-weight:bold;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Timing of revenue recognition:</div></div></div></td> <td style="vertical-align: bottom; width: 2%;">  </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"> </td> <td style="vertical-align: bottom; width: 2%;">  </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"> </td> <td style="vertical-align: bottom; width: 2%;">  </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"> </td> <td style="vertical-align: bottom; width: 2%;">  </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"> </td></tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);"> <td style="vertical-align: top; width: 74%;"><div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Products transferred at a point in time</div></div></td> <td style="vertical-align: bottom; width: 2%;">  </td> <td style="vertical-align: bottom; white-space: nowrap;">$</td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">1,663</td> <td style="vertical-align: bottom; white-space: nowrap; font-family: &quot;Times New Roman&quot;;"> </td> <td style="vertical-align: bottom; width: 2%;">  </td> <td style="vertical-align: bottom; white-space: nowrap;">$</td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">2,091</td> <td style="vertical-align: bottom; white-space: nowrap; font-family: &quot;Times New Roman&quot;;"> </td> <td style="vertical-align: bottom; width: 2%;">  </td> <td style="vertical-align: bottom; white-space: nowrap;">$</td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">6,062</td> <td style="vertical-align: bottom; white-space: nowrap; font-family: &quot;Times New Roman&quot;;"> </td> <td style="vertical-align: bottom; width: 2%;">  </td> <td style="vertical-align: bottom; white-space: nowrap;">$</td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">6,060</td> <td style="vertical-align: bottom; white-space: nowrap; font-family: &quot;Times New Roman&quot;;"> </td></tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;"> <td style="vertical-align: top; width: 74%;"><div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Products and services transferred over time</div></div></td> <td style="vertical-align: bottom; width: 2%;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">6,053</td> <td style="vertical-align: bottom; white-space: nowrap; font-family: &quot;Times New Roman&quot;;"> </td> <td style="vertical-align: bottom; width: 2%;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">6,016</td> <td style="vertical-align: bottom; white-space: nowrap; font-family: &quot;Times New Roman&quot;;"> </td> <td style="vertical-align: bottom; width: 2%;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">19,292</td> <td style="vertical-align: bottom; white-space: nowrap; font-family: &quot;Times New Roman&quot;;"> </td> <td style="vertical-align: bottom; width: 2%;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">16,968</td> <td style="vertical-align: bottom; white-space: nowrap; font-family: &quot;Times New Roman&quot;;"> </td></tr> <tr style="font-size: 1px;"> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; width: 74%;"> </td> <td style="vertical-align: bottom; width: 2%;">  </td> <td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></td> <td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></td> <td> </td> <td style="vertical-align: bottom; width: 2%;">  </td> <td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></td> <td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></td> <td> </td> <td style="vertical-align: bottom; width: 2%;">  </td> <td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></td> <td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></td> <td> </td> <td style="vertical-align: bottom; width: 2%;">  </td> <td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></td> <td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></td> <td> </td></tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);"> <td style="vertical-align: top; width: 74%;"><div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-weight:bold;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Total revenue</div></div></div></td> <td style="vertical-align: bottom; width: 2%;">  </td> <td style="vertical-align: bottom; white-space: nowrap;">$</td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">7,716</td> <td style="vertical-align: bottom; white-space: nowrap; font-family: &quot;Times New Roman&quot;;"> </td> <td style="vertical-align: bottom; width: 2%;">  </td> <td style="vertical-align: bottom; white-space: nowrap;">$</td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">8,107</td> <td style="vertical-align: bottom; white-space: nowrap; font-family: &quot;Times New Roman&quot;;"> </td> <td style="vertical-align: bottom; width: 2%;">  </td> <td style="vertical-align: bottom; white-space: nowrap;">$</td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">25,354</td> <td style="vertical-align: bottom; white-space: nowrap; font-family: &quot;Times New Roman&quot;;"> </td> <td style="vertical-align: bottom; width: 2%;">  </td> <td style="vertical-align: bottom; white-space: nowrap;">$</td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">23,028</td> <td style="vertical-align: bottom; white-space: nowrap; font-family: &quot;Times New Roman&quot;;"> </td></tr> <tr style="font-size: 1px;"> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; width: 74%;"> </td> <td style="vertical-align: bottom; width: 2%;">  </td> <td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></td> <td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></td> <td> </td> <td style="vertical-align: bottom; width: 2%;">  </td> <td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></td> <td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></td> <td> </td> <td style="vertical-align: bottom; width: 2%;">  </td> <td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></td> <td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></td> <td> </td> <td style="vertical-align: bottom; width: 2%;">  </td> <td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></td> <td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></td> <td> </td></tr></table> 5985000 5994000 19068000 16827000 1663000 2091000 6062000 6060000 68000 22000 224000 141000 7716000 8107000 25354000 23028000 1663000 2091000 6062000 6060000 6053000 6016000 19292000 16968000 7716000 8107000 25354000 23028000 <table cellpadding="0" cellspacing="0" style="margin: 0px auto; border: 0px currentcolor; width: 100%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;"> <tr style="font-size: 0px;"> <td style="width: 88%;"/> <td style="width: 9%; vertical-align: bottom;"/> <td/> <td/> <td/> </tr> <tr style="font-family: Times New Roman; font-size: 8pt; page-break-inside: avoid;"> <td style="vertical-align: bottom; padding-bottom: 1pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 1pt;">  </td> <td colspan="2" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Deferred Revenue</div></div></td> <td style="vertical-align: bottom; padding-bottom: 1pt;"> </td> </tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);"> <td style="vertical-align: top; width: 88%;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Balance at January 1, 2021</div></div> </td> <td style="vertical-align: bottom; width: 9%;">  </td> <td style="vertical-align: bottom; white-space: nowrap;">$</td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">753</td> <td style="vertical-align: bottom; white-space: nowrap; font-family: &quot;Times New Roman&quot;;"> </td> </tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;"> <td style="vertical-align: top; width: 88%;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Deferred revenue recognized during period</div></div> </td> <td style="vertical-align: bottom; width: 9%;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">(25,354</td> <td style="vertical-align: bottom; white-space: nowrap;">) </td> </tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);"> <td style="vertical-align: top; width: 88%;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Additions to deferred revenue during period</div></div> </td> <td style="vertical-align: bottom; width: 9%;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">25,259</td> <td style="vertical-align: bottom; white-space: nowrap; font-family: &quot;Times New Roman&quot;;"> </td> </tr> <tr style="font-size: 1px;"> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; width: 88%;"> </td> <td style="vertical-align: bottom; width: 9%;">  </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td> </td> </tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;"> <td style="vertical-align: top; width: 88%;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Balance at September 30, 2021</div></div> </td> <td style="vertical-align: bottom; width: 9%;">  </td> <td style="vertical-align: bottom; white-space: nowrap;">$</td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">658</td> <td style="vertical-align: bottom; white-space: nowrap; font-family: &quot;Times New Roman&quot;;"> </td> </tr> <tr style="font-size: 1px;"> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; width: 88%;"> </td> <td style="vertical-align: bottom; width: 9%;">  </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td> </td> </tr> </table> 753000 25354000 25259000 658000 753000 151000 <div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 18pt; margin-bottom: 0pt;"><div style="font-weight:bold;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Note 5. Inventory </div></div></div> <div style="font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Components of inventory consisted of the following: </div></div> <div style="font-size: 12pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-size: 12pt; letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> <table cellpadding="0" cellspacing="0" style="margin: 0px auto; border: 0px currentcolor; width: 100%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;"> <tr style="font-size: 0px;"> <td style="width: 82%;"/> <td style="width: 6%; vertical-align: bottom;"/> <td/> <td/> <td/> <td style="width: 6%; vertical-align: bottom;"/> <td/> <td/> <td/> </tr> <tr style="font-family: Times New Roman; font-size: 8pt; page-break-inside: avoid;"> <td style="vertical-align: bottom; padding-bottom: 1pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 1pt;">  </td> <td colspan="2" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">September 30,<br/> 2021</div></div></td> <td style="vertical-align: bottom; padding-bottom: 1pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 1pt;">  </td> <td colspan="2" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">December 31,<br/> 2020</div></div></td> <td style="vertical-align: bottom; padding-bottom: 1pt;"> </td> </tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);"> <td style="vertical-align: top; width: 82%;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Raw materials</div></div> </td> <td style="vertical-align: bottom; width: 6%;">  </td> <td style="vertical-align: bottom; white-space: nowrap;">$</td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">418</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; width: 6%;">  </td> <td style="vertical-align: bottom; white-space: nowrap;">$</td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">521</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> </tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;"> <td style="vertical-align: top; width: 82%;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;"><div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">Work-in-process</div></div></div> </td> <td style="vertical-align: bottom; width: 6%;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">40</td> <td style="vertical-align: bottom; white-space: nowrap; font-family: &quot;Times New Roman&quot;;"> </td> <td style="vertical-align: bottom; width: 6%;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">36</td> <td style="vertical-align: bottom; white-space: nowrap; font-family: &quot;Times New Roman&quot;;"> </td> </tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);"> <td style="vertical-align: top; width: 82%;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Finished goods</div></div> </td> <td style="vertical-align: bottom; width: 6%;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">115</td> <td style="vertical-align: bottom; white-space: nowrap; font-family: &quot;Times New Roman&quot;;"> </td> <td style="vertical-align: bottom; width: 6%;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">170</td> <td style="vertical-align: bottom; white-space: nowrap; font-family: &quot;Times New Roman&quot;;"> </td> </tr> <tr style="font-size: 1px;"> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; width: 82%;"> </td> <td style="vertical-align: bottom; width: 6%;">  </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td> </td> <td style="vertical-align: bottom; width: 6%;">  </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td> </td> </tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;"> <td style="vertical-align: top; width: 82%;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Total</div></div> </td> <td style="vertical-align: bottom; width: 6%;">  </td> <td style="vertical-align: bottom; white-space: nowrap;">$</td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">573</td> <td style="vertical-align: bottom; white-space: nowrap; font-family: &quot;Times New Roman&quot;;"> </td> <td style="vertical-align: bottom; width: 6%;">  </td> <td style="vertical-align: bottom; white-space: nowrap;">$</td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">727</td> <td style="vertical-align: bottom; white-space: nowrap; font-family: &quot;Times New Roman&quot;;"> </td> </tr> <tr style="font-size: 1px;"> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; width: 82%;"> </td> <td style="vertical-align: bottom; width: 6%;">  </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td> </td> <td style="vertical-align: bottom; width: 6%;">  </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td> </td> </tr> </table> <table cellpadding="0" cellspacing="0" style="margin: 0px auto; border: 0px currentcolor; width: 100%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;"> <tr style="font-size: 0px;"> <td style="width: 82%;"/> <td style="width: 6%; vertical-align: bottom;"/> <td/> <td/> <td/> <td style="width: 6%; vertical-align: bottom;"/> <td/> <td/> <td/> </tr> <tr style="font-family: Times New Roman; font-size: 8pt; page-break-inside: avoid;"> <td style="vertical-align: bottom; padding-bottom: 1pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 1pt;">  </td> <td colspan="2" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">September 30,<br/> 2021</div></div></td> <td style="vertical-align: bottom; padding-bottom: 1pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 1pt;">  </td> <td colspan="2" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">December 31,<br/> 2020</div></div></td> <td style="vertical-align: bottom; padding-bottom: 1pt;"> </td> </tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);"> <td style="vertical-align: top; width: 82%;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Raw materials</div></div> </td> <td style="vertical-align: bottom; width: 6%;">  </td> <td style="vertical-align: bottom; white-space: nowrap;">$</td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">418</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; width: 6%;">  </td> <td style="vertical-align: bottom; white-space: nowrap;">$</td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">521</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> </tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;"> <td style="vertical-align: top; width: 82%;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;"><div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">Work-in-process</div></div></div> </td> <td style="vertical-align: bottom; width: 6%;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">40</td> <td style="vertical-align: bottom; white-space: nowrap; font-family: &quot;Times New Roman&quot;;"> </td> <td style="vertical-align: bottom; width: 6%;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">36</td> <td style="vertical-align: bottom; white-space: nowrap; font-family: &quot;Times New Roman&quot;;"> </td> </tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);"> <td style="vertical-align: top; width: 82%;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Finished goods</div></div> </td> <td style="vertical-align: bottom; width: 6%;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">115</td> <td style="vertical-align: bottom; white-space: nowrap; font-family: &quot;Times New Roman&quot;;"> </td> <td style="vertical-align: bottom; width: 6%;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">170</td> <td style="vertical-align: bottom; white-space: nowrap; font-family: &quot;Times New Roman&quot;;"> </td> </tr> <tr style="font-size: 1px;"> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; width: 82%;"> </td> <td style="vertical-align: bottom; width: 6%;">  </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td> </td> <td style="vertical-align: bottom; width: 6%;">  </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td> </td> </tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;"> <td style="vertical-align: top; width: 82%;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Total</div></div> </td> <td style="vertical-align: bottom; width: 6%;">  </td> <td style="vertical-align: bottom; white-space: nowrap;">$</td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">573</td> <td style="vertical-align: bottom; white-space: nowrap; font-family: &quot;Times New Roman&quot;;"> </td> <td style="vertical-align: bottom; width: 6%;">  </td> <td style="vertical-align: bottom; white-space: nowrap;">$</td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">727</td> <td style="vertical-align: bottom; white-space: nowrap; font-family: &quot;Times New Roman&quot;;"> </td> </tr> <tr style="font-size: 1px;"> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; width: 82%;"> </td> <td style="vertical-align: bottom; width: 6%;">  </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td> </td> <td style="vertical-align: bottom; width: 6%;">  </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td> </td> </tr> </table> 418000 521000 40000 36000 115000 170000 573000 727000 <div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 18pt; margin-bottom: 0pt;"><div style="font-weight:bold;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Note 6. Prepaid Expenses and Other Current Assets </div></div></div> <div style="font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Prepaid expenses and other current assets consisted of the following: </div></div> <div style="font-size: 12pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-size: 12pt; letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> <table cellpadding="0" cellspacing="0" style="margin: 0px auto; border: 0px currentcolor; width: 100%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;"> <tr style="font-size: 0px;"> <td style="width: 82%;"/> <td style="width: 5%; vertical-align: bottom;"/> <td/> <td/> <td/> <td style="width: 5%; vertical-align: bottom;"/> <td/> <td/> <td/> </tr> <tr style="font-family: Times New Roman; font-size: 8pt; page-break-inside: avoid;"> <td style="vertical-align: bottom; padding-bottom: 1pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 1pt;">  </td> <td colspan="2" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">September 30,<br/> 2021</div></div></td> <td style="vertical-align: bottom; padding-bottom: 1pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 1pt;">  </td> <td colspan="2" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">December 31,<br/> 2020</div></div></td> <td style="vertical-align: bottom; padding-bottom: 1pt;"> </td> </tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);"> <td style="vertical-align: top; width: 82%;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Prepaid expenses</div></div> </td> <td style="vertical-align: bottom; width: 5%;">  </td> <td style="vertical-align: bottom; white-space: nowrap;">$</td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">698</td> <td style="vertical-align: bottom; white-space: nowrap; font-family: &quot;Times New Roman&quot;;"> </td> <td style="vertical-align: bottom; width: 5%;">  </td> <td style="vertical-align: bottom; white-space: nowrap;">$</td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">646</td> <td style="vertical-align: bottom; white-space: nowrap; font-family: &quot;Times New Roman&quot;;"> </td> </tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;"> <td style="vertical-align: top; width: 82%;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Security deposits</div></div> </td> <td style="vertical-align: bottom; width: 5%;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">259</td> <td style="vertical-align: bottom; white-space: nowrap; font-family: &quot;Times New Roman&quot;;"> </td> <td style="vertical-align: bottom; width: 5%;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">259</td> <td style="vertical-align: bottom; white-space: nowrap; font-family: &quot;Times New Roman&quot;;"> </td> </tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);"> <td style="vertical-align: top; width: 82%;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">VAT receivable</div></div> </td> <td style="vertical-align: bottom; width: 5%;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">950</td> <td style="vertical-align: bottom; white-space: nowrap; font-family: &quot;Times New Roman&quot;;"> </td> <td style="vertical-align: bottom; width: 5%;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">975</td> <td style="vertical-align: bottom; white-space: nowrap; font-family: &quot;Times New Roman&quot;;"> </td> </tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;"> <td style="vertical-align: top; width: 82%;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Other current assets</div></div> </td> <td style="vertical-align: bottom; width: 5%;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">1</td> <td style="vertical-align: bottom; white-space: nowrap; font-family: &quot;Times New Roman&quot;;"> </td> <td style="vertical-align: bottom; width: 5%;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">30</td> <td style="vertical-align: bottom; white-space: nowrap; font-family: &quot;Times New Roman&quot;;"> </td> </tr> <tr style="font-size: 1px;"> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; width: 82%;"> </td> <td style="vertical-align: bottom; width: 5%;">  </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td> </td> <td style="vertical-align: bottom; width: 5%;">  </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td> </td> </tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);"> <td style="vertical-align: top; width: 82%;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Total</div></div> </td> <td style="vertical-align: bottom; width: 5%;">  </td> <td style="vertical-align: bottom; white-space: nowrap;">$</td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">1,908</td> <td style="vertical-align: bottom; white-space: nowrap; font-family: &quot;Times New Roman&quot;;"> </td> <td style="vertical-align: bottom; width: 5%;">  </td> <td style="vertical-align: bottom; white-space: nowrap;">$</td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">1,910</td> <td style="vertical-align: bottom; white-space: nowrap; font-family: &quot;Times New Roman&quot;;"> </td> </tr> <tr style="font-size: 1px;"> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; width: 82%;"> </td> <td style="vertical-align: bottom; width: 5%;">  </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td> </td> <td style="vertical-align: bottom; width: 5%;">  </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td> </td> </tr> </table> <table cellpadding="0" cellspacing="0" style="margin: 0px auto; border: 0px currentcolor; width: 100%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;"> <tr style="font-size: 0px;"> <td style="width: 82%;"/> <td style="width: 5%; vertical-align: bottom;"/> <td/> <td/> <td/> <td style="width: 5%; vertical-align: bottom;"/> <td/> <td/> <td/> </tr> <tr style="font-family: Times New Roman; font-size: 8pt; page-break-inside: avoid;"> <td style="vertical-align: bottom; padding-bottom: 1pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 1pt;">  </td> <td colspan="2" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">September 30,<br/> 2021</div></div></td> <td style="vertical-align: bottom; padding-bottom: 1pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 1pt;">  </td> <td colspan="2" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">December 31,<br/> 2020</div></div></td> <td style="vertical-align: bottom; padding-bottom: 1pt;"> </td> </tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);"> <td style="vertical-align: top; width: 82%;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Prepaid expenses</div></div> </td> <td style="vertical-align: bottom; width: 5%;">  </td> <td style="vertical-align: bottom; white-space: nowrap;">$</td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">698</td> <td style="vertical-align: bottom; white-space: nowrap; font-family: &quot;Times New Roman&quot;;"> </td> <td style="vertical-align: bottom; width: 5%;">  </td> <td style="vertical-align: bottom; white-space: nowrap;">$</td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">646</td> <td style="vertical-align: bottom; white-space: nowrap; font-family: &quot;Times New Roman&quot;;"> </td> </tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;"> <td style="vertical-align: top; width: 82%;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Security deposits</div></div> </td> <td style="vertical-align: bottom; width: 5%;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">259</td> <td style="vertical-align: bottom; white-space: nowrap; font-family: &quot;Times New Roman&quot;;"> </td> <td style="vertical-align: bottom; width: 5%;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">259</td> <td style="vertical-align: bottom; white-space: nowrap; font-family: &quot;Times New Roman&quot;;"> </td> </tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);"> <td style="vertical-align: top; width: 82%;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">VAT receivable</div></div> </td> <td style="vertical-align: bottom; width: 5%;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">950</td> <td style="vertical-align: bottom; white-space: nowrap; font-family: &quot;Times New Roman&quot;;"> </td> <td style="vertical-align: bottom; width: 5%;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">975</td> <td style="vertical-align: bottom; white-space: nowrap; font-family: &quot;Times New Roman&quot;;"> </td> </tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;"> <td style="vertical-align: top; width: 82%;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Other current assets</div></div> </td> <td style="vertical-align: bottom; width: 5%;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">1</td> <td style="vertical-align: bottom; white-space: nowrap; font-family: &quot;Times New Roman&quot;;"> </td> <td style="vertical-align: bottom; width: 5%;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">30</td> <td style="vertical-align: bottom; white-space: nowrap; font-family: &quot;Times New Roman&quot;;"> </td> </tr> <tr style="font-size: 1px;"> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; width: 82%;"> </td> <td style="vertical-align: bottom; width: 5%;">  </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td> </td> <td style="vertical-align: bottom; width: 5%;">  </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td> </td> </tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);"> <td style="vertical-align: top; width: 82%;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Total</div></div> </td> <td style="vertical-align: bottom; width: 5%;">  </td> <td style="vertical-align: bottom; white-space: nowrap;">$</td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">1,908</td> <td style="vertical-align: bottom; white-space: nowrap; font-family: &quot;Times New Roman&quot;;"> </td> <td style="vertical-align: bottom; width: 5%;">  </td> <td style="vertical-align: bottom; white-space: nowrap;">$</td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">1,910</td> <td style="vertical-align: bottom; white-space: nowrap; font-family: &quot;Times New Roman&quot;;"> </td> </tr> <tr style="font-size: 1px;"> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; width: 82%;"> </td> <td style="vertical-align: bottom; width: 5%;">  </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td> </td> <td style="vertical-align: bottom; width: 5%;">  </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td> </td> </tr> </table> 698000 646000 259000 259000 950000 975000 1000 30000 1908000 1910000 <div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 18pt; margin-bottom: 0pt;"><div style="font-weight:bold;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Note 7. Property and Equipment, net </div></div></div> <div style="font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Property and equipment consisted of the following: </div></div> <div style="font-size: 12pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-size: 12pt; letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> <table cellpadding="0" cellspacing="0" style="margin: 0px auto; border: 0px currentcolor; width: 100%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;"> <tr style="font-size: 0px;"> <td style="width: 82%;"/> <td style="width: 4%; vertical-align: bottom;"/> <td/> <td/> <td/> <td style="width: 4%; vertical-align: bottom;"/> <td/> <td/> <td/> </tr> <tr style="font-family: Times New Roman; font-size: 8pt; page-break-inside: avoid;"> <td style="vertical-align: bottom; padding-bottom: 1pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 1pt;">  </td> <td colspan="2" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">September 30,<br/> 2021</div></div></td> <td style="vertical-align: bottom; padding-bottom: 1pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 1pt;">  </td> <td colspan="2" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">December 31,<br/> 2020</div></div></td> <td style="vertical-align: bottom; padding-bottom: 1pt;"> </td> </tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);"> <td style="vertical-align: top; width: 82%;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Machinery and equipment</div></div> </td> <td style="vertical-align: bottom; width: 4%;">  </td> <td style="vertical-align: bottom; white-space: nowrap;">$</td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">1,388</td> <td style="vertical-align: bottom; white-space: nowrap; font-family: &quot;Times New Roman&quot;;"> </td> <td style="vertical-align: bottom; width: 4%;">  </td> <td style="vertical-align: bottom; white-space: nowrap;">$</td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">1,430</td> <td style="vertical-align: bottom; white-space: nowrap; font-family: &quot;Times New Roman&quot;;"> </td> </tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;"> <td style="vertical-align: top; width: 82%;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Computers and IT equipment</div></div> </td> <td style="vertical-align: bottom; width: 4%;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">5,631</td> <td style="vertical-align: bottom; white-space: nowrap; font-family: &quot;Times New Roman&quot;;"> </td> <td style="vertical-align: bottom; width: 4%;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">5,193</td> <td style="vertical-align: bottom; white-space: nowrap; font-family: &quot;Times New Roman&quot;;"> </td> </tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);"> <td style="vertical-align: top; width: 82%;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Furniture and fixtures</div></div> </td> <td style="vertical-align: bottom; width: 4%;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">49</td> <td style="vertical-align: bottom; white-space: nowrap; font-family: &quot;Times New Roman&quot;;"> </td> <td style="vertical-align: bottom; width: 4%;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">50</td> <td style="vertical-align: bottom; white-space: nowrap; font-family: &quot;Times New Roman&quot;;"> </td> </tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;"> <td style="vertical-align: top; width: 82%;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Leasehold improvements</div></div> </td> <td style="vertical-align: bottom; width: 4%;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">2,477</td> <td style="vertical-align: bottom; white-space: nowrap; font-family: &quot;Times New Roman&quot;;"> </td> <td style="vertical-align: bottom; width: 4%;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">2,520</td> <td style="vertical-align: bottom; white-space: nowrap; font-family: &quot;Times New Roman&quot;;"> </td> </tr> <tr style="font-size: 1px;"> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; width: 82%;"> </td> <td style="vertical-align: bottom; width: 4%;">  </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td> </td> <td style="vertical-align: bottom; width: 4%;">  </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td> </td> </tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);"> <td style="vertical-align: top; font-family: &quot;Times New Roman&quot;; width: 82%;"> </td> <td style="vertical-align: bottom; width: 4%;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">9,545</td> <td style="vertical-align: bottom; white-space: nowrap; font-family: &quot;Times New Roman&quot;;"> </td> <td style="vertical-align: bottom; width: 4%;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">9,193</td> <td style="vertical-align: bottom; white-space: nowrap; font-family: &quot;Times New Roman&quot;;"> </td> </tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;"> <td style="vertical-align: top; width: 82%;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Less: Accumulated depreciation</div></div> </td> <td style="vertical-align: bottom; width: 4%;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">(8,455</td> <td style="vertical-align: bottom; white-space: nowrap;">) </td> <td style="vertical-align: bottom; width: 4%;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">(8,245</td> <td style="vertical-align: bottom; white-space: nowrap;">) </td> </tr> <tr style="font-size: 1px;"> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; width: 82%;"> </td> <td style="vertical-align: bottom; width: 4%;">  </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td> </td> <td style="vertical-align: bottom; width: 4%;">  </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td> </td> </tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);"> <td style="vertical-align: top; width: 82%;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Property and equipment, net</div></div> </td> <td style="vertical-align: bottom; width: 4%;">  </td> <td style="vertical-align: bottom; white-space: nowrap;">$</td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">1,090</td> <td style="vertical-align: bottom; white-space: nowrap; font-family: &quot;Times New Roman&quot;;"> </td> <td style="vertical-align: bottom; width: 4%;">  </td> <td style="vertical-align: bottom; white-space: nowrap;">$</td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">948</td> <td style="vertical-align: bottom; white-space: nowrap; font-family: &quot;Times New Roman&quot;;"> </td> </tr> <tr style="font-size: 1px;"> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; width: 82%;"> </td> <td style="vertical-align: bottom; width: 4%;">  </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td> </td> <td style="vertical-align: bottom; width: 4%;">  </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td> </td> </tr> </table> <div style="font-size: 8pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-size: 8pt; letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> <div style="font-family: Times New Roman; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">For the three months ended September 30, 2021 and 2020, depreciation expense totaled $146 and $115, respectively. For the nine months ended September 30, 2021 and 2020, depreciation expense totaled $424 and $362, respectively. Of these amounts, depreciation charged to cost of revenue was $113 and $78 for the three months ended September 30, 2021 and 2020, respectively, and $324 and $249 for the nine months ended September 30, 2021 and 2020, respectively. </div></div> <table cellpadding="0" cellspacing="0" style="margin: 0px auto; border: 0px currentcolor; width: 100%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;"> <tr style="font-size: 0px;"> <td style="width: 82%;"/> <td style="width: 4%; vertical-align: bottom;"/> <td/> <td/> <td/> <td style="width: 4%; vertical-align: bottom;"/> <td/> <td/> <td/> </tr> <tr style="font-family: Times New Roman; font-size: 8pt; page-break-inside: avoid;"> <td style="vertical-align: bottom; padding-bottom: 1pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 1pt;">  </td> <td colspan="2" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">September 30,<br/> 2021</div></div></td> <td style="vertical-align: bottom; padding-bottom: 1pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 1pt;">  </td> <td colspan="2" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">December 31,<br/> 2020</div></div></td> <td style="vertical-align: bottom; padding-bottom: 1pt;"> </td> </tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);"> <td style="vertical-align: top; width: 82%;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Machinery and equipment</div></div> </td> <td style="vertical-align: bottom; width: 4%;">  </td> <td style="vertical-align: bottom; white-space: nowrap;">$</td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">1,388</td> <td style="vertical-align: bottom; white-space: nowrap; font-family: &quot;Times New Roman&quot;;"> </td> <td style="vertical-align: bottom; width: 4%;">  </td> <td style="vertical-align: bottom; white-space: nowrap;">$</td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">1,430</td> <td style="vertical-align: bottom; white-space: nowrap; font-family: &quot;Times New Roman&quot;;"> </td> </tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;"> <td style="vertical-align: top; width: 82%;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Computers and IT equipment</div></div> </td> <td style="vertical-align: bottom; width: 4%;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">5,631</td> <td style="vertical-align: bottom; white-space: nowrap; font-family: &quot;Times New Roman&quot;;"> </td> <td style="vertical-align: bottom; width: 4%;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">5,193</td> <td style="vertical-align: bottom; white-space: nowrap; font-family: &quot;Times New Roman&quot;;"> </td> </tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);"> <td style="vertical-align: top; width: 82%;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Furniture and fixtures</div></div> </td> <td style="vertical-align: bottom; width: 4%;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">49</td> <td style="vertical-align: bottom; white-space: nowrap; font-family: &quot;Times New Roman&quot;;"> </td> <td style="vertical-align: bottom; width: 4%;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">50</td> <td style="vertical-align: bottom; white-space: nowrap; font-family: &quot;Times New Roman&quot;;"> </td> </tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;"> <td style="vertical-align: top; width: 82%;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Leasehold improvements</div></div> </td> <td style="vertical-align: bottom; width: 4%;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">2,477</td> <td style="vertical-align: bottom; white-space: nowrap; font-family: &quot;Times New Roman&quot;;"> </td> <td style="vertical-align: bottom; width: 4%;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">2,520</td> <td style="vertical-align: bottom; white-space: nowrap; font-family: &quot;Times New Roman&quot;;"> </td> </tr> <tr style="font-size: 1px;"> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; width: 82%;"> </td> <td style="vertical-align: bottom; width: 4%;">  </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td> </td> <td style="vertical-align: bottom; width: 4%;">  </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td> </td> </tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);"> <td style="vertical-align: top; font-family: &quot;Times New Roman&quot;; width: 82%;"> </td> <td style="vertical-align: bottom; width: 4%;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">9,545</td> <td style="vertical-align: bottom; white-space: nowrap; font-family: &quot;Times New Roman&quot;;"> </td> <td style="vertical-align: bottom; width: 4%;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">9,193</td> <td style="vertical-align: bottom; white-space: nowrap; font-family: &quot;Times New Roman&quot;;"> </td> </tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;"> <td style="vertical-align: top; width: 82%;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Less: Accumulated depreciation</div></div> </td> <td style="vertical-align: bottom; width: 4%;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">(8,455</td> <td style="vertical-align: bottom; white-space: nowrap;">) </td> <td style="vertical-align: bottom; width: 4%;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">(8,245</td> <td style="vertical-align: bottom; white-space: nowrap;">) </td> </tr> <tr style="font-size: 1px;"> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; width: 82%;"> </td> <td style="vertical-align: bottom; width: 4%;">  </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td> </td> <td style="vertical-align: bottom; width: 4%;">  </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td> </td> </tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);"> <td style="vertical-align: top; width: 82%;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Property and equipment, net</div></div> </td> <td style="vertical-align: bottom; width: 4%;">  </td> <td style="vertical-align: bottom; white-space: nowrap;">$</td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">1,090</td> <td style="vertical-align: bottom; white-space: nowrap; font-family: &quot;Times New Roman&quot;;"> </td> <td style="vertical-align: bottom; width: 4%;">  </td> <td style="vertical-align: bottom; white-space: nowrap;">$</td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">948</td> <td style="vertical-align: bottom; white-space: nowrap; font-family: &quot;Times New Roman&quot;;"> </td> </tr> <tr style="font-size: 1px;"> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; width: 82%;"> </td> <td style="vertical-align: bottom; width: 4%;">  </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td> </td> <td style="vertical-align: bottom; width: 4%;">  </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td> </td> </tr> </table> 1388000 1430000 5631000 5193000 49000 50000 2477000 2520000 9545000 9193000 8455000 8245000 1090000 948000 146000 115000 424000 362000 113000 78000 324000 249000 <div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 18pt; margin-bottom: 0pt;"><div style="font-weight:bold;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Note 8. Accrued Expenses and Other Liabilities </div></div></div> <div style="font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Accrued expenses consisted of the following: </div></div> <div style="font-size: 12pt; margin-top: 0pt; margin-bottom: 0pt; text-indent: 0px;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-size: 12pt; letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></div> <table cellpadding="0" cellspacing="0" style="margin: 0px auto; border: 0px currentcolor; width: 100%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px; text-indent: 0px;"> <tr style="font-size: 0px;"> <td style="width: 82%;"/> <td style="width: 5%; vertical-align: bottom;"/> <td/> <td/> <td/> <td style="width: 5%; vertical-align: bottom;"/> <td/> <td/> <td/> </tr> <tr style="font-family: Times New Roman; font-size: 8pt; page-break-inside: avoid;"> <td style="vertical-align: bottom; padding-bottom: 1pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align: bottom; padding-bottom: 1pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">  </div></td> <td colspan="2" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">September 30,<br/> 2021</div></div></div></td> <td style="vertical-align: bottom; padding-bottom: 1pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align: bottom; padding-bottom: 1pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">  </div></td> <td colspan="2" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">December 31,<br/> 2020</div></div></div></td> <td style="vertical-align: bottom; padding-bottom: 1pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> </tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);"> <td style="vertical-align: top; width: 82%;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Accrued selling expenses</div></div> </td> <td style="vertical-align: bottom; width: 5%;">  </td> <td style="vertical-align: bottom; white-space: nowrap;">$</td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">712</td> <td style="vertical-align: bottom; white-space: nowrap; font-family: &quot;Times New Roman&quot;;"> </td> <td style="vertical-align: bottom; width: 5%;">  </td> <td style="vertical-align: bottom; white-space: nowrap;">$</td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">947</td> <td style="vertical-align: bottom; white-space: nowrap; font-family: &quot;Times New Roman&quot;;"> </td> </tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;"> <td style="vertical-align: top; width: 82%;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Accrued compensation</div></div> </td> <td style="vertical-align: bottom; width: 5%;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">757</td> <td style="vertical-align: bottom; white-space: nowrap; font-family: &quot;Times New Roman&quot;;"> </td> <td style="vertical-align: bottom; width: 5%;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">876</td> <td style="vertical-align: bottom; white-space: nowrap; font-family: &quot;Times New Roman&quot;;"> </td> </tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);"> <td style="vertical-align: top; width: 82%;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Interest payable</div></div> </td> <td style="vertical-align: bottom; width: 5%;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">—  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; width: 5%;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">612</td> <td style="vertical-align: bottom; white-space: nowrap; font-family: &quot;Times New Roman&quot;;"> </td> </tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;"> <td style="vertical-align: top; width: 82%;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Taxes payable</div></div> </td> <td style="vertical-align: bottom; width: 5%;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">306</td> <td style="vertical-align: bottom; white-space: nowrap; font-family: &quot;Times New Roman&quot;;"> </td> <td style="vertical-align: bottom; width: 5%;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">477</td> <td style="vertical-align: bottom; white-space: nowrap; font-family: &quot;Times New Roman&quot;;"> </td> </tr> <tr> <td style="vertical-align: top; font-size: 10pt; background-color: rgb(204, 238, 255); width: 82%;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Accrued transaction costs</div></div></div> </td> <td style="vertical-align: bottom; background-color: rgb(204, 238, 255); width: 5%;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">  </div></td> <td style="vertical-align: bottom; white-space: nowrap; background-color: rgb(204, 238, 255);"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align: bottom; white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">450</div></td> <td style="vertical-align: bottom; white-space: nowrap; background-color: rgb(204, 238, 255);"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align: bottom; background-color: rgb(204, 238, 255); width: 5%;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">  </div></td> <td style="vertical-align: bottom; white-space: nowrap; background-color: rgb(204, 238, 255);"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align: bottom; white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">—  </div></td> <td style="vertical-align: bottom; white-space: nowrap; background-color: rgb(204, 238, 255);"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> </tr> <tr style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; break-inside: avoid;"> <td style="vertical-align: top; background-color: rgba(255, 255, 255, 0); width: 82%;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Accrued acquisition of property and equipment</div></div> </td> <td style="vertical-align: bottom; background-color: rgba(255, 255, 255, 0); width: 5%;">  </td> <td style="vertical-align: bottom; white-space: nowrap; background-color: rgba(255, 255, 255, 0);"> </td> <td style="vertical-align: bottom; white-space: nowrap; background-color: rgba(255, 255, 255, 0);;text-align:right;">441</td> <td style="vertical-align: bottom; white-space: nowrap; font-family: &quot;Times New Roman&quot;; background-color: rgba(255, 255, 255, 0);"> </td> <td style="vertical-align: bottom; background-color: rgba(255, 255, 255, 0); width: 5%;">  </td> <td style="vertical-align: bottom; white-space: nowrap; background-color: rgba(255, 255, 255, 0);"> </td> <td style="vertical-align: bottom; white-space: nowrap; background-color: rgba(255, 255, 255, 0);;text-align:right;">—  </td> <td style="vertical-align: bottom; white-space: nowrap; background-color: rgba(255, 255, 255, 0);"> </td> </tr> <tr> <td style="vertical-align: top; background-color: rgb(204, 238, 255); width: 82%;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">Shapeways credits</div></div> </td> <td style="vertical-align: bottom; background-color: rgb(204, 238, 255); width: 5%;">  </td> <td style="vertical-align: bottom; white-space: nowrap; background-color: rgb(204, 238, 255);"> </td> <td style="vertical-align: bottom; white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;">300</td> <td style="vertical-align: bottom; white-space: nowrap; background-color: rgb(204, 238, 255);"> </td> <td style="vertical-align: bottom; background-color: rgb(204, 238, 255); width: 5%;">  </td> <td style="vertical-align: bottom; white-space: nowrap; background-color: rgb(204, 238, 255);"> </td> <td style="vertical-align: bottom; white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;">313</td> <td style="vertical-align: bottom; white-space: nowrap; background-color: rgb(204, 238, 255);"> </td> </tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;"> <td style="vertical-align: top; background-color: rgba(255, 255, 255, 0); width: 82%;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Other</div></div> </td> <td style="vertical-align: bottom; background-color: rgba(255, 255, 255, 0); width: 5%;">  </td> <td style="vertical-align: bottom; white-space: nowrap; background-color: rgba(255, 255, 255, 0);"> </td> <td style="vertical-align: bottom; white-space: nowrap; background-color: rgba(255, 255, 255, 0);;text-align:right;">734</td> <td style="vertical-align: bottom; white-space: nowrap; font-family: &quot;Times New Roman&quot;; background-color: rgba(255, 255, 255, 0);"> </td> <td style="vertical-align: bottom; background-color: rgba(255, 255, 255, 0); width: 5%;">  </td> <td style="vertical-align: bottom; white-space: nowrap; background-color: rgba(255, 255, 255, 0);"> </td> <td style="vertical-align: bottom; white-space: nowrap; background-color: rgba(255, 255, 255, 0);;text-align:right;">94</td> <td style="vertical-align: bottom; white-space: nowrap; font-family: &quot;Times New Roman&quot;; background-color: rgba(255, 255, 255, 0);"> </td> </tr> <tr style="font-size: 1px;"> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; background-color: rgb(204, 238, 255); width: 82%;"> </td> <td style="vertical-align: bottom; background-color: rgb(204, 238, 255); width: 5%;">  </td> <td style="vertical-align: bottom; background-color: rgb(204, 238, 255);"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="vertical-align: bottom; background-color: rgb(204, 238, 255);"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="background-color: rgb(204, 238, 255);"> </td> <td style="vertical-align: bottom; background-color: rgb(204, 238, 255); width: 5%;">  </td> <td style="vertical-align: bottom; background-color: rgb(204, 238, 255);"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="vertical-align: bottom; background-color: rgb(204, 238, 255);"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="background-color: rgb(204, 238, 255);"> </td> </tr> <tr style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; break-inside: avoid;"> <td style="vertical-align: top; background-color: rgb(204, 238, 255); width: 82%;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Total</div></div> </td> <td style="vertical-align: bottom; background-color: rgb(204, 238, 255); width: 5%;">  </td> <td style="vertical-align: bottom; white-space: nowrap; background-color: rgb(204, 238, 255);">$</td> <td style="vertical-align: bottom; white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;">3,700</td> <td style="vertical-align: bottom; white-space: nowrap; font-family: &quot;Times New Roman&quot;; background-color: rgb(204, 238, 255);"> </td> <td style="vertical-align: bottom; background-color: rgb(204, 238, 255); width: 5%;">  </td> <td style="vertical-align: bottom; white-space: nowrap; background-color: rgb(204, 238, 255);">$</td> <td style="vertical-align: bottom; white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;">3,319</td> <td style="vertical-align: bottom; white-space: nowrap; font-family: &quot;Times New Roman&quot;; background-color: rgb(204, 238, 255);"> </td> </tr> <tr style="font-size: 1px;"> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; background-color: rgba(255, 255, 255, 0); width: 82%;"> </td> <td style="vertical-align: bottom; background-color: rgba(255, 255, 255, 0); width: 5%;">  </td> <td style="vertical-align: bottom; background-color: rgba(255, 255, 255, 0);"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="vertical-align: bottom; background-color: rgba(255, 255, 255, 0);"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="background-color: rgba(255, 255, 255, 0);"> </td> <td style="vertical-align: bottom; background-color: rgba(255, 255, 255, 0); width: 5%;">  </td> <td style="vertical-align: bottom; background-color: rgba(255, 255, 255, 0);"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="vertical-align: bottom; background-color: rgba(255, 255, 255, 0);"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="background-color: rgba(255, 255, 255, 0);"> </td> </tr> </table> <div style="clear: both; max-height: 0px; text-indent: 0px;"/> <div style="font-size: 12pt; margin-top: 0pt; margin-bottom: 0pt; text-indent: 0px;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-size: 12pt; letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></div> <table cellpadding="0" cellspacing="0" style="margin: 0px auto; border: 0px currentcolor; width: 100%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px; text-indent: 0px;"> <tr style="font-size: 0px;"> <td style="width: 82%;"/> <td style="width: 5%; vertical-align: bottom;"/> <td/> <td/> <td/> <td style="width: 5%; vertical-align: bottom;"/> <td/> <td/> <td/> </tr> <tr style="font-family: Times New Roman; font-size: 8pt; page-break-inside: avoid;"> <td style="vertical-align: bottom; padding-bottom: 1pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align: bottom; padding-bottom: 1pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">  </div></td> <td colspan="2" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">September 30,<br/> 2021</div></div></div></td> <td style="vertical-align: bottom; padding-bottom: 1pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align: bottom; padding-bottom: 1pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">  </div></td> <td colspan="2" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">December 31,<br/> 2020</div></div></div></td> <td style="vertical-align: bottom; padding-bottom: 1pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> </tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);"> <td style="vertical-align: top; width: 82%;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Accrued selling expenses</div></div> </td> <td style="vertical-align: bottom; width: 5%;">  </td> <td style="vertical-align: bottom; white-space: nowrap;">$</td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">712</td> <td style="vertical-align: bottom; white-space: nowrap; font-family: &quot;Times New Roman&quot;;"> </td> <td style="vertical-align: bottom; width: 5%;">  </td> <td style="vertical-align: bottom; white-space: nowrap;">$</td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">947</td> <td style="vertical-align: bottom; white-space: nowrap; font-family: &quot;Times New Roman&quot;;"> </td> </tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;"> <td style="vertical-align: top; width: 82%;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Accrued compensation</div></div> </td> <td style="vertical-align: bottom; width: 5%;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">757</td> <td style="vertical-align: bottom; white-space: nowrap; font-family: &quot;Times New Roman&quot;;"> </td> <td style="vertical-align: bottom; width: 5%;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">876</td> <td style="vertical-align: bottom; white-space: nowrap; font-family: &quot;Times New Roman&quot;;"> </td> </tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);"> <td style="vertical-align: top; width: 82%;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Interest payable</div></div> </td> <td style="vertical-align: bottom; width: 5%;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">—  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; width: 5%;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">612</td> <td style="vertical-align: bottom; white-space: nowrap; font-family: &quot;Times New Roman&quot;;"> </td> </tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;"> <td style="vertical-align: top; width: 82%;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Taxes payable</div></div> </td> <td style="vertical-align: bottom; width: 5%;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">306</td> <td style="vertical-align: bottom; white-space: nowrap; font-family: &quot;Times New Roman&quot;;"> </td> <td style="vertical-align: bottom; width: 5%;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">477</td> <td style="vertical-align: bottom; white-space: nowrap; font-family: &quot;Times New Roman&quot;;"> </td> </tr> <tr> <td style="vertical-align: top; font-size: 10pt; background-color: rgb(204, 238, 255); width: 82%;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Accrued transaction costs</div></div></div> </td> <td style="vertical-align: bottom; background-color: rgb(204, 238, 255); width: 5%;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">  </div></td> <td style="vertical-align: bottom; white-space: nowrap; background-color: rgb(204, 238, 255);"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align: bottom; white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">450</div></td> <td style="vertical-align: bottom; white-space: nowrap; background-color: rgb(204, 238, 255);"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align: bottom; background-color: rgb(204, 238, 255); width: 5%;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">  </div></td> <td style="vertical-align: bottom; white-space: nowrap; background-color: rgb(204, 238, 255);"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align: bottom; white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">—  </div></td> <td style="vertical-align: bottom; white-space: nowrap; background-color: rgb(204, 238, 255);"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> </tr> <tr style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; break-inside: avoid;"> <td style="vertical-align: top; background-color: rgba(255, 255, 255, 0); width: 82%;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Accrued acquisition of property and equipment</div></div> </td> <td style="vertical-align: bottom; background-color: rgba(255, 255, 255, 0); width: 5%;">  </td> <td style="vertical-align: bottom; white-space: nowrap; background-color: rgba(255, 255, 255, 0);"> </td> <td style="vertical-align: bottom; white-space: nowrap; background-color: rgba(255, 255, 255, 0);;text-align:right;">441</td> <td style="vertical-align: bottom; white-space: nowrap; font-family: &quot;Times New Roman&quot;; background-color: rgba(255, 255, 255, 0);"> </td> <td style="vertical-align: bottom; background-color: rgba(255, 255, 255, 0); width: 5%;">  </td> <td style="vertical-align: bottom; white-space: nowrap; background-color: rgba(255, 255, 255, 0);"> </td> <td style="vertical-align: bottom; white-space: nowrap; background-color: rgba(255, 255, 255, 0);;text-align:right;">—  </td> <td style="vertical-align: bottom; white-space: nowrap; background-color: rgba(255, 255, 255, 0);"> </td> </tr> <tr> <td style="vertical-align: top; background-color: rgb(204, 238, 255); width: 82%;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">Shapeways credits</div></div> </td> <td style="vertical-align: bottom; background-color: rgb(204, 238, 255); width: 5%;">  </td> <td style="vertical-align: bottom; white-space: nowrap; background-color: rgb(204, 238, 255);"> </td> <td style="vertical-align: bottom; white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;">300</td> <td style="vertical-align: bottom; white-space: nowrap; background-color: rgb(204, 238, 255);"> </td> <td style="vertical-align: bottom; background-color: rgb(204, 238, 255); width: 5%;">  </td> <td style="vertical-align: bottom; white-space: nowrap; background-color: rgb(204, 238, 255);"> </td> <td style="vertical-align: bottom; white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;">313</td> <td style="vertical-align: bottom; white-space: nowrap; background-color: rgb(204, 238, 255);"> </td> </tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;"> <td style="vertical-align: top; background-color: rgba(255, 255, 255, 0); width: 82%;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Other</div></div> </td> <td style="vertical-align: bottom; background-color: rgba(255, 255, 255, 0); width: 5%;">  </td> <td style="vertical-align: bottom; white-space: nowrap; background-color: rgba(255, 255, 255, 0);"> </td> <td style="vertical-align: bottom; white-space: nowrap; background-color: rgba(255, 255, 255, 0);;text-align:right;">734</td> <td style="vertical-align: bottom; white-space: nowrap; font-family: &quot;Times New Roman&quot;; background-color: rgba(255, 255, 255, 0);"> </td> <td style="vertical-align: bottom; background-color: rgba(255, 255, 255, 0); width: 5%;">  </td> <td style="vertical-align: bottom; white-space: nowrap; background-color: rgba(255, 255, 255, 0);"> </td> <td style="vertical-align: bottom; white-space: nowrap; background-color: rgba(255, 255, 255, 0);;text-align:right;">94</td> <td style="vertical-align: bottom; white-space: nowrap; font-family: &quot;Times New Roman&quot;; background-color: rgba(255, 255, 255, 0);"> </td> </tr> <tr style="font-size: 1px;"> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; background-color: rgb(204, 238, 255); width: 82%;"> </td> <td style="vertical-align: bottom; background-color: rgb(204, 238, 255); width: 5%;">  </td> <td style="vertical-align: bottom; background-color: rgb(204, 238, 255);"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="vertical-align: bottom; background-color: rgb(204, 238, 255);"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="background-color: rgb(204, 238, 255);"> </td> <td style="vertical-align: bottom; background-color: rgb(204, 238, 255); width: 5%;">  </td> <td style="vertical-align: bottom; background-color: rgb(204, 238, 255);"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="vertical-align: bottom; background-color: rgb(204, 238, 255);"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="background-color: rgb(204, 238, 255);"> </td> </tr> <tr style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; break-inside: avoid;"> <td style="vertical-align: top; background-color: rgb(204, 238, 255); width: 82%;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Total</div></div> </td> <td style="vertical-align: bottom; background-color: rgb(204, 238, 255); width: 5%;">  </td> <td style="vertical-align: bottom; white-space: nowrap; background-color: rgb(204, 238, 255);">$</td> <td style="vertical-align: bottom; white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;">3,700</td> <td style="vertical-align: bottom; white-space: nowrap; font-family: &quot;Times New Roman&quot;; background-color: rgb(204, 238, 255);"> </td> <td style="vertical-align: bottom; background-color: rgb(204, 238, 255); width: 5%;">  </td> <td style="vertical-align: bottom; white-space: nowrap; background-color: rgb(204, 238, 255);">$</td> <td style="vertical-align: bottom; white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;">3,319</td> <td style="vertical-align: bottom; white-space: nowrap; font-family: &quot;Times New Roman&quot;; background-color: rgb(204, 238, 255);"> </td> </tr> <tr style="font-size: 1px;"> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; background-color: rgba(255, 255, 255, 0); width: 82%;"> </td> <td style="vertical-align: bottom; background-color: rgba(255, 255, 255, 0); width: 5%;">  </td> <td style="vertical-align: bottom; background-color: rgba(255, 255, 255, 0);"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="vertical-align: bottom; background-color: rgba(255, 255, 255, 0);"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="background-color: rgba(255, 255, 255, 0);"> </td> <td style="vertical-align: bottom; background-color: rgba(255, 255, 255, 0); width: 5%;">  </td> <td style="vertical-align: bottom; background-color: rgba(255, 255, 255, 0);"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="vertical-align: bottom; background-color: rgba(255, 255, 255, 0);"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="background-color: rgba(255, 255, 255, 0);"> </td> </tr> </table> <div style="clear: both; max-height: 0px; text-indent: 0px;"/> 712000 947000 757000 876000 612000 306000 477000 450000 441000 300000 313000 734000 94000 3700000 3319000 <div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 18pt; margin-bottom: 0pt;"><div style="font-weight:bold;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Note 9. Commitments and Contingencies </div></div></div> <div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt;"><div style="font-weight:bold;display:inline;"><div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">Leases </div></div></div></div> <div style="font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">During the <div style="letter-spacing: 0px; top: 0px;;display:inline;">three <div style="letter-spacing: 0px; top: 0px;;display:inline;">a</div>nd </div>nine months ended September 30, 2021, the Company maintained three leases of facilities located in the United States and the Netherlands, as well as, one lease of office equipment, under operating leases. The Company maintained one additional lease of equipment under a finance lease arrangement which expired during the nine months ended September 30, 2020. Additionally, the Company terminated one lease of office space during the nine months ended September 30, 2021. </div></div> <div style="font-family: Times New Roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">The table below presents certain information related to the Company’s lease costs: </div></div> <div style="font-size: 12pt; margin-top: 0pt; margin-bottom: 0pt; text-indent: 0px;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-size: 12pt; letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></div> <table cellpadding="0" cellspacing="0" style="margin: 0px auto; border: 0px currentcolor; width: 100%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px; text-indent: 0px;"> <tr style="font-size: 0px;"> <td style="width: 79%;"/> <td style="width: 2%; vertical-align: bottom;"/> <td/> <td/> <td/> <td style="width: 2%; vertical-align: bottom;"/> <td/> <td/> <td/> <td style="width: 2%; vertical-align: bottom;"/> <td/> <td/> <td/> <td style="width: 2%; vertical-align: bottom;"/> <td/> <td/> <td/> </tr> <tr style="font-family: Times New Roman; font-size: 8pt; page-break-inside: avoid;"> <td style="vertical-align: bottom; padding-bottom: 1pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align: bottom; padding-bottom: 1pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">  </div></td> <td colspan="6" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Three Months Ended<br/> September 30,</div></div></div></td> <td style="vertical-align: bottom; padding-bottom: 1pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align: bottom; padding-bottom: 1pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">  </div></td> <td colspan="6" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Nine Months Ended<br/> September 30,</div></div></div></td> <td style="vertical-align: bottom; padding-bottom: 1pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> </tr> <tr style="font-family: Times New Roman; font-size: 8pt; page-break-inside: avoid;"> <td style="vertical-align: bottom; padding-bottom: 1pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align: bottom; padding-bottom: 1pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">  </div></td> <td colspan="2" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">2021</div></div></div></td> <td style="vertical-align: bottom; padding-bottom: 1pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align: bottom; padding-bottom: 1pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">  </div></td> <td colspan="2" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">2020</div></div></div></td> <td style="vertical-align: bottom; padding-bottom: 1pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align: bottom; padding-bottom: 1pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">  </div></td> <td colspan="2" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">2021</div></div></div></td> <td style="vertical-align: bottom; padding-bottom: 1pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align: bottom; padding-bottom: 1pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">  </div></td> <td colspan="2" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">2020</div></div></div></td> <td style="vertical-align: bottom; padding-bottom: 1pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> </tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);"> <td style="vertical-align: top; width: 79%;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Operating lease expense</div></div> </td> <td style="vertical-align: bottom; width: 2%;">  </td> <td style="vertical-align: bottom; white-space: nowrap;">$</td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">144</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; width: 2%;">  </td> <td style="vertical-align: bottom; white-space: nowrap;">$</td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">482</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; width: 2%;">  </td> <td style="vertical-align: bottom; white-space: nowrap;">$</td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">696</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; width: 2%;">  </td> <td style="vertical-align: bottom; white-space: nowrap;">$</td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">1,585</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> </tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;"> <td style="vertical-align: top; width: 79%;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Finance lease expense</div></div> </td> <td style="vertical-align: bottom; width: 2%;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">—  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; width: 2%;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">—  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; width: 2%;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">—  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; width: 2%;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">16</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> </tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);"> <td style="vertical-align: top; width: 79%;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Interest expense on finance lease liabilities</div></div> </td> <td style="vertical-align: bottom; width: 2%;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">—  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; width: 2%;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">—  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; width: 2%;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">—  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; width: 2%;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">1</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> </tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;"> <td style="vertical-align: top; width: 79%;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Short-term lease expense</div></div> </td> <td style="vertical-align: bottom; width: 2%;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">—  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; width: 2%;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">—  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; width: 2%;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">—  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; width: 2%;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">14</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> </tr> <tr style="font-size: 1px;"> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; width: 79%;"> </td> <td style="vertical-align: bottom; width: 2%;">  </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td> </td> <td style="vertical-align: bottom; width: 2%;">  </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td> </td> <td style="vertical-align: bottom; width: 2%;">  </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td> </td> <td style="vertical-align: bottom; width: 2%;">  </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td> </td> </tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);"> <td style="vertical-align: top; width: 79%;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Total lease cost</div></div> </td> <td style="vertical-align: bottom; width: 2%;">  </td> <td style="vertical-align: bottom; white-space: nowrap;">$</td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">144</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; width: 2%;">  </td> <td style="vertical-align: bottom; white-space: nowrap;">$</td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">482</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; width: 2%;">  </td> <td style="vertical-align: bottom; white-space: nowrap;">$</td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">696</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; width: 2%;">  </td> <td style="vertical-align: bottom; white-space: nowrap;">$</td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">1,616</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> </tr> <tr style="font-size: 1px;"> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; width: 79%;"> </td> <td style="vertical-align: bottom; width: 2%;">  </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td> </td> <td style="vertical-align: bottom; width: 2%;">  </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td> </td> <td style="vertical-align: bottom; width: 2%;">  </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td> </td> <td style="vertical-align: bottom; width: 2%;">  </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td> </td> </tr> </table> <div style="clear: both; max-height: 0px; text-indent: 0px;"/> <div style="font-size: 8pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-size: 8pt; letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> <div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; text-indent: 0px;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Right of use assets and lease liabilities for operating leases were <div style="letter-spacing: 0px; top: 0px;;display:inline;">recorded </div>in the condensed consolidated balance sheets as follows: </div></div></div> <div style="font-size: 12pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-size: 12pt; letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> <table cellpadding="0" cellspacing="0" style="margin: 0px auto; border: 0px currentcolor; width: 100%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;"> <tr style="font-size: 0px;"> <td style="width: 82%;"/> <td style="width: 5%; vertical-align: bottom;"/> <td/> <td/> <td/> <td style="width: 5%; vertical-align: bottom;"/> <td/> <td/> <td/> </tr> <tr style="font-family: Times New Roman; font-size: 8pt; page-break-inside: avoid;"> <td style="vertical-align: bottom; padding-bottom: 1pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 1pt;">  </td> <td colspan="2" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">September 30,<br/> 2021</div></div></td> <td style="vertical-align: bottom; padding-bottom: 1pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 1pt;">  </td> <td colspan="2" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">December 31,<br/> 2020</div></div></td> <td style="vertical-align: bottom; padding-bottom: 1pt;"> </td> </tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);"> <td style="vertical-align: top; width: 82%;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-weight:bold;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Assets:</div></div></div> </td> <td style="vertical-align: bottom; width: 5%;">  </td> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom; width: 5%;">  </td> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom;"> </td> </tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;"> <td style="vertical-align: top; width: 82%;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; line-height: normal;"><div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;"><div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">Right-of-use</div></div> assets, net</div> </td> <td style="vertical-align: bottom; width: 5%;">  </td> <td style="vertical-align: bottom; white-space: nowrap;">$</td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">982</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; width: 5%;">  </td> <td style="vertical-align: bottom; white-space: nowrap;">$</td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">2,102</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> </tr> <tr style="font-size: 1px;"> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; width: 82%;"> </td> <td style="vertical-align: bottom; width: 5%;">  </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td> </td> <td style="vertical-align: bottom; width: 5%;">  </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td> </td> </tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);"> <td style="vertical-align: top; width: 82%;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 5em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Total lease assets</div></div> </td> <td style="vertical-align: bottom; width: 5%;">  </td> <td style="vertical-align: bottom; white-space: nowrap;">$</td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">982</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; width: 5%;">  </td> <td style="vertical-align: bottom; white-space: nowrap;">$</td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">2,102</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> </tr> <tr style="font-size: 1px;"> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; width: 82%;"> </td> <td style="vertical-align: bottom; width: 5%;">  </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td> </td> <td style="vertical-align: bottom; width: 5%;">  </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td> </td> </tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;"> <td style="vertical-align: top; width: 82%;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-weight:bold;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Liabilities:</div></div></div> </td> <td style="vertical-align: bottom; width: 5%;">  </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"> </td> <td style="vertical-align: bottom; width: 5%;">  </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"> </td> </tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);"> <td style="vertical-align: top; width: 82%;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Current liabilities:</div></div> </td> <td style="vertical-align: bottom; width: 5%;">  </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"> </td> <td style="vertical-align: bottom; width: 5%;">  </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"> </td> </tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;"> <td style="vertical-align: top; width: 82%;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Operating lease liabilities, current</div></div> </td> <td style="vertical-align: bottom; width: 5%;">  </td> <td style="vertical-align: bottom; white-space: nowrap;">$</td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">631</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; width: 5%;">  </td> <td style="vertical-align: bottom; white-space: nowrap;">$</td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">1,222</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> </tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);"> <td style="vertical-align: top; width: 82%;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">Non-current</div> liabilities:</div> </td> <td style="vertical-align: bottom; width: 5%;">  </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"> </td> <td style="vertical-align: bottom; width: 5%;">  </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"> </td> </tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;"> <td style="vertical-align: top; width: 82%;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Operating lease liabilities, net of current portion</div></div> </td> <td style="vertical-align: bottom; width: 5%;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">499</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; width: 5%;">  </td> <td style="vertical-align: bottom; white-space: nowrap;">$</td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">1,094</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> </tr> <tr style="font-size: 1px;"> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; width: 82%;"> </td> <td style="vertical-align: bottom; width: 5%;">  </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td> </td> <td style="vertical-align: bottom; width: 5%;">  </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td> </td> </tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);"> <td style="vertical-align: top; width: 82%;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 5em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Total lease liability</div></div> </td> <td style="vertical-align: bottom; width: 5%;">  </td> <td style="vertical-align: bottom; white-space: nowrap;">$</td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">1,130</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; width: 5%;">  </td> <td style="vertical-align: bottom; white-space: nowrap;">$</td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">2,316</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> </tr> <tr style="font-size: 1px;"> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; width: 82%;"> </td> <td style="vertical-align: bottom; width: 5%;">  </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td> </td> <td style="vertical-align: bottom; width: 5%;">  </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td> </td> </tr> </table> <div style="font-family: Times New Roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">The Company’s lease agreements do not state an implicit borrowing rate; therefore, an internal incremental borrowing rate was determined based on information available at the lease commencement date for the purposes of determining the present value of lease payments. The incremental borrowing rate reflects the cost to borrow on a securitized basis in each market. The weighted-average remaining lease term for operating leases was 2.05 years and the weighted-average incremental borrowing rate was 5.34% as of September 30, 2021. </div></div> <div style="font-family: Times New Roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Supplemental cash flow information related to the Company’s leases was as follows: </div></div> <div style="font-size: 12pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-size: 12pt; letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> <table cellpadding="0" cellspacing="0" style="margin: 0px auto; border: 0px currentcolor; width: 100%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;"> <tr style="font-size: 0px;"> <td style="width: 89%;"/> <td style="width: 2%; vertical-align: bottom;"/> <td/> <td/> <td/> <td style="width: 2%; vertical-align: bottom;"/> <td/> <td/> <td/> </tr> <tr style="font-family: Times New Roman; font-size: 8pt; page-break-inside: avoid;"> <td style="vertical-align: bottom; padding-bottom: 1pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 1pt;">  </td> <td colspan="6" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Nine Months Ended<br/> September 30,</div></div></td> <td style="vertical-align: bottom; padding-bottom: 1pt;"> </td> </tr> <tr style="font-family: Times New Roman; font-size: 8pt; page-break-inside: avoid;"> <td style="vertical-align: bottom; padding-bottom: 1pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 1pt;">  </td> <td colspan="2" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">2021</div></div></td> <td style="vertical-align: bottom; padding-bottom: 1pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 1pt;">  </td> <td colspan="2" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">2020</div></div></td> <td style="vertical-align: bottom; padding-bottom: 1pt;"> </td> </tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);"> <td style="vertical-align: top; width: 89%;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Operating cash flows from operating leases</div></div> </td> <td style="vertical-align: bottom; width: 2%;">  </td> <td style="vertical-align: bottom; white-space: nowrap;">$</td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">762</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; width: 2%;">  </td> <td style="vertical-align: bottom; white-space: nowrap;">$</td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">1,754</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> </tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;"> <td style="vertical-align: top; width: 89%;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Operating cash flows from finance leases</div></div> </td> <td style="vertical-align: bottom; width: 2%;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">—  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; width: 2%;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">1</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> </tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);"> <td style="vertical-align: top; width: 89%;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Financing cash flows from finance leases</div></div> </td> <td style="vertical-align: bottom; width: 2%;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">—  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; width: 2%;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">18</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> </tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;"> <td style="vertical-align: top; width: 89%;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;">Lease liabilities arising from obtaining <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;"><div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">right-of-use</div></div> assets</div> </td> <td style="vertical-align: bottom; width: 2%;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">—  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; width: 2%;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">4,025</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> </tr> </table> <div style="font-family: Times New Roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">As of September 30, 2021, future <div style="letter-spacing: 0px; top: 0px;;display:inline;">minimum </div>lease payments required under operating leases are as follows: </div></div> <div style="font-size: 12pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-size: 12pt; letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> <table cellpadding="0" cellspacing="0" style="margin: 0px auto; border: 0px currentcolor; width: 100%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;"> <tr style="font-size: 0px;"> <td style="width: 94%; font-family: &quot;Times New Roman&quot;;"/> <td style="width: 1%; vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"/> <td style="font-family: &quot;Times New Roman&quot;;"/> <td style="font-family: &quot;Times New Roman&quot;;"/> <td style="font-family: &quot;Times New Roman&quot;;"/> </tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);"> <td style="vertical-align: top; width: 94%;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Rest of 2021</div></div> </td> <td style="vertical-align: bottom; width: 1%;">  </td> <td style="vertical-align: bottom; white-space: nowrap;">$</td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">167</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> </tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;"> <td style="vertical-align: top; width: 94%;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">2022</div></div> </td> <td style="vertical-align: bottom; width: 1%;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">680</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> </tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);"> <td style="vertical-align: top; width: 94%;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">2023</div></div> </td> <td style="vertical-align: bottom; width: 1%;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">214</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> </tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;"> <td style="vertical-align: top; width: 94%;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">2024</div></div> </td> <td style="vertical-align: bottom; width: 1%;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">132</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> </tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);"> <td style="vertical-align: top; width: 94%;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">2025</div></div> </td> <td style="vertical-align: bottom; width: 1%;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">1</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> </tr> <tr style="font-size: 1px;"> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; width: 94%;"> </td> <td style="vertical-align: bottom; width: 1%;">  </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td> </td> </tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;"> <td style="vertical-align: top; width: 94%;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Total minimum lease payments</div></div> </td> <td style="vertical-align: bottom; width: 1%;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">1,194</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> </tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);"> <td style="vertical-align: top; width: 94%;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Less effects of discounting</div></div> </td> <td style="vertical-align: bottom; width: 1%;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">(64</td> <td style="vertical-align: bottom; white-space: nowrap;">) </td> </tr> <tr style="font-size: 1px;"> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; width: 94%;"> </td> <td style="vertical-align: bottom; width: 1%;">  </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td> </td> </tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;"> <td style="vertical-align: top; width: 94%;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Present value of future minimum lease payments</div></div> </td> <td style="vertical-align: bottom; width: 1%;">  </td> <td style="vertical-align: bottom; white-space: nowrap;">$</td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">1,130</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> </tr> <tr style="font-size: 1px;"> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; width: 94%;"> </td> <td style="vertical-align: bottom; width: 1%;">  </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td> </td> </tr> </table> <table cellpadding="0" cellspacing="0" style="margin: 0px auto; border: 0px currentcolor; width: 68%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;"> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;"> <td colspan="0"/> </tr> <tr style="font-size: 1px;"> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"/> <td style="vertical-align: bottom;"/> <td style="vertical-align: bottom;"/> <td style="vertical-align: bottom;"/> <td/> </tr> </table> <div style="clear: both; max-height: 0px;"/> <div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 18pt; margin-bottom: 0pt; text-indent: 0px;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;"><div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">Desktop Metal </div></div></div></div></div> <div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt; text-indent: 0px;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">On March 26, 2021, the Company entered into a non-binding Memorandum of Understanding (“MOU”) with Desktop Metal, pursuant to which Desktop Metal agreed to invest $20.0 million in the PIPE Investment. Upon consummation of this investment, the Company became obligated to purchase $20.0 million of equipment, materials and services from Desktop Metal. In conjunction with these obligations, the Company and Desktop Metal agreed to develop a strategic partnership. In November 2021, the Company paid $3.5 million to Desktop Metal for equipment received, and </div></div><div style="letter-spacing: 0px; top: 0px;;display:inline;">has a commitment to place purchase orders for another<div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">$16.5 million </div></div><div style="letter-spacing: 0px; top: 0px;;display:inline;">of equipment and materials under the MOU by or before December <div style="letter-spacing: 0px; top: 0px;;display:inline;">3</div></div><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">1, 2021. </div></div></div> <div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 18pt; margin-bottom: 0pt; text-indent: 0px;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;"><div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="text-indent: 0px;;font-style:italic;display:inline;">Legal Proceedings</div></div></div></div></div> <div style="font-weight:bold;display:inline;"><div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;"> </div></div></div> <div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt; text-indent: 0px;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">The Company is involved in various legal proceedings which arise from time to time in the normal course of business. While the results of such matters generally cannot be predicted with certainty, management does not expect any such matters to have a material adverse effect on the Company’s condensed consolidated financial position or results of operations as of September 30, 2021 and December 31, 2020, and for the three and nine months ended September 30, 2021 and 2020. </div></div></div> 3 1 1 <div style="font-size: 12pt; margin-top: 0pt; margin-bottom: 0pt; text-indent: 0px;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-size: 12pt; letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></div> <table cellpadding="0" cellspacing="0" style="margin: 0px auto; border: 0px currentcolor; width: 100%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px; text-indent: 0px;"> <tr style="font-size: 0px;"> <td style="width: 79%;"/> <td style="width: 2%; vertical-align: bottom;"/> <td/> <td/> <td/> <td style="width: 2%; vertical-align: bottom;"/> <td/> <td/> <td/> <td style="width: 2%; vertical-align: bottom;"/> <td/> <td/> <td/> <td style="width: 2%; vertical-align: bottom;"/> <td/> <td/> <td/> </tr> <tr style="font-family: Times New Roman; font-size: 8pt; page-break-inside: avoid;"> <td style="vertical-align: bottom; padding-bottom: 1pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align: bottom; padding-bottom: 1pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">  </div></td> <td colspan="6" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Three Months Ended<br/> September 30,</div></div></div></td> <td style="vertical-align: bottom; padding-bottom: 1pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align: bottom; padding-bottom: 1pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">  </div></td> <td colspan="6" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Nine Months Ended<br/> September 30,</div></div></div></td> <td style="vertical-align: bottom; padding-bottom: 1pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> </tr> <tr style="font-family: Times New Roman; font-size: 8pt; page-break-inside: avoid;"> <td style="vertical-align: bottom; padding-bottom: 1pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align: bottom; padding-bottom: 1pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">  </div></td> <td colspan="2" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">2021</div></div></div></td> <td style="vertical-align: bottom; padding-bottom: 1pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align: bottom; padding-bottom: 1pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">  </div></td> <td colspan="2" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">2020</div></div></div></td> <td style="vertical-align: bottom; padding-bottom: 1pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align: bottom; padding-bottom: 1pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">  </div></td> <td colspan="2" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">2021</div></div></div></td> <td style="vertical-align: bottom; padding-bottom: 1pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align: bottom; padding-bottom: 1pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">  </div></td> <td colspan="2" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">2020</div></div></div></td> <td style="vertical-align: bottom; padding-bottom: 1pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> </tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);"> <td style="vertical-align: top; width: 79%;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Operating lease expense</div></div> </td> <td style="vertical-align: bottom; width: 2%;">  </td> <td style="vertical-align: bottom; white-space: nowrap;">$</td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">144</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; width: 2%;">  </td> <td style="vertical-align: bottom; white-space: nowrap;">$</td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">482</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; width: 2%;">  </td> <td style="vertical-align: bottom; white-space: nowrap;">$</td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">696</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; width: 2%;">  </td> <td style="vertical-align: bottom; white-space: nowrap;">$</td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">1,585</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> </tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;"> <td style="vertical-align: top; width: 79%;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Finance lease expense</div></div> </td> <td style="vertical-align: bottom; width: 2%;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">—  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; width: 2%;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">—  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; width: 2%;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">—  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; width: 2%;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">16</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> </tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);"> <td style="vertical-align: top; width: 79%;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Interest expense on finance lease liabilities</div></div> </td> <td style="vertical-align: bottom; width: 2%;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">—  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; width: 2%;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">—  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; width: 2%;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">—  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; width: 2%;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">1</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> </tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;"> <td style="vertical-align: top; width: 79%;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Short-term lease expense</div></div> </td> <td style="vertical-align: bottom; width: 2%;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">—  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; width: 2%;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">—  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; width: 2%;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">—  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; width: 2%;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">14</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> </tr> <tr style="font-size: 1px;"> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; width: 79%;"> </td> <td style="vertical-align: bottom; width: 2%;">  </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td> </td> <td style="vertical-align: bottom; width: 2%;">  </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td> </td> <td style="vertical-align: bottom; width: 2%;">  </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td> </td> <td style="vertical-align: bottom; width: 2%;">  </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td> </td> </tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);"> <td style="vertical-align: top; width: 79%;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Total lease cost</div></div> </td> <td style="vertical-align: bottom; width: 2%;">  </td> <td style="vertical-align: bottom; white-space: nowrap;">$</td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">144</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; width: 2%;">  </td> <td style="vertical-align: bottom; white-space: nowrap;">$</td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">482</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; width: 2%;">  </td> <td style="vertical-align: bottom; white-space: nowrap;">$</td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">696</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; width: 2%;">  </td> <td style="vertical-align: bottom; white-space: nowrap;">$</td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">1,616</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> </tr> <tr style="font-size: 1px;"> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; width: 79%;"> </td> <td style="vertical-align: bottom; width: 2%;">  </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td> </td> <td style="vertical-align: bottom; width: 2%;">  </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td> </td> <td style="vertical-align: bottom; width: 2%;">  </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td> </td> <td style="vertical-align: bottom; width: 2%;">  </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td> </td> </tr> </table> <div style="clear: both; max-height: 0px; text-indent: 0px;"/> 144000 482000 696000 1585000 16000 1000 14000 144000 482000 696000 1616000 <table cellpadding="0" cellspacing="0" style="margin: 0px auto; border: 0px currentcolor; width: 100%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;"> <tr style="font-size: 0px;"> <td style="width: 82%;"/> <td style="width: 5%; vertical-align: bottom;"/> <td/> <td/> <td/> <td style="width: 5%; vertical-align: bottom;"/> <td/> <td/> <td/> </tr> <tr style="font-family: Times New Roman; font-size: 8pt; page-break-inside: avoid;"> <td style="vertical-align: bottom; padding-bottom: 1pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 1pt;">  </td> <td colspan="2" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">September 30,<br/> 2021</div></div></td> <td style="vertical-align: bottom; padding-bottom: 1pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 1pt;">  </td> <td colspan="2" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">December 31,<br/> 2020</div></div></td> <td style="vertical-align: bottom; padding-bottom: 1pt;"> </td> </tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);"> <td style="vertical-align: top; width: 82%;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-weight:bold;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Assets:</div></div></div> </td> <td style="vertical-align: bottom; width: 5%;">  </td> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom; width: 5%;">  </td> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom;"> </td> </tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;"> <td style="vertical-align: top; width: 82%;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; line-height: normal;"><div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;"><div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">Right-of-use</div></div> assets, net</div> </td> <td style="vertical-align: bottom; width: 5%;">  </td> <td style="vertical-align: bottom; white-space: nowrap;">$</td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">982</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; width: 5%;">  </td> <td style="vertical-align: bottom; white-space: nowrap;">$</td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">2,102</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> </tr> <tr style="font-size: 1px;"> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; width: 82%;"> </td> <td style="vertical-align: bottom; width: 5%;">  </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td> </td> <td style="vertical-align: bottom; width: 5%;">  </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td> </td> </tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);"> <td style="vertical-align: top; width: 82%;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 5em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Total lease assets</div></div> </td> <td style="vertical-align: bottom; width: 5%;">  </td> <td style="vertical-align: bottom; white-space: nowrap;">$</td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">982</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; width: 5%;">  </td> <td style="vertical-align: bottom; white-space: nowrap;">$</td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">2,102</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> </tr> <tr style="font-size: 1px;"> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; width: 82%;"> </td> <td style="vertical-align: bottom; width: 5%;">  </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td> </td> <td style="vertical-align: bottom; width: 5%;">  </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td> </td> </tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;"> <td style="vertical-align: top; width: 82%;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-weight:bold;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Liabilities:</div></div></div> </td> <td style="vertical-align: bottom; width: 5%;">  </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"> </td> <td style="vertical-align: bottom; width: 5%;">  </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"> </td> </tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);"> <td style="vertical-align: top; width: 82%;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Current liabilities:</div></div> </td> <td style="vertical-align: bottom; width: 5%;">  </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"> </td> <td style="vertical-align: bottom; width: 5%;">  </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"> </td> </tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;"> <td style="vertical-align: top; width: 82%;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Operating lease liabilities, current</div></div> </td> <td style="vertical-align: bottom; width: 5%;">  </td> <td style="vertical-align: bottom; white-space: nowrap;">$</td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">631</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; width: 5%;">  </td> <td style="vertical-align: bottom; white-space: nowrap;">$</td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">1,222</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> </tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);"> <td style="vertical-align: top; width: 82%;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">Non-current</div> liabilities:</div> </td> <td style="vertical-align: bottom; width: 5%;">  </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"> </td> <td style="vertical-align: bottom; width: 5%;">  </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"> </td> </tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;"> <td style="vertical-align: top; width: 82%;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Operating lease liabilities, net of current portion</div></div> </td> <td style="vertical-align: bottom; width: 5%;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">499</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; width: 5%;">  </td> <td style="vertical-align: bottom; white-space: nowrap;">$</td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">1,094</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> </tr> <tr style="font-size: 1px;"> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; width: 82%;"> </td> <td style="vertical-align: bottom; width: 5%;">  </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td> </td> <td style="vertical-align: bottom; width: 5%;">  </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td> </td> </tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);"> <td style="vertical-align: top; width: 82%;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 5em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Total lease liability</div></div> </td> <td style="vertical-align: bottom; width: 5%;">  </td> <td style="vertical-align: bottom; white-space: nowrap;">$</td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">1,130</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; width: 5%;">  </td> <td style="vertical-align: bottom; white-space: nowrap;">$</td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">2,316</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> </tr> <tr style="font-size: 1px;"> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; width: 82%;"> </td> <td style="vertical-align: bottom; width: 5%;">  </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td> </td> <td style="vertical-align: bottom; width: 5%;">  </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td> </td> </tr> </table> 982000 2102000 982000 2102000 631000 1222000 499000 1094000 1130000 2316000 P2Y18D 0.0534 <table cellpadding="0" cellspacing="0" style="margin: 0px auto; border: 0px currentcolor; width: 100%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;"> <tr style="font-size: 0px;"> <td style="width: 89%;"/> <td style="width: 2%; vertical-align: bottom;"/> <td/> <td/> <td/> <td style="width: 2%; vertical-align: bottom;"/> <td/> <td/> <td/> </tr> <tr style="font-family: Times New Roman; font-size: 8pt; page-break-inside: avoid;"> <td style="vertical-align: bottom; padding-bottom: 1pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 1pt;">  </td> <td colspan="6" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Nine Months Ended<br/> September 30,</div></div></td> <td style="vertical-align: bottom; padding-bottom: 1pt;"> </td> </tr> <tr style="font-family: Times New Roman; font-size: 8pt; page-break-inside: avoid;"> <td style="vertical-align: bottom; padding-bottom: 1pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 1pt;">  </td> <td colspan="2" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">2021</div></div></td> <td style="vertical-align: bottom; padding-bottom: 1pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 1pt;">  </td> <td colspan="2" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">2020</div></div></td> <td style="vertical-align: bottom; padding-bottom: 1pt;"> </td> </tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);"> <td style="vertical-align: top; width: 89%;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Operating cash flows from operating leases</div></div> </td> <td style="vertical-align: bottom; width: 2%;">  </td> <td style="vertical-align: bottom; white-space: nowrap;">$</td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">762</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; width: 2%;">  </td> <td style="vertical-align: bottom; white-space: nowrap;">$</td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">1,754</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> </tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;"> <td style="vertical-align: top; width: 89%;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Operating cash flows from finance leases</div></div> </td> <td style="vertical-align: bottom; width: 2%;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">—  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; width: 2%;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">1</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> </tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);"> <td style="vertical-align: top; width: 89%;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Financing cash flows from finance leases</div></div> </td> <td style="vertical-align: bottom; width: 2%;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">—  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; width: 2%;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">18</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> </tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;"> <td style="vertical-align: top; width: 89%;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;">Lease liabilities arising from obtaining <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;"><div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">right-of-use</div></div> assets</div> </td> <td style="vertical-align: bottom; width: 2%;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">—  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; width: 2%;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">4,025</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> </tr> </table> 762000 1754000 1000 18000 4025000 <div style="font-size: 12pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-size: 12pt; letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> <table cellpadding="0" cellspacing="0" style="margin: 0px auto; border: 0px currentcolor; width: 100%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;"> <tr style="font-size: 0px;"> <td style="width: 94%; font-family: &quot;Times New Roman&quot;;"/> <td style="width: 1%; vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"/> <td style="font-family: &quot;Times New Roman&quot;;"/> <td style="font-family: &quot;Times New Roman&quot;;"/> <td style="font-family: &quot;Times New Roman&quot;;"/> </tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);"> <td style="vertical-align: top; width: 94%;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Rest of 2021</div></div> </td> <td style="vertical-align: bottom; width: 1%;">  </td> <td style="vertical-align: bottom; white-space: nowrap;">$</td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">167</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> </tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;"> <td style="vertical-align: top; width: 94%;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">2022</div></div> </td> <td style="vertical-align: bottom; width: 1%;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">680</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> </tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);"> <td style="vertical-align: top; width: 94%;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">2023</div></div> </td> <td style="vertical-align: bottom; width: 1%;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">214</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> </tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;"> <td style="vertical-align: top; width: 94%;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">2024</div></div> </td> <td style="vertical-align: bottom; width: 1%;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">132</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> </tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);"> <td style="vertical-align: top; width: 94%;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">2025</div></div> </td> <td style="vertical-align: bottom; width: 1%;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">1</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> </tr> <tr style="font-size: 1px;"> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; width: 94%;"> </td> <td style="vertical-align: bottom; width: 1%;">  </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td> </td> </tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;"> <td style="vertical-align: top; width: 94%;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Total minimum lease payments</div></div> </td> <td style="vertical-align: bottom; width: 1%;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">1,194</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> </tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);"> <td style="vertical-align: top; width: 94%;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Less effects of discounting</div></div> </td> <td style="vertical-align: bottom; width: 1%;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">(64</td> <td style="vertical-align: bottom; white-space: nowrap;">) </td> </tr> <tr style="font-size: 1px;"> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; width: 94%;"> </td> <td style="vertical-align: bottom; width: 1%;">  </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td> </td> </tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;"> <td style="vertical-align: top; width: 94%;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Present value of future minimum lease payments</div></div> </td> <td style="vertical-align: bottom; width: 1%;">  </td> <td style="vertical-align: bottom; white-space: nowrap;">$</td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">1,130</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> </tr> <tr style="font-size: 1px;"> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; width: 94%;"> </td> <td style="vertical-align: bottom; width: 1%;">  </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td> </td> </tr> </table> 167000 680000 214000 132000 1000 1194000 64000 1130000 20000000.0 20000000.0 3500000 16500000 <div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-weight:bold;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Note 10. Borrowing Arrangements </div></div></div> <div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt; text-indent: 0px;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">The Company’s outstanding debt obligations consisted of the following: </div></div></div> <div style="font-size: 12pt; margin-top: 0pt; margin-bottom: 0pt; text-indent: 0px;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-size: 12pt; letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></div> <table cellpadding="0" cellspacing="0" style="margin: 0px auto; border: 0px currentcolor; width: 100%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px; text-indent: 0px;"> <tr style="font-size: 0px;"> <td style="width: 82%;"/> <td style="width: 5%; vertical-align: bottom;"/> <td/> <td/> <td/> <td style="width: 5%; vertical-align: bottom;"/> <td/> <td/> <td/> </tr> <tr style="font-family: Times New Roman; font-size: 8pt; page-break-inside: avoid;"> <td style="vertical-align: bottom; padding-bottom: 1pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align: bottom; padding-bottom: 1pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">  </div></td> <td colspan="2" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">September 30,<br/> 2021</div></div></div></td> <td style="vertical-align: bottom; padding-bottom: 1pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align: bottom; padding-bottom: 1pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">  </div></td> <td colspan="2" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">December 31,<br/> 2020</div></div></div></td> <td style="vertical-align: bottom; padding-bottom: 1pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> </tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);"> <td style="vertical-align: top; font-size: 10pt; width: 82%;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Dutch Landlord Loan</div></div></div> </td> <td style="vertical-align: bottom; width: 5%;">  </td> <td style="vertical-align: bottom; white-space: nowrap;">$</td> <td style="vertical-align: bottom; white-space: nowrap; text-align: right;">127</td> <td style="vertical-align: bottom; white-space: nowrap; font-family: &quot;Times New Roman&quot;;"> </td> <td style="vertical-align: bottom; width: 5%;">  </td> <td style="vertical-align: bottom; white-space: nowrap;">$</td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">163</td> <td style="vertical-align: bottom; white-space: nowrap; font-family: &quot;Times New Roman&quot;;"> </td> </tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;"> <td style="vertical-align: top; font-size: 10pt; width: 82%;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Term Loan</div></div></div> </td> <td style="vertical-align: bottom; width: 5%;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap; padding: 0pt 5pt 0pt 0pt;;text-align:right;">—</td> <td style="vertical-align: bottom; white-space: nowrap; font-family: &quot;Times New Roman&quot;;"> </td> <td style="vertical-align: bottom; width: 5%;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">3,423</td> <td style="vertical-align: bottom; white-space: nowrap; font-family: &quot;Times New Roman&quot;;"> </td> </tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);"> <td style="vertical-align: top; font-size: 10pt; width: 82%;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Convertible Promissory Notes</div></div></div> </td> <td style="vertical-align: bottom; width: 5%;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">—  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; width: 5%;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">5,000</td> <td style="vertical-align: bottom; white-space: nowrap; font-family: &quot;Times New Roman&quot;;"> </td> </tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;"> <td style="vertical-align: top; font-size: 10pt; width: 82%;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">PPP Loan</div></div></div> </td> <td style="vertical-align: bottom; width: 5%;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">—  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; width: 5%;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">1,982</td> <td style="vertical-align: bottom; white-space: nowrap; font-family: &quot;Times New Roman&quot;;"> </td> </tr> <tr style="font-size: 1px;"> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; width: 82%;"> </td> <td style="vertical-align: bottom; width: 5%;">  </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td> </td> <td style="vertical-align: bottom; width: 5%;">  </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td> </td> </tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);"> <td style="vertical-align: top; font-family: &quot;Times New Roman&quot;; width: 82%;"> </td> <td style="vertical-align: bottom; width: 5%;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">127</td> <td style="vertical-align: bottom; white-space: nowrap; font-family: &quot;Times New Roman&quot;;"> </td> <td style="vertical-align: bottom; width: 5%;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">10,568</td> <td style="vertical-align: bottom; white-space: nowrap; font-family: &quot;Times New Roman&quot;;"> </td> </tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;"> <td style="vertical-align: top; width: 82%;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Less: current portion</div></div> </td> <td style="vertical-align: bottom; width: 5%;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">(39</td> <td style="vertical-align: bottom; white-space: nowrap;">) </td> <td style="vertical-align: bottom; width: 5%;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">(8,332</td> <td style="vertical-align: bottom; white-space: nowrap;">) </td> </tr> <tr style="font-size: 1px;"> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; width: 82%;"> </td> <td style="vertical-align: bottom; width: 5%;">  </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td> </td> <td style="vertical-align: bottom; width: 5%;">  </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td> </td> </tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);"> <td style="vertical-align: top; width: 82%;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Long-term debt</div></div> </td> <td style="vertical-align: bottom; width: 5%;">  </td> <td style="vertical-align: bottom; white-space: nowrap;">$</td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">88</td> <td style="vertical-align: bottom; white-space: nowrap; font-family: &quot;Times New Roman&quot;;"> </td> <td style="vertical-align: bottom; width: 5%;">  </td> <td style="vertical-align: bottom; white-space: nowrap;">$</td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">2,236</td> <td style="vertical-align: bottom; white-space: nowrap; font-family: &quot;Times New Roman&quot;;"> </td> </tr> <tr style="font-size: 1px;"> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; width: 82%;"> </td> <td style="vertical-align: bottom; width: 5%;">  </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td> </td> <td style="vertical-align: bottom; width: 5%;">  </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td> </td> </tr> </table> <div style="clear: both; max-height: 0px; text-indent: 0px;"/> <div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 18pt; margin-bottom: 0pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;"><div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">Dutch Landlord Loan </div></div></div></div></div> <div style="font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px; text-indent: 0px;;display:inline;">On May 12<div style="letter-spacing: 0px; top: 0px;;display:inline;">, </div></div></div><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">2014, the Company entered into a loan agreement with its landlord at the Eindhoven factory (the “Dutch Landlord Loan”) to advance </div></div><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"> €242 (equivalent to $280 and $297 </div><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px; text-indent: 0px;;display:inline;">in total at September 30, 2021 and December 31, 2020, respectively) to finance leasehold improvements</div></div><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">. </div>The Dutch Landlord Loan is unsecured and required interest-only payments until September 30, 2016, followed by monthly payments of principal and interest. Interest accrues at 8.50% per annum through the maturity date on September 30, 2024. </div></div> <div style="font-family: Times New Roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;"/> <div style="font-family: Times New Roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">For the three months ended September 30, 2021 and 2020, interest expense totaled $5, respectively. For the nine months ended September 30, 2021 and 2020, interest expense totaled $14, respectively.</div></div> <div style="margin-top: 1em; margin-bottom: 1em"/> <div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 18pt; margin-bottom: 0pt; text-indent: 0px;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;"><div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">Term Loan </div></div></div></div></div> <div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt; text-indent: 0px;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">On October 29, 2018, the Company entered into a loan and security agreement (the “Term Loan”) for the principal sum of $5,000 with a maturity date of October 29, 2022. The Term Loan requires interest-only payments until October 29, 2019, followed by monthly payments of principal and interest. Interest is payable at a rate equal to the prime rate, plus 0.25% per annum. At the Closing of the Business Combination, the Company repaid and terminated the Term Loan in full. As of December 31, 2020, the interest rate was 3.50%. In connection with the Term Loan, the bank is due a $75 fee in the event of a liquidity event valuing the Company above a certain threshold. </div></div></div> <div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt; text-indent: 0px;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">For the three months ended September 30, 2021 and 2020, interest expense totaled $12 and $36, respectively. For the nine months ended September 30, 2021 and 2020, interest expense totaled $66 and $129, respectively. </div></div></div> <div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"> </div> <div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 18pt; margin-bottom: 0pt;"><div style="font-weight:bold;display:inline;"><div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">Convertible Promissory Notes </div></div></div></div> <div style="font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt;">On June 19, 2019, the Company entered into note purchase agreements (the “Convertible Promissory Notes”) with certain stockholders of the Company for the aggregate principal sum of $5,000. The Convertible Promissory Notes bear interest at a rate of 8% per annum with all principal and interest due on or before the earlier of (i) December 19, 2020; and (ii) the closing of a Qualified Equity Financing, as defined below. The Convertible Promissory Notes are automatically converted into conversion shares upon the closing of a Qualified Equity Financing. Qualified Equity Financing is defined as the next sale by the Company of preferred stock following the date of the Convertible Promissory Notes on or prior to the maturity date with the principal purpose of raising capital. In the event there is a <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">non-Qualified</div> Equity Financing, the outstanding principal and unpaid accrued interest of each note may be converted, at the written election of the holders of the Convertible Promissory Notes, into conversion shares. <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">Non-Qualified</div> Equity Financing shall mean the next sale by the Company of its equity following the date of the Convertible Promissory Notes on or prior to the maturity date with the principal purpose of raising capital which is not a Qualified Equity Financing. If the next equity financing or a corporate transaction has not occurred on or before the maturity date of the Convertible Promissory Notes, the principal and unpaid accrued interest of each outstanding note may be converted, at the written election of each holder of the Convertible Promissory Notes, into conversion shares on the date of such written election. The number of conversion shares to be issued upon conversion shall be equal to the quotient obtained by dividing (i) the outstanding principal and unpaid accrued interest due on a Convertible Promissory Note to be converted on the date of the conversion by (ii) the Conversion Price. The conversion price is defined as the Discounted Conversion Price, which is 70% of the next equity price per share. The Convertible Promissory Notes are subordinated in right of payment to all indebtedness of the Company arising under the Term Loan. At inception, the terms of the notes gave rise to a contingent beneficial conversion feature. </div> <div style="font-family: Times New Roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">On December 14, 2020, the Company executed an amendment to the Convertible Promissory Notes that extended the maturity date to August 10, 2021. All other relevant terms and conditions of the Convertible Promissory Notes remain binding. </div></div> <div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; text-indent: 0px;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Immediately prior to the completion of the Business Combination, the Convertible Promissory Notes in the aggregate principal amount of </div></div><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">$5,000 </div><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">were converted into<div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></div>1,434,391<div style="font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"> </div><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">shares of common stock of Legacy Shapeways (1,189,558 shares of Common Stock post Business Combination), and the related unpaid and accrued interest totaling<div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></div><div style="font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">$</div>913<div style="font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"> were<div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div>converted into </div>261,884<div style="font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"> shares of common stock of Legacy </div><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Shapeways (217,183 shares of Common Stock post Business Combination). </div></div></div> <div style="font-family: Times New Roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">For the three months ended September 30, 2021 and 2020, interest expense totaled $109 and $100, respectively. For the nine months ended September 30, 2021 and 2020, interest expense totaled $309 and $300, respectively. </div></div> <div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 18pt; margin-bottom: 0pt;"><div style="font-weight:bold;display:inline;"><div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">Paycheck Protection Program Loan </div></div></div></div> <div style="font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">On May 4, 2020, the Company received an unsecured loan of $1,982 under the Paycheck Protection Program (the “PPP Loan”). The Paycheck Protection Program (or “PPP”) was established under the recently enacted CARES Act and is administered by the U.S. Small Business Administration (“SBA”). On May 4, 2020, the Company entered into a promissory note with Pacific Western Bank evidencing the unsecured PPP Loan. </div></div> <div style="font-family: Times New Roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">The PPP Loan has a maturity date of May 4, 2022 and accrues interest at an annual rate of 1.00%. To the extent the loan amount is not forgiven under the PPP, the Company is obligated to make monthly payments of principal and interest, beginning six months from the date of the note, until the maturity date. In October 2020, the PPP Flexibility Act of 2020 extended the deferral period for borrower payments on all PPP loans from six months to ten months. Interest expense totaled $18 for the nine months ended September 30, 2021. There was no interest expense incurred for the nine months ended September 30, 2020. </div></div> <div style="font-family: Times New Roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">The CARES Act and the PPP provide a mechanism for forgiveness of up to the full amount borrowed. Under the PPP, the Company may apply for and be granted forgiveness for all or part of the PPP Loan. The amount of the loan proceeds eligible for forgiveness is based on a formula that takes into account a number of factors, including the amount of loan proceeds used by the Company during the eight-week period after the loan origination for certain purposes including payroll costs, and certain rent payments, mortgage payments, and utility payments, provided that at least 75% of the loan amount is used for eligible payroll costs. Subject to the other requirements and limitations on loan forgiveness, only loan proceeds spent on payroll and other eligible costs during the covered eight-week period will qualify for forgiveness. </div></div> <div style="font-family: Times New Roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">As of September 30, 2021, the full principal and interest amount of $2,000 of </div><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">the PPP Loan was forgiven and recorded in other income on the condensed consolidated statement of operations and comprehensive loss. Although the PPP Loan has been forgiven as of September 30, 2021, the Company intends to repay the PPP Loan in its entirety during the fourth quarter of 2021 and will reverse the previously recognized gain on debt forgiveness when repaid. </div></div></div> <div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt; text-indent: 0px;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">The Company’s outstanding debt obligations consisted of the following: </div></div></div> <div style="font-size: 12pt; margin-top: 0pt; margin-bottom: 0pt; text-indent: 0px;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-size: 12pt; letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></div> <table cellpadding="0" cellspacing="0" style="margin: 0px auto; border: 0px currentcolor; width: 100%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px; text-indent: 0px;"> <tr style="font-size: 0px;"> <td style="width: 82%;"/> <td style="width: 5%; vertical-align: bottom;"/> <td/> <td/> <td/> <td style="width: 5%; vertical-align: bottom;"/> <td/> <td/> <td/> </tr> <tr style="font-family: Times New Roman; font-size: 8pt; page-break-inside: avoid;"> <td style="vertical-align: bottom; padding-bottom: 1pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align: bottom; padding-bottom: 1pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">  </div></td> <td colspan="2" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">September 30,<br/> 2021</div></div></div></td> <td style="vertical-align: bottom; padding-bottom: 1pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align: bottom; padding-bottom: 1pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">  </div></td> <td colspan="2" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">December 31,<br/> 2020</div></div></div></td> <td style="vertical-align: bottom; padding-bottom: 1pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> </tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);"> <td style="vertical-align: top; font-size: 10pt; width: 82%;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Dutch Landlord Loan</div></div></div> </td> <td style="vertical-align: bottom; width: 5%;">  </td> <td style="vertical-align: bottom; white-space: nowrap;">$</td> <td style="vertical-align: bottom; white-space: nowrap; text-align: right;">127</td> <td style="vertical-align: bottom; white-space: nowrap; font-family: &quot;Times New Roman&quot;;"> </td> <td style="vertical-align: bottom; width: 5%;">  </td> <td style="vertical-align: bottom; white-space: nowrap;">$</td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">163</td> <td style="vertical-align: bottom; white-space: nowrap; font-family: &quot;Times New Roman&quot;;"> </td> </tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;"> <td style="vertical-align: top; font-size: 10pt; width: 82%;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Term Loan</div></div></div> </td> <td style="vertical-align: bottom; width: 5%;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap; padding: 0pt 5pt 0pt 0pt;;text-align:right;">—</td> <td style="vertical-align: bottom; white-space: nowrap; font-family: &quot;Times New Roman&quot;;"> </td> <td style="vertical-align: bottom; width: 5%;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">3,423</td> <td style="vertical-align: bottom; white-space: nowrap; font-family: &quot;Times New Roman&quot;;"> </td> </tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);"> <td style="vertical-align: top; font-size: 10pt; width: 82%;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Convertible Promissory Notes</div></div></div> </td> <td style="vertical-align: bottom; width: 5%;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">—  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; width: 5%;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">5,000</td> <td style="vertical-align: bottom; white-space: nowrap; font-family: &quot;Times New Roman&quot;;"> </td> </tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;"> <td style="vertical-align: top; font-size: 10pt; width: 82%;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">PPP Loan</div></div></div> </td> <td style="vertical-align: bottom; width: 5%;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">—  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; width: 5%;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">1,982</td> <td style="vertical-align: bottom; white-space: nowrap; font-family: &quot;Times New Roman&quot;;"> </td> </tr> <tr style="font-size: 1px;"> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; width: 82%;"> </td> <td style="vertical-align: bottom; width: 5%;">  </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td> </td> <td style="vertical-align: bottom; width: 5%;">  </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td> </td> </tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);"> <td style="vertical-align: top; font-family: &quot;Times New Roman&quot;; width: 82%;"> </td> <td style="vertical-align: bottom; width: 5%;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">127</td> <td style="vertical-align: bottom; white-space: nowrap; font-family: &quot;Times New Roman&quot;;"> </td> <td style="vertical-align: bottom; width: 5%;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">10,568</td> <td style="vertical-align: bottom; white-space: nowrap; font-family: &quot;Times New Roman&quot;;"> </td> </tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;"> <td style="vertical-align: top; width: 82%;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Less: current portion</div></div> </td> <td style="vertical-align: bottom; width: 5%;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">(39</td> <td style="vertical-align: bottom; white-space: nowrap;">) </td> <td style="vertical-align: bottom; width: 5%;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">(8,332</td> <td style="vertical-align: bottom; white-space: nowrap;">) </td> </tr> <tr style="font-size: 1px;"> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; width: 82%;"> </td> <td style="vertical-align: bottom; width: 5%;">  </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td> </td> <td style="vertical-align: bottom; width: 5%;">  </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td> </td> </tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);"> <td style="vertical-align: top; width: 82%;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Long-term debt</div></div> </td> <td style="vertical-align: bottom; width: 5%;">  </td> <td style="vertical-align: bottom; white-space: nowrap;">$</td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">88</td> <td style="vertical-align: bottom; white-space: nowrap; font-family: &quot;Times New Roman&quot;;"> </td> <td style="vertical-align: bottom; width: 5%;">  </td> <td style="vertical-align: bottom; white-space: nowrap;">$</td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">2,236</td> <td style="vertical-align: bottom; white-space: nowrap; font-family: &quot;Times New Roman&quot;;"> </td> </tr> <tr style="font-size: 1px;"> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; width: 82%;"> </td> <td style="vertical-align: bottom; width: 5%;">  </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td> </td> <td style="vertical-align: bottom; width: 5%;">  </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td> </td> </tr> </table> <div style="clear: both; max-height: 0px; text-indent: 0px;"/> 127000 163000 0 3423000 0 5000000 0 1982000 127000 10568000 39000 8332000 88000 2236000 242000 280000 297000 0.0850 0.0850 5000 5000 14000 14000 5000000 0.0025 0.0350 75000 12000 36000 66000 129000 5000000 0.08 0.70 5000000 1434391 1189558 913000 261884 217183 109000 100000 309000 300000 1982000 0.0100 18000 0 0.75 2000000 <div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 18pt; margin-bottom: 0pt;"><div style="font-weight:bold;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Note 11. Stockholders’ Equity (Deficit) </div></div></div> <div style="font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt;"><div style="letter-spacing: 0px; top: 0px; text-indent: 0px;;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px; text-indent: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">The condensed consolidated statements of changes in stockholders’ equity (deficit) reflects the Business Combination as defined in Note 1 as of September 29, 2021. As Legacy Shapeways was deemed the accounting acquirer in the Business Combination with Galileo, all periods prior to the consummation date reflect the balances and activity of Legacy Shapeways. The balances as of January 1, 2021 and 2020 from the consolidated financial statements of Legacy Shapeways as of that date, share activity (convertible preferred stock, common stock, additional paid in capital, accumulated deficit, and accumulated other comprehensive loss) and per share amounts were retroactively adjusted, where applicable, using the recapitalization conversion ratio of</div></div></div><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px; text-indent: 0px;;display:inline;"> 0.8293 <div style="letter-spacing: 0px; top: 0px;;display:inline;">(the “Conversion Ratio”).</div></div></div> <div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 18pt; margin-bottom: 0pt;"><div style="font-weight:bold;display:inline;"><div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">Common Stock </div></div></div></div> <div style="font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Upon closing of the Business Combination, pursuant to the terms of the Certificate of Incorporation, the Company authorized 120,000,000 shares of <div style="letter-spacing: 0px; top: 0px;;display:inline;">C</div>ommon <div style="letter-spacing: 0px; top: 0px;;display:inline;">S</div>tock with a par value $0.0001. The holders of <div style="letter-spacing: 0px; top: 0px;;display:inline;">C</div>ommon <div style="letter-spacing: 0px; top: 0px;;display:inline;">S</div>tock are entitled to one vote per share on all matters submitted to the stockholders for their vote or approval and are entitled to receive dividends, as and if declared by the Board out of legally available funds. </div></div> <div style="font-family: Times New Roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">The Company has issued and outstanding 48,296,484 shares of <div style="letter-spacing: 0px; top: 0px;;display:inline;">C</div>ommon <div style="letter-spacing: 0px; top: 0px;;display:inline;">S</div>tock as of September 30, 2021. </div></div> <div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 18pt; margin-bottom: 0pt;"><div style="font-weight:bold;display:inline;"><div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">Legacy Shapeways Common Stock Warrants </div></div></div></div> <div style="font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">On December 18, 2013, in connection with executing a loan agreement, the Company issued warrants to purchase 40,000 shares of Legacy Shapeways common stock. The warrants had an exercise price of $1.25 per share and had an expiration date of December 18, 2023. </div></div> <div style="font-family: Times New Roman; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">On February 3, 2014, in connection with executing a lease agreement, the Company issued warrants to purchase 248,000 shares of Legacy Shapeways common stock. The warrants had an exercise price of $1.25 per share and expired upon the latest to occur i) seven years from the original issuance date or ii) five years from the effective date of an initial public offering. </div></div> <div style="font-family: Times New Roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">On April 22, 2015, in connection to an amended loan agreement, the Company issued warrants to purchase 13,750 shares of Legacy Shapeways common stock. The warrants had an exercise price of $1.70 per share and had an expiration date of April 22, 2025. </div></div> <div style="font-family: Times New Roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Immediately prior to the completion of the Business Combination, all outstanding Legacy Shapeways common stock warrants were exercised into an aggregate of 255,917 </div><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">shares of Legacy Shapeways common stock (<div style="letter-spacing: 0px; top: 0px;;display:inline;">212,234</div> shares of Common Stock post Business Combination). </div></div></div> <div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"> </div> <div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 18pt; margin-bottom: 0pt;"><div style="font-weight:bold;display:inline;"><div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">Legacy Shapeways Convertible Preferred Stock </div></div></div></div> <div style="font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt;">Immediately prior to the completion of the Business Combination, all outstanding shares of the Legacy Shapeways Series <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">A-1,</div> Series <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">A-2,</div> Series B, Series <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">B-1,</div> Series C, Series D, and Series E preferred stock converted into an aggregate of 22,579,695 shares of common stock. Each share of Legacy Shapeways convertible preferred stock was converted into one share of Legacy Shapeways common stock. </div> <div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 18pt; margin-bottom: 0pt;"><div style="font-weight:bold;display:inline;"><div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">Legacy Shapeways Preferred Stock Warrants </div></div></div></div> <div style="font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt;">On March 8, 2013, the Company issued warrants to purchase a total of 23,125 shares of Series <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">B-1</div> preferred stock of Legacy Shapeways. The warrants had an exercise price of $2.5946 per share and were exercisable for ten years from the date of grant. On May 10, 2021, the 23,125 warrants were exercised for 23,125 shares of Series <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">B-1</div> preferred stock of Legacy Shapeways at an exercise price of $2.5946 per share. </div> <div style="font-family: Times New Roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">On June 30, 2017, in connection with executing a loan agreement, the Company issued warrants to purchase a total of 57,051 shares of Series D preferred stock of Legacy Shapeways. The warrants had an exercise price of $5.2584 per share and were exercisable for ten years from the date of grant. Immediately prior to the completion of the Business Combination, the 57,051 warrants were exercised for 107,580 shares of Legacy Shapeways common stock. </div></div> <div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 18pt; margin-bottom: 0pt;"><div style="font-weight:bold;display:inline;"><div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">Public Warrants </div></div></div></div> <div style="font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Prior to the Merger, the Company had outstanding 13,800,000 Public Warrants. Each Public Warrant entitles the holder to purchase one share of <div style="letter-spacing: 0px; top: 0px;;display:inline;">C</div>ommon <div style="letter-spacing: 0px; top: 0px;;display:inline;">S</div>tock of the Company at an exercise price of $11.50 per share. The Public Warrants become exercisable 30 days after the Closing Date, and expire five years after the Closing Date or earlier upon redemption or liquidation. </div></div> <div style="font-family: Times New Roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;">The Company may redeem the Public Warrants as follows: in whole and not in part; at a price of $0.01 per warrant; at any time while the Public Warrants are exercisable, upon not less than 30 days’ prior written notice of redemption to each Public Warrant holder; if, and only if, the reported last sale price of the Company’s ordinary shares equals or exceeds $18.00 per share, for any 20 trading days within a <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">30-trading</div> day period ending on the third business day prior to the notice of redemption to the warrant holders; and if, and only if, there is a current registration statement in effect with respect to the ordinary shares underlying such warrants at the time of redemption and for the entire <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">30-day</div> trading period referred to above and continuing each day thereafter until the date of redemption. Certain of these conditions have not been met to redeem the Public Warrants. If the Company calls the Public Warrants for redemption, management will have the option to require all holders that wish to exercise the Public Warrants to do so on a “cashless basis,” as described in the warrant agreement. </div> <div style="font-family: Times New Roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px; text-indent: 0px;;display:inline;">As of September 30, 2021, there <div style="letter-spacing: 0px; top: 0px;;display:inline;">we</div>re 13,800,000 <div style="letter-spacing: 0px; top: 0px;;display:inline;">Public Warrants outstanding.</div></div></div> 0.8293 120000000 0.0001 one vote per share 48296484 48296484 40000 1.25 2023-12-18 248000 1.25 P7Y P5Y 13750 1.70 2025-04-22 255917 212234 22579695 22579695 22579695 22579695 22579695 22579695 22579695 23125 2.5946 P10Y 23125 23125 2.5946 57051 5.2584 P10Y 57051 107580 13800000 1 11.50 P30D P5Y 0.01 P30D 18.00 20 30 30 13800000 <div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 18pt; margin-bottom: 0pt;"><div style="font-weight:bold;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Note 12. Stock-Based Compensation </div></div></div> <div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt;"><div style="font-weight:bold;display:inline;"><div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">2010 Stock Plan </div></div></div></div> <div style="font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt;">Prior to the Business Combination, Legacy Shapeways maintained its 2010 Stock Plan (the “2010 Plan”), under which Legacy Shapeways granted statutory and <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">non-statutory</div> stock to employees, outside directors and consultants. The maximum number of shares of common stock that was issuable under the 2010 Plan was 16,942,546 shares. </div> <div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt; text-indent: 0px;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">In connection with the Business Combination, each Legacy Shapeways stock option that was outstanding immediately prior to Closing, whether vested or unvested, was converted into an option to acquire a number of shares of common stock (each such option, an “Exchanged Option”) equal to the product (rounded down to the nearest whole number) of (i) the number of shares of Legacy Shapeways common stock subject to such Legacy Shapeways option immediately prior to the Business Combination and (ii) 90% of the Conversion Ratio, at an exercise price per share (rounded up to the nearest whole cent) equal to (A) the exercise price per share of such Legacy Shapeways </div></div></div> <div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"> </div> <div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; text-indent: 0px;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">option immediately prior to the consummation of the Business Combination, divided by (B) 90% of the Conversion Ratio. Except as specifically provided in the Business Combination Agreement, following the Business Combination, each Exchanged Option will continue to be governed by the same terms and conditions (including vesting and exercisability terms) as were applicable to the corresponding former Legacy Shapeways option immediately prior to the consummation of the Business Combination. All stock option activity was retroactively restated to reflect the Exchanged Options. </div></div></div> <div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"> </div> <div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt; text-indent: 0px;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">In addition, as discussed in Note 3, each holder of an <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;"><div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">in-the-money</div></div> Legacy Shapeways option held by individuals remaining in continuous service to the Company through the Closing, was granted a right to receive an award of restricted stock units denominated in shares of common stock granted under the 2021 Plan (each, an “Earnout RSU”) equal to the product of (A) the number of shares of Legacy Shapeways common stock that were subject to the option immediately prior to Closing, multiplied by (B) ten percent </div>(10%) <div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">of the Conversion<div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div>Ratio (rounded down to the nearest whole number of shares). The Earnout RSUs are subject to substantially the same service-based vesting conditions and acceleration provisions as applied to the Legacy Shapeways option provided that, in addition to such service-based vesting conditions, Earnout RSUs will be subject to vesting and forfeiture conditions based upon the dollar volume-weighted price of the Company’s <div style="letter-spacing: 0px; top: 0px;;display:inline;">C</div>ommon <div style="letter-spacing: 0px; top: 0px;;display:inline;">S</div>tock reaching certain targets (the “RSU Performance Milestones”). </div></div></div> <div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt; text-indent: 0px;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">If the service of the holder of an Earnout RSU terminates before the RSU Performance Milestones have been satisfied, then the portion of the Earnout RSUs for which the service-based vesting conditions has been satisfied (taking into account any acceleration provisions) shall remain outstanding and eligible to vest upon achievement of the applicable RSU Performance Milestone. Any Earnout RSUs for which the service-based vested conditions has not been satisfied as of such termination of service (taking into account any acceleration provisions) shall be forfeited and cancelled without payment. If any RSU Performance Milestone fails to be satisfied by the end of the Earnout Period, then the Earnout RSUs corresponding to such RSU Performance Milestone shall be forfeited and cancelled without payment as of the end of the Earnout Period. </div></div></div> <div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"> </div> <div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt; text-indent: 0px;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Upon the Closing of the Business Combination, the outstanding and unexercised Legacy Shapeways options became options to purchase an aggregate of 4,901,207 shares of the Company’s Common Stock under the 2010 Plan at an average exercise price of $0.62 per share. </div></div></div> <div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 18pt; margin-bottom: 0pt;"><div style="font-weight:bold;display:inline;"><div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">2021 Equity Incentive Plan </div></div></div></div> <div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt; text-indent: 0px;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="display:inline;">Upon</div> the closing of the Business Combination, the Company adopted the 2021 Equity Incentive Plan (the “2021 Plan”). The 2021 Plan permits the granting of incentive stock options, restricted stock awards, other share-based awards or other cash-based awards to employees, consultants, and <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">non-employee </div> directors. As of September 30, 2021,<div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div>7,621,401<div style="font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"> </div><div style="font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">shares of <div style="letter-spacing: 0px; top: 0px;;display:inline;">C</div>ommon <div style="letter-spacing: 0px; top: 0px;;display:inline;">S</div>tock are authorized for issuance pursuant to awards under the 2021 Plan. As of September 30, 2021,</div></div></div><div style="font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"> </div>no<div style="font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"> shares have been awarded and </div>7,621,401<div style="font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"> </div><div style="font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">shares remain available for issuance under the 2021 Plan.</div></div> <div style="font-family: Times New Roman; font-size: 10pt; margin-top: 18pt; margin-bottom: 0pt;"><div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">Option Awards </div></div></div> <div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt; text-indent: 0px;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">The Company accounts for share-based payments pursuant to ASC 718, <div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">Stock Compensation</div></div> and, accordingly, the Company records stock compensation expense for share-based awards based upon an assessment of the grant date fair value for stock options using the Black-Scholes option pricing model. The Company is a public company and lacks company-specific historical and implied volatility information. Therefore, it estimates its expected stock volatility based on the historical volatility of a publicly traded set of peer companies. Due to the lack of historical exercise history, the expected term of the Company’s stock options for employees has been determined utilizing the “simplified” method for awards. The risk-free interest rate is determined by reference to the U.S. Treasury yield curve. Expected dividend yield is zero based on the fact that the Company has never paid cash dividends and does not expect to pay any cash dividends in the foreseeable future. </div></div> <div style="font-family: Times New Roman; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">The fair value of stock options under the Black-Scholes model requires management to make assumptions regarding projected employee stock option exercise behaviors, risk-free interest rates, volatility of the Company’s stock price and expected dividends. The Company generally recognizes stock compensation expense on the grant date and over the period of vesting or period that services will be provided. The assumptions used to estimate the fair value of stock options granted during the periods presented were as follows: </div></div> <div style="font-size: 12pt; margin-top: 0pt; margin-bottom: 0pt; text-indent: 0px;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-size: 12pt; letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></div> <table cellpadding="0" cellspacing="0" style="margin: 0px auto; border: 0px currentcolor; width: 100%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px; text-indent: 0px;"> <tr style="font-size: 0px;"> <td style="width: 74%;"/> <td style="width: 10%; vertical-align: bottom;"/> <td/> <td/> <td/> <td style="width: 10%; vertical-align: bottom;"/> <td/> <td/> <td/> </tr> <tr style="font-family: Times New Roman; font-size: 8pt; page-break-inside: avoid;"> <td style="vertical-align: bottom; padding-bottom: 1pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align: bottom; padding-bottom: 1pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">  </div></td> <td colspan="6" style="vertical-align: bottom; border-bottom: 1pt solid rgb(0, 0, 0);;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Three and Nine Months Ended<br/> September 30,</div></div></div></td> <td style="vertical-align: bottom; padding-bottom: 1pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> </tr> <tr style="font-family: Times New Roman; font-size: 8pt; page-break-inside: avoid;"> <td style="vertical-align: bottom; padding-bottom: 1pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align: bottom; padding-bottom: 1pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">  </div></td> <td colspan="2" style="vertical-align: bottom; border-bottom: 1pt solid rgb(0, 0, 0);;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">2021</div></div></div></td> <td style="vertical-align: bottom; padding-bottom: 1pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align: bottom; padding-bottom: 1pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td colspan="2" style="vertical-align: bottom; border-bottom: 1pt solid rgb(0, 0, 0);;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">2020</div></div></div></td> <td style="vertical-align: bottom; padding-bottom: 1pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> </tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);"> <td style="vertical-align: top; width: 74%;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Strike price</div></div></div> </td> <td style="vertical-align: bottom; width: 10%;">  </td> <td style="vertical-align: bottom; white-space: nowrap;">$</td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">0.17</td> <td style="vertical-align: bottom; white-space: nowrap; font-family: &quot;Times New Roman&quot;;"> </td> <td style="vertical-align: bottom; width: 10%;">  </td> <td style="vertical-align: bottom; white-space: nowrap;">$</td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">0.37</td> <td style="vertical-align: bottom; white-space: nowrap; font-family: &quot;Times New Roman&quot;;"> </td> </tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;"> <td style="vertical-align: top; width: 74%;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Expected term (in years)</div></div></div> </td> <td style="vertical-align: bottom; width: 10%;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap; text-align: right;">5.55 - 6.05</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; width: 10%;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap; text-align: right;">5.00 - 6.04</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> </tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);"> <td style="vertical-align: top; width: 74%;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Expected volatility</div></div></div> </td> <td style="vertical-align: bottom; width: 10%;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap; text-align: right;"><div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">57.09% - 57.81</div></td> <td style="vertical-align: bottom; white-space: nowrap;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">% </div></td> <td style="vertical-align: bottom; width: 10%;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"><div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">49.15% - 52.41</div></td> <td style="vertical-align: bottom; white-space: nowrap;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">% </div></td> </tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;"> <td style="vertical-align: top; width: 74%;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Risk-free interest rate</div></div></div> </td> <td style="vertical-align: bottom; width: 10%;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap; text-align: right;">0.50% - 0.57</td> <td style="vertical-align: bottom; white-space: nowrap;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">% </div></td> <td style="vertical-align: bottom; width: 10%;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap; text-align: right;">0.37% - 1.46</td> <td style="vertical-align: bottom; white-space: nowrap;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">% </div></td> </tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);"> <td style="vertical-align: top; width: 74%;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Dividend yield</div></div></div> </td> <td style="vertical-align: bottom; width: 10%;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">—  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; width: 10%;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">—  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> </tr> </table> <div style="clear: both; max-height: 0px; text-indent: 0px;"/> <div style="font-family: Times New Roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">The following table summarizes the Company’s stock option plan and the activity: </div></div> <div style="font-size: 12pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-size: 12pt; letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> <table cellpadding="0" cellspacing="0" style="margin: 0px auto; border: 0px currentcolor; width: 100%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;"> <tr style="font-size: 0px;"> <td style="width: 71%;"/> <td style="width: 5%; vertical-align: bottom;"/> <td/> <td/> <td/> <td style="width: 5%; vertical-align: bottom;"/> <td/> <td/> <td/> <td style="width: 5%; vertical-align: bottom;"/> <td/> <td/> <td/> </tr> <tr style="font-family: Times New Roman; font-size: 8pt; page-break-inside: avoid;"> <td style="vertical-align: bottom; padding-bottom: 1pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 1pt;">  </td> <td colspan="2" style="vertical-align: bottom; border-bottom: 1pt solid rgb(0, 0, 0);;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Shares<br/> Underlying<br/> Options</div></div></td> <td style="vertical-align: bottom; padding-bottom: 1pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 1pt;">  </td> <td colspan="2" style="vertical-align: bottom; border-bottom: 1pt solid rgb(0, 0, 0);;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Weighted<br/> Average Exercise<br/> Price</div></div></td> <td style="vertical-align: bottom; padding-bottom: 1pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 1pt;">  </td> <td colspan="2" style="vertical-align: bottom; border-bottom: 1pt solid rgb(0, 0, 0);;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Weighted<br/> Average<br/> Remaining<br/> Contractual<br/> Term (in years)</div></div></td> <td style="vertical-align: bottom; padding-bottom: 1pt;"> </td> </tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);"> <td style="vertical-align: top; width: 71%;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Outstanding at January 1, 2021 (as previously reported)</div></div> </td> <td style="vertical-align: bottom; width: 5%;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">8,247,340</td> <td style="vertical-align: bottom; white-space: nowrap; font-family: &quot;Times New Roman&quot;;"> </td> <td style="vertical-align: bottom; width: 5%;">  </td> <td style="vertical-align: bottom; white-space: nowrap;">$</td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">0.44</td> <td style="vertical-align: bottom; white-space: nowrap; font-family: &quot;Times New Roman&quot;;"> </td> <td style="vertical-align: bottom; width: 5%;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">6.72</td> <td style="vertical-align: bottom; white-space: nowrap; font-family: &quot;Times New Roman&quot;;"> </td> </tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;"> <td style="vertical-align: top; width: 71%;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Retroactive application of reverse recapitalization</div></div> </td> <td style="vertical-align: bottom; width: 5%;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">(1,967,440</td> <td style="vertical-align: bottom; white-space: nowrap;">) </td> <td style="vertical-align: bottom; width: 5%;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">—  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; width: 5%;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">—  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> </tr> <tr style="font-size: 1px;"> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; width: 71%;"> </td> <td style="vertical-align: bottom; width: 5%;">  </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td> </td> <td style="vertical-align: bottom; width: 5%;">  </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td> </td> <td style="vertical-align: bottom; width: 5%;">  </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td> </td> </tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);"> <td style="vertical-align: top; width: 71%;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Outstanding as of January 1, 2021, effect of Merger</div></div> </td> <td style="vertical-align: bottom; width: 5%;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">6,279,900</td> <td style="vertical-align: bottom; white-space: nowrap; font-family: &quot;Times New Roman&quot;;"> </td> <td style="vertical-align: bottom; width: 5%;">  </td> <td style="vertical-align: bottom; white-space: nowrap;">$</td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">0.58</td> <td style="vertical-align: bottom; white-space: nowrap; font-family: &quot;Times New Roman&quot;;"> </td> <td style="vertical-align: bottom; width: 5%;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">6.64</td> <td style="vertical-align: bottom; white-space: nowrap; font-family: &quot;Times New Roman&quot;;"> </td> </tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;"> <td style="vertical-align: top; width: 71%;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Granted</div></div> </td> <td style="vertical-align: bottom; width: 5%;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">29,420</td> <td style="vertical-align: bottom; white-space: nowrap; font-family: &quot;Times New Roman&quot;;"> </td> <td style="vertical-align: bottom; width: 5%;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">0.36</td> <td style="vertical-align: bottom; white-space: nowrap; font-family: &quot;Times New Roman&quot;;"> </td> <td style="vertical-align: bottom; width: 5%;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">9.82</td> <td style="vertical-align: bottom; white-space: nowrap; font-family: &quot;Times New Roman&quot;;"> </td> </tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);"> <td style="vertical-align: top; width: 71%;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Forfeited</div></div> </td> <td style="vertical-align: bottom; width: 5%;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">(145,878</td> <td style="vertical-align: bottom; white-space: nowrap;">) </td> <td style="vertical-align: bottom; width: 5%;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">0.43</td> <td style="vertical-align: bottom; white-space: nowrap; font-family: &quot;Times New Roman&quot;;"> </td> <td style="vertical-align: bottom; width: 5%;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">—  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> </tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;"> <td style="vertical-align: top; width: 71%;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Exercised</div></div> </td> <td style="vertical-align: bottom; width: 5%;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">(35,895</td> <td style="vertical-align: bottom; white-space: nowrap;">) </td> <td style="vertical-align: bottom; width: 5%;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">0.43</td> <td style="vertical-align: bottom; white-space: nowrap; font-family: &quot;Times New Roman&quot;;"> </td> <td style="vertical-align: bottom; width: 5%;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">—  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> </tr> <tr style="font-size: 1px;"> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; width: 71%;"> </td> <td style="vertical-align: bottom; width: 5%;">  </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td> </td> <td style="vertical-align: bottom; width: 5%;">  </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td> </td> <td style="vertical-align: bottom; width: 5%;">  </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td> </td> </tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);"> <td style="vertical-align: top; width: 71%;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Outstanding at March 31, 2021</div></div> </td> <td style="vertical-align: bottom; width: 5%;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">6,127,547</td> <td style="vertical-align: bottom; white-space: nowrap; font-family: &quot;Times New Roman&quot;;"> </td> <td style="vertical-align: bottom; width: 5%;">  </td> <td style="vertical-align: bottom; white-space: nowrap;">$</td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">0.58</td> <td style="vertical-align: bottom; white-space: nowrap; font-family: &quot;Times New Roman&quot;;"> </td> <td style="vertical-align: bottom; width: 5%;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">6.53</td> <td style="vertical-align: bottom; white-space: nowrap; font-family: &quot;Times New Roman&quot;;"> </td> </tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;"> <td style="vertical-align: top; width: 71%;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Granted</div></div> </td> <td style="vertical-align: bottom; width: 5%;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">—   </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; width: 5%;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">—   </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; width: 5%;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">—  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> </tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);"> <td style="vertical-align: top; width: 71%;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Forfeited</div></div> </td> <td style="vertical-align: bottom; width: 5%;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">(39,309</td> <td style="vertical-align: bottom; white-space: nowrap;">) </td> <td style="vertical-align: bottom; width: 5%;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">0.44</td> <td style="vertical-align: bottom; white-space: nowrap; font-family: &quot;Times New Roman&quot;;"> </td> <td style="vertical-align: bottom; width: 5%;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">—  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> </tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;"> <td style="vertical-align: top; width: 71%;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Exercised</div></div> </td> <td style="vertical-align: bottom; width: 5%;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">(63,506</td> <td style="vertical-align: bottom; white-space: nowrap;">) </td> <td style="vertical-align: bottom; width: 5%;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">0.45</td> <td style="vertical-align: bottom; white-space: nowrap; font-family: &quot;Times New Roman&quot;;"> </td> <td style="vertical-align: bottom; width: 5%;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">—  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> </tr> <tr style="font-size: 1px;"> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; width: 71%;"> </td> <td style="vertical-align: bottom; width: 5%;">  </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td> </td> <td style="vertical-align: bottom; width: 5%;">  </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td> </td> <td style="vertical-align: bottom; width: 5%;">  </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td> </td> </tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);"> <td style="vertical-align: top; width: 71%;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Outstanding at June 30, 2021</div></div> </td> <td style="vertical-align: bottom; width: 5%;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">6,024,732</td> <td style="vertical-align: bottom; white-space: nowrap; font-family: &quot;Times New Roman&quot;;"> </td> <td style="vertical-align: bottom; width: 5%;">  </td> <td style="vertical-align: bottom; white-space: nowrap;">$</td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">0.59</td> <td style="vertical-align: bottom; white-space: nowrap; font-family: &quot;Times New Roman&quot;;"> </td> <td style="vertical-align: bottom; width: 5%;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">6.26</td> <td style="vertical-align: bottom; white-space: nowrap; font-family: &quot;Times New Roman&quot;;"> </td> </tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;"> <td style="vertical-align: top; width: 71%;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Granted</div></div> </td> <td style="vertical-align: bottom; width: 5%;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">—   </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; width: 5%;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">—   </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; width: 5%;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">—  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> </tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);"> <td style="vertical-align: top; width: 71%;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Forfeited</div></div> </td> <td style="vertical-align: bottom; width: 5%;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">(10,496</td> <td style="vertical-align: bottom; white-space: nowrap;">) </td> <td style="vertical-align: bottom; width: 5%;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">0.40</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; width: 5%;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">—  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> </tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;"> <td style="vertical-align: top; width: 71%;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Exercised</div></div> </td> <td style="vertical-align: bottom; width: 5%;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">(1,113,029</td> <td style="vertical-align: bottom; white-space: nowrap;">) </td> <td style="vertical-align: bottom; width: 5%;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">0.44</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; width: 5%;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">—  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> </tr> <tr style="font-size: 1px;"> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; width: 71%;"> </td> <td style="vertical-align: bottom; width: 5%;">  </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td> </td> <td style="vertical-align: bottom; width: 5%;">  </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td> </td> <td style="vertical-align: bottom; width: 5%;">  </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td> </td> </tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);"> <td style="vertical-align: top; width: 71%;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Outstanding at September 30, 2021</div></div> </td> <td style="vertical-align: bottom; width: 5%;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">4,901,207</td> <td style="vertical-align: bottom; white-space: nowrap; font-family: &quot;Times New Roman&quot;;"> </td> <td style="vertical-align: bottom; width: 5%;">  </td> <td style="vertical-align: bottom; white-space: nowrap;">$</td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">0.62</td> <td style="vertical-align: bottom; white-space: nowrap; font-family: &quot;Times New Roman&quot;;"> </td> <td style="vertical-align: bottom; width: 5%;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">6.80</td> <td style="vertical-align: bottom; white-space: nowrap; font-family: &quot;Times New Roman&quot;;"> </td> </tr> <tr style="font-size: 1px;"> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; width: 71%;"> </td> <td style="vertical-align: bottom; width: 5%;">  </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td> </td> <td style="vertical-align: bottom; width: 5%;">  </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td> </td> <td style="vertical-align: bottom; width: 5%;">  </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td> </td> </tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;"> <td style="vertical-align: top; width: 71%;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Exercisable at September 30, 2021</div></div> </td> <td style="vertical-align: bottom; width: 5%;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">4,833,059</td> <td style="vertical-align: bottom; white-space: nowrap; font-family: &quot;Times New Roman&quot;;"> </td> <td style="vertical-align: bottom; width: 5%;">  </td> <td style="vertical-align: bottom; white-space: nowrap;">$</td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">0.62</td> <td style="vertical-align: bottom; white-space: nowrap; font-family: &quot;Times New Roman&quot;;"> </td> <td style="vertical-align: bottom; width: 5%;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">6.79 </td> <td style="vertical-align: bottom; white-space: nowrap; font-family: &quot;Times New Roman&quot;;"> </td> </tr> <tr style="font-size: 1px;"> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; width: 71%;"> </td> <td style="vertical-align: bottom; width: 5%;">  </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td> </td> <td style="vertical-align: bottom; width: 5%;">  </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td> </td> <td style="vertical-align: bottom; width: 5%;">  </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td> </td> </tr> </table> <div style="font-family: Times New Roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;">The aggregate intrinsic value in the above table is calculated as the difference between fair value of the Company’s <div style="letter-spacing: 0px; top: 0px;;display:inline;">C</div>ommon <div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="text-indent: 0px; letter-spacing: 0px; top: 0px;;display:inline;">Stock</div></div> price and the exercise price of the stock options. The weighted-average grant-date fair value per stock option granted during the nine months ended September 30, 2021 and 2020 was $0.36 and $0.50, respectively. As of September 30, 2021, approximately $193 of unrecognized compensation expense related to <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">non-vested</div> awards is expected to be recognized over the weighted average period of 1.80 years. </div> <div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 18pt; margin-bottom: 0pt; text-indent: 0px;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;"><div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">2021 Employee Stock Purchase Plan</div></div></div></div></div> <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-style: normal; font-variant-ligatures: normal; font-variant-caps: normal; font-weight: 400; letter-spacing: normal; orphans: 2; text-align: left; text-indent: 0px; text-transform: none; white-space: normal; widows: 2; word-spacing: 0px; -webkit-text-stroke-width: 0px; background-color: rgb(255, 255, 255); text-decoration-thickness: initial; text-decoration-style: initial; text-decoration-color: initial; margin-top: 6pt; margin-bottom: 0pt; font-size: 10pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"><div style="display:inline;">Upon</div> the closing of the Business Combination, the Company adopted the 2021 Employee Stock Purchase Plan (the “ESPP”). The purpose of the ESPP is to provide eligible employees with an opportunity to increase their proprietary interest in the success of the Company by purchasing Common Stock from the Company on favorable terms and to pay for such purchases through payroll deductions or other approved contributions. As of September 30, 2021, 895,721 shares of Common Stock are available for purchase under the ESPP. As of September 30, 2021, no shares have been purchased under the ESPP.</div></div></div> 16942546 0.90 0.90 0.10 4901207 0.62 7621401 0 7621401 The assumptions used to estimate the fair value of stock options granted during the periods presented were as follows: <div style="font-size: 12pt; margin-top: 0pt; margin-bottom: 0pt; text-indent: 0px;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-size: 12pt; letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></div> <table cellpadding="0" cellspacing="0" style="margin: 0px auto; border: 0px currentcolor; width: 100%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px; text-indent: 0px;"> <tr style="font-size: 0px;"> <td style="width: 74%;"/> <td style="width: 10%; vertical-align: bottom;"/> <td/> <td/> <td/> <td style="width: 10%; vertical-align: bottom;"/> <td/> <td/> <td/> </tr> <tr style="font-family: Times New Roman; font-size: 8pt; page-break-inside: avoid;"> <td style="vertical-align: bottom; padding-bottom: 1pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align: bottom; padding-bottom: 1pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">  </div></td> <td colspan="6" style="vertical-align: bottom; border-bottom: 1pt solid rgb(0, 0, 0);;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Three and Nine Months Ended<br/> September 30,</div></div></div></td> <td style="vertical-align: bottom; padding-bottom: 1pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> </tr> <tr style="font-family: Times New Roman; font-size: 8pt; page-break-inside: avoid;"> <td style="vertical-align: bottom; padding-bottom: 1pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align: bottom; padding-bottom: 1pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">  </div></td> <td colspan="2" style="vertical-align: bottom; border-bottom: 1pt solid rgb(0, 0, 0);;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">2021</div></div></div></td> <td style="vertical-align: bottom; padding-bottom: 1pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align: bottom; padding-bottom: 1pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td colspan="2" style="vertical-align: bottom; border-bottom: 1pt solid rgb(0, 0, 0);;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">2020</div></div></div></td> <td style="vertical-align: bottom; padding-bottom: 1pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> </tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);"> <td style="vertical-align: top; width: 74%;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Strike price</div></div></div> </td> <td style="vertical-align: bottom; width: 10%;">  </td> <td style="vertical-align: bottom; white-space: nowrap;">$</td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">0.17</td> <td style="vertical-align: bottom; white-space: nowrap; font-family: &quot;Times New Roman&quot;;"> </td> <td style="vertical-align: bottom; width: 10%;">  </td> <td style="vertical-align: bottom; white-space: nowrap;">$</td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">0.37</td> <td style="vertical-align: bottom; white-space: nowrap; font-family: &quot;Times New Roman&quot;;"> </td> </tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;"> <td style="vertical-align: top; width: 74%;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Expected term (in years)</div></div></div> </td> <td style="vertical-align: bottom; width: 10%;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap; text-align: right;">5.55 - 6.05</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; width: 10%;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap; text-align: right;">5.00 - 6.04</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> </tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);"> <td style="vertical-align: top; width: 74%;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Expected volatility</div></div></div> </td> <td style="vertical-align: bottom; width: 10%;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap; text-align: right;"><div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">57.09% - 57.81</div></td> <td style="vertical-align: bottom; white-space: nowrap;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">% </div></td> <td style="vertical-align: bottom; width: 10%;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"><div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">49.15% - 52.41</div></td> <td style="vertical-align: bottom; white-space: nowrap;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">% </div></td> </tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;"> <td style="vertical-align: top; width: 74%;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Risk-free interest rate</div></div></div> </td> <td style="vertical-align: bottom; width: 10%;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap; text-align: right;">0.50% - 0.57</td> <td style="vertical-align: bottom; white-space: nowrap;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">% </div></td> <td style="vertical-align: bottom; width: 10%;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap; text-align: right;">0.37% - 1.46</td> <td style="vertical-align: bottom; white-space: nowrap;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">% </div></td> </tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);"> <td style="vertical-align: top; width: 74%;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Dividend yield</div></div></div> </td> <td style="vertical-align: bottom; width: 10%;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">—  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; width: 10%;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">—  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> </tr> </table> <div style="clear: both; max-height: 0px; text-indent: 0px;"/> 0.17 0.37 P5Y6M18D P6Y18D P5Y P6Y14D 0.5709 0.5781 0.4915 0.5241 0.0050 0.0057 0.0037 0.0146 0 0 <div style="font-family: Times New Roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">The following table summarizes the Company’s stock option plan and the activity: </div></div> <div style="font-size: 12pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-size: 12pt; letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> <table cellpadding="0" cellspacing="0" style="margin: 0px auto; border: 0px currentcolor; width: 100%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;"> <tr style="font-size: 0px;"> <td style="width: 71%;"/> <td style="width: 5%; vertical-align: bottom;"/> <td/> <td/> <td/> <td style="width: 5%; vertical-align: bottom;"/> <td/> <td/> <td/> <td style="width: 5%; vertical-align: bottom;"/> <td/> <td/> <td/> </tr> <tr style="font-family: Times New Roman; font-size: 8pt; page-break-inside: avoid;"> <td style="vertical-align: bottom; padding-bottom: 1pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 1pt;">  </td> <td colspan="2" style="vertical-align: bottom; border-bottom: 1pt solid rgb(0, 0, 0);;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Shares<br/> Underlying<br/> Options</div></div></td> <td style="vertical-align: bottom; padding-bottom: 1pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 1pt;">  </td> <td colspan="2" style="vertical-align: bottom; border-bottom: 1pt solid rgb(0, 0, 0);;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Weighted<br/> Average Exercise<br/> Price</div></div></td> <td style="vertical-align: bottom; padding-bottom: 1pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 1pt;">  </td> <td colspan="2" style="vertical-align: bottom; border-bottom: 1pt solid rgb(0, 0, 0);;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Weighted<br/> Average<br/> Remaining<br/> Contractual<br/> Term (in years)</div></div></td> <td style="vertical-align: bottom; padding-bottom: 1pt;"> </td> </tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);"> <td style="vertical-align: top; width: 71%;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Outstanding at January 1, 2021 (as previously reported)</div></div> </td> <td style="vertical-align: bottom; width: 5%;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">8,247,340</td> <td style="vertical-align: bottom; white-space: nowrap; font-family: &quot;Times New Roman&quot;;"> </td> <td style="vertical-align: bottom; width: 5%;">  </td> <td style="vertical-align: bottom; white-space: nowrap;">$</td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">0.44</td> <td style="vertical-align: bottom; white-space: nowrap; font-family: &quot;Times New Roman&quot;;"> </td> <td style="vertical-align: bottom; width: 5%;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">6.72</td> <td style="vertical-align: bottom; white-space: nowrap; font-family: &quot;Times New Roman&quot;;"> </td> </tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;"> <td style="vertical-align: top; width: 71%;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Retroactive application of reverse recapitalization</div></div> </td> <td style="vertical-align: bottom; width: 5%;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">(1,967,440</td> <td style="vertical-align: bottom; white-space: nowrap;">) </td> <td style="vertical-align: bottom; width: 5%;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">—  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; width: 5%;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">—  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> </tr> <tr style="font-size: 1px;"> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; width: 71%;"> </td> <td style="vertical-align: bottom; width: 5%;">  </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td> </td> <td style="vertical-align: bottom; width: 5%;">  </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td> </td> <td style="vertical-align: bottom; width: 5%;">  </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td> </td> </tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);"> <td style="vertical-align: top; width: 71%;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Outstanding as of January 1, 2021, effect of Merger</div></div> </td> <td style="vertical-align: bottom; width: 5%;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">6,279,900</td> <td style="vertical-align: bottom; white-space: nowrap; font-family: &quot;Times New Roman&quot;;"> </td> <td style="vertical-align: bottom; width: 5%;">  </td> <td style="vertical-align: bottom; white-space: nowrap;">$</td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">0.58</td> <td style="vertical-align: bottom; white-space: nowrap; font-family: &quot;Times New Roman&quot;;"> </td> <td style="vertical-align: bottom; width: 5%;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">6.64</td> <td style="vertical-align: bottom; white-space: nowrap; font-family: &quot;Times New Roman&quot;;"> </td> </tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;"> <td style="vertical-align: top; width: 71%;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Granted</div></div> </td> <td style="vertical-align: bottom; width: 5%;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">29,420</td> <td style="vertical-align: bottom; white-space: nowrap; font-family: &quot;Times New Roman&quot;;"> </td> <td style="vertical-align: bottom; width: 5%;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">0.36</td> <td style="vertical-align: bottom; white-space: nowrap; font-family: &quot;Times New Roman&quot;;"> </td> <td style="vertical-align: bottom; width: 5%;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">9.82</td> <td style="vertical-align: bottom; white-space: nowrap; font-family: &quot;Times New Roman&quot;;"> </td> </tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);"> <td style="vertical-align: top; width: 71%;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Forfeited</div></div> </td> <td style="vertical-align: bottom; width: 5%;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">(145,878</td> <td style="vertical-align: bottom; white-space: nowrap;">) </td> <td style="vertical-align: bottom; width: 5%;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">0.43</td> <td style="vertical-align: bottom; white-space: nowrap; font-family: &quot;Times New Roman&quot;;"> </td> <td style="vertical-align: bottom; width: 5%;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">—  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> </tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;"> <td style="vertical-align: top; width: 71%;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Exercised</div></div> </td> <td style="vertical-align: bottom; width: 5%;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">(35,895</td> <td style="vertical-align: bottom; white-space: nowrap;">) </td> <td style="vertical-align: bottom; width: 5%;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">0.43</td> <td style="vertical-align: bottom; white-space: nowrap; font-family: &quot;Times New Roman&quot;;"> </td> <td style="vertical-align: bottom; width: 5%;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">—  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> </tr> <tr style="font-size: 1px;"> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; width: 71%;"> </td> <td style="vertical-align: bottom; width: 5%;">  </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td> </td> <td style="vertical-align: bottom; width: 5%;">  </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td> </td> <td style="vertical-align: bottom; width: 5%;">  </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td> </td> </tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);"> <td style="vertical-align: top; width: 71%;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Outstanding at March 31, 2021</div></div> </td> <td style="vertical-align: bottom; width: 5%;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">6,127,547</td> <td style="vertical-align: bottom; white-space: nowrap; font-family: &quot;Times New Roman&quot;;"> </td> <td style="vertical-align: bottom; width: 5%;">  </td> <td style="vertical-align: bottom; white-space: nowrap;">$</td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">0.58</td> <td style="vertical-align: bottom; white-space: nowrap; font-family: &quot;Times New Roman&quot;;"> </td> <td style="vertical-align: bottom; width: 5%;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">6.53</td> <td style="vertical-align: bottom; white-space: nowrap; font-family: &quot;Times New Roman&quot;;"> </td> </tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;"> <td style="vertical-align: top; width: 71%;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Granted</div></div> </td> <td style="vertical-align: bottom; width: 5%;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">—   </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; width: 5%;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">—   </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; width: 5%;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">—  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> </tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);"> <td style="vertical-align: top; width: 71%;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Forfeited</div></div> </td> <td style="vertical-align: bottom; width: 5%;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">(39,309</td> <td style="vertical-align: bottom; white-space: nowrap;">) </td> <td style="vertical-align: bottom; width: 5%;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">0.44</td> <td style="vertical-align: bottom; white-space: nowrap; font-family: &quot;Times New Roman&quot;;"> </td> <td style="vertical-align: bottom; width: 5%;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">—  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> </tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;"> <td style="vertical-align: top; width: 71%;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Exercised</div></div> </td> <td style="vertical-align: bottom; width: 5%;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">(63,506</td> <td style="vertical-align: bottom; white-space: nowrap;">) </td> <td style="vertical-align: bottom; width: 5%;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">0.45</td> <td style="vertical-align: bottom; white-space: nowrap; font-family: &quot;Times New Roman&quot;;"> </td> <td style="vertical-align: bottom; width: 5%;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">—  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> </tr> <tr style="font-size: 1px;"> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; width: 71%;"> </td> <td style="vertical-align: bottom; width: 5%;">  </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td> </td> <td style="vertical-align: bottom; width: 5%;">  </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td> </td> <td style="vertical-align: bottom; width: 5%;">  </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td> </td> </tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);"> <td style="vertical-align: top; width: 71%;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Outstanding at June 30, 2021</div></div> </td> <td style="vertical-align: bottom; width: 5%;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">6,024,732</td> <td style="vertical-align: bottom; white-space: nowrap; font-family: &quot;Times New Roman&quot;;"> </td> <td style="vertical-align: bottom; width: 5%;">  </td> <td style="vertical-align: bottom; white-space: nowrap;">$</td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">0.59</td> <td style="vertical-align: bottom; white-space: nowrap; font-family: &quot;Times New Roman&quot;;"> </td> <td style="vertical-align: bottom; width: 5%;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">6.26</td> <td style="vertical-align: bottom; white-space: nowrap; font-family: &quot;Times New Roman&quot;;"> </td> </tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;"> <td style="vertical-align: top; width: 71%;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Granted</div></div> </td> <td style="vertical-align: bottom; width: 5%;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">—   </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; width: 5%;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">—   </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; width: 5%;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">—  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> </tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);"> <td style="vertical-align: top; width: 71%;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Forfeited</div></div> </td> <td style="vertical-align: bottom; width: 5%;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">(10,496</td> <td style="vertical-align: bottom; white-space: nowrap;">) </td> <td style="vertical-align: bottom; width: 5%;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">0.40</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; width: 5%;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">—  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> </tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;"> <td style="vertical-align: top; width: 71%;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Exercised</div></div> </td> <td style="vertical-align: bottom; width: 5%;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">(1,113,029</td> <td style="vertical-align: bottom; white-space: nowrap;">) </td> <td style="vertical-align: bottom; width: 5%;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">0.44</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; width: 5%;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">—  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> </tr> <tr style="font-size: 1px;"> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; width: 71%;"> </td> <td style="vertical-align: bottom; width: 5%;">  </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td> </td> <td style="vertical-align: bottom; width: 5%;">  </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td> </td> <td style="vertical-align: bottom; width: 5%;">  </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td> </td> </tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);"> <td style="vertical-align: top; width: 71%;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Outstanding at September 30, 2021</div></div> </td> <td style="vertical-align: bottom; width: 5%;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">4,901,207</td> <td style="vertical-align: bottom; white-space: nowrap; font-family: &quot;Times New Roman&quot;;"> </td> <td style="vertical-align: bottom; width: 5%;">  </td> <td style="vertical-align: bottom; white-space: nowrap;">$</td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">0.62</td> <td style="vertical-align: bottom; white-space: nowrap; font-family: &quot;Times New Roman&quot;;"> </td> <td style="vertical-align: bottom; width: 5%;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">6.80</td> <td style="vertical-align: bottom; white-space: nowrap; font-family: &quot;Times New Roman&quot;;"> </td> </tr> <tr style="font-size: 1px;"> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; width: 71%;"> </td> <td style="vertical-align: bottom; width: 5%;">  </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td> </td> <td style="vertical-align: bottom; width: 5%;">  </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td> </td> <td style="vertical-align: bottom; width: 5%;">  </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td> </td> </tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;"> <td style="vertical-align: top; width: 71%;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Exercisable at September 30, 2021</div></div> </td> <td style="vertical-align: bottom; width: 5%;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">4,833,059</td> <td style="vertical-align: bottom; white-space: nowrap; font-family: &quot;Times New Roman&quot;;"> </td> <td style="vertical-align: bottom; width: 5%;">  </td> <td style="vertical-align: bottom; white-space: nowrap;">$</td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">0.62</td> <td style="vertical-align: bottom; white-space: nowrap; font-family: &quot;Times New Roman&quot;;"> </td> <td style="vertical-align: bottom; width: 5%;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">6.79 </td> <td style="vertical-align: bottom; white-space: nowrap; font-family: &quot;Times New Roman&quot;;"> </td> </tr> <tr style="font-size: 1px;"> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; width: 71%;"> </td> <td style="vertical-align: bottom; width: 5%;">  </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td> </td> <td style="vertical-align: bottom; width: 5%;">  </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td> </td> <td style="vertical-align: bottom; width: 5%;">  </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td> </td> </tr> </table> 8247340 0.44 P6Y8M19D -1967440 0 6279900 0.58 P6Y7M20D 29420 0.36 P9Y9M25D 145878 0.43 35895 0.43 6127547 0.58 P6Y6M10D 0 0 39309 0.44 63506 0.45 6024732 0.59 P6Y3M3D 0 0 10496 0.40 1113029 0.44 4901207 0.62 P6Y9M18D 4833059 0.62 6790 0.36 0.50 193000 P1Y9M18D 895721 0 <div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 18pt; margin-bottom: 0pt;"><div style="font-weight:bold;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Note 13. Fair Value Measurements </div></div></div> <div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt; text-indent: 0px;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Fair value measurements discussed herein are based upon certain market assumptions and pertinent information available to management as of September 30, 2021 and December 31, 2020. The carrying amounts of accounts receivable, inventory, prepaid expenses and other current assets, accounts payable, accrued expenses and other liabilities, and deferred revenue approximated fair value as they are short term in nature. The fair value of warrants issued for settlement and services are estimated based on the Black-Scholes model. The carrying value of the Company’s debt and operating lease liabilities approximated its fair value, as the obligation bears interest at rates currently available for debt with similar maturities and collateral requirements. </div></div></div> <div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"> </div> <div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-weight:bold;display:inline;"><div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">Fair Value on a Recurring Basis </div></div></div></div> <div style="font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt;">The Company follows the guidance in ASC 820 for its financial assets and liabilities that are <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">re-measured</div> and reported at fair value at each reporting period, and <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">non-financial</div> assets and liabilities that are <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">re-measured</div> and reported at fair value at least annually. The estimated fair value of the warrant liabilities represent Level 3 measurements. The following table presents information about the Company’s liabilities that are measured at fair value on a recurring basis at September 30, 2021 and December 31, 2020, and indicates the fair value hierarchy of the valuation inputs the Company utilized to determine such fair value: </div> <div style="font-size: 12pt; margin-top: 0pt; margin-bottom: 0pt; text-indent: 0px;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-size: 12pt; letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></div> <table cellpadding="0" cellspacing="0" style="margin: 0px auto; border: 0px currentcolor; width: 100%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px; text-indent: 0px;"> <tr style="font-size: 0px;"> <td style="width: 77%;"/> <td style="width: 5%; vertical-align: bottom;"/> <td/> <td/> <td/> <td style="width: 5%; vertical-align: bottom;"/> <td/> <td/> <td/> <td style="width: 5%; vertical-align: bottom;"/> <td/> <td/> <td/> </tr> <tr style="font-family: Times New Roman; font-size: 8pt; page-break-inside: avoid;"> <td style="vertical-align: bottom; white-space: nowrap; padding-bottom: 1pt;"> <div style="font-family: &quot;Times New Roman&quot;; font-size: 8pt; margin-top: 0pt; margin-bottom: 0pt; border-bottom: 1pt solid rgb(0, 0, 0); display: table-cell; line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 8pt; letter-spacing: 0px; top: 0px;;display:inline;">Description</div></div></div></div> </td> <td style="vertical-align: bottom; padding-bottom: 1pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">  </div></td> <td colspan="2" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Level</div></div></div></td> <td style="vertical-align: bottom; padding-bottom: 1pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align: bottom; padding-bottom: 1pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">  </div></td> <td colspan="2" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">September 30,<br/> 2021</div></div></div></td> <td style="vertical-align: bottom; padding-bottom: 1pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align: bottom; padding-bottom: 1pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">  </div></td> <td colspan="2" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">December 31,<br/> 2020</div></div></div></td> <td style="vertical-align: bottom; padding-bottom: 1pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> </tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);"> <td style="vertical-align: top; font-size: 10pt; width: 77%;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Liabilities:</div></div></div> </td> <td style="vertical-align: bottom; width: 5%;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">  </div></td> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom; width: 5%;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">  </div></td> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom; width: 5%;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">  </div></td> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom;"> </td> </tr> <tr style="font-size: 0px;"> <td style="width: 77%; font-family: &quot;Times New Roman&quot;;"/> <td style="width: 5%; vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"/> <td style="font-family: &quot;Times New Roman&quot;;"/> <td style="font-family: &quot;Times New Roman&quot;;"/> <td style="font-family: &quot;Times New Roman&quot;;"/> <td style="width: 5%; vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"/> <td style="font-family: &quot;Times New Roman&quot;;"/> <td style="font-family: &quot;Times New Roman&quot;;"/> <td style="font-family: &quot;Times New Roman&quot;;"/> <td style="width: 5%; vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"/> <td style="font-family: &quot;Times New Roman&quot;;"/> <td style="font-family: &quot;Times New Roman&quot;;"/> <td style="font-family: &quot;Times New Roman&quot;;"/> </tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;"> <td style="vertical-align: top; width: 77%;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Warrant liabilities</div></div> </td> <td style="vertical-align: bottom; width: 5%;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">3</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; width: 5%;">  </td> <td style="vertical-align: bottom; white-space: nowrap;">$</td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">6,777</td> <td style="vertical-align: bottom; white-space: nowrap; font-family: &quot;Times New Roman&quot;;"> </td> <td style="vertical-align: bottom; width: 5%;">  </td> <td style="vertical-align: bottom; white-space: nowrap;">$</td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">—  </td> <td style="vertical-align: bottom; white-space: nowrap; font-family: &quot;Times New Roman&quot;;"> </td> </tr> </table> <div style="clear: both; max-height: 0px; text-indent: 0px;"/> <div style="font-family: Times New Roman; font-size: 10pt; margin-top: 18pt; margin-bottom: 0pt;"><div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">Warrant Liabilities </div></div></div> <div style="font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Prior to the Business Combination, the Company had outstanding 4,110,000 <div style="letter-spacing: 0px; top: 0px;;display:inline;">warrants </div>(the “Private Warrant”) that were issued upon the consummation of the initial public offering of Galileo. Additionally, at the Closing, a lender holding a convertible note issued by the Company with an aggregate principal amount of $500 converted the note into 500,000 warrants (the “Sponsor Warrants”) exercisable for <div style="letter-spacing: 0px; top: 0px;;display:inline;">C</div>ommon <div style="letter-spacing: 0px; top: 0px;;display:inline;">S</div>tock at a purchase price of $1.00 per warrant. </div></div> <div style="font-family: Times New Roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">The Private Warrants and Sponsor <div style="letter-spacing: 0px; top: 0px;;display:inline;">Warrants </div>are identical to the Public Warrants except that the Private and Sponsor Warrants (i) are not redeemable by the Company and (ii) may be exercised for cash or on a cashless basis, so long as they are held by the initial purchaser or any of its permitted transferees. If the Private Warrants are held by someone other than the initial purchasers or their permitted transferees, the Private Warrants will be redeemable by the Company and exercisable by such holders on the same basis as the Public Warrants. </div></div> <div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt; text-indent: 0px;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">The Private and Sponsor Warrants are not indexed to the Company’s common shares in the manner contemplated by ASC <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;"><div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">815-40-15</div></div> because the holder of the instrument is not an input into the pricing of a <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;"><div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">fixed-for-fixed</div></div> option on equity shares. The Company classifies the Private and Sponsor Warrants as derivative liabilities in its unaudited condensed consolidated balance sheet as of September 30, 2021. </div></div> <div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt; text-indent: 0px;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">The Company utilizes a Binomial Lattice model approach to value the Private Warrants and Sponsor Warrants at each reporting period with changes in fair value recognized in the statement of operations. The estimated fair value of the warrant liabilities is determined using Level 3 inputs. Inherent in a binomial options pricing model are assumptions related to expected share-price volatility, expected life, risk-free interest rate and dividend yield. The Company estimates the volatility of its Common Stock based on historical volatility that matches the expected remaining life of the warrants. The risk-free interest rate is based on the U.S. Treasury <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">zero-coupon</div> yield curve on the grant date for a maturity similar to the expected remaining life of the warrants. The expected life of the warrants is assumed to be equivalent to their remaining contractual term. The dividend rate is based on the historical rate, which the Company anticipates to remain at zero. </div></div> <div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt; text-indent: 0px;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">The significant unobservable inputs used in the Binomial Lattice Model to measure the warrant liabilities that are categorized within Level 3 of the fair value hierarchy are as follows: </div></div></div> <div style="font-size: 12pt; margin-top: 0pt; margin-bottom: 0pt; text-indent: 0px;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-size: 12pt; letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></div> <table cellpadding="0" cellspacing="0" style="margin: 0px auto; border: 0px currentcolor; width: 100%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px; text-indent: 0px;"> <tr style="font-size: 0px;"> <td style="width: 76%;"/> <td style="width: 8%; vertical-align: bottom;"/> <td/> <td/> <td/> <td style="width: 8%; vertical-align: bottom;"/> <td/> <td/> <td/> </tr> <tr style="font-family: Times New Roman; font-size: 8pt; page-break-inside: avoid;"> <td style="vertical-align: bottom; padding-bottom: 1pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align: bottom; padding-bottom: 1pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">  </div></td> <td colspan="2" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">September 30,<br/> 2021</div></div></div></td> <td style="vertical-align: bottom; padding-bottom: 1pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align: bottom; padding-bottom: 1pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td colspan="2" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">At Closing<br/> (September 29, 2021)</div></div></div></td> <td style="vertical-align: bottom; padding-bottom: 1pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> </tr> <tr style="font-size: 0px;"> <td style="width: 76%;"/> <td style="width: 8%; vertical-align: bottom;"/> <td/> <td/> <td/> <td style="width: 8%; vertical-align: bottom;"/> <td/> <td/> <td/> </tr> <tr style="font-family: Times New Roman; font-size: 11pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);"> <td style="vertical-align: bottom; width: 76%;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Stock price on valuation date</div></div> </td> <td style="vertical-align: bottom; width: 8%;">  </td> <td style="vertical-align: bottom;">$</td> <td style="vertical-align: bottom;;text-align:right;">7.70</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; width: 8%;"> </td> <td style="vertical-align: bottom;">$</td> <td style="vertical-align: bottom;;text-align:right;">8.54</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> </tr> <tr style="font-family: Times New Roman; font-size: 11pt; page-break-inside: avoid;"> <td style="vertical-align: bottom; width: 76%;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Exercise price per share</div></div> </td> <td style="vertical-align: bottom; width: 8%;">  </td> <td style="vertical-align: bottom;">$</td> <td style="vertical-align: bottom;;text-align:right;">11.50</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; width: 8%;"> </td> <td style="vertical-align: bottom;">$</td> <td style="vertical-align: bottom;;text-align:right;">11.50</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> </tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);"> <td style="vertical-align: top; width: 76%;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Expected life</div></div> </td> <td style="vertical-align: bottom; width: 8%;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">5 years</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; width: 8%;"> </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">5 years</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> </tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;"> <td style="vertical-align: top; width: 76%;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Volatility</div></div> </td> <td style="vertical-align: bottom; width: 8%;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">34.8</td> <td style="vertical-align: bottom; white-space: nowrap;">%<div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div> </td> <td style="vertical-align: bottom; width: 8%;"> </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">43.9</td> <td style="vertical-align: bottom; white-space: nowrap;">% </td> </tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);"> <td style="vertical-align: top; width: 76%;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Risk-free rate</div></div> </td> <td style="vertical-align: bottom; width: 8%;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">1.0</td> <td style="vertical-align: bottom; white-space: nowrap;">% </td> <td style="vertical-align: bottom; width: 8%;"> </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">1.0</td> <td style="vertical-align: bottom; white-space: nowrap;">% </td> </tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;"> <td style="vertical-align: top; width: 76%;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Dividend yield</div></div> </td> <td style="vertical-align: bottom; width: 8%;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">—  </td> <td style="vertical-align: bottom; white-space: nowrap;">% </td> <td style="vertical-align: bottom; width: 8%;"> </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">—  </td> <td style="vertical-align: bottom; white-space: nowrap;">% </td> </tr> <tr style="font-size: 1px;"> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; width: 76%;"> </td> <td style="vertical-align: bottom; width: 8%;">  </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td> </td> <td style="vertical-align: bottom; width: 8%;"> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td> </td> </tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);"> <td style="vertical-align: top; width: 76%;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Fair value per warrant</div></div> </td> <td style="vertical-align: bottom; width: 8%;">  </td> <td style="vertical-align: bottom; white-space: nowrap;">$</td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">1.47</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; width: 8%;"> </td> <td style="vertical-align: bottom; white-space: nowrap;">$</td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">2.57</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> </tr> <tr style="font-size: 1px;"> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; width: 76%;"> </td> <td style="vertical-align: bottom; width: 8%;">  </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td> </td> <td style="vertical-align: bottom; width: 8%;"> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td> </td> </tr> </table> <div style="clear: both; max-height: 0px; text-indent: 0px;"/> <div style="font-size: 8pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-size: 8pt; letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> <div style="font-size: 8pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-size: 8pt; letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> <div style="font-family: Times New Roman; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">The following table provides a summary of changes in fair value of the Company’s Level 3 financial instruments that are measured at fair value on a recurring basis: </div></div> <div style="font-size: 12pt; margin-top: 0pt; margin-bottom: 0pt; text-indent: 0px;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-size: 12pt; letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></div> <div style="clear: both; max-height: 0px; text-indent: 0px;"/> <table cellpadding="0" cellspacing="0" style="margin: 0px auto; border: 0px currentcolor; width: 100%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;"> <tr style="font-size: 0px;"> <td style="width: 93%;"/> <td style="width: 2%; vertical-align: bottom;"/> <td/> <td/> <td/> </tr> <tr style="font-family: Times New Roman; font-size: 8pt; page-break-inside: avoid;"> <td style="vertical-align: bottom; padding-bottom: 1pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 1pt;">  </td> <td colspan="2" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Warrant<br/> Liabilities</div></div></td> <td style="vertical-align: bottom; padding-bottom: 1pt;"> </td> </tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);"> <td style="vertical-align: top; width: 93%;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Balance at December 31, 2020</div></div> </td> <td style="vertical-align: bottom; width: 2%;">  </td> <td style="vertical-align: bottom; white-space: nowrap;">$</td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">—  </td> <td style="vertical-align: bottom; white-space: nowrap; font-family: &quot;Times New Roman&quot;;"> </td> </tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;"> <td style="vertical-align: top; width: 93%;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Additions pursuant to Merger</div></div> </td> <td style="vertical-align: bottom; width: 2%;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">11,865</td> <td style="vertical-align: bottom; white-space: nowrap; font-family: &quot;Times New Roman&quot;;"> </td> </tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);"> <td style="vertical-align: top; width: 93%;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Change in fair value</div></div> </td> <td style="vertical-align: bottom; width: 2%;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">(5,088</td> <td style="vertical-align: bottom; white-space: nowrap;">) </td> </tr> <tr style="font-size: 1px;"> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; width: 93%;"> </td> <td style="vertical-align: bottom; width: 2%;">  </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td> </td> </tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;"> <td style="vertical-align: top; width: 93%;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Balance at September 30, 2021</div></div> </td> <td style="vertical-align: bottom; width: 2%;">  </td> <td style="vertical-align: bottom; white-space: nowrap;">$</td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">6,777</td> <td style="vertical-align: bottom; white-space: nowrap; font-family: &quot;Times New Roman&quot;;"> </td> </tr> <tr style="font-size: 1px;"> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; width: 93%;"> </td> <td style="vertical-align: bottom; width: 2%;">  </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td> </td> </tr> </table> <div style="font-family: Times New Roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">As of September 30, 2021, 4,110,000 Private Warrants and 500,000 Sponsor Warrants remain outstanding, respectively. </div></div> <div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 18pt; margin-bottom: 0pt;"><div style="font-weight:bold;display:inline;"><div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">Fair Value on a <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">Non-Recurring</div> Basis </div></div></div></div> <div style="font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt;">The fair value of the Earnout Shares has been estimated using the trading price of our <div style="letter-spacing: 0px; top: 0px;;display:inline;">C</div>ommon <div style="letter-spacing: 0px; top: 0px;;display:inline;">S</div>tock at Closing ($7.70), discounted based on the probability of the Earnout Terms being met as determined at Closing, and thus represents a Level 2 fair value measurement as defined in ASC 820. The Earnout Shares, if achieved, would be issued to Legacy Shapeways shareholders. The Earnout Shares are a fixed number of shares to be issued to such shareholders on a pro rata basis. The fair value of the Earnout Shares were recognized as a deemed dividend. Upon closing of the Merger, the estimated fair value of the Earnout Shares was $18,132 with such amount recognized as a deemed dividend. As the Company is in an accumulated deficit position as of the measurement date, the resulting deemed dividend is recorded as a reduction of additional <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">paid-in</div> capital with a corresponding offset recorded to additional <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">paid-in</div> capital. </div> The following table presents information about the Company’s liabilities that are measured at fair value on a recurring basis at September 30, 2021 and December 31, 2020, and indicates the fair value hierarchy of the valuation inputs the Company utilized to determine such fair value: <div style="font-size: 12pt; margin-top: 0pt; margin-bottom: 0pt; text-indent: 0px;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-size: 12pt; letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></div> <table cellpadding="0" cellspacing="0" style="margin: 0px auto; border: 0px currentcolor; width: 100%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px; text-indent: 0px;"> <tr style="font-size: 0px;"> <td style="width: 77%;"/> <td style="width: 5%; vertical-align: bottom;"/> <td/> <td/> <td/> <td style="width: 5%; vertical-align: bottom;"/> <td/> <td/> <td/> <td style="width: 5%; vertical-align: bottom;"/> <td/> <td/> <td/> </tr> <tr style="font-family: Times New Roman; font-size: 8pt; page-break-inside: avoid;"> <td style="vertical-align: bottom; white-space: nowrap; padding-bottom: 1pt;"> <div style="font-family: &quot;Times New Roman&quot;; font-size: 8pt; margin-top: 0pt; margin-bottom: 0pt; border-bottom: 1pt solid rgb(0, 0, 0); display: table-cell; line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 8pt; letter-spacing: 0px; top: 0px;;display:inline;">Description</div></div></div></div> </td> <td style="vertical-align: bottom; padding-bottom: 1pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">  </div></td> <td colspan="2" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Level</div></div></div></td> <td style="vertical-align: bottom; padding-bottom: 1pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align: bottom; padding-bottom: 1pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">  </div></td> <td colspan="2" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">September 30,<br/> 2021</div></div></div></td> <td style="vertical-align: bottom; padding-bottom: 1pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align: bottom; padding-bottom: 1pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">  </div></td> <td colspan="2" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">December 31,<br/> 2020</div></div></div></td> <td style="vertical-align: bottom; padding-bottom: 1pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> </tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);"> <td style="vertical-align: top; font-size: 10pt; width: 77%;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Liabilities:</div></div></div> </td> <td style="vertical-align: bottom; width: 5%;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">  </div></td> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom; width: 5%;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">  </div></td> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom; width: 5%;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">  </div></td> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom;"> </td> </tr> <tr style="font-size: 0px;"> <td style="width: 77%; font-family: &quot;Times New Roman&quot;;"/> <td style="width: 5%; vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"/> <td style="font-family: &quot;Times New Roman&quot;;"/> <td style="font-family: &quot;Times New Roman&quot;;"/> <td style="font-family: &quot;Times New Roman&quot;;"/> <td style="width: 5%; vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"/> <td style="font-family: &quot;Times New Roman&quot;;"/> <td style="font-family: &quot;Times New Roman&quot;;"/> <td style="font-family: &quot;Times New Roman&quot;;"/> <td style="width: 5%; vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"/> <td style="font-family: &quot;Times New Roman&quot;;"/> <td style="font-family: &quot;Times New Roman&quot;;"/> <td style="font-family: &quot;Times New Roman&quot;;"/> </tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;"> <td style="vertical-align: top; width: 77%;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Warrant liabilities</div></div> </td> <td style="vertical-align: bottom; width: 5%;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">3</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; width: 5%;">  </td> <td style="vertical-align: bottom; white-space: nowrap;">$</td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">6,777</td> <td style="vertical-align: bottom; white-space: nowrap; font-family: &quot;Times New Roman&quot;;"> </td> <td style="vertical-align: bottom; width: 5%;">  </td> <td style="vertical-align: bottom; white-space: nowrap;">$</td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">—  </td> <td style="vertical-align: bottom; white-space: nowrap; font-family: &quot;Times New Roman&quot;;"> </td> </tr> </table> <div style="clear: both; max-height: 0px; text-indent: 0px;"/> 6777000 0 4110000 500000 500000 1.00 <div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt; text-indent: 0px;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">The significant unobservable inputs used in the Binomial Lattice Model to measure the warrant liabilities that are categorized within Level 3 of the fair value hierarchy are as follows: </div></div></div> <div style="font-size: 12pt; margin-top: 0pt; margin-bottom: 0pt; text-indent: 0px;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-size: 12pt; letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></div> <table cellpadding="0" cellspacing="0" style="margin: 0px auto; border: 0px currentcolor; width: 100%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px; text-indent: 0px;"> <tr style="font-size: 0px;"> <td style="width: 76%;"/> <td style="width: 8%; vertical-align: bottom;"/> <td/> <td/> <td/> <td style="width: 8%; vertical-align: bottom;"/> <td/> <td/> <td/> </tr> <tr style="font-family: Times New Roman; font-size: 8pt; page-break-inside: avoid;"> <td style="vertical-align: bottom; padding-bottom: 1pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align: bottom; padding-bottom: 1pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">  </div></td> <td colspan="2" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">September 30,<br/> 2021</div></div></div></td> <td style="vertical-align: bottom; padding-bottom: 1pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align: bottom; padding-bottom: 1pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td colspan="2" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">At Closing<br/> (September 29, 2021)</div></div></div></td> <td style="vertical-align: bottom; padding-bottom: 1pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> </tr> <tr style="font-size: 0px;"> <td style="width: 76%;"/> <td style="width: 8%; vertical-align: bottom;"/> <td/> <td/> <td/> <td style="width: 8%; vertical-align: bottom;"/> <td/> <td/> <td/> </tr> <tr style="font-family: Times New Roman; font-size: 11pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);"> <td style="vertical-align: bottom; width: 76%;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Stock price on valuation date</div></div> </td> <td style="vertical-align: bottom; width: 8%;">  </td> <td style="vertical-align: bottom;">$</td> <td style="vertical-align: bottom;;text-align:right;">7.70</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; width: 8%;"> </td> <td style="vertical-align: bottom;">$</td> <td style="vertical-align: bottom;;text-align:right;">8.54</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> </tr> <tr style="font-family: Times New Roman; font-size: 11pt; page-break-inside: avoid;"> <td style="vertical-align: bottom; width: 76%;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Exercise price per share</div></div> </td> <td style="vertical-align: bottom; width: 8%;">  </td> <td style="vertical-align: bottom;">$</td> <td style="vertical-align: bottom;;text-align:right;">11.50</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; width: 8%;"> </td> <td style="vertical-align: bottom;">$</td> <td style="vertical-align: bottom;;text-align:right;">11.50</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> </tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);"> <td style="vertical-align: top; width: 76%;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Expected life</div></div> </td> <td style="vertical-align: bottom; width: 8%;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">5 years</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; width: 8%;"> </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">5 years</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> </tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;"> <td style="vertical-align: top; width: 76%;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Volatility</div></div> </td> <td style="vertical-align: bottom; width: 8%;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">34.8</td> <td style="vertical-align: bottom; white-space: nowrap;">%<div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div> </td> <td style="vertical-align: bottom; width: 8%;"> </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">43.9</td> <td style="vertical-align: bottom; white-space: nowrap;">% </td> </tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);"> <td style="vertical-align: top; width: 76%;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Risk-free rate</div></div> </td> <td style="vertical-align: bottom; width: 8%;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">1.0</td> <td style="vertical-align: bottom; white-space: nowrap;">% </td> <td style="vertical-align: bottom; width: 8%;"> </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">1.0</td> <td style="vertical-align: bottom; white-space: nowrap;">% </td> </tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;"> <td style="vertical-align: top; width: 76%;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Dividend yield</div></div> </td> <td style="vertical-align: bottom; width: 8%;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">—  </td> <td style="vertical-align: bottom; white-space: nowrap;">% </td> <td style="vertical-align: bottom; width: 8%;"> </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">—  </td> <td style="vertical-align: bottom; white-space: nowrap;">% </td> </tr> <tr style="font-size: 1px;"> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; width: 76%;"> </td> <td style="vertical-align: bottom; width: 8%;">  </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td> </td> <td style="vertical-align: bottom; width: 8%;"> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td> </td> </tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);"> <td style="vertical-align: top; width: 76%;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Fair value per warrant</div></div> </td> <td style="vertical-align: bottom; width: 8%;">  </td> <td style="vertical-align: bottom; white-space: nowrap;">$</td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">1.47</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; width: 8%;"> </td> <td style="vertical-align: bottom; white-space: nowrap;">$</td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">2.57</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> </tr> <tr style="font-size: 1px;"> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; width: 76%;"> </td> <td style="vertical-align: bottom; width: 8%;">  </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td> </td> <td style="vertical-align: bottom; width: 8%;"> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td> </td> </tr> </table> <div style="clear: both; max-height: 0px; text-indent: 0px;"/> 7.70 8.54 11.50 11.50 5 5 34.8 43.9 1.0 1.0 0 0 1.47 2.57 <div style="font-family: Times New Roman; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">The following table provides a summary of changes in fair value of the Company’s Level 3 financial instruments that are measured at fair value on a recurring basis: </div></div> <div style="font-size: 12pt; margin-top: 0pt; margin-bottom: 0pt; text-indent: 0px;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-size: 12pt; letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></div> <div style="clear: both; max-height: 0px; text-indent: 0px;"/> <table cellpadding="0" cellspacing="0" style="margin: 0px auto; border: 0px currentcolor; width: 100%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;"> <tr style="font-size: 0px;"> <td style="width: 93%;"/> <td style="width: 2%; vertical-align: bottom;"/> <td/> <td/> <td/> </tr> <tr style="font-family: Times New Roman; font-size: 8pt; page-break-inside: avoid;"> <td style="vertical-align: bottom; padding-bottom: 1pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 1pt;">  </td> <td colspan="2" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Warrant<br/> Liabilities</div></div></td> <td style="vertical-align: bottom; padding-bottom: 1pt;"> </td> </tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);"> <td style="vertical-align: top; width: 93%;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Balance at December 31, 2020</div></div> </td> <td style="vertical-align: bottom; width: 2%;">  </td> <td style="vertical-align: bottom; white-space: nowrap;">$</td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">—  </td> <td style="vertical-align: bottom; white-space: nowrap; font-family: &quot;Times New Roman&quot;;"> </td> </tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;"> <td style="vertical-align: top; width: 93%;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Additions pursuant to Merger</div></div> </td> <td style="vertical-align: bottom; width: 2%;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">11,865</td> <td style="vertical-align: bottom; white-space: nowrap; font-family: &quot;Times New Roman&quot;;"> </td> </tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);"> <td style="vertical-align: top; width: 93%;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Change in fair value</div></div> </td> <td style="vertical-align: bottom; width: 2%;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">(5,088</td> <td style="vertical-align: bottom; white-space: nowrap;">) </td> </tr> <tr style="font-size: 1px;"> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; width: 93%;"> </td> <td style="vertical-align: bottom; width: 2%;">  </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td> </td> </tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;"> <td style="vertical-align: top; width: 93%;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Balance at September 30, 2021</div></div> </td> <td style="vertical-align: bottom; width: 2%;">  </td> <td style="vertical-align: bottom; white-space: nowrap;">$</td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">6,777</td> <td style="vertical-align: bottom; white-space: nowrap; font-family: &quot;Times New Roman&quot;;"> </td> </tr> <tr style="font-size: 1px;"> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; width: 93%;"> </td> <td style="vertical-align: bottom; width: 2%;">  </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td> </td> </tr> </table> 0 11865000 -5088000 6777000 4110000 500000 7.70 18132000 <div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 18pt; margin-bottom: 0pt; text-indent: 0px;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Note 14. Significant Concentrations </div></div></div></div> <div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt; text-indent: 0px;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">One customer accounted for approximately 22% and 23% of revenue for the three months ended September 30, 2021 and 2020, respectively. No other customers represented more than 10% of revenue for the three months ended September 30, 2021 and 2020. </div></div></div> <div style="background: none; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px; background: none; text-decoration: none;;display:inline;"> </div></div><div style="background: none;;font-weight:bold;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px; background: none; text-decoration: none;;display:inline;"> </div></div> <div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">One customer accounted for approximately 23% and 22% of revenue for the nine months ended September 30, 2021 and 2020, respectively. No other customers represented more than 10% of revenue for the nine months ended September 30, 2021 and 2020. </div></div> <div style="font-family: Times New Roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">One vendor accounted for approximately 15% of purchases for the nine months ended September 30, 2021. No other vendors represented more than 10% of purchases for the nine months ended September 30, 2021 and 2020. </div></div> <div style="font-family: Times New Roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">As of September 30, 2021 and December 31, 2020, one customer accounted for approximately 55% and 32% of accounts receivable, respectively. No other customers represented more than 10% of outstanding accounts receivable as of September 30, 2021 and December 31, 2020. </div></div> <div style="font-family: Times New Roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">As of September 30, 2021, four vendors accounted for approximately 19%, 12%, 12%, and 11% of accounts payable. As of December 31, 2020, five vendors accounted for approximately 18%, 15%, 15%, 11% and 10% of accounts payable. No other vendors represented more than 10% of outstanding accounts payable balance as of September 30, 2021 and December 31, 2020. </div></div> 1 1 0.22 0.23 0 0 0.10 0.10 1 1 0.23 0.22 0 0 0.10 0.10 1 1 0.15 0.15 0 0 1 1 0.55 0.32 0 0 4 0.19 0.12 0.12 0.11 5 0.18 0.15 0.15 0 0 <div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 18pt; margin-bottom: 0pt;"><div style="font-weight:bold;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Note 15. Related Party Transactions </div></div></div> <div style="font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt;">During 2012, the Company signed a $175 promissory note (the “Related Party Note”) with an officer of the Company, bearing interest equal to the greater of (a) 0.88% per annum or (b) the <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">mid-term</div> Applicable Federal Rate under Section 1274(d) of the Internal Revenue Code in effect during the time the note is outstanding. The average interest rates for the nine months ended September 30, 2021 and 2020 were 0.84% and 0.90%, respectively. On May 12, 2020, the Related Party Note was amended to extend the maturity date such that the remainder of the principal and accrued interest be due and payable on August 10, 2021. The Related Party Note was secured by the assets of the borrower. Immediately prior to the completion of the Business Combination, the Company entered into a stock repurchase agreement with the holder of the Related Party Note to which the Company repurchased 19,226 shares of <div style="letter-spacing: 0px; top: 0px;;display:inline;">C</div>ommon <div style="letter-spacing: 0px; top: 0px;;display:inline;">S</div>tock held by the holder in exchange for settlement of the Related Party Note. </div> 175000 0.0088 0.0084 0.0090 2021-08-10 19226 <div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 18pt; margin-bottom: 0pt;"><div style="font-weight:bold;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Note 16. Subsequent Events </div></div></div> <div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt; text-indent: 0px;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">The Company has evaluated all known subsequent events through November 15, 2021, which is the date these condensed consolidated financial statements were available to be issued, and has determined that no subsequent events have occurred requiring recognition or disclosure in these condensed consolidated financial statements. </div></div></div> <div style="letter-spacing: 0px; top: 0px; background: none;;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px; background: none; text-decoration: none;;display:inline;"> </div></div> XML 12 R1.htm IDEA: XBRL DOCUMENT v3.21.2
Cover Page - shares
9 Months Ended
Sep. 30, 2021
Nov. 10, 2021
Document Information [Line Items]    
Document Type 10-Q  
Document Period End Date Sep. 30, 2021  
Document Quarterly Report true  
Document Transition Report false  
Entity File Number 001-39092  
Entity Registrant Name Shapeways Holdings, Inc.  
Entity Incorporation, State or Country Code DE  
Entity Address, Address Line One 30-02 48th Avenue  
Entity Address, City or Town Long Island City  
Entity Address, State or Province NY  
Entity Address, Postal Zip Code 11101  
City Area Code 646  
Local Phone Number 979-9885  
Entity Current Reporting Status Yes  
Entity Interactive Data Current Yes  
Entity Filer Category Non-accelerated Filer  
Entity Small Business true  
Entity Emerging Growth Company true  
Entity Ex Transition Period false  
Entity Shell Company false  
Entity Common Stock, Shares Outstanding   48,296,484
Entity Central Index Key 0001784851  
Current Fiscal Year End Date --12-31  
Document Fiscal Year Focus 2021  
Document Fiscal Period Focus Q3  
Amendment Flag false  
Entity Tax Identification Number 87-2876494  
Warrant [Member]    
Document Information [Line Items]    
Security Exchange Name NYSE  
Title of 12(b) Security Warrants, each whole warrant exercisable for one share of Common Stock for $11.50 per share  
Trading Symbol SHPW WS  
Common Stock [Member]    
Document Information [Line Items]    
Security Exchange Name NYSE  
Title of 12(b) Security Common Stock, par value $0.0001 per share  
Trading Symbol SHPW  
XML 13 R2.htm IDEA: XBRL DOCUMENT v3.21.2
Condensed Consolidated Balance Sheets - USD ($)
$ in Thousands
Sep. 30, 2021
Dec. 31, 2020
Current assets    
Cash and cash equivalents $ 90,108 $ 8,564
Restricted cash 143 145
Accounts receivable 1,114 185
Inventory 573 727
Promissory note due from related party 0 151
Prepaid expenses and other current assets 1,908 1,910
Total current assets 93,846 11,682
Property and equipment, net 1,090 948
Right-of-use assets, net 982 2,102
Goodwill 1,835 1,835
Security deposits 175 175
Total assets 97,928 16,742
LIABILITIES    
Accounts payable 1,168 1,633
Accrued expenses and other liabilities 3,700 3,319
Current portion of long-term debt 39 8,332
Operating lease liabilities, current 631 1,222
Deferred revenue 658 753
Total current liabilities 6,196 15,259
Operating lease liabilities, net of current portion 499 1,094
Warrant Liabilities 6,777 0
Long-term debt 88 2,236
Total liabilities 13,560 18,589
Commitments and Contingencies
Shareholders' Equity    
Preferred stock ($0.0001 par value; 10,000,000 shares authorized; none issued and outstanding as of September 30, 2021 and December 31, 2020, respectively) 0 0
Common stock ($0.0001 par value; 120,000,000 shares authorized; 48,296,484 and 32,170,068 shares issued and outstanding as of September 30, 2021 and December 31, 2020, respectively) 5 3
Additional paid-in capital 195,121 112,994
Accumulated deficit (110,442) (114,567)
Accumulated other comprehensive loss (316) (277)
Total stockholders' equity (deficit) 84,368 (1,847)
Total liabilities and stockholders' equity (deficit) $ 97,928 $ 16,742
XML 14 R3.htm IDEA: XBRL DOCUMENT v3.21.2
Condensed Consolidated Balance Sheets (Parenthetical) - $ / shares
Sep. 30, 2021
Dec. 31, 2020
CONSOLIDATED BALANCE SHEETS    
Preferred stock, par value $ 0.0001 $ 0.0001
Preferred stock, shares authorized 10,000,000 10,000,000
Preferred stock, shares issued 0 0
Preferred stock, shares outstanding 0 0
Common stock, par value $ 0.0001 $ 0.0001
Common stock, shares authorized 120,000,000 120,000,000
Common stock, shares issued 48,296,484 32,170,068
Common stock, shares outstanding 48,296,484 32,170,068
XML 15 R4.htm IDEA: XBRL DOCUMENT v3.21.2
Condensed Consolidated Statements of Operations and Comprehensive Loss - USD ($)
$ in Thousands
3 Months Ended 9 Months Ended
Sep. 30, 2021
Sep. 30, 2020
Sep. 30, 2021
Sep. 30, 2020
Revenue, net $ 7,716 $ 8,107 $ 25,354 $ 23,028
Cost of revenue 4,055 4,406 13,271 13,030
Gross profit 3,661 3,701 12,083 9,998
Operating expenses        
Selling, general and administrative 4,366 2,461 10,513 8,075
Research and development 1,673 1,516 4,099 4,289
Amortization and depreciation 33 37 100 113
Total operating expenses 6,072 4,014 14,712 12,477
Loss from operations (2,411) (313) (2,629) (2,479)
Other income (expense)        
Long-term debt forgiveness 0 0 2,000 0
Interest expense (126) (141) (407) (444)
Change in fair value of warrant liabilities 5,088 0 5,088 0
Interest Income 1 0 1 0
Other income 0 4 1 7
Loss on disposal of assets 0 0 0 (4)
Total other income (expense), net 4,963 (137) 6,683 (441)
Income (loss) before income tax benefit 2,552 (450) 4,054 (2,920)
Income tax benefit 0 0 (71)  
Net income (loss) 2,552 (450) 4,125 (2,920)
Deemed dividend - Earnout Shares (18,132) 0 (18,132)  
Net loss attributable to common stockholders $ (15,580) $ (450) $ (14,007) $ (2,920)
Net income (loss) per share:        
Basic $ 0.07 $ (0.01) $ 0.11 $ (0.08)
Diluted 0.07 (0.01) 0.11 (0.08)
Net loss per share attributable to common stockholders:        
Basic (0.41) (0.01) (0.38) (0.08)
Diluted $ (0.41) $ (0.01) $ (0.38) $ (0.08)
Weighted Average Common Shares Outstanding [Abstract]        
Basic 37,932,345 35,787,986 37,351,244 35,660,635
Diluted 37,932,345 35,787,986 37,351,244 35,660,635
Other comprehensive (loss) income        
Foreign currency translation adjustment $ (22) $ 65 $ (39) $ 32
Comprehensive loss $ (15,602) $ (385) $ (14,046) $ (2,888)
XML 16 R5.htm IDEA: XBRL DOCUMENT v3.21.2
Condensed Consolidated Statements of Changes in Stockholders' Equity (Deficit) - USD ($)
$ in Thousands
Total
Series B1 Preferred Stock [Member]
Previously Reported [Member]
Preferred Stock
Preferred Stock
Previously Reported [Member]
Preferred Stock
Revision of Prior Period, Adjustment [Member]
Common Stock
Common Stock
Series B1 Preferred Stock [Member]
Common Stock
Series D Preferred Stock [Member]
Common Stock
Previously Reported [Member]
Common Stock
Revision of Prior Period, Adjustment [Member]
Additional Paid-in Capital
Additional Paid-in Capital
Series B1 Preferred Stock [Member]
Additional Paid-in Capital
Previously Reported [Member]
Additional Paid-in Capital
Revision of Prior Period, Adjustment [Member]
Accumulated Deficit
Accumulated Deficit
Previously Reported [Member]
Accumulated Other Comprehensive Loss
Accumulated Other Comprehensive Loss
Previously Reported [Member]
Beginning Balance at Dec. 31, 2019 $ 431   $ 431   $ 2   $ 3     $ 2   $ 112,187   $ 112,186   $ (111,399) $ (111,399) $ (360) $ (360)
Beginning Balance (in Shares) at Dec. 31, 2019       0 22,579,695   31,921,259     15,894,428                  
Retroactive application of reverse recapitalization           $ (2)         $ 1       $ 1        
Retroactive application of reverse recapitalization (Shares)           (22,579,695)         16,026,831                
Issuance of Legacy Shapeways common stock upon exercise of stock options (Shares)             994                        
Stock-based compensation expense 171                     171              
Net loss (1,435)                             (1,435)      
Foreign currency translation (61)                                 (61)  
Ending Balance at Mar. 31, 2020 (894)     $ 0     $ 3         112,358       (112,834)   (421)  
Ending Balance (in shares) at Mar. 31, 2020       0     31,922,253                        
Beginning Balance at Dec. 31, 2019 431   431   $ 2   $ 3     $ 2   112,187   112,186   (111,399) (111,399) (360) (360)
Beginning Balance (in Shares) at Dec. 31, 2019       0 22,579,695   31,921,259     15,894,428                  
Net loss (2,920)                                    
Ending Balance at Sep. 30, 2020 (1,845)     $ 0     $ 3         112,799       (114,319)   (328)  
Ending Balance (in shares) at Sep. 30, 2020       0     32,132,078                        
Beginning Balance at Mar. 31, 2020 (894)     $ 0     $ 3         112,358       (112,834)   (421)  
Beginning Balance (in Shares) at Mar. 31, 2020       0     31,922,253                        
Issuance of Legacy Shapeways common stock upon exercise of stock options 47                     47              
Issuance of Legacy Shapeways common stock upon exercise of stock options (Shares)             141,270                        
Stock-based compensation expense 190                     190              
Net loss (1,035)                             (1,035)      
Foreign currency translation 28                                 28  
Ending Balance at Jun. 30, 2020 (1,664)     $ 0     $ 3         112,595       (113,869)   (393)  
Ending Balance (in shares) at Jun. 30, 2020       0     32,063,523                        
Issuance of Legacy Shapeways common stock upon exercise of stock options 21                     21              
Issuance of Legacy Shapeways common stock upon exercise of stock options (Shares)             68,555                        
Stock-based compensation expense 183                     183              
Net loss (450)                             (450)      
Foreign currency translation 65                                 65  
Ending Balance at Sep. 30, 2020 (1,845)     $ 0     $ 3         112,799       (114,319)   (328)  
Ending Balance (in shares) at Sep. 30, 2020       0     32,132,078                        
Beginning Balance at Dec. 31, 2020 $ (1,847)   (1,847) $ 0 $ 2   $ 3     $ 2   112,994   112,993   (114,567) (114,567) (277) (277)
Beginning Balance (in Shares) at Dec. 31, 2020 32,170,068     0 22,579,695   32,184,263     16,211,567                  
Retroactive application of reverse recapitalization           $ (2)         $ 1       $ 1        
Retroactive application of reverse recapitalization (Shares)           (22,579,695)         15,972,696                
Issuance of Legacy Shapeways common stock upon exercise of stock options $ 16                     16              
Issuance of Legacy Shapeways common stock upon exercise of stock options (Shares) 35,895           35,895                        
Stock-based compensation expense $ 174                     174              
Net loss 1,708                             1,708      
Foreign currency translation (9)                                 (9)  
Ending Balance at Mar. 31, 2021 42     $ 0     $ 3         113,184       (112,859)   (286)  
Ending Balance (in shares) at Mar. 31, 2021       0     32,220,158                        
Beginning Balance at Dec. 31, 2020 $ (1,847)   $ (1,847) $ 0 $ 2   $ 3     $ 2   112,994   $ 112,993   (114,567) $ (114,567) (277) $ (277)
Beginning Balance (in Shares) at Dec. 31, 2020 32,170,068     0 22,579,695   32,184,263     16,211,567                  
Net loss $ 4,125                                    
Ending Balance at Sep. 30, 2021 $ 84,368     $ 0     $ 5         195,121       (110,442)   (316)  
Ending Balance (in shares) at Sep. 30, 2021 48,296,484     0     48,296,484                        
Beginning Balance at Mar. 31, 2021 $ 42     $ 0     $ 3         113,184       (112,859)   (286)  
Beginning Balance (in Shares) at Mar. 31, 2021       0     32,220,158                        
Issuance of Legacy Shapeways common stock upon exercise of stock options $ 55                     55              
Issuance of Legacy Shapeways common stock upon exercise of stock options (Shares) 63,506           63,506                        
Issuance of Legacy Shapeways convertible Series preferred stock resulting from exercise of warrants   $ 60                     $ 60            
Issuance of Legacy Shapeways convertible Series preferred stock resulting from exercise of warrants (shares)               19,177                      
Stock-based compensation expense $ 171                     171              
Net loss (135)                             (135)      
Foreign currency translation (8)                                 (8)  
Ending Balance at Jun. 30, 2021 185     $ 0     $ 3         113,470       (112,994)   (294)  
Ending Balance (in shares) at Jun. 30, 2021       0     32,302,841                        
Issuance of Legacy Shapeways common stock upon exercise of stock options $ 481                     481              
Issuance of Legacy Shapeways common stock upon exercise of stock options (Shares) 1,113,029           1,113,029                        
Issuance of Legacy Shapeways convertible Series preferred stock resulting from exercise of warrants (shares)                 89,217                    
Issuance of Legacy Shapeways common stock upon conversion of convertible notes $ 5,913                     5,913              
Issuance of Legacy Shapeways common stock upon conversion of convertible notes (shares)             1,406,741                        
Issuance of Legacy Shapeways common stock upon exercise of warrants (shares)             212,234                        
Repurchase of Legacy Shapeways common stock (152)                     (152)              
Repurchase of Legacy Shapeways common stock (shares)             (19,226)                        
Effect of Merger and recapitalization, net of redemptions and issuance costs 10,036           $ 1         10,035              
Effect of Merger and recapitalization, net of redemptions and issuance costs (shares)             5,691,648                        
Issuance of common stock pursuant to PIPE financing, net of issuance costs 64,937           $ 1         64,936              
Issuance of common stock pursuant to PIPE financing, net of issuance costs (shares)             7,500,000                        
Stock-based compensation expense 438                     438              
Net loss 2,552                             2,552      
Foreign currency translation (22)                                 (22)  
Ending Balance at Sep. 30, 2021 $ 84,368     $ 0     $ 5         $ 195,121       $ (110,442)   $ (316)  
Ending Balance (in shares) at Sep. 30, 2021 48,296,484     0     48,296,484                        
XML 17 R6.htm IDEA: XBRL DOCUMENT v3.21.2
Condensed Consolidated Statements of Cash Flows - USD ($)
$ in Thousands
9 Months Ended
Sep. 30, 2021
Sep. 30, 2020
Cash Flows from Operating Activities:    
Net income (loss) $ 4,125 $ (2,920)
Adjustments to reconcile net income (loss) to net cash used in operating activities:    
Depreciation and amortization 424 362
Loss on disposal of assets 0 4
Stock-based compensation expense 783 544
Non-cash lease expense 696 1,586
Non-cash debt forgiveness (2,000) 0
Change in fair value of warrant liabilities (5,088) 0
Change in operating assets and liabilities:    
Accounts receivable (924) (763)
Inventory 173 (102)
Prepaid expenses and other assets 83 337
Interest on promissory note due from related party 0 50
Accounts payable (512) (775)
Accrued expenses and other liabilities 853 713
Lease liabilities (762) (1,674)
Deferred revenue (101) 67
Deferred rent 0 (283)
Net cash used in operating activities (2,250) (2,854)
Cash flows from investing activities:    
Purchases of property and equipment (125) (23)
Net cash used in investing activities (125) (23)
Cash flows from financing activities:    
Principal payments on capital leases 0 (18)
Proceeds from issuance of common stock 552 68
Proceeds received from exercise of preferred stock warrants 60 0
Effect of Merger, net of transaction costs 86,792  
Repayments of loans payable (3,459) (851)
Proceeds from loans payable 0 1,983
Net cash provided by financing activities 83,945 1,182
Net change in cash and cash equivalents and restricted cash 81,570 (1,695)
Effect of change in foreign currency exchange rates on cash and cash equivalents and restricted cash (28) 8
Cash and cash equivalents and restricted cash at beginning of period 8,709 9,605
Cash and cash equivalents and restricted cash at end of period 90,251 7,918
Supplemental disclosure of cash and non-cash transactions:    
Cash paid for interest 88 145
Accrued acquisition of property and equipment 441 0
Issuance of Legacy Shapeways common stock upon conversion of convertible notes 5,913 0
Repurchase of Legacy Shapeways common stock $ (152) $ 0
XML 18 R7.htm IDEA: XBRL DOCUMENT v3.21.2
Organization
9 Months Ended
Sep. 30, 2021
Organization  
Organization
Note 1. Organization
On September 29, 2021 (the “Closing” or the “Closing Date”), Galileo Acquisition Corp., a Cayman Islands exempted company (“Galileo” and after the Domestication (as defined below) “Shapeways”), a publicly-traded special purpose acquisition company, consummated the transactions described in the Agreement and Plan of Merger and Reorganization (the “Merger Agreement”) dated April 28, 2021, by and among Galileo Founders Holdings, L.P. (the “Sponsor”), Galileo Acquisition Corp., Galileo Acquisition Holdings, Inc., a Delaware corporation and wholly-owned subsidiary of Galileo (“Merger Sub”), and Shapeways, Inc., a Delaware corporation (“Legacy Shapeways”),
 
whereby Merger Sub merged with and into Legacy Shapeways, the separate corporate existence of Merger Sub ceasing and Legacy Shapeways being the surviving corporation and a wholly owned subsidiary of Shapeways (the “Merger”).
Further, on the Closing Date, as contemplated by the Merger Agreement, Galileo filed a notice of deregistration with the Cayman Islands Registrar of Companies, together with the necessary accompanying documents, and filed a certificate of incorporation and a certificate of corporate domestication with the Secretary of State of the State of Delaware, under which Galileo was domesticated and continued as a Delaware corporation (the “Domestication” and, together with the Merger, the “Business Combination”), changing its name to “Shapeways Holdings, Inc.” (the “Company” and/or “Shapeways”).
Shapeways is a leader in the large and fast-growing digital manufacturing industry combining high quality, flexible on-demand manufacturing powered by purpose-built proprietary software which enables customers to rapidly transform digital designs into physical products, globally. Shapeways makes industrial-grade additive manufacturing accessible by fully digitizing the end-to-end manufacturing process , and by providing a broad range of solutions utilizing 11 additive manufacturing technologies and more than 90 materials and finishes, with the ability to easily scale new innovation. Shapeways has delivered over 21 million parts to 1 million customers in over 160 countries.
XML 19 R8.htm IDEA: XBRL DOCUMENT v3.21.2
Summary of Significant Accounting Policies
9 Months Ended
Sep. 30, 2021
Summary of Significant Accounting Policies  
Summary of Significant Accounting Policies
Note 2. Summary of Significant Accounting Policies
Basis of Presentation and Principles of Consolidation
The accompanying condensed consolidated interim financial statements have been prepared in accordance with accounting principles generally accepted in the United States of America (“U.S. GAAP”) for interim financial information as defined by the Financial Accounting Standards Board (“FASB”) Accounting Standards Codification (“ASC”) and in accordance with the instruction to Form
10-Q
and Article 8 of Regulation
S-X
of the SEC. Certain information or footnote disclosures normally included in financial statements prepared in accordance with GAAP have been condensed or omitted, pursuant to the rules and regulations of the SEC for interim financial reporting. Accordingly, they do not include all the information and footnotes necessary for a complete presentation of financial position, results of operations, or cash flows. The condensed consolidated financial statements include the accounts of its wholly owned subsidiaries, Legacy Shapeways and Shapeways BV. All intercompany accounts and transactions have been eliminated in consolidation. In the opinion of management, the accompanying condensed consolidated interim financial statements include all adjustments, consisting of a normal recurring nature, which are necessary for a fair presentation of the financial position, operating results and cash flows for the periods presented. These unaudited condensed consolidated interim financial statements should be read along with the final proxy statement/prospectus as filed with the SEC on September 7, 2021.
The Business Combination has been accounted for as a reverse recapitalization, in accordance with U.S. GAAP (the “Reverse Recapitalization”). Under this method of accounting, Galileo has been treated as the “acquired” company for financial reporting purposes. Accordingly, the Business Combination has been treated as the equivalent of Legacy Shapeways issuing stock for the net assets of Galileo, accompanied by a recapitalization. The net assets of Galileo are stated at historical cost, with no goodwill or other intangible assets recorded. There has been no accounting effect or change in the carrying amount of the assets and liabilities as a result of the Business Combination.
Legacy Shapeways has been treated as the accounting acquirer based on evaluation of the following facts and circumstances with regard to the Company as of the Closing:
 
 
 
Legacy Shapeways’ directors represented the majority of the new board of directors of the Company;
 
 
 
The executive officers and senior management of Legacy Shapeways are the executive officers and senior management of the Company;
 
 
 
The assets of Legacy Shapeways represent a significant majority of the assets of the Company (excluding cash formerly held in the Galileo trust account); and
 
   
The business of the Company will be the continued business of Legacy Shapeways. The business of the Company will continue to focus on Legacy Shapeways’ core offerings related to the facilitation of the sale, design and manufacturing of 3D printed items.
The consolidated assets, liabilities and results of operations prior to the Reverse Recapitalization are those of Legacy Shapeways. The shares and corresponding capital amounts and losses per share, prior to the Merger, have been retroactively adjusted based on shares reflecting the conversion ratio (as defined below) established in the Merger.
Use of Estimates
The preparation of the Company’s
unaudited
condensed consolidated financial statements, in conformity with U.S. GAAP, requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the condensed consolidated financial statements and reported amounts of revenues and expenses during the reporting period. Actual results may differ from those estimates.
In March 2020, the World Health Organization declared the outbreak of a novel coronavirus
(COVID-19)
as a pandemic, which continues to spread throughout the United States. While the disruption is currently expected to be temporary, there is uncertainty around the duration. The Company has considered information available to it as of the date of issuance of these unaudited condensed consolidated financial statements and is not aware of any specific events or circumstances that would require an update to its estimates or judgements, or an adjustment to the carrying value of its assets or liabilities. The accounting estimates and other matters assessed include, but were not limited to, goodwill and other long-lived assets, warrant liabilities and revenue recognition. These estimates may change as new events occur and additional information becomes available. Actual results could differ materially from these estimates.
Functional Currency
The local currency is the functional currency for Shapeways BV’s (a
wholly
-owned subsidiary of the Company) operations outside the United States. Assets and liabilities of these operations are translated into U.S. Dollars at the exchange rate in effect at the end of each period. Income statement accounts are translated at the average exchange rate prevailing during the period. Translation adjustments arising from the use of differing exchange rates from period to period are included as a component of other comprehensive loss within stockholders’ equity (deficit). Gains and losses from foreign currency transactions are included in net loss for the period.
Cash, Cash Equivalents
and
Restricted Cash
Cash includes cash on hand and demand deposits. The Company maintains its deposits at high quality financial institutions and monitors the credit ratings of those institutions. The Company considers all highly liquid investments with original maturities of three months or less to be cash equivalents. While cash held by financial institutions may at times exceed federally insured
limits
, the Company believes that no material credit or market risk exposure exists due to the high quality of the institutions. The Company has not experienced any losses on such accounts. Restricted cash represents cash required to be held as collateral for the Company’s credit cards and security deposit for our facility in the Netherlands. Accordingly, these balances contain restrictions as to their availability and usage and are classified as restricted cash in the condensed consolidated balance sheets.
The reconciliation of cash, cash equivalents and restricted cash reported within the applicable consolidated balance sheet that sum to the total of the same such amount shown in the condensed consolidated statements of cash flows is as follows:
 
 
  
September 30, 2021
 
  
December 31, 2020
 
Cash and cash equivalents
   $ 90,108      $ 8,564  
Restricted cash
     143        145  
    
 
 
    
 
 
 
     $ 90,251      $ 8,709  
    
 
 
    
 
 
 
Accounts Receivable
Accounts receivables are recorded at the invoiced amount and are generally unsecured as they are uncollateralized. The Company provides an allowance for doubtful accounts to reduce receivables to their estimated net realizable value. Judgement is exercised in establishing allowances and estimates are based on the customers’ payment history and liquidity. Any amounts that were previously recognized as revenue and subsequently determined to be uncollectible are charged to bad debt expense included in selling, general and administrative expense in the accompanying condensed consolidated statements of operations and comprehensive loss. Given the nature and historical collectability of the Company’s accounts receivable, an allowance for doubtful accounts was not deemed necessary at September 30, 2021 and December 31, 2020.
 
Inventory
Inventory consists of raw materials, work in progress and finished goods at the Company’s distribution center. Raw materials are stated at the lower of cost or net realizable value, determined by the
first-in-first-out
method. Finished goods and work in progress are valued using a methodology to determine the cost of each 3D printed object using allocations for material, labor, machine time and overhead. The Company periodically reviews its inventory for slow-moving, damaged and discontinued items and provides allowances to reduce such items identified to their recoverable amounts. As of September 30, 2021 and December 31, 2020, the Company determined an allowance was not deemed necessary.
Property and Equipment, net
Property and equipment are stated at cost, less accumulated depreciation. Maintenance and repairs are charged to expense when incurred. Additions and improvements that extend the economic useful life of the asset are capitalized and depreciated over the remaining useful lives of the assets. The cost and accumulated depreciation of assets sold or retired are removed from the respective accounts, and any resulting gain or loss is reflected in current earnings. No impairment charges were recorded for the periods ended September 30, 2021 and December 31, 2020. Depreciation is recognized using the straight-line method in amounts considered to be sufficient to allocate the cost of the assets to operations over the estimated useful lives or lease terms, as follows:
 
Asset Category
  
Depreciable Life
Machinery and equipment
   5 years
Computers and IT equipment
   3 years
Furniture and fixtures
   7 years
Leasehold improvements
   **
 
**
Leasehold improvements are amortized using the straight-line method over the shorter of the lease term or estimated useful life of the asset.
Long-Lived Assets, Including Definite-Lived Intangible Assets
Intangible assets, which consist of technology, customer relationships, and trademarks, are stated at cost less accumulated amortization. Amortization is generally recorded on a straight-line basis over estimated useful lives ranging from three to eight years. The Company periodically reviews the estimated useful lives of intangible assets and adjusts when events indicate that a shorter life is appropriate. In accordance with authoritative accounting guidance, capitalization of costs to develop software begin when preliminary development efforts are successfully and completed. Costs related to the design or maintenance of
internal-use
software are expensed as incurred.
Long-lived assets, other than goodwill and other indefinite-lived intangibles, are evaluated for impairment whenever events or changes in circumstances indicate that the carrying amount of the assets may not be recoverable through the estimated undiscounted future cash flows derived from such assets.
Factors that the Company considers in deciding when to perform an impairment review include significant changes in the Company’s forecasted projections for the asset or asset group for reasons including, but not limited to, significant underperformance of a product in relation to expectations, significant changes, or planned changes in the Company’s use of the assets, significant negative industry or economic trends, and new or competing products that enter the marketplace. The impairment test is based on a comparison of the undiscounted cash flows expected to be generated from the use of the asset group. If impairment is indicated, the asset is written down by the amount by which the carrying value of the asset exceeds the related fair value of the asset with the related impairment charge recognized within the statements of operations and comprehensive loss. No impairment charges were recorded for the periods ended September 30, 2021 and December 31, 2020.
Goodwill
Goodwill, which represents the excess of purchase prices over the fair value of net assets acquired, is carried at cost. Goodwill is not amortized; rather, it is subject to a periodic assessment for impairment by applying a fair value-based test. Goodwill is evaluated for impairment on an annual basis at a level of reporting referred to as the reporting unit, and more frequently if adverse events or changes in circumstances indicate that the asset may be impaired.
Under ASC 350,
Intangibles - Goodwill and Other
,
the Company has the option to first assess the qualitative factors to determine whether it is more likely than not that the fair value of the reporting unit is less than its carrying amount as a basis for determining whether it is necessary to perform a quantitative goodwill impairment test. If the Company determines that it is more likely than not that
the fair value of a reporting unit is less than its carrying amount, then the goodwill impairment test is performed. Impairment tests are performed, at a minimum, in the fourth quarter of each year. Management uses the future discounted cash flows valuation approach to determine the fair value of reporting units and determines whether the fair value of reporting units exceeded its carrying amounts. If the fair value exceeds the carrying amount, then no impairment is recognized. If the carrying amount recorded exceeds the fair value calculated, then an impairment charge is recognized for the difference. The impairment review requires management to make judgments in determining various assumptions with respect to revenues, operating margins, growth rates and discount rates. The judgments made in determining the projected cash flows used to estimate the fair value can materially impact the Company’s financial condition and results of operations. There was no impairment of goodwill as of September 30, 2021 or December 31,
2020
.
Fair Value Measurements
The Company applies ASC 820,
Fair Value Measurement
(“ASC 820”), which establishes framework for measuring fair value and clarifies the definition of fair value within that framework. ASC 820 defines fair value as an exit price, which is the price that would be received for an asset or paid to transfer a liability in the Company’s principal or most advantageous market in an orderly transaction between market participants on the measurement date. The fair value hierarchy established in ASC 820 generally requires an entity to maximize the use of observable inputs and minimize the use of unobservable inputs when measuring fair value. Observable inputs reflect the assumptions that market participants would use in pricing the asset or liability and are developed based on market data obtained from sources independent of the reporting entity. Unobservable inputs reflect the entity’s own assumptions based on market data and the entity’s judgments about the assumptions that market participants would use in pricing the asset or liability and are to be developed based on the best information available in the circumstances.
The valuation hierarchy is composed of three levels. The classification within the valuation hierarchy is based on the lowest level of input that is significant to the fair value measurement. The levels within the valuation hierarchy are described below:
Level 1
-
Assets and liabilities with unadjusted, quoted prices listed on active market exchanges. Inputs to the fair value measurement are observable inputs, such as quoted prices in active markets for identical assets or liabilities.
Level 2
-
Inputs to the fair value measurement are determined using prices for recently traded assets and liabilities with similar underlying terms, as well as direct or indirect observable inputs, such as interest rates and yield curves that are observable at commonly quoted intervals.
Level 3
-
Inputs to the fair value measurement are unobservable inputs, such as estimates, assumptions, and valuation techniques when little or no market data exists for the assets or liabilities.
Revenue Recognition
Revenue is derived from two primary sources: a) products and services and b) software.
The Company recognizes revenue following the five-step model prescribed under ASC 606: (i) identify contract(s) with a customer; (ii) identify the performance obligation(s) in the contract; (iii) determine the transaction price; (iv) allocate the transaction price to the performance obligation(s) in the contract; and (v) recognize revenue when (or as) the Company satisfies a performance obligation. The Company only applies the five-step model to contracts when it is probable that the Company will collect the consideration it is entitled to in exchange for the products or services it transfers to the customer. These contracts have different terms based on the scope, performance obligations, and complexity of the project, which often requires us to make judgments and estimates in recognizing revenues.
Performance obligations are satisfied both at a
point
of time and over time. All revenue is recognized based on the satisfaction of the performance obligation to date (see Note 4).
Leases
The Company’s lease arrangements relate primarily to office and manufacturing space, and equipment. The Company’s leases generally have initial terms ranging from 5 to 10 years and may include renewal options and rent escalation clauses. The Company is typically required to make fixed minimum rent payments relating to its right to use an underlying leased asset. Additionally, the Company’s leases do not contain significantly restrictive covenants or residual value guarantees.
The Company determines if an arrangement is a lease at inception and classifies its leases at commencement. Operating leases are presented as
right-of-use
(“ROU”) assets and the corresponding lease liabilities are included in operating lease liabilities, current and operating lease liabilities on the Company’s condensed consolidated balance sheets. The Company does not currently maintain any finance lease
arrangements. ROU assets represent the Company’s right to use an underlying asset, and lease liabilities represent the Company’s obligation for lease payments in exchange for the ability to use the asset for the duration of the lease term. The Company does not recognize short term leases that have a term of twelve months or less as ROU assets or lease liabilities. The Company’s short-term leases are not material and do not have a material impact on its ROU assets or lease liabilities.
ROU assets and lease
liabilities
are recognized at commencement date and determined using the present value of the future minimum lease payments over the lease term. The Company uses an incremental borrowing rate based on estimated rate of interest for collateralized borrowing since the Company’s leases do not include an implicit interest rate. The estimated incremental borrowing rate considers market data, actual lease economic environment, and actual lease term at commencement date. The lease term may include options to extend when it is reasonably certain that the Company will exercise that option. ROU assets include lease payments made in advance, and excludes any incentives received or initial direct costs incurred. The Company recognizes lease expense on a straight-line basis over the lease term
The Company has lease agreements which contain both lease and
non-lease
components, which it has elected to account for as a single lease component. As such, minimum lease payments include fixed payments for
non-lease
components within a lease agreement, but exclude variable lease payments not dependent on an index or rate, such as common area maintenance, operating expenses, utilities, or other costs that are subject to fluctuation from period to period.
Stock-based Compensation
The Company recognizes stock-based compensation expense for all options and other arrangements within the scope of ASC 718,
Stock Compensation
. Stock-based compensation expense is measured at the date of grant, based on the fair value of the award, and is recognized using the straight-line method over the employee’s requisite service period. Compensation for stock-based awards with vesting conditions other than service are recognized at the time that those conditions will be achieved. Forfeitures are recognized as they are incurred.
Public and Private Common Stock Warrant Liabilities
As part of Galileo’s initial public offering, Galileo issued to third party investors 13,800,000 units, consisting of one ordinary share of Galileo and one warrant, at a price of $10.00 per unit. Each whole warrant entitles the holder to purchase one share of 
C
ommon
S
tock at an exercise price of $11.50 per share (the “Public Warrants”). Simultaneously with the closing of Galileo’s initial public offering, Galileo completed the private sale of 4,110,000 warrants to Galileo’s sponsor and EarlyBirdCapital, Inc. at a purchase price of $1.00 per warrant (the “Private Warrants”). In connection with the Business Combination, Galileo’s sponsor exercised its right to convert the aggregate outstanding principal amount of the convertible promissory note issued by Galileo into an aggregate of 500,000 Sponsor Warrants, with terms equivalents to the Private Warrants.
The Private Warrants are
identical
to the Public Warrants, except that the Private Warrants (i) will not be redeemable by the Company and (ii) may be exercised for cash or on a cashless basis, so long as they are held by the initial purchaser or any of its permitted transferees. If the Private Warrants are held by holders other than the initial purchasers or any of their permitted transferees, the Private Warrants will be redeemable by the Company and exercisable by the holders on the same basis as the Public Warrants.
The Company evaluated the Public and Private Warrants under ASC
815-40,
Derivatives and Hedging—Contracts in Entity’s Own Equity
(“ASC
815-40”),
and concluded that the Private Warrants do not meet the criteria to be classified in stockholders’ equity. Since the Private Warrants meet the definition of a derivative under ASC 815, the Company recorded these warrants as liabilities on the condensed consolidated balance sheet at fair value, with subsequent changes in their respective fair values recognized in the condensed consolidated statement of operations at each reporting date.
Research and Development Costs
Research and development expenses consist primarily of allocated personnel costs, fees paid to consultants and outside service providers, and allocations for rent and overhead. Research and development costs are expensed as incurred. Advance payments for goods and services that will be used in future research and development activities are expensed when the activity has been performed or when the goods have been received. For the three months ended September 30, 2021 and 2020, research and development costs were $1,673 and $1,516, respectively. For the nine months ended September 30, 2021 and 2020, research and development costs were $4,099 and $4,289, respectively.
Advertising
Advertising costs are expensed as incurred. For the three months ended September 30, 2021 and 2020, advertising costs were $568 and $123, respectively. For the nine months ended September 30, 2021 and 2020, advertising costs were $1,008 and $353, respectively, which are included in selling, general and administrative expense on the
 condensed
consolidated statements of operations and comprehensive loss.
Income Taxes
The Company files income tax returns in
the
U.S. federal jurisdiction and various state jurisdictions. Income taxes are accounted for under the asset and liability method. Deferred tax assets and liabilities are recognized for the estimated future tax consequences attributable to differences between the financial statement carrying amounts of existing assets and liabilities and their respective tax bases. Deferred tax assets and liabilities are measured using enacted tax rates in effect for the year in which those temporary differences are expected to be recovered or settled. Where applicable, the Company records a valuation allowance to reduce any deferred tax assets that it determines will not be realizable in the future.
The Company recognizes the benefit of an uncertain tax position that it has taken or expects to take on income tax returns it files if such tax position is more likely than not to be sustained on examination by the taxing authorities, based on the technical merits of the position. These tax benefits are measured based on the largest benefit that has a greater than 50% likelihood of being realized upon ultimate resolution. Although the Company believes that i
t
 has adequately reserved for uncertain tax positions (including interest and penalties), it can provide no assurance that the final tax outcome of these matters will not be materially different. The Company makes adjustments to these reserves in accordance with the income tax accounting guidance when facts and circumstances change, such as the closing of a tax audit or the refinement of an estimate. To the extent that the final tax outcome of these matters is different than the amounts recorded, such differences will affect the provision for income taxes in the period in which such determination is made, and could have a material impact on the Company’s financial condition and operating results. Carryforward attributes that were generated in tax years prior to those that remain open for examination may still be adjusted by relevant tax authorities upon examination if they either have been, or will be, used in a future period.
In applying the estimated annual effective tax rate approach prescribed under ASC 740,
Income Taxes,
based on present evidence and conclusions around the realizability of deferred tax assets, we determined that any deferred tax benefits related to the forecasted tax rate and pretax activity during the three and nine months ended September 30, 2021 and 2020 are neither more likely than not to be realized in the current year, nor realizable as a deferred tax asset at the end of the year. Therefore, the appropriate amount of income tax benefit to recognize related to deferred tax assets during the three and nine months ended September 30, 2021 and 2020 is zero. The Company’s effective tax rate of
(1.78)%
for the nine months ended September 30, 2021 differs from the applicable statutory tax rate primarily due to the fact that income recognized for the forgiveness of loans granted under the PPP loan program and changes in the fair value of warrant liabilities are not taxable under current U.S. tax law.
Income (Loss) per Share
In accordance with the provisions of ASC 260,
Earnings Per Share
, net income (loss) per common share is computed by dividing net income (loss) by the weighted-average shares of Common Stock outstanding during the period. Basic income (loss) per share is computed by dividing net income (loss) attributable to common stockholders by the weighted average number of shares outstanding during the period. Diluted income (loss) per share gives effect to all dilutive potential common shares outstanding during the period including stock options and warrants, using the treasury stock method, and convertible debt and convertible securities, using the
if-converted
method. During a loss period, the effect of the potential exercise of stock options and convertible debt are not considered in the diluted loss per common share calculation since the effect would be anti-dilutive.
The following outstanding shares of Common Stock equivalents were excluded from the computation of the diluted net loss per share attributable to Common Stock for the periods in which a net loss is presented because their effect would have been anti-dilutive:
 
    
Three Months Ended
September 30,
    
Nine Months Ended
September 30,
 
    
2021
    
2020
    
2021
    
2020
 
Common stock warrants
     18,410,000        —          18,410,000        —    
Earnout Shares
     3,510,405        —          3,510,405        —    
Included in income (loss) per common share are 
4,833,059 and 3,673,963 shares of
options
due to their nominal exercise prices as of September 30, 2021 and 2020, respectively.
Segment Information
The Company has determined that it operates and reports in one segment, which focuses on providing additive manufacturing services to customers. The Company’s operating segment is reported in a manner consistent with the internal reporting provided to the chief operating decision maker (“CODM”). The Company’s CODM has been identified as its Chief Executive Officer.
Recent Accounting Pronouncements
Accounting Pronouncements Recently Adopted
In January 2017, the FASB issued Accounting Standard Update (“ASU”)
No. 2017-04,
Intangibles—Goodwill and Other (Topic 350): Simplifying the Test for Goodwill Impairment,
which aims to simplify the subsequent measurement of goodwill by eliminating Step 2 from the goodwill impairment test. Under the new guidance, goodwill impairment will be measured as the amount by which the carrying value exceeds the fair value. The loss recognized should not exceed the total amount of goodwill allocated to the reporting unit. The standard is effective for annual and interim reporting periods beginning after December 15, 2021. Early adoption is permitted. The Company adopted ASU
2017-04
effective January 1, 2021. The adoption of this standard did not have a significant impact on the Company’s condensed consolidated financial statements.
In December 2019, the FASB issued ASU
No. 2019-12,
Income Taxes (Topic 740): Simplifying the Accounting for Income Taxes
. The purpose of Update
No. 2019-12
is to continue the FASB’s Simplification Initiative to reduce complexity in accounting standards. The amendments in Update
No. 2019-12
simplify the accounting for income taxes by removing certain exceptions related to the incremental approach for intraperiod tax allocation, the requirement to recognize or derecognize deferred tax liabilities related to equity method investments that are also foreign subsidiaries, and the methodology for calculating income taxes in an interim period. In addition to removing these exceptions, Update
No. 2019-12
also clarifies and simplifies other aspects of the accounting for income taxes. The Company adopted ASU
2019-12
effective January 1, 2021. The adoption of this standard did not have a significant impact on the Company’s condensed consolidated financial statements.
In August 2020, the FASB issued ASU
2020-06,
Debt — Debt with Conversion and Other Options (Subtopic
470-20)
and Derivatives and Hedging — Contracts in Entity’s Own Equity (Subtopic
815-40):
Accounting for Convertible Instruments and Contracts in an Entity’s Own Equity
, which simplifies the accounting for convertible instruments by removing certain separation models in Subtopic
470-20,
Debt—Debt with Conversion and Other Options, for convertible instruments and also increases information transparency by making disclosure amendments. The standard is effective for fiscal years beginning after December 15, 2023, including interim periods within those fiscal years. Early adoption is permitted, but no earlier than fiscal years beginning after December 15, 2020, including interim periods within those fiscal years. The Company adopted ASU
2020-06
effective January 1, 2021. The adoption of this standard did not have a significant impact on the Company’s condensed consolidated financial statements.
In August 2018, the FASB issued ASU
No. 2018-15,
Intangibles – Goodwill and Other –
Internal-Use
Software (Subtopic
350-40):
Customer’s Accounting for Implementation Costs Incurred in a Cloud Computing Arrangement That Is a Service Contract
, which aligns the requirements for capitalizing implementation costs incurred in a hosting arrangement that is a service contract with the requirements for capitalizing implementation costs incurred to develop or obtain
internal-use
software (and hosting arrangements that include an
internal-use
software license). The standard is effective for annual reporting periods beginning after December 15, 2020 and interim periods within annual periods beginning after December 15, 2021. Early adoption is permitted. The Company adopted ASU 2018-15 effective January 1, 2021. The adoption of this standard did not have a significant impact on the Company’s condensed consolidated financial statements.
Accounting Pronouncements Not Yet Adopted
In June 2016, the FASB issued ASU No. 2016-13, Accounting for Credit Losses (Topic 326), which requires the use of an “expected loss” model on certain types of financial instruments. The standard also amends the impairment model for available-for-sale debt securities and requires estimated credit losses to be recorded as allowances instead of reductions to amortized cost of the securities. Update No. 2016-13 is effective for annual periods beginning after December 15, 2022, including interim periods within those annual periods. Early adoption is permitted, including adoption in an interim period. The Company is currently evaluating the impact the standard will have on its condensed consolidated financial statements.
XML 20 R9.htm IDEA: XBRL DOCUMENT v3.21.2
Reverse Recapitalization
9 Months Ended
Sep. 30, 2021
Reverse Recapitalization [Abstract]  
Reverse Recapitalization
Note 3. Reverse Recapitalization
As discussed in Note 1, on September 29, 2021, Galileo closed the Business Combination with Shapeways, Inc., as a result of which Legacy Shapeways became a wholly-owned subsidiary of Galileo. While Galileo was the legal acquirer of Legacy Shapeways in the business combination, for accounting purposes, the Business Combination is treated as a Reverse Recapitalization, whereby Legacy Shapeways is deemed to be the accounting acquirer, and the historical financial statements of Legacy Shapeways became the historical financial statements of Galileo upon the closing of the Business Combination. Under this method of accounting, Galileo was treated as the “acquired” company and Legacy Shapeways is treated as the acquirer for financial reporting purposes. Accordingly, for accounting purposes, the Business Combination was treated as the equivalent of Legacy Shapeways issuing stock for the net assets of Galileo, accompanied by a recapitalization. The net assets of Galileo were stated at historical cost, with no goodwill or other intangible assets recorded.
 
At the closing of the Business Combination, (1) all outstanding shares of Legacy Shapeways’ preferred stock (including shares of Legacy Shapeways’ preferred stock issuable upon conversion of Legacy Shapeways’ convertible notes outstanding as of the Closing) and Shapeways’ common stock were converted into an aggregate of 35,104,836 shares of Common Stock of the Company, par value $0.0001 per share, representing aggregate consideration value equal to $406,000 (the “Merger Consideration”), 3,510,405
shares of which are subject to the Earnout Terms (as defined below, and such shares, the “Earnout Shares”), (2) options to purchase Legacy Shapeways’ common stock (whether vested or unvested, exercisable or unexercisable) issued pursuant to the Legacy Shapeways 2010 Stock Plan, as amended (the “2010 Stock Plan”), and outstanding immediately prior to the Closing were assumed and converted into (a) options to purchase an aggregate of
 
4,901,207
shares of Common Stock under the
2021
Equity Incentive Plan (the “Incentive Plan”) and (b) in the case of
in-the-money
options held by individuals who were service providers as of the Closing Date, an aggregate of
493,489
restricted stock units denominated in a number of shares of Common Stock (“Earnout RSUs”) granted under the Incentive Plan, which Earnout RSUs are subject to the earnout vesting and forfeiture conditions described in the Merger Agreement,
(3)
 all warrants to purchase Legacy Shapeways’ common stock and Shapeways’ preferred stock outstanding immediately prior to the Closing were exercised in full and converted into shares of Legacy Shapeways preferred stock or Legacy Shapeways common stock, as applicable, in accordance with their terms, and each such share of Legacy Shapeways preferred stock and Legacy Shapeways common stock issued upon the exercise of such warrants was converted into an aggregate of
301,750
shares of Common Stock (for the avoidance of doubt, such shares of Common Stock are included in the aggregate shares of Common Stock described in clause
(1)
 above) and
(4)
 any Legacy Shapeways
non-plan
options outstanding immediately prior to Closing were cancelled without payment in accordance with the terms described in the Merger Agreement.
At the Closing, there were 3,510,405 shares of Common Stock issued as part of the Merger Consideration (the “Stockholder Merger Consideration” and/or “Earnout Shares”) subject to vesting and forfeiture conditions (the “Earnout Terms”) based upon the
volume-weighted average
trading price of Common Stock reaching targets of $14.00 and $16.00, respectively (with 50% released at each target) for a period of 30 consecutive trading days during the three-year period after the Closing, with the portion of such shares that would otherwise be deliverable to Shapeways Stockholders at the Closing being withheld and deposited into escrow. A pro rata portion of the Stockholder Merger Consideration earnout has also been allocated to Legacy Shapeways options and warrants that, as of the Closing, have been exchanged for options and warrants (as applicable) exercisable for shares of Common Stock (as described below).
Legacy Shapeways options issued pursuant to Legacy Shapeways’ 2010 Stock Plan that were not exercised prior to the Closing have been assumed by the Company and converted, subject to certain adjustments that are described in the Merger Agreement, into options exercisable for shares of Common Stock and, in the case of
in-the-money
Legacy Shapeways options held by individuals remaining in continuous service to the Company through the Closing, a right to receive an award of restricted stock units (“RSUs”) denominated in shares of Common Stock that are subject to the Earnout Terms and to service-based vesting and forfeiture restrictions. As a result of the Closing, outstanding Legacy Shapeways Convertible Notes were converted into shares of Legacy Shapeways Preferred Stock at the election of the holders thereof, which were then converted into shares of Shapeways Common Stock prior to the Closing
Simultaneously with the execution of the Business Combination, Galileo entered into subscription agreements (collectively, the “Subscription Agreements”) pursuant to which certain investors agreed to purchase an aggregate of 7,500,000 shares of Common Stock for a purchase price of $10.00 per share and $75,000,000 in the aggregate (the “PIPE Investment”). At the Closing, the Company consummated the PIPE Investment.
The following table reconciles the elements of the Business Combination to the unaudited condensed consolidated statement of cash flows for the nine months ended September 30, 2021:
 
    
Recapitalization
 
Cash - Galileo trust and cash, net of redemption
   $ 28,115  
Cash - PIPE Investment, net of transaction costs
     75,000  
Less: transaction costs and advisory fees allocated to equity
     (16,323
    
 
 
 
Effect of Merger, net of redemption, transaction costs and advisory costs
   $ 86,792  
    
 
 
 
 
The following table reconciles the elements of the Business Combination to the unaudited condensed consolidated statement of changes in stockholders’ equity (deficit) for the three and nine months ended September 30, 2021:
 
    
Recapitalization
 
Cash - Galileo trust and cash, net of redemption
   $ 28,115  
Non-cash
net working capital assumed from Galileo
     46  
Less: fair value of Private and Sponsor Warrant liabilities
     (11,865
Less: transaction costs and advisory fees allocated to equity
     (6,260
    
 
 
 
Effect of Merger, net of redemption, transaction costs and advisory costs
   $ 10,036  
    
 
 
 
         
The following table details the number of shares of Common Stock issued immediately following the consummation of the Business Combination:
 
    
Number of Shares
 
Common stock, outstanding prior to Business Combination
     13,800,000  
Less: redemption of Galileo shares
     (11,018,352
    
 
 
 
Common stock of Galileo
     2,781,648  
Galileo founder and representative shares, net of forfeited shares
     2,910,000  
Shares issued in PIPE Investment
     7,500,000  
    
 
 
 
Merger and PIPE Investment - common stock
     13,191,648  
Legacy Shapeways shares - common stock
(1)
     35,104,836  
    
 
 
 
Total shares of common stock immediately after Business Combination
     48,296,484  
    
 
 
 
 
(1)
Includes 3,510,405 Earnout Shares
XML 21 R10.htm IDEA: XBRL DOCUMENT v3.21.2
Revenue Recognition
9 Months Ended
Sep. 30, 2021
Revenue from Contract with Customer [Abstract]  
Revenue Recognition
Note 4. Revenue Recognition
Under ASC 606, revenue is recognized throughout the life of the executed agreement. The Company measures revenue based on consideration specified in a contract with a customer. Furthermore, the Company recognizes revenue when a performance obligation is satisfied by transferring control of the product or service to the customer which could occur over time or at a point in time.
A performance obligation is a promise in a contract to transfer a distinct service to the customer. The transaction price of a contract is allocated to each distinct performance obligation and recognized as revenue when or as the customer receives the benefit of the performance obligation. Customers typically receive the benefit of the Company’s services as (or when) they are performed. Substantially all customer contracts provide that compensation is received for services performed to date. Taxes assessed by a governmental au
thority that are both imposed on and concurrent with a specific revenue-producing transaction, that are collected by us from a customer, are excluded from revenue.
Nature of Products and Services
The following is a description of the Company’s
products
and
services
from which the Company generates revenue, as well as the nature, timing of satisfaction of performance obligations, and significant payment terms for each:
Direct sales
The Company provides customers with an additive manufacturing service, allowing for the customer to select the specifications of the model which they wish to have printed. Shapeways prints the 3D model and ships the product directly to the customer.
The Company recognizes the sale of shop owner products through their
e-commerce
website over time using the output method. Contracts involving the sale of shop owner products through their
e-commerce
website do not include other performance obligations. As such, allocation of the transaction price was not necessary as the entire contract price is attributed to the sole performance obligation identified.
Marketplace sales
The Company provides a platform for shop owners to sell their products to customers through Shapeways’ marketplace website. Shapeways receives a 3.5% markup fee from the shop owner upon the sale of any products through the marketplace.
 
The Company handles the financial transaction, manufacturing, distribution and customer service on behalf of the shop owners. The Company is responsible for billing the customer in this arrangement and transmitting the applicable fees to the shop owner. The Company assessed whether it is responsible for providing the actual product or service as a principal, or for arranging for the product or service to be provided by the third party as an agent. Judgment is applied to determine whether the Company is the principal or the agent by evaluating whether it has control of the product or service prior to it being transferred to the customer. The principal versus agent assessment is performed at the performance obligation level. Indicators that the Company has considered include whether it has the primary responsibility for fulfilling the promise to provide the specified product or service to the customer and whether it has inventory risk prior to transferring the product or service to the customer. The Company has the responsibility to fulfill the promise to provide the specific good or service on behalf of the shop owners to the customer. In addition, the Company has inventory risk before the specific good or service is transferred to a customer. As such, the Company is deemed the principal and shall recognize revenue on a gross basis for the price it charges to the shop owner for each product or service.
The Company recognizes the sale of 3D products to customers at a point in time, specifically upon shipping the goods to the customer (FOB Origin) given the transfer of significant risks and rewards of ownership at that point in time. Contracts involving the manufacturing and delivery of 3D printed products to customers do not include other performance obligations. As such, allocation of the transaction price was not necessary as the entire contract price is attributed to the sole performance obligation identified.
Software revenue
In 2020, Shapeways launched their software under the brand of “Powered by Shapeways” to a limited set of design customers to gain feedback on product market fit. The software enables other manufacturers to leverage Shapeways’ existing end-to-end manufacturing software to scale their businesses and shift to digital manufacturing. 
For each of the performance obligations classified as software revenue, the performance obligations are satisfied evenly over the term of the contract. For contracts including performance obligations classified as software revenue, the Company identified that each performance obligation has an explicitly stated standalone selling price. As such, allocation is not necessary as the prices included in the contract are attributed to each separate performance obligation.
The following table presents our revenues disaggregated by revenue discipline:
 
    
Three Months Ended
September 30,
    
Nine Months Ended
September 30,
 
    
2021
    
2020
    
2021
    
2020
 
Major products/service lines:
                                   
Direct sales
   $ 5,985      $ 5,994      $ 19,068      $ 16,827  
Marketplace sales
     1,663        2,091        6,062        6,060  
Software
     68        22        224        141  
    
 
 
    
 
 
    
 
 
    
 
 
 
Total revenue
   $ 7,716      $ 8,107      $ 25,354      $ 23,028  
    
 
 
    
 
 
    
 
 
    
 
 
 
Timing of revenue recognition:
                                   
Products transferred at a point in time
   $ 1,663      $ 2,091      $ 6,062      $ 6,060  
Products and services transferred over time
     6,053        6,016        19,292        16,968  
    
 
 
    
 
 
    
 
 
    
 
 
 
Total revenue
   $ 7,716      $ 8,107      $ 25,354      $ 23,028  
    
 
 
    
 
 
    
 
 
    
 
 
 
Deferred Revenue
The Company records deferred revenue when cash payments are received in advance of performance.
 
Deferred revenue activity consisted of the following for the nine months ended September 30, 2021:
 
    
Deferred Revenue
 
Balance at January 1, 2021
   $ 753  
Deferred revenue recognized during period
     (25,354
Additions to deferred revenue during period
     25,259  
    
 
 
 
Balance at September 30, 2021
   $ 658  
    
 
 
 
The Company expects to satisfy its remaining performance obligations within the next twelve months. The $753 of deferred revenue as of January 1, 2021 was recognized during the nine months ended September 30, 2021. The opening balance of accounts receivable as of January 1, 2020 was $151.
Practical Expedients and Exemptions
We apply the practical expedient related to incremental costs of obtaining a contract. Although certain of our commission costs qualify for capitalization under ASC
340-40,
Contracts with customers, their amortization period is less than one year. Therefore, utilizing the practical expedient, we expense these costs as incurred.
XML 22 R11.htm IDEA: XBRL DOCUMENT v3.21.2
Inventory
9 Months Ended
Sep. 30, 2021
Inventory Disclosure [Abstract]  
Inventory
Note 5. Inventory
Components of inventory consisted of the following:
 
    
September 30,
2021
    
December 31,
2020
 
Raw materials
   $ 418      $ 521  
Work-in-process
     40        36  
Finished goods
     115        170  
    
 
 
    
 
 
 
Total
   $ 573      $ 727  
    
 
 
    
 
 
 
XML 23 R12.htm IDEA: XBRL DOCUMENT v3.21.2
Prepaid Expenses and Other Current Assets
9 Months Ended
Sep. 30, 2021
Prepaid Expense and Other Assets, Current [Abstract]  
Prepaid Expenses and Other Current Assets
Note 6. Prepaid Expenses and Other Current Assets
Prepaid expenses and other current assets consisted of the following:
 
    
September 30,
2021
    
December 31,
2020
 
Prepaid expenses
   $ 698      $ 646  
Security deposits
     259        259  
VAT receivable
     950        975  
Other current assets
     1        30  
    
 
 
    
 
 
 
Total
   $ 1,908      $ 1,910  
    
 
 
    
 
 
 
XML 24 R13.htm IDEA: XBRL DOCUMENT v3.21.2
Property and Equipment, net
9 Months Ended
Sep. 30, 2021
Property, Plant and Equipment [Abstract]  
Property and Equipment, net
Note 7. Property and Equipment, net
Property and equipment consisted of the following:
 
    
September 30,
2021
    
December 31,
2020
 
Machinery and equipment
   $ 1,388      $ 1,430  
Computers and IT equipment
     5,631        5,193  
Furniture and fixtures
     49        50  
Leasehold improvements
     2,477        2,520  
    
 
 
    
 
 
 
       9,545        9,193  
Less: Accumulated depreciation
     (8,455      (8,245
    
 
 
    
 
 
 
Property and equipment, net
   $ 1,090      $ 948  
    
 
 
    
 
 
 
 
For the three months ended September 30, 2021 and 2020, depreciation expense totaled $146 and $115, respectively. For the nine months ended September 30, 2021 and 2020, depreciation expense totaled $424 and $362, respectively. Of these amounts, depreciation charged to cost of revenue was $113 and $78 for the three months ended September 30, 2021 and 2020, respectively, and $324 and $249 for the nine months ended September 30, 2021 and 2020, respectively.
XML 25 R14.htm IDEA: XBRL DOCUMENT v3.21.2
Accrued Expenses and Other Liabilities
9 Months Ended
Sep. 30, 2021
Accrued Expenses And Other Liabilities Current [Abstract]  
Accrued Expenses and Other Liabilities
Note 8. Accrued Expenses and Other Liabilities
Accrued expenses consisted of the following:
 
 
  
September 30,
2021
 
  
December 31,
2020
 
Accrued selling expenses
   $ 712      $ 947  
Accrued compensation
     757        876  
Interest payable
     —          612  
Taxes payable
     306        477  
Accrued transaction costs
  
 
450
 
  
 
—  
 
Accrued acquisition of property and equipment
     441        —    
Shapeways credits
     300        313  
Other
     734        94  
    
 
 
    
 
 
 
Total
   $ 3,700      $ 3,319  
    
 
 
    
 
 
 
XML 26 R15.htm IDEA: XBRL DOCUMENT v3.21.2
Commitments and Contingencies
9 Months Ended
Sep. 30, 2021
Commitments and Contingencies Disclosure [Abstract]  
Commitments and Contingencies
Note 9. Commitments and Contingencies
Leases
During the
three
a
nd
nine months ended September 30, 2021, the Company maintained three leases of facilities located in the United States and the Netherlands, as well as, one lease of office equipment, under operating leases. The Company maintained one additional lease of equipment under a finance lease arrangement which expired during the nine months ended September 30, 2020. Additionally, the Company terminated one lease of office space during the nine months ended September 30, 2021.
The table below presents certain information related to the Company’s lease costs:
 
 
  
Three Months Ended
September 30,
 
  
Nine Months Ended
September 30,
 
 
  
2021
 
  
2020
 
  
2021
 
  
2020
 
Operating lease expense
   $ 144      $ 482      $ 696      $ 1,585  
Finance lease expense
     —          —          —          16  
Interest expense on finance lease liabilities
     —          —          —          1  
Short-term lease expense
     —          —          —          14  
    
 
 
    
 
 
    
 
 
    
 
 
 
Total lease cost
   $ 144      $ 482      $ 696      $ 1,616  
    
 
 
    
 
 
    
 
 
    
 
 
 
 
Right of use assets and lease liabilities for operating leases were
recorded
in the condensed consolidated balance sheets as follows:
 
    
September 30,
2021
    
December 31,
2020
 
Assets:
                 
Right-of-use
assets, net
   $ 982      $ 2,102  
    
 
 
    
 
 
 
Total lease assets
   $ 982      $ 2,102  
    
 
 
    
 
 
 
Liabilities:
                 
Current liabilities:
                 
Operating lease liabilities, current
   $ 631      $ 1,222  
Non-current
liabilities:
                 
Operating lease liabilities, net of current portion
     499      $ 1,094  
    
 
 
    
 
 
 
Total lease liability
   $ 1,130      $ 2,316  
    
 
 
    
 
 
 
The Company’s lease agreements do not state an implicit borrowing rate; therefore, an internal incremental borrowing rate was determined based on information available at the lease commencement date for the purposes of determining the present value of lease payments. The incremental borrowing rate reflects the cost to borrow on a securitized basis in each market. The weighted-average remaining lease term for operating leases was 2.05 years and the weighted-average incremental borrowing rate was 5.34% as of September 30, 2021.
Supplemental cash flow information related to the Company’s leases was as follows:
 
    
Nine Months Ended
September 30,
 
    
2021
    
2020
 
Operating cash flows from operating leases
   $ 762      $ 1,754  
Operating cash flows from finance leases
     —          1  
Financing cash flows from finance leases
     —          18  
Lease liabilities arising from obtaining
right-of-use
assets
     —          4,025  
As of September 30, 2021, future
minimum
lease payments required under operating leases are as follows:
 
Rest of 2021
   $ 167  
2022
     680  
2023
     214  
2024
     132  
2025
     1  
    
 
 
 
Total minimum lease payments
     1,194  
Less effects of discounting
     (64
    
 
 
 
Present value of future minimum lease payments
   $ 1,130  
    
 
 
 
Desktop Metal
On March 26, 2021, the Company entered into a non-binding Memorandum of Understanding (“MOU”) with Desktop Metal, pursuant to which Desktop Metal agreed to invest $20.0 million in the PIPE Investment. Upon consummation of this investment, the Company became obligated to purchase $20.0 million of equipment, materials and services from Desktop Metal. In conjunction with these obligations, the Company and Desktop Metal agreed to develop a strategic partnership. In November 2021, the Company paid $3.5 million to Desktop Metal for equipment received, and 
has a commitment to place purchase orders for another
 
$16.5 million
of equipment and materials under the MOU by or before December
3
1, 2021.
Legal Proceedings
The Company is involved in various legal proceedings which arise from time to time in the normal course of business. While the results of such matters generally cannot be predicted with certainty, management does not expect any such matters to have a material adverse effect on the Company’s condensed consolidated financial position or results of operations as of September 30, 2021 and December 31, 2020, and for the three and nine months ended September 30, 2021 and 2020.
XML 27 R16.htm IDEA: XBRL DOCUMENT v3.21.2
Borrowing Arrangements
9 Months Ended
Sep. 30, 2021
Debt Disclosure [Abstract]  
Borrowing Arrangements
Note 10. Borrowing Arrangements
The Company’s outstanding debt obligations consisted of the following:
 
 
  
September 30,
2021
 
  
December 31,
2020
 
Dutch Landlord Loan
   $ 127      $ 163  
Term Loan
            3,423  
Convertible Promissory Notes
     —          5,000  
PPP Loan
     —          1,982  
    
 
 
    
 
 
 
       127        10,568  
Less: current portion
     (39      (8,332
    
 
 
    
 
 
 
Long-term debt
   $ 88      $ 2,236  
    
 
 
    
 
 
 
Dutch Landlord Loan
On May 12
,
2014, the Company entered into a loan agreement with its landlord at the Eindhoven factory (the “Dutch Landlord Loan”) to advance
€242 (equivalent to $280 and $297
in total at September 30, 2021 and December 31, 2020, respectively) to finance leasehold improvements
.
The Dutch Landlord Loan is unsecured and required interest-only payments until September 30, 2016, followed by monthly payments of principal and interest. Interest accrues at 8.50% per annum through the maturity date on September 30, 2024.
For the three months ended September 30, 2021 and 2020, interest expense totaled $5, respectively. For the nine months ended September 30, 2021 and 2020, interest expense totaled $14, respectively.
Term Loan
On October 29, 2018, the Company entered into a loan and security agreement (the “Term Loan”) for the principal sum of $5,000 with a maturity date of October 29, 2022. The Term Loan requires interest-only payments until October 29, 2019, followed by monthly payments of principal and interest. Interest is payable at a rate equal to the prime rate, plus 0.25% per annum. At the Closing of the Business Combination, the Company repaid and terminated the Term Loan in full. As of December 31, 2020, the interest rate was 3.50%. In connection with the Term Loan, the bank is due a $75 fee in the event of a liquidity event valuing the Company above a certain threshold.
For the three months ended September 30, 2021 and 2020, interest expense totaled $12 and $36, respectively. For the nine months ended September 30, 2021 and 2020, interest expense totaled $66 and $129, respectively.
Convertible Promissory Notes
On June 19, 2019, the Company entered into note purchase agreements (the “Convertible Promissory Notes”) with certain stockholders of the Company for the aggregate principal sum of $5,000. The Convertible Promissory Notes bear interest at a rate of 8% per annum with all principal and interest due on or before the earlier of (i) December 19, 2020; and (ii) the closing of a Qualified Equity Financing, as defined below. The Convertible Promissory Notes are automatically converted into conversion shares upon the closing of a Qualified Equity Financing. Qualified Equity Financing is defined as the next sale by the Company of preferred stock following the date of the Convertible Promissory Notes on or prior to the maturity date with the principal purpose of raising capital. In the event there is a
non-Qualified
Equity Financing, the outstanding principal and unpaid accrued interest of each note may be converted, at the written election of the holders of the Convertible Promissory Notes, into conversion shares.
Non-Qualified
Equity Financing shall mean the next sale by the Company of its equity following the date of the Convertible Promissory Notes on or prior to the maturity date with the principal purpose of raising capital which is not a Qualified Equity Financing. If the next equity financing or a corporate transaction has not occurred on or before the maturity date of the Convertible Promissory Notes, the principal and unpaid accrued interest of each outstanding note may be converted, at the written election of each holder of the Convertible Promissory Notes, into conversion shares on the date of such written election. The number of conversion shares to be issued upon conversion shall be equal to the quotient obtained by dividing (i) the outstanding principal and unpaid accrued interest due on a Convertible Promissory Note to be converted on the date of the conversion by (ii) the Conversion Price. The conversion price is defined as the Discounted Conversion Price, which is 70% of the next equity price per share. The Convertible Promissory Notes are subordinated in right of payment to all indebtedness of the Company arising under the Term Loan. At inception, the terms of the notes gave rise to a contingent beneficial conversion feature.
On December 14, 2020, the Company executed an amendment to the Convertible Promissory Notes that extended the maturity date to August 10, 2021. All other relevant terms and conditions of the Convertible Promissory Notes remain binding.
Immediately prior to the completion of the Business Combination, the Convertible Promissory Notes in the aggregate principal amount of
$5,000
were converted into
 
1,434,391
shares of common stock of Legacy Shapeways (1,189,558 shares of Common Stock post Business Combination), and the related unpaid and accrued interest totaling
 
$
913
were
 
converted into
261,884
shares of common stock of Legacy
Shapeways (217,183 shares of Common Stock post Business Combination).
For the three months ended September 30, 2021 and 2020, interest expense totaled $109 and $100, respectively. For the nine months ended September 30, 2021 and 2020, interest expense totaled $309 and $300, respectively.
Paycheck Protection Program Loan
On May 4, 2020, the Company received an unsecured loan of $1,982 under the Paycheck Protection Program (the “PPP Loan”). The Paycheck Protection Program (or “PPP”) was established under the recently enacted CARES Act and is administered by the U.S. Small Business Administration (“SBA”). On May 4, 2020, the Company entered into a promissory note with Pacific Western Bank evidencing the unsecured PPP Loan.
The PPP Loan has a maturity date of May 4, 2022 and accrues interest at an annual rate of 1.00%. To the extent the loan amount is not forgiven under the PPP, the Company is obligated to make monthly payments of principal and interest, beginning six months from the date of the note, until the maturity date. In October 2020, the PPP Flexibility Act of 2020 extended the deferral period for borrower payments on all PPP loans from six months to ten months. Interest expense totaled $18 for the nine months ended September 30, 2021. There was no interest expense incurred for the nine months ended September 30, 2020.
The CARES Act and the PPP provide a mechanism for forgiveness of up to the full amount borrowed. Under the PPP, the Company may apply for and be granted forgiveness for all or part of the PPP Loan. The amount of the loan proceeds eligible for forgiveness is based on a formula that takes into account a number of factors, including the amount of loan proceeds used by the Company during the eight-week period after the loan origination for certain purposes including payroll costs, and certain rent payments, mortgage payments, and utility payments, provided that at least 75% of the loan amount is used for eligible payroll costs. Subject to the other requirements and limitations on loan forgiveness, only loan proceeds spent on payroll and other eligible costs during the covered eight-week period will qualify for forgiveness.
As of September 30, 2021, the full principal and interest amount of $2,000 of
the PPP Loan was forgiven and recorded in other income on the condensed consolidated statement of operations and comprehensive loss. Although the PPP Loan has been forgiven as of September 30, 2021, the Company intends to repay the PPP Loan in its entirety during the fourth quarter of 2021 and will reverse the previously recognized gain on debt forgiveness when repaid.
XML 28 R17.htm IDEA: XBRL DOCUMENT v3.21.2
Stockholders' Equity (Deficit)
9 Months Ended
Sep. 30, 2021
Stockholders' Equity Note [Abstract]  
Stockholders' Equity (Deficit)
Note 11. Stockholders’ Equity (Deficit)
The condensed consolidated statements of changes in stockholders’ equity (deficit) reflects the Business Combination as defined in Note 1 as of September 29, 2021. As Legacy Shapeways was deemed the accounting acquirer in the Business Combination with Galileo, all periods prior to the consummation date reflect the balances and activity of Legacy Shapeways. The balances as of January 1, 2021 and 2020 from the consolidated financial statements of Legacy Shapeways as of that date, share activity (convertible preferred stock, common stock, additional paid in capital, accumulated deficit, and accumulated other comprehensive loss) and per share amounts were retroactively adjusted, where applicable, using the recapitalization conversion ratio of
 0.8293
(the “Conversion Ratio”).
Common Stock
Upon closing of the Business Combination, pursuant to the terms of the Certificate of Incorporation, the Company authorized 120,000,000 shares of
C
ommon
S
tock with a par value $0.0001. The holders of
C
ommon
S
tock are entitled to one vote per share on all matters submitted to the stockholders for their vote or approval and are entitled to receive dividends, as and if declared by the Board out of legally available funds.
The Company has issued and outstanding 48,296,484 shares of
C
ommon
S
tock as of September 30, 2021.
Legacy Shapeways Common Stock Warrants
On December 18, 2013, in connection with executing a loan agreement, the Company issued warrants to purchase 40,000 shares of Legacy Shapeways common stock. The warrants had an exercise price of $1.25 per share and had an expiration date of December 18, 2023.
On February 3, 2014, in connection with executing a lease agreement, the Company issued warrants to purchase 248,000 shares of Legacy Shapeways common stock. The warrants had an exercise price of $1.25 per share and expired upon the latest to occur i) seven years from the original issuance date or ii) five years from the effective date of an initial public offering.
On April 22, 2015, in connection to an amended loan agreement, the Company issued warrants to purchase 13,750 shares of Legacy Shapeways common stock. The warrants had an exercise price of $1.70 per share and had an expiration date of April 22, 2025.
Immediately prior to the completion of the Business Combination, all outstanding Legacy Shapeways common stock warrants were exercised into an aggregate of 255,917
shares of Legacy Shapeways common stock (
212,234
shares of Common Stock post Business Combination).
Legacy Shapeways Convertible Preferred Stock
Immediately prior to the completion of the Business Combination, all outstanding shares of the Legacy Shapeways Series
A-1,
Series
A-2,
Series B, Series
B-1,
Series C, Series D, and Series E preferred stock converted into an aggregate of 22,579,695 shares of common stock. Each share of Legacy Shapeways convertible preferred stock was converted into one share of Legacy Shapeways common stock.
Legacy Shapeways Preferred Stock Warrants
On March 8, 2013, the Company issued warrants to purchase a total of 23,125 shares of Series
B-1
preferred stock of Legacy Shapeways. The warrants had an exercise price of $2.5946 per share and were exercisable for ten years from the date of grant. On May 10, 2021, the 23,125 warrants were exercised for 23,125 shares of Series
B-1
preferred stock of Legacy Shapeways at an exercise price of $2.5946 per share.
On June 30, 2017, in connection with executing a loan agreement, the Company issued warrants to purchase a total of 57,051 shares of Series D preferred stock of Legacy Shapeways. The warrants had an exercise price of $5.2584 per share and were exercisable for ten years from the date of grant. Immediately prior to the completion of the Business Combination, the 57,051 warrants were exercised for 107,580 shares of Legacy Shapeways common stock.
Public Warrants
Prior to the Merger, the Company had outstanding 13,800,000 Public Warrants. Each Public Warrant entitles the holder to purchase one share of
C
ommon
S
tock of the Company at an exercise price of $11.50 per share. The Public Warrants become exercisable 30 days after the Closing Date, and expire five years after the Closing Date or earlier upon redemption or liquidation.
The Company may redeem the Public Warrants as follows: in whole and not in part; at a price of $0.01 per warrant; at any time while the Public Warrants are exercisable, upon not less than 30 days’ prior written notice of redemption to each Public Warrant holder; if, and only if, the reported last sale price of the Company’s ordinary shares equals or exceeds $18.00 per share, for any 20 trading days within a
30-trading
day period ending on the third business day prior to the notice of redemption to the warrant holders; and if, and only if, there is a current registration statement in effect with respect to the ordinary shares underlying such warrants at the time of redemption and for the entire
30-day
trading period referred to above and continuing each day thereafter until the date of redemption. Certain of these conditions have not been met to redeem the Public Warrants. If the Company calls the Public Warrants for redemption, management will have the option to require all holders that wish to exercise the Public Warrants to do so on a “cashless basis,” as described in the warrant agreement.
As of September 30, 2021, there
we
re 13,800,000
Public Warrants outstanding.
XML 29 R18.htm IDEA: XBRL DOCUMENT v3.21.2
Stock-Based Compensation
9 Months Ended
Sep. 30, 2021
Share-based Payment Arrangement [Abstract]  
Stock-Based Compensation
Note 12. Stock-Based Compensation
2010 Stock Plan
Prior to the Business Combination, Legacy Shapeways maintained its 2010 Stock Plan (the “2010 Plan”), under which Legacy Shapeways granted statutory and
non-statutory
stock to employees, outside directors and consultants. The maximum number of shares of common stock that was issuable under the 2010 Plan was 16,942,546 shares.
In connection with the Business Combination, each Legacy Shapeways stock option that was outstanding immediately prior to Closing, whether vested or unvested, was converted into an option to acquire a number of shares of common stock (each such option, an “Exchanged Option”) equal to the product (rounded down to the nearest whole number) of (i) the number of shares of Legacy Shapeways common stock subject to such Legacy Shapeways option immediately prior to the Business Combination and (ii) 90% of the Conversion Ratio, at an exercise price per share (rounded up to the nearest whole cent) equal to (A) the exercise price per share of such Legacy Shapeways
option immediately prior to the consummation of the Business Combination, divided by (B) 90% of the Conversion Ratio. Except as specifically provided in the Business Combination Agreement, following the Business Combination, each Exchanged Option will continue to be governed by the same terms and conditions (including vesting and exercisability terms) as were applicable to the corresponding former Legacy Shapeways option immediately prior to the consummation of the Business Combination. All stock option activity was retroactively restated to reflect the Exchanged Options.
In addition, as discussed in Note 3, each holder of an
in-the-money
Legacy Shapeways option held by individuals remaining in continuous service to the Company through the Closing, was granted a right to receive an award of restricted stock units denominated in shares of common stock granted under the 2021 Plan (each, an “Earnout RSU”) equal to the product of (A) the number of shares of Legacy Shapeways common stock that were subject to the option immediately prior to Closing, multiplied by (B) ten percent
(10%)
of the Conversion
 
Ratio (rounded down to the nearest whole number of shares). The Earnout RSUs are subject to substantially the same service-based vesting conditions and acceleration provisions as applied to the Legacy Shapeways option provided that, in addition to such service-based vesting conditions, Earnout RSUs will be subject to vesting and forfeiture conditions based upon the dollar volume-weighted price of the Company’s
C
ommon
S
tock reaching certain targets (the “RSU Performance Milestones”).
If the service of the holder of an Earnout RSU terminates before the RSU Performance Milestones have been satisfied, then the portion of the Earnout RSUs for which the service-based vesting conditions has been satisfied (taking into account any acceleration provisions) shall remain outstanding and eligible to vest upon achievement of the applicable RSU Performance Milestone. Any Earnout RSUs for which the service-based vested conditions has not been satisfied as of such termination of service (taking into account any acceleration provisions) shall be forfeited and cancelled without payment. If any RSU Performance Milestone fails to be satisfied by the end of the Earnout Period, then the Earnout RSUs corresponding to such RSU Performance Milestone shall be forfeited and cancelled without payment as of the end of the Earnout Period.
Upon the Closing of the Business Combination, the outstanding and unexercised Legacy Shapeways options became options to purchase an aggregate of 4,901,207 shares of the Company’s Common Stock under the 2010 Plan at an average exercise price of $0.62 per share.
2021 Equity Incentive Plan
Upon
 the closing of the Business Combination, the Company adopted the 2021 Equity Incentive Plan (the “2021 Plan”). The 2021 Plan permits the granting of incentive stock options, restricted stock awards, other share-based awards or other cash-based awards to employees, consultants, and
non-employee
directors. As of September 30, 2021,
 
7,621,401
shares of
C
ommon
S
tock are authorized for issuance pursuant to awards under the 2021 Plan. As of September 30, 2021,
no
shares have been awarded and
7,621,401
shares remain available for issuance under the 2021 Plan.
Option Awards
The Company accounts for share-based payments pursuant to ASC 718,
Stock Compensation
and, accordingly, the Company records stock compensation expense for share-based awards based upon an assessment of the grant date fair value for stock options using the Black-Scholes option pricing model. The Company is a public company and lacks company-specific historical and implied volatility information. Therefore, it estimates its expected stock volatility based on the historical volatility of a publicly traded set of peer companies. Due to the lack of historical exercise history, the expected term of the Company’s stock options for employees has been determined utilizing the “simplified” method for awards. The risk-free interest rate is determined by reference to the U.S. Treasury yield curve. Expected dividend yield is zero based on the fact that the Company has never paid cash dividends and does not expect to pay any cash dividends in the foreseeable future.
The fair value of stock options under the Black-Scholes model requires management to make assumptions regarding projected employee stock option exercise behaviors, risk-free interest rates, volatility of the Company’s stock price and expected dividends. The Company generally recognizes stock compensation expense on the grant date and over the period of vesting or period that services will be provided. The assumptions used to estimate the fair value of stock options granted during the periods presented were as follows:
 
 
  
Three and Nine Months Ended
September 30,
 
 
  
2021
 
 
2020
 
Strike price
   $ 0.17      $ 0.37  
Expected term (in years)
     5.55 - 6.05        5.00 - 6.04  
Expected volatility
    
57.09% - 57.81
    
49.15% - 52.41
Risk-free interest rate
     0.50% - 0.57
     0.37% - 1.46
Dividend yield
     —          —    
The following table summarizes the Company’s stock option plan and the activity:
 
    
Shares
Underlying
Options
    
Weighted
Average Exercise
Price
    
Weighted
Average
Remaining
Contractual
Term (in years)
 
Outstanding at January 1, 2021 (as previously reported)
     8,247,340      $ 0.44        6.72  
Retroactive application of reverse recapitalization
     (1,967,440      —          —    
    
 
 
    
 
 
    
 
 
 
Outstanding as of January 1, 2021, effect of Merger
     6,279,900      $ 0.58        6.64  
Granted
     29,420        0.36        9.82  
Forfeited
     (145,878      0.43        —    
Exercised
     (35,895      0.43        —    
    
 
 
    
 
 
    
 
 
 
Outstanding at March 31, 2021
     6,127,547      $ 0.58        6.53  
Granted
     —           —           —    
Forfeited
     (39,309      0.44        —    
Exercised
     (63,506      0.45        —    
    
 
 
    
 
 
    
 
 
 
Outstanding at June 30, 2021
     6,024,732      $ 0.59        6.26  
Granted
     —           —           —    
Forfeited
     (10,496      0.40        —    
Exercised
     (1,113,029      0.44        —    
    
 
 
    
 
 
    
 
 
 
Outstanding at September 30, 2021
     4,901,207      $ 0.62        6.80  
    
 
 
    
 
 
    
 
 
 
Exercisable at September 30, 2021
     4,833,059      $ 0.62        6.79  
    
 
 
    
 
 
    
 
 
 
The aggregate intrinsic value in the above table is calculated as the difference between fair value of the Company’s
C
ommon
Stock
price and the exercise price of the stock options. The weighted-average grant-date fair value per stock option granted during the nine months ended September 30, 2021 and 2020 was $0.36 and $0.50, respectively. As of September 30, 2021, approximately $193 of unrecognized compensation expense related to
non-vested
awards is expected to be recognized over the weighted average period of 1.80 years.
2021 Employee Stock Purchase Plan
Upon
 the closing of the Business Combination, the Company adopted the 2021 Employee Stock Purchase Plan (the “ESPP”). The purpose of the ESPP is to provide eligible employees with an opportunity to increase their proprietary interest in the success of the Company by purchasing Common Stock from the Company on favorable terms and to pay for such purchases through payroll deductions or other approved contributions. As of September 30, 2021, 895,721 shares of Common Stock are available for purchase under the ESPP. As of September 30, 2021, no shares have been purchased under the ESPP.
XML 30 R19.htm IDEA: XBRL DOCUMENT v3.21.2
Fair Value Measurements
9 Months Ended
Sep. 30, 2021
Fair Value Disclosures [Abstract]  
Fair Value Measurements
Note 13. Fair Value Measurements
Fair value measurements discussed herein are based upon certain market assumptions and pertinent information available to management as of September 30, 2021 and December 31, 2020. The carrying amounts of accounts receivable, inventory, prepaid expenses and other current assets, accounts payable, accrued expenses and other liabilities, and deferred revenue approximated fair value as they are short term in nature. The fair value of warrants issued for settlement and services are estimated based on the Black-Scholes model. The carrying value of the Company’s debt and operating lease liabilities approximated its fair value, as the obligation bears interest at rates currently available for debt with similar maturities and collateral requirements.
Fair Value on a Recurring Basis
The Company follows the guidance in ASC 820 for its financial assets and liabilities that are
re-measured
and reported at fair value at each reporting period, and
non-financial
assets and liabilities that are
re-measured
and reported at fair value at least annually. The estimated fair value of the warrant liabilities represent Level 3 measurements. The following table presents information about the Company’s liabilities that are measured at fair value on a recurring basis at September 30, 2021 and December 31, 2020, and indicates the fair value hierarchy of the valuation inputs the Company utilized to determine such fair value:
 
Description
  
Level
 
  
September 30,
2021
 
  
December 31,
2020
 
Liabilities:
  
     
  
     
  
     
Warrant liabilities
     3      $ 6,777      $ —    
Warrant Liabilities
Prior to the Business Combination, the Company had outstanding 4,110,000
warrants
(the “Private Warrant”) that were issued upon the consummation of the initial public offering of Galileo. Additionally, at the Closing, a lender holding a convertible note issued by the Company with an aggregate principal amount of $500 converted the note into 500,000 warrants (the “Sponsor Warrants”) exercisable for
C
ommon
S
tock at a purchase price of $1.00 per warrant.
The Private Warrants and Sponsor
Warrants
are identical to the Public Warrants except that the Private and Sponsor Warrants (i) are not redeemable by the Company and (ii) may be exercised for cash or on a cashless basis, so long as they are held by the initial purchaser or any of its permitted transferees. If the Private Warrants are held by someone other than the initial purchasers or their permitted transferees, the Private Warrants will be redeemable by the Company and exercisable by such holders on the same basis as the Public Warrants.
The Private and Sponsor Warrants are not indexed to the Company’s common shares in the manner contemplated by ASC
815-40-15
because the holder of the instrument is not an input into the pricing of a
fixed-for-fixed
option on equity shares. The Company classifies the Private and Sponsor Warrants as derivative liabilities in its unaudited condensed consolidated balance sheet as of September 30, 2021.
The Company utilizes a Binomial Lattice model approach to value the Private Warrants and Sponsor Warrants at each reporting period with changes in fair value recognized in the statement of operations. The estimated fair value of the warrant liabilities is determined using Level 3 inputs. Inherent in a binomial options pricing model are assumptions related to expected share-price volatility, expected life, risk-free interest rate and dividend yield. The Company estimates the volatility of its Common Stock based on historical volatility that matches the expected remaining life of the warrants. The risk-free interest rate is based on the U.S. Treasury
zero-coupon
yield curve on the grant date for a maturity similar to the expected remaining life of the warrants. The expected life of the warrants is assumed to be equivalent to their remaining contractual term. The dividend rate is based on the historical rate, which the Company anticipates to remain at zero.
The significant unobservable inputs used in the Binomial Lattice Model to measure the warrant liabilities that are categorized within Level 3 of the fair value hierarchy are as follows:
 
 
  
September 30,
2021
 
 
At Closing
(September 29, 2021)
 
Stock price on valuation date
   $ 7.70     $ 8.54  
Exercise price per share
   $ 11.50     $ 11.50  
Expected life
     5 years       5 years  
Volatility
     34.8 %
 
 
    43.9
Risk-free rate
     1.0     1.0
Dividend yield
     —       —  
    
 
 
   
 
 
 
Fair value per warrant
   $ 1.47     $ 2.57  
    
 
 
   
 
 
 
 
 
The following table provides a summary of changes in fair value of the Company’s Level 3 financial instruments that are measured at fair value on a recurring basis:
 
    
Warrant
Liabilities
 
Balance at December 31, 2020
   $ —    
Additions pursuant to Merger
     11,865  
Change in fair value
     (5,088
    
 
 
 
Balance at September 30, 2021
   $ 6,777  
    
 
 
 
As of September 30, 2021, 4,110,000 Private Warrants and 500,000 Sponsor Warrants remain outstanding, respectively.
Fair Value on a
Non-Recurring
Basis
The fair value of the Earnout Shares has been estimated using the trading price of our
C
ommon
S
tock at Closing ($7.70), discounted based on the probability of the Earnout Terms being met as determined at Closing, and thus represents a Level 2 fair value measurement as defined in ASC 820. The Earnout Shares, if achieved, would be issued to Legacy Shapeways shareholders. The Earnout Shares are a fixed number of shares to be issued to such shareholders on a pro rata basis. The fair value of the Earnout Shares were recognized as a deemed dividend. Upon closing of the Merger, the estimated fair value of the Earnout Shares was $18,132 with such amount recognized as a deemed dividend. As the Company is in an accumulated deficit position as of the measurement date, the resulting deemed dividend is recorded as a reduction of additional
paid-in
capital with a corresponding offset recorded to additional
paid-in
capital.
XML 31 R20.htm IDEA: XBRL DOCUMENT v3.21.2
Significant Concentrations
9 Months Ended
Sep. 30, 2021
Risks and Uncertainties [Abstract]  
Significant Concentrations
Note 14. Significant Concentrations
One customer accounted for approximately 22% and 23% of revenue for the three months ended September 30, 2021 and 2020, respectively. No other customers represented more than 10% of revenue for the three months ended September 30, 2021 and 2020.
One customer accounted for approximately 23% and 22% of revenue for the nine months ended September 30, 2021 and 2020, respectively. No other customers represented more than 10% of revenue for the nine months ended September 30, 2021 and 2020.
One vendor accounted for approximately 15% of purchases for the nine months ended September 30, 2021. No other vendors represented more than 10% of purchases for the nine months ended September 30, 2021 and 2020.
As of September 30, 2021 and December 31, 2020, one customer accounted for approximately 55% and 32% of accounts receivable, respectively. No other customers represented more than 10% of outstanding accounts receivable as of September 30, 2021 and December 31, 2020.
As of September 30, 2021, four vendors accounted for approximately 19%, 12%, 12%, and 11% of accounts payable. As of December 31, 2020, five vendors accounted for approximately 18%, 15%, 15%, 11% and 10% of accounts payable. No other vendors represented more than 10% of outstanding accounts payable balance as of September 30, 2021 and December 31, 2020.
XML 32 R21.htm IDEA: XBRL DOCUMENT v3.21.2
Related Party Transactions
9 Months Ended
Sep. 30, 2021
Related Party Transactions [Abstract]  
Related Party Transactions
Note 15. Related Party Transactions
During 2012, the Company signed a $175 promissory note (the “Related Party Note”) with an officer of the Company, bearing interest equal to the greater of (a) 0.88% per annum or (b) the
mid-term
Applicable Federal Rate under Section 1274(d) of the Internal Revenue Code in effect during the time the note is outstanding. The average interest rates for the nine months ended September 30, 2021 and 2020 were 0.84% and 0.90%, respectively. On May 12, 2020, the Related Party Note was amended to extend the maturity date such that the remainder of the principal and accrued interest be due and payable on August 10, 2021. The Related Party Note was secured by the assets of the borrower. Immediately prior to the completion of the Business Combination, the Company entered into a stock repurchase agreement with the holder of the Related Party Note to which the Company repurchased 19,226 shares of
C
ommon
S
tock held by the holder in exchange for settlement of the Related Party Note.
XML 33 R22.htm IDEA: XBRL DOCUMENT v3.21.2
Subsequent Events
9 Months Ended
Sep. 30, 2021
Subsequent Events [Abstract]  
Subsequent Events
Note 16. Subsequent Events
The Company has evaluated all known subsequent events through November 15, 2021, which is the date these condensed consolidated financial statements were available to be issued, and has determined that no subsequent events have occurred requiring recognition or disclosure in these condensed consolidated financial statements.
XML 34 R23.htm IDEA: XBRL DOCUMENT v3.21.2
Summary of Significant Accounting Policies (Policies)
9 Months Ended
Sep. 30, 2021
Summary of Significant Accounting Policies  
Basis of Presentation and Principles of Consolidation
Basis of Presentation and Principles of Consolidation
The accompanying condensed consolidated interim financial statements have been prepared in accordance with accounting principles generally accepted in the United States of America (“U.S. GAAP”) for interim financial information as defined by the Financial Accounting Standards Board (“FASB”) Accounting Standards Codification (“ASC”) and in accordance with the instruction to Form
10-Q
and Article 8 of Regulation
S-X
of the SEC. Certain information or footnote disclosures normally included in financial statements prepared in accordance with GAAP have been condensed or omitted, pursuant to the rules and regulations of the SEC for interim financial reporting. Accordingly, they do not include all the information and footnotes necessary for a complete presentation of financial position, results of operations, or cash flows. The condensed consolidated financial statements include the accounts of its wholly owned subsidiaries, Legacy Shapeways and Shapeways BV. All intercompany accounts and transactions have been eliminated in consolidation. In the opinion of management, the accompanying condensed consolidated interim financial statements include all adjustments, consisting of a normal recurring nature, which are necessary for a fair presentation of the financial position, operating results and cash flows for the periods presented. These unaudited condensed consolidated interim financial statements should be read along with the final proxy statement/prospectus as filed with the SEC on September 7, 2021.
The Business Combination has been accounted for as a reverse recapitalization, in accordance with U.S. GAAP (the “Reverse Recapitalization”). Under this method of accounting, Galileo has been treated as the “acquired” company for financial reporting purposes. Accordingly, the Business Combination has been treated as the equivalent of Legacy Shapeways issuing stock for the net assets of Galileo, accompanied by a recapitalization. The net assets of Galileo are stated at historical cost, with no goodwill or other intangible assets recorded. There has been no accounting effect or change in the carrying amount of the assets and liabilities as a result of the Business Combination.
Legacy Shapeways has been treated as the accounting acquirer based on evaluation of the following facts and circumstances with regard to the Company as of the Closing:
 
 
 
Legacy Shapeways’ directors represented the majority of the new board of directors of the Company;
 
 
 
The executive officers and senior management of Legacy Shapeways are the executive officers and senior management of the Company;
 
 
 
The assets of Legacy Shapeways represent a significant majority of the assets of the Company (excluding cash formerly held in the Galileo trust account); and
 
   
The business of the Company will be the continued business of Legacy Shapeways. The business of the Company will continue to focus on Legacy Shapeways’ core offerings related to the facilitation of the sale, design and manufacturing of 3D printed items.
The consolidated assets, liabilities and results of operations prior to the Reverse Recapitalization are those of Legacy Shapeways. The shares and corresponding capital amounts and losses per share, prior to the Merger, have been retroactively adjusted based on shares reflecting the conversion ratio (as defined below) established in the Merger.
Use of Estimates
Use of Estimates
The preparation of the Company’s
unaudited
condensed consolidated financial statements, in conformity with U.S. GAAP, requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the condensed consolidated financial statements and reported amounts of revenues and expenses during the reporting period. Actual results may differ from those estimates.
In March 2020, the World Health Organization declared the outbreak of a novel coronavirus
(COVID-19)
as a pandemic, which continues to spread throughout the United States. While the disruption is currently expected to be temporary, there is uncertainty around the duration. The Company has considered information available to it as of the date of issuance of these unaudited condensed consolidated financial statements and is not aware of any specific events or circumstances that would require an update to its estimates or judgements, or an adjustment to the carrying value of its assets or liabilities. The accounting estimates and other matters assessed include, but were not limited to, goodwill and other long-lived assets, warrant liabilities and revenue recognition. These estimates may change as new events occur and additional information becomes available. Actual results could differ materially from these estimates.
Functional Currency
Functional Currency
The local currency is the functional currency for Shapeways BV’s (a
wholly
-owned subsidiary of the Company) operations outside the United States. Assets and liabilities of these operations are translated into U.S. Dollars at the exchange rate in effect at the end of each period. Income statement accounts are translated at the average exchange rate prevailing during the period. Translation adjustments arising from the use of differing exchange rates from period to period are included as a component of other comprehensive loss within stockholders’ equity (deficit). Gains and losses from foreign currency transactions are included in net loss for the period.
Cash, Cash Equivalents and Restricted Cash
Cash, Cash Equivalents
and
Restricted Cash
Cash includes cash on hand and demand deposits. The Company maintains its deposits at high quality financial institutions and monitors the credit ratings of those institutions. The Company considers all highly liquid investments with original maturities of three months or less to be cash equivalents. While cash held by financial institutions may at times exceed federally insured
limits
, the Company believes that no material credit or market risk exposure exists due to the high quality of the institutions. The Company has not experienced any losses on such accounts. Restricted cash represents cash required to be held as collateral for the Company’s credit cards and security deposit for our facility in the Netherlands. Accordingly, these balances contain restrictions as to their availability and usage and are classified as restricted cash in the condensed consolidated balance sheets.
The reconciliation of cash, cash equivalents and restricted cash reported within the applicable consolidated balance sheet that sum to the total of the same such amount shown in the condensed consolidated statements of cash flows is as follows:
 
 
  
September 30, 2021
 
  
December 31, 2020
 
Cash and cash equivalents
   $ 90,108      $ 8,564  
Restricted cash
     143        145  
    
 
 
    
 
 
 
     $ 90,251      $ 8,709  
    
 
 
    
 
 
 
Accounts Receivable
Accounts Receivable
Accounts receivables are recorded at the invoiced amount and are generally unsecured as they are uncollateralized. The Company provides an allowance for doubtful accounts to reduce receivables to their estimated net realizable value. Judgement is exercised in establishing allowances and estimates are based on the customers’ payment history and liquidity. Any amounts that were previously recognized as revenue and subsequently determined to be uncollectible are charged to bad debt expense included in selling, general and administrative expense in the accompanying condensed consolidated statements of operations and comprehensive loss. Given the nature and historical collectability of the Company’s accounts receivable, an allowance for doubtful accounts was not deemed necessary at September 30, 2021 and December 31, 2020.
Inventory
Inventory
Inventory consists of raw materials, work in progress and finished goods at the Company’s distribution center. Raw materials are stated at the lower of cost or net realizable value, determined by the
first-in-first-out
method. Finished goods and work in progress are valued using a methodology to determine the cost of each 3D printed object using allocations for material, labor, machine time and overhead. The Company periodically reviews its inventory for slow-moving, damaged and discontinued items and provides allowances to reduce such items identified to their recoverable amounts. As of September 30, 2021 and December 31, 2020, the Company determined an allowance was not deemed necessary.
Property and Equipment, net
Property and Equipment, net
Property and equipment are stated at cost, less accumulated depreciation. Maintenance and repairs are charged to expense when incurred. Additions and improvements that extend the economic useful life of the asset are capitalized and depreciated over the remaining useful lives of the assets. The cost and accumulated depreciation of assets sold or retired are removed from the respective accounts, and any resulting gain or loss is reflected in current earnings. No impairment charges were recorded for the periods ended September 30, 2021 and December 31, 2020. Depreciation is recognized using the straight-line method in amounts considered to be sufficient to allocate the cost of the assets to operations over the estimated useful lives or lease terms, as follows:
 
Asset Category
  
Depreciable Life
Machinery and equipment
   5 years
Computers and IT equipment
   3 years
Furniture and fixtures
   7 years
Leasehold improvements
   **
 
**
Leasehold improvements are amortized using the straight-line method over the shorter of the lease term or estimated useful life of the asset.
Long-Lived Assets, Including Definite-Lived Intangible Assets
Long-Lived Assets, Including Definite-Lived Intangible Assets
Intangible assets, which consist of technology, customer relationships, and trademarks, are stated at cost less accumulated amortization. Amortization is generally recorded on a straight-line basis over estimated useful lives ranging from three to eight years. The Company periodically reviews the estimated useful lives of intangible assets and adjusts when events indicate that a shorter life is appropriate. In accordance with authoritative accounting guidance, capitalization of costs to develop software begin when preliminary development efforts are successfully and completed. Costs related to the design or maintenance of
internal-use
software are expensed as incurred.
Long-lived assets, other than goodwill and other indefinite-lived intangibles, are evaluated for impairment whenever events or changes in circumstances indicate that the carrying amount of the assets may not be recoverable through the estimated undiscounted future cash flows derived from such assets.
Factors that the Company considers in deciding when to perform an impairment review include significant changes in the Company’s forecasted projections for the asset or asset group for reasons including, but not limited to, significant underperformance of a product in relation to expectations, significant changes, or planned changes in the Company’s use of the assets, significant negative industry or economic trends, and new or competing products that enter the marketplace. The impairment test is based on a comparison of the undiscounted cash flows expected to be generated from the use of the asset group. If impairment is indicated, the asset is written down by the amount by which the carrying value of the asset exceeds the related fair value of the asset with the related impairment charge recognized within the statements of operations and comprehensive loss. No impairment charges were recorded for the periods ended September 30, 2021 and December 31, 2020.
Goodwill
Goodwill
Goodwill, which represents the excess of purchase prices over the fair value of net assets acquired, is carried at cost. Goodwill is not amortized; rather, it is subject to a periodic assessment for impairment by applying a fair value-based test. Goodwill is evaluated for impairment on an annual basis at a level of reporting referred to as the reporting unit, and more frequently if adverse events or changes in circumstances indicate that the asset may be impaired.
Under ASC 350,
Intangibles - Goodwill and Other
,
the Company has the option to first assess the qualitative factors to determine whether it is more likely than not that the fair value of the reporting unit is less than its carrying amount as a basis for determining whether it is necessary to perform a quantitative goodwill impairment test. If the Company determines that it is more likely than not that
the fair value of a reporting unit is less than its carrying amount, then the goodwill impairment test is performed. Impairment tests are performed, at a minimum, in the fourth quarter of each year. Management uses the future discounted cash flows valuation approach to determine the fair value of reporting units and determines whether the fair value of reporting units exceeded its carrying amounts. If the fair value exceeds the carrying amount, then no impairment is recognized. If the carrying amount recorded exceeds the fair value calculated, then an impairment charge is recognized for the difference. The impairment review requires management to make judgments in determining various assumptions with respect to revenues, operating margins, growth rates and discount rates. The judgments made in determining the projected cash flows used to estimate the fair value can materially impact the Company’s financial condition and results of operations. There was no impairment of goodwill as of September 30, 2021 or December 31,
2020
.
Fair Value Measurements
Fair Value Measurements
The Company applies ASC 820,
Fair Value Measurement
(“ASC 820”), which establishes framework for measuring fair value and clarifies the definition of fair value within that framework. ASC 820 defines fair value as an exit price, which is the price that would be received for an asset or paid to transfer a liability in the Company’s principal or most advantageous market in an orderly transaction between market participants on the measurement date. The fair value hierarchy established in ASC 820 generally requires an entity to maximize the use of observable inputs and minimize the use of unobservable inputs when measuring fair value. Observable inputs reflect the assumptions that market participants would use in pricing the asset or liability and are developed based on market data obtained from sources independent of the reporting entity. Unobservable inputs reflect the entity’s own assumptions based on market data and the entity’s judgments about the assumptions that market participants would use in pricing the asset or liability and are to be developed based on the best information available in the circumstances.
The valuation hierarchy is composed of three levels. The classification within the valuation hierarchy is based on the lowest level of input that is significant to the fair value measurement. The levels within the valuation hierarchy are described below:
Level 1
-
Assets and liabilities with unadjusted, quoted prices listed on active market exchanges. Inputs to the fair value measurement are observable inputs, such as quoted prices in active markets for identical assets or liabilities.
Level 2
-
Inputs to the fair value measurement are determined using prices for recently traded assets and liabilities with similar underlying terms, as well as direct or indirect observable inputs, such as interest rates and yield curves that are observable at commonly quoted intervals.
Level 3
-
Inputs to the fair value measurement are unobservable inputs, such as estimates, assumptions, and valuation techniques when little or no market data exists for the assets or liabilities.
Revenue Recognition
Revenue Recognition
Revenue is derived from two primary sources: a) products and services and b) software.
The Company recognizes revenue following the five-step model prescribed under ASC 606: (i) identify contract(s) with a customer; (ii) identify the performance obligation(s) in the contract; (iii) determine the transaction price; (iv) allocate the transaction price to the performance obligation(s) in the contract; and (v) recognize revenue when (or as) the Company satisfies a performance obligation. The Company only applies the five-step model to contracts when it is probable that the Company will collect the consideration it is entitled to in exchange for the products or services it transfers to the customer. These contracts have different terms based on the scope, performance obligations, and complexity of the project, which often requires us to make judgments and estimates in recognizing revenues.
Performance obligations are satisfied both at a
point
of time and over time. All revenue is recognized based on the satisfaction of the performance obligation to date (see Note 4).
Leases
Leases
The Company’s lease arrangements relate primarily to office and manufacturing space, and equipment. The Company’s leases generally have initial terms ranging from 5 to 10 years and may include renewal options and rent escalation clauses. The Company is typically required to make fixed minimum rent payments relating to its right to use an underlying leased asset. Additionally, the Company’s leases do not contain significantly restrictive covenants or residual value guarantees.
The Company determines if an arrangement is a lease at inception and classifies its leases at commencement. Operating leases are presented as
right-of-use
(“ROU”) assets and the corresponding lease liabilities are included in operating lease liabilities, current and operating lease liabilities on the Company’s condensed consolidated balance sheets. The Company does not currently maintain any finance lease
arrangements. ROU assets represent the Company’s right to use an underlying asset, and lease liabilities represent the Company’s obligation for lease payments in exchange for the ability to use the asset for the duration of the lease term. The Company does not recognize short term leases that have a term of twelve months or less as ROU assets or lease liabilities. The Company’s short-term leases are not material and do not have a material impact on its ROU assets or lease liabilities.
ROU assets and lease
liabilities
are recognized at commencement date and determined using the present value of the future minimum lease payments over the lease term. The Company uses an incremental borrowing rate based on estimated rate of interest for collateralized borrowing since the Company’s leases do not include an implicit interest rate. The estimated incremental borrowing rate considers market data, actual lease economic environment, and actual lease term at commencement date. The lease term may include options to extend when it is reasonably certain that the Company will exercise that option. ROU assets include lease payments made in advance, and excludes any incentives received or initial direct costs incurred. The Company recognizes lease expense on a straight-line basis over the lease term
The Company has lease agreements which contain both lease and
non-lease
components, which it has elected to account for as a single lease component. As such, minimum lease payments include fixed payments for
non-lease
components within a lease agreement, but exclude variable lease payments not dependent on an index or rate, such as common area maintenance, operating expenses, utilities, or other costs that are subject to fluctuation from period to period.
Stock-based Compensation
Stock-based Compensation
The Company recognizes stock-based compensation expense for all options and other arrangements within the scope of ASC 718,
Stock Compensation
. Stock-based compensation expense is measured at the date of grant, based on the fair value of the award, and is recognized using the straight-line method over the employee’s requisite service period. Compensation for stock-based awards with vesting conditions other than service are recognized at the time that those conditions will be achieved. Forfeitures are recognized as they are incurred.
Public and Private Common Stock Warrant Liabilities
Public and Private Common Stock Warrant Liabilities
As part of Galileo’s initial public offering, Galileo issued to third party investors 13,800,000 units, consisting of one ordinary share of Galileo and one warrant, at a price of $10.00 per unit. Each whole warrant entitles the holder to purchase one share of 
C
ommon
S
tock at an exercise price of $11.50 per share (the “Public Warrants”). Simultaneously with the closing of Galileo’s initial public offering, Galileo completed the private sale of 4,110,000 warrants to Galileo’s sponsor and EarlyBirdCapital, Inc. at a purchase price of $1.00 per warrant (the “Private Warrants”). In connection with the Business Combination, Galileo’s sponsor exercised its right to convert the aggregate outstanding principal amount of the convertible promissory note issued by Galileo into an aggregate of 500,000 Sponsor Warrants, with terms equivalents to the Private Warrants.
The Private Warrants are
identical
to the Public Warrants, except that the Private Warrants (i) will not be redeemable by the Company and (ii) may be exercised for cash or on a cashless basis, so long as they are held by the initial purchaser or any of its permitted transferees. If the Private Warrants are held by holders other than the initial purchasers or any of their permitted transferees, the Private Warrants will be redeemable by the Company and exercisable by the holders on the same basis as the Public Warrants.
The Company evaluated the Public and Private Warrants under ASC
815-40,
Derivatives and Hedging—Contracts in Entity’s Own Equity
(“ASC
815-40”),
and concluded that the Private Warrants do not meet the criteria to be classified in stockholders’ equity. Since the Private Warrants meet the definition of a derivative under ASC 815, the Company recorded these warrants as liabilities on the condensed consolidated balance sheet at fair value, with subsequent changes in their respective fair values recognized in the condensed consolidated statement of operations at each reporting date.
Research and Development Costs
Research and Development Costs
Research and development expenses consist primarily of allocated personnel costs, fees paid to consultants and outside service providers, and allocations for rent and overhead. Research and development costs are expensed as incurred. Advance payments for goods and services that will be used in future research and development activities are expensed when the activity has been performed or when the goods have been received. For the three months ended September 30, 2021 and 2020, research and development costs were $1,673 and $1,516, respectively. For the nine months ended September 30, 2021 and 2020, research and development costs were $4,099 and $4,289, respectively.
Advertising
Advertising
Advertising costs are expensed as incurred. For the three months ended September 30, 2021 and 2020, advertising costs were $568 and $123, respectively. For the nine months ended September 30, 2021 and 2020, advertising costs were $1,008 and $353, respectively, which are included in selling, general and administrative expense on the
 condensed
consolidated statements of operations and comprehensive loss.
Income Taxes
Income Taxes
The Company files income tax returns in
the
U.S. federal jurisdiction and various state jurisdictions. Income taxes are accounted for under the asset and liability method. Deferred tax assets and liabilities are recognized for the estimated future tax consequences attributable to differences between the financial statement carrying amounts of existing assets and liabilities and their respective tax bases. Deferred tax assets and liabilities are measured using enacted tax rates in effect for the year in which those temporary differences are expected to be recovered or settled. Where applicable, the Company records a valuation allowance to reduce any deferred tax assets that it determines will not be realizable in the future.
The Company recognizes the benefit of an uncertain tax position that it has taken or expects to take on income tax returns it files if such tax position is more likely than not to be sustained on examination by the taxing authorities, based on the technical merits of the position. These tax benefits are measured based on the largest benefit that has a greater than 50% likelihood of being realized upon ultimate resolution. Although the Company believes that i
t
 has adequately reserved for uncertain tax positions (including interest and penalties), it can provide no assurance that the final tax outcome of these matters will not be materially different. The Company makes adjustments to these reserves in accordance with the income tax accounting guidance when facts and circumstances change, such as the closing of a tax audit or the refinement of an estimate. To the extent that the final tax outcome of these matters is different than the amounts recorded, such differences will affect the provision for income taxes in the period in which such determination is made, and could have a material impact on the Company’s financial condition and operating results. Carryforward attributes that were generated in tax years prior to those that remain open for examination may still be adjusted by relevant tax authorities upon examination if they either have been, or will be, used in a future period.
In applying the estimated annual effective tax rate approach prescribed under ASC 740,
Income Taxes,
based on present evidence and conclusions around the realizability of deferred tax assets, we determined that any deferred tax benefits related to the forecasted tax rate and pretax activity during the three and nine months ended September 30, 2021 and 2020 are neither more likely than not to be realized in the current year, nor realizable as a deferred tax asset at the end of the year. Therefore, the appropriate amount of income tax benefit to recognize related to deferred tax assets during the three and nine months ended September 30, 2021 and 2020 is zero. The Company’s effective tax rate of
(1.78)%
for the nine months ended September 30, 2021 differs from the applicable statutory tax rate primarily due to the fact that income recognized for the forgiveness of loans granted under the PPP loan program and changes in the fair value of warrant liabilities are not taxable under current U.S. tax law.
Income (Loss) per Share
Income (Loss) per Share
In accordance with the provisions of ASC 260,
Earnings Per Share
, net income (loss) per common share is computed by dividing net income (loss) by the weighted-average shares of Common Stock outstanding during the period. Basic income (loss) per share is computed by dividing net income (loss) attributable to common stockholders by the weighted average number of shares outstanding during the period. Diluted income (loss) per share gives effect to all dilutive potential common shares outstanding during the period including stock options and warrants, using the treasury stock method, and convertible debt and convertible securities, using the
if-converted
method. During a loss period, the effect of the potential exercise of stock options and convertible debt are not considered in the diluted loss per common share calculation since the effect would be anti-dilutive.
The following outstanding shares of Common Stock equivalents were excluded from the computation of the diluted net loss per share attributable to Common Stock for the periods in which a net loss is presented because their effect would have been anti-dilutive:
 
    
Three Months Ended
September 30,
    
Nine Months Ended
September 30,
 
    
2021
    
2020
    
2021
    
2020
 
Common stock warrants
     18,410,000        —          18,410,000        —    
Earnout Shares
     3,510,405        —          3,510,405        —    
Included in income (loss) per common share are 
4,833,059 and 3,673,963 shares of
options
due to their nominal exercise prices as of September 30, 2021 and 2020, respectively.
Segment Information
Segment Information
The Company has determined that it operates and reports in one segment, which focuses on providing additive manufacturing services to customers. The Company’s operating segment is reported in a manner consistent with the internal reporting provided to the chief operating decision maker (“CODM”). The Company’s CODM has been identified as its Chief Executive Officer.
Recent Accounting Standards
Recent Accounting Pronouncements
Accounting Pronouncements Recently Adopted
In January 2017, the FASB issued Accounting Standard Update (“ASU”)
No. 2017-04,
Intangibles—Goodwill and Other (Topic 350): Simplifying the Test for Goodwill Impairment,
which aims to simplify the subsequent measurement of goodwill by eliminating Step 2 from the goodwill impairment test. Under the new guidance, goodwill impairment will be measured as the amount by which the carrying value exceeds the fair value. The loss recognized should not exceed the total amount of goodwill allocated to the reporting unit. The standard is effective for annual and interim reporting periods beginning after December 15, 2021. Early adoption is permitted. The Company adopted ASU
2017-04
effective January 1, 2021. The adoption of this standard did not have a significant impact on the Company’s condensed consolidated financial statements.
In December 2019, the FASB issued ASU
No. 2019-12,
Income Taxes (Topic 740): Simplifying the Accounting for Income Taxes
. The purpose of Update
No. 2019-12
is to continue the FASB’s Simplification Initiative to reduce complexity in accounting standards. The amendments in Update
No. 2019-12
simplify the accounting for income taxes by removing certain exceptions related to the incremental approach for intraperiod tax allocation, the requirement to recognize or derecognize deferred tax liabilities related to equity method investments that are also foreign subsidiaries, and the methodology for calculating income taxes in an interim period. In addition to removing these exceptions, Update
No. 2019-12
also clarifies and simplifies other aspects of the accounting for income taxes. The Company adopted ASU
2019-12
effective January 1, 2021. The adoption of this standard did not have a significant impact on the Company’s condensed consolidated financial statements.
In August 2020, the FASB issued ASU
2020-06,
Debt — Debt with Conversion and Other Options (Subtopic
470-20)
and Derivatives and Hedging — Contracts in Entity’s Own Equity (Subtopic
815-40):
Accounting for Convertible Instruments and Contracts in an Entity’s Own Equity
, which simplifies the accounting for convertible instruments by removing certain separation models in Subtopic
470-20,
Debt—Debt with Conversion and Other Options, for convertible instruments and also increases information transparency by making disclosure amendments. The standard is effective for fiscal years beginning after December 15, 2023, including interim periods within those fiscal years. Early adoption is permitted, but no earlier than fiscal years beginning after December 15, 2020, including interim periods within those fiscal years. The Company adopted ASU
2020-06
effective January 1, 2021. The adoption of this standard did not have a significant impact on the Company’s condensed consolidated financial statements.
In August 2018, the FASB issued ASU
No. 2018-15,
Intangibles – Goodwill and Other –
Internal-Use
Software (Subtopic
350-40):
Customer’s Accounting for Implementation Costs Incurred in a Cloud Computing Arrangement That Is a Service Contract
, which aligns the requirements for capitalizing implementation costs incurred in a hosting arrangement that is a service contract with the requirements for capitalizing implementation costs incurred to develop or obtain
internal-use
software (and hosting arrangements that include an
internal-use
software license). The standard is effective for annual reporting periods beginning after December 15, 2020 and interim periods within annual periods beginning after December 15, 2021. Early adoption is permitted. The Company adopted ASU 2018-15 effective January 1, 2021. The adoption of this standard did not have a significant impact on the Company’s condensed consolidated financial statements.
Accounting Pronouncements Not Yet Adopted
In June 2016, the FASB issued ASU No. 2016-13, Accounting for Credit Losses (Topic 326), which requires the use of an “expected loss” model on certain types of financial instruments. The standard also amends the impairment model for available-for-sale debt securities and requires estimated credit losses to be recorded as allowances instead of reductions to amortized cost of the securities. Update No. 2016-13 is effective for annual periods beginning after December 15, 2022, including interim periods within those annual periods. Early adoption is permitted, including adoption in an interim period. The Company is currently evaluating the impact the standard will have on its condensed consolidated financial statements.
XML 35 R24.htm IDEA: XBRL DOCUMENT v3.21.2
Summary of Significant Accounting Policies (Tables)
9 Months Ended
Sep. 30, 2021
Summary of Significant Accounting Policies  
Summary Of Reconciliation Of Cash And Cash Equivalents
The reconciliation of cash, cash equivalents and restricted cash reported within the applicable consolidated balance sheet that sum to the total of the same such amount shown in the condensed consolidated statements of cash flows is as follows:
 
 
  
September 30, 2021
 
  
December 31, 2020
 
Cash and cash equivalents
   $ 90,108      $ 8,564  
Restricted cash
     143        145  
    
 
 
    
 
 
 
     $ 90,251      $ 8,709  
    
 
 
    
 
 
 
Summary Of Useful Lives Of Property Plant And Equipment
 
Asset Category
  
Depreciable Life
Machinery and equipment
   5 years
Computers and IT equipment
   3 years
Furniture and fixtures
   7 years
Leasehold improvements
   **
Summary Of Common Stock equivalents Outstanding Were Excluded From Computation Of Diluted Net Loss Per Share
The following outstanding shares of Common Stock equivalents were excluded from the computation of the diluted net loss per share attributable to Common Stock for the periods in which a net loss is presented because their effect would have been anti-dilutive:
 
    
Three Months Ended
September 30,
    
Nine Months Ended
September 30,
 
    
2021
    
2020
    
2021
    
2020
 
Common stock warrants
     18,410,000        —          18,410,000        —    
Earnout Shares
     3,510,405        —          3,510,405        —    
XML 36 R25.htm IDEA: XBRL DOCUMENT v3.21.2
Reverse Recapitalization (Tables)
9 Months Ended
Sep. 30, 2021
Reverse Recapitalization [Abstract]  
Schedule Of Common Stock Shares Issued Following The Consummation Of Merger
The following table reconciles the elements of the Business Combination to the unaudited condensed consolidated statement of cash flows for the nine months ended September 30, 2021:
 
    
Recapitalization
 
Cash - Galileo trust and cash, net of redemption
   $ 28,115  
Cash - PIPE Investment, net of transaction costs
     75,000  
Less: transaction costs and advisory fees allocated to equity
     (16,323
    
 
 
 
Effect of Merger, net of redemption, transaction costs and advisory costs
   $ 86,792  
    
 
 
 
Schedule of reconciles the elements of business combination to the unaudited consolidated statement of changes in stockholders equity
The following table reconciles the elements of the Business Combination to the unaudited condensed consolidated statement of changes in stockholders’ equity (deficit) for the three and nine months ended September 30, 2021:
 
    
Recapitalization
 
Cash - Galileo trust and cash, net of redemption
   $ 28,115  
Non-cash
net working capital assumed from Galileo
     46  
Less: fair value of Private and Sponsor Warrant liabilities
     (11,865
Less: transaction costs and advisory fees allocated to equity
     (6,260
    
 
 
 
Effect of Merger, net of redemption, transaction costs and advisory costs
   $ 10,036  
    
 
 
 
Schedule Of Common Stock Shares Issued Following The Consummation Of Business Combination
The following table details the number of shares of Common Stock issued immediately following the consummation of the Business Combination:
 
    
Number of Shares
 
Common stock, outstanding prior to Business Combination
     13,800,000  
Less: redemption of Galileo shares
     (11,018,352
    
 
 
 
Common stock of Galileo
     2,781,648  
Galileo founder and representative shares, net of forfeited shares
     2,910,000  
Shares issued in PIPE Investment
     7,500,000  
    
 
 
 
Merger and PIPE Investment - common stock
     13,191,648  
Legacy Shapeways shares - common stock
(1)
     35,104,836  
    
 
 
 
Total shares of common stock immediately after Business Combination
     48,296,484  
    
 
 
 
 
(1)
Includes 3,510,405 Earnout Shares
XML 37 R26.htm IDEA: XBRL DOCUMENT v3.21.2
Revenue Recognition (Tables)
9 Months Ended
Sep. 30, 2021
Revenue from Contract with Customer [Abstract]  
Summary of amount disaggregated by revenue
    
Three Months Ended
September 30,
    
Nine Months Ended
September 30,
 
    
2021
    
2020
    
2021
    
2020
 
Major products/service lines:
                                   
Direct sales
   $ 5,985      $ 5,994      $ 19,068      $ 16,827  
Marketplace sales
     1,663        2,091        6,062        6,060  
Software
     68        22        224        141  
    
 
 
    
 
 
    
 
 
    
 
 
 
Total revenue
   $ 7,716      $ 8,107      $ 25,354      $ 23,028  
    
 
 
    
 
 
    
 
 
    
 
 
 
Timing of revenue recognition:
                                   
Products transferred at a point in time
   $ 1,663      $ 2,091      $ 6,062      $ 6,060  
Products and services transferred over time
     6,053        6,016        19,292        16,968  
    
 
 
    
 
 
    
 
 
    
 
 
 
Total revenue
   $ 7,716      $ 8,107      $ 25,354      $ 23,028  
    
 
 
    
 
 
    
 
 
    
 
 
 
Summary of deferred revenue activity
    
Deferred Revenue
 
Balance at January 1, 2021
   $ 753  
Deferred revenue recognized during period
     (25,354
Additions to deferred revenue during period
     25,259  
    
 
 
 
Balance at September 30, 2021
   $ 658  
    
 
 
 
XML 38 R27.htm IDEA: XBRL DOCUMENT v3.21.2
Inventory (Tables)
9 Months Ended
Sep. 30, 2021
Inventory Disclosure [Abstract]  
Summary of components of inventory
    
September 30,
2021
    
December 31,
2020
 
Raw materials
   $ 418      $ 521  
Work-in-process
     40        36  
Finished goods
     115        170  
    
 
 
    
 
 
 
Total
   $ 573      $ 727  
    
 
 
    
 
 
 
XML 39 R28.htm IDEA: XBRL DOCUMENT v3.21.2
Prepaid Expenses and Other Current Assets (Tables)
9 Months Ended
Sep. 30, 2021
Prepaid Expense and Other Assets, Current [Abstract]  
Summary of prepaid expenses and other current assets
    
September 30,
2021
    
December 31,
2020
 
Prepaid expenses
   $ 698      $ 646  
Security deposits
     259        259  
VAT receivable
     950        975  
Other current assets
     1        30  
    
 
 
    
 
 
 
Total
   $ 1,908      $ 1,910  
    
 
 
    
 
 
 
XML 40 R29.htm IDEA: XBRL DOCUMENT v3.21.2
Property and Equipment, net (Tables)
9 Months Ended
Sep. 30, 2021
Property, Plant and Equipment [Abstract]  
Summary of property and equipment
    
September 30,
2021
    
December 31,
2020
 
Machinery and equipment
   $ 1,388      $ 1,430  
Computers and IT equipment
     5,631        5,193  
Furniture and fixtures
     49        50  
Leasehold improvements
     2,477        2,520  
    
 
 
    
 
 
 
       9,545        9,193  
Less: Accumulated depreciation
     (8,455      (8,245
    
 
 
    
 
 
 
Property and equipment, net
   $ 1,090      $ 948  
    
 
 
    
 
 
 
XML 41 R30.htm IDEA: XBRL DOCUMENT v3.21.2
Accrued Expenses and Other Liabilities (Tables)
9 Months Ended
Sep. 30, 2021
Accrued Expenses And Other Liabilities Current [Abstract]  
Summary of accrued expenses and other liabilities
 
 
  
September 30,
2021
 
  
December 31,
2020
 
Accrued selling expenses
   $ 712      $ 947  
Accrued compensation
     757        876  
Interest payable
     —          612  
Taxes payable
     306        477  
Accrued transaction costs
  
 
450
 
  
 
—  
 
Accrued acquisition of property and equipment
     441        —    
Shapeways credits
     300        313  
Other
     734        94  
    
 
 
    
 
 
 
Total
   $ 3,700      $ 3,319  
    
 
 
    
 
 
 
XML 42 R31.htm IDEA: XBRL DOCUMENT v3.21.2
Commitments and Contingencies (Tables)
9 Months Ended
Sep. 30, 2021
Commitments and Contingencies Disclosure [Abstract]  
Summary of certain information related to the lease costs
 
 
  
Three Months Ended
September 30,
 
  
Nine Months Ended
September 30,
 
 
  
2021
 
  
2020
 
  
2021
 
  
2020
 
Operating lease expense
   $ 144      $ 482      $ 696      $ 1,585  
Finance lease expense
     —          —          —          16  
Interest expense on finance lease liabilities
     —          —          —          1  
Short-term lease expense
     —          —          —          14  
    
 
 
    
 
 
    
 
 
    
 
 
 
Total lease cost
   $ 144      $ 482      $ 696      $ 1,616  
    
 
 
    
 
 
    
 
 
    
 
 
 
Summary of right of use assets and lease liabilities for operating leases
    
September 30,
2021
    
December 31,
2020
 
Assets:
                 
Right-of-use
assets, net
   $ 982      $ 2,102  
    
 
 
    
 
 
 
Total lease assets
   $ 982      $ 2,102  
    
 
 
    
 
 
 
Liabilities:
                 
Current liabilities:
                 
Operating lease liabilities, current
   $ 631      $ 1,222  
Non-current
liabilities:
                 
Operating lease liabilities, net of current portion
     499      $ 1,094  
    
 
 
    
 
 
 
Total lease liability
   $ 1,130      $ 2,316  
    
 
 
    
 
 
 
Summary of supplemental cash flow information related to the Company's leases
    
Nine Months Ended
September 30,
 
    
2021
    
2020
 
Operating cash flows from operating leases
   $ 762      $ 1,754  
Operating cash flows from finance leases
     —          1  
Financing cash flows from finance leases
     —          18  
Lease liabilities arising from obtaining
right-of-use
assets
     —          4,025  
Summary of future minimum lease payments required under operating leases
 
Rest of 2021
   $ 167  
2022
     680  
2023
     214  
2024
     132  
2025
     1  
    
 
 
 
Total minimum lease payments
     1,194  
Less effects of discounting
     (64
    
 
 
 
Present value of future minimum lease payments
   $ 1,130  
    
 
 
 
XML 43 R32.htm IDEA: XBRL DOCUMENT v3.21.2
Borrowing Arrangements (Tables)
9 Months Ended
Sep. 30, 2021
Debt Disclosure [Abstract]  
Summary of outstanding debt obligation
The Company’s outstanding debt obligations consisted of the following:
 
 
  
September 30,
2021
 
  
December 31,
2020
 
Dutch Landlord Loan
   $ 127      $ 163  
Term Loan
            3,423  
Convertible Promissory Notes
     —          5,000  
PPP Loan
     —          1,982  
    
 
 
    
 
 
 
       127        10,568  
Less: current portion
     (39      (8,332
    
 
 
    
 
 
 
Long-term debt
   $ 88      $ 2,236  
    
 
 
    
 
 
 
XML 44 R33.htm IDEA: XBRL DOCUMENT v3.21.2
Stock-Based Compensation (Tables)
9 Months Ended
Sep. 30, 2021
Share-based Payment Arrangement [Abstract]  
Summary of assumptions used to determine the fair value of the stock options The assumptions used to estimate the fair value of stock options granted during the periods presented were as follows:
 
 
  
Three and Nine Months Ended
September 30,
 
 
  
2021
 
 
2020
 
Strike price
   $ 0.17      $ 0.37  
Expected term (in years)
     5.55 - 6.05        5.00 - 6.04  
Expected volatility
    
57.09% - 57.81
    
49.15% - 52.41
Risk-free interest rate
     0.50% - 0.57
     0.37% - 1.46
Dividend yield
     —          —    
Summary of stock option plan and the activity
The following table summarizes the Company’s stock option plan and the activity:
 
    
Shares
Underlying
Options
    
Weighted
Average Exercise
Price
    
Weighted
Average
Remaining
Contractual
Term (in years)
 
Outstanding at January 1, 2021 (as previously reported)
     8,247,340      $ 0.44        6.72  
Retroactive application of reverse recapitalization
     (1,967,440      —          —    
    
 
 
    
 
 
    
 
 
 
Outstanding as of January 1, 2021, effect of Merger
     6,279,900      $ 0.58        6.64  
Granted
     29,420        0.36        9.82  
Forfeited
     (145,878      0.43        —    
Exercised
     (35,895      0.43        —    
    
 
 
    
 
 
    
 
 
 
Outstanding at March 31, 2021
     6,127,547      $ 0.58        6.53  
Granted
     —           —           —    
Forfeited
     (39,309      0.44        —    
Exercised
     (63,506      0.45        —    
    
 
 
    
 
 
    
 
 
 
Outstanding at June 30, 2021
     6,024,732      $ 0.59        6.26  
Granted
     —           —           —    
Forfeited
     (10,496      0.40        —    
Exercised
     (1,113,029      0.44        —    
    
 
 
    
 
 
    
 
 
 
Outstanding at September 30, 2021
     4,901,207      $ 0.62        6.80  
    
 
 
    
 
 
    
 
 
 
Exercisable at September 30, 2021
     4,833,059      $ 0.62        6.79  
    
 
 
    
 
 
    
 
 
 
XML 45 R34.htm IDEA: XBRL DOCUMENT v3.21.2
Fair Value Measurements (Tables)
9 Months Ended
Sep. 30, 2021
Fair Value Disclosures [Abstract]  
Schedule of assets and liabilities that are measured at fair value on a recurring basis The following table presents information about the Company’s liabilities that are measured at fair value on a recurring basis at September 30, 2021 and December 31, 2020, and indicates the fair value hierarchy of the valuation inputs the Company utilized to determine such fair value:
 
Description
  
Level
 
  
September 30,
2021
 
  
December 31,
2020
 
Liabilities:
  
     
  
     
  
     
Warrant liabilities
     3      $ 6,777      $ —    
Schedule of key inputs
The significant unobservable inputs used in the Binomial Lattice Model to measure the warrant liabilities that are categorized within Level 3 of the fair value hierarchy are as follows:
 
 
  
September 30,
2021
 
 
At Closing
(September 29, 2021)
 
Stock price on valuation date
   $ 7.70     $ 8.54  
Exercise price per share
   $ 11.50     $ 11.50  
Expected life
     5 years       5 years  
Volatility
     34.8 %
 
 
    43.9
Risk-free rate
     1.0     1.0
Dividend yield
     —       —  
    
 
 
   
 
 
 
Fair value per warrant
   $ 1.47     $ 2.57  
    
 
 
   
 
 
 
Schedule of changes in the fair value of warrant liabilities
The following table provides a summary of changes in fair value of the Company’s Level 3 financial instruments that are measured at fair value on a recurring basis:
 
    
Warrant
Liabilities
 
Balance at December 31, 2020
   $ —    
Additions pursuant to Merger
     11,865  
Change in fair value
     (5,088
    
 
 
 
Balance at September 30, 2021
   $ 6,777  
    
 
 
 
XML 46 R35.htm IDEA: XBRL DOCUMENT v3.21.2
Organization (Details) - Shapeways Inc [Member]
Supplychainpartners in Millions, Customers in Millions
9 Months Ended
Sep. 30, 2021
Countries
Additivetechnolgies
Supplychainpartners
Customers
Materialsandfinishes
Subsidiary, Sale of Stock [Line Items]  
Number of manufacturing parts delivered | Supplychainpartners 21
Number of customers | Customers 1
Number of countries | Countries 160
Number of utilization of additive technologies | Additivetechnolgies 11
Minimum [Member]  
Subsidiary, Sale of Stock [Line Items]  
Number of materials and finishes | Materialsandfinishes 90
XML 47 R36.htm IDEA: XBRL DOCUMENT v3.21.2
Summary of Significant Accounting Policies (Details) - USD ($)
$ / shares in Units, $ in Thousands
3 Months Ended 9 Months Ended 12 Months Ended
Oct. 22, 2019
Sep. 30, 2021
Sep. 30, 2020
Sep. 30, 2021
Sep. 30, 2020
Dec. 31, 2020
Financing Receivable, Impaired [Line Items]            
Asset impairment charges       $ 0   $ 0
Goodwill impairment loss       0   $ 0
Research and development expense   $ 1,673 $ 1,516 4,099 $ 4,289  
Advertising expense   $ 568 $ 123 $ 1,008 $ 353  
Percentage of largest benefit greater than likelyhood of resolution for tax benefit measurement       50.00%    
Effective income tax reconciliation rate       1.78%    
Weighted average shares included in computation of earning per share       4,833,059   3,673,963
Tangible asset impairment charges       $ 0   $ 0
IPO [Member]            
Financing Receivable, Impaired [Line Items]            
Stock issued during period new shares issued 13,800,000          
Sale of stock price per share $ 10.00          
Warrants exercise price per share $ 11.50          
Private Placement [Member] | Private Warrants [Member]            
Financing Receivable, Impaired [Line Items]            
Stock issued during period new shares issued 4,110,000          
Warrants exercise price per share $ 1.00          
Convesrion of promissory note, warrants issued 500,000          
XML 48 R37.htm IDEA: XBRL DOCUMENT v3.21.2
Summary of Significant Accounting Policies - Summary of reconciliation of cash and cash equivalents (Details) - USD ($)
$ in Thousands
Sep. 30, 2021
Dec. 31, 2020
Cash and Cash Equivalents [Abstract]    
Cash and cash equivalents $ 90,108 $ 8,564
Restricted cash 143 145
Total $ 90,251 $ 8,709
XML 49 R38.htm IDEA: XBRL DOCUMENT v3.21.2
Summary of Significant Accounting Policies - Summary of useful lives of property plant and equipment (Details)
9 Months Ended
Sep. 30, 2021
Machinery and Equipment [Member]  
Property, Plant and Equipment [Line Items]  
Property, Plant and Equipment, Useful Life 5 years
Computers and IT equipment  
Property, Plant and Equipment [Line Items]  
Property, Plant and Equipment, Useful Life 3 years
Furniture and fixtures  
Property, Plant and Equipment [Line Items]  
Property, Plant and Equipment, Useful Life 7 years
Leasehold improvements  
Property, Plant and Equipment [Line Items]  
Property, Plant and Equipment, Useful Life 0 years
XML 50 R39.htm IDEA: XBRL DOCUMENT v3.21.2
Summary of Significant Accounting Policies - Summary of common stock equivalents outstanding were excluded from computation of diluted net loss per share (Details) - USD ($)
$ in Thousands
Sep. 30, 2021
Sep. 30, 2020
Equity [Abstract]    
Common stock warrants $ 18,410,000 $ 0
Earnout Shares $ 3,510,405 $ 0
XML 51 R40.htm IDEA: XBRL DOCUMENT v3.21.2
Reverse Recapitalization - Schedule of common stock shares issued following the consummation of merger (Details) - Reverse Recapitalization [Member] - Business Combination Elements To Unaudited consolidated Statement Of Cash Flows [Member]
$ in Thousands
9 Months Ended
Sep. 30, 2021
USD ($)
Schedule Of Reconciliation Of Elements Of The business Combination To The Unaudited Consolidated Of Cash Flows [Line Items]  
Less: transaction costs and advisory fees allocated to equity $ (16,323)
Effect of Merger, net of redemption, transaction costs and advisory costs 86,792
PIPE Investment [Member]  
Schedule Of Reconciliation Of Elements Of The business Combination To The Unaudited Consolidated Of Cash Flows [Line Items]  
Payments to Acquire Businesses, Gross 75,000
Galileo [Member]  
Schedule Of Reconciliation Of Elements Of The business Combination To The Unaudited Consolidated Of Cash Flows [Line Items]  
Payments to Acquire Businesses, Gross $ 28,115
XML 52 R41.htm IDEA: XBRL DOCUMENT v3.21.2
Reverse Recapitalization - Schedule of reconciles the elements of business combination to the unaudited consolidated statement of changes in stockholders equity (Details) - Reverse Recapitalization [Member] - Business Combination Elements To Unaudited consolidated Statement Of Equity [Member]
$ in Thousands
9 Months Ended
Sep. 30, 2021
USD ($)
Schedule Of Reconciliation Of Elements Of Business Combination to Changes In Stockholders Equity [Line Items]  
Cash - Galileo trust and cash, net of redemption $ 28,115
Less: transaction costs and advisory fees allocated to equity (6,260)
Effect of Merger, net of redemption, transaction costs and advisory costs 10,036
Private Sponsor Warrant Liabilities [Member]  
Schedule Of Reconciliation Of Elements Of Business Combination to Changes In Stockholders Equity [Line Items]  
Less: fair value of Private and Sponsor Warrant liabilities (11,865)
Galileo [Member]  
Schedule Of Reconciliation Of Elements Of Business Combination to Changes In Stockholders Equity [Line Items]  
Non-cash net working capital assumed from Galileo $ 46
XML 53 R42.htm IDEA: XBRL DOCUMENT v3.21.2
Reverse Recapitalization - Schedule of common stock shares issued following the consummation of business combination (Details)
9 Months Ended
Sep. 30, 2021
shares
Disclosure Of Common Stock Shares Issued Following The Consummation Of Business Combination [Line Items]  
Beginning Balance (in Shares) 32,170,068
Ending Balance (in shares) 48,296,484
Common Stock [Member]  
Disclosure Of Common Stock Shares Issued Following The Consummation Of Business Combination [Line Items]  
Beginning Balance (in Shares) 32,184,263
Ending Balance (in shares) 48,296,484
Reverse Recapitalization [Member] | PIPE Investment [Member]  
Disclosure Of Common Stock Shares Issued Following The Consummation Of Business Combination [Line Items]  
Stock issued during period new shares issued 7,500,000
Reverse Recapitalization [Member] | Founder and Representative Shares [Member]  
Disclosure Of Common Stock Shares Issued Following The Consummation Of Business Combination [Line Items]  
Stock issued during period new shares issued 2,910,000
Reverse Recapitalization [Member] | Common Stock [Member] | Merger And Investment [Member]  
Disclosure Of Common Stock Shares Issued Following The Consummation Of Business Combination [Line Items]  
Stock issued during period new shares issued 13,191,648
Reverse Recapitalization [Member] | Common Stock [Member] | Immediately After Business Combination [Member]  
Disclosure Of Common Stock Shares Issued Following The Consummation Of Business Combination [Line Items]  
Ending Balance (in shares) 48,296,484
Reverse Recapitalization [Member] | Galileo [Member]  
Disclosure Of Common Stock Shares Issued Following The Consummation Of Business Combination [Line Items]  
Less: redemption of Galileo shares (11,018,352)
Reverse Recapitalization [Member] | Galileo [Member] | Common Stock [Member]  
Disclosure Of Common Stock Shares Issued Following The Consummation Of Business Combination [Line Items]  
Stock issued during period new shares issued 2,781,648
Reverse Recapitalization [Member] | Shapeways Inc [Member] | Common Stock [Member]  
Disclosure Of Common Stock Shares Issued Following The Consummation Of Business Combination [Line Items]  
Stock issued during period new shares issued 35,104,836
Reverse Recapitalization [Member] | Prior to business combination [Member] | Common Stock [Member]  
Disclosure Of Common Stock Shares Issued Following The Consummation Of Business Combination [Line Items]  
Beginning Balance (in Shares) 13,800,000
XML 54 R43.htm IDEA: XBRL DOCUMENT v3.21.2
Reverse Recapitalization - Schedule of common stock shares issued following the consummation of business combination (Parenthetical) (Details)
Sep. 30, 2021
shares
Reverse Recapitalization [Abstract]  
Earnout shares 3,510,405
XML 55 R44.htm IDEA: XBRL DOCUMENT v3.21.2
Reverse Recapitalization (Details) - USD ($)
$ / shares in Units, $ in Thousands
9 Months Ended
Sep. 30, 2021
Sep. 29, 2021
Sep. 30, 2021
Dec. 31, 2020
Reverse Recapitalization [Line Items]        
Common stock, par value $ 0.0001   $ 0.0001 $ 0.0001
Reverse Recapitalization [Member]        
Reverse Recapitalization [Line Items]        
Conversion of preferred and common stock issued upon exercise of warrants converted into aggregate number of shares of common stock   301,750    
Number of consecutive trading days to determine the trading price per share 30 days      
Reverse Recapitalization [Member] | Pipe Investors [Member] | Subscription Agreement [Member]        
Reverse Recapitalization [Line Items]        
Stock issued during period new shares issued     7,500,000  
Purchase price per share $ 10.00   $ 10.00  
Shared issued value     $ 75,000,000  
Reverse Recapitalization [Member] | Trading Price One [Member]        
Reverse Recapitalization [Line Items]        
Volume weighted average trading price of common stock 14.00   $ 14.00  
Reverse Recapitalization [Member] | Trading Price Two [Member]        
Reverse Recapitalization [Line Items]        
Volume weighted average trading price of common stock $ 16.00   $ 16.00  
Earnout Restricted Stock Units [Member] | Reverse Recapitalization [Member]        
Reverse Recapitalization [Line Items]        
Number of restricted stock units granted   493,489    
Two Thousand Twenty One Equity Incentive Plan [Member] | Reverse Recapitalization [Member]        
Reverse Recapitalization [Line Items]        
Conversion of stock in to Aggregate number of options to purchase   4,901,207    
Shapeways Inc [Member] | Reverse Recapitalization [Member] | Galileo [Member]        
Reverse Recapitalization [Line Items]        
Aggregate merger consideration value   $ 406,000    
Common Stock [Member] | Shapeways Inc [Member] | Reverse Recapitalization [Member]        
Reverse Recapitalization [Line Items]        
Conversion of stock shares issued   35,104,836    
Common stock, par value   $ 0.0001    
Stock issued during period new shares issued     35,104,836  
Earnout Shares [Member] | Reverse Recapitalization [Member]        
Reverse Recapitalization [Line Items]        
Conversion of stock shares issued   3,510,405    
Earnout Shares [Member] | Reverse Recapitalization [Member] | Galileo [Member]        
Reverse Recapitalization [Line Items]        
Number of shares issued as merger consideration     3,510,405  
XML 56 R45.htm IDEA: XBRL DOCUMENT v3.21.2
Revenue Recognition - Marketplace sales (Details)
9 Months Ended
Sep. 30, 2021
Disaggregation of Revenue [Line Items]  
Percentage of markup fee upon the sale of products through the marketplace 3.50%
XML 57 R46.htm IDEA: XBRL DOCUMENT v3.21.2
Revenue Recognition - Disaggregation of revenues (Details) - USD ($)
$ in Thousands
3 Months Ended 9 Months Ended
Sep. 30, 2021
Sep. 30, 2020
Sep. 30, 2021
Sep. 30, 2020
Disaggregation of Revenue [Line Items]        
Total revenue $ 7,716 $ 8,107 $ 25,354 $ 23,028
Direct sales        
Disaggregation of Revenue [Line Items]        
Total revenue 5,985 5,994 19,068 16,827
Marketplace sales        
Disaggregation of Revenue [Line Items]        
Total revenue 1,663 2,091 6,062 6,060
Software        
Disaggregation of Revenue [Line Items]        
Total revenue 68 22 224 141
Products transferred at a point in time        
Disaggregation of Revenue [Line Items]        
Total revenue 1,663 2,091 6,062 6,060
Products and services transferred over time        
Disaggregation of Revenue [Line Items]        
Total revenue $ 6,053 $ 6,016 $ 19,292 $ 16,968
XML 58 R47.htm IDEA: XBRL DOCUMENT v3.21.2
Revenue Recognition - Deferred revenues (Details) - USD ($)
$ in Thousands
9 Months Ended
Sep. 30, 2021
Dec. 31, 2020
Jan. 01, 2020
Revenue from Contract with Customer [Abstract]      
Deferred revenue at beginning of period $ 753    
Deferred revenue recognized during period (25,354)    
Additions to deferred revenue during period 25,259    
Deferred revenue at end of period 658    
Deferred revenue recognized 753    
Accounts receivable $ 1,114 $ 185 $ 151
XML 59 R48.htm IDEA: XBRL DOCUMENT v3.21.2
Revenue Recognition - Practical expedients and exemptions (Details)
9 Months Ended
Sep. 30, 2021
Revenue from Contract with Customer [Abstract]  
Practical Expedients, incremental costs of obtaining a contract true
XML 60 R49.htm IDEA: XBRL DOCUMENT v3.21.2
Inventory (Details) - USD ($)
$ in Thousands
Sep. 30, 2021
Dec. 31, 2020
Inventory, Net, Items Net of Reserve Alternative [Abstract]    
Raw materials $ 418 $ 521
Work-in-process 40 36
Finished goods 115 170
Total $ 573 $ 727
XML 61 R50.htm IDEA: XBRL DOCUMENT v3.21.2
Prepaid Expenses and Other Current Assets (Details) - USD ($)
$ in Thousands
Sep. 30, 2021
Dec. 31, 2020
Prepaid Expense and Other Assets, Current [Abstract]    
Prepaid expenses $ 698 $ 646
Security deposits 259 259
VAT receivable 950 975
Other current assets 1 30
Total $ 1,908 $ 1,910
XML 62 R51.htm IDEA: XBRL DOCUMENT v3.21.2
Property and Equipment, net (Details) - USD ($)
$ in Thousands
3 Months Ended 9 Months Ended
Sep. 30, 2021
Sep. 30, 2020
Sep. 30, 2021
Sep. 30, 2020
Dec. 31, 2020
Property, Plant and Equipment [Line Items]          
Property and equipment, gross $ 9,545   $ 9,545   $ 9,193
Less: Accumulated depreciation (8,455)   (8,455)   (8,245)
Property and equipment, net 1,090   1,090   948
Depreciation expense 146 $ 115 424 $ 362  
Depreciation charged to cost of revenue 113 $ 78 324 $ 249  
Machinery and equipment          
Property, Plant and Equipment [Line Items]          
Property and equipment, gross 1,388   1,388   1,430
Computers and IT equipment          
Property, Plant and Equipment [Line Items]          
Property and equipment, gross 5,631   5,631   5,193
Furniture and fixtures          
Property, Plant and Equipment [Line Items]          
Property and equipment, gross 49   49   50
Leasehold improvements          
Property, Plant and Equipment [Line Items]          
Property and equipment, gross $ 2,477   $ 2,477   $ 2,520
XML 63 R52.htm IDEA: XBRL DOCUMENT v3.21.2
Accrued Expenses and Other Liabilities (Details) - USD ($)
$ in Thousands
Sep. 30, 2021
Dec. 31, 2020
Accrued Expenses And Other Liabilities Current [Abstract]    
Accrued selling expenses $ 712 $ 947
Accrued compensation 757 876
Interest payable   612
Taxes payable 306 477
Accrued transaction costs 450  
Accrued acquisition of property and equipment 441  
Shapeways credits 300 313
Other 734 94
Total $ 3,700 $ 3,319
XML 64 R53.htm IDEA: XBRL DOCUMENT v3.21.2
Commitments and Contingencies - Leases (Details) - lease
9 Months Ended
Sep. 30, 2021
Sep. 30, 2020
Commitments and Contingencies Disclosure [Abstract]    
Number of leases of facilities located in the United States and the Netherlands 3  
Number of leases of office equipment, under operating leases 1  
Number of additional lease of equipment under a finance lease arrangement   1
XML 65 R54.htm IDEA: XBRL DOCUMENT v3.21.2
Commitments and Contingencies - Company's lease costs (Details) - USD ($)
$ in Thousands
3 Months Ended 9 Months Ended
Sep. 30, 2021
Sep. 30, 2020
Sep. 30, 2021
Sep. 30, 2020
Lease, Cost [Abstract]        
Operating lease expense $ 144 $ 482 $ 696 $ 1,585
Finance lease expense       16
Interest expense on finance lease liabilities       1
Short-term lease expense       14
Total lease cost $ 144 $ 482 $ 696 $ 1,616
XML 66 R55.htm IDEA: XBRL DOCUMENT v3.21.2
Commitments and Contingencies - Right of use assets and lease liabilities for operating leases (Details) - USD ($)
$ in Thousands
Sep. 30, 2021
Dec. 31, 2020
Assets:    
Right-of-use assets, net $ 982 $ 2,102
Total lease assets 982 2,102
Liabilities:    
Operating lease liabilities, current 631 1,222
Non-current liabilities: Operating lease liabilities, net of current portion 499 1,094
Total lease liability $ 1,130 $ 2,316
XML 67 R56.htm IDEA: XBRL DOCUMENT v3.21.2
Commitments and Contingencies - Weighted-average (Details)
Sep. 30, 2021
Commitments and Contingencies Disclosure [Abstract]  
Weighted-average remaining lease term for operating leases 2 years 18 days
Weighted-average incremental borrowing rate 5.34%
XML 68 R57.htm IDEA: XBRL DOCUMENT v3.21.2
Commitments and Contingencies - Supplemental cash flow (Details) - USD ($)
$ in Thousands
9 Months Ended
Sep. 30, 2021
Sep. 30, 2020
Summary Of Leases Supplemental Cash Flow Information [Abstract]    
Operating cash flows from operating leases $ 762 $ 1,754
Operating cash flows from finance leases   1
Financing cash flows from finance leases   18
Lease liabilities arising from obtaining right-of-use assets   $ 4,025
XML 69 R58.htm IDEA: XBRL DOCUMENT v3.21.2
Commitments and Contingencies - Future minimum lease payments (Details) - USD ($)
$ in Thousands
Sep. 30, 2021
Dec. 31, 2020
Lessee, Operating Lease, Liability, Payment, Due [Abstract]    
Rest of 2021 $ 167  
2022 680  
2023 214  
2024 132  
2025 1  
Total minimum lease payments 1,194  
Less effects of discounting (64)  
Present value of future minimum lease payments $ 1,130 $ 2,316
XML 70 R59.htm IDEA: XBRL DOCUMENT v3.21.2
Commitments and Contingencies - Additional Information (Details) - Desktop Metal [Member] - USD ($)
$ in Millions
1 Months Ended
Mar. 26, 2021
Nov. 30, 2021
Dec. 31, 2021
Other Commitments [Line Items]      
Long-term Purchase Commitment, Amount $ 20.0    
Purchase obligation $ 20.0    
Subsequent Event [Member]      
Other Commitments [Line Items]      
Payments to Acquire desktop metal   $ 3.5  
Property purchase payable     $ 16.5
XML 71 R60.htm IDEA: XBRL DOCUMENT v3.21.2
Borrowing Arrangements - Term Loan (Details) - Term Loan [Member] - USD ($)
$ in Thousands
3 Months Ended 9 Months Ended
Oct. 29, 2018
Sep. 30, 2021
Sep. 30, 2020
Sep. 30, 2021
Sep. 30, 2020
Dec. 31, 2020
Debt Instrument [Line Items]            
Aggregate principal amount $ 5,000          
Interest rate           3.50%
Fee in the event of liquidity event   $ 75   $ 75    
Interest expense   $ 12 $ 36 $ 66 $ 129  
Prime Rate [Member]            
Debt Instrument [Line Items]            
Spread on variable rate 0.25%          
XML 72 R61.htm IDEA: XBRL DOCUMENT v3.21.2
Borrowing Arrangements - Dutch landlord loan (Details) - Dutch Landlord Loan [Member]
€ in Thousands, $ in Thousands
3 Months Ended 9 Months Ended
Sep. 30, 2021
USD ($)
Sep. 30, 2020
USD ($)
Sep. 30, 2021
USD ($)
Sep. 30, 2020
USD ($)
Dec. 31, 2020
USD ($)
May 12, 2014
EUR (€)
Debt Instrument [Line Items]            
Aggregate principal amount $ 280   $ 280   $ 297 € 242
Interest rate 8.50%   8.50%   8.50%  
Interest expense $ 5 $ 5 $ 14 $ 14    
XML 73 R62.htm IDEA: XBRL DOCUMENT v3.21.2
Borrowing Arrangements - Outstanding debt obligations (Details) - USD ($)
$ in Thousands
Sep. 30, 2021
Dec. 31, 2020
Debt Instrument [Line Items]    
Long-term debt, including current portion $ 127 $ 10,568
Less: current portion (39) (8,332)
Long-term debt 88 2,236
Dutch Landlord Loan    
Debt Instrument [Line Items]    
Long-term debt, including current portion 127 163
Term Loan    
Debt Instrument [Line Items]    
Long-term debt, including current portion 0 3,423
Convertible Promissory Notes    
Debt Instrument [Line Items]    
Long-term debt, including current portion 0 5,000
PPP Loan    
Debt Instrument [Line Items]    
Long-term debt, including current portion $ 0 $ 1,982
XML 74 R63.htm IDEA: XBRL DOCUMENT v3.21.2
Borrowing Arrangements - Convertible promissory notes (Details) - USD ($)
$ in Thousands
3 Months Ended 9 Months Ended 12 Months Ended
Sep. 29, 2021
Sep. 30, 2021
Sep. 30, 2020
Sep. 30, 2021
Sep. 30, 2020
Dec. 31, 2020
Jun. 30, 2021
Mar. 31, 2021
Jun. 30, 2020
Mar. 31, 2020
Dec. 31, 2019
Jun. 19, 2019
Debt Instrument [Line Items]                        
Common Stock, Shares, Outstanding   48,296,484   48,296,484   32,170,068            
Legacy Shapeways [Member] | Post Business Combination [Member]                        
Debt Instrument [Line Items]                        
Common Stock, Shares, Outstanding   1,189,558   1,189,558                
Legacy Shapeways [Member] | Unpaid And Accrued Interest [Member] | Post Business Combination [Member]                        
Debt Instrument [Line Items]                        
Common Stock, Shares, Outstanding   217,183   217,183                
Common Stock [Member]                        
Debt Instrument [Line Items]                        
Common Stock, Shares, Outstanding   48,296,484 32,132,078 48,296,484 32,132,078 32,184,263 32,302,841 32,220,158 32,063,523 31,922,253 31,921,259  
Convertible Notes Payable [Member]                        
Debt Instrument [Line Items]                        
Aggregate principal amount                       $ 5,000
Interest rate                       8.00%
Conversion price defined as percentage of next equity price per share           70.00%            
Interest expense   $ 109 $ 100 $ 309 $ 300              
Debt conversion convertible instrument amount $ 5,000                      
Debt instrument unpaid and accrued interest   $ 913   $ 913                
Convertible Notes Payable [Member] | Common Stock [Member]                        
Debt Instrument [Line Items]                        
Debt conversion converted instrument shares issued 1,434,391                      
Convertible Notes Payable [Member] | Common Stock [Member] | Unpaid And Accrued Interest [Member]                        
Debt Instrument [Line Items]                        
Debt conversion converted instrument shares issued 261,884                      
XML 75 R64.htm IDEA: XBRL DOCUMENT v3.21.2
Borrowing Arrangements - Paycheck protection program loan (Details) - PPP Loan - USD ($)
$ in Thousands
9 Months Ended
May 04, 2020
Sep. 30, 2021
Sep. 30, 2020
Debt Instrument [Line Items]      
Amount of loan received $ 1,982    
Accrues interest at annual rate 1.00%    
Interest expense     $ 0
Percentage of loan amount is used for eligible payroll costs used to determine the loan proceeds eligible for forgiveness   75.00%  
Other Income [Member]      
Debt Instrument [Line Items]      
Principal and interest amount of loan forgiven   $ 2,000  
Shapeways Inc [Member]      
Debt Instrument [Line Items]      
Interest expense   $ 18  
XML 76 R65.htm IDEA: XBRL DOCUMENT v3.21.2
Stockholders' Equity (Deficit) (Details)
9 Months Ended
Sep. 30, 2021
$ / shares
shares
Sep. 29, 2021
shares
May 10, 2021
$ / shares
shares
Jun. 30, 2017
$ / shares
shares
Apr. 22, 2015
$ / shares
shares
Feb. 03, 2014
$ / shares
shares
Dec. 18, 2013
$ / shares
shares
Mar. 08, 2013
$ / shares
shares
Sep. 30, 2021
Day
$ / shares
shares
Dec. 31, 2020
$ / shares
shares
Class of Stock [Line Items]                    
Recapitalization conversion ratio    0.8293                
Common stock, shares authorized 120,000,000               120,000,000 120,000,000
Common stock, par value | $ / shares $ 0.0001               $ 0.0001 $ 0.0001
Common stock voting rights                 one vote per share  
Common stock, shares issued 48,296,484               48,296,484 32,170,068
Common stock, shares outstanding 48,296,484               48,296,484 32,170,068
Warrants expiry term 5 years               5 years  
Redemption price (per warrant) | $ / shares                 $ 0.01  
Redemption notice period                 30 days  
Redemption share price basis | $ / shares                 $ 18.00  
Redemption share price basis number of days | Day                 20  
Redemption, registration statement to be maintained | Day                 30  
Public Warrants [Member]                    
Class of Stock [Line Items]                    
Exercise price of warrants | $ / shares $ 11.50               $ 11.50  
Warrant outstanding 13,800,000               13,800,000  
Number of shares purchased 1               1  
Warrants exercisable period 30 days                  
Legacy Shapeways Series A-1 Preferred Stock [Member]                    
Class of Stock [Line Items]                    
Preferred stock converted in to aggregate number of shares of common stock   22,579,695                
Legacy Shapeways Series A-2 Preferred Stock [Member]                    
Class of Stock [Line Items]                    
Preferred stock converted in to aggregate number of shares of common stock   22,579,695                
Legacy Shapeways Series B Preferred Stock [Member]                    
Class of Stock [Line Items]                    
Preferred stock converted in to aggregate number of shares of common stock   22,579,695                
Legacy Shapeways Series B-1 Preferred Stock [Member]                    
Class of Stock [Line Items]                    
Preferred stock converted in to aggregate number of shares of common stock   22,579,695                
Legacy Shapeways Series C Preferred Stock [Member]                    
Class of Stock [Line Items]                    
Preferred stock converted in to aggregate number of shares of common stock   22,579,695                
Legacy Shapeways Series D Preferred Stock [Member]                    
Class of Stock [Line Items]                    
Preferred stock converted in to aggregate number of shares of common stock   22,579,695                
Legacy Shapeways Series E Preferred Stock [Member]                    
Class of Stock [Line Items]                    
Preferred stock converted in to aggregate number of shares of common stock   22,579,695                
Prior to Merger [Member] | Public Warrants [Member]                    
Class of Stock [Line Items]                    
Warrant outstanding 13,800,000               13,800,000  
Legacy Shapeways Common Stock Warrants [Member] | Legacy Shapeways Series B-1 Preferred Stock [Member]                    
Class of Stock [Line Items]                    
Warrants exercised for number of shares of preferred stock     23,125              
Legacy Shapeways Common Stock Warrants [Member] | Executing a Loan Agreement [Member]                    
Class of Stock [Line Items]                    
Purchase of stock and warrants           248,000 40,000      
Exercise price of warrants | $ / shares           $ 1.25 $ 1.25      
Expiration date of warrants             Dec. 18, 2023      
Expiraiton period of warrants from the original issuance date           7 years        
Expiraiton period of warrants from the effective date of an initial public offering           5 years        
Legacy Shapeways Common Stock Warrants [Member] | Amended Loan Agreement [Member]                    
Class of Stock [Line Items]                    
Purchase of stock and warrants         13,750          
Exercise price of warrants | $ / shares         $ 1.70          
Expiration date of warrants         Apr. 22, 2025          
Legacy Shapeways Common Stock Warrants [Member] | Prior to the Business Combination [Member]                    
Class of Stock [Line Items]                    
Common stock, shares outstanding 212,234               212,234  
Outstanding warrants exercised in aggregate of shares of common stock   255,917                
Legacy Shapeways Preferred Stock Warrants [Member]                    
Class of Stock [Line Items]                    
Exercise price of warrants | $ / shares     $ 2.5946 $ 5.2584       $ 2.5946    
Warrants exercisable period from the date of grant       10 years       10 years    
Number of warrants exercised 57,051   23,125              
Warrants exercised for number of shares of Common stock 107,580                  
Legacy Shapeways Preferred Stock Warrants [Member] | Legacy Shapeways Series B-1 Preferred Stock [Member]                    
Class of Stock [Line Items]                    
Purchase of stock and warrants               23,125    
Legacy Shapeways Preferred Stock Warrants [Member] | Legacy Shapeways Series D Preferred Stock [Member]                    
Class of Stock [Line Items]                    
Purchase of stock and warrants       57,051            
XML 77 R66.htm IDEA: XBRL DOCUMENT v3.21.2
Stock-Based Compensation - Fair value of stock-based compensation (Details) - $ / shares
9 Months Ended
Sep. 30, 2021
Sep. 30, 2020
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]    
Share Price $ 0.17 $ 0.37
Expected volatility , minimum 57.09% 49.15%
Expected volatility , maximum 57.81% 52.41%
Risk-free interest rate , mininum 0.50% 0.37%
Risk-free interest rate , maximum 0.57% 1.46%
Dividend yield 0.00% 0.00%
Maximum [Member]    
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]    
Expected term (in years) 6 years 18 days 6 years 14 days
Minimum [Member]    
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]    
Expected term (in years) 5 years 6 months 18 days 5 years
XML 78 R67.htm IDEA: XBRL DOCUMENT v3.21.2
Stock-Based Compensation - Stock option plan (Details) - USD ($)
3 Months Ended 9 Months Ended 12 Months Ended
Sep. 30, 2021
Jun. 30, 2021
Mar. 31, 2021
Sep. 30, 2021
Dec. 31, 2020
Shares Underlying Options          
Outstanding at beginning 6,024,732 6,127,547 8,247,340 8,247,340  
Retroactive application of reverse recapitalization         (1,967,440)
Granted 0 0 29,420    
Forfeited (10,496) (39,309) (145,878)    
Exercised (1,113,029) (63,506) (35,895)    
Outstanding at ending 4,901,207 6,024,732 6,127,547 4,901,207 8,247,340
Exercisable 4,833,059     4,833,059  
Weighted Average Exercise Price          
Outstanding at beginning (in dollars per share) $ 0.59 $ 0.58 $ 0.44 $ 0.44  
Retroactive application of reverse recapitalization (in dollars per share)         $ 0
Granted (in dollars per share) 0 0 0.36    
Forfeited (in dollars per share) 0.40 0.44 0.43    
Exercised (in dollars per share) 0.44 0.45 0.43    
Outstanding at ending (in dollars per share) 0.62 $ 0.59 $ 0.58 0.62 $ 0.44
Exercisable (in dollars per share) $ 0.62     $ 0.62  
Weighted Average Remaining Contractual Term (in years)          
Outstanding (in years) 6 years 9 months 18 days 6 years 3 months 3 days 6 years 6 months 10 days   6 years 8 months 19 days
Granted (in years)     9 years 9 months 25 days    
Exercisable at the end (in dollars) $ 6,790     $ 6,790  
Cumulative Effect Adjusted [Member]          
Shares Underlying Options          
Outstanding at beginning     6,279,900 6,279,900  
Outstanding at ending         6,279,900
Weighted Average Exercise Price          
Outstanding at beginning (in dollars per share)     $ 0.58 $ 0.58  
Outstanding at ending (in dollars per share)         $ 0.58
Weighted Average Remaining Contractual Term (in years)          
Outstanding (in years)     6 years 7 months 20 days    
XML 79 R68.htm IDEA: XBRL DOCUMENT v3.21.2
Stock-Based Compensation (Details) - USD ($)
$ / shares in Units, $ in Thousands
3 Months Ended 9 Months Ended
Sep. 29, 2021
Sep. 30, 2021
Jun. 30, 2021
Mar. 31, 2021
Sep. 30, 2021
Sep. 30, 2020
Dec. 31, 2020
Share-based Payment Arrangement, Expensed and Capitalized, Amount [Line Items]              
Average exercise price per share   $ 0.62 $ 0.59 $ 0.58 $ 0.62   $ 0.44
Number of shares awarded   0 0 29,420      
2010 Stock Plan [Member]              
Share-based Payment Arrangement, Expensed and Capitalized, Amount [Line Items]              
Maximum number of shares authorized for issuance 16,942,546            
Percentage of exchange ratio used to determine the number of restricted stock units granted as right to receive         10.00%    
Aggregate number of options to purchase   4,901,207     4,901,207    
Average exercise price per share   $ 0.62     $ 0.62    
2010 Stock Plan [Member] | Legacy Shapeways Stock Option [Member]              
Share-based Payment Arrangement, Expensed and Capitalized, Amount [Line Items]              
Percentage of recapitalization conversion ratio for conversion in to common stock 90.00%            
Percentage of recapitalization conversion ratio as divider for determining exercise price 90.00%            
2021 Equity Incentive Plan [Member]              
Share-based Payment Arrangement, Expensed and Capitalized, Amount [Line Items]              
Maximum number of shares authorized for issuance   7,621,401     7,621,401    
Number of shares awarded         0    
Number of shares remain available for issuance   7,621,401     7,621,401    
Weighted-average grant-date fair value per stock option granted         $ 0.36 $ 0.50  
Unrecognized compensation expense   $ 193     $ 193    
Unrecognized compensation expense expected to be recognized over the weighted average period         1 year 9 months 18 days    
Number of shares available for purchase   895,721     895,721    
Number of shares purchased         0    
XML 80 R69.htm IDEA: XBRL DOCUMENT v3.21.2
Fair Value Measurements - Initial measurement (Details) - Private Placement Warrants - Level 3
Sep. 30, 2021
shares
yr
Sep. 29, 2021
shares
yr
Fair Value Measurement Inputs and Valuation Techniques [Line Items]    
Warrants measurement input 1.0 1.0
Stock price on valuation date    
Fair Value Measurement Inputs and Valuation Techniques [Line Items]    
Warrants measurement input 7.70 8.54
Exercise price per share    
Fair Value Measurement Inputs and Valuation Techniques [Line Items]    
Warrants measurement input 11.50 11.50
Expected life    
Fair Value Measurement Inputs and Valuation Techniques [Line Items]    
Warrants measurement input | yr 5 5
Volatility    
Fair Value Measurement Inputs and Valuation Techniques [Line Items]    
Warrants measurement input 34.8 43.9
Dividend yield    
Fair Value Measurement Inputs and Valuation Techniques [Line Items]    
Warrants measurement input 0 0
Fair value per warrant    
Fair Value Measurement Inputs and Valuation Techniques [Line Items]    
Warrants measurement input 1.47 2.57
XML 81 R70.htm IDEA: XBRL DOCUMENT v3.21.2
Fair Value Measurements - Subsequent measurement (Details) - Level 3
$ in Thousands
9 Months Ended
Sep. 30, 2021
USD ($)
Fair Value Measurement Inputs and Valuation Techniques [Line Items]  
Fair value, Beginning period $ 0
Additions pursuant to Merger 11,865
Change in fair value (5,088)
Fair value, End period $ 6,777
XML 82 R71.htm IDEA: XBRL DOCUMENT v3.21.2
Fair Value Measurements (Details) - USD ($)
$ / shares in Units, $ in Thousands
9 Months Ended
Sep. 30, 2021
Dec. 31, 2020
Sep. 30, 2020
Schedule of Held-to-maturity Securities [Line Items]      
Share price $ 0.17   $ 0.37
Earnout Shares [Member]      
Schedule of Held-to-maturity Securities [Line Items]      
Estimated fair value of the shares recognized as a deemed dividend $ 18,132    
Convertible Note [Member]      
Schedule of Held-to-maturity Securities [Line Items]      
Debt conversion convertible instrument amount $ 500    
Nonrecurring | Earnout Shares [Member]      
Schedule of Held-to-maturity Securities [Line Items]      
Fair value of shares estimated based on trading price of common stock $ 7.70    
Sponsor Warrants [Member]      
Schedule of Held-to-maturity Securities [Line Items]      
Warrant outstanding 500,000    
Share price $ 1.00    
Sponsor Warrants [Member] | Convertible Note [Member]      
Schedule of Held-to-maturity Securities [Line Items]      
Debt conversion converted instrument warrants issued 500,000    
Private Warrants [Member]      
Schedule of Held-to-maturity Securities [Line Items]      
Warrant outstanding 4,110,000    
Level 3      
Liabilities:      
Warrant liability $ 6,777 $ 0  
Level 3 | Warrant Liability | Recurring      
Liabilities:      
Warrant liability $ 6,777 $ 0  
XML 83 R72.htm IDEA: XBRL DOCUMENT v3.21.2
Significant Concentrations (Details)
3 Months Ended 9 Months Ended 12 Months Ended
Sep. 30, 2021
Customer
Sep. 30, 2020
Customer
Sep. 30, 2021
Customer
Vendor
Customers
Vendors
Sep. 30, 2020
Customer
Customers
Vendors
Vendor
Dec. 31, 2020
Vendors
Customers
Customer
Accounts Payable [Member] | Other Vendor [Member]          
Concentration Risk [Line Items]          
Number of major vendor accounts payable over ten percent benchmark     0    
Supplier Concentration Risk [Member] | Cost of Goods and Service Benchmark [Member] | Major Vendor [Member]          
Concentration Risk [Line Items]          
Concentration risk percentage     15.00% 15.00%  
Number of major vendor over ten percent benchmark | Vendor     1 1  
Supplier Concentration Risk [Member] | Cost of Goods and Service Benchmark [Member] | Other Vendor [Member]          
Concentration Risk [Line Items]          
Number of major vendor over ten percent benchmark     0 0  
Supplier Concentration Risk [Member] | Accounts Payable [Member]          
Concentration Risk [Line Items]          
Number of major vendor accounts payable over ten percent benchmark     4   5
Supplier Concentration Risk [Member] | Accounts Payable [Member] | Major Vendor One [Member]          
Concentration Risk [Line Items]          
Concentration risk percentage     19.00%   18.00%
Supplier Concentration Risk [Member] | Accounts Payable [Member] | Major Vendor Two [Member]          
Concentration Risk [Line Items]          
Concentration risk percentage     12.00%   15.00%
Supplier Concentration Risk [Member] | Accounts Payable [Member] | Major Vendor Three [Member]          
Concentration Risk [Line Items]          
Concentration risk percentage     12.00%   15.00%
Supplier Concentration Risk [Member] | Accounts Payable [Member] | Major Vendor Four [Member]          
Concentration Risk [Line Items]          
Concentration risk percentage     11.00%    
Supplier Concentration Risk [Member] | Accounts Payable [Member] | Other Vendor [Member]          
Concentration Risk [Line Items]          
Number of major vendor accounts payable over ten percent benchmark         0
Major Customer [Member] | Customer Concentration Risk [Member] | Revenue Benchmark [Member]          
Concentration Risk [Line Items]          
Concentration risk percentage 22.00% 23.00% 23.00% 22.00%  
Number of customers over ten percent benchmark | Customer 0 0 1 1  
Number of major vendor over ten percent benchmark | Customer 1 1      
Major Customer [Member] | Customer Concentration Risk [Member] | Accounts Receivable [Member]          
Concentration Risk [Line Items]          
Concentration risk percentage     55.00%   32.00%
Number of major customers accounts receivableover ten percent benchmark | Customer     1   1
Other Customer [Member] | Customer Concentration Risk [Member] | Revenue Benchmark [Member]          
Concentration Risk [Line Items]          
Concentration risk percentage 10.00% 10.00% 10.00% 10.00%  
Number of customers over ten percent benchmark | Customers     0 0  
Other Customer [Member] | Customer Concentration Risk [Member] | Accounts Receivable [Member]          
Concentration Risk [Line Items]          
Number of major customers accounts receivableover ten percent benchmark | Customers     0   0
XML 84 R73.htm IDEA: XBRL DOCUMENT v3.21.2
Related Party Transactions (Details) - Related Party Note [Member] - Officer [Member] - USD ($)
$ in Thousands
9 Months Ended
Sep. 29, 2021
Sep. 30, 2021
Sep. 30, 2020
Dec. 31, 2012
Related Party Transaction [Line Items]        
Debt instrument face amount       $ 175
Debt instrument interest rate stated percentage       0.88%
Debt weighted average interest rate   0.84% 0.90%  
Debt instrument maturity date   Aug. 10, 2021    
Merger Agreement [Member]        
Related Party Transaction [Line Items]        
Stock repurchased during period shares 19,226      
EXCEL 85 Financial_Report.xlsx IDEA: XBRL DOCUMENT begin 644 Financial_Report.xlsx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�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end

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end XML 86 Show.js IDEA: XBRL DOCUMENT // Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission. Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105. var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0); e.removeAttribute('id');a.parentNode.appendChild(e)}} if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'} e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}} XML 87 report.css IDEA: XBRL DOCUMENT /* Updated 2009-11-04 */ /* v2.2.0.24 */ /* DefRef Styles */ ..report table.authRefData{ background-color: #def; border: 2px solid #2F4497; font-size: 1em; position: absolute; } ..report table.authRefData a { display: block; font-weight: bold; } ..report table.authRefData p { margin-top: 0px; } ..report table.authRefData .hide { background-color: #2F4497; padding: 1px 3px 0px 0px; text-align: right; } ..report table.authRefData .hide a:hover { background-color: #2F4497; } ..report table.authRefData .body { height: 150px; overflow: auto; width: 400px; } ..report table.authRefData table{ font-size: 1em; } /* Report Styles */ ..pl a, .pl a:visited { color: black; text-decoration: none; } /* table */ ..report { background-color: white; border: 2px solid #acf; clear: both; color: black; font: normal 8pt Helvetica, Arial, san-serif; margin-bottom: 2em; } ..report hr { border: 1px solid #acf; } /* Top labels */ ..report th { background-color: #acf; color: black; font-weight: bold; text-align: center; } ..report th.void { background-color: transparent; color: #000000; font: bold 10pt Helvetica, Arial, san-serif; text-align: left; } ..report .pl { text-align: left; vertical-align: top; white-space: normal; width: 200px; white-space: normal; /* word-wrap: break-word; */ } ..report td.pl a.a { cursor: pointer; display: block; width: 200px; overflow: hidden; } ..report td.pl div.a { width: 200px; } ..report td.pl a:hover { background-color: #ffc; } /* Header rows... */ ..report tr.rh { background-color: #acf; color: black; font-weight: bold; } /* Calendars... */ ..report .rc { background-color: #f0f0f0; } /* Even rows... */ ..report .re, .report .reu { background-color: #def; } ..report .reu td { border-bottom: 1px solid black; } /* Odd rows... */ ..report .ro, .report .rou { background-color: white; } ..report .rou td { border-bottom: 1px solid black; } ..report .rou table td, .report .reu table td { border-bottom: 0px solid black; } /* styles for footnote marker */ ..report .fn { white-space: nowrap; } /* styles for numeric types */ ..report .num, .report .nump { text-align: right; white-space: nowrap; } ..report .nump { padding-left: 2em; } ..report .nump { padding: 0px 0.4em 0px 2em; } /* styles for text types */ ..report .text { text-align: left; white-space: normal; } ..report .text .big { margin-bottom: 1em; width: 17em; } ..report .text .more { display: none; } ..report .text .note { font-style: italic; font-weight: bold; } ..report .text .small { width: 10em; } ..report sup { font-style: italic; } ..report .outerFootnotes { font-size: 1em; } XML 88 FilingSummary.xml IDEA: XBRL DOCUMENT 3.21.2 html 312 441 1 false 101 0 false 17 false false R1.htm 1001 - Document - Cover Page Sheet http://www.shapeways.com/role/CoverPage Cover Page Cover 1 false false R2.htm 1002 - Statement - Condensed Consolidated Balance Sheets Sheet http://www.shapeways.com/role/CondensedConsolidatedBalanceSheets Condensed Consolidated Balance Sheets Statements 2 false false R3.htm 1003 - Statement - Condensed Consolidated Balance Sheets (Parenthetical) Sheet http://www.shapeways.com/role/CondensedConsolidatedBalanceSheetsParenthetical Condensed Consolidated Balance Sheets (Parenthetical) Statements 3 false false R4.htm 1004 - Statement - Condensed Consolidated Statements of Operations and Comprehensive Loss Sheet http://www.shapeways.com/role/CondensedConsolidatedStatementsOfOperationsAndComprehensiveLoss Condensed Consolidated Statements of Operations and Comprehensive Loss Statements 4 false false R5.htm 1005 - Statement - Condensed Consolidated Statements of Changes in Stockholders' Equity (Deficit) Sheet http://www.shapeways.com/role/CondensedConsolidatedStatementsOfChangesInStockholdersEquityDeficit Condensed Consolidated Statements of Changes in Stockholders' Equity (Deficit) Statements 5 false false R6.htm 1006 - Statement - Condensed Consolidated Statements of Cash Flows Sheet http://www.shapeways.com/role/CondensedConsolidatedStatementsOfCashFlows Condensed Consolidated Statements of Cash Flows Statements 6 false false R7.htm 1007 - Disclosure - Organization Sheet http://www.shapeways.com/role/Organization Organization Notes 7 false false R8.htm 1008 - Disclosure - Summary of Significant Accounting Policies Sheet http://www.shapeways.com/role/SummaryOfSignificantAccountingPolicies Summary of Significant Accounting Policies Notes 8 false false R9.htm 1009 - Disclosure - Reverse Recapitalization Sheet http://www.shapeways.com/role/ReverseRecapitalization Reverse Recapitalization Notes 9 false false R10.htm 1010 - Disclosure - Revenue Recognition Sheet http://www.shapeways.com/role/RevenueRecognition Revenue Recognition Notes 10 false false R11.htm 1011 - Disclosure - Inventory Sheet http://www.shapeways.com/role/Inventory Inventory Notes 11 false false R12.htm 1012 - Disclosure - Prepaid Expenses and Other Current Assets Sheet http://www.shapeways.com/role/PrepaidExpensesAndOtherCurrentAssets Prepaid Expenses and Other Current Assets Notes 12 false false R13.htm 1013 - Disclosure - Property and Equipment, net Sheet http://www.shapeways.com/role/PropertyAndEquipmentNet Property and Equipment, net Notes 13 false false R14.htm 1014 - Disclosure - Accrued Expenses and Other Liabilities Sheet http://www.shapeways.com/role/AccruedExpensesAndOtherLiabilities Accrued Expenses and Other Liabilities Notes 14 false false R15.htm 1015 - Disclosure - Commitments and Contingencies Sheet http://www.shapeways.com/role/CommitmentsAndContingencies Commitments and Contingencies Notes 15 false false R16.htm 1016 - Disclosure - Borrowing Arrangements Sheet http://www.shapeways.com/role/BorrowingArrangements Borrowing Arrangements Notes 16 false false R17.htm 1017 - Disclosure - Stockholders' Equity (Deficit) Sheet http://www.shapeways.com/role/StockholdersEquityDeficit Stockholders' Equity (Deficit) Notes 17 false false R18.htm 1018 - Disclosure - Stock-Based Compensation Sheet http://www.shapeways.com/role/StockBasedCompensation Stock-Based Compensation Notes 18 false false R19.htm 1019 - Disclosure - Fair Value Measurements Sheet http://www.shapeways.com/role/FairValueMeasurements Fair Value Measurements Notes 19 false false R20.htm 1020 - Disclosure - Significant Concentrations Sheet http://www.shapeways.com/role/SignificantConcentrations Significant Concentrations Notes 20 false false R21.htm 1021 - Disclosure - Related Party Transactions Sheet http://www.shapeways.com/role/RelatedPartyTransactions Related Party Transactions Notes 21 false false R22.htm 1022 - Disclosure - Subsequent Events Sheet http://www.shapeways.com/role/SubsequentEvents Subsequent Events Notes 22 false false R23.htm 1023 - Disclosure - Summary of Significant Accounting Policies (Policies) Sheet http://www.shapeways.com/role/SummaryOfSignificantAccountingPoliciesPolicies Summary of Significant Accounting Policies (Policies) Policies http://www.shapeways.com/role/SummaryOfSignificantAccountingPolicies 23 false false R24.htm 1024 - Disclosure - Summary of Significant Accounting Policies (Tables) Sheet http://www.shapeways.com/role/SummaryOfSignificantAccountingPoliciesTables Summary of Significant Accounting Policies (Tables) Tables http://www.shapeways.com/role/SummaryOfSignificantAccountingPolicies 24 false false R25.htm 1025 - Disclosure - Reverse Recapitalization (Tables) Sheet http://www.shapeways.com/role/ReverseRecapitalizationTables Reverse Recapitalization (Tables) Tables http://www.shapeways.com/role/ReverseRecapitalization 25 false false R26.htm 1026 - Disclosure - Revenue Recognition (Tables) Sheet http://www.shapeways.com/role/RevenueRecognitionTables Revenue Recognition (Tables) Tables http://www.shapeways.com/role/RevenueRecognition 26 false false R27.htm 1027 - Disclosure - Inventory (Tables) Sheet http://www.shapeways.com/role/InventoryTables Inventory (Tables) Tables http://www.shapeways.com/role/Inventory 27 false false R28.htm 1028 - Disclosure - Prepaid Expenses and Other Current Assets (Tables) Sheet http://www.shapeways.com/role/PrepaidExpensesAndOtherCurrentAssetsTables Prepaid Expenses and Other Current Assets (Tables) Tables http://www.shapeways.com/role/PrepaidExpensesAndOtherCurrentAssets 28 false false R29.htm 1029 - Disclosure - Property and Equipment, net (Tables) Sheet http://www.shapeways.com/role/PropertyAndEquipmentNetTables Property and Equipment, net (Tables) Tables http://www.shapeways.com/role/PropertyAndEquipmentNet 29 false false R30.htm 1030 - Disclosure - Accrued Expenses and Other Liabilities (Tables) Sheet http://www.shapeways.com/role/AccruedExpensesAndOtherLiabilitiesTables Accrued Expenses and Other Liabilities (Tables) Tables http://www.shapeways.com/role/AccruedExpensesAndOtherLiabilities 30 false false R31.htm 1031 - Disclosure - Commitments and Contingencies (Tables) Sheet http://www.shapeways.com/role/CommitmentsAndContingenciesTables Commitments and Contingencies (Tables) Tables http://www.shapeways.com/role/CommitmentsAndContingencies 31 false false R32.htm 1032 - Disclosure - Borrowing Arrangements (Tables) Sheet http://www.shapeways.com/role/BorrowingArrangementsTables Borrowing Arrangements (Tables) Tables http://www.shapeways.com/role/BorrowingArrangements 32 false false R33.htm 1033 - Disclosure - Stock-Based Compensation (Tables) Sheet http://www.shapeways.com/role/StockBasedCompensationTables Stock-Based Compensation (Tables) Tables http://www.shapeways.com/role/StockBasedCompensation 33 false false R34.htm 1034 - Disclosure - Fair Value Measurements (Tables) Sheet http://www.shapeways.com/role/FairValueMeasurementsTables Fair Value Measurements (Tables) Tables http://www.shapeways.com/role/FairValueMeasurements 34 false false R35.htm 1035 - Disclosure - Organization (Details) Sheet http://www.shapeways.com/role/OrganizationDetails Organization (Details) Details http://www.shapeways.com/role/Organization 35 false false R36.htm 1036 - Disclosure - Summary of Significant Accounting Policies (Details) Sheet http://www.shapeways.com/role/SummaryOfSignificantAccountingPoliciesDetails Summary of Significant Accounting Policies (Details) Details http://www.shapeways.com/role/SummaryOfSignificantAccountingPoliciesTables 36 false false R37.htm 1037 - Disclosure - Summary of Significant Accounting Policies - Summary of reconciliation of cash and cash equivalents (Details) Sheet http://www.shapeways.com/role/SummaryOfSignificantAccountingPoliciesSummaryOfReconciliationOfCashAndCashEquivalentsDetails Summary of Significant Accounting Policies - Summary of reconciliation of cash and cash equivalents (Details) Details 37 false false R38.htm 1038 - Disclosure - Summary of Significant Accounting Policies - Summary of useful lives of property plant and equipment (Details) Sheet http://www.shapeways.com/role/SummaryOfSignificantAccountingPoliciesSummaryOfUsefulLivesOfPropertyPlantAndEquipmentDetails Summary of Significant Accounting Policies - Summary of useful lives of property plant and equipment (Details) Details 38 false false R39.htm 1039 - Disclosure - Summary of Significant Accounting Policies - Summary of common stock equivalents outstanding were excluded from computation of diluted net loss per share (Details) Sheet http://www.shapeways.com/role/SummaryOfSignificantAccountingPoliciesSummaryOfCommonStockEquivalentsOutstandingWereExcludedFromComputationOfDilutedNetLossPerShareDetails Summary of Significant Accounting Policies - Summary of common stock equivalents outstanding were excluded from computation of diluted net loss per share (Details) Details 39 false false R40.htm 1040 - Disclosure - Reverse Recapitalization - Schedule of common stock shares issued following the consummation of merger (Details) Sheet http://www.shapeways.com/role/ReverseRecapitalizationScheduleOfCommonStockSharesIssuedFollowingTheConsummationOfMergerDetails Reverse Recapitalization - Schedule of common stock shares issued following the consummation of merger (Details) Details 40 false false R41.htm 1041 - Disclosure - Reverse Recapitalization - Schedule of reconciles the elements of business combination to the unaudited consolidated statement of changes in stockholders equity (Details) Sheet http://www.shapeways.com/role/ReverseRecapitalizationScheduleOfReconcilesTheElementsOfBusinessCombinationToTheUnauditedConsolidatedStatementOfChangesInStockholdersEquityDetails Reverse Recapitalization - Schedule of reconciles the elements of business combination to the unaudited consolidated statement of changes in stockholders equity (Details) Details 41 false false R42.htm 1042 - Disclosure - Reverse Recapitalization - Schedule of common stock shares issued following the consummation of business combination (Details) Sheet http://www.shapeways.com/role/ReverseRecapitalizationScheduleOfCommonStockSharesIssuedFollowingTheConsummationOfBusinessCombinationDetails Reverse Recapitalization - Schedule of common stock shares issued following the consummation of business combination (Details) Details 42 false false R43.htm 1043 - Disclosure - Reverse Recapitalization - Schedule of common stock shares issued following the consummation of business combination (Parenthetical) (Details) Sheet http://www.shapeways.com/role/ReverseRecapitalizationScheduleOfCommonStockSharesIssuedFollowingTheConsummationOfBusinessCombinationParentheticalDetails Reverse Recapitalization - Schedule of common stock shares issued following the consummation of business combination (Parenthetical) (Details) Details 43 false false R44.htm 1044 - Disclosure - Reverse Recapitalization (Details) Sheet http://www.shapeways.com/role/ReverseRecapitalizationDetails Reverse Recapitalization (Details) Details http://www.shapeways.com/role/ReverseRecapitalizationTables 44 false false R45.htm 1045 - Disclosure - Revenue Recognition - Marketplace sales (Details) Sheet http://www.shapeways.com/role/RevenueRecognitionMarketplaceSalesDetails Revenue Recognition - Marketplace sales (Details) Details 45 false false R46.htm 1046 - Disclosure - Revenue Recognition - Disaggregation of revenues (Details) Sheet http://www.shapeways.com/role/RevenueRecognitionDisaggregationOfRevenuesDetails Revenue Recognition - Disaggregation of revenues (Details) Details 46 false false R47.htm 1047 - Disclosure - Revenue Recognition - Deferred revenues (Details) Sheet http://www.shapeways.com/role/RevenueRecognitionDeferredRevenuesDetails Revenue Recognition - Deferred revenues (Details) Details 47 false false R48.htm 1048 - Disclosure - Revenue Recognition - Practical expedients and exemptions (Details) Sheet http://www.shapeways.com/role/RevenueRecognitionPracticalExpedientsAndExemptionsDetails Revenue Recognition - Practical expedients and exemptions (Details) Details 48 false false R49.htm 1049 - Disclosure - Inventory (Details) Sheet http://www.shapeways.com/role/InventoryDetails Inventory (Details) Details http://www.shapeways.com/role/InventoryTables 49 false false R50.htm 1050 - Disclosure - Prepaid Expenses and Other Current Assets (Details) Sheet http://www.shapeways.com/role/PrepaidExpensesAndOtherCurrentAssetsDetails Prepaid Expenses and Other Current Assets (Details) Details http://www.shapeways.com/role/PrepaidExpensesAndOtherCurrentAssetsTables 50 false false R51.htm 1051 - Disclosure - Property and Equipment, net (Details) Sheet http://www.shapeways.com/role/PropertyAndEquipmentNetDetails Property and Equipment, net (Details) Details http://www.shapeways.com/role/PropertyAndEquipmentNetTables 51 false false R52.htm 1052 - Disclosure - Accrued Expenses and Other Liabilities (Details) Sheet http://www.shapeways.com/role/AccruedExpensesAndOtherLiabilitiesDetails Accrued Expenses and Other Liabilities (Details) Details http://www.shapeways.com/role/AccruedExpensesAndOtherLiabilitiesTables 52 false false R53.htm 1053 - Disclosure - Commitments and Contingencies - Leases (Details) Sheet http://www.shapeways.com/role/CommitmentsAndContingenciesLeasesDetails Commitments and Contingencies - Leases (Details) Details 53 false false R54.htm 1054 - Disclosure - Commitments and Contingencies - Company's lease costs (Details) Sheet http://www.shapeways.com/role/CommitmentsAndContingenciesCompanysLeaseCostsDetails Commitments and Contingencies - Company's lease costs (Details) Details 54 false false R55.htm 1055 - Disclosure - Commitments and Contingencies - Right of use assets and lease liabilities for operating leases (Details) Sheet http://www.shapeways.com/role/CommitmentsAndContingenciesRightOfUseAssetsAndLeaseLiabilitiesForOperatingLeasesDetails Commitments and Contingencies - Right of use assets and lease liabilities for operating leases (Details) Details 55 false false R56.htm 1056 - Disclosure - Commitments and Contingencies - Weighted-average (Details) Sheet http://www.shapeways.com/role/CommitmentsAndContingenciesWeightedAverageDetails Commitments and Contingencies - Weighted-average (Details) Details 56 false false R57.htm 1057 - Disclosure - Commitments and Contingencies - Supplemental cash flow (Details) Sheet http://www.shapeways.com/role/CommitmentsAndContingenciesSupplementalCashFlowDetails Commitments and Contingencies - Supplemental cash flow (Details) Details 57 false false R58.htm 1058 - Disclosure - Commitments and Contingencies - Future minimum lease payments (Details) Sheet http://www.shapeways.com/role/CommitmentsAndContingenciesFutureMinimumLeasePaymentsDetails Commitments and Contingencies - Future minimum lease payments (Details) Details 58 false false R59.htm 1059 - Disclosure - Commitments and Contingencies - Additional Information (Details) Sheet http://www.shapeways.com/role/CommitmentsAndContingenciesAdditionalInformationDetails Commitments and Contingencies - Additional Information (Details) Details 59 false false R60.htm 1060 - Disclosure - Borrowing Arrangements - Term Loan (Details) Sheet http://www.shapeways.com/role/BorrowingArrangementsTermLoanDetails Borrowing Arrangements - Term Loan (Details) Details 60 false false R61.htm 1061 - Disclosure - Borrowing Arrangements - Dutch landlord loan (Details) Sheet http://www.shapeways.com/role/BorrowingArrangementsDutchLandlordLoanDetails Borrowing Arrangements - Dutch landlord loan (Details) Details 61 false false R62.htm 1062 - Disclosure - Borrowing Arrangements - Outstanding debt obligations (Details) Sheet http://www.shapeways.com/role/BorrowingArrangementsOutstandingDebtObligationsDetails Borrowing Arrangements - Outstanding debt obligations (Details) Details 62 false false R63.htm 1063 - Disclosure - Borrowing Arrangements - Convertible promissory notes (Details) Notes http://www.shapeways.com/role/BorrowingArrangementsConvertiblePromissoryNotesDetails Borrowing Arrangements - Convertible promissory notes (Details) Details 63 false false R64.htm 1064 - Disclosure - Borrowing Arrangements - Paycheck protection program loan (Details) Sheet http://www.shapeways.com/role/BorrowingArrangementsPaycheckProtectionProgramLoanDetails Borrowing Arrangements - Paycheck protection program loan (Details) Details 64 false false R65.htm 1065 - Disclosure - Stockholders' Equity (Deficit) (Details) Sheet http://www.shapeways.com/role/StockholdersEquityDeficitDetails Stockholders' Equity (Deficit) (Details) Details http://www.shapeways.com/role/StockholdersEquityDeficit 65 false false R66.htm 1066 - Disclosure - Stock-Based Compensation - Fair value of stock-based compensation (Details) Sheet http://www.shapeways.com/role/StockBasedCompensationFairValueOfStockBasedCompensationDetails Stock-Based Compensation - Fair value of stock-based compensation (Details) Details 66 false false R67.htm 1067 - Disclosure - Stock-Based Compensation - Stock option plan (Details) Sheet http://www.shapeways.com/role/StockBasedCompensationStockOptionPlanDetails Stock-Based Compensation - Stock option plan (Details) Details 67 false false R68.htm 1068 - Disclosure - Stock-Based Compensation (Details) Sheet http://www.shapeways.com/role/StockBasedCompensationDetails Stock-Based Compensation (Details) Details http://www.shapeways.com/role/StockBasedCompensationTables 68 false false R69.htm 1069 - Disclosure - Fair Value Measurements - Initial measurement (Details) Sheet http://www.shapeways.com/role/FairValueMeasurementsInitialMeasurementDetails Fair Value Measurements - Initial measurement (Details) Details 69 false false R70.htm 1070 - Disclosure - Fair Value Measurements - Subsequent measurement (Details) Sheet http://www.shapeways.com/role/FairValueMeasurementsSubsequentMeasurementDetails Fair Value Measurements - Subsequent measurement (Details) Details 70 false false R71.htm 1071 - Disclosure - Fair Value Measurements (Details) Sheet http://www.shapeways.com/role/FairValueMeasurementsDetails Fair Value Measurements (Details) Details http://www.shapeways.com/role/FairValueMeasurementsTables 71 false false R72.htm 1072 - Disclosure - Significant Concentrations (Details) Sheet http://www.shapeways.com/role/SignificantConcentrationsDetails Significant Concentrations (Details) Details http://www.shapeways.com/role/SignificantConcentrations 72 false false R73.htm 1073 - Disclosure - Related Party Transactions (Details) Sheet http://www.shapeways.com/role/RelatedPartyTransactionsDetails Related Party Transactions (Details) Details http://www.shapeways.com/role/RelatedPartyTransactions 73 false false All Reports Book All Reports d216471d10q.htm d216471dex311.htm d216471dex312.htm d216471dex321.htm d216471dex322.htm shpw-20210930.xsd shpw-20210930_cal.xml shpw-20210930_def.xml shpw-20210930_lab.xml shpw-20210930_pre.xml http://xbrl.sec.gov/dei/2021 http://fasb.org/us-gaap/2021-01-31 http://fasb.org/srt/2021-01-31 true true JSON 91 MetaLinks.json IDEA: XBRL DOCUMENT { "instance": { "d216471d10q.htm": { "axisCustom": 8, "axisStandard": 31, "contextCount": 312, "dts": { "calculationLink": { "local": [ "shpw-20210930_cal.xml" ] }, "definitionLink": { "local": [ "shpw-20210930_def.xml" ] }, "inline": { "local": [ "d216471d10q.htm" ] }, "labelLink": { "local": [ "shpw-20210930_lab.xml" ] }, "presentationLink": { "local": [ "shpw-20210930_pre.xml" ] }, "schema": { "local": [ "shpw-20210930.xsd" ], "remote": [ "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd", "http://www.xbrl.org/2003/xl-2003-12-31.xsd", "http://www.xbrl.org/2003/xlink-2003-12-31.xsd", "https://xbrl.sec.gov/dei/2021/dei-2021.xsd", "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd", "http://www.xbrl.org/2005/xbrldt-2005.xsd", "https://www.xbrl.org/dtr/type/2020-01-21/types.xsd", "https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd", "https://www.xbrl.org/2020/extensible-enumerations-2.0.xsd", "http://www.xbrl.org/2006/ref-2006-02-27.xsd", "https://xbrl.fasb.org/us-gaap/2021/elts/us-types-2021-01-31.xsd", "https://xbrl.fasb.org/srt/2021/elts/srt-types-2021-01-31.xsd", "https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd", "https://xbrl.sec.gov/country/2021/country-2021.xsd", "https://xbrl.fasb.org/srt/2021/elts/srt-roles-2021-01-31.xsd", "https://xbrl.fasb.org/us-gaap/2021/elts/us-roles-2021-01-31.xsd", "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd", "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd", "https://xbrl.sec.gov/currency/2021/currency-2021.xsd", "https://xbrl.sec.gov/exch/2021/exch-2021.xsd", "https://xbrl.sec.gov/naics/2021/naics-2021.xsd", "https://xbrl.sec.gov/sic/2021/sic-2021.xsd", "https://xbrl.sec.gov/stpr/2021/stpr-2021.xsd", "http://www.xbrl.org/lrr/arcrole/factExplanatory-2009-12-16.xsd", "http://www.xbrl.org/lrr/role/reference-2009-12-16.xsd" ] } }, "elementCount": 656, "entityCount": 1, "hidden": { "http://fasb.org/us-gaap/2021-01-31": 2, "http://xbrl.sec.gov/dei/2021": 7, "total": 9 }, "keyCustom": 99, "keyStandard": 342, "memberCustom": 59, "memberStandard": 41, "nsprefix": "shpw", "nsuri": "http://www.shapeways.com/20210930", "report": { "R1": { "firstAnchor": { "ancestors": [ "div", "div", "div", "div", "div", "body", "html" ], "baseRef": "d216471d10q.htm", "contextRef": "P01_01_2021To09_30_2021", "decimals": null, "first": true, "lang": "en-US", "name": "dei:DocumentType", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "document", "isDefault": "true", "longName": "1001 - Document - Cover Page", "role": "http://www.shapeways.com/role/CoverPage", "shortName": "Cover Page", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "div", "div", "div", "div", "div", "body", "html" ], "baseRef": "d216471d10q.htm", "contextRef": "P01_01_2021To09_30_2021", "decimals": null, "first": true, "lang": "en-US", "name": "dei:DocumentType", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R10": { "firstAnchor": { "ancestors": [ "div", "div", "body", "html" ], "baseRef": "d216471d10q.htm", "contextRef": "P01_01_2021To09_30_2021", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:RevenueFromContractWithCustomerTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "1010 - Disclosure - Revenue Recognition", "role": "http://www.shapeways.com/role/RevenueRecognition", "shortName": "Revenue Recognition", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "div", "div", "body", "html" ], "baseRef": "d216471d10q.htm", "contextRef": "P01_01_2021To09_30_2021", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:RevenueFromContractWithCustomerTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R11": { "firstAnchor": { "ancestors": [ "div", "div", "body", "html" ], "baseRef": "d216471d10q.htm", "contextRef": "P01_01_2021To09_30_2021", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:InventoryDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "1011 - Disclosure - Inventory", "role": "http://www.shapeways.com/role/Inventory", "shortName": "Inventory", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "div", "div", "body", "html" ], "baseRef": "d216471d10q.htm", "contextRef": "P01_01_2021To09_30_2021", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:InventoryDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R12": { "firstAnchor": { "ancestors": [ "div", "div", "body", "html" ], "baseRef": "d216471d10q.htm", "contextRef": "P01_01_2021To09_30_2021", "decimals": null, "first": true, "lang": "en-US", "name": "shpw:PrepaidExpensesAndOtherCurrentAssetsTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "1012 - Disclosure - Prepaid Expenses and Other Current Assets", "role": "http://www.shapeways.com/role/PrepaidExpensesAndOtherCurrentAssets", "shortName": "Prepaid Expenses and Other Current Assets", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "div", "div", "body", "html" ], "baseRef": "d216471d10q.htm", "contextRef": "P01_01_2021To09_30_2021", "decimals": null, "first": true, "lang": "en-US", "name": "shpw:PrepaidExpensesAndOtherCurrentAssetsTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R13": { "firstAnchor": { "ancestors": [ "div", "div", "body", "html" ], "baseRef": "d216471d10q.htm", "contextRef": "P01_01_2021To09_30_2021", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "1013 - Disclosure - Property and Equipment, net", "role": "http://www.shapeways.com/role/PropertyAndEquipmentNet", "shortName": "Property and Equipment, net", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "div", "div", "body", "html" ], "baseRef": "d216471d10q.htm", "contextRef": "P01_01_2021To09_30_2021", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R14": { "firstAnchor": { "ancestors": [ "div", "div", "body", "html" ], "baseRef": "d216471d10q.htm", "contextRef": "P01_01_2021To09_30_2021", "decimals": null, "first": true, "lang": "en-US", "name": "shpw:AccruedLiabilitiesAndOtherLiabilitiesTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "1014 - Disclosure - Accrued Expenses and Other Liabilities", "role": "http://www.shapeways.com/role/AccruedExpensesAndOtherLiabilities", "shortName": "Accrued Expenses and Other Liabilities", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "div", "div", "body", "html" ], "baseRef": "d216471d10q.htm", "contextRef": "P01_01_2021To09_30_2021", "decimals": null, "first": true, "lang": "en-US", "name": "shpw:AccruedLiabilitiesAndOtherLiabilitiesTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R15": { "firstAnchor": { "ancestors": [ "div", "div", "body", "html" ], "baseRef": "d216471d10q.htm", "contextRef": "P01_01_2021To09_30_2021", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "1015 - Disclosure - Commitments and Contingencies", "role": "http://www.shapeways.com/role/CommitmentsAndContingencies", "shortName": "Commitments and Contingencies", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "div", "div", "body", "html" ], "baseRef": "d216471d10q.htm", "contextRef": "P01_01_2021To09_30_2021", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R16": { "firstAnchor": { "ancestors": [ "div", "div", "body", "html" ], "baseRef": "d216471d10q.htm", "contextRef": "P01_01_2021To09_30_2021", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:DebtDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "1016 - Disclosure - Borrowing Arrangements", "role": "http://www.shapeways.com/role/BorrowingArrangements", "shortName": "Borrowing Arrangements", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "div", "div", "body", "html" ], "baseRef": "d216471d10q.htm", "contextRef": "P01_01_2021To09_30_2021", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:DebtDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R17": { "firstAnchor": { "ancestors": [ "div", "div", "body", "html" ], "baseRef": "d216471d10q.htm", "contextRef": "P01_01_2021To09_30_2021", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:StockholdersEquityNoteDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "1017 - Disclosure - Stockholders' Equity (Deficit)", "role": "http://www.shapeways.com/role/StockholdersEquityDeficit", "shortName": "Stockholders' Equity (Deficit)", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "div", "div", "body", "html" ], "baseRef": "d216471d10q.htm", "contextRef": "P01_01_2021To09_30_2021", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:StockholdersEquityNoteDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R18": { "firstAnchor": { "ancestors": [ "div", "div", "body", "html" ], "baseRef": "d216471d10q.htm", "contextRef": "P01_01_2021To09_30_2021", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "1018 - Disclosure - Stock-Based Compensation", "role": "http://www.shapeways.com/role/StockBasedCompensation", "shortName": "Stock-Based Compensation", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "div", "div", "body", "html" ], "baseRef": "d216471d10q.htm", "contextRef": "P01_01_2021To09_30_2021", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R19": { "firstAnchor": { "ancestors": [ "div", "div", "body", "html" ], "baseRef": "d216471d10q.htm", "contextRef": "P01_01_2021To09_30_2021", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:FairValueDisclosuresTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "1019 - Disclosure - Fair Value Measurements", "role": "http://www.shapeways.com/role/FairValueMeasurements", "shortName": "Fair Value Measurements", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "div", "div", "body", "html" ], "baseRef": "d216471d10q.htm", "contextRef": "P01_01_2021To09_30_2021", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:FairValueDisclosuresTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R2": { "firstAnchor": { "ancestors": [ "td", "tr", "table", "div", "div", "body", "html" ], "baseRef": "d216471d10q.htm", "contextRef": "PAsOn09_30_2021", "decimals": "-3", "first": true, "lang": null, "name": "us-gaap:CashAndCashEquivalentsAtCarryingValue", "reportCount": 1, "unitRef": "Unit_USD", "xsiNil": "false" }, "groupType": "statement", "isDefault": "false", "longName": "1002 - Statement - Condensed Consolidated Balance Sheets", "role": "http://www.shapeways.com/role/CondensedConsolidatedBalanceSheets", "shortName": "Condensed Consolidated Balance Sheets", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "td", "tr", "table", "div", "div", "body", "html" ], "baseRef": "d216471d10q.htm", "contextRef": "PAsOn09_30_2021", "decimals": "-3", "lang": null, "name": "us-gaap:RestrictedCashCurrent", "reportCount": 1, "unique": true, "unitRef": "Unit_USD", "xsiNil": "false" } }, "R20": { "firstAnchor": { "ancestors": [ "div", "div", "body", "html" ], "baseRef": "d216471d10q.htm", "contextRef": "P01_01_2021To09_30_2021", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ConcentrationRiskDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "1020 - Disclosure - Significant Concentrations", "role": "http://www.shapeways.com/role/SignificantConcentrations", "shortName": "Significant Concentrations", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "div", "div", "body", "html" ], "baseRef": "d216471d10q.htm", "contextRef": "P01_01_2021To09_30_2021", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ConcentrationRiskDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R21": { "firstAnchor": { "ancestors": [ "div", "div", "body", "html" ], "baseRef": "d216471d10q.htm", "contextRef": "P01_01_2021To09_30_2021", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:RelatedPartyTransactionsDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "1021 - Disclosure - Related Party Transactions", "role": "http://www.shapeways.com/role/RelatedPartyTransactions", "shortName": "Related Party Transactions", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "div", "div", "body", "html" ], "baseRef": "d216471d10q.htm", "contextRef": "P01_01_2021To09_30_2021", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:RelatedPartyTransactionsDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R22": { "firstAnchor": { "ancestors": [ "div", "div", "body", "html" ], "baseRef": "d216471d10q.htm", "contextRef": "P01_01_2021To09_30_2021", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:SubsequentEventsTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "1022 - Disclosure - Subsequent Events", "role": "http://www.shapeways.com/role/SubsequentEvents", "shortName": "Subsequent Events", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "div", "div", "body", "html" ], "baseRef": "d216471d10q.htm", "contextRef": "P01_01_2021To09_30_2021", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:SubsequentEventsTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R23": { "firstAnchor": { "ancestors": [ "us-gaap:SignificantAccountingPoliciesTextBlock", "div", "div", "body", "html" ], "baseRef": "d216471d10q.htm", "contextRef": "P01_01_2021To09_30_2021", "decimals": null, "first": true, "lang": "en-US", "name": "shpw:BasisOfPresentationAndPrinciplesOfConsolidationPolicyTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "1023 - Disclosure - Summary of Significant Accounting Policies (Policies)", "role": "http://www.shapeways.com/role/SummaryOfSignificantAccountingPoliciesPolicies", "shortName": "Summary of Significant Accounting Policies (Policies)", "subGroupType": "policies", "uniqueAnchor": { "ancestors": [ "us-gaap:SignificantAccountingPoliciesTextBlock", "div", "div", "body", "html" ], "baseRef": "d216471d10q.htm", "contextRef": "P01_01_2021To09_30_2021", "decimals": null, "first": true, "lang": "en-US", "name": "shpw:BasisOfPresentationAndPrinciplesOfConsolidationPolicyTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R24": { "firstAnchor": { "ancestors": [ "ix:continuation", "div", "div", "body", "html" ], "baseRef": "d216471d10q.htm", "contextRef": "P01_01_2021To09_30_2021", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfCashAndCashEquivalentsTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "1024 - Disclosure - Summary of Significant Accounting Policies (Tables)", "role": "http://www.shapeways.com/role/SummaryOfSignificantAccountingPoliciesTables", "shortName": "Summary of Significant Accounting Policies (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "ix:continuation", "div", "div", "body", "html" ], "baseRef": "d216471d10q.htm", "contextRef": "P01_01_2021To09_30_2021", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfCashAndCashEquivalentsTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R25": { "firstAnchor": { "ancestors": [ "ix:continuation", "div", "div", "body", "html" ], "baseRef": "d216471d10q.htm", "contextRef": "P01_01_2021To09_30_2021", "decimals": null, "first": true, "lang": "en-US", "name": "shpw:DisclosureOfCommonStockSharesIssuedFollowingTheConsummationOfMergerTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "1025 - Disclosure - Reverse Recapitalization (Tables)", "role": "http://www.shapeways.com/role/ReverseRecapitalizationTables", "shortName": "Reverse Recapitalization (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "ix:continuation", "div", "div", "body", "html" ], "baseRef": "d216471d10q.htm", "contextRef": "P01_01_2021To09_30_2021", "decimals": null, "first": true, "lang": "en-US", "name": "shpw:DisclosureOfCommonStockSharesIssuedFollowingTheConsummationOfMergerTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R26": { "firstAnchor": { "ancestors": [ "ix:continuation", "div", "div", "body", "html" ], "baseRef": "d216471d10q.htm", "contextRef": "P01_01_2021To09_30_2021", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:DisaggregationOfRevenueTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "1026 - Disclosure - Revenue Recognition (Tables)", "role": "http://www.shapeways.com/role/RevenueRecognitionTables", "shortName": "Revenue Recognition (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "ix:continuation", "div", "div", "body", "html" ], "baseRef": "d216471d10q.htm", "contextRef": "P01_01_2021To09_30_2021", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:DisaggregationOfRevenueTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R27": { "firstAnchor": { "ancestors": [ "us-gaap:InventoryDisclosureTextBlock", "div", "div", "body", "html" ], "baseRef": "d216471d10q.htm", "contextRef": "P01_01_2021To09_30_2021", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfInventoryCurrentTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "1027 - Disclosure - Inventory (Tables)", "role": "http://www.shapeways.com/role/InventoryTables", "shortName": "Inventory (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "us-gaap:InventoryDisclosureTextBlock", "div", "div", "body", "html" ], "baseRef": "d216471d10q.htm", "contextRef": "P01_01_2021To09_30_2021", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfInventoryCurrentTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R28": { "firstAnchor": { "ancestors": [ "shpw:PrepaidExpensesAndOtherCurrentAssetsTextBlock", "div", "div", "body", "html" ], "baseRef": "d216471d10q.htm", "contextRef": "P01_01_2021To09_30_2021", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:DeferredCostsCapitalizedPrepaidAndOtherAssetsDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "1028 - Disclosure - Prepaid Expenses and Other Current Assets (Tables)", "role": "http://www.shapeways.com/role/PrepaidExpensesAndOtherCurrentAssetsTables", "shortName": "Prepaid Expenses and Other Current Assets (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "shpw:PrepaidExpensesAndOtherCurrentAssetsTextBlock", "div", "div", "body", "html" ], "baseRef": "d216471d10q.htm", "contextRef": "P01_01_2021To09_30_2021", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:DeferredCostsCapitalizedPrepaidAndOtherAssetsDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R29": { "firstAnchor": { "ancestors": [ "us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock", "div", "div", "body", "html" ], "baseRef": "d216471d10q.htm", "contextRef": "P01_01_2021To09_30_2021", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:PropertyPlantAndEquipmentTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "1029 - Disclosure - Property and Equipment, net (Tables)", "role": "http://www.shapeways.com/role/PropertyAndEquipmentNetTables", "shortName": "Property and Equipment, net (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock", "div", "div", "body", "html" ], "baseRef": "d216471d10q.htm", "contextRef": "P01_01_2021To09_30_2021", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:PropertyPlantAndEquipmentTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R3": { "firstAnchor": { "ancestors": [ "us-gaap:PreferredStockParOrStatedValuePerShare", "div", "div", "td", "tr", "table", "div", "div", "body", "html" ], "baseRef": "d216471d10q.htm", "contextRef": "PAsOn09_30_2021", "decimals": "INF", "first": true, "lang": null, "name": "us-gaap:PreferredStockParOrStatedValuePerShare", "reportCount": 1, "unique": true, "unitRef": "Unit_USD_per_Share", "xsiNil": "false" }, "groupType": "statement", "isDefault": "false", "longName": "1003 - Statement - Condensed Consolidated Balance Sheets (Parenthetical)", "role": "http://www.shapeways.com/role/CondensedConsolidatedBalanceSheetsParenthetical", "shortName": "Condensed Consolidated Balance Sheets (Parenthetical)", "subGroupType": "parenthetical", "uniqueAnchor": { "ancestors": [ "us-gaap:PreferredStockParOrStatedValuePerShare", "div", "div", "td", "tr", "table", "div", "div", "body", "html" ], "baseRef": "d216471d10q.htm", "contextRef": "PAsOn09_30_2021", "decimals": "INF", "first": true, "lang": null, "name": "us-gaap:PreferredStockParOrStatedValuePerShare", "reportCount": 1, "unique": true, "unitRef": "Unit_USD_per_Share", "xsiNil": "false" } }, "R30": { "firstAnchor": { "ancestors": [ "shpw:AccruedLiabilitiesAndOtherLiabilitiesTextBlock", "div", "div", "body", "html" ], "baseRef": "d216471d10q.htm", "contextRef": "P01_01_2021To09_30_2021", "decimals": null, "first": true, "lang": "en-US", "name": "shpw:AccruedLiabilitiesAndOtherLiabilitiesTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "1030 - Disclosure - Accrued Expenses and Other Liabilities (Tables)", "role": "http://www.shapeways.com/role/AccruedExpensesAndOtherLiabilitiesTables", "shortName": "Accrued Expenses and Other Liabilities (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "shpw:AccruedLiabilitiesAndOtherLiabilitiesTextBlock", "div", "div", "body", "html" ], "baseRef": "d216471d10q.htm", "contextRef": "P01_01_2021To09_30_2021", "decimals": null, "first": true, "lang": "en-US", "name": "shpw:AccruedLiabilitiesAndOtherLiabilitiesTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R31": { "firstAnchor": { "ancestors": [ "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock", "div", "div", "body", "html" ], "baseRef": "d216471d10q.htm", "contextRef": "P01_01_2021To09_30_2021", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:LeaseCostTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "1031 - Disclosure - Commitments and Contingencies (Tables)", "role": "http://www.shapeways.com/role/CommitmentsAndContingenciesTables", "shortName": "Commitments and Contingencies (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock", "div", "div", "body", "html" ], "baseRef": "d216471d10q.htm", "contextRef": "P01_01_2021To09_30_2021", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:LeaseCostTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R32": { "firstAnchor": { "ancestors": [ "us-gaap:DebtDisclosureTextBlock", "div", "div", "body", "html" ], "baseRef": "d216471d10q.htm", "contextRef": "P01_01_2021To09_30_2021", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfDebtTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "1032 - Disclosure - Borrowing Arrangements (Tables)", "role": "http://www.shapeways.com/role/BorrowingArrangementsTables", "shortName": "Borrowing Arrangements (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "us-gaap:DebtDisclosureTextBlock", "div", "div", "body", "html" ], "baseRef": "d216471d10q.htm", "contextRef": "P01_01_2021To09_30_2021", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfDebtTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R33": { "firstAnchor": { "ancestors": [ "div", "div", "ix:continuation", "div", "div", "body", "html" ], "baseRef": "d216471d10q.htm", "contextRef": "P01_01_2021To09_30_2021", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "1033 - Disclosure - Stock-Based Compensation (Tables)", "role": "http://www.shapeways.com/role/StockBasedCompensationTables", "shortName": "Stock-Based Compensation (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "div", "div", "ix:continuation", "div", "div", "body", "html" ], "baseRef": "d216471d10q.htm", "contextRef": "P01_01_2021To09_30_2021", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R34": { "firstAnchor": { "ancestors": [ "div", "ix:continuation", "div", "div", "body", "html" ], "baseRef": "d216471d10q.htm", "contextRef": "P01_01_2021To09_30_2021", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "1034 - Disclosure - Fair Value Measurements (Tables)", "role": "http://www.shapeways.com/role/FairValueMeasurementsTables", "shortName": "Fair Value Measurements (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "div", "ix:continuation", "div", "div", "body", "html" ], "baseRef": "d216471d10q.htm", "contextRef": "P01_01_2021To09_30_2021", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R35": { "firstAnchor": { "ancestors": [ "div", "div", "div", "us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock", "div", "div", "body", "html" ], "baseRef": "d216471d10q.htm", "contextRef": "P01_01_2021To09_30_2021_ShapewaysIncMemberdeiLegalEntityAxis", "decimals": "-6", "first": true, "lang": null, "name": "shpw:NumberOfManufacturingPartsDelivered", "reportCount": 1, "unique": true, "unitRef": "Unit_Supplychainpartners", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "1035 - Disclosure - Organization (Details)", "role": "http://www.shapeways.com/role/OrganizationDetails", "shortName": "Organization (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "div", "div", "div", "us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock", "div", "div", "body", "html" ], "baseRef": "d216471d10q.htm", "contextRef": "P01_01_2021To09_30_2021_ShapewaysIncMemberdeiLegalEntityAxis", "decimals": "-6", "first": true, "lang": null, "name": "shpw:NumberOfManufacturingPartsDelivered", "reportCount": 1, "unique": true, "unitRef": "Unit_Supplychainpartners", "xsiNil": "false" } }, "R36": { "firstAnchor": { "ancestors": [ "us-gaap:AssetImpairmentCharges", "div", "div", "us-gaap:GoodwillAndIntangibleAssetsIntangibleAssetsIndefiniteLivedPolicy", "ix:continuation", "div", "div", "body", "html" ], "baseRef": "d216471d10q.htm", "contextRef": "P01_01_2021To09_30_2021", "decimals": "-3", "first": true, "lang": null, "name": "us-gaap:AssetImpairmentCharges", "reportCount": 1, "unique": true, "unitRef": "Unit_USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "1036 - Disclosure - Summary of Significant Accounting Policies (Details)", "role": "http://www.shapeways.com/role/SummaryOfSignificantAccountingPoliciesDetails", "shortName": "Summary of Significant Accounting Policies (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "us-gaap:AssetImpairmentCharges", "div", "div", "us-gaap:GoodwillAndIntangibleAssetsIntangibleAssetsIndefiniteLivedPolicy", "ix:continuation", "div", "div", "body", "html" ], "baseRef": "d216471d10q.htm", "contextRef": "P01_01_2021To09_30_2021", "decimals": "-3", "first": true, "lang": null, "name": "us-gaap:AssetImpairmentCharges", "reportCount": 1, "unique": true, "unitRef": "Unit_USD", "xsiNil": "false" } }, "R37": { "firstAnchor": { "ancestors": [ "td", "tr", "table", "div", "div", "body", "html" ], "baseRef": "d216471d10q.htm", "contextRef": "PAsOn09_30_2021", "decimals": "-3", "first": true, "lang": null, "name": "us-gaap:CashAndCashEquivalentsAtCarryingValue", "reportCount": 1, "unitRef": "Unit_USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "1037 - Disclosure - Summary of Significant Accounting Policies - Summary of reconciliation of cash and cash equivalents (Details)", "role": "http://www.shapeways.com/role/SummaryOfSignificantAccountingPoliciesSummaryOfReconciliationOfCashAndCashEquivalentsDetails", "shortName": "Summary of Significant Accounting Policies - Summary of reconciliation of cash and cash equivalents (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "td", "tr", "table", "ix:continuation", "us-gaap:ScheduleOfCashAndCashEquivalentsTableTextBlock", "ix:continuation", "div", "div", "body", "html" ], "baseRef": "d216471d10q.htm", "contextRef": "PAsOn09_30_2021", "decimals": "-3", "lang": null, "name": "us-gaap:RestrictedCash", "reportCount": 1, "unique": true, "unitRef": "Unit_USD", "xsiNil": "false" } }, "R38": { "firstAnchor": { "ancestors": [ "td", "tr", "table", "shpw:ScheduleOfUsefulLivesOfPropertyPlantAndEquipmentTableTextBlock", "us-gaap:PropertyPlantAndEquipmentPolicyTextBlock", "ix:continuation", "div", "div", "body", "html" ], "baseRef": "d216471d10q.htm", "contextRef": "P01_01_2021To09_30_2021_MachineryAndEquipmentMemberusgaapPropertyPlantAndEquipmentByTypeAxis", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:PropertyPlantAndEquipmentUsefulLife", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "1038 - Disclosure - Summary of Significant Accounting Policies - Summary of useful lives of property plant and equipment (Details)", "role": "http://www.shapeways.com/role/SummaryOfSignificantAccountingPoliciesSummaryOfUsefulLivesOfPropertyPlantAndEquipmentDetails", "shortName": "Summary of Significant Accounting Policies - Summary of useful lives of property plant and equipment (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "td", "tr", "table", "shpw:ScheduleOfUsefulLivesOfPropertyPlantAndEquipmentTableTextBlock", "us-gaap:PropertyPlantAndEquipmentPolicyTextBlock", "ix:continuation", "div", "div", "body", "html" ], "baseRef": "d216471d10q.htm", "contextRef": "P01_01_2021To09_30_2021_MachineryAndEquipmentMemberusgaapPropertyPlantAndEquipmentByTypeAxis", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:PropertyPlantAndEquipmentUsefulLife", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R39": { "firstAnchor": { "ancestors": [ "td", "tr", "table", "us-gaap:ScheduleOfCommonStockOutstandingRollForwardTableTextBlock", "us-gaap:EarningsPerSharePolicyTextBlock", "ix:continuation", "div", "div", "body", "html" ], "baseRef": "d216471d10q.htm", "contextRef": "PAsOn09_30_2021", "decimals": "-3", "first": true, "lang": null, "name": "shpw:CommonStockWarrantsOutstanding", "reportCount": 1, "unique": true, "unitRef": "Unit_USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "1039 - Disclosure - Summary of Significant Accounting Policies - Summary of common stock equivalents outstanding were excluded from computation of diluted net loss per share (Details)", "role": "http://www.shapeways.com/role/SummaryOfSignificantAccountingPoliciesSummaryOfCommonStockEquivalentsOutstandingWereExcludedFromComputationOfDilutedNetLossPerShareDetails", "shortName": "Summary of Significant Accounting Policies - Summary of common stock equivalents outstanding were excluded from computation of diluted net loss per share (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "td", "tr", "table", "us-gaap:ScheduleOfCommonStockOutstandingRollForwardTableTextBlock", "us-gaap:EarningsPerSharePolicyTextBlock", "ix:continuation", "div", "div", "body", "html" ], "baseRef": "d216471d10q.htm", "contextRef": "PAsOn09_30_2021", "decimals": "-3", "first": true, "lang": null, "name": "shpw:CommonStockWarrantsOutstanding", "reportCount": 1, "unique": true, "unitRef": "Unit_USD", "xsiNil": "false" } }, "R4": { "firstAnchor": { "ancestors": [ "td", "tr", "table", "div", "div", "body", "html" ], "baseRef": "d216471d10q.htm", "contextRef": "P07_01_2021To09_30_2021", "decimals": "-3", "first": true, "lang": null, "name": "us-gaap:Revenues", "reportCount": 1, "unique": true, "unitRef": "Unit_USD", "xsiNil": "false" }, "groupType": "statement", "isDefault": "false", "longName": "1004 - Statement - Condensed Consolidated Statements of Operations and Comprehensive Loss", "role": "http://www.shapeways.com/role/CondensedConsolidatedStatementsOfOperationsAndComprehensiveLoss", "shortName": "Condensed Consolidated Statements of Operations and Comprehensive Loss", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "td", "tr", "table", "div", "div", "body", "html" ], "baseRef": "d216471d10q.htm", "contextRef": "P07_01_2021To09_30_2021", "decimals": "-3", "first": true, "lang": null, "name": "us-gaap:Revenues", "reportCount": 1, "unique": true, "unitRef": "Unit_USD", "xsiNil": "false" } }, "R40": { "firstAnchor": { "ancestors": [ "td", "tr", "table", "shpw:DisclosureOfCommonStockSharesIssuedFollowingTheConsummationOfMergerTableTextBlock", "ix:continuation", "div", "div", "body", "html" ], "baseRef": "d216471d10q.htm", "contextRef": "P01_01_2021To09_30_2021_BusinessCombinationElementsToUnauditedConsolidatedStatementOfCashFlowsMemberSHPWReconciliationAxis_ReverseRecapitalizationMemberSHPWReverseRecapitalizationnAxis", "decimals": "-3", "first": true, "lang": null, "name": "shpw:TransactionCostsAndAdvisoryFeesAllocatedToEquity", "reportCount": 1, "unique": true, "unitRef": "Unit_USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "1040 - Disclosure - Reverse Recapitalization - Schedule of common stock shares issued following the consummation of merger (Details)", "role": "http://www.shapeways.com/role/ReverseRecapitalizationScheduleOfCommonStockSharesIssuedFollowingTheConsummationOfMergerDetails", "shortName": "Reverse Recapitalization - Schedule of common stock shares issued following the consummation of merger (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "td", "tr", "table", "shpw:DisclosureOfCommonStockSharesIssuedFollowingTheConsummationOfMergerTableTextBlock", "ix:continuation", "div", "div", "body", "html" ], "baseRef": "d216471d10q.htm", "contextRef": "P01_01_2021To09_30_2021_BusinessCombinationElementsToUnauditedConsolidatedStatementOfCashFlowsMemberSHPWReconciliationAxis_ReverseRecapitalizationMemberSHPWReverseRecapitalizationnAxis", "decimals": "-3", "first": true, "lang": null, "name": "shpw:TransactionCostsAndAdvisoryFeesAllocatedToEquity", "reportCount": 1, "unique": true, "unitRef": "Unit_USD", "xsiNil": "false" } }, "R41": { "firstAnchor": { "ancestors": [ "td", "tr", "table", "shpw:ScheduleOfReconciliationOfElementsOfBusinessCombinationToChangesInStockholdersEquityTableTextBlock", "ix:continuation", "div", "div", "body", "html" ], "baseRef": "d216471d10q.htm", "contextRef": "P01_01_2021To09_30_2021_BusinessCombinationElementsToUnauditedConsolidatedStatementOfEquityMemberSHPWReconciliationAxis_ReverseRecapitalizationMemberSHPWReverseRecapitalizationnAxis", "decimals": "-3", "first": true, "lang": null, "name": "us-gaap:PaymentsToAcquireBusinessesGross", "reportCount": 1, "unique": true, "unitRef": "Unit_USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "1041 - Disclosure - Reverse Recapitalization - Schedule of reconciles the elements of business combination to the unaudited consolidated statement of changes in stockholders equity (Details)", "role": "http://www.shapeways.com/role/ReverseRecapitalizationScheduleOfReconcilesTheElementsOfBusinessCombinationToTheUnauditedConsolidatedStatementOfChangesInStockholdersEquityDetails", "shortName": "Reverse Recapitalization - Schedule of reconciles the elements of business combination to the unaudited consolidated statement of changes in stockholders equity (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "td", "tr", "table", "shpw:ScheduleOfReconciliationOfElementsOfBusinessCombinationToChangesInStockholdersEquityTableTextBlock", "ix:continuation", "div", "div", "body", "html" ], "baseRef": "d216471d10q.htm", "contextRef": "P01_01_2021To09_30_2021_BusinessCombinationElementsToUnauditedConsolidatedStatementOfEquityMemberSHPWReconciliationAxis_ReverseRecapitalizationMemberSHPWReverseRecapitalizationnAxis", "decimals": "-3", "first": true, "lang": null, "name": "us-gaap:PaymentsToAcquireBusinessesGross", "reportCount": 1, "unique": true, "unitRef": "Unit_USD", "xsiNil": "false" } }, "R42": { "firstAnchor": { "ancestors": [ "div", "div", "td", "tr", "table", "div", "div", "body", "html" ], "baseRef": "d216471d10q.htm", "contextRef": "PAsOn12_31_2020", "decimals": "INF", "first": true, "lang": null, "name": "us-gaap:CommonStockSharesOutstanding", "reportCount": 1, "unitRef": "Unit_shares", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "1042 - Disclosure - Reverse Recapitalization - Schedule of common stock shares issued following the consummation of business combination (Details)", "role": "http://www.shapeways.com/role/ReverseRecapitalizationScheduleOfCommonStockSharesIssuedFollowingTheConsummationOfBusinessCombinationDetails", "shortName": "Reverse Recapitalization - Schedule of common stock shares issued following the consummation of business combination (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "td", "tr", "table", "shpw:DisclosureOfCommonStockSharesIssuedFollowingTheConsummationOfBusinessCombinationTableTextBlock", "ix:continuation", "div", "div", "body", "html" ], "baseRef": "d216471d10q.htm", "contextRef": "P01_01_2021To09_30_2021_PipeInvestmentMemberusgaapInvestmentTypeAxis_ReverseRecapitalizationMemberSHPWReverseRecapitalizationnAxis", "decimals": "INF", "lang": null, "name": "us-gaap:StockIssuedDuringPeriodSharesNewIssues", "reportCount": 1, "unique": true, "unitRef": "Unit_shares", "xsiNil": "false" } }, "R43": { "firstAnchor": { "ancestors": [ "div", "div", "div", "td", "tr", "table", "shpw:DisclosureOfCommonStockSharesIssuedFollowingTheConsummationOfBusinessCombinationTableTextBlock", "ix:continuation", "div", "div", "body", "html" ], "baseRef": "d216471d10q.htm", "contextRef": "PAsOn09_30_2021", "decimals": "0", "first": true, "lang": null, "name": "shpw:EarnOutSharesOutstandingShares", "reportCount": 1, "unique": true, "unitRef": "Unit_shares", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "1043 - Disclosure - Reverse Recapitalization - Schedule of common stock shares issued following the consummation of business combination (Parenthetical) (Details)", "role": "http://www.shapeways.com/role/ReverseRecapitalizationScheduleOfCommonStockSharesIssuedFollowingTheConsummationOfBusinessCombinationParentheticalDetails", "shortName": "Reverse Recapitalization - Schedule of common stock shares issued following the consummation of business combination (Parenthetical) (Details)", "subGroupType": "parenthetical", "uniqueAnchor": { "ancestors": [ "div", "div", "div", "td", "tr", "table", "shpw:DisclosureOfCommonStockSharesIssuedFollowingTheConsummationOfBusinessCombinationTableTextBlock", "ix:continuation", "div", "div", "body", "html" ], "baseRef": "d216471d10q.htm", "contextRef": "PAsOn09_30_2021", "decimals": "0", "first": true, "lang": null, "name": "shpw:EarnOutSharesOutstandingShares", "reportCount": 1, "unique": true, "unitRef": "Unit_shares", "xsiNil": "false" } }, "R44": { "firstAnchor": { "ancestors": [ "us-gaap:CommonStockParOrStatedValuePerShare", "div", "div", "td", "tr", "table", "div", "div", "body", "html" ], "baseRef": "d216471d10q.htm", "contextRef": "PAsOn09_30_2021", "decimals": "INF", "first": true, "lang": null, "name": "us-gaap:CommonStockParOrStatedValuePerShare", "reportCount": 1, "unitRef": "Unit_USD_per_Share", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "1044 - Disclosure - Reverse Recapitalization (Details)", "role": "http://www.shapeways.com/role/ReverseRecapitalizationDetails", "shortName": "Reverse Recapitalization (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "div", "ix:continuation", "div", "div", "body", "html" ], "baseRef": "d216471d10q.htm", "contextRef": "PAsOn09_29_2021_ReverseRecapitalizationMemberSHPWReverseRecapitalizationnAxis", "decimals": "INF", "lang": null, "name": "shpw:ConversionOfPreferredAndCommonStockIssuedUponExerciseOfWarrantsConvertedIntoAggregateNumberOfSharesOfCommonStock", "reportCount": 1, "unique": true, "unitRef": "Unit_shares", "xsiNil": "false" } }, "R45": { "firstAnchor": { "ancestors": [ "div", "div", "us-gaap:RevenueFromContractWithCustomerTextBlock", "div", "div", "body", "html" ], "baseRef": "d216471d10q.htm", "contextRef": "P01_01_2021To09_30_2021", "decimals": "INF", "first": true, "lang": null, "name": "shpw:PercentageOfMarkupFeeUponSaleOfProductsThroughMarketplace", "reportCount": 1, "unique": true, "unitRef": "Unit_pure", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "1045 - Disclosure - Revenue Recognition - Marketplace sales (Details)", "role": "http://www.shapeways.com/role/RevenueRecognitionMarketplaceSalesDetails", "shortName": "Revenue Recognition - Marketplace sales (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "div", "div", "us-gaap:RevenueFromContractWithCustomerTextBlock", "div", "div", "body", "html" ], "baseRef": "d216471d10q.htm", "contextRef": "P01_01_2021To09_30_2021", "decimals": "INF", "first": true, "lang": null, "name": "shpw:PercentageOfMarkupFeeUponSaleOfProductsThroughMarketplace", "reportCount": 1, "unique": true, "unitRef": "Unit_pure", "xsiNil": "false" } }, "R46": { "firstAnchor": { "ancestors": [ "td", "tr", "table", "us-gaap:DisaggregationOfRevenueTableTextBlock", "ix:continuation", "div", "div", "body", "html" ], "baseRef": "d216471d10q.htm", "contextRef": "P07_01_2021To09_30_2021", "decimals": "-3", "first": true, "lang": null, "name": "us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax", "reportCount": 1, "unique": true, "unitRef": "Unit_USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "1046 - Disclosure - Revenue Recognition - Disaggregation of revenues (Details)", "role": "http://www.shapeways.com/role/RevenueRecognitionDisaggregationOfRevenuesDetails", "shortName": "Revenue Recognition - Disaggregation of revenues (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "td", "tr", "table", "us-gaap:DisaggregationOfRevenueTableTextBlock", "ix:continuation", "div", "div", "body", "html" ], "baseRef": "d216471d10q.htm", "contextRef": "P07_01_2021To09_30_2021", "decimals": "-3", "first": true, "lang": null, "name": "us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax", "reportCount": 1, "unique": true, "unitRef": "Unit_USD", "xsiNil": "false" } }, "R47": { "firstAnchor": { "ancestors": [ "td", "tr", "table", "us-gaap:ContractWithCustomerAssetAndLiabilityTableTextBlock", "ix:continuation", "div", "div", "body", "html" ], "baseRef": "d216471d10q.htm", "contextRef": "PAsOn12_31_2020", "decimals": "-3", "first": true, "lang": null, "name": "us-gaap:ContractWithCustomerLiability", "reportCount": 1, "unique": true, "unitRef": "Unit_USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "1047 - Disclosure - Revenue Recognition - Deferred revenues (Details)", "role": "http://www.shapeways.com/role/RevenueRecognitionDeferredRevenuesDetails", "shortName": "Revenue Recognition - Deferred revenues (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "td", "tr", "table", "us-gaap:ContractWithCustomerAssetAndLiabilityTableTextBlock", "ix:continuation", "div", "div", "body", "html" ], "baseRef": "d216471d10q.htm", "contextRef": "PAsOn12_31_2020", "decimals": "-3", "first": true, "lang": null, "name": "us-gaap:ContractWithCustomerLiability", "reportCount": 1, "unique": true, "unitRef": "Unit_USD", "xsiNil": "false" } }, "R48": { "firstAnchor": null, "groupType": "disclosure", "isDefault": "false", "longName": "1048 - Disclosure - Revenue Recognition - Practical expedients and exemptions (Details)", "role": "http://www.shapeways.com/role/RevenueRecognitionPracticalExpedientsAndExemptionsDetails", "shortName": "Revenue Recognition - Practical expedients and exemptions (Details)", "subGroupType": "details", "uniqueAnchor": null }, "R49": { "firstAnchor": { "ancestors": [ "td", "tr", "table", "us-gaap:ScheduleOfInventoryCurrentTableTextBlock", "us-gaap:InventoryDisclosureTextBlock", "div", "div", "body", "html" ], "baseRef": "d216471d10q.htm", "contextRef": "PAsOn09_30_2021", "decimals": "-3", "first": true, "lang": null, "name": "us-gaap:InventoryRawMaterialsNetOfReserves", "reportCount": 1, "unique": true, "unitRef": "Unit_USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "1049 - Disclosure - Inventory (Details)", "role": "http://www.shapeways.com/role/InventoryDetails", "shortName": "Inventory (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "td", "tr", "table", "us-gaap:ScheduleOfInventoryCurrentTableTextBlock", "us-gaap:InventoryDisclosureTextBlock", "div", "div", "body", "html" ], "baseRef": "d216471d10q.htm", "contextRef": "PAsOn09_30_2021", "decimals": "-3", "first": true, "lang": null, "name": "us-gaap:InventoryRawMaterialsNetOfReserves", "reportCount": 1, "unique": true, "unitRef": "Unit_USD", "xsiNil": "false" } }, "R5": { "firstAnchor": { "ancestors": [ "td", "tr", "table", "div", "div", "body", "html" ], "baseRef": "d216471d10q.htm", "contextRef": "PAsOn12_31_2019", "decimals": "-3", "first": true, "lang": null, "name": "us-gaap:StockholdersEquity", "reportCount": 1, "unitRef": "Unit_USD", "xsiNil": "false" }, "groupType": "statement", "isDefault": "false", "longName": "1005 - Statement - Condensed Consolidated Statements of Changes in Stockholders' Equity (Deficit)", "role": "http://www.shapeways.com/role/CondensedConsolidatedStatementsOfChangesInStockholdersEquityDeficit", "shortName": "Condensed Consolidated Statements of Changes in Stockholders' Equity (Deficit)", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "td", "tr", "table", "div", "div", "body", "html" ], "baseRef": "d216471d10q.htm", "contextRef": "P01_01_2020To03_31_2020_PreferredStockMemberusgaapStatementEquityComponentsAxis_RestatementAdjustmentMembersrtRestatementAxis", "decimals": "-3", "lang": null, "name": "shpw:RetroactiveApplicationOfReverseRecapitalizationSharesValue", "reportCount": 1, "unique": true, "unitRef": "Unit_USD", "xsiNil": "false" } }, "R50": { "firstAnchor": { "ancestors": [ "td", "tr", "table", "us-gaap:DeferredCostsCapitalizedPrepaidAndOtherAssetsDisclosureTextBlock", "shpw:PrepaidExpensesAndOtherCurrentAssetsTextBlock", "div", "div", "body", "html" ], "baseRef": "d216471d10q.htm", "contextRef": "PAsOn09_30_2021", "decimals": "-3", "first": true, "lang": null, "name": "us-gaap:PrepaidExpenseCurrent", "reportCount": 1, "unique": true, "unitRef": "Unit_USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "1050 - Disclosure - Prepaid Expenses and Other Current Assets (Details)", "role": "http://www.shapeways.com/role/PrepaidExpensesAndOtherCurrentAssetsDetails", "shortName": "Prepaid Expenses and Other Current Assets (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "td", "tr", "table", "us-gaap:DeferredCostsCapitalizedPrepaidAndOtherAssetsDisclosureTextBlock", "shpw:PrepaidExpensesAndOtherCurrentAssetsTextBlock", "div", "div", "body", "html" ], "baseRef": "d216471d10q.htm", "contextRef": "PAsOn09_30_2021", "decimals": "-3", "first": true, "lang": null, "name": "us-gaap:PrepaidExpenseCurrent", "reportCount": 1, "unique": true, "unitRef": "Unit_USD", "xsiNil": "false" } }, "R51": { "firstAnchor": { "ancestors": [ "td", "tr", "table", "us-gaap:PropertyPlantAndEquipmentTextBlock", "us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock", "div", "div", "body", "html" ], "baseRef": "d216471d10q.htm", "contextRef": "PAsOn09_30_2021", "decimals": "-3", "first": true, "lang": null, "name": "us-gaap:PropertyPlantAndEquipmentGross", "reportCount": 1, "unitRef": "Unit_USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "1051 - Disclosure - Property and Equipment, net (Details)", "role": "http://www.shapeways.com/role/PropertyAndEquipmentNetDetails", "shortName": "Property and Equipment, net (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "td", "tr", "table", "us-gaap:PropertyPlantAndEquipmentTextBlock", "us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock", "div", "div", "body", "html" ], "baseRef": "d216471d10q.htm", "contextRef": "PAsOn12_31_2020", "decimals": "-3", "lang": null, "name": "us-gaap:PropertyPlantAndEquipmentGross", "reportCount": 1, "unique": true, "unitRef": "Unit_USD", "xsiNil": "false" } }, "R52": { "firstAnchor": { "ancestors": [ "td", "tr", "table", "shpw:AccruedLiabilitiesAndOtherLiabilitiesTableTextBlock", "shpw:AccruedLiabilitiesAndOtherLiabilitiesTextBlock", "div", "div", "body", "html" ], "baseRef": "d216471d10q.htm", "contextRef": "PAsOn09_30_2021", "decimals": "-3", "first": true, "lang": null, "name": "shpw:AccruedSellingExpensesCurrent", "reportCount": 1, "unique": true, "unitRef": "Unit_USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "1052 - Disclosure - Accrued Expenses and Other Liabilities (Details)", "role": "http://www.shapeways.com/role/AccruedExpensesAndOtherLiabilitiesDetails", "shortName": "Accrued Expenses and Other Liabilities (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "td", "tr", "table", "shpw:AccruedLiabilitiesAndOtherLiabilitiesTableTextBlock", "shpw:AccruedLiabilitiesAndOtherLiabilitiesTextBlock", "div", "div", "body", "html" ], "baseRef": "d216471d10q.htm", "contextRef": "PAsOn09_30_2021", "decimals": "-3", "first": true, "lang": null, "name": "shpw:AccruedSellingExpensesCurrent", "reportCount": 1, "unique": true, "unitRef": "Unit_USD", "xsiNil": "false" } }, "R53": { "firstAnchor": { "ancestors": [ "div", "div", "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock", "div", "div", "body", "html" ], "baseRef": "d216471d10q.htm", "contextRef": "P01_01_2021To09_30_2021", "decimals": "INF", "first": true, "lang": null, "name": "shpw:NumberOfLeasesOfFacilitiesLocatedInUnitedStatesAndNetherlands", "reportCount": 1, "unique": true, "unitRef": "Unit_lease", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "1053 - Disclosure - Commitments and Contingencies - Leases (Details)", "role": "http://www.shapeways.com/role/CommitmentsAndContingenciesLeasesDetails", "shortName": "Commitments and Contingencies - Leases (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "div", "div", "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock", "div", "div", "body", "html" ], "baseRef": "d216471d10q.htm", "contextRef": "P01_01_2021To09_30_2021", "decimals": "INF", "first": true, "lang": null, "name": "shpw:NumberOfLeasesOfFacilitiesLocatedInUnitedStatesAndNetherlands", "reportCount": 1, "unique": true, "unitRef": "Unit_lease", "xsiNil": "false" } }, "R54": { "firstAnchor": { "ancestors": [ "td", "tr", "table", "us-gaap:LeaseCostTableTextBlock", "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock", "div", "div", "body", "html" ], "baseRef": "d216471d10q.htm", "contextRef": "P07_01_2021To09_30_2021", "decimals": "-3", "first": true, "lang": null, "name": "us-gaap:OperatingLeaseCost", "reportCount": 1, "unique": true, "unitRef": "Unit_USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "1054 - Disclosure - Commitments and Contingencies - Company's lease costs (Details)", "role": "http://www.shapeways.com/role/CommitmentsAndContingenciesCompanysLeaseCostsDetails", "shortName": "Commitments and Contingencies - Company's lease costs (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "td", "tr", "table", "us-gaap:LeaseCostTableTextBlock", "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock", "div", "div", "body", "html" ], "baseRef": "d216471d10q.htm", "contextRef": "P07_01_2021To09_30_2021", "decimals": "-3", "first": true, "lang": null, "name": "us-gaap:OperatingLeaseCost", "reportCount": 1, "unique": true, "unitRef": "Unit_USD", "xsiNil": "false" } }, "R55": { "firstAnchor": { "ancestors": [ "td", "tr", "table", "div", "div", "body", "html" ], "baseRef": "d216471d10q.htm", "contextRef": "PAsOn09_30_2021", "decimals": "-3", "first": true, "lang": null, "name": "us-gaap:OperatingLeaseRightOfUseAsset", "reportCount": 1, "unitRef": "Unit_USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "1055 - Disclosure - Commitments and Contingencies - Right of use assets and lease liabilities for operating leases (Details)", "role": "http://www.shapeways.com/role/CommitmentsAndContingenciesRightOfUseAssetsAndLeaseLiabilitiesForOperatingLeasesDetails", "shortName": "Commitments and Contingencies - Right of use assets and lease liabilities for operating leases (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "td", "tr", "table", "shpw:LesseeBalanceSheetInformationTableTextBlock", "ix:continuation", "div", "div", "body", "html" ], "baseRef": "d216471d10q.htm", "contextRef": "PAsOn09_30_2021", "decimals": "-3", "lang": null, "name": "shpw:AssetsOnLease", "reportCount": 1, "unique": true, "unitRef": "Unit_USD", "xsiNil": "false" } }, "R56": { "firstAnchor": { "ancestors": [ "div", "div", "ix:continuation", "div", "div", "body", "html" ], "baseRef": "d216471d10q.htm", "contextRef": "PAsOn09_30_2021", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:OperatingLeaseWeightedAverageRemainingLeaseTerm1", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "1056 - Disclosure - Commitments and Contingencies - Weighted-average (Details)", "role": "http://www.shapeways.com/role/CommitmentsAndContingenciesWeightedAverageDetails", "shortName": "Commitments and Contingencies - Weighted-average (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "div", "div", "ix:continuation", "div", "div", "body", "html" ], "baseRef": "d216471d10q.htm", "contextRef": "PAsOn09_30_2021", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:OperatingLeaseWeightedAverageRemainingLeaseTerm1", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R57": { "firstAnchor": { "ancestors": [ "td", "tr", "table", "shpw:LesseeCashFlowsInformationTableTextBlock", "ix:continuation", "div", "div", "body", "html" ], "baseRef": "d216471d10q.htm", "contextRef": "P01_01_2021To09_30_2021", "decimals": "-3", "first": true, "lang": null, "name": "us-gaap:OperatingLeasePayments", "reportCount": 1, "unique": true, "unitRef": "Unit_USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "1057 - Disclosure - Commitments and Contingencies - Supplemental cash flow (Details)", "role": "http://www.shapeways.com/role/CommitmentsAndContingenciesSupplementalCashFlowDetails", "shortName": "Commitments and Contingencies - Supplemental cash flow (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "td", "tr", "table", "shpw:LesseeCashFlowsInformationTableTextBlock", "ix:continuation", "div", "div", "body", "html" ], "baseRef": "d216471d10q.htm", "contextRef": "P01_01_2021To09_30_2021", "decimals": "-3", "first": true, "lang": null, "name": "us-gaap:OperatingLeasePayments", "reportCount": 1, "unique": true, "unitRef": "Unit_USD", "xsiNil": "false" } }, "R58": { "firstAnchor": { "ancestors": [ "td", "tr", "table", "us-gaap:LesseeOperatingLeaseLiabilityMaturityTableTextBlock", "ix:continuation", "div", "div", "body", "html" ], "baseRef": "d216471d10q.htm", "contextRef": "PAsOn09_30_2021", "decimals": "-3", "first": true, "lang": null, "name": "us-gaap:LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear", "reportCount": 1, "unique": true, "unitRef": "Unit_USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "1058 - Disclosure - Commitments and Contingencies - Future minimum lease payments (Details)", "role": "http://www.shapeways.com/role/CommitmentsAndContingenciesFutureMinimumLeasePaymentsDetails", "shortName": "Commitments and Contingencies - Future minimum lease payments (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "td", "tr", "table", "us-gaap:LesseeOperatingLeaseLiabilityMaturityTableTextBlock", "ix:continuation", "div", "div", "body", "html" ], "baseRef": "d216471d10q.htm", "contextRef": "PAsOn09_30_2021", "decimals": "-3", "first": true, "lang": null, "name": "us-gaap:LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear", "reportCount": 1, "unique": true, "unitRef": "Unit_USD", "xsiNil": "false" } }, "R59": { "firstAnchor": { "ancestors": [ "div", "div", "div", "ix:continuation", "div", "div", "body", "html" ], "baseRef": "d216471d10q.htm", "contextRef": "P03_26_2021To03_26_2021_DesktopMetalMemberusgaapPropertyPlantAndEquipmentByTypeAxis", "decimals": "-5", "first": true, "lang": null, "name": "us-gaap:LongTermPurchaseCommitmentAmount", "reportCount": 1, "unique": true, "unitRef": "Unit_USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "1059 - Disclosure - Commitments and Contingencies - Additional Information (Details)", "role": "http://www.shapeways.com/role/CommitmentsAndContingenciesAdditionalInformationDetails", "shortName": "Commitments and Contingencies - Additional Information (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "div", "div", "div", "ix:continuation", "div", "div", "body", "html" ], "baseRef": "d216471d10q.htm", "contextRef": "P03_26_2021To03_26_2021_DesktopMetalMemberusgaapPropertyPlantAndEquipmentByTypeAxis", "decimals": "-5", "first": true, "lang": null, "name": "us-gaap:LongTermPurchaseCommitmentAmount", "reportCount": 1, "unique": true, "unitRef": "Unit_USD", "xsiNil": "false" } }, "R6": { "firstAnchor": { "ancestors": [ "td", "tr", "table", "div", "div", "body", "html" ], "baseRef": "d216471d10q.htm", "contextRef": "P01_01_2021To09_30_2021", "decimals": "-3", "first": true, "lang": null, "name": "us-gaap:ProfitLoss", "reportCount": 1, "unique": true, "unitRef": "Unit_USD", "xsiNil": "false" }, "groupType": "statement", "isDefault": "false", "longName": "1006 - Statement - Condensed Consolidated Statements of Cash Flows", "role": "http://www.shapeways.com/role/CondensedConsolidatedStatementsOfCashFlows", "shortName": "Condensed Consolidated Statements of Cash Flows", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "td", "tr", "table", "div", "div", "body", "html" ], "baseRef": "d216471d10q.htm", "contextRef": "P01_01_2021To09_30_2021", "decimals": "-3", "first": true, "lang": null, "name": "us-gaap:ProfitLoss", "reportCount": 1, "unique": true, "unitRef": "Unit_USD", "xsiNil": "false" } }, "R60": { "firstAnchor": { "ancestors": [ "div", "div", "div", "ix:continuation", "div", "div", "body", "html" ], "baseRef": "d216471d10q.htm", "contextRef": "PAsOn10_29_2018_TermLoanMemberusgaapLongtermDebtTypeAxis", "decimals": "-3", "first": true, "lang": null, "name": "us-gaap:DebtInstrumentFaceAmount", "reportCount": 1, "unique": true, "unitRef": "Unit_USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "1060 - Disclosure - Borrowing Arrangements - Term Loan (Details)", "role": "http://www.shapeways.com/role/BorrowingArrangementsTermLoanDetails", "shortName": "Borrowing Arrangements - Term Loan (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "div", "div", "div", "ix:continuation", "div", "div", "body", "html" ], "baseRef": "d216471d10q.htm", "contextRef": "PAsOn10_29_2018_TermLoanMemberusgaapLongtermDebtTypeAxis", "decimals": "-3", "first": true, "lang": null, "name": "us-gaap:DebtInstrumentFaceAmount", "reportCount": 1, "unique": true, "unitRef": "Unit_USD", "xsiNil": "false" } }, "R61": { "firstAnchor": { "ancestors": [ "div", "div", "ix:continuation", "div", "div", "body", "html" ], "baseRef": "d216471d10q.htm", "contextRef": "PAsOn09_30_2021_DutchLandlordLoanMemberusgaapLongtermDebtTypeAxis", "decimals": "-3", "first": true, "lang": null, "name": "us-gaap:DebtInstrumentFaceAmount", "reportCount": 1, "unitRef": "Unit_USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "1061 - Disclosure - Borrowing Arrangements - Dutch landlord loan (Details)", "role": "http://www.shapeways.com/role/BorrowingArrangementsDutchLandlordLoanDetails", "shortName": "Borrowing Arrangements - Dutch landlord loan (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "div", "div", "ix:continuation", "div", "div", "body", "html" ], "baseRef": "d216471d10q.htm", "contextRef": "PAsOn12_31_2020_DutchLandlordLoanMemberusgaapLongtermDebtTypeAxis", "decimals": "-3", "lang": null, "name": "us-gaap:DebtInstrumentFaceAmount", "reportCount": 1, "unique": true, "unitRef": "Unit_USD", "xsiNil": "false" } }, "R62": { "firstAnchor": { "ancestors": [ "td", "tr", "table", "us-gaap:ScheduleOfDebtTableTextBlock", "us-gaap:DebtDisclosureTextBlock", "div", "div", "body", "html" ], "baseRef": "d216471d10q.htm", "contextRef": "PAsOn09_30_2021", "decimals": "-3", "first": true, "lang": null, "name": "us-gaap:LongTermDebt", "reportCount": 1, "unique": true, "unitRef": "Unit_USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "1062 - Disclosure - Borrowing Arrangements - Outstanding debt obligations (Details)", "role": "http://www.shapeways.com/role/BorrowingArrangementsOutstandingDebtObligationsDetails", "shortName": "Borrowing Arrangements - Outstanding debt obligations (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "td", "tr", "table", "us-gaap:ScheduleOfDebtTableTextBlock", "us-gaap:DebtDisclosureTextBlock", "div", "div", "body", "html" ], "baseRef": "d216471d10q.htm", "contextRef": "PAsOn09_30_2021", "decimals": "-3", "first": true, "lang": null, "name": "us-gaap:LongTermDebt", "reportCount": 1, "unique": true, "unitRef": "Unit_USD", "xsiNil": "false" } }, "R63": { "firstAnchor": { "ancestors": [ "div", "div", "td", "tr", "table", "div", "div", "body", "html" ], "baseRef": "d216471d10q.htm", "contextRef": "PAsOn09_30_2021", "decimals": "INF", "first": true, "lang": null, "name": "us-gaap:CommonStockSharesOutstanding", "reportCount": 1, "unitRef": "Unit_shares", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "1063 - Disclosure - Borrowing Arrangements - Convertible promissory notes (Details)", "role": "http://www.shapeways.com/role/BorrowingArrangementsConvertiblePromissoryNotesDetails", "shortName": "Borrowing Arrangements - Convertible promissory notes (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "div", "ix:continuation", "div", "div", "body", "html" ], "baseRef": "d216471d10q.htm", "contextRef": "PAsOn06_19_2019_ConvertibleNotesPayableMemberusgaapLongtermDebtTypeAxis", "decimals": "-3", "lang": null, "name": "us-gaap:DebtInstrumentFaceAmount", "reportCount": 1, "unique": true, "unitRef": "Unit_USD", "xsiNil": "false" } }, "R64": { "firstAnchor": { "ancestors": [ "div", "div", "ix:continuation", "div", "div", "body", "html" ], "baseRef": "d216471d10q.htm", "contextRef": "P05_04_2020To05_04_2020_PaymentProtectionProgramLoanMemberusgaapLongtermDebtTypeAxis", "decimals": "-3", "first": true, "lang": null, "name": "us-gaap:ProceedsFromNotesPayable", "reportCount": 1, "unique": true, "unitRef": "Unit_USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "1064 - Disclosure - Borrowing Arrangements - Paycheck protection program loan (Details)", "role": "http://www.shapeways.com/role/BorrowingArrangementsPaycheckProtectionProgramLoanDetails", "shortName": "Borrowing Arrangements - Paycheck protection program loan (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "div", "div", "ix:continuation", "div", "div", "body", "html" ], "baseRef": "d216471d10q.htm", "contextRef": "P05_04_2020To05_04_2020_PaymentProtectionProgramLoanMemberusgaapLongtermDebtTypeAxis", "decimals": "-3", "first": true, "lang": null, "name": "us-gaap:ProceedsFromNotesPayable", "reportCount": 1, "unique": true, "unitRef": "Unit_USD", "xsiNil": "false" } }, "R65": { "firstAnchor": { "ancestors": [ "div", "div", "us-gaap:StockholdersEquityNoteDisclosureTextBlock", "div", "div", "body", "html" ], "baseRef": "d216471d10q.htm", "contextRef": "P09_29_2021To09_29_2021", "decimals": "4", "first": true, "lang": null, "name": "shpw:RecapitalizationConversionRatio", "reportCount": 1, "unique": true, "unitRef": "Unit_pure", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "1065 - Disclosure - Stockholders' Equity (Deficit) (Details)", "role": "http://www.shapeways.com/role/StockholdersEquityDeficitDetails", "shortName": "Stockholders' Equity (Deficit) (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "div", "div", "us-gaap:StockholdersEquityNoteDisclosureTextBlock", "div", "div", "body", "html" ], "baseRef": "d216471d10q.htm", "contextRef": "P09_29_2021To09_29_2021", "decimals": "4", "first": true, "lang": null, "name": "shpw:RecapitalizationConversionRatio", "reportCount": 1, "unique": true, "unitRef": "Unit_pure", "xsiNil": "false" } }, "R66": { "firstAnchor": { "ancestors": [ "td", "tr", "table", "ix:continuation", "ix:continuation", "div", "div", "body", "html" ], "baseRef": "d216471d10q.htm", "contextRef": "PAsOn09_30_2021", "decimals": "2", "first": true, "lang": null, "name": "us-gaap:SharePrice", "reportCount": 1, "unitRef": "Unit_USD_per_Share", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "1066 - Disclosure - Stock-Based Compensation - Fair value of stock-based compensation (Details)", "role": "http://www.shapeways.com/role/StockBasedCompensationFairValueOfStockBasedCompensationDetails", "shortName": "Stock-Based Compensation - Fair value of stock-based compensation (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "div", "td", "tr", "table", "ix:continuation", "ix:continuation", "div", "div", "body", "html" ], "baseRef": "d216471d10q.htm", "contextRef": "P01_01_2021To09_30_2021", "decimals": "4", "lang": null, "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum", "reportCount": 1, "unique": true, "unitRef": "Unit_pure", "xsiNil": "false" } }, "R67": { "firstAnchor": { "ancestors": [ "td", "tr", "table", "us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock", "ix:continuation", "div", "div", "body", "html" ], "baseRef": "d216471d10q.htm", "contextRef": "PAsOn06_30_2021", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber", "reportCount": 1, "unitRef": "Unit_shares", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "1067 - Disclosure - Stock-Based Compensation - Stock option plan (Details)", "role": "http://www.shapeways.com/role/StockBasedCompensationStockOptionPlanDetails", "shortName": "Stock-Based Compensation - Stock option plan (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "td", "tr", "table", "us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock", "ix:continuation", "div", "div", "body", "html" ], "baseRef": "d216471d10q.htm", "contextRef": "P01_01_2020To12_31_2020", "decimals": "0", "lang": null, "name": "shpw:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsRetroactiveApplicationOfReverseRecapitalization", "reportCount": 1, "unique": true, "unitRef": "Unit_shares", "xsiNil": "false" } }, "R68": { "firstAnchor": { "ancestors": [ "td", "tr", "table", "us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock", "ix:continuation", "div", "div", "body", "html" ], "baseRef": "d216471d10q.htm", "contextRef": "PAsOn09_30_2021", "decimals": "2", "first": true, "lang": null, "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice", "reportCount": 1, "unitRef": "Unit_USD_per_Share", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "1068 - Disclosure - Stock-Based Compensation (Details)", "role": "http://www.shapeways.com/role/StockBasedCompensationDetails", "shortName": "Stock-Based Compensation (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "div", "us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock", "div", "div", "body", "html" ], "baseRef": "d216471d10q.htm", "contextRef": "PAsOn09_29_2021_TwoThousandTenStockPlanMemberusgaapPlanNameAxis", "decimals": "0", "lang": null, "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized", "reportCount": 1, "unique": true, "unitRef": "Unit_shares", "xsiNil": "false" } }, "R69": { "firstAnchor": { "ancestors": [ "td", "tr", "table", "us-gaap:FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock", "ix:continuation", "div", "div", "body", "html" ], "baseRef": "d216471d10q.htm", "contextRef": "PAsOn09_30_2021_FairValueInputsLevel3MemberusgaapFairValueByFairValueHierarchyLevelAxis_PrivatePlacementWarrantsMemberusgaapClassOfWarrantOrRightAxis", "decimals": "1", "first": true, "lang": null, "name": "us-gaap:WarrantsAndRightsOutstandingMeasurementInput", "reportCount": 1, "unique": true, "unitRef": "Unit_pure", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "1069 - Disclosure - Fair Value Measurements - Initial measurement (Details)", "role": "http://www.shapeways.com/role/FairValueMeasurementsInitialMeasurementDetails", "shortName": "Fair Value Measurements - Initial measurement (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "td", "tr", "table", "us-gaap:FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock", "ix:continuation", "div", "div", "body", "html" ], "baseRef": "d216471d10q.htm", "contextRef": "PAsOn09_30_2021_FairValueInputsLevel3MemberusgaapFairValueByFairValueHierarchyLevelAxis_PrivatePlacementWarrantsMemberusgaapClassOfWarrantOrRightAxis", "decimals": "1", "first": true, "lang": null, "name": "us-gaap:WarrantsAndRightsOutstandingMeasurementInput", "reportCount": 1, "unique": true, "unitRef": "Unit_pure", "xsiNil": "false" } }, "R7": { "firstAnchor": { "ancestors": [ "div", "div", "body", "html" ], "baseRef": "d216471d10q.htm", "contextRef": "P01_01_2021To09_30_2021", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "1007 - Disclosure - Organization", "role": "http://www.shapeways.com/role/Organization", "shortName": "Organization", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "div", "div", "body", "html" ], "baseRef": "d216471d10q.htm", "contextRef": "P01_01_2021To09_30_2021", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R70": { "firstAnchor": { "ancestors": [ "td", "tr", "table", "shpw:SummaryOfChangesInFairValueOfWarrantLiabilitiesTableTextBlock", "ix:continuation", "div", "div", "body", "html" ], "baseRef": "d216471d10q.htm", "contextRef": "PAsOn12_31_2020_FairValueInputsLevel3MemberusgaapFairValueByFairValueHierarchyLevelAxis", "decimals": "-3", "first": true, "lang": null, "name": "us-gaap:SharesSubjectToMandatoryRedemptionSettlementTermsFairValueOfShares", "reportCount": 1, "unitRef": "Unit_USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "1070 - Disclosure - Fair Value Measurements - Subsequent measurement (Details)", "role": "http://www.shapeways.com/role/FairValueMeasurementsSubsequentMeasurementDetails", "shortName": "Fair Value Measurements - Subsequent measurement (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "td", "tr", "table", "shpw:SummaryOfChangesInFairValueOfWarrantLiabilitiesTableTextBlock", "ix:continuation", "div", "div", "body", "html" ], "baseRef": "d216471d10q.htm", "contextRef": "P01_01_2021To09_30_2021_FairValueInputsLevel3MemberusgaapFairValueByFairValueHierarchyLevelAxis", "decimals": "-3", "lang": null, "name": "shpw:AdditionsPursuantToMergerOfWarrantLiabilities", "reportCount": 1, "unique": true, "unitRef": "Unit_USD", "xsiNil": "false" } }, "R71": { "firstAnchor": { "ancestors": [ "td", "tr", "table", "ix:continuation", "ix:continuation", "div", "div", "body", "html" ], "baseRef": "d216471d10q.htm", "contextRef": "PAsOn09_30_2021", "decimals": "2", "first": true, "lang": null, "name": "us-gaap:SharePrice", "reportCount": 1, "unitRef": "Unit_USD_per_Share", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "1071 - Disclosure - Fair Value Measurements (Details)", "role": "http://www.shapeways.com/role/FairValueMeasurementsDetails", "shortName": "Fair Value Measurements (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "div", "ix:continuation", "div", "div", "body", "html" ], "baseRef": "d216471d10q.htm", "contextRef": "PAsOn09_30_2021_EarnoutSharesMemberusgaapStatementEquityComponentsAxis", "decimals": "-3", "lang": null, "name": "shpw:EstimatedFairValueOfTheSharesRecognizedAsADeemedDividendAmount", "reportCount": 1, "unique": true, "unitRef": "Unit_USD", "xsiNil": "false" } }, "R72": { "firstAnchor": { "ancestors": [ "shpw:NumberOfMajorVendorAccountsPayableOverTenPercentBenchmark", "div", "div", "us-gaap:ConcentrationRiskDisclosureTextBlock", "div", "div", "body", "html" ], "baseRef": "d216471d10q.htm", "contextRef": "P01_01_2021To09_30_2021_AccountsPayableMemberusgaapConcentrationRiskByBenchmarkAxis_OtherVendorMemberusgaapShareBasedGoodsAndNonemployeeServicesTransactionBySupplierAxis", "decimals": "INF", "first": true, "lang": null, "name": "shpw:NumberOfMajorVendorAccountsPayableOverTenPercentBenchmark", "reportCount": 1, "unique": true, "unitRef": "Unit_Vendors", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "1072 - Disclosure - Significant Concentrations (Details)", "role": "http://www.shapeways.com/role/SignificantConcentrationsDetails", "shortName": "Significant Concentrations (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "shpw:NumberOfMajorVendorAccountsPayableOverTenPercentBenchmark", "div", "div", "us-gaap:ConcentrationRiskDisclosureTextBlock", "div", "div", "body", "html" ], "baseRef": "d216471d10q.htm", "contextRef": "P01_01_2021To09_30_2021_AccountsPayableMemberusgaapConcentrationRiskByBenchmarkAxis_OtherVendorMemberusgaapShareBasedGoodsAndNonemployeeServicesTransactionBySupplierAxis", "decimals": "INF", "first": true, "lang": null, "name": "shpw:NumberOfMajorVendorAccountsPayableOverTenPercentBenchmark", "reportCount": 1, "unique": true, "unitRef": "Unit_Vendors", "xsiNil": "false" } }, "R73": { "firstAnchor": { "ancestors": [ "div", "us-gaap:RelatedPartyTransactionsDisclosureTextBlock", "div", "div", "body", "html" ], "baseRef": "d216471d10q.htm", "contextRef": "PAsOn12_31_2012_OfficerMemberusgaapRelatedPartyTransactionsByRelatedPartyAxis_RelatedPartyNoteMemberusgaapRelatedPartyTransactionAxis", "decimals": "-3", "first": true, "lang": null, "name": "us-gaap:DebtInstrumentFaceAmount", "reportCount": 1, "unique": true, "unitRef": "Unit_USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "1073 - Disclosure - Related Party Transactions (Details)", "role": "http://www.shapeways.com/role/RelatedPartyTransactionsDetails", "shortName": "Related Party Transactions (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "div", "us-gaap:RelatedPartyTransactionsDisclosureTextBlock", "div", "div", "body", "html" ], "baseRef": "d216471d10q.htm", "contextRef": "PAsOn12_31_2012_OfficerMemberusgaapRelatedPartyTransactionsByRelatedPartyAxis_RelatedPartyNoteMemberusgaapRelatedPartyTransactionAxis", "decimals": "-3", "first": true, "lang": null, "name": "us-gaap:DebtInstrumentFaceAmount", "reportCount": 1, "unique": true, "unitRef": "Unit_USD", "xsiNil": "false" } }, "R8": { "firstAnchor": { "ancestors": [ "div", "div", "body", "html" ], "baseRef": "d216471d10q.htm", "contextRef": "P01_01_2021To09_30_2021", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:SignificantAccountingPoliciesTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "1008 - Disclosure - Summary of Significant Accounting Policies", "role": "http://www.shapeways.com/role/SummaryOfSignificantAccountingPolicies", "shortName": "Summary of Significant Accounting Policies", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "div", "div", "body", "html" ], "baseRef": "d216471d10q.htm", "contextRef": "P01_01_2021To09_30_2021", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:SignificantAccountingPoliciesTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R9": { "firstAnchor": { "ancestors": [ "div", "div", "body", "html" ], "baseRef": "d216471d10q.htm", "contextRef": "P01_01_2021To09_30_2021", "decimals": null, "first": true, "lang": "en-US", "name": "shpw:ReverseRecapitalizationTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "1009 - Disclosure - Reverse Recapitalization", "role": "http://www.shapeways.com/role/ReverseRecapitalization", "shortName": "Reverse Recapitalization", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "div", "div", "body", "html" ], "baseRef": "d216471d10q.htm", "contextRef": "P01_01_2021To09_30_2021", "decimals": null, "first": true, "lang": "en-US", "name": "shpw:ReverseRecapitalizationTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } } }, "segmentCount": 101, "tag": { "dei_AmendmentFlag": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.", "label": "Amendment Flag" } } }, "localname": "AmendmentFlag", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://www.shapeways.com/role/CoverPage" ], "xbrltype": "booleanItemType" }, "dei_CityAreaCode": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Area code of city", "label": "City Area Code" } } }, "localname": "CityAreaCode", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://www.shapeways.com/role/CoverPage" ], "xbrltype": "normalizedStringItemType" }, "dei_CoverAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Cover page.", "label": "Cover [Abstract]" } } }, "localname": "CoverAbstract", "nsuri": "http://xbrl.sec.gov/dei/2021", "xbrltype": "stringItemType" }, "dei_CurrentFiscalYearEndDate": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "End date of current fiscal year in the format --MM-DD.", "label": "Current Fiscal Year End Date" } } }, "localname": "CurrentFiscalYearEndDate", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://www.shapeways.com/role/CoverPage" ], "xbrltype": "gMonthDayItemType" }, "dei_DocumentFiscalPeriodFocus": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Fiscal period values are FY, Q1, Q2, and Q3. 1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY.", "label": "Document Fiscal Period Focus" } } }, "localname": "DocumentFiscalPeriodFocus", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://www.shapeways.com/role/CoverPage" ], "xbrltype": "fiscalPeriodItemType" }, "dei_DocumentFiscalYearFocus": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "This is focus fiscal year of the document report in YYYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006.", "label": "Document Fiscal Year Focus" } } }, "localname": "DocumentFiscalYearFocus", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://www.shapeways.com/role/CoverPage" ], "xbrltype": "gYearItemType" }, "dei_DocumentInformationLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Document Information [Line Items]" } } }, "localname": "DocumentInformationLineItems", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://www.shapeways.com/role/CoverPage" ], "xbrltype": "stringItemType" }, "dei_DocumentInformationTable": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Container to support the formal attachment of each official or unofficial, public or private document as part of a submission package.", "label": "Document Information [Table]" } } }, "localname": "DocumentInformationTable", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://www.shapeways.com/role/CoverPage" ], "xbrltype": "stringItemType" }, "dei_DocumentPeriodEndDate": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period. The format of the date is YYYY-MM-DD.", "label": "Document Period End Date" } } }, "localname": "DocumentPeriodEndDate", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://www.shapeways.com/role/CoverPage" ], "xbrltype": "dateItemType" }, "dei_DocumentQuarterlyReport": { "auth_ref": [ "r654" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true only for a form used as an quarterly report.", "label": "Document Quarterly Report" } } }, "localname": "DocumentQuarterlyReport", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://www.shapeways.com/role/CoverPage" ], "xbrltype": "booleanItemType" }, "dei_DocumentTransitionReport": { "auth_ref": [ "r655" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true only for a form used as a transition report.", "label": "Document Transition Report" } } }, "localname": "DocumentTransitionReport", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://www.shapeways.com/role/CoverPage" ], "xbrltype": "booleanItemType" }, "dei_DocumentType": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.", "label": "Document Type" } } }, "localname": "DocumentType", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://www.shapeways.com/role/CoverPage" ], "xbrltype": "submissionTypeItemType" }, "dei_EntityAddressAddressLine1": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Address Line 1 such as Attn, Building Name, Street Name", "label": "Entity Address, Address Line One" } } }, "localname": "EntityAddressAddressLine1", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://www.shapeways.com/role/CoverPage" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressCityOrTown": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Name of the City or Town", "label": "Entity Address, City or Town" } } }, "localname": "EntityAddressCityOrTown", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://www.shapeways.com/role/CoverPage" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressPostalZipCode": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Code for the postal or zip code", "label": "Entity Address, Postal Zip Code" } } }, "localname": "EntityAddressPostalZipCode", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://www.shapeways.com/role/CoverPage" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressStateOrProvince": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Name of the state or province.", "label": "Entity Address, State or Province" } } }, "localname": "EntityAddressStateOrProvince", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://www.shapeways.com/role/CoverPage" ], "xbrltype": "stateOrProvinceItemType" }, "dei_EntityCentralIndexKey": { "auth_ref": [ "r656" ], "lang": { "en-us": { "role": { "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.", "label": "Entity Central Index Key" } } }, "localname": "EntityCentralIndexKey", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://www.shapeways.com/role/CoverPage" ], "xbrltype": "centralIndexKeyItemType" }, "dei_EntityCommonStockSharesOutstanding": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.", "label": "Entity Common Stock, Shares Outstanding" } } }, "localname": "EntityCommonStockSharesOutstanding", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://www.shapeways.com/role/CoverPage" ], "xbrltype": "sharesItemType" }, "dei_EntityCurrentReportingStatus": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Indicate 'Yes' or 'No' whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure.", "label": "Entity Current Reporting Status" } } }, "localname": "EntityCurrentReportingStatus", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://www.shapeways.com/role/CoverPage" ], "xbrltype": "yesNoItemType" }, "dei_EntityDomain": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "All the names of the entities being reported upon in a document. Any legal structure used to conduct activities or to hold assets. Some examples of such structures are corporations, partnerships, limited liability companies, grantor trusts, and other trusts. This item does not include business and geographical segments which are included in the geographical or business segments domains.", "label": "Entity [Domain]" } } }, "localname": "EntityDomain", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://www.shapeways.com/role/BorrowingArrangementsConvertiblePromissoryNotesDetails", "http://www.shapeways.com/role/BorrowingArrangementsDutchLandlordLoanDetails", "http://www.shapeways.com/role/BorrowingArrangementsPaycheckProtectionProgramLoanDetails", "http://www.shapeways.com/role/BorrowingArrangementsTermLoanDetails", "http://www.shapeways.com/role/OrganizationDetails", "http://www.shapeways.com/role/ReverseRecapitalizationDetails", "http://www.shapeways.com/role/ReverseRecapitalizationScheduleOfCommonStockSharesIssuedFollowingTheConsummationOfBusinessCombinationDetails" ], "xbrltype": "domainItemType" }, "dei_EntityEmergingGrowthCompany": { "auth_ref": [ "r656" ], "lang": { "en-us": { "role": { "documentation": "Indicate if registrant meets the emerging growth company criteria.", "label": "Entity Emerging Growth Company" } } }, "localname": "EntityEmergingGrowthCompany", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://www.shapeways.com/role/CoverPage" ], "xbrltype": "booleanItemType" }, "dei_EntityExTransitionPeriod": { "auth_ref": [ "r665" ], "lang": { "en-us": { "role": { "documentation": "Indicate if an emerging growth company has elected not to use the extended transition period for complying with any new or revised financial accounting standards.", "label": "Entity Ex Transition Period" } } }, "localname": "EntityExTransitionPeriod", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://www.shapeways.com/role/CoverPage" ], "xbrltype": "booleanItemType" }, "dei_EntityFileNumber": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.", "label": "Entity File Number" } } }, "localname": "EntityFileNumber", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://www.shapeways.com/role/CoverPage" ], "xbrltype": "fileNumberItemType" }, "dei_EntityFilerCategory": { "auth_ref": [ "r656" ], "lang": { "en-us": { "role": { "documentation": "Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure.", "label": "Entity Filer Category" } } }, "localname": "EntityFilerCategory", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://www.shapeways.com/role/CoverPage" ], "xbrltype": "filerCategoryItemType" }, "dei_EntityIncorporationStateCountryCode": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Two-character EDGAR code representing the state or country of incorporation.", "label": "Entity Incorporation, State or Country Code" } } }, "localname": "EntityIncorporationStateCountryCode", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://www.shapeways.com/role/CoverPage" ], "xbrltype": "edgarStateCountryItemType" }, "dei_EntityInteractiveDataCurrent": { "auth_ref": [ "r664" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).", "label": "Entity Interactive Data Current" } } }, "localname": "EntityInteractiveDataCurrent", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://www.shapeways.com/role/CoverPage" ], "xbrltype": "yesNoItemType" }, "dei_EntityRegistrantName": { "auth_ref": [ "r656" ], "lang": { "en-us": { "role": { "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.", "label": "Entity Registrant Name" } } }, "localname": "EntityRegistrantName", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://www.shapeways.com/role/CoverPage" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityShellCompany": { "auth_ref": [ "r656" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the registrant is a shell company as defined in Rule 12b-2 of the Exchange Act.", "label": "Entity Shell Company" } } }, "localname": "EntityShellCompany", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://www.shapeways.com/role/CoverPage" ], "xbrltype": "booleanItemType" }, "dei_EntitySmallBusiness": { "auth_ref": [ "r656" ], "lang": { "en-us": { "role": { "documentation": "Indicates that the company is a Smaller Reporting Company (SRC).", "label": "Entity Small Business" } } }, "localname": "EntitySmallBusiness", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://www.shapeways.com/role/CoverPage" ], "xbrltype": "booleanItemType" }, "dei_EntityTaxIdentificationNumber": { "auth_ref": [ "r656" ], "lang": { "en-us": { "role": { "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.", "label": "Entity Tax Identification Number" } } }, "localname": "EntityTaxIdentificationNumber", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://www.shapeways.com/role/CoverPage" ], "xbrltype": "employerIdItemType" }, "dei_LegalEntityAxis": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The set of legal entities associated with a report.", "label": "Legal Entity [Axis]" } } }, "localname": "LegalEntityAxis", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://www.shapeways.com/role/BorrowingArrangementsConvertiblePromissoryNotesDetails", "http://www.shapeways.com/role/BorrowingArrangementsDutchLandlordLoanDetails", "http://www.shapeways.com/role/BorrowingArrangementsPaycheckProtectionProgramLoanDetails", "http://www.shapeways.com/role/BorrowingArrangementsTermLoanDetails", "http://www.shapeways.com/role/OrganizationDetails", "http://www.shapeways.com/role/ReverseRecapitalizationDetails", "http://www.shapeways.com/role/ReverseRecapitalizationScheduleOfCommonStockSharesIssuedFollowingTheConsummationOfBusinessCombinationDetails" ], "xbrltype": "stringItemType" }, "dei_LocalPhoneNumber": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Local phone number for entity.", "label": "Local Phone Number" } } }, "localname": "LocalPhoneNumber", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://www.shapeways.com/role/CoverPage" ], "xbrltype": "normalizedStringItemType" }, "dei_Security12bTitle": { "auth_ref": [ "r652" ], "lang": { "en-us": { "role": { "documentation": "Title of a 12(b) registered security.", "label": "Title of 12(b) Security" } } }, "localname": "Security12bTitle", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://www.shapeways.com/role/CoverPage" ], "xbrltype": "securityTitleItemType" }, "dei_SecurityExchangeName": { "auth_ref": [ "r653" ], "lang": { "en-us": { "role": { "documentation": "Name of the Exchange on which a security is registered.", "label": "Security Exchange Name" } } }, "localname": "SecurityExchangeName", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://www.shapeways.com/role/CoverPage" ], "xbrltype": "edgarExchangeCodeItemType" }, "dei_TradingSymbol": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Trading symbol of an instrument as listed on an exchange.", "label": "Trading Symbol" } } }, "localname": "TradingSymbol", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://www.shapeways.com/role/CoverPage" ], "xbrltype": "tradingSymbolItemType" }, "shpw_AccruedAcquisitionOfPropertyAndEquipment": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Accrued acquisition of property and equipment.", "label": "Accrued Acquisition Of Property And Equipment", "terseLabel": "Accrued acquisition of property and equipment" } } }, "localname": "AccruedAcquisitionOfPropertyAndEquipment", "nsuri": "http://www.shapeways.com/20210930", "presentation": [ "http://www.shapeways.com/role/CondensedConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "shpw_AccruedAcquisitionOfPropertyAndEquipmentCurrent": { "auth_ref": [], "calculation": { "http://www.shapeways.com/role/AccruedExpensesAndOtherLiabilitiesDetails": { "order": 4.0, "parentTag": "shpw_AccruedAndOtherLiabilitiesCurrent", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Accrued acquisition of property and equipment current.", "label": "Accrued Acquisition Of Property And Equipment Current", "terseLabel": "Accrued acquisition of property and equipment" } } }, "localname": "AccruedAcquisitionOfPropertyAndEquipmentCurrent", "nsuri": "http://www.shapeways.com/20210930", "presentation": [ "http://www.shapeways.com/role/AccruedExpensesAndOtherLiabilitiesDetails" ], "xbrltype": "monetaryItemType" }, "shpw_AccruedAndOtherLiabilitiesCurrent": { "auth_ref": [], "calculation": { "http://www.shapeways.com/role/AccruedExpensesAndOtherLiabilitiesDetails": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of expenses incurred but not yet paid nor invoiced, and liabilities classified as other.", "label": "Accrued And Other Liabilities Current", "totalLabel": "Total" } } }, "localname": "AccruedAndOtherLiabilitiesCurrent", "nsuri": "http://www.shapeways.com/20210930", "presentation": [ "http://www.shapeways.com/role/AccruedExpensesAndOtherLiabilitiesDetails" ], "xbrltype": "monetaryItemType" }, "shpw_AccruedCompensationCurrent": { "auth_ref": [], "calculation": { "http://www.shapeways.com/role/AccruedExpensesAndOtherLiabilitiesDetails": { "order": 6.0, "parentTag": "shpw_AccruedAndOtherLiabilitiesCurrent", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Carrying value as of the balance sheet date of obligations incurred through that date and payable for compensation. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).", "label": "Accrued Compensation Current", "terseLabel": "Accrued compensation" } } }, "localname": "AccruedCompensationCurrent", "nsuri": "http://www.shapeways.com/20210930", "presentation": [ "http://www.shapeways.com/role/AccruedExpensesAndOtherLiabilitiesDetails" ], "xbrltype": "monetaryItemType" }, "shpw_AccruedExpensesAndOtherLiabilitiesCurrentAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Accrued expenses and other liabilities current.", "label": "Accrued Expenses And Other Liabilities Current [Abstract]" } } }, "localname": "AccruedExpensesAndOtherLiabilitiesCurrentAbstract", "nsuri": "http://www.shapeways.com/20210930", "xbrltype": "stringItemType" }, "shpw_AccruedLiabilitiesAndOtherLiabilitiesTableTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The tabular disclosure on accrued expenses and other liabilities.", "label": "Accrued Liabilities And Other Liabilities [Table Text Block]", "terseLabel": "Summary of accrued expenses and other liabilities" } } }, "localname": "AccruedLiabilitiesAndOtherLiabilitiesTableTextBlock", "nsuri": "http://www.shapeways.com/20210930", "presentation": [ "http://www.shapeways.com/role/AccruedExpensesAndOtherLiabilitiesTables" ], "xbrltype": "textBlockItemType" }, "shpw_AccruedLiabilitiesAndOtherLiabilitiesTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The entire disclosure on accrued expenses and other liabilities.", "label": "Accrued Liabilities And Other Liabilities [Text Block]", "terseLabel": "Accrued Expenses and Other Liabilities" } } }, "localname": "AccruedLiabilitiesAndOtherLiabilitiesTextBlock", "nsuri": "http://www.shapeways.com/20210930", "presentation": [ "http://www.shapeways.com/role/AccruedExpensesAndOtherLiabilities" ], "xbrltype": "textBlockItemType" }, "shpw_AccruedSellingExpensesCurrent": { "auth_ref": [], "calculation": { "http://www.shapeways.com/role/AccruedExpensesAndOtherLiabilitiesDetails": { "order": 1.0, "parentTag": "shpw_AccruedAndOtherLiabilitiesCurrent", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Accrued selling expenses current.", "label": "Accrued Selling Expenses Current", "terseLabel": "Accrued selling expenses" } } }, "localname": "AccruedSellingExpensesCurrent", "nsuri": "http://www.shapeways.com/20210930", "presentation": [ "http://www.shapeways.com/role/AccruedExpensesAndOtherLiabilitiesDetails" ], "xbrltype": "monetaryItemType" }, "shpw_AccruedTransactionCosts": { "auth_ref": [], "calculation": { "http://www.shapeways.com/role/AccruedExpensesAndOtherLiabilitiesDetails": { "order": 7.0, "parentTag": "shpw_AccruedAndOtherLiabilitiesCurrent", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Accrued transaction costs.", "label": "Accrued Transaction Costs", "terseLabel": "Accrued transaction costs" } } }, "localname": "AccruedTransactionCosts", "nsuri": "http://www.shapeways.com/20210930", "presentation": [ "http://www.shapeways.com/role/AccruedExpensesAndOtherLiabilitiesDetails" ], "xbrltype": "monetaryItemType" }, "shpw_AdditionsPursuantToMergerOfWarrantLiabilities": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Additions pursuant to merger of warrant liabilities.", "label": "Additions Pursuant To Merger Of Warrant Liabilities", "terseLabel": "Additions pursuant to Merger" } } }, "localname": "AdditionsPursuantToMergerOfWarrantLiabilities", "nsuri": "http://www.shapeways.com/20210930", "presentation": [ "http://www.shapeways.com/role/FairValueMeasurementsSubsequentMeasurementDetails" ], "xbrltype": "monetaryItemType" }, "shpw_AfterBusinessCombinationAxis": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "After Business Combination", "label": "After Business Combination [Axis]" } } }, "localname": "AfterBusinessCombinationAxis", "nsuri": "http://www.shapeways.com/20210930", "presentation": [ "http://www.shapeways.com/role/ReverseRecapitalizationScheduleOfCommonStockSharesIssuedFollowingTheConsummationOfBusinessCombinationDetails" ], "xbrltype": "stringItemType" }, "shpw_AfterBusinessCombinationDomain": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "After Business Combination", "label": "After Business Combination [Domain]" } } }, "localname": "AfterBusinessCombinationDomain", "nsuri": "http://www.shapeways.com/20210930", "presentation": [ "http://www.shapeways.com/role/ReverseRecapitalizationScheduleOfCommonStockSharesIssuedFollowingTheConsummationOfBusinessCombinationDetails" ], "xbrltype": "domainItemType" }, "shpw_AgreementAxis": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Agreement [Axis].", "label": "Agreement [Axis]" } } }, "localname": "AgreementAxis", "nsuri": "http://www.shapeways.com/20210930", "presentation": [ "http://www.shapeways.com/role/RelatedPartyTransactionsDetails" ], "xbrltype": "stringItemType" }, "shpw_AgreementDomain": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Agreement [Domain].", "label": "Agreement [Domain]" } } }, "localname": "AgreementDomain", "nsuri": "http://www.shapeways.com/20210930", "presentation": [ "http://www.shapeways.com/role/RelatedPartyTransactionsDetails" ], "xbrltype": "domainItemType" }, "shpw_AmendedLoanAgreementMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Amended loan agreement [Member].", "label": "Amended Loan Agreement [Member]", "terseLabel": "Amended Loan Agreement [Member]" } } }, "localname": "AmendedLoanAgreementMember", "nsuri": "http://www.shapeways.com/20210930", "presentation": [ "http://www.shapeways.com/role/StockholdersEquityDeficitDetails" ], "xbrltype": "domainItemType" }, "shpw_AssetsLesseeAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Amount Of Assets Lessee [Abstract]", "label": "Assets Lessee [Abstract]", "terseLabel": "Assets:" } } }, "localname": "AssetsLesseeAbstract", "nsuri": "http://www.shapeways.com/20210930", "presentation": [ "http://www.shapeways.com/role/CommitmentsAndContingenciesRightOfUseAssetsAndLeaseLiabilitiesForOperatingLeasesDetails" ], "xbrltype": "stringItemType" }, "shpw_AssetsOnLease": { "auth_ref": [], "calculation": { "http://www.shapeways.com/role/CommitmentsAndContingenciesRightOfUseAssetsAndLeaseLiabilitiesForOperatingLeasesDetails": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The amount of assets covered under lease.", "label": "Assets On Lease", "totalLabel": "Total lease assets" } } }, "localname": "AssetsOnLease", "nsuri": "http://www.shapeways.com/20210930", "presentation": [ "http://www.shapeways.com/role/CommitmentsAndContingenciesRightOfUseAssetsAndLeaseLiabilitiesForOperatingLeasesDetails" ], "xbrltype": "monetaryItemType" }, "shpw_BasisOfPresentationAndPrinciplesOfConsolidationPolicyTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Basis of presentation and principles of consolidation [Policy Text Block].", "label": "Basis Of Presentation And Principles Of Consolidation [Policy Text Block]", "terseLabel": "Basis of Presentation and Principles of Consolidation" } } }, "localname": "BasisOfPresentationAndPrinciplesOfConsolidationPolicyTextBlock", "nsuri": "http://www.shapeways.com/20210930", "presentation": [ "http://www.shapeways.com/role/SummaryOfSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "shpw_BusinessCombinationElementsToUnauditedConsolidatedStatementOfCashFlowsMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Business Combination Elements To Unaudited consolidated Statement Of Cash Flows", "label": "Business Combination Elements To Unaudited consolidated Statement Of Cash Flows [Member]" } } }, "localname": "BusinessCombinationElementsToUnauditedConsolidatedStatementOfCashFlowsMember", "nsuri": "http://www.shapeways.com/20210930", "presentation": [ "http://www.shapeways.com/role/ReverseRecapitalizationScheduleOfCommonStockSharesIssuedFollowingTheConsummationOfMergerDetails" ], "xbrltype": "domainItemType" }, "shpw_BusinessCombinationElementsToUnauditedConsolidatedStatementOfEquityMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Business Combination Elements To Unaudited consolidated Statement Of Equity", "label": "Business Combination Elements To Unaudited consolidated Statement Of Equity [Member]" } } }, "localname": "BusinessCombinationElementsToUnauditedConsolidatedStatementOfEquityMember", "nsuri": "http://www.shapeways.com/20210930", "presentation": [ "http://www.shapeways.com/role/ReverseRecapitalizationScheduleOfReconcilesTheElementsOfBusinessCombinationToTheUnauditedConsolidatedStatementOfChangesInStockholdersEquityDetails" ], "xbrltype": "domainItemType" }, "shpw_ChangeInFairValueOfWarrantLiabilities": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Change in fair value of warrant liabilities.", "label": "Change In Fair Value Of Warrant Liabilities", "terseLabel": "Change in fair value" } } }, "localname": "ChangeInFairValueOfWarrantLiabilities", "nsuri": "http://www.shapeways.com/20210930", "presentation": [ "http://www.shapeways.com/role/FairValueMeasurementsSubsequentMeasurementDetails" ], "xbrltype": "monetaryItemType" }, "shpw_ClassOfWarrantOrRightExpirationDate": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Class of warrant or right expiration date.", "label": "Class Of Warrant Or Right Expiration Date", "terseLabel": "Expiration date of warrants" } } }, "localname": "ClassOfWarrantOrRightExpirationDate", "nsuri": "http://www.shapeways.com/20210930", "presentation": [ "http://www.shapeways.com/role/StockholdersEquityDeficitDetails" ], "xbrltype": "dateItemType" }, "shpw_ClassOfWarrantOrRightExpirationPeriodFromTheEffectiveDateOfAnInitialPublicOffering": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Class of warrant or right expiration period from the effective date of an initial public offering.", "label": "Class Of Warrant Or Right Expiration period From The Effective Date Of An Initial Public Offering", "terseLabel": "Expiraiton period of warrants from the effective date of an initial public offering" } } }, "localname": "ClassOfWarrantOrRightExpirationPeriodFromTheEffectiveDateOfAnInitialPublicOffering", "nsuri": "http://www.shapeways.com/20210930", "presentation": [ "http://www.shapeways.com/role/StockholdersEquityDeficitDetails" ], "xbrltype": "durationItemType" }, "shpw_ClassOfWarrantOrRightExpirationPeriodFromTheOriginalIssuanceDate": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Class of warrant or right expiration period from the original issuance date.", "label": "Class Of Warrant Or Right Expiration Period From The Original Issuance Date", "terseLabel": "Expiraiton period of warrants from the original issuance date" } } }, "localname": "ClassOfWarrantOrRightExpirationPeriodFromTheOriginalIssuanceDate", "nsuri": "http://www.shapeways.com/20210930", "presentation": [ "http://www.shapeways.com/role/StockholdersEquityDeficitDetails" ], "xbrltype": "durationItemType" }, "shpw_ClassOfWarrantOrRightPeriodRightsBecomeExercisableFollowingCompletionOfAcquisitionOrInitialPublicOffering": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Represents the period that the rights become exercisable following completion of acquisition , or specified period after initial public offering. in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.", "label": "Class Of Warrant Or Right, Period Rights Become Exercisable Following Completion of Acquisition or Initial Public Offering", "terseLabel": "Warrants exercisable period" } } }, "localname": "ClassOfWarrantOrRightPeriodRightsBecomeExercisableFollowingCompletionOfAcquisitionOrInitialPublicOffering", "nsuri": "http://www.shapeways.com/20210930", "presentation": [ "http://www.shapeways.com/role/StockholdersEquityDeficitDetails" ], "xbrltype": "durationItemType" }, "shpw_ClassOfWarrantOrRightRedemptionNoticePeriod": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Represents the prior written notice of redemption to each Public Warrant holder in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.", "label": "Class Of Warrant Or Right Redemption , Notice Period", "terseLabel": "Redemption notice period" } } }, "localname": "ClassOfWarrantOrRightRedemptionNoticePeriod", "nsuri": "http://www.shapeways.com/20210930", "presentation": [ "http://www.shapeways.com/role/StockholdersEquityDeficitDetails" ], "xbrltype": "durationItemType" }, "shpw_ClassOfWarrantOrRightRedemptionNumberOfConsecutiveTradingDaysOrdinarySharesPriceMustRemainAsTargetInTradingDays": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Redemption of warrants based upon the ordinary share price, represents the number of consecutive trading days the share price must stay as per target in the specified days.", "label": "Class Of Warrant Or Right Redemption, Number Of Consecutive Trading Days Ordinary Shares Price Must Remain as Target In Trading Days", "terseLabel": "Redemption share price basis number of days" } } }, "localname": "ClassOfWarrantOrRightRedemptionNumberOfConsecutiveTradingDaysOrdinarySharesPriceMustRemainAsTargetInTradingDays", "nsuri": "http://www.shapeways.com/20210930", "presentation": [ "http://www.shapeways.com/role/StockholdersEquityDeficitDetails" ], "xbrltype": "integerItemType" }, "shpw_ClassOfWarrantOrRightRedemptionNumberOfConsecutiveTradingDaysRegistrationStatementToBeMaintained": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Redemption of warrants registration statement to be maintained for the specified number of trading days.", "label": "Class Of Warrant Or Right Redemption, Number Of Consecutive Trading Days, Registration Statement To be Maintained", "terseLabel": "Redemption, registration statement to be maintained" } } }, "localname": "ClassOfWarrantOrRightRedemptionNumberOfConsecutiveTradingDaysRegistrationStatementToBeMaintained", "nsuri": "http://www.shapeways.com/20210930", "presentation": [ "http://www.shapeways.com/role/StockholdersEquityDeficitDetails" ], "xbrltype": "integerItemType" }, "shpw_ClassOfWarrantOrRightRedemptionOrdinarySharesPrice": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Represents redemption price of ordinary shares.", "label": "Class Of Warrant Or Right Redemption, Ordinary Shares Price", "terseLabel": "Redemption share price basis" } } }, "localname": "ClassOfWarrantOrRightRedemptionOrdinarySharesPrice", "nsuri": "http://www.shapeways.com/20210930", "presentation": [ "http://www.shapeways.com/role/StockholdersEquityDeficitDetails" ], "xbrltype": "perShareItemType" }, "shpw_ClassOfWarrantOrRightRedemptionPricePerRight": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Represents the redemption price per right.", "label": "Class Of Warrant Or Right Redemption Price Per Right", "terseLabel": "Redemption price (per warrant)" } } }, "localname": "ClassOfWarrantOrRightRedemptionPricePerRight", "nsuri": "http://www.shapeways.com/20210930", "presentation": [ "http://www.shapeways.com/role/StockholdersEquityDeficitDetails" ], "xbrltype": "perShareItemType" }, "shpw_ClassOfWarrantOrRightsExercisablePeriodFromTheDateOfGrant": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Class of warrant or rights exercisable period from the date of grant.", "label": "Class Of Warrant Or Rights Exercisable Period From The Date Of Grant", "terseLabel": "Warrants exercisable period from the date of grant" } } }, "localname": "ClassOfWarrantOrRightsExercisablePeriodFromTheDateOfGrant", "nsuri": "http://www.shapeways.com/20210930", "presentation": [ "http://www.shapeways.com/role/StockholdersEquityDeficitDetails" ], "xbrltype": "durationItemType" }, "shpw_ClassOfWarrantsOrRightsExercisedInAggregateOfSharesOfCommonStock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Class of Warrant\"s or rights exercised in aggregate of shares of common stock.", "label": "Class Of Warrants Or Rights Exercised In Aggregate Of Shares Of Common Stock", "terseLabel": "Outstanding warrants exercised in aggregate of shares of common stock" } } }, "localname": "ClassOfWarrantsOrRightsExercisedInAggregateOfSharesOfCommonStock", "nsuri": "http://www.shapeways.com/20210930", "presentation": [ "http://www.shapeways.com/role/StockholdersEquityDeficitDetails" ], "xbrltype": "sharesItemType" }, "shpw_CommonStockWarrantsOutstanding": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Common stock warrants outstanding.", "label": "Common Stock Warrants Outstanding", "terseLabel": "Common stock warrants" } } }, "localname": "CommonStockWarrantsOutstanding", "nsuri": "http://www.shapeways.com/20210930", "presentation": [ "http://www.shapeways.com/role/SummaryOfSignificantAccountingPoliciesSummaryOfCommonStockEquivalentsOutstandingWereExcludedFromComputationOfDilutedNetLossPerShareDetails" ], "xbrltype": "monetaryItemType" }, "shpw_ContractWithCustomerLiabilityAddition": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of addition to deferred revenue.", "label": "Contract With Customer Liability Addition", "terseLabel": "Additions to deferred revenue during period" } } }, "localname": "ContractWithCustomerLiabilityAddition", "nsuri": "http://www.shapeways.com/20210930", "presentation": [ "http://www.shapeways.com/role/RevenueRecognitionDeferredRevenuesDetails" ], "xbrltype": "monetaryItemType" }, "shpw_ConversionAxis": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Conversion.", "label": "Conversion [Axis]" } } }, "localname": "ConversionAxis", "nsuri": "http://www.shapeways.com/20210930", "presentation": [ "http://www.shapeways.com/role/BorrowingArrangementsConvertiblePromissoryNotesDetails" ], "xbrltype": "stringItemType" }, "shpw_ConversionDomain": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Conversion.", "label": "Conversion [Domain]" } } }, "localname": "ConversionDomain", "nsuri": "http://www.shapeways.com/20210930", "presentation": [ "http://www.shapeways.com/role/BorrowingArrangementsConvertiblePromissoryNotesDetails" ], "xbrltype": "domainItemType" }, "shpw_ConversionOfPreferredAndCommonStockIssuedUponExerciseOfWarrantsConvertedIntoAggregateNumberOfSharesOfCommonStock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Conversion Of Preferred and Common Stock Issued Upon Exercise Of Warrants Converted Into Aggregate number of shares of common stock", "label": "Conversion Of Preferred and Common Stock Issued Upon Exercise Of Warrants Converted Into Aggregate number of shares of common stock", "terseLabel": "Conversion of preferred and common stock issued upon exercise of warrants converted into aggregate number of shares of common stock" } } }, "localname": "ConversionOfPreferredAndCommonStockIssuedUponExerciseOfWarrantsConvertedIntoAggregateNumberOfSharesOfCommonStock", "nsuri": "http://www.shapeways.com/20210930", "presentation": [ "http://www.shapeways.com/role/ReverseRecapitalizationDetails" ], "xbrltype": "sharesItemType" }, "shpw_ConversionPriceDefinedAsPercentageOfNextEquityPricePerShare": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Conversion price defined as percentage of next equity price per share.", "label": "Conversion Price Defined As Percentage Of Next Equity Price Per Share", "terseLabel": "Conversion price defined as percentage of next equity price per share" } } }, "localname": "ConversionPriceDefinedAsPercentageOfNextEquityPricePerShare", "nsuri": "http://www.shapeways.com/20210930", "presentation": [ "http://www.shapeways.com/role/BorrowingArrangementsConvertiblePromissoryNotesDetails" ], "xbrltype": "percentItemType" }, "shpw_ConvertibleNoteMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Convertible note.", "label": "Convertible Note [Member]" } } }, "localname": "ConvertibleNoteMember", "nsuri": "http://www.shapeways.com/20210930", "presentation": [ "http://www.shapeways.com/role/FairValueMeasurementsDetails" ], "xbrltype": "domainItemType" }, "shpw_DebtInstrumentAccruedInterestRateStatedPercentage": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Debt instrument accrued interest rate stated percentage.", "label": "Debt Instrument Accrued Interest Rate Stated Percentage", "terseLabel": "Accrues interest at annual rate" } } }, "localname": "DebtInstrumentAccruedInterestRateStatedPercentage", "nsuri": "http://www.shapeways.com/20210930", "presentation": [ "http://www.shapeways.com/role/BorrowingArrangementsPaycheckProtectionProgramLoanDetails" ], "xbrltype": "percentItemType" }, "shpw_DebtInstrumentUnpaidAndAccruedInterestAmount": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Debt instrument unpaid and accrued interest amount.", "label": "Debt Instrument Unpaid And Accrued Interest Amount", "terseLabel": "Debt instrument unpaid and accrued interest" } } }, "localname": "DebtInstrumentUnpaidAndAccruedInterestAmount", "nsuri": "http://www.shapeways.com/20210930", "presentation": [ "http://www.shapeways.com/role/BorrowingArrangementsConvertiblePromissoryNotesDetails" ], "xbrltype": "monetaryItemType" }, "shpw_DesktopMetalMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Desktop Metal.", "label": "Desktop Metal [Member]" } } }, "localname": "DesktopMetalMember", "nsuri": "http://www.shapeways.com/20210930", "presentation": [ "http://www.shapeways.com/role/CommitmentsAndContingenciesAdditionalInformationDetails" ], "xbrltype": "domainItemType" }, "shpw_DirectSalesMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Direct sales.", "label": "Direct Sales [Member]", "terseLabel": "Direct sales" } } }, "localname": "DirectSalesMember", "nsuri": "http://www.shapeways.com/20210930", "presentation": [ "http://www.shapeways.com/role/RevenueRecognitionDisaggregationOfRevenuesDetails" ], "xbrltype": "domainItemType" }, "shpw_DisclosureOfCommonStockSharesIssuedFollowingTheConsummationOfBusinessCombinationLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Disclosure Of Common Stock Shares Issued Following The Consummation Of Business Combination", "label": "Disclosure Of Common Stock Shares Issued Following The Consummation Of Business Combination [Line Items]" } } }, "localname": "DisclosureOfCommonStockSharesIssuedFollowingTheConsummationOfBusinessCombinationLineItems", "nsuri": "http://www.shapeways.com/20210930", "presentation": [ "http://www.shapeways.com/role/ReverseRecapitalizationScheduleOfCommonStockSharesIssuedFollowingTheConsummationOfBusinessCombinationDetails" ], "xbrltype": "stringItemType" }, "shpw_DisclosureOfCommonStockSharesIssuedFollowingTheConsummationOfBusinessCombinationTable": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Disclosure Of Common Stock Shares Issued Following The Consummation Of Business Combination", "label": "Disclosure Of Common Stock Shares Issued Following The Consummation Of Business Combination [Table]" } } }, "localname": "DisclosureOfCommonStockSharesIssuedFollowingTheConsummationOfBusinessCombinationTable", "nsuri": "http://www.shapeways.com/20210930", "presentation": [ "http://www.shapeways.com/role/ReverseRecapitalizationScheduleOfCommonStockSharesIssuedFollowingTheConsummationOfBusinessCombinationDetails" ], "xbrltype": "stringItemType" }, "shpw_DisclosureOfCommonStockSharesIssuedFollowingTheConsummationOfBusinessCombinationTableTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Disclosure Of Common Stock Shares Issued Following The Consummation Of Business Combination", "label": "Disclosure Of Common Stock Shares Issued Following The Consummation Of Business Combination [Table Text Block]", "terseLabel": "Schedule Of Common Stock Shares Issued Following The Consummation Of Business Combination" } } }, "localname": "DisclosureOfCommonStockSharesIssuedFollowingTheConsummationOfBusinessCombinationTableTextBlock", "nsuri": "http://www.shapeways.com/20210930", "presentation": [ "http://www.shapeways.com/role/ReverseRecapitalizationTables" ], "xbrltype": "textBlockItemType" }, "shpw_DisclosureOfCommonStockSharesIssuedFollowingTheConsummationOfMergerTableTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Disclosure Of Common Stock Shares Issued Following The Consummation Of Merger", "label": "Disclosure Of Common Stock Shares Issued Following The Consummation Of Merger [Table Text Block]", "terseLabel": "Schedule Of Common Stock Shares Issued Following The Consummation Of Merger" } } }, "localname": "DisclosureOfCommonStockSharesIssuedFollowingTheConsummationOfMergerTableTextBlock", "nsuri": "http://www.shapeways.com/20210930", "presentation": [ "http://www.shapeways.com/role/ReverseRecapitalizationTables" ], "xbrltype": "textBlockItemType" }, "shpw_DisclosureOfOperatingLeaseAssetsAndLiabilitiesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Disclosure of operating lease assets and liabilities.", "label": "Disclosure Of Operating Lease Assets And Liabilities [Abstract]" } } }, "localname": "DisclosureOfOperatingLeaseAssetsAndLiabilitiesAbstract", "nsuri": "http://www.shapeways.com/20210930", "xbrltype": "stringItemType" }, "shpw_DutchLandlordLoanMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Dutch landlord loan.", "label": "Dutch Landlord Loan [Member]", "terseLabel": "Dutch Landlord Loan" } } }, "localname": "DutchLandlordLoanMember", "nsuri": "http://www.shapeways.com/20210930", "presentation": [ "http://www.shapeways.com/role/BorrowingArrangementsDutchLandlordLoanDetails", "http://www.shapeways.com/role/BorrowingArrangementsOutstandingDebtObligationsDetails" ], "xbrltype": "domainItemType" }, "shpw_EarnOutSharesOutstanding": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Earn out shares outstanding.", "label": "Earn Out Shares Outstanding", "terseLabel": "Earnout Shares" } } }, "localname": "EarnOutSharesOutstanding", "nsuri": "http://www.shapeways.com/20210930", "presentation": [ "http://www.shapeways.com/role/SummaryOfSignificantAccountingPoliciesSummaryOfCommonStockEquivalentsOutstandingWereExcludedFromComputationOfDilutedNetLossPerShareDetails" ], "xbrltype": "monetaryItemType" }, "shpw_EarnOutSharesOutstandingShares": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Earnout shares outstanding in shares.", "label": "Earn Out Shares Outstanding Shares", "terseLabel": "Earnout shares" } } }, "localname": "EarnOutSharesOutstandingShares", "nsuri": "http://www.shapeways.com/20210930", "presentation": [ "http://www.shapeways.com/role/ReverseRecapitalizationScheduleOfCommonStockSharesIssuedFollowingTheConsummationOfBusinessCombinationParentheticalDetails" ], "xbrltype": "sharesItemType" }, "shpw_EarnoutRestrictedStockUnitsMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Earnout Restricted Stock Units", "label": "Earnout Restricted Stock Units [Member]" } } }, "localname": "EarnoutRestrictedStockUnitsMember", "nsuri": "http://www.shapeways.com/20210930", "presentation": [ "http://www.shapeways.com/role/ReverseRecapitalizationDetails" ], "xbrltype": "domainItemType" }, "shpw_EarnoutSharesMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Earnout shares.", "label": "Earnout Shares [Member]" } } }, "localname": "EarnoutSharesMember", "nsuri": "http://www.shapeways.com/20210930", "presentation": [ "http://www.shapeways.com/role/FairValueMeasurementsDetails", "http://www.shapeways.com/role/ReverseRecapitalizationDetails" ], "xbrltype": "domainItemType" }, "shpw_EstimatedFairValueOfTheSharesRecognizedAsADeemedDividendAmount": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Estimated fair value of the shares recognized as a deemed dividend amount.", "label": "Estimated Fair Value Of The Shares Recognized As A Deemed Dividend Amount", "terseLabel": "Estimated fair value of the shares recognized as a deemed dividend" } } }, "localname": "EstimatedFairValueOfTheSharesRecognizedAsADeemedDividendAmount", "nsuri": "http://www.shapeways.com/20210930", "presentation": [ "http://www.shapeways.com/role/FairValueMeasurementsDetails" ], "xbrltype": "monetaryItemType" }, "shpw_EventAxis": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Event [Axis].", "label": "Event [Axis]" } } }, "localname": "EventAxis", "nsuri": "http://www.shapeways.com/20210930", "presentation": [ "http://www.shapeways.com/role/BorrowingArrangementsConvertiblePromissoryNotesDetails", "http://www.shapeways.com/role/ReverseRecapitalizationScheduleOfCommonStockSharesIssuedFollowingTheConsummationOfBusinessCombinationDetails", "http://www.shapeways.com/role/StockholdersEquityDeficitDetails" ], "xbrltype": "stringItemType" }, "shpw_EventDomain": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Event [Domain].", "label": "Event [Domain]" } } }, "localname": "EventDomain", "nsuri": "http://www.shapeways.com/20210930", "presentation": [ "http://www.shapeways.com/role/BorrowingArrangementsConvertiblePromissoryNotesDetails", "http://www.shapeways.com/role/ReverseRecapitalizationScheduleOfCommonStockSharesIssuedFollowingTheConsummationOfBusinessCombinationDetails", "http://www.shapeways.com/role/StockholdersEquityDeficitDetails" ], "xbrltype": "domainItemType" }, "shpw_ExecutingALoanAgreementMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Executing a loan agreement [Member].", "label": "Executing A Loan Agreement [Member]", "terseLabel": "Executing a Loan Agreement [Member]" } } }, "localname": "ExecutingALoanAgreementMember", "nsuri": "http://www.shapeways.com/20210930", "presentation": [ "http://www.shapeways.com/role/StockholdersEquityDeficitDetails" ], "xbrltype": "domainItemType" }, "shpw_FairValueOfAdditionsPursuantToWarrantLiabilities": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Fair value of additions pursuant to warrant liabilities.", "label": "Fair Value Of Additions Pursuant To Warrant Liabilities", "negatedLabel": "Less: fair value of Private and Sponsor Warrant liabilities" } } }, "localname": "FairValueOfAdditionsPursuantToWarrantLiabilities", "nsuri": "http://www.shapeways.com/20210930", "presentation": [ "http://www.shapeways.com/role/ReverseRecapitalizationScheduleOfReconcilesTheElementsOfBusinessCombinationToTheUnauditedConsolidatedStatementOfChangesInStockholdersEquityDetails" ], "xbrltype": "monetaryItemType" }, "shpw_FairValueOfCommonStockEstimatedBasedOnTradingPriceOfCommonStock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Fair value of common stock estimated based on trading price of common stock.", "label": "Fair Value Of Common Stock Estimated Based On Trading Price Of Common Stock", "terseLabel": "Fair value of shares estimated based on trading price of common stock" } } }, "localname": "FairValueOfCommonStockEstimatedBasedOnTradingPriceOfCommonStock", "nsuri": "http://www.shapeways.com/20210930", "presentation": [ "http://www.shapeways.com/role/FairValueMeasurementsDetails" ], "xbrltype": "perShareItemType" }, "shpw_FounderAndRepresentativeSharesMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Founder and Representative Shares", "label": "Founder and Representative Shares [Member]" } } }, "localname": "FounderAndRepresentativeSharesMember", "nsuri": "http://www.shapeways.com/20210930", "presentation": [ "http://www.shapeways.com/role/ReverseRecapitalizationScheduleOfCommonStockSharesIssuedFollowingTheConsummationOfBusinessCombinationDetails" ], "xbrltype": "domainItemType" }, "shpw_GalileoMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Galileo", "label": "Galileo [Member]" } } }, "localname": "GalileoMember", "nsuri": "http://www.shapeways.com/20210930", "presentation": [ "http://www.shapeways.com/role/ReverseRecapitalizationDetails", "http://www.shapeways.com/role/ReverseRecapitalizationScheduleOfCommonStockSharesIssuedFollowingTheConsummationOfBusinessCombinationDetails", "http://www.shapeways.com/role/ReverseRecapitalizationScheduleOfCommonStockSharesIssuedFollowingTheConsummationOfMergerDetails", "http://www.shapeways.com/role/ReverseRecapitalizationScheduleOfReconcilesTheElementsOfBusinessCombinationToTheUnauditedConsolidatedStatementOfChangesInStockholdersEquityDetails" ], "xbrltype": "domainItemType" }, "shpw_ImmediatelyAfterBusinessCombinationMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Immediately After Business Combination", "label": "Immediately After Business Combination [Member]" } } }, "localname": "ImmediatelyAfterBusinessCombinationMember", "nsuri": "http://www.shapeways.com/20210930", "presentation": [ "http://www.shapeways.com/role/ReverseRecapitalizationScheduleOfCommonStockSharesIssuedFollowingTheConsummationOfBusinessCombinationDetails" ], "xbrltype": "domainItemType" }, "shpw_IncreaseDecreaseInDeferredRent": { "auth_ref": [], "calculation": { "http://www.shapeways.com/role/CondensedConsolidatedStatementsOfCashFlows": { "order": 19.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Increase decrease in deferred rent.", "label": "Increase Decrease In Deferred Rent", "terseLabel": "Deferred rent" } } }, "localname": "IncreaseDecreaseInDeferredRent", "nsuri": "http://www.shapeways.com/20210930", "presentation": [ "http://www.shapeways.com/role/CondensedConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "shpw_IncreaseDecreaseInInterestOnPromissoryNoteDueFromRelatedParty": { "auth_ref": [], "calculation": { "http://www.shapeways.com/role/CondensedConsolidatedStatementsOfCashFlows": { "order": 14.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Increase decrease in interest on promissory note due from related party.", "label": "Increase Decrease In Interest On Promissory Note Due From Related Party", "negatedLabel": "Interest on promissory note due from related party" } } }, "localname": "IncreaseDecreaseInInterestOnPromissoryNoteDueFromRelatedParty", "nsuri": "http://www.shapeways.com/20210930", "presentation": [ "http://www.shapeways.com/role/CondensedConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "shpw_IncreaseDecreaseInLeaseLiabilities": { "auth_ref": [], "calculation": { "http://www.shapeways.com/role/CondensedConsolidatedStatementsOfCashFlows": { "order": 17.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Increase decrease in lease liabilities.", "label": "Increase Decrease In Lease Liabilities", "terseLabel": "Lease liabilities" } } }, "localname": "IncreaseDecreaseInLeaseLiabilities", "nsuri": "http://www.shapeways.com/20210930", "presentation": [ "http://www.shapeways.com/role/CondensedConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "shpw_IssuanceOfCommonStockPursuantToPipeFinancingSharesNetOfIssuanceCosts": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Issuance of common stock pursuant to pipe financing shares net of issuance costs.", "label": "Issuance Of Common Stock Pursuant To PIPE Financing Shares Net Of Issuance Costs", "terseLabel": "Issuance of common stock pursuant to PIPE financing, net of issuance costs (shares)" } } }, "localname": "IssuanceOfCommonStockPursuantToPipeFinancingSharesNetOfIssuanceCosts", "nsuri": "http://www.shapeways.com/20210930", "presentation": [ "http://www.shapeways.com/role/CondensedConsolidatedStatementsOfChangesInStockholdersEquityDeficit" ], "xbrltype": "sharesItemType" }, "shpw_IssuanceOfCommonStockPursuantToPipeFinancingSharesValueNetOfIssuanceCosts": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Issuance of common stock pursuant to pipe financing shares value net of issuance costs.", "label": "Issuance Of Common Stock Pursuant To PIPE Financing Shares Value Net Of Issuance Costs", "terseLabel": "Issuance of common stock pursuant to PIPE financing, net of issuance costs" } } }, "localname": "IssuanceOfCommonStockPursuantToPipeFinancingSharesValueNetOfIssuanceCosts", "nsuri": "http://www.shapeways.com/20210930", "presentation": [ "http://www.shapeways.com/role/CondensedConsolidatedStatementsOfChangesInStockholdersEquityDeficit" ], "xbrltype": "monetaryItemType" }, "shpw_IssuanceOfLegacyShapewaysCommonStockUponConvesrionOfConvertibleNotes": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Issuance of legacy shapeways common stock upon convesrion of convertible notes.", "label": "Issuance Of Legacy Shapeways Common Stock Upon Convesrion Of Convertible Notes", "terseLabel": "Issuance of Legacy Shapeways common stock upon conversion of convertible notes" } } }, "localname": "IssuanceOfLegacyShapewaysCommonStockUponConvesrionOfConvertibleNotes", "nsuri": "http://www.shapeways.com/20210930", "presentation": [ "http://www.shapeways.com/role/CondensedConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "shpw_LegacyShapewaysCommonStockWarrantsMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Legacy shapeways common stock warrants [Member].", "label": "Legacy Shapeways Common Stock Warrants [Member]", "terseLabel": "Legacy Shapeways Common Stock Warrants [Member]" } } }, "localname": "LegacyShapewaysCommonStockWarrantsMember", "nsuri": "http://www.shapeways.com/20210930", "presentation": [ "http://www.shapeways.com/role/StockholdersEquityDeficitDetails" ], "xbrltype": "domainItemType" }, "shpw_LegacyShapewaysMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Legacy shapeways.", "label": "Legacy Shapeways [Member]" } } }, "localname": "LegacyShapewaysMember", "nsuri": "http://www.shapeways.com/20210930", "presentation": [ "http://www.shapeways.com/role/BorrowingArrangementsConvertiblePromissoryNotesDetails" ], "xbrltype": "domainItemType" }, "shpw_LegacyShapewaysPreferredStockWarrantsMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Legacy shapeways preferred stock warrants [Member].", "label": "Legacy Shapeways Preferred Stock Warrants [Member]", "terseLabel": "Legacy Shapeways Preferred Stock Warrants [Member]" } } }, "localname": "LegacyShapewaysPreferredStockWarrantsMember", "nsuri": "http://www.shapeways.com/20210930", "presentation": [ "http://www.shapeways.com/role/StockholdersEquityDeficitDetails" ], "xbrltype": "domainItemType" }, "shpw_LegacyShapewaysSeriesAOnePreferredStockMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Legacy shapeways series\u00a0A-1 preferred stock [Member].", "label": "Legacy Shapeways Series A One Preferred Stock [Member]", "terseLabel": "Legacy Shapeways Series\u00a0A-1 Preferred Stock [Member]" } } }, "localname": "LegacyShapewaysSeriesAOnePreferredStockMember", "nsuri": "http://www.shapeways.com/20210930", "presentation": [ "http://www.shapeways.com/role/StockholdersEquityDeficitDetails" ], "xbrltype": "domainItemType" }, "shpw_LegacyShapewaysSeriesATwoPreferredStockMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Legacy shapeways series\u00a0A-2 preferred stock [Member].", "label": "Legacy Shapeways Series A Two Preferred Stock [Member]", "terseLabel": "Legacy Shapeways Series\u00a0A-2 Preferred Stock [Member]" } } }, "localname": "LegacyShapewaysSeriesATwoPreferredStockMember", "nsuri": "http://www.shapeways.com/20210930", "presentation": [ "http://www.shapeways.com/role/StockholdersEquityDeficitDetails" ], "xbrltype": "domainItemType" }, "shpw_LegacyShapewaysSeriesBOnePreferredStockMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Legacy shapeways series\u00a0B-1 preferred stock [Member].", "label": "Legacy Shapeways Series B One Preferred Stock [Member]", "terseLabel": "Legacy Shapeways Series\u00a0B-1 Preferred Stock [Member]" } } }, "localname": "LegacyShapewaysSeriesBOnePreferredStockMember", "nsuri": "http://www.shapeways.com/20210930", "presentation": [ "http://www.shapeways.com/role/StockholdersEquityDeficitDetails" ], "xbrltype": "domainItemType" }, "shpw_LegacyShapewaysSeriesBPreferredStockMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Legacy shapeways series\u00a0B preferred stock [Member].", "label": "Legacy Shapeways Series B Preferred Stock [Member]", "terseLabel": "Legacy Shapeways Series\u00a0B Preferred Stock [Member]" } } }, "localname": "LegacyShapewaysSeriesBPreferredStockMember", "nsuri": "http://www.shapeways.com/20210930", "presentation": [ "http://www.shapeways.com/role/StockholdersEquityDeficitDetails" ], "xbrltype": "domainItemType" }, "shpw_LegacyShapewaysSeriesCPreferredStockMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Legacy shapeways series\u00a0C preferred stock [Member].", "label": "Legacy Shapeways Series C Preferred Stock [Member]", "terseLabel": "Legacy Shapeways Series\u00a0C Preferred Stock [Member]" } } }, "localname": "LegacyShapewaysSeriesCPreferredStockMember", "nsuri": "http://www.shapeways.com/20210930", "presentation": [ "http://www.shapeways.com/role/StockholdersEquityDeficitDetails" ], "xbrltype": "domainItemType" }, "shpw_LegacyShapewaysSeriesDPreferredStockMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Legacy shapeways series\u00a0D preferred stock [Member].", "label": "Legacy Shapeways Series D Preferred Stock [Member]", "terseLabel": "Legacy Shapeways Series\u00a0D Preferred Stock [Member]" } } }, "localname": "LegacyShapewaysSeriesDPreferredStockMember", "nsuri": "http://www.shapeways.com/20210930", "presentation": [ "http://www.shapeways.com/role/StockholdersEquityDeficitDetails" ], "xbrltype": "domainItemType" }, "shpw_LegacyShapewaysSeriesEPreferredStockMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Legacy shapeways series\u00a0E preferred stock [Member].", "label": "Legacy Shapeways Series E Preferred Stock [Member]", "terseLabel": "Legacy Shapeways Series\u00a0E Preferred Stock [Member]" } } }, "localname": "LegacyShapewaysSeriesEPreferredStockMember", "nsuri": "http://www.shapeways.com/20210930", "presentation": [ "http://www.shapeways.com/role/StockholdersEquityDeficitDetails" ], "xbrltype": "domainItemType" }, "shpw_LegacyShapewaysStockOptionMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Legacy shapeways stock option.", "label": "Legacy Shapeways Stock Option [Member]" } } }, "localname": "LegacyShapewaysStockOptionMember", "nsuri": "http://www.shapeways.com/20210930", "presentation": [ "http://www.shapeways.com/role/StockBasedCompensationDetails" ], "xbrltype": "domainItemType" }, "shpw_LesseeBalanceSheetInformationTableTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The tabular disclosure of right of use assets and lease liabilities relating to leases.", "label": "Lessee Balance Sheet Information [Table Text Block]", "terseLabel": "Summary of right of use assets and lease liabilities for operating leases" } } }, "localname": "LesseeBalanceSheetInformationTableTextBlock", "nsuri": "http://www.shapeways.com/20210930", "presentation": [ "http://www.shapeways.com/role/CommitmentsAndContingenciesTables" ], "xbrltype": "textBlockItemType" }, "shpw_LesseeCashFlowsInformationTableTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The tabular disclosure of supplemental cash flow information related to the Company's leases.", "label": "Lessee Cash Flows Information [Table Text Block]", "terseLabel": "Summary of supplemental cash flow information related to the Company's leases" } } }, "localname": "LesseeCashFlowsInformationTableTextBlock", "nsuri": "http://www.shapeways.com/20210930", "presentation": [ "http://www.shapeways.com/role/CommitmentsAndContingenciesTables" ], "xbrltype": "textBlockItemType" }, "shpw_LongTermDebtForgiveness": { "auth_ref": [], "calculation": { "http://www.shapeways.com/role/CondensedConsolidatedStatementsOfOperationsAndComprehensiveLoss": { "order": 8.0, "parentTag": "us-gaap_NonoperatingIncomeExpense", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Long-term debt forgiveness.", "label": "Long Term Debt Forgiveness", "terseLabel": "Long-term debt forgiveness" } } }, "localname": "LongTermDebtForgiveness", "nsuri": "http://www.shapeways.com/20210930", "presentation": [ "http://www.shapeways.com/role/CondensedConsolidatedStatementsOfOperationsAndComprehensiveLoss" ], "xbrltype": "monetaryItemType" }, "shpw_MajorCustomerMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Major customer [Member].", "label": "Major Customer [Member]" } } }, "localname": "MajorCustomerMember", "nsuri": "http://www.shapeways.com/20210930", "presentation": [ "http://www.shapeways.com/role/SignificantConcentrationsDetails" ], "xbrltype": "domainItemType" }, "shpw_MajorVendorFourMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Major vendor four [Member].", "label": "Major Vendor Four [Member]" } } }, "localname": "MajorVendorFourMember", "nsuri": "http://www.shapeways.com/20210930", "presentation": [ "http://www.shapeways.com/role/SignificantConcentrationsDetails" ], "xbrltype": "domainItemType" }, "shpw_MajorVendorMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Major vendor [Member].", "label": "Major Vendor [Member]" } } }, "localname": "MajorVendorMember", "nsuri": "http://www.shapeways.com/20210930", "presentation": [ "http://www.shapeways.com/role/SignificantConcentrationsDetails" ], "xbrltype": "domainItemType" }, "shpw_MajorVendorOneMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Major vendor one [Member].", "label": "Major Vendor One [Member]" } } }, "localname": "MajorVendorOneMember", "nsuri": "http://www.shapeways.com/20210930", "presentation": [ "http://www.shapeways.com/role/SignificantConcentrationsDetails" ], "xbrltype": "domainItemType" }, "shpw_MajorVendorThreeMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Major vendor three [Member].", "label": "Major Vendor Three [Member]" } } }, "localname": "MajorVendorThreeMember", "nsuri": "http://www.shapeways.com/20210930", "presentation": [ "http://www.shapeways.com/role/SignificantConcentrationsDetails" ], "xbrltype": "domainItemType" }, "shpw_MajorVendorTwoMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Major vendor two [Member].", "label": "Major Vendor Two [Member]" } } }, "localname": "MajorVendorTwoMember", "nsuri": "http://www.shapeways.com/20210930", "presentation": [ "http://www.shapeways.com/role/SignificantConcentrationsDetails" ], "xbrltype": "domainItemType" }, "shpw_MarketPlaceSalesMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Market place sales.", "label": "Market Place Sales [Member]", "terseLabel": "Marketplace sales" } } }, "localname": "MarketPlaceSalesMember", "nsuri": "http://www.shapeways.com/20210930", "presentation": [ "http://www.shapeways.com/role/RevenueRecognitionDisaggregationOfRevenuesDetails" ], "xbrltype": "domainItemType" }, "shpw_MeasurementInputFairValuePerWarrantMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Measurement input fair value per warrant [Member].", "label": "Measurement Input Fair Value Per Warrant [Member]", "terseLabel": "Fair value per warrant" } } }, "localname": "MeasurementInputFairValuePerWarrantMember", "nsuri": "http://www.shapeways.com/20210930", "presentation": [ "http://www.shapeways.com/role/FairValueMeasurementsInitialMeasurementDetails" ], "xbrltype": "domainItemType" }, "shpw_MergerAgreementMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Merger agreement [Member].", "label": "Merger Agreement [Member]" } } }, "localname": "MergerAgreementMember", "nsuri": "http://www.shapeways.com/20210930", "presentation": [ "http://www.shapeways.com/role/RelatedPartyTransactionsDetails" ], "xbrltype": "domainItemType" }, "shpw_MergerAndInvestmentMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Merger And Investment.", "label": "Merger And Investment [Member]" } } }, "localname": "MergerAndInvestmentMember", "nsuri": "http://www.shapeways.com/20210930", "presentation": [ "http://www.shapeways.com/role/ReverseRecapitalizationScheduleOfCommonStockSharesIssuedFollowingTheConsummationOfBusinessCombinationDetails" ], "xbrltype": "domainItemType" }, "shpw_NetLossPerShareAttributableToCommonStockholdersAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Net loss per Share attributable to common stockholders.", "label": "Net Loss Per Share Attributable To Common Stockholders [Abstract]", "terseLabel": "Net loss per share attributable to common stockholders:" } } }, "localname": "NetLossPerShareAttributableToCommonStockholdersAbstract", "nsuri": "http://www.shapeways.com/20210930", "presentation": [ "http://www.shapeways.com/role/CondensedConsolidatedStatementsOfOperationsAndComprehensiveLoss" ], "xbrltype": "stringItemType" }, "shpw_NetLossPerShareAttributableToCommonStockholdersbasic": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Net loss per share attributable to common stockholders basic.", "label": "Net Loss Per Share Attributable To Common Stockholders Basic", "terseLabel": "Basic" } } }, "localname": "NetLossPerShareAttributableToCommonStockholdersbasic", "nsuri": "http://www.shapeways.com/20210930", "presentation": [ "http://www.shapeways.com/role/CondensedConsolidatedStatementsOfOperationsAndComprehensiveLoss" ], "xbrltype": "perShareItemType" }, "shpw_NetLossPerShareAttributableToCommonStockholdersdiluted": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Net loss per share attributable to common stockholders diluted.", "label": "Net Loss Per Share Attributable To Common Stockholders Diluted", "terseLabel": "Diluted" } } }, "localname": "NetLossPerShareAttributableToCommonStockholdersdiluted", "nsuri": "http://www.shapeways.com/20210930", "presentation": [ "http://www.shapeways.com/role/CondensedConsolidatedStatementsOfOperationsAndComprehensiveLoss" ], "xbrltype": "perShareItemType" }, "shpw_NonCashDebtForgiveness": { "auth_ref": [], "calculation": { "http://www.shapeways.com/role/CondensedConsolidatedStatementsOfCashFlows": { "order": 10.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Non cash debt forgiveness.", "label": "Non Cash Debt Forgiveness", "negatedLabel": "Non-cash debt forgiveness" } } }, "localname": "NonCashDebtForgiveness", "nsuri": "http://www.shapeways.com/20210930", "presentation": [ "http://www.shapeways.com/role/CondensedConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "shpw_NonCashLeaseExpense": { "auth_ref": [], "calculation": { "http://www.shapeways.com/role/CondensedConsolidatedStatementsOfCashFlows": { "order": 9.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Non cash lease expense.", "label": "Non Cash Lease Expense", "terseLabel": "Non-cash lease expense" } } }, "localname": "NonCashLeaseExpense", "nsuri": "http://www.shapeways.com/20210930", "presentation": [ "http://www.shapeways.com/role/CondensedConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "shpw_NonCashNetWorkingCapitalAssumedLiabilitiesAcquired": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Non cash net working capital assumed liabilities acquired.", "label": "Non Cash Net Working Capital Assumed Liabilities Acquired", "terseLabel": "Non-cash\u00a0net working capital assumed from Galileo" } } }, "localname": "NonCashNetWorkingCapitalAssumedLiabilitiesAcquired", "nsuri": "http://www.shapeways.com/20210930", "presentation": [ "http://www.shapeways.com/role/ReverseRecapitalizationScheduleOfReconcilesTheElementsOfBusinessCombinationToTheUnauditedConsolidatedStatementOfChangesInStockholdersEquityDetails" ], "xbrltype": "monetaryItemType" }, "shpw_NumberOfConsecutiveTradingDaysToDetermineTheTradingPricePerShare": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Number Of Consecutive Trading Days TO Determine The Trading Price Per Share", "label": "Number Of Consecutive Trading Days TO Determine The Trading Price Per Share", "terseLabel": "Number of consecutive trading days to determine the trading price per share" } } }, "localname": "NumberOfConsecutiveTradingDaysToDetermineTheTradingPricePerShare", "nsuri": "http://www.shapeways.com/20210930", "presentation": [ "http://www.shapeways.com/role/ReverseRecapitalizationDetails" ], "xbrltype": "durationItemType" }, "shpw_NumberOfCountries": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Number of countries.", "label": "Number Of Countries", "terseLabel": "Number of countries" } } }, "localname": "NumberOfCountries", "nsuri": "http://www.shapeways.com/20210930", "presentation": [ "http://www.shapeways.com/role/OrganizationDetails" ], "xbrltype": "integerItemType" }, "shpw_NumberOfCustomers": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Number of customers.", "label": "Number Of Customers", "terseLabel": "Number of customers" } } }, "localname": "NumberOfCustomers", "nsuri": "http://www.shapeways.com/20210930", "presentation": [ "http://www.shapeways.com/role/OrganizationDetails" ], "xbrltype": "integerItemType" }, "shpw_NumberOfLeasesOfFacilitiesLocatedInUnitedStatesAndNetherlands": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Represents the number of leases of facilities located in the United States and the Netherlands.", "label": "Number Of Leases Of Facilities Located In United States And Netherlands", "terseLabel": "Number of leases of facilities located in the United States and the Netherlands" } } }, "localname": "NumberOfLeasesOfFacilitiesLocatedInUnitedStatesAndNetherlands", "nsuri": "http://www.shapeways.com/20210930", "presentation": [ "http://www.shapeways.com/role/CommitmentsAndContingenciesLeasesDetails" ], "xbrltype": "integerItemType" }, "shpw_NumberOfMajorCustomersAccountsReceivableOverTenPercentBenchmark": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Number of major customers accounts receivable over ten percent benchmark.", "label": "Number Of Major Customers Accounts Receivable Over Ten Percent Benchmark", "terseLabel": "Number of major customers accounts receivableover ten percent benchmark" } } }, "localname": "NumberOfMajorCustomersAccountsReceivableOverTenPercentBenchmark", "nsuri": "http://www.shapeways.com/20210930", "presentation": [ "http://www.shapeways.com/role/SignificantConcentrationsDetails" ], "xbrltype": "integerItemType" }, "shpw_NumberOfMajorCustomersOverTenPercentBenchmark": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Number of customers over ten percent benchmark.", "label": "Number Of Major Customers Over Ten Percent Benchmark", "terseLabel": "Number of customers over ten percent benchmark" } } }, "localname": "NumberOfMajorCustomersOverTenPercentBenchmark", "nsuri": "http://www.shapeways.com/20210930", "presentation": [ "http://www.shapeways.com/role/SignificantConcentrationsDetails" ], "xbrltype": "integerItemType" }, "shpw_NumberOfMajorVendorAccountsPayableOverTenPercentBenchmark": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Number of major vendor accounts payable over ten percent benchmark.", "label": "Number Of Major Vendor Accounts Payable Over Ten Percent Benchmark", "terseLabel": "Number of major vendor accounts payable over ten percent benchmark" } } }, "localname": "NumberOfMajorVendorAccountsPayableOverTenPercentBenchmark", "nsuri": "http://www.shapeways.com/20210930", "presentation": [ "http://www.shapeways.com/role/SignificantConcentrationsDetails" ], "xbrltype": "integerItemType" }, "shpw_NumberOfMajorVendorOverTenPercentBenchmark": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Number of major vendor over ten percent benchmark.", "label": "Number of Major Vendor Over Ten Percent Benchmark", "terseLabel": "Number of major vendor over ten percent benchmark" } } }, "localname": "NumberOfMajorVendorOverTenPercentBenchmark", "nsuri": "http://www.shapeways.com/20210930", "presentation": [ "http://www.shapeways.com/role/SignificantConcentrationsDetails" ], "xbrltype": "integerItemType" }, "shpw_NumberOfManufacturingPartsDelivered": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Number of manufacturing parts delivered.", "label": "Number Of Manufacturing Parts Delivered", "terseLabel": "Number of manufacturing parts delivered" } } }, "localname": "NumberOfManufacturingPartsDelivered", "nsuri": "http://www.shapeways.com/20210930", "presentation": [ "http://www.shapeways.com/role/OrganizationDetails" ], "xbrltype": "integerItemType" }, "shpw_NumberOfMaterialsAndFinishes": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Number of materials and finishes.", "label": "Number Of Materials And Finishes", "terseLabel": "Number of materials and finishes" } } }, "localname": "NumberOfMaterialsAndFinishes", "nsuri": "http://www.shapeways.com/20210930", "presentation": [ "http://www.shapeways.com/role/OrganizationDetails" ], "xbrltype": "integerItemType" }, "shpw_NumberOfUtilizationOfAdditiveTechnologies": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Number of utilization of additive technologies.", "label": "Number Of Utilization Of Additive Technologies", "terseLabel": "Number of utilization of additive technologies" } } }, "localname": "NumberOfUtilizationOfAdditiveTechnologies", "nsuri": "http://www.shapeways.com/20210930", "presentation": [ "http://www.shapeways.com/role/OrganizationDetails" ], "xbrltype": "integerItemType" }, "shpw_NumberOfWarrantsExercisedDuringPeriod": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Number of warrants exercised during period.", "label": "Number Of Warrants Exercised During Period", "terseLabel": "Number of warrants exercised" } } }, "localname": "NumberOfWarrantsExercisedDuringPeriod", "nsuri": "http://www.shapeways.com/20210930", "presentation": [ "http://www.shapeways.com/role/StockholdersEquityDeficitDetails" ], "xbrltype": "sharesItemType" }, "shpw_OperatingLeasesNumberOfAdditionalLeasesOfEquipmentOperatingLeasesNumberOfAdditionalLeasesOfEquipment": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Represents the number of additional lease of equipment under a finance lease arrangement.", "label": "Operating Leases Number Of Additional Leases Of Equipment operating Leases Number Of Additional Leases Of Equipment", "terseLabel": "Number of additional lease of equipment under a finance lease arrangement" } } }, "localname": "OperatingLeasesNumberOfAdditionalLeasesOfEquipmentOperatingLeasesNumberOfAdditionalLeasesOfEquipment", "nsuri": "http://www.shapeways.com/20210930", "presentation": [ "http://www.shapeways.com/role/CommitmentsAndContingenciesLeasesDetails" ], "xbrltype": "integerItemType" }, "shpw_OperatingLeasesNumberOfLeasesOfOfficeEquipment": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Represents the number of leases of office equipment, under operating leases.", "label": "Operating Leases Number Of Leases Of Office Equipment", "terseLabel": "Number of leases of office equipment, under operating leases" } } }, "localname": "OperatingLeasesNumberOfLeasesOfOfficeEquipment", "nsuri": "http://www.shapeways.com/20210930", "presentation": [ "http://www.shapeways.com/role/CommitmentsAndContingenciesLeasesDetails" ], "xbrltype": "integerItemType" }, "shpw_OtherVendorMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Other vendor [Member].", "label": "Other Vendor [Member]" } } }, "localname": "OtherVendorMember", "nsuri": "http://www.shapeways.com/20210930", "presentation": [ "http://www.shapeways.com/role/SignificantConcentrationsDetails" ], "xbrltype": "domainItemType" }, "shpw_PaymentProtectionProgramLoanMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Payment protection program loan.", "label": "Payment Protection Program Loan [Member]", "terseLabel": "PPP Loan" } } }, "localname": "PaymentProtectionProgramLoanMember", "nsuri": "http://www.shapeways.com/20210930", "presentation": [ "http://www.shapeways.com/role/BorrowingArrangementsOutstandingDebtObligationsDetails", "http://www.shapeways.com/role/BorrowingArrangementsPaycheckProtectionProgramLoanDetails" ], "xbrltype": "domainItemType" }, "shpw_PaymentsOfMergerRelatedCostFinancingActivities": { "auth_ref": [], "calculation": { "http://www.shapeways.com/role/CondensedConsolidatedStatementsOfCashFlows": { "order": 26.0, "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Payments of merger related cost, financing activities.", "label": "Payments of Merger Related Cost, Financing Activities", "negatedLabel": "Effect of Merger, net of transaction costs" } } }, "localname": "PaymentsOfMergerRelatedCostFinancingActivities", "nsuri": "http://www.shapeways.com/20210930", "presentation": [ "http://www.shapeways.com/role/CondensedConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "shpw_PercentageOfExchangeRatioUsedToDetermineTheNumberOfRestrictedStockUnitsGrantedAsRightToReceive": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Percentage of exchange ratio used to determine the number of restricted stock units granted as right to receive.", "label": "Percentage Of Exchange Ratio Used TO Determine The Number Of Restricted Stock units Granted As Right To Receive", "terseLabel": "Percentage of exchange ratio used to determine the number of restricted stock units granted as right to receive" } } }, "localname": "PercentageOfExchangeRatioUsedToDetermineTheNumberOfRestrictedStockUnitsGrantedAsRightToReceive", "nsuri": "http://www.shapeways.com/20210930", "presentation": [ "http://www.shapeways.com/role/StockBasedCompensationDetails" ], "xbrltype": "percentItemType" }, "shpw_PercentageOfLargestBenefitGreaterThanLikelyhoodOfResolutionForTaxBenefitMeasurement": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Percentage of largest benefit greater than likelyhood of resolution for tax benefit measurement.", "label": "Percentage Of Largest Benefit Greater Than Likelyhood Of Resolution For Tax Benefit Measurement", "terseLabel": "Percentage of largest benefit greater than likelyhood of resolution for tax benefit measurement" } } }, "localname": "PercentageOfLargestBenefitGreaterThanLikelyhoodOfResolutionForTaxBenefitMeasurement", "nsuri": "http://www.shapeways.com/20210930", "presentation": [ "http://www.shapeways.com/role/SummaryOfSignificantAccountingPoliciesDetails" ], "xbrltype": "percentItemType" }, "shpw_PercentageOfLoanAmountIsUsedForEligiblePayrollCostsUsedToDetermineTheLoanProceedsEligibleForForgiveness": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Percentage of loan amount is used for eligible payroll costs used to determine the loan proceeds eligible for forgiveness.", "label": "Percentage Of Loan Amount Is Used For Eligible Payroll Costs Used To Determine The Loan Proceeds Eligible For Forgiveness", "terseLabel": "Percentage of loan amount is used for eligible payroll costs used to determine the loan proceeds eligible for forgiveness" } } }, "localname": "PercentageOfLoanAmountIsUsedForEligiblePayrollCostsUsedToDetermineTheLoanProceedsEligibleForForgiveness", "nsuri": "http://www.shapeways.com/20210930", "presentation": [ "http://www.shapeways.com/role/BorrowingArrangementsPaycheckProtectionProgramLoanDetails" ], "xbrltype": "percentItemType" }, "shpw_PercentageOfMarkupFeeUponSaleOfProductsThroughMarketplace": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Represents the percentage of markup fee upon the sale of products through the marketplace.", "label": "Percentage Of Markup Fee Upon Sale Of Products Through Marketplace", "terseLabel": "Percentage of markup fee upon the sale of products through the marketplace" } } }, "localname": "PercentageOfMarkupFeeUponSaleOfProductsThroughMarketplace", "nsuri": "http://www.shapeways.com/20210930", "presentation": [ "http://www.shapeways.com/role/RevenueRecognitionMarketplaceSalesDetails" ], "xbrltype": "percentItemType" }, "shpw_PercentageOfRecapitalizationConversionRatioAsDividerForDeterminingExercisePrice": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Percentage of recapitalization conversion ratio as divider for determining exercise price.", "label": "Percentage of Recapitalization Conversion Ratio as Divider for Determining Exercise Price", "verboseLabel": "Percentage of recapitalization conversion ratio as divider for determining exercise price" } } }, "localname": "PercentageOfRecapitalizationConversionRatioAsDividerForDeterminingExercisePrice", "nsuri": "http://www.shapeways.com/20210930", "presentation": [ "http://www.shapeways.com/role/StockBasedCompensationDetails" ], "xbrltype": "percentItemType" }, "shpw_PercentageOfRecapitalizationConversionRatioForConversionInToCommonStock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Percentage of recapitalization conversion ratio for conversion in to common stock.", "label": "Percentage of Recapitalization Conversion Ratio for Conversion in to Common Stock", "verboseLabel": "Percentage of recapitalization conversion ratio for conversion in to common stock" } } }, "localname": "PercentageOfRecapitalizationConversionRatioForConversionInToCommonStock", "nsuri": "http://www.shapeways.com/20210930", "presentation": [ "http://www.shapeways.com/role/StockBasedCompensationDetails" ], "xbrltype": "percentItemType" }, "shpw_PipeInvestmentMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "PIPE Investment", "label": "PIPE Investment [Member]" } } }, "localname": "PipeInvestmentMember", "nsuri": "http://www.shapeways.com/20210930", "presentation": [ "http://www.shapeways.com/role/ReverseRecapitalizationScheduleOfCommonStockSharesIssuedFollowingTheConsummationOfBusinessCombinationDetails", "http://www.shapeways.com/role/ReverseRecapitalizationScheduleOfCommonStockSharesIssuedFollowingTheConsummationOfMergerDetails" ], "xbrltype": "domainItemType" }, "shpw_PipeInvestorsMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "PIPE Investors.", "label": "Pipe Investors [Member]" } } }, "localname": "PipeInvestorsMember", "nsuri": "http://www.shapeways.com/20210930", "presentation": [ "http://www.shapeways.com/role/ReverseRecapitalizationDetails" ], "xbrltype": "domainItemType" }, "shpw_PostBusinessCombinationMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Post Business Combination.", "label": "Post Business Combination [Member]" } } }, "localname": "PostBusinessCombinationMember", "nsuri": "http://www.shapeways.com/20210930", "presentation": [ "http://www.shapeways.com/role/BorrowingArrangementsConvertiblePromissoryNotesDetails" ], "xbrltype": "domainItemType" }, "shpw_PrepaidExpensesAndOtherCurrentAssetsTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The entire disclosure of prepaid expenses and other current assets.", "label": "Prepaid Expenses And Other Current Assets [Text Block]", "terseLabel": "Prepaid Expenses and Other Current Assets" } } }, "localname": "PrepaidExpensesAndOtherCurrentAssetsTextBlock", "nsuri": "http://www.shapeways.com/20210930", "presentation": [ "http://www.shapeways.com/role/PrepaidExpensesAndOtherCurrentAssets" ], "xbrltype": "textBlockItemType" }, "shpw_PrincipalPaymentsOnCapitalLeases": { "auth_ref": [], "calculation": { "http://www.shapeways.com/role/CondensedConsolidatedStatementsOfCashFlows": { "order": 21.0, "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Principal payments on capital leases.", "label": "Principal Payments On Capital Leases", "negatedLabel": "Principal payments on capital leases" } } }, "localname": "PrincipalPaymentsOnCapitalLeases", "nsuri": "http://www.shapeways.com/20210930", "presentation": [ "http://www.shapeways.com/role/CondensedConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "shpw_PriorToBusinessCombinationAxis": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Prior To Business Combination", "label": "Prior To Business Combination [Axis]" } } }, "localname": "PriorToBusinessCombinationAxis", "nsuri": "http://www.shapeways.com/20210930", "presentation": [ "http://www.shapeways.com/role/ReverseRecapitalizationScheduleOfCommonStockSharesIssuedFollowingTheConsummationOfBusinessCombinationDetails" ], "xbrltype": "stringItemType" }, "shpw_PriorToBusinessCombinationDomain": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Prior To Business Combination", "label": "Prior To Business Combination [Domain]" } } }, "localname": "PriorToBusinessCombinationDomain", "nsuri": "http://www.shapeways.com/20210930", "presentation": [ "http://www.shapeways.com/role/ReverseRecapitalizationScheduleOfCommonStockSharesIssuedFollowingTheConsummationOfBusinessCombinationDetails" ], "xbrltype": "domainItemType" }, "shpw_PriorToBusinessCombinationMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Prior to business combination", "label": "Prior to business combination [Member]" } } }, "localname": "PriorToBusinessCombinationMember", "nsuri": "http://www.shapeways.com/20210930", "presentation": [ "http://www.shapeways.com/role/ReverseRecapitalizationScheduleOfCommonStockSharesIssuedFollowingTheConsummationOfBusinessCombinationDetails" ], "xbrltype": "domainItemType" }, "shpw_PriorToMergerMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Prior to merger [Member].", "label": "Prior To Merger [Member]", "terseLabel": "Prior to Merger [Member]" } } }, "localname": "PriorToMergerMember", "nsuri": "http://www.shapeways.com/20210930", "presentation": [ "http://www.shapeways.com/role/StockholdersEquityDeficitDetails" ], "xbrltype": "domainItemType" }, "shpw_PriorToTheBusinessCombinationMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Prior to the business combination [Member].", "label": "Prior To The Business Combination [Member]", "terseLabel": "Prior to the Business Combination [Member]" } } }, "localname": "PriorToTheBusinessCombinationMember", "nsuri": "http://www.shapeways.com/20210930", "presentation": [ "http://www.shapeways.com/role/StockholdersEquityDeficitDetails" ], "xbrltype": "domainItemType" }, "shpw_PrivatePlacementWarrantsMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Represents a redeemable warrant (Private Placement Warrant) that entitles the holder to purchase shares of common stock if the underwriter's option is exercised in full.", "label": "Private Placement Warrants [Member]", "terseLabel": "Private Placement Warrants" } } }, "localname": "PrivatePlacementWarrantsMember", "nsuri": "http://www.shapeways.com/20210930", "presentation": [ "http://www.shapeways.com/role/FairValueMeasurementsInitialMeasurementDetails" ], "xbrltype": "domainItemType" }, "shpw_PrivateSponsorWarrantLiabilitiesMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Private & Sponsor Warrant Liabilities", "label": "Private Sponsor Warrant Liabilities [Member]" } } }, "localname": "PrivateSponsorWarrantLiabilitiesMember", "nsuri": "http://www.shapeways.com/20210930", "presentation": [ "http://www.shapeways.com/role/ReverseRecapitalizationScheduleOfReconcilesTheElementsOfBusinessCombinationToTheUnauditedConsolidatedStatementOfChangesInStockholdersEquityDetails" ], "xbrltype": "domainItemType" }, "shpw_PrivateWarrantsMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "This member stands for private warrants.", "label": "Private Warrants [Member]", "verboseLabel": "Private Warrants [Member]" } } }, "localname": "PrivateWarrantsMember", "nsuri": "http://www.shapeways.com/20210930", "presentation": [ "http://www.shapeways.com/role/FairValueMeasurementsDetails", "http://www.shapeways.com/role/SummaryOfSignificantAccountingPoliciesDetails" ], "xbrltype": "domainItemType" }, "shpw_PropertyPurchasePayable": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Property Purchase Payable.", "label": "Property Purchase Payable", "verboseLabel": "Property purchase payable" } } }, "localname": "PropertyPurchasePayable", "nsuri": "http://www.shapeways.com/20210930", "presentation": [ "http://www.shapeways.com/role/CommitmentsAndContingenciesAdditionalInformationDetails" ], "xbrltype": "monetaryItemType" }, "shpw_PublicAndPrivateCommonStockWarrantLiabilitiesPolicyTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Public and private common stock warrant liabilities [Policy text block].", "label": "Public And Private Common Stock Warrant Liabilities [Policy Text Block]", "terseLabel": "Public and Private Common Stock Warrant Liabilities" } } }, "localname": "PublicAndPrivateCommonStockWarrantLiabilitiesPolicyTextBlock", "nsuri": "http://www.shapeways.com/20210930", "presentation": [ "http://www.shapeways.com/role/SummaryOfSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "shpw_PublicWarrantsMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Public warrants [Member].", "label": "Public Warrants [Member]", "terseLabel": "Public Warrants [Member]" } } }, "localname": "PublicWarrantsMember", "nsuri": "http://www.shapeways.com/20210930", "presentation": [ "http://www.shapeways.com/role/StockholdersEquityDeficitDetails" ], "xbrltype": "domainItemType" }, "shpw_RecapitalizationConversionRatio": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Recapitalization conversion ratio.", "label": "Recapitalization Conversion Ratio", "verboseLabel": "Recapitalization conversion ratio" } } }, "localname": "RecapitalizationConversionRatio", "nsuri": "http://www.shapeways.com/20210930", "presentation": [ "http://www.shapeways.com/role/StockholdersEquityDeficitDetails" ], "xbrltype": "pureItemType" }, "shpw_ReconciliationAxis": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Reconciliation", "label": "Reconciliation [Axis]" } } }, "localname": "ReconciliationAxis", "nsuri": "http://www.shapeways.com/20210930", "presentation": [ "http://www.shapeways.com/role/ReverseRecapitalizationScheduleOfCommonStockSharesIssuedFollowingTheConsummationOfMergerDetails", "http://www.shapeways.com/role/ReverseRecapitalizationScheduleOfReconcilesTheElementsOfBusinessCombinationToTheUnauditedConsolidatedStatementOfChangesInStockholdersEquityDetails" ], "xbrltype": "stringItemType" }, "shpw_ReconciliationDomain": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Reconciliation", "label": "Reconciliation [Domain]" } } }, "localname": "ReconciliationDomain", "nsuri": "http://www.shapeways.com/20210930", "presentation": [ "http://www.shapeways.com/role/ReverseRecapitalizationScheduleOfCommonStockSharesIssuedFollowingTheConsummationOfMergerDetails", "http://www.shapeways.com/role/ReverseRecapitalizationScheduleOfReconcilesTheElementsOfBusinessCombinationToTheUnauditedConsolidatedStatementOfChangesInStockholdersEquityDetails" ], "xbrltype": "domainItemType" }, "shpw_RelatedPartyNoteMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Related party note [Member].", "label": "Related Party Note [Member]" } } }, "localname": "RelatedPartyNoteMember", "nsuri": "http://www.shapeways.com/20210930", "presentation": [ "http://www.shapeways.com/role/RelatedPartyTransactionsDetails" ], "xbrltype": "domainItemType" }, "shpw_RepurchaseOfLgeacyShapewaysCommonStock": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Repurchase of lgeacy shapeways common stock.", "label": "Repurchase Of Lgeacy Shapeways Common Stock", "terseLabel": "Repurchase of Legacy Shapeways common stock" } } }, "localname": "RepurchaseOfLgeacyShapewaysCommonStock", "nsuri": "http://www.shapeways.com/20210930", "presentation": [ "http://www.shapeways.com/role/CondensedConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "shpw_RetroactiveApplicationOfReverseRecapitalizationShares": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Retroactive Application Of Reverse Recapitalization Shares .", "label": "Retroactive Application Of Reverse Recapitalization Shares", "terseLabel": "Retroactive application of reverse recapitalization (Shares)" } } }, "localname": "RetroactiveApplicationOfReverseRecapitalizationShares", "nsuri": "http://www.shapeways.com/20210930", "presentation": [ "http://www.shapeways.com/role/CondensedConsolidatedStatementsOfChangesInStockholdersEquityDeficit" ], "xbrltype": "sharesItemType" }, "shpw_RetroactiveApplicationOfReverseRecapitalizationSharesValue": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Retroactive Application Of Reverse Recapitalization Shares Value .", "label": "Retroactive Application Of Reverse Recapitalization Shares Value", "terseLabel": "Retroactive application of reverse recapitalization" } } }, "localname": "RetroactiveApplicationOfReverseRecapitalizationSharesValue", "nsuri": "http://www.shapeways.com/20210930", "presentation": [ "http://www.shapeways.com/role/CondensedConsolidatedStatementsOfChangesInStockholdersEquityDeficit" ], "xbrltype": "monetaryItemType" }, "shpw_ReverseRecapitalizationAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Reverse Recapitalization", "label": "Reverse Recapitalization [Abstract]" } } }, "localname": "ReverseRecapitalizationAbstract", "nsuri": "http://www.shapeways.com/20210930", "xbrltype": "stringItemType" }, "shpw_ReverseRecapitalizationLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Reverse Recapitalization", "label": "Reverse Recapitalization [Line Items]" } } }, "localname": "ReverseRecapitalizationLineItems", "nsuri": "http://www.shapeways.com/20210930", "presentation": [ "http://www.shapeways.com/role/ReverseRecapitalizationDetails" ], "xbrltype": "stringItemType" }, "shpw_ReverseRecapitalizationMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Reverse Recapitalization", "label": "Reverse Recapitalization [Member]" } } }, "localname": "ReverseRecapitalizationMember", "nsuri": "http://www.shapeways.com/20210930", "presentation": [ "http://www.shapeways.com/role/ReverseRecapitalizationDetails", "http://www.shapeways.com/role/ReverseRecapitalizationScheduleOfCommonStockSharesIssuedFollowingTheConsummationOfBusinessCombinationDetails", "http://www.shapeways.com/role/ReverseRecapitalizationScheduleOfCommonStockSharesIssuedFollowingTheConsummationOfMergerDetails", "http://www.shapeways.com/role/ReverseRecapitalizationScheduleOfReconcilesTheElementsOfBusinessCombinationToTheUnauditedConsolidatedStatementOfChangesInStockholdersEquityDetails" ], "xbrltype": "domainItemType" }, "shpw_ReverseRecapitalizationTable": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Reverse Recapitalization", "label": "Reverse Recapitalization [Table]" } } }, "localname": "ReverseRecapitalizationTable", "nsuri": "http://www.shapeways.com/20210930", "presentation": [ "http://www.shapeways.com/role/ReverseRecapitalizationDetails" ], "xbrltype": "stringItemType" }, "shpw_ReverseRecapitalizationTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Reverse Recapitalization", "label": "Reverse Recapitalization [Text Block]", "terseLabel": "Reverse Recapitalization" } } }, "localname": "ReverseRecapitalizationTextBlock", "nsuri": "http://www.shapeways.com/20210930", "presentation": [ "http://www.shapeways.com/role/ReverseRecapitalization" ], "xbrltype": "textBlockItemType" }, "shpw_ReverseRecapitalizationnAxis": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Reverse Recapitalizationn", "label": "Reverse Recapitalizationn [Axis]" } } }, "localname": "ReverseRecapitalizationnAxis", "nsuri": "http://www.shapeways.com/20210930", "presentation": [ "http://www.shapeways.com/role/ReverseRecapitalizationDetails", "http://www.shapeways.com/role/ReverseRecapitalizationScheduleOfCommonStockSharesIssuedFollowingTheConsummationOfBusinessCombinationDetails", "http://www.shapeways.com/role/ReverseRecapitalizationScheduleOfCommonStockSharesIssuedFollowingTheConsummationOfMergerDetails", "http://www.shapeways.com/role/ReverseRecapitalizationScheduleOfReconcilesTheElementsOfBusinessCombinationToTheUnauditedConsolidatedStatementOfChangesInStockholdersEquityDetails" ], "xbrltype": "stringItemType" }, "shpw_ReverseRecapitalizationnDomain": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Reverse Recapitalizationn", "label": "Reverse Recapitalizationn [Domain]" } } }, "localname": "ReverseRecapitalizationnDomain", "nsuri": "http://www.shapeways.com/20210930", "presentation": [ "http://www.shapeways.com/role/ReverseRecapitalizationDetails", "http://www.shapeways.com/role/ReverseRecapitalizationScheduleOfCommonStockSharesIssuedFollowingTheConsummationOfBusinessCombinationDetails", "http://www.shapeways.com/role/ReverseRecapitalizationScheduleOfCommonStockSharesIssuedFollowingTheConsummationOfMergerDetails", "http://www.shapeways.com/role/ReverseRecapitalizationScheduleOfReconcilesTheElementsOfBusinessCombinationToTheUnauditedConsolidatedStatementOfChangesInStockholdersEquityDetails" ], "xbrltype": "domainItemType" }, "shpw_ScheduleOfReconciliationOfElementsOfBusinessCombinationToChangesInStockholdersEquityLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Schedule Of Reconciliation Of Elements Of Business Combination to Changes In Stockholders Equity", "label": "Schedule Of Reconciliation Of Elements Of Business Combination to Changes In Stockholders Equity [Line Items]" } } }, "localname": "ScheduleOfReconciliationOfElementsOfBusinessCombinationToChangesInStockholdersEquityLineItems", "nsuri": "http://www.shapeways.com/20210930", "presentation": [ "http://www.shapeways.com/role/ReverseRecapitalizationScheduleOfReconcilesTheElementsOfBusinessCombinationToTheUnauditedConsolidatedStatementOfChangesInStockholdersEquityDetails" ], "xbrltype": "stringItemType" }, "shpw_ScheduleOfReconciliationOfElementsOfBusinessCombinationToChangesInStockholdersEquityTable": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Schedule Of Reconciliation Of Elements Of Business Combination to Changes In Stockholders Equity", "label": "Schedule Of Reconciliation Of Elements Of Business Combination to Changes In Stockholders Equity [Table]" } } }, "localname": "ScheduleOfReconciliationOfElementsOfBusinessCombinationToChangesInStockholdersEquityTable", "nsuri": "http://www.shapeways.com/20210930", "presentation": [ "http://www.shapeways.com/role/ReverseRecapitalizationScheduleOfReconcilesTheElementsOfBusinessCombinationToTheUnauditedConsolidatedStatementOfChangesInStockholdersEquityDetails" ], "xbrltype": "stringItemType" }, "shpw_ScheduleOfReconciliationOfElementsOfBusinessCombinationToChangesInStockholdersEquityTableTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Schedule Of Reconciliation Of Elements Of Business Combination to Changes In Stockholders Equity", "label": "Schedule Of Reconciliation Of Elements Of Business Combination to Changes In Stockholders Equity [Table Text Block]", "terseLabel": "Schedule of reconciles the elements of business combination to the unaudited consolidated statement of changes in stockholders equity" } } }, "localname": "ScheduleOfReconciliationOfElementsOfBusinessCombinationToChangesInStockholdersEquityTableTextBlock", "nsuri": "http://www.shapeways.com/20210930", "presentation": [ "http://www.shapeways.com/role/ReverseRecapitalizationTables" ], "xbrltype": "textBlockItemType" }, "shpw_ScheduleOfReconciliationOfElementsOfTheBusinessCombinationToTheUnauditedConsolidatedOfCashFlowsLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Schedule Of Reconciliation Of Elements Of The business Combination To The Unaudited Consolidated Of Cash Flows", "label": "Schedule Of Reconciliation Of Elements Of The business Combination To The Unaudited Consolidated Of Cash Flows [Line Items]" } } }, "localname": "ScheduleOfReconciliationOfElementsOfTheBusinessCombinationToTheUnauditedConsolidatedOfCashFlowsLineItems", "nsuri": "http://www.shapeways.com/20210930", "presentation": [ "http://www.shapeways.com/role/ReverseRecapitalizationScheduleOfCommonStockSharesIssuedFollowingTheConsummationOfMergerDetails" ], "xbrltype": "stringItemType" }, "shpw_ScheduleOfReconciliationOfElementsOfTheBusinessCombinationToTheUnauditedConsolidatedOfCashFlowsTable": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Schedule Of Reconciliation Of Elements Of The business Combination To The Unaudited Consolidated Of Cash Flows", "label": "Schedule Of Reconciliation Of Elements Of The business Combination To The Unaudited Consolidated Of Cash Flows [Table]" } } }, "localname": "ScheduleOfReconciliationOfElementsOfTheBusinessCombinationToTheUnauditedConsolidatedOfCashFlowsTable", "nsuri": "http://www.shapeways.com/20210930", "presentation": [ "http://www.shapeways.com/role/ReverseRecapitalizationScheduleOfCommonStockSharesIssuedFollowingTheConsummationOfMergerDetails" ], "xbrltype": "stringItemType" }, "shpw_ScheduleOfUsefulLivesOfPropertyPlantAndEquipmentTableTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Schedule of useful lives of property plant and equipment [Table text block].", "label": "Schedule Of Useful Lives Of Property Plant And Equipment [Table Text Block]", "terseLabel": "Summary Of Useful Lives Of Property Plant And Equipment" } } }, "localname": "ScheduleOfUsefulLivesOfPropertyPlantAndEquipmentTableTextBlock", "nsuri": "http://www.shapeways.com/20210930", "presentation": [ "http://www.shapeways.com/role/SummaryOfSignificantAccountingPoliciesTables" ], "xbrltype": "textBlockItemType" }, "shpw_SeriesB1PreferredStockMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Series B1 Preferred stock [Member].", "label": "Series B1 Preferred Stock [Member]" } } }, "localname": "SeriesB1PreferredStockMember", "nsuri": "http://www.shapeways.com/20210930", "presentation": [ "http://www.shapeways.com/role/CondensedConsolidatedStatementsOfChangesInStockholdersEquityDeficit" ], "xbrltype": "domainItemType" }, "shpw_ShapewaysCreditsCurrent": { "auth_ref": [], "calculation": { "http://www.shapeways.com/role/AccruedExpensesAndOtherLiabilitiesDetails": { "order": 8.0, "parentTag": "shpw_AccruedAndOtherLiabilitiesCurrent", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Shapeways credits current.", "label": "Shapeways Credits Current", "verboseLabel": "Shapeways credits" } } }, "localname": "ShapewaysCreditsCurrent", "nsuri": "http://www.shapeways.com/20210930", "presentation": [ "http://www.shapeways.com/role/AccruedExpensesAndOtherLiabilitiesDetails" ], "xbrltype": "monetaryItemType" }, "shpw_ShapewaysIncMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Shapeways inc.", "label": "Shapeways Inc [Member]", "terseLabel": "Shapeways Inc [Member]" } } }, "localname": "ShapewaysIncMember", "nsuri": "http://www.shapeways.com/20210930", "presentation": [ "http://www.shapeways.com/role/BorrowingArrangementsPaycheckProtectionProgramLoanDetails", "http://www.shapeways.com/role/OrganizationDetails", "http://www.shapeways.com/role/ReverseRecapitalizationDetails", "http://www.shapeways.com/role/ReverseRecapitalizationScheduleOfCommonStockSharesIssuedFollowingTheConsummationOfBusinessCombinationDetails" ], "xbrltype": "domainItemType" }, "shpw_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForPurchase": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Share based compensation arrangement by share based payment award number of shares available for purchase.", "label": "Share Based Compensation Arrangement By Share Based Payment Award Number Of Shares Available For Purchase", "terseLabel": "Number of shares available for purchase" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForPurchase", "nsuri": "http://www.shapeways.com/20210930", "presentation": [ "http://www.shapeways.com/role/StockBasedCompensationDetails" ], "xbrltype": "sharesItemType" }, "shpw_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAggregateOptionsToPurchase": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Share based compensation arrangement by share based payment award options aggregate options to purchase.", "label": "Share Based Compensation Arrangement By Share Based Payment Award Options Aggregate Options To Purchase", "terseLabel": "Aggregate number of options to purchase" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAggregateOptionsToPurchase", "nsuri": "http://www.shapeways.com/20210930", "presentation": [ "http://www.shapeways.com/role/StockBasedCompensationDetails" ], "xbrltype": "sharesItemType" }, "shpw_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsConvertedIntoAggregateOptionsToPurchase": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Share Based Compensation Arrangement By Share Based Payment Award Options Converted Into Aggregate Options To Purchase", "label": "Share Based Compensation Arrangement By Share Based Payment Award Options Converted Into Aggregate Options To Purchase", "terseLabel": "Conversion of stock in to Aggregate number of options to purchase" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsConvertedIntoAggregateOptionsToPurchase", "nsuri": "http://www.shapeways.com/20210930", "presentation": [ "http://www.shapeways.com/role/ReverseRecapitalizationDetails" ], "xbrltype": "sharesItemType" }, "shpw_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantedWeightedAverageRemainingContractualTerm": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Share based compensation arrangement by share based payment award options granted weighted average remaining contractual term.", "label": "Share Based Compensation Arrangement By Share based Payment Award Options Granted Weighted Average Remaining Contractual Term", "terseLabel": "Granted (in years)" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantedWeightedAverageRemainingContractualTerm", "nsuri": "http://www.shapeways.com/20210930", "presentation": [ "http://www.shapeways.com/role/StockBasedCompensationStockOptionPlanDetails" ], "xbrltype": "durationItemType" }, "shpw_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforwardAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price Rollforward", "label": "Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price Rollforward [Abstract]", "terseLabel": "Weighted Average Exercise Price" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforwardAbstract", "nsuri": "http://www.shapeways.com/20210930", "presentation": [ "http://www.shapeways.com/role/StockBasedCompensationStockOptionPlanDetails" ], "xbrltype": "stringItemType" }, "shpw_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsRetroactiveApplicationOfReverseRecapitalization": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Share Based Compensation Arrangement By Share Based Payment Award Options Retroactive Application Of Reverse Recapitalization", "label": "Share Based Compensation Arrangement By Share Based Payment Award Options Retroactive Application Of Reverse Recapitalization", "terseLabel": "Retroactive application of reverse recapitalization" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsRetroactiveApplicationOfReverseRecapitalization", "nsuri": "http://www.shapeways.com/20210930", "presentation": [ "http://www.shapeways.com/role/StockBasedCompensationStockOptionPlanDetails" ], "xbrltype": "sharesItemType" }, "shpw_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsRetroactiveApplicationOfReverseRecapitalizationWeightedAverageExercisePrice": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Share based compensation arrangements by share based payment award options retroactive application of reverse recapitalization weighted average exercise price.", "label": "Share Based Compensation Arrangements By Share Based Payment Award Options Retroactive Application Of Reverse Recapitalization Weighted Average Exercise Price", "terseLabel": "Retroactive application of reverse recapitalization (in dollars per share)" } } }, "localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsRetroactiveApplicationOfReverseRecapitalizationWeightedAverageExercisePrice", "nsuri": "http://www.shapeways.com/20210930", "presentation": [ "http://www.shapeways.com/role/StockBasedCompensationStockOptionPlanDetails" ], "xbrltype": "perShareItemType" }, "shpw_SponsorWarrantsMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Sponsor warrants.", "label": "Sponsor Warrants [Member]" } } }, "localname": "SponsorWarrantsMember", "nsuri": "http://www.shapeways.com/20210930", "presentation": [ "http://www.shapeways.com/role/FairValueMeasurementsDetails" ], "xbrltype": "domainItemType" }, "shpw_StockAndWarrantsIssuedDuringPeriodSharesNewWarrants": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Number of stock and warrants issued during the period warrants new issues.", "label": "Stock and Warrants Issued During Period, Shares, New Warrants", "terseLabel": "Purchase of stock and warrants" } } }, "localname": "StockAndWarrantsIssuedDuringPeriodSharesNewWarrants", "nsuri": "http://www.shapeways.com/20210930", "presentation": [ "http://www.shapeways.com/role/StockholdersEquityDeficitDetails" ], "xbrltype": "sharesItemType" }, "shpw_StockIssuedDuringPeriodSharesIssuedUponExerciseOfWarrants": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Stock issued during period shares issued upon exercise of warrants.", "label": "Stock Issued During Period Shares Issued Upon Exercise Of Warrants", "terseLabel": "Issuance of Legacy Shapeways common stock upon exercise of warrants (shares)" } } }, "localname": "StockIssuedDuringPeriodSharesIssuedUponExerciseOfWarrants", "nsuri": "http://www.shapeways.com/20210930", "presentation": [ "http://www.shapeways.com/role/CondensedConsolidatedStatementsOfChangesInStockholdersEquityDeficit" ], "xbrltype": "sharesItemType" }, "shpw_SubscriptionAgreementMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "SHPW Subscription Agreement", "label": "Subscription Agreement [Member]" } } }, "localname": "SubscriptionAgreementMember", "nsuri": "http://www.shapeways.com/20210930", "presentation": [ "http://www.shapeways.com/role/ReverseRecapitalizationDetails" ], "xbrltype": "domainItemType" }, "shpw_SummaryOfChangesInFairValueOfWarrantLiabilitiesTableTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The tabular disclosure of changes in the fair value of warrant liabilities.", "label": "Summary Of Changes In Fair Value Of Warrant Liabilities [Table Text Block]", "terseLabel": "Schedule of changes in the fair value of warrant liabilities" } } }, "localname": "SummaryOfChangesInFairValueOfWarrantLiabilitiesTableTextBlock", "nsuri": "http://www.shapeways.com/20210930", "presentation": [ "http://www.shapeways.com/role/FairValueMeasurementsTables" ], "xbrltype": "textBlockItemType" }, "shpw_SummaryOfLeasesSupplementalCashFlowInformationAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Summary of leases supplemental cash flow information.", "label": "Summary Of Leases Supplemental Cash Flow Information [Abstract]" } } }, "localname": "SummaryOfLeasesSupplementalCashFlowInformationAbstract", "nsuri": "http://www.shapeways.com/20210930", "xbrltype": "stringItemType" }, "shpw_TermLoanMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Term loan.", "label": "Term Loan [Member]", "terseLabel": "Term Loan" } } }, "localname": "TermLoanMember", "nsuri": "http://www.shapeways.com/20210930", "presentation": [ "http://www.shapeways.com/role/BorrowingArrangementsOutstandingDebtObligationsDetails", "http://www.shapeways.com/role/BorrowingArrangementsTermLoanDetails" ], "xbrltype": "domainItemType" }, "shpw_TotalRevenueRecognizedFromBothBeginningBalanceAndCurrentPeriodIncreaseInContractLiability": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of revenue recognized that was previously included in balance of obligation to transfer good or service to customer for which consideration from customer has been received or is due, and from current period increase in contract liability.", "label": "Total Revenue Recognized From Both Beginning Balance And Current Period Increase In Contract Liability", "negatedLabel": "Deferred revenue recognized during period" } } }, "localname": "TotalRevenueRecognizedFromBothBeginningBalanceAndCurrentPeriodIncreaseInContractLiability", "nsuri": "http://www.shapeways.com/20210930", "presentation": [ "http://www.shapeways.com/role/RevenueRecognitionDeferredRevenuesDetails" ], "xbrltype": "monetaryItemType" }, "shpw_TradingPriceOfTriggeringEventAxis": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Trading Price Of Triggering Event", "label": "Trading Price Of Triggering Event [Axis]" } } }, "localname": "TradingPriceOfTriggeringEventAxis", "nsuri": "http://www.shapeways.com/20210930", "presentation": [ "http://www.shapeways.com/role/ReverseRecapitalizationDetails" ], "xbrltype": "stringItemType" }, "shpw_TradingPriceOfTriggeringEventDomain": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Trading Price Of Triggering Event", "label": "Trading Price Of Triggering Event [Domain]" } } }, "localname": "TradingPriceOfTriggeringEventDomain", "nsuri": "http://www.shapeways.com/20210930", "presentation": [ "http://www.shapeways.com/role/ReverseRecapitalizationDetails" ], "xbrltype": "domainItemType" }, "shpw_TradingPriceOneMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Trading Price One", "label": "Trading Price One [Member]" } } }, "localname": "TradingPriceOneMember", "nsuri": "http://www.shapeways.com/20210930", "presentation": [ "http://www.shapeways.com/role/ReverseRecapitalizationDetails" ], "xbrltype": "domainItemType" }, "shpw_TradingPriceTwoMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Trading Price Two", "label": "Trading Price Two [Member]" } } }, "localname": "TradingPriceTwoMember", "nsuri": "http://www.shapeways.com/20210930", "presentation": [ "http://www.shapeways.com/role/ReverseRecapitalizationDetails" ], "xbrltype": "domainItemType" }, "shpw_TransactionCostsAndAdvisoryFeesAllocatedToEquity": { "auth_ref": [], "calculation": { "http://www.shapeways.com/role/ReverseRecapitalizationScheduleOfCommonStockSharesIssuedFollowingTheConsummationOfMergerDetails": { "order": 2.0, "parentTag": "us-gaap_PaymentsOfMergerRelatedCostsFinancingActivities", "weight": -1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Transaction Costs and Advisory Fees Allocated TO Equity", "label": "Transaction Costs and Advisory Fees Allocated TO Equity", "negatedLabel": "Less: transaction costs and advisory fees allocated to equity" } } }, "localname": "TransactionCostsAndAdvisoryFeesAllocatedToEquity", "nsuri": "http://www.shapeways.com/20210930", "presentation": [ "http://www.shapeways.com/role/ReverseRecapitalizationScheduleOfCommonStockSharesIssuedFollowingTheConsummationOfMergerDetails" ], "xbrltype": "monetaryItemType" }, "shpw_TransactionsCostsAndAdbisoryFeesAllocatedToEquity": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Transactions Costs and Adbisory Fees Allocated TO Equity", "label": "Transactions Costs and Adbisory Fees Allocated TO Equity", "negatedLabel": "Less: transaction costs and advisory fees allocated to equity" } } }, "localname": "TransactionsCostsAndAdbisoryFeesAllocatedToEquity", "nsuri": "http://www.shapeways.com/20210930", "presentation": [ "http://www.shapeways.com/role/ReverseRecapitalizationScheduleOfReconcilesTheElementsOfBusinessCombinationToTheUnauditedConsolidatedStatementOfChangesInStockholdersEquityDetails" ], "xbrltype": "monetaryItemType" }, "shpw_TwoThousandTenStockPlanMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "2010 Stock Plan [Member].", "label": "Two Thousand Ten Stock Plan [Member]", "terseLabel": "2010 Stock Plan [Member]" } } }, "localname": "TwoThousandTenStockPlanMember", "nsuri": "http://www.shapeways.com/20210930", "presentation": [ "http://www.shapeways.com/role/StockBasedCompensationDetails" ], "xbrltype": "domainItemType" }, "shpw_TwoThousandTwentyOneEquityIncentivePlanMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "2021 Equity Incentive Plan [Member].", "label": "Two Thousand Twenty One Equity Incentive Plan [Member]", "terseLabel": "2021 Equity Incentive Plan [Member]" } } }, "localname": "TwoThousandTwentyOneEquityIncentivePlanMember", "nsuri": "http://www.shapeways.com/20210930", "presentation": [ "http://www.shapeways.com/role/ReverseRecapitalizationDetails", "http://www.shapeways.com/role/StockBasedCompensationDetails" ], "xbrltype": "domainItemType" }, "shpw_UnpaidAndAccruedInterestMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Unpaid and accrued interest.", "label": "Unpaid And Accrued Interest [Member]" } } }, "localname": "UnpaidAndAccruedInterestMember", "nsuri": "http://www.shapeways.com/20210930", "presentation": [ "http://www.shapeways.com/role/BorrowingArrangementsConvertiblePromissoryNotesDetails" ], "xbrltype": "domainItemType" }, "shpw_VolumeWeightedAverageTradingPriceOfCommonStock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Volume Weighted Average Trading Price Of Common Stock", "label": "Volume Weighted Average Trading Price Of Common Stock", "terseLabel": "Volume weighted average trading price of common stock" } } }, "localname": "VolumeWeightedAverageTradingPriceOfCommonStock", "nsuri": "http://www.shapeways.com/20210930", "presentation": [ "http://www.shapeways.com/role/ReverseRecapitalizationDetails" ], "xbrltype": "perShareItemType" }, "shpw_WarrantLiabilities": { "auth_ref": [], "calculation": { "http://www.shapeways.com/role/CondensedConsolidatedBalanceSheets": { "order": 26.0, "parentTag": "us-gaap_Liabilities", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Warrant liabilities.", "label": "Warrant Liabilities" } } }, "localname": "WarrantLiabilities", "nsuri": "http://www.shapeways.com/20210930", "presentation": [ "http://www.shapeways.com/role/CondensedConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "shpw_WarrantLiabilityMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The member represents warrant liability.", "label": "Warrant Liability [Member]", "terseLabel": "Warrant Liability" } } }, "localname": "WarrantLiabilityMember", "nsuri": "http://www.shapeways.com/20210930", "presentation": [ "http://www.shapeways.com/role/FairValueMeasurementsDetails" ], "xbrltype": "domainItemType" }, "shpw_WarrantsExercisedForNumberOfSharesOfCommonStock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Warrants exercised for number of shares of common stock.", "label": "Warrants Exercised For Number Of Shares Of Common Stock", "terseLabel": "Warrants exercised for number of shares of Common stock" } } }, "localname": "WarrantsExercisedForNumberOfSharesOfCommonStock", "nsuri": "http://www.shapeways.com/20210930", "presentation": [ "http://www.shapeways.com/role/StockholdersEquityDeficitDetails" ], "xbrltype": "sharesItemType" }, "shpw_WarrantsExercisedForNumberOfSharesOfPreferredStock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Warrants exercised for number of shares of preferred stock.", "label": "Warrants Exercised For Number Of Shares Of Preferred Stock", "terseLabel": "Warrants exercised for number of shares of preferred stock" } } }, "localname": "WarrantsExercisedForNumberOfSharesOfPreferredStock", "nsuri": "http://www.shapeways.com/20210930", "presentation": [ "http://www.shapeways.com/role/StockholdersEquityDeficitDetails" ], "xbrltype": "sharesItemType" }, "shpw_WeightedAverageCommonSharesOutstandingAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Weighted average common shares outstanding abstract.", "label": "Weighted Average Common Shares Outstanding [Abstract]" } } }, "localname": "WeightedAverageCommonSharesOutstandingAbstract", "nsuri": "http://www.shapeways.com/20210930", "presentation": [ "http://www.shapeways.com/role/CondensedConsolidatedStatementsOfOperationsAndComprehensiveLoss" ], "xbrltype": "stringItemType" }, "srt_CumulativeEffectPeriodOfAdoptionAdjustedBalanceMember": { "auth_ref": [ "r0", "r133", "r139", "r225", "r411", "r412", "r413", "r429", "r430", "r458", "r461", "r462", "r666" ], "lang": { "en-us": { "role": { "label": "Cumulative Effect, Period of Adoption, Adjusted Balance [Member]", "terseLabel": "Cumulative Effect Adjusted [Member]" } } }, "localname": "CumulativeEffectPeriodOfAdoptionAdjustedBalanceMember", "nsuri": "http://fasb.org/srt/2021-01-31", "presentation": [ "http://www.shapeways.com/role/StockBasedCompensationStockOptionPlanDetails" ], "xbrltype": "domainItemType" }, "srt_CumulativeEffectPeriodOfAdoptionAxis": { "auth_ref": [ "r0", "r133", "r139", "r146", "r225", "r411", "r412", "r413", "r429", "r430", "r458", "r460", "r461", "r462", "r666" ], "lang": { "en-us": { "role": { "label": "Cumulative Effect, Period of Adoption [Axis]" } } }, "localname": "CumulativeEffectPeriodOfAdoptionAxis", "nsuri": "http://fasb.org/srt/2021-01-31", "presentation": [ "http://www.shapeways.com/role/StockBasedCompensationStockOptionPlanDetails" ], "xbrltype": "stringItemType" }, "srt_CumulativeEffectPeriodOfAdoptionDomain": { "auth_ref": [ "r0", "r133", "r139", "r146", "r225", "r411", "r412", "r413", "r429", "r430", "r458", "r460", "r461", "r462", "r666" ], "lang": { "en-us": { "role": { "label": "Cumulative Effect, Period of Adoption [Domain]" } } }, "localname": "CumulativeEffectPeriodOfAdoptionDomain", "nsuri": "http://fasb.org/srt/2021-01-31", "presentation": [ "http://www.shapeways.com/role/StockBasedCompensationStockOptionPlanDetails" ], "xbrltype": "domainItemType" }, "srt_MajorCustomersAxis": { "auth_ref": [ "r206", "r360", "r366", "r613" ], "lang": { "en-us": { "role": { "label": "Customer [Axis]" } } }, "localname": "MajorCustomersAxis", "nsuri": "http://fasb.org/srt/2021-01-31", "presentation": [ "http://www.shapeways.com/role/SignificantConcentrationsDetails" ], "xbrltype": "stringItemType" }, "srt_MaximumMember": { "auth_ref": [ "r283", "r322", "r383", "r386", "r536", "r537", "r538", "r539", "r540", "r541", "r560", "r609", "r614", "r649", "r650" ], "lang": { "en-us": { "role": { "label": "Maximum [Member]" } } }, "localname": "MaximumMember", "nsuri": "http://fasb.org/srt/2021-01-31", "presentation": [ "http://www.shapeways.com/role/StockBasedCompensationFairValueOfStockBasedCompensationDetails" ], "xbrltype": "domainItemType" }, "srt_MinimumMember": { "auth_ref": [ "r283", "r322", "r383", "r386", "r536", "r537", "r538", "r539", "r540", "r541", "r560", "r609", "r614", "r649", "r650" ], "lang": { "en-us": { "role": { "label": "Minimum [Member]", "terseLabel": "Minimum [Member]" } } }, "localname": "MinimumMember", "nsuri": "http://fasb.org/srt/2021-01-31", "presentation": [ "http://www.shapeways.com/role/OrganizationDetails", "http://www.shapeways.com/role/StockBasedCompensationFairValueOfStockBasedCompensationDetails" ], "xbrltype": "domainItemType" }, "srt_NameOfMajorCustomerDomain": { "auth_ref": [ "r206", "r360", "r366", "r613" ], "lang": { "en-us": { "role": { "label": "Customer [Domain]" } } }, "localname": "NameOfMajorCustomerDomain", "nsuri": "http://fasb.org/srt/2021-01-31", "presentation": [ "http://www.shapeways.com/role/SignificantConcentrationsDetails" ], "xbrltype": "domainItemType" }, "srt_OfficerMember": { "auth_ref": [ "r207" ], "lang": { "en-us": { "role": { "label": "Officer [Member]" } } }, "localname": "OfficerMember", "nsuri": "http://fasb.org/srt/2021-01-31", "presentation": [ "http://www.shapeways.com/role/RelatedPartyTransactionsDetails" ], "xbrltype": "domainItemType" }, "srt_ProductOrServiceAxis": { "auth_ref": [ "r204", "r360", "r364", "r563", "r607", "r612" ], "lang": { "en-us": { "role": { "label": "Product and Service [Axis]" } } }, "localname": "ProductOrServiceAxis", "nsuri": "http://fasb.org/srt/2021-01-31", "presentation": [ "http://www.shapeways.com/role/RevenueRecognitionDisaggregationOfRevenuesDetails", "http://www.shapeways.com/role/RevenueRecognitionMarketplaceSalesDetails" ], "xbrltype": "stringItemType" }, "srt_ProductsAndServicesDomain": { "auth_ref": [ "r204", "r360", "r364", "r563", "r607", "r612" ], "lang": { "en-us": { "role": { "label": "Product and Service [Domain]" } } }, "localname": "ProductsAndServicesDomain", "nsuri": "http://fasb.org/srt/2021-01-31", "presentation": [ "http://www.shapeways.com/role/RevenueRecognitionDisaggregationOfRevenuesDetails", "http://www.shapeways.com/role/RevenueRecognitionMarketplaceSalesDetails" ], "xbrltype": "domainItemType" }, "srt_RangeAxis": { "auth_ref": [ "r283", "r322", "r372", "r383", "r386", "r536", "r537", "r538", "r539", "r540", "r541", "r560", "r609", "r614", "r649", "r650" ], "lang": { "en-us": { "role": { "label": "Statistical Measurement [Axis]" } } }, "localname": "RangeAxis", "nsuri": "http://fasb.org/srt/2021-01-31", "presentation": [ "http://www.shapeways.com/role/OrganizationDetails", "http://www.shapeways.com/role/StockBasedCompensationFairValueOfStockBasedCompensationDetails" ], "xbrltype": "stringItemType" }, "srt_RangeMember": { "auth_ref": [ "r283", "r322", "r372", "r383", "r386", "r536", "r537", "r538", "r539", "r540", "r541", "r560", "r609", "r614", "r649", "r650" ], "lang": { "en-us": { "role": { "label": "Statistical Measurement [Domain]" } } }, "localname": "RangeMember", "nsuri": "http://fasb.org/srt/2021-01-31", "presentation": [ "http://www.shapeways.com/role/OrganizationDetails", "http://www.shapeways.com/role/StockBasedCompensationFairValueOfStockBasedCompensationDetails" ], "xbrltype": "domainItemType" }, "srt_RestatementAdjustmentMember": { "auth_ref": [ "r130", "r131", "r132", "r134", "r135", "r136", "r137", "r139", "r141", "r142", "r144", "r145", "r161", "r461", "r462" ], "lang": { "en-us": { "role": { "label": "Revision of Prior Period, Adjustment [Member]" } } }, "localname": "RestatementAdjustmentMember", "nsuri": "http://fasb.org/srt/2021-01-31", "presentation": [ "http://www.shapeways.com/role/CondensedConsolidatedStatementsOfChangesInStockholdersEquityDeficit" ], "xbrltype": "domainItemType" }, "srt_RestatementAxis": { "auth_ref": [ "r1", "r130", "r131", "r132", "r134", "r135", "r136", "r137", "r138", "r139", "r141", "r142", "r143", "r144", "r145", "r146", "r161", "r226", "r227", "r414", "r430", "r459", "r461", "r462", "r463", "r616", "r617", "r618", "r619", "r620", "r621", "r622", "r623", "r624", "r625", "r667", "r668" ], "lang": { "en-us": { "role": { "label": "Revision of Prior Period [Axis]" } } }, "localname": "RestatementAxis", "nsuri": "http://fasb.org/srt/2021-01-31", "presentation": [ "http://www.shapeways.com/role/CondensedConsolidatedStatementsOfChangesInStockholdersEquityDeficit" ], "xbrltype": "stringItemType" }, "srt_RestatementDomain": { "auth_ref": [ "r1", "r130", "r131", "r132", "r134", "r135", "r136", "r137", "r138", "r139", "r141", "r142", "r143", "r144", "r145", "r146", "r161", "r226", "r227", "r414", "r430", "r459", "r461", "r462", "r463", "r616", "r617", "r618", "r619", "r620", "r621", "r622", "r623", "r624", "r625", "r667", "r668" ], "lang": { "en-us": { "role": { "label": "Revision of Prior Period [Domain]" } } }, "localname": "RestatementDomain", "nsuri": "http://fasb.org/srt/2021-01-31", "presentation": [ "http://www.shapeways.com/role/CondensedConsolidatedStatementsOfChangesInStockholdersEquityDeficit" ], "xbrltype": "domainItemType" }, "srt_ScenarioPreviouslyReportedMember": { "auth_ref": [ "r1", "r130", "r132", "r134", "r135", "r136", "r137", "r138", "r139", "r141", "r142", "r144", "r145", "r161", "r226", "r227", "r414", "r430", "r459", "r461", "r462", "r463", "r616", "r617", "r618", "r619", "r620", "r621", "r622", "r623", "r624", "r625", "r667", "r668" ], "lang": { "en-us": { "role": { "label": "Previously Reported [Member]" } } }, "localname": "ScenarioPreviouslyReportedMember", "nsuri": "http://fasb.org/srt/2021-01-31", "presentation": [ "http://www.shapeways.com/role/CondensedConsolidatedStatementsOfChangesInStockholdersEquityDeficit" ], "xbrltype": "domainItemType" }, "srt_ScenarioUnspecifiedDomain": { "auth_ref": [ "r140", "r146", "r384" ], "lang": { "en-us": { "role": { "label": "Scenario [Domain]", "terseLabel": "Scenario [Domain]" } } }, "localname": "ScenarioUnspecifiedDomain", "nsuri": "http://fasb.org/srt/2021-01-31", "presentation": [ "http://www.shapeways.com/role/RelatedPartyTransactionsDetails" ], "xbrltype": "domainItemType" }, "srt_StatementScenarioAxis": { "auth_ref": [ "r140", "r146", "r264", "r384", "r528" ], "lang": { "en-us": { "role": { "label": "Scenario [Axis]" } } }, "localname": "StatementScenarioAxis", "nsuri": "http://fasb.org/srt/2021-01-31", "presentation": [ "http://www.shapeways.com/role/RelatedPartyTransactionsDetails" ], "xbrltype": "stringItemType" }, "srt_TitleOfIndividualAxis": { "auth_ref": [ "r207", "r519" ], "lang": { "en-us": { "role": { "label": "Title of Individual [Axis]" } } }, "localname": "TitleOfIndividualAxis", "nsuri": "http://fasb.org/srt/2021-01-31", "presentation": [ "http://www.shapeways.com/role/CommitmentsAndContingenciesAdditionalInformationDetails" ], "xbrltype": "stringItemType" }, "srt_TitleOfIndividualWithRelationshipToEntityDomain": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Title of Individual [Domain]", "terseLabel": "Relationship to Entity [Domain]" } } }, "localname": "TitleOfIndividualWithRelationshipToEntityDomain", "nsuri": "http://fasb.org/srt/2021-01-31", "presentation": [ "http://www.shapeways.com/role/CommitmentsAndContingenciesAdditionalInformationDetails" ], "xbrltype": "domainItemType" }, "us-gaap_AccountingPoliciesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Summary of Significant Accounting Policies" } } }, "localname": "AccountingPoliciesAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "xbrltype": "stringItemType" }, "us-gaap_AccountsPayableCurrent": { "auth_ref": [ "r51", "r525" ], "calculation": { "http://www.shapeways.com/role/CondensedConsolidatedBalanceSheets": { "order": 20.0, "parentTag": "us-gaap_LiabilitiesCurrent", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Carrying value as of the balance sheet date of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).", "label": "Accounts Payable, Current", "terseLabel": "Accounts payable" } } }, "localname": "AccountsPayableCurrent", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.shapeways.com/role/CondensedConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_AccountsPayableMember": { "auth_ref": [ "r18" ], "lang": { "en-us": { "role": { "documentation": "Obligations incurred and payable to vendors for goods and services received.", "label": "Accounts Payable [Member]" } } }, "localname": "AccountsPayableMember", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.shapeways.com/role/SignificantConcentrationsDetails" ], "xbrltype": "domainItemType" }, "us-gaap_AccountsReceivableMember": { "auth_ref": [ "r644" ], "lang": { "en-us": { "role": { "documentation": "Due from customers or clients for goods or services that have been delivered or sold.", "label": "Accounts Receivable [Member]" } } }, "localname": "AccountsReceivableMember", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.shapeways.com/role/SignificantConcentrationsDetails" ], "xbrltype": "domainItemType" }, "us-gaap_AccountsReceivableNetCurrent": { "auth_ref": [ "r7", "r30", "r208", "r209" ], "calculation": { "http://www.shapeways.com/role/CondensedConsolidatedBalanceSheets": { "order": 4.0, "parentTag": "us-gaap_AssetsCurrent", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount, after allowance for credit loss, of right to consideration from customer for product sold and service rendered in normal course of business, classified as current.", "label": "Accounts Receivable, after Allowance for Credit Loss, Current", "terseLabel": "Accounts receivable" } } }, "localname": "AccountsReceivableNetCurrent", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.shapeways.com/role/CondensedConsolidatedBalanceSheets", "http://www.shapeways.com/role/RevenueRecognitionDeferredRevenuesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_AccruedLiabilitiesCurrent": { "auth_ref": [ "r55" ], "calculation": { "http://www.shapeways.com/role/CondensedConsolidatedBalanceSheets": { "order": 21.0, "parentTag": "us-gaap_LiabilitiesCurrent", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Carrying value as of the balance sheet date of obligations incurred and payable, pertaining to costs that are statutory in nature, are incurred on contractual obligations, or accumulate over time and for which invoices have not yet been received or will not be rendered. Examples include taxes, interest, rent and utilities. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).", "label": "Accrued Liabilities, Current", "terseLabel": "Accrued expenses and other liabilities" } } }, "localname": "AccruedLiabilitiesCurrent", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.shapeways.com/role/CondensedConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment": { "auth_ref": [ "r49", "r254" ], "calculation": { "http://www.shapeways.com/role/PropertyAndEquipmentNetDetails": { "order": 2.0, "parentTag": "us-gaap_PropertyPlantAndEquipmentNet", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of accumulated depreciation, depletion and amortization for physical assets used in the normal conduct of business to produce goods and services.", "label": "Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment", "negatedLabel": "Less: Accumulated depreciation" } } }, "localname": "AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.shapeways.com/role/PropertyAndEquipmentNetDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax": { "auth_ref": [ "r33", "r70", "r71", "r72", "r596", "r621", "r625" ], "calculation": { "http://www.shapeways.com/role/CondensedConsolidatedBalanceSheets": { "order": 17.0, "parentTag": "us-gaap_StockholdersEquity", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Accumulated change in equity from transactions and other events and circumstances from non-owner sources, net of tax effect, at period end. Excludes Net Income (Loss), and accumulated changes in equity from transactions resulting from investments by owners and distributions to owners. Includes foreign currency translation items, certain pension adjustments, unrealized gains and losses on certain investments in debt and equity securities, other than temporary impairment (OTTI) losses related to factors other than credit losses on available-for-sale and held-to-maturity debt securities that an entity does not intend to sell and it is not more likely than not that the entity will be required to sell before recovery of the amortized cost basis, as well as changes in the fair value of derivatives related to the effective portion of a designated cash flow hedge.", "label": "Accumulated Other Comprehensive Income (Loss), Net of Tax", "terseLabel": "Accumulated other comprehensive loss" } } }, "localname": "AccumulatedOtherComprehensiveIncomeLossNetOfTax", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.shapeways.com/role/CondensedConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_AccumulatedOtherComprehensiveIncomeMember": { "auth_ref": [ "r69", "r72", "r79", "r80", "r81", "r130", "r131", "r132", "r450", "r616", "r617", "r668" ], "lang": { "en-us": { "role": { "documentation": "Accumulated increase (decrease) in equity from transactions and other events and circumstances from non-owner sources, attributable to the parent. Excludes net income (loss), and accumulated changes in equity from transactions resulting from investments by owners and distributions to owners.", "label": "AOCI Attributable to Parent [Member]", "terseLabel": "Accumulated Other Comprehensive Loss" } } }, "localname": "AccumulatedOtherComprehensiveIncomeMember", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.shapeways.com/role/CondensedConsolidatedStatementsOfChangesInStockholdersEquityDeficit" ], "xbrltype": "domainItemType" }, "us-gaap_AdditionalPaidInCapital": { "auth_ref": [ "r31", "r414", "r525" ], "calculation": { "http://www.shapeways.com/role/CondensedConsolidatedBalanceSheets": { "order": 15.0, "parentTag": "us-gaap_StockholdersEquity", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of excess of issue price over par or stated value of stock and from other transaction involving stock or stockholder. Includes, but is not limited to, additional paid-in capital (APIC) for common and preferred stock.", "label": "Additional Paid in Capital", "terseLabel": "Additional paid-in capital" } } }, "localname": "AdditionalPaidInCapital", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.shapeways.com/role/CondensedConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_AdditionalPaidInCapitalMember": { "auth_ref": [ "r130", "r131", "r132", "r411", "r412", "r413", "r461" ], "lang": { "en-us": { "role": { "documentation": "Excess of issue price over par or stated value of the entity's capital stock and amounts received from other transactions involving the entity's stock or stockholders.", "label": "Additional Paid-in Capital [Member]", "terseLabel": "Additional Paid-in Capital" } } }, "localname": "AdditionalPaidInCapitalMember", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.shapeways.com/role/CondensedConsolidatedStatementsOfChangesInStockholdersEquityDeficit" ], "xbrltype": "domainItemType" }, "us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Adjustments to Reconcile Net Income (Loss) to Cash Provided by (Used in) Operating Activities [Abstract]", "terseLabel": "Adjustments to reconcile net income (loss) to net cash used in operating activities:" } } }, "localname": "AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.shapeways.com/role/CondensedConsolidatedStatementsOfCashFlows" ], "xbrltype": "stringItemType" }, "us-gaap_AdvertisingCostsPolicyTextBlock": { "auth_ref": [ "r418" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for advertising cost.", "label": "Advertising Cost [Policy Text Block]", "terseLabel": "Advertising" } } }, "localname": "AdvertisingCostsPolicyTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.shapeways.com/role/SummaryOfSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_AdvertisingExpense": { "auth_ref": [ "r419" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount charged to advertising expense for the period, which are expenses incurred with the objective of increasing revenue for a specified brand, product or product line.", "label": "Advertising Expense", "terseLabel": "Advertising expense" } } }, "localname": "AdvertisingExpense", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.shapeways.com/role/SummaryOfSignificantAccountingPoliciesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_AllocatedShareBasedCompensationExpense": { "auth_ref": [ "r388", "r408", "r416" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.", "label": "Share-based Payment Arrangement, Expense", "terseLabel": "Stock-based compensation expense" } } }, "localname": "AllocatedShareBasedCompensationExpense", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.shapeways.com/role/CondensedConsolidatedStatementsOfChangesInStockholdersEquityDeficit" ], "xbrltype": "monetaryItemType" }, "us-gaap_ArrangementsAndNonarrangementTransactionsMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Collaborative arrangement and arrangement other than collaborative applicable to revenue-generating activity or operations.", "label": "Collaborative Arrangement and Arrangement Other than Collaborative [Domain]" } } }, "localname": "ArrangementsAndNonarrangementTransactionsMember", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.shapeways.com/role/ReverseRecapitalizationDetails" ], "xbrltype": "domainItemType" }, "us-gaap_AssetImpairmentCharges": { "auth_ref": [ "r108", "r251" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of write-down of assets recognized in the income statement. Includes, but is not limited to, losses from tangible assets, intangible assets and goodwill.", "label": "Asset Impairment Charges", "terseLabel": "Asset impairment charges" } } }, "localname": "AssetImpairmentCharges", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.shapeways.com/role/SummaryOfSignificantAccountingPoliciesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_Assets": { "auth_ref": [ "r125", "r187", "r196", "r202", "r224", "r267", "r268", "r269", "r271", "r272", "r273", "r274", "r275", "r276", "r278", "r279", "r445", "r451", "r481", "r523", "r525", "r579", "r593" ], "calculation": { "http://www.shapeways.com/role/CondensedConsolidatedBalanceSheets": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Sum of the carrying amounts as of the balance sheet date of all assets that are recognized. Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.", "label": "Assets", "totalLabel": "Total assets" } } }, "localname": "Assets", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.shapeways.com/role/CondensedConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_AssetsAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Assets [Abstract]", "terseLabel": "ASSETS" } } }, "localname": "AssetsAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.shapeways.com/role/CondensedConsolidatedBalanceSheets" ], "xbrltype": "stringItemType" }, "us-gaap_AssetsCurrent": { "auth_ref": [ "r10", "r12", "r68", "r125", "r224", "r267", "r268", "r269", "r271", "r272", "r273", "r274", "r275", "r276", "r278", "r279", "r445", "r451", "r481", "r523", "r525" ], "calculation": { "http://www.shapeways.com/role/CondensedConsolidatedBalanceSheets": { "order": 1.0, "parentTag": "us-gaap_Assets", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Sum of the carrying amounts as of the balance sheet date of all assets that are expected to be realized in cash, sold, or consumed within one year (or the normal operating cycle, if longer). Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.", "label": "Assets, Current", "totalLabel": "Total current assets" } } }, "localname": "AssetsCurrent", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.shapeways.com/role/CondensedConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_AssetsCurrentAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Assets, Current [Abstract]", "terseLabel": "Current assets" } } }, "localname": "AssetsCurrentAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.shapeways.com/role/CondensedConsolidatedBalanceSheets" ], "xbrltype": "stringItemType" }, "us-gaap_AwardTypeAxis": { "auth_ref": [ "r389", "r410" ], "lang": { "en-us": { "role": { "documentation": "Information by type of award under share-based payment arrangement.", "label": "Award Type [Axis]" } } }, "localname": "AwardTypeAxis", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.shapeways.com/role/ReverseRecapitalizationDetails", "http://www.shapeways.com/role/StockBasedCompensationDetails" ], "xbrltype": "stringItemType" }, "us-gaap_BusinessAcquisitionAcquireeDomain": { "auth_ref": [ "r382", "r385" ], "lang": { "en-us": { "role": { "documentation": "Identification of the acquiree in a material business combination (or series of individually immaterial business combinations), which may include the name or other type of identification of the acquiree.", "label": "Business Acquisition, Acquiree [Domain]" } } }, "localname": "BusinessAcquisitionAcquireeDomain", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.shapeways.com/role/ReverseRecapitalizationDetails", "http://www.shapeways.com/role/ReverseRecapitalizationScheduleOfCommonStockSharesIssuedFollowingTheConsummationOfMergerDetails", "http://www.shapeways.com/role/ReverseRecapitalizationScheduleOfReconcilesTheElementsOfBusinessCombinationToTheUnauditedConsolidatedStatementOfChangesInStockholdersEquityDetails" ], "xbrltype": "domainItemType" }, "us-gaap_BusinessAcquisitionAxis": { "auth_ref": [ "r382", "r385", "r433", "r434" ], "lang": { "en-us": { "role": { "documentation": "Information by business combination or series of individually immaterial business combinations.", "label": "Business Acquisition [Axis]" } } }, "localname": "BusinessAcquisitionAxis", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.shapeways.com/role/ReverseRecapitalizationDetails", "http://www.shapeways.com/role/ReverseRecapitalizationScheduleOfCommonStockSharesIssuedFollowingTheConsummationOfMergerDetails", "http://www.shapeways.com/role/ReverseRecapitalizationScheduleOfReconcilesTheElementsOfBusinessCombinationToTheUnauditedConsolidatedStatementOfChangesInStockholdersEquityDetails" ], "xbrltype": "stringItemType" }, "us-gaap_BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued": { "auth_ref": [ "r441" ], "lang": { "en-us": { "role": { "documentation": "Number of shares of equity interests issued or issuable to acquire entity.", "label": "Business Acquisition, Equity Interest Issued or Issuable, Number of Shares", "terseLabel": "Number of shares issued as merger consideration" } } }, "localname": "BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.shapeways.com/role/ReverseRecapitalizationDetails" ], "xbrltype": "sharesItemType" }, "us-gaap_BusinessCombinationConsiderationTransferred1": { "auth_ref": [ "r437", "r438", "r439" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of consideration transferred, consisting of acquisition-date fair value of assets transferred by the acquirer, liabilities incurred by the acquirer, and equity interest issued by the acquirer.", "label": "Business Combination, Consideration Transferred", "terseLabel": "Aggregate merger consideration value" } } }, "localname": "BusinessCombinationConsiderationTransferred1", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.shapeways.com/role/ReverseRecapitalizationDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet": { "auth_ref": [ "r435", "r436" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount recognized as of the acquisition date for the identifiable assets acquired in excess of (less than) the aggregate liabilities assumed.", "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Net", "terseLabel": "Effect of Merger, net of redemption, transaction costs and advisory costs" } } }, "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.shapeways.com/role/ReverseRecapitalizationScheduleOfReconcilesTheElementsOfBusinessCombinationToTheUnauditedConsolidatedStatementOfChangesInStockholdersEquityDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_CashAndCashEquivalentsAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Cash and Cash Equivalents [Abstract]" } } }, "localname": "CashAndCashEquivalentsAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "xbrltype": "stringItemType" }, "us-gaap_CashAndCashEquivalentsAtCarryingValue": { "auth_ref": [ "r5", "r46", "r110" ], "calculation": { "http://www.shapeways.com/role/CondensedConsolidatedBalanceSheets": { "order": 2.0, "parentTag": "us-gaap_AssetsCurrent", "weight": 1.0 }, "http://www.shapeways.com/role/SummaryOfSignificantAccountingPoliciesSummaryOfReconciliationOfCashAndCashEquivalentsDetails": { "order": 1.0, "parentTag": "us-gaap_RestrictedCashAndCashEquivalentsAtCarryingValue", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "definitionGuidance": "Cash and cash equivalents", "disclosureGuidance": "Cash and cash equivalents", "documentation": "Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation.", "label": "Cash and Cash Equivalents, at Carrying Value" } } }, "localname": "CashAndCashEquivalentsAtCarryingValue", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.shapeways.com/role/CondensedConsolidatedBalanceSheets", "http://www.shapeways.com/role/SummaryOfSignificantAccountingPoliciesSummaryOfReconciliationOfCashAndCashEquivalentsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_CashAndCashEquivalentsPolicyTextBlock": { "auth_ref": [ "r19", "r111" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for cash and cash equivalents, including the policy for determining which items are treated as cash equivalents. Other information that may be disclosed includes (1) the nature of any restrictions on the entity's use of its cash and cash equivalents, (2) whether the entity's cash and cash equivalents are insured or expose the entity to credit risk, (3) the classification of any negative balance accounts (overdrafts), and (4) the carrying basis of cash equivalents (for example, at cost) and whether the carrying amount of cash equivalents approximates fair value.", "label": "Cash and Cash Equivalents, Policy [Policy Text Block]", "terseLabel": "Cash, Cash Equivalents and Restricted Cash" } } }, "localname": "CashAndCashEquivalentsPolicyTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.shapeways.com/role/SummaryOfSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents": { "auth_ref": [ "r104", "r110", "r116" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage. Excludes amount for disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.", "label": "Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents", "periodEndLabel": "Cash and cash equivalents and restricted cash at end of period", "periodStartLabel": "Cash and cash equivalents and restricted cash at beginning of period" } } }, "localname": "CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.shapeways.com/role/CondensedConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect": { "auth_ref": [ "r104", "r482" ], "calculation": { "http://www.shapeways.com/role/CondensedConsolidatedStatementsOfCashFlows": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of increase (decrease) in cash, cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; including effect from exchange rate change. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.", "label": "Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect", "totalLabel": "Net change in cash and cash equivalents and restricted cash" } } }, "localname": "CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.shapeways.com/role/CondensedConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_ClassOfStockDomain": { "auth_ref": [ "r122", "r125", "r150", "r151", "r152", "r155", "r157", "r165", "r166", "r167", "r224", "r267", "r272", "r273", "r274", "r278", "r279", "r320", "r321", "r325", "r329", "r481", "r657" ], "lang": { "en-us": { "role": { "documentation": "Share of stock differentiated by the voting rights the holder receives. Examples include, but are not limited to, common stock, redeemable preferred stock, nonredeemable preferred stock, and convertible stock.", "label": "Class of Stock [Domain]", "terseLabel": "Class of Stock [Domain]" } } }, "localname": "ClassOfStockDomain", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.shapeways.com/role/CondensedConsolidatedStatementsOfChangesInStockholdersEquityDeficit", "http://www.shapeways.com/role/CondensedConsolidatedStatementsOfOperationsAndComprehensiveLoss", "http://www.shapeways.com/role/CoverPage", "http://www.shapeways.com/role/OrganizationDetails", "http://www.shapeways.com/role/StockholdersEquityDeficitDetails" ], "xbrltype": "domainItemType" }, "us-gaap_ClassOfStockLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Class of Stock [Line Items]" } } }, "localname": "ClassOfStockLineItems", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.shapeways.com/role/StockholdersEquityDeficitDetails" ], "xbrltype": "stringItemType" }, "us-gaap_ClassOfWarrantOrRightAxis": { "auth_ref": [ "r346", "r387" ], "lang": { "en-us": { "role": { "documentation": "Information by type of warrant or right issued.", "label": "Class of Warrant or Right [Axis]" } } }, "localname": "ClassOfWarrantOrRightAxis", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.shapeways.com/role/FairValueMeasurementsDetails", "http://www.shapeways.com/role/FairValueMeasurementsInitialMeasurementDetails", "http://www.shapeways.com/role/FairValueMeasurementsSubsequentMeasurementDetails", "http://www.shapeways.com/role/StockholdersEquityDeficitDetails", "http://www.shapeways.com/role/SummaryOfSignificantAccountingPoliciesDetails" ], "xbrltype": "stringItemType" }, "us-gaap_ClassOfWarrantOrRightDomain": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Name of the class or type of warrant or right outstanding. Warrants and rights represent derivative securities that give the holder the right to purchase securities (usually equity) from the issuer at a specific price within a certain time frame. Warrants are often included in a new debt issue to entice investors by a higher return potential. The main difference between warrants and call options is that warrants are issued and guaranteed by the company, whereas options are exchange instruments and are not issued by the company. Also, the lifetime of a warrant is often measured in years, while the lifetime of a typical option is measured in months.", "label": "Class of Warrant or Right [Domain]", "terseLabel": "Class of Warrant or Right [Domain]" } } }, "localname": "ClassOfWarrantOrRightDomain", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.shapeways.com/role/FairValueMeasurementsDetails", "http://www.shapeways.com/role/FairValueMeasurementsInitialMeasurementDetails", "http://www.shapeways.com/role/FairValueMeasurementsSubsequentMeasurementDetails", "http://www.shapeways.com/role/StockholdersEquityDeficitDetails", "http://www.shapeways.com/role/SummaryOfSignificantAccountingPoliciesDetails" ], "xbrltype": "domainItemType" }, "us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1": { "auth_ref": [ "r338" ], "lang": { "en-us": { "role": { "definitionGuidance": "Exercise price of warrants", "disclosureGuidance": "Warrants exercise price per share", "documentation": "Exercise price per share or per unit of warrants or rights outstanding.", "label": "Class of Warrant or Right, Exercise Price of Warrants or Rights" } } }, "localname": "ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.shapeways.com/role/StockholdersEquityDeficitDetails", "http://www.shapeways.com/role/SummaryOfSignificantAccountingPoliciesDetails" ], "xbrltype": "perShareItemType" }, "us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Number of securities into which each warrant or right may be converted. For example, but not limited to, each warrant may be converted into two shares.", "label": "Class of Warrant or Right, Number of Securities Called by Each Warrant or Right", "terseLabel": "Number of shares purchased" } } }, "localname": "ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.shapeways.com/role/StockholdersEquityDeficitDetails" ], "xbrltype": "sharesItemType" }, "us-gaap_ClassOfWarrantOrRightOutstanding": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Number of warrants or rights outstanding.", "label": "Class of Warrant or Right, Outstanding", "terseLabel": "Warrant outstanding" } } }, "localname": "ClassOfWarrantOrRightOutstanding", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.shapeways.com/role/FairValueMeasurementsDetails", "http://www.shapeways.com/role/StockholdersEquityDeficitDetails" ], "xbrltype": "sharesItemType" }, "us-gaap_CommitmentsAndContingencies": { "auth_ref": [ "r61", "r263", "r583", "r600" ], "calculation": { "http://www.shapeways.com/role/CondensedConsolidatedBalanceSheets": { "order": 28.0, "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Represents the caption on the face of the balance sheet to indicate that the entity has entered into (1) purchase or supply arrangements that will require expending a portion of its resources to meet the terms thereof, and (2) is exposed to potential losses or, less frequently, gains, arising from (a) possible claims against a company's resources due to future performance under contract terms, and (b) possible losses or likely gains from uncertainties that will ultimately be resolved when one or more future events that are deemed likely to occur do occur or fail to occur.", "label": "Commitments and Contingencies", "terseLabel": "Commitments and Contingencies" } } }, "localname": "CommitmentsAndContingencies", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.shapeways.com/role/CondensedConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_CommitmentsAndContingenciesDisclosureAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Commitments and Contingencies Disclosure [Abstract]", "terseLabel": "Commitments and Contingencies", "verboseLabel": "Commitments and Contingencies Disclosure [Abstract]" } } }, "localname": "CommitmentsAndContingenciesDisclosureAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "xbrltype": "stringItemType" }, "us-gaap_CommitmentsAndContingenciesDisclosureTextBlock": { "auth_ref": [ "r260", "r261", "r262", "r265", "r645" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for commitments and contingencies.", "label": "Commitments and Contingencies Disclosure [Text Block]", "terseLabel": "Commitments and Contingencies" } } }, "localname": "CommitmentsAndContingenciesDisclosureTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.shapeways.com/role/CommitmentsAndContingencies" ], "xbrltype": "textBlockItemType" }, "us-gaap_CommonStockMember": { "auth_ref": [ "r130", "r131", "r461" ], "lang": { "en-us": { "role": { "documentation": "Stock that is subordinate to all other stock of the issuer.", "label": "Common Stock [Member]", "terseLabel": "Common Stock" } } }, "localname": "CommonStockMember", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.shapeways.com/role/BorrowingArrangementsConvertiblePromissoryNotesDetails", "http://www.shapeways.com/role/CondensedConsolidatedStatementsOfChangesInStockholdersEquityDeficit", "http://www.shapeways.com/role/CoverPage", "http://www.shapeways.com/role/ReverseRecapitalizationDetails", "http://www.shapeways.com/role/ReverseRecapitalizationScheduleOfCommonStockSharesIssuedFollowingTheConsummationOfBusinessCombinationDetails" ], "xbrltype": "domainItemType" }, "us-gaap_CommonStockParOrStatedValuePerShare": { "auth_ref": [ "r28" ], "lang": { "en-us": { "role": { "documentation": "Face amount or stated value per share of common stock.", "label": "Common Stock, Par or Stated Value Per Share", "terseLabel": "Common stock, par value" } } }, "localname": "CommonStockParOrStatedValuePerShare", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.shapeways.com/role/CondensedConsolidatedBalanceSheetsParenthetical", "http://www.shapeways.com/role/ReverseRecapitalizationDetails", "http://www.shapeways.com/role/StockholdersEquityDeficitDetails" ], "xbrltype": "perShareItemType" }, "us-gaap_CommonStockSharesAuthorized": { "auth_ref": [ "r28" ], "lang": { "en-us": { "role": { "documentation": "The maximum number of common shares permitted to be issued by an entity's charter and bylaws.", "label": "Common Stock, Shares Authorized", "terseLabel": "Common stock, shares authorized" } } }, "localname": "CommonStockSharesAuthorized", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.shapeways.com/role/CondensedConsolidatedBalanceSheetsParenthetical", "http://www.shapeways.com/role/StockholdersEquityDeficitDetails" ], "xbrltype": "sharesItemType" }, "us-gaap_CommonStockSharesIssued": { "auth_ref": [ "r28" ], "lang": { "en-us": { "role": { "documentation": "Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury.", "label": "Common Stock, Shares, Issued", "terseLabel": "Common stock, shares issued" } } }, "localname": "CommonStockSharesIssued", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.shapeways.com/role/CondensedConsolidatedBalanceSheetsParenthetical", "http://www.shapeways.com/role/StockholdersEquityDeficitDetails" ], "xbrltype": "sharesItemType" }, "us-gaap_CommonStockSharesOutstanding": { "auth_ref": [ "r28", "r337" ], "lang": { "en-us": { "role": { "documentation": "Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.", "label": "Common Stock, Shares, Outstanding", "periodEndLabel": "Ending Balance (in shares)", "periodStartLabel": "Beginning Balance (in Shares)", "terseLabel": "Common stock, shares outstanding" } } }, "localname": "CommonStockSharesOutstanding", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.shapeways.com/role/BorrowingArrangementsConvertiblePromissoryNotesDetails", "http://www.shapeways.com/role/CondensedConsolidatedBalanceSheetsParenthetical", "http://www.shapeways.com/role/CondensedConsolidatedStatementsOfChangesInStockholdersEquityDeficit", "http://www.shapeways.com/role/ReverseRecapitalizationScheduleOfCommonStockSharesIssuedFollowingTheConsummationOfBusinessCombinationDetails", "http://www.shapeways.com/role/StockholdersEquityDeficitDetails" ], "xbrltype": "sharesItemType" }, "us-gaap_CommonStockValue": { "auth_ref": [ "r28", "r525" ], "calculation": { "http://www.shapeways.com/role/CondensedConsolidatedBalanceSheets": { "order": 14.0, "parentTag": "us-gaap_StockholdersEquity", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Aggregate par or stated value of issued nonredeemable common stock (or common stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable common shares, par value and other disclosure concepts are in another section within stockholders' equity.", "label": "Common Stock, Value, Issued", "terseLabel": "Common stock ($0.0001 par value; 120,000,000 shares authorized; 48,296,484 and 32,170,068 shares issued and outstanding as of September 30, 2021 and December 31, 2020, respectively)" } } }, "localname": "CommonStockValue", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.shapeways.com/role/CondensedConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_CommonStockVotingRights": { "auth_ref": [ "r338" ], "lang": { "en-us": { "role": { "documentation": "Description of voting rights of common stock. Includes eligibility to vote and votes per share owned. Include also, if any, unusual voting rights.", "label": "Common Stock, Voting Rights", "terseLabel": "Common stock voting rights" } } }, "localname": "CommonStockVotingRights", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.shapeways.com/role/StockholdersEquityDeficitDetails" ], "xbrltype": "stringItemType" }, "us-gaap_ComprehensiveIncomeNetOfTax": { "auth_ref": [ "r74", "r76", "r77", "r86", "r586", "r602" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income and other comprehensive income, attributable to parent entity. Excludes changes in equity resulting from investments by owners and distributions to owners.", "label": "Comprehensive Income (Loss), Net of Tax, Attributable to Parent", "terseLabel": "Comprehensive loss" } } }, "localname": "ComprehensiveIncomeNetOfTax", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.shapeways.com/role/CondensedConsolidatedStatementsOfOperationsAndComprehensiveLoss" ], "xbrltype": "monetaryItemType" }, "us-gaap_ComputerEquipmentMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Long lived, depreciable assets that are used in the creation, maintenance and utilization of information systems.", "label": "Computer Equipment [Member]", "verboseLabel": "Computers and IT equipment" } } }, "localname": "ComputerEquipmentMember", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.shapeways.com/role/PropertyAndEquipmentNetDetails", "http://www.shapeways.com/role/SummaryOfSignificantAccountingPoliciesSummaryOfUsefulLivesOfPropertyPlantAndEquipmentDetails" ], "xbrltype": "domainItemType" }, "us-gaap_ConcentrationRiskBenchmarkDomain": { "auth_ref": [ "r174", "r175", "r206", "r478", "r479", "r644" ], "lang": { "en-us": { "role": { "documentation": "The denominator in a calculation of a disclosed concentration risk percentage.", "label": "Concentration Risk Benchmark [Domain]" } } }, "localname": "ConcentrationRiskBenchmarkDomain", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.shapeways.com/role/SignificantConcentrationsDetails" ], "xbrltype": "domainItemType" }, "us-gaap_ConcentrationRiskByBenchmarkAxis": { "auth_ref": [ "r174", "r175", "r206", "r478", "r479", "r627", "r644" ], "lang": { "en-us": { "role": { "documentation": "Information by benchmark of concentration risk.", "label": "Concentration Risk Benchmark [Axis]" } } }, "localname": "ConcentrationRiskByBenchmarkAxis", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.shapeways.com/role/SignificantConcentrationsDetails" ], "xbrltype": "stringItemType" }, "us-gaap_ConcentrationRiskByTypeAxis": { "auth_ref": [ "r174", "r175", "r206", "r478", "r479", "r627", "r644" ], "lang": { "en-us": { "role": { "documentation": "Information by type of concentration risk, for example, but not limited to, asset, liability, net assets, geographic, customer, employees, supplier, lender.", "label": "Concentration Risk Type [Axis]" } } }, "localname": "ConcentrationRiskByTypeAxis", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.shapeways.com/role/SignificantConcentrationsDetails" ], "xbrltype": "stringItemType" }, "us-gaap_ConcentrationRiskDisclosureTextBlock": { "auth_ref": [ "r180" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for any concentrations existing at the date of the financial statements that make an entity vulnerable to a reasonably possible, near-term, severe impact. This disclosure informs financial statement users about the general nature of the risk associated with the concentration, and may indicate the percentage of concentration risk as of the balance sheet date.", "label": "Concentration Risk Disclosure [Text Block]", "terseLabel": "Significant Concentrations" } } }, "localname": "ConcentrationRiskDisclosureTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.shapeways.com/role/SignificantConcentrations" ], "xbrltype": "textBlockItemType" }, "us-gaap_ConcentrationRiskLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Concentration Risk [Line Items]" } } }, "localname": "ConcentrationRiskLineItems", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.shapeways.com/role/SignificantConcentrationsDetails" ], "xbrltype": "stringItemType" }, "us-gaap_ConcentrationRiskPercentage1": { "auth_ref": [ "r174", "r175", "r206", "r478", "r479" ], "lang": { "en-us": { "role": { "documentation": "For an entity that discloses a concentration risk in relation to quantitative amount, which serves as the \"benchmark\" (or denominator) in the equation, this concept represents the concentration percentage derived from the division.", "label": "Concentration Risk, Percentage", "terseLabel": "Concentration risk percentage" } } }, "localname": "ConcentrationRiskPercentage1", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.shapeways.com/role/SignificantConcentrationsDetails" ], "xbrltype": "percentItemType" }, "us-gaap_ConcentrationRiskTable": { "auth_ref": [ "r172", "r174", "r175", "r176", "r478", "r480", "r644" ], "lang": { "en-us": { "role": { "documentation": "Describes the nature of a concentration, a benchmark to which it is compared, and the percentage that the risk is to the benchmark.", "label": "Concentration Risk [Table]" } } }, "localname": "ConcentrationRiskTable", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.shapeways.com/role/SignificantConcentrationsDetails" ], "xbrltype": "stringItemType" }, "us-gaap_ConcentrationRiskTypeDomain": { "auth_ref": [ "r174", "r175", "r206", "r478", "r479", "r644" ], "lang": { "en-us": { "role": { "documentation": "For an entity that discloses a concentration risk as a percentage of some financial balance or benchmark, identifies the type (for example, asset, liability, net assets, geographic, customer, employees, supplier, lender) of the concentration.", "label": "Concentration Risk Type [Domain]" } } }, "localname": "ConcentrationRiskTypeDomain", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.shapeways.com/role/SignificantConcentrationsDetails" ], "xbrltype": "domainItemType" }, "us-gaap_ContractWithCustomerAssetAndLiabilityTableTextBlock": { "auth_ref": [ "r350" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of receivable, contract asset, and contract liability from contract with customer. Includes, but is not limited to, change in contract asset and contract liability.", "label": "Contract with Customer, Contract Asset, Contract Liability, and Receivable [Table Text Block]", "terseLabel": "Summary of deferred revenue activity" } } }, "localname": "ContractWithCustomerAssetAndLiabilityTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.shapeways.com/role/RevenueRecognitionTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ContractWithCustomerLiability": { "auth_ref": [ "r348", "r349", "r361" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of obligation to transfer good or service to customer for which consideration has been received or is receivable.", "label": "Contract with Customer, Liability", "periodEndLabel": "Deferred revenue at end of period", "periodStartLabel": "Deferred revenue at beginning of period" } } }, "localname": "ContractWithCustomerLiability", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.shapeways.com/role/RevenueRecognitionDeferredRevenuesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_ContractWithCustomerLiabilityRevenueRecognized": { "auth_ref": [ "r362" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of revenue recognized that was previously included in balance of obligation to transfer good or service to customer for which consideration from customer has been received or is due.", "label": "Contract with Customer, Liability, Revenue Recognized", "terseLabel": "Deferred revenue recognized" } } }, "localname": "ContractWithCustomerLiabilityRevenueRecognized", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.shapeways.com/role/RevenueRecognitionDeferredRevenuesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_ConversionOfStockSharesIssued1": { "auth_ref": [ "r113", "r114", "r115" ], "lang": { "en-us": { "role": { "documentation": "The number of new shares issued in the conversion of stock in a noncash (or part noncash) transaction. Noncash is defined as transactions during a period that do not result in cash receipts or cash payments in the period. \"Part noncash\" refers to that portion of the transaction not resulting in cash receipts or cash payments in the period.", "label": "Conversion of Stock, Shares Issued", "terseLabel": "Conversion of stock shares issued" } } }, "localname": "ConversionOfStockSharesIssued1", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.shapeways.com/role/ReverseRecapitalizationDetails" ], "xbrltype": "sharesItemType" }, "us-gaap_ConvertibleNotesPayableMember": { "auth_ref": [ "r23", "r580", "r592", "r628" ], "lang": { "en-us": { "role": { "documentation": "Written promise to pay a note which can be exchanged for a specified quantity of securities (typically common stock), at the option of the issuer or the holder.", "label": "Convertible Notes Payable [Member]", "verboseLabel": "Convertible Promissory Notes" } } }, "localname": "ConvertibleNotesPayableMember", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.shapeways.com/role/BorrowingArrangementsConvertiblePromissoryNotesDetails", "http://www.shapeways.com/role/BorrowingArrangementsOutstandingDebtObligationsDetails" ], "xbrltype": "domainItemType" }, "us-gaap_ConvertiblePreferredStockSharesIssuedUponConversion": { "auth_ref": [ "r26", "r27", "r332", "r338", "r341" ], "lang": { "en-us": { "role": { "documentation": "Number of shares issued for each share of convertible preferred stock that is converted.", "label": "Convertible Preferred Stock, Shares Issued upon Conversion", "terseLabel": "Preferred stock converted in to aggregate number of shares of common stock" } } }, "localname": "ConvertiblePreferredStockSharesIssuedUponConversion", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.shapeways.com/role/StockholdersEquityDeficitDetails" ], "xbrltype": "sharesItemType" }, "us-gaap_CostOfGoodsAndServicesSoldDepreciation": { "auth_ref": [ "r88", "r252" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of expense for allocation of cost of tangible asset over its useful life directly used in production of good and rendering of service.", "label": "Cost, Depreciation", "terseLabel": "Depreciation charged to cost of revenue" } } }, "localname": "CostOfGoodsAndServicesSoldDepreciation", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.shapeways.com/role/PropertyAndEquipmentNetDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_CostOfGoodsTotalMember": { "auth_ref": [ "r174" ], "lang": { "en-us": { "role": { "documentation": "Cost of product sold and service rendered, when it serves as benchmark in concentration of risk calculation.", "label": "Cost of Goods and Service Benchmark [Member]" } } }, "localname": "CostOfGoodsTotalMember", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.shapeways.com/role/SignificantConcentrationsDetails" ], "xbrltype": "domainItemType" }, "us-gaap_CostOfRevenue": { "auth_ref": [ "r90", "r125", "r224", "r267", "r268", "r269", "r272", "r273", "r274", "r275", "r276", "r278", "r279", "r481" ], "calculation": { "http://www.shapeways.com/role/CondensedConsolidatedStatementsOfOperationsAndComprehensiveLoss": { "order": 7.0, "parentTag": "us-gaap_GrossProfit", "weight": -1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The aggregate cost of goods produced and sold and services rendered during the reporting period.", "label": "Cost of Revenue", "terseLabel": "Cost of revenue" } } }, "localname": "CostOfRevenue", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.shapeways.com/role/CondensedConsolidatedStatementsOfOperationsAndComprehensiveLoss" ], "xbrltype": "monetaryItemType" }, "us-gaap_CustomerConcentrationRiskMember": { "auth_ref": [ "r173", "r206" ], "lang": { "en-us": { "role": { "documentation": "Reflects the percentage that revenues in the period from one or more significant customers is to net revenues, as defined by the entity, such as total net revenues, product line revenues, segment revenues. The risk is the materially adverse effects of loss of a significant customer.", "label": "Customer Concentration Risk [Member]" } } }, "localname": "CustomerConcentrationRiskMember", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.shapeways.com/role/SignificantConcentrationsDetails" ], "xbrltype": "domainItemType" }, "us-gaap_DebtConversionConvertedInstrumentAmount1": { "auth_ref": [ "r113", "r115" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The value of the financial instrument(s) that the original debt is being converted into in a noncash (or part noncash) transaction. \"Part noncash\" refers to that portion of the transaction not resulting in cash receipts or cash payments in the period.", "label": "Debt Conversion, Converted Instrument, Amount", "terseLabel": "Debt conversion convertible instrument amount", "verboseLabel": "Debt conversion convertible instrument amount" } } }, "localname": "DebtConversionConvertedInstrumentAmount1", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.shapeways.com/role/BorrowingArrangementsConvertiblePromissoryNotesDetails", "http://www.shapeways.com/role/FairValueMeasurementsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DebtConversionConvertedInstrumentSharesIssued1": { "auth_ref": [ "r113", "r115" ], "lang": { "en-us": { "role": { "documentation": "The number of shares issued in exchange for the original debt being converted in a noncash (or part noncash) transaction. \"Part noncash\" refers to that portion of the transaction not resulting in cash receipts or payments in the period.", "label": "Debt Conversion, Converted Instrument, Shares Issued", "terseLabel": "Debt conversion converted instrument shares issued" } } }, "localname": "DebtConversionConvertedInstrumentSharesIssued1", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.shapeways.com/role/BorrowingArrangementsConvertiblePromissoryNotesDetails" ], "xbrltype": "sharesItemType" }, "us-gaap_DebtConversionConvertedInstrumentWarrantsOrOptionsIssued1": { "auth_ref": [ "r113", "r115" ], "lang": { "en-us": { "role": { "documentation": "The number of warrants issued in exchange for the original debt being converted in a noncash (or part noncash) transaction. \"Part noncash\" refers to that portion of the transaction not resulting in cash receipts or cash payments in the period.", "label": "Debt Conversion, Converted Instrument, Warrants or Options Issued", "terseLabel": "Convesrion of promissory note, warrants issued", "verboseLabel": "Debt conversion converted instrument warrants issued" } } }, "localname": "DebtConversionConvertedInstrumentWarrantsOrOptionsIssued1", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.shapeways.com/role/FairValueMeasurementsDetails", "http://www.shapeways.com/role/SummaryOfSignificantAccountingPoliciesDetails" ], "xbrltype": "sharesItemType" }, "us-gaap_DebtDisclosureAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Debt Disclosure [Abstract]", "terseLabel": "PPP Loan" } } }, "localname": "DebtDisclosureAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "xbrltype": "stringItemType" }, "us-gaap_DebtDisclosureTextBlock": { "auth_ref": [ "r121", "r286", "r287", "r288", "r289", "r290", "r291", "r292", "r297", "r304", "r305", "r307", "r314" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for information about short-term and long-term debt arrangements, which includes amounts of borrowings under each line of credit, note payable, commercial paper issue, bonds indenture, debenture issue, own-share lending arrangements and any other contractual agreement to repay funds, and about the underlying arrangements, rationale for a classification as long-term, including repayment terms, interest rates, collateral provided, restrictions on use of assets and activities, whether or not in compliance with debt covenants, and other matters important to users of the financial statements, such as the effects of refinancing and noncompliance with debt covenants.", "label": "Debt Disclosure [Text Block]", "terseLabel": "Borrowing Arrangements" } } }, "localname": "DebtDisclosureTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.shapeways.com/role/BorrowingArrangements" ], "xbrltype": "textBlockItemType" }, "us-gaap_DebtInstrumentAxis": { "auth_ref": [ "r23", "r24", "r25", "r124", "r128", "r280", "r281", "r282", "r283", "r284", "r285", "r287", "r293", "r294", "r295", "r296", "r298", "r299", "r300", "r301", "r302", "r303", "r310", "r311", "r312", "r313", "r495", "r580", "r581", "r592" ], "lang": { "en-us": { "role": { "documentation": "Information by type of debt instrument, including, but not limited to, draws against credit facilities.", "label": "Debt Instrument [Axis]" } } }, "localname": "DebtInstrumentAxis", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.shapeways.com/role/FairValueMeasurementsDetails" ], "xbrltype": "stringItemType" }, "us-gaap_DebtInstrumentBasisSpreadOnVariableRate1": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Percentage points added to the reference rate to compute the variable rate on the debt instrument.", "label": "Debt Instrument, Basis Spread on Variable Rate", "terseLabel": "Spread on variable rate" } } }, "localname": "DebtInstrumentBasisSpreadOnVariableRate1", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.shapeways.com/role/BorrowingArrangementsTermLoanDetails" ], "xbrltype": "percentItemType" }, "us-gaap_DebtInstrumentDecreaseForgiveness": { "auth_ref": [ "r124" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Decrease for amounts of indebtedness forgiven by the holder of the debt instrument.", "label": "Debt Instrument, Decrease, Forgiveness", "terseLabel": "Principal and interest amount of loan forgiven" } } }, "localname": "DebtInstrumentDecreaseForgiveness", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.shapeways.com/role/BorrowingArrangementsPaycheckProtectionProgramLoanDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DebtInstrumentFaceAmount": { "auth_ref": [ "r280", "r310", "r311", "r493", "r495", "r496" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Face (par) amount of debt instrument at time of issuance.", "label": "Debt Instrument, Face Amount", "terseLabel": "Debt instrument face amount", "verboseLabel": "Aggregate principal amount" } } }, "localname": "DebtInstrumentFaceAmount", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.shapeways.com/role/BorrowingArrangementsConvertiblePromissoryNotesDetails", "http://www.shapeways.com/role/BorrowingArrangementsDutchLandlordLoanDetails", "http://www.shapeways.com/role/BorrowingArrangementsTermLoanDetails", "http://www.shapeways.com/role/RelatedPartyTransactionsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DebtInstrumentFeeAmount": { "auth_ref": [ "r59" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of the fee that accompanies borrowing money under the debt instrument.", "label": "Debt Instrument, Fee Amount", "verboseLabel": "Fee in the event of liquidity event" } } }, "localname": "DebtInstrumentFeeAmount", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.shapeways.com/role/BorrowingArrangementsTermLoanDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DebtInstrumentInterestRateStatedPercentage": { "auth_ref": [ "r57", "r281" ], "lang": { "en-us": { "role": { "documentation": "Contractual interest rate for funds borrowed, under the debt agreement.", "label": "Debt Instrument, Interest Rate, Stated Percentage", "terseLabel": "Debt instrument interest rate stated percentage", "verboseLabel": "Interest rate" } } }, "localname": "DebtInstrumentInterestRateStatedPercentage", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.shapeways.com/role/BorrowingArrangementsConvertiblePromissoryNotesDetails", "http://www.shapeways.com/role/BorrowingArrangementsDutchLandlordLoanDetails", "http://www.shapeways.com/role/BorrowingArrangementsTermLoanDetails", "http://www.shapeways.com/role/RelatedPartyTransactionsDetails" ], "xbrltype": "percentItemType" }, "us-gaap_DebtInstrumentLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Debt Instrument [Line Items]" } } }, "localname": "DebtInstrumentLineItems", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.shapeways.com/role/BorrowingArrangementsConvertiblePromissoryNotesDetails", "http://www.shapeways.com/role/BorrowingArrangementsDutchLandlordLoanDetails", "http://www.shapeways.com/role/BorrowingArrangementsOutstandingDebtObligationsDetails", "http://www.shapeways.com/role/BorrowingArrangementsPaycheckProtectionProgramLoanDetails", "http://www.shapeways.com/role/BorrowingArrangementsTermLoanDetails" ], "xbrltype": "stringItemType" }, "us-gaap_DebtInstrumentMaturityDate": { "auth_ref": [ "r58", "r283", "r469" ], "lang": { "en-us": { "role": { "documentation": "Date when the debt instrument is scheduled to be fully repaid, in YYYY-MM-DD format.", "label": "Debt Instrument, Maturity Date", "terseLabel": "Debt instrument maturity date" } } }, "localname": "DebtInstrumentMaturityDate", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.shapeways.com/role/RelatedPartyTransactionsDetails" ], "xbrltype": "dateItemType" }, "us-gaap_DebtInstrumentNameDomain": { "auth_ref": [ "r60", "r124", "r128", "r280", "r281", "r282", "r283", "r284", "r285", "r287", "r293", "r294", "r295", "r296", "r298", "r299", "r300", "r301", "r302", "r303", "r310", "r311", "r312", "r313", "r495" ], "lang": { "en-us": { "role": { "documentation": "The name for the particular debt instrument or borrowing that distinguishes it from other debt instruments or borrowings, including draws against credit facilities.", "label": "Debt Instrument, Name [Domain]" } } }, "localname": "DebtInstrumentNameDomain", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.shapeways.com/role/FairValueMeasurementsDetails" ], "xbrltype": "domainItemType" }, "us-gaap_DebtInstrumentTable": { "auth_ref": [ "r60", "r124", "r128", "r280", "r281", "r282", "r283", "r284", "r285", "r287", "r293", "r294", "r295", "r296", "r298", "r299", "r300", "r301", "r302", "r303", "r306", "r310", "r311", "r312", "r313", "r338", "r342", "r343", "r344", "r492", "r493", "r495", "r496", "r591" ], "lang": { "en-us": { "role": { "documentation": "A table or schedule providing information pertaining to long-term debt instruments or arrangements, including identification, terms, features, collateral requirements and other information necessary to a fair presentation. These are debt arrangements that originally required repayment more than twelve months after issuance or greater than the normal operating cycle of the company, if longer.", "label": "Schedule of Long-term Debt Instruments [Table]" } } }, "localname": "DebtInstrumentTable", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.shapeways.com/role/BorrowingArrangementsConvertiblePromissoryNotesDetails", "http://www.shapeways.com/role/BorrowingArrangementsDutchLandlordLoanDetails", "http://www.shapeways.com/role/BorrowingArrangementsOutstandingDebtObligationsDetails", "http://www.shapeways.com/role/BorrowingArrangementsPaycheckProtectionProgramLoanDetails", "http://www.shapeways.com/role/BorrowingArrangementsTermLoanDetails" ], "xbrltype": "stringItemType" }, "us-gaap_DebtWeightedAverageInterestRate": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Weighted average interest rate of debt outstanding.", "label": "Debt, Weighted Average Interest Rate", "terseLabel": "Debt weighted average interest rate" } } }, "localname": "DebtWeightedAverageInterestRate", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.shapeways.com/role/RelatedPartyTransactionsDetails" ], "xbrltype": "percentItemType" }, "us-gaap_DeferredCostsCapitalizedPrepaidAndOtherAssetsDisclosureTextBlock": { "auth_ref": [ "r50" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of the amounts paid in advance for capitalized costs that will be expensed with the passage of time or the occurrence of a triggering event, and will be charged against earnings within one year or the normal operating cycle, if longer; the aggregate carrying amount of current assets, not separately presented elsewhere in the balance sheet; and other deferred costs.", "label": "Deferred Costs, Capitalized, Prepaid, and Other Assets Disclosure [Table Text Block]", "terseLabel": "Summary of prepaid expenses and other current assets" } } }, "localname": "DeferredCostsCapitalizedPrepaidAndOtherAssetsDisclosureTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.shapeways.com/role/PrepaidExpensesAndOtherCurrentAssetsTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_DeferredRevenueCurrent": { "auth_ref": [ "r37" ], "calculation": { "http://www.shapeways.com/role/CondensedConsolidatedBalanceSheets": { "order": 24.0, "parentTag": "us-gaap_LiabilitiesCurrent", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of deferred income and obligation to transfer product and service to customer for which consideration has been received or is receivable, classified as current.", "label": "Deferred Revenue, Current", "terseLabel": "Deferred revenue" } } }, "localname": "DeferredRevenueCurrent", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.shapeways.com/role/CondensedConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_DepositsAssetsCurrent": { "auth_ref": [ "r50" ], "calculation": { "http://www.shapeways.com/role/PrepaidExpensesAndOtherCurrentAssetsDetails": { "order": 2.0, "parentTag": "us-gaap_PrepaidExpenseAndOtherAssetsCurrent", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Carrying value of amounts transferred to third parties for security purposes that are expected to be returned or applied towards payment within one year or during the operating cycle, if shorter.", "label": "Deposits Assets, Current", "terseLabel": "Security deposits" } } }, "localname": "DepositsAssetsCurrent", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.shapeways.com/role/PrepaidExpensesAndOtherCurrentAssetsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DepositsAssetsNoncurrent": { "auth_ref": [ "r50" ], "calculation": { "http://www.shapeways.com/role/CondensedConsolidatedBalanceSheets": { "order": 11.0, "parentTag": "us-gaap_Assets", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Carrying value of amounts transferred to third parties for security purposes that are expected to be returned or applied towards payment after one year or beyond the operating cycle, if longer.", "label": "Deposits Assets, Noncurrent", "terseLabel": "Security deposits" } } }, "localname": "DepositsAssetsNoncurrent", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.shapeways.com/role/CondensedConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_Depreciation": { "auth_ref": [ "r108", "r252" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The amount of expense recognized in the current period that reflects the allocation of the cost of tangible assets over the assets' useful lives. Includes production and non-production related depreciation.", "label": "Depreciation", "verboseLabel": "Depreciation expense" } } }, "localname": "Depreciation", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.shapeways.com/role/PropertyAndEquipmentNetDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DepreciationAndAmortization": { "auth_ref": [ "r108", "r252" ], "calculation": { "http://www.shapeways.com/role/CondensedConsolidatedStatementsOfOperationsAndComprehensiveLoss": { "order": 4.0, "parentTag": "us-gaap_OperatingExpenses", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The current period expense charged against earnings on long-lived, physical assets not used in production, and which are not intended for resale, to allocate or recognize the cost of such assets over their useful lives; or to record the reduction in book value of an intangible asset over the benefit period of such asset; or to reflect consumption during the period of an asset that is not used in production.", "label": "Depreciation, Depletion and Amortization, Nonproduction", "terseLabel": "Amortization and depreciation" } } }, "localname": "DepreciationAndAmortization", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.shapeways.com/role/CondensedConsolidatedStatementsOfOperationsAndComprehensiveLoss" ], "xbrltype": "monetaryItemType" }, "us-gaap_DepreciationDepletionAndAmortization": { "auth_ref": [ "r108", "r185" ], "calculation": { "http://www.shapeways.com/role/CondensedConsolidatedStatementsOfCashFlows": { "order": 6.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The aggregate expense recognized in the current period that allocates the cost of tangible assets, intangible assets, or depleting assets to periods that benefit from use of the assets.", "label": "Depreciation, Depletion and Amortization", "verboseLabel": "Depreciation and amortization" } } }, "localname": "DepreciationDepletionAndAmortization", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.shapeways.com/role/CondensedConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_DisaggregationOfRevenueAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Disaggregation of Revenue [Abstract]" } } }, "localname": "DisaggregationOfRevenueAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "xbrltype": "stringItemType" }, "us-gaap_DisaggregationOfRevenueLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Disaggregation of Revenue [Line Items]" } } }, "localname": "DisaggregationOfRevenueLineItems", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.shapeways.com/role/RevenueRecognitionDisaggregationOfRevenuesDetails", "http://www.shapeways.com/role/RevenueRecognitionMarketplaceSalesDetails" ], "xbrltype": "stringItemType" }, "us-gaap_DisaggregationOfRevenueTable": { "auth_ref": [ "r360", "r364", "r365", "r366", "r367", "r368", "r369", "r370" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of information about disaggregation of revenue into categories depicting how nature, amount, timing, and uncertainty of revenue and cash flows are affected by economic factor.", "label": "Disaggregation of Revenue [Table]" } } }, "localname": "DisaggregationOfRevenueTable", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.shapeways.com/role/RevenueRecognitionDisaggregationOfRevenuesDetails", "http://www.shapeways.com/role/RevenueRecognitionMarketplaceSalesDetails" ], "xbrltype": "stringItemType" }, "us-gaap_DisaggregationOfRevenueTableTextBlock": { "auth_ref": [ "r360" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of disaggregation of revenue into categories depicting how nature, amount, timing, and uncertainty of revenue and cash flows are affected by economic factor.", "label": "Disaggregation of Revenue [Table Text Block]", "terseLabel": "Summary of amount disaggregated by revenue" } } }, "localname": "DisaggregationOfRevenueTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.shapeways.com/role/RevenueRecognitionTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock": { "auth_ref": [ "r417" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for share-based payment arrangement.", "label": "Share-based Payment Arrangement [Text Block]", "terseLabel": "Stock-Based Compensation" } } }, "localname": "DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.shapeways.com/role/StockBasedCompensation" ], "xbrltype": "textBlockItemType" }, "us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Share-based Payment Arrangement [Abstract]" } } }, "localname": "DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "xbrltype": "stringItemType" }, "us-gaap_DueFromRelatedPartiesCurrent": { "auth_ref": [ "r8", "r20", "r29", "r127", "r270", "r272", "r273", "r277", "r278", "r279", "r517" ], "calculation": { "http://www.shapeways.com/role/CondensedConsolidatedBalanceSheets": { "order": 6.0, "parentTag": "us-gaap_AssetsCurrent", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The aggregate amount of receivables to be collected from related parties where one party can exercise control or significant influence over another party; including affiliates, owners or officers and their immediate families, pension trusts, and so forth, at the financial statement date. which are usually due within one year (or one business cycle).", "label": "Due from Related Parties, Current", "terseLabel": "Promissory note due from related party" } } }, "localname": "DueFromRelatedPartiesCurrent", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.shapeways.com/role/CondensedConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_EarningsPerShareAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Earnings Per Share [Abstract]", "terseLabel": "Net income (loss) per share:" } } }, "localname": "EarningsPerShareAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.shapeways.com/role/CondensedConsolidatedStatementsOfOperationsAndComprehensiveLoss" ], "xbrltype": "stringItemType" }, "us-gaap_EarningsPerShareBasic": { "auth_ref": [ "r87", "r136", "r137", "r139", "r140", "r141", "r147", "r150", "r155", "r156", "r157", "r161", "r162", "r462", "r463", "r587", "r603" ], "lang": { "en-us": { "role": { "documentation": "The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period.", "label": "Earnings Per Share, Basic", "terseLabel": "Basic" } } }, "localname": "EarningsPerShareBasic", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.shapeways.com/role/CondensedConsolidatedStatementsOfOperationsAndComprehensiveLoss" ], "xbrltype": "perShareItemType" }, "us-gaap_EarningsPerShareDiluted": { "auth_ref": [ "r87", "r136", "r137", "r139", "r140", "r141", "r150", "r155", "r156", "r157", "r161", "r162", "r462", "r463", "r587", "r603" ], "lang": { "en-us": { "role": { "documentation": "The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.", "label": "Earnings Per Share, Diluted", "terseLabel": "Diluted" } } }, "localname": "EarningsPerShareDiluted", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.shapeways.com/role/CondensedConsolidatedStatementsOfOperationsAndComprehensiveLoss" ], "xbrltype": "perShareItemType" }, "us-gaap_EarningsPerSharePolicyTextBlock": { "auth_ref": [ "r159", "r160" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for computing basic and diluted earnings or loss per share for each class of common stock and participating security. Addresses all significant policy factors, including any antidilutive items that have been excluded from the computation and takes into account stock dividends, splits and reverse splits that occur after the balance sheet date of the latest reporting period but before the issuance of the financial statements.", "label": "Earnings Per Share, Policy [Policy Text Block]", "verboseLabel": "Income (Loss) per Share" } } }, "localname": "EarningsPerSharePolicyTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.shapeways.com/role/SummaryOfSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents": { "auth_ref": [ "r482" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of increase (decrease) from effect of exchange rate changes on cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; held in foreign currencies. Excludes amounts for disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.", "label": "Effect of Exchange Rate on Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents", "terseLabel": "Effect of change in foreign currency exchange rates on cash and cash equivalents and restricted cash" } } }, "localname": "EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.shapeways.com/role/CondensedConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_EffectiveIncomeTaxRateContinuingOperations": { "auth_ref": [ "r424" ], "lang": { "en-us": { "role": { "documentation": "Percentage of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.", "label": "Effective Income Tax Rate Reconciliation, Percent", "terseLabel": "Effective income tax reconciliation rate" } } }, "localname": "EffectiveIncomeTaxRateContinuingOperations", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.shapeways.com/role/SummaryOfSignificantAccountingPoliciesDetails" ], "xbrltype": "percentItemType" }, "us-gaap_EmployeeServiceShareBasedCompensationAggregateDisclosuresAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Share-based Payment Arrangement, Additional Disclosure [Abstract]" } } }, "localname": "EmployeeServiceShareBasedCompensationAggregateDisclosuresAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "xbrltype": "stringItemType" }, "us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Share-based Payment Arrangement, Expensed and Capitalized, Amount [Line Items]" } } }, "localname": "EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.shapeways.com/role/StockBasedCompensationDetails" ], "xbrltype": "stringItemType" }, "us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1": { "auth_ref": [ "r409" ], "lang": { "en-us": { "role": { "documentation": "Weighted-average period over which cost not yet recognized is expected to be recognized for award under share-based payment arrangement, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.", "label": "Share-based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Period for Recognition", "terseLabel": "Unrecognized compensation expense expected to be recognized over the weighted average period" } } }, "localname": "EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.shapeways.com/role/StockBasedCompensationDetails" ], "xbrltype": "durationItemType" }, "us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions": { "auth_ref": [ "r409" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of cost to be recognized for option under share-based payment arrangement.", "label": "Share-based Payment Arrangement, Nonvested Award, Option, Cost Not yet Recognized, Amount", "terseLabel": "Unrecognized compensation expense" } } }, "localname": "EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.shapeways.com/role/StockBasedCompensationDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_EquityAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Equity [Abstract]" } } }, "localname": "EquityAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "xbrltype": "stringItemType" }, "us-gaap_EquityComponentDomain": { "auth_ref": [ "r0", "r79", "r80", "r81", "r130", "r131", "r132", "r135", "r142", "r145", "r164", "r225", "r337", "r345", "r411", "r412", "r413", "r429", "r430", "r461", "r483", "r484", "r485", "r486", "r487", "r488", "r616", "r617", "r618", "r668" ], "lang": { "en-us": { "role": { "documentation": "Components of equity are the parts of the total Equity balance including that which is allocated to common, preferred, treasury stock, retained earnings, etc.", "label": "Equity Component [Domain]", "terseLabel": "Equity Component [Domain]" } } }, "localname": "EquityComponentDomain", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.shapeways.com/role/BorrowingArrangementsConvertiblePromissoryNotesDetails", "http://www.shapeways.com/role/CondensedConsolidatedStatementsOfChangesInStockholdersEquityDeficit", "http://www.shapeways.com/role/CoverPage", "http://www.shapeways.com/role/FairValueMeasurementsDetails", "http://www.shapeways.com/role/RelatedPartyTransactionsDetails", "http://www.shapeways.com/role/ReverseRecapitalizationDetails", "http://www.shapeways.com/role/ReverseRecapitalizationScheduleOfCommonStockSharesIssuedFollowingTheConsummationOfBusinessCombinationDetails", "http://www.shapeways.com/role/StockholdersEquityDeficitDetails" ], "xbrltype": "domainItemType" }, "us-gaap_FairValueAdjustmentOfWarrants": { "auth_ref": [ "r108", "r315" ], "calculation": { "http://www.shapeways.com/role/CondensedConsolidatedStatementsOfCashFlows": { "order": 5.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 }, "http://www.shapeways.com/role/CondensedConsolidatedStatementsOfOperationsAndComprehensiveLoss": { "order": 10.0, "parentTag": "us-gaap_NonoperatingIncomeExpense", "weight": -1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of expense (income) related to adjustment to fair value of warrant liability.", "label": "Fair Value Adjustment of Warrants", "negatedLabel": "Change in fair value of warrant liabilities", "terseLabel": "Change in fair value of warrant liabilities" } } }, "localname": "FairValueAdjustmentOfWarrants", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.shapeways.com/role/CondensedConsolidatedStatementsOfCashFlows", "http://www.shapeways.com/role/CondensedConsolidatedStatementsOfOperationsAndComprehensiveLoss" ], "xbrltype": "monetaryItemType" }, "us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTableTextBlock": { "auth_ref": [ "r464", "r465", "r466", "r473", "r474" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of financial instruments measured at fair value, including those classified in shareholders' equity measured on a recurring or nonrecurring basis. Disclosures include, but are not limited to, fair value measurements recorded and the reasons for the measurements, level within the fair value hierarchy in which the fair value measurements are categorized and transfers between levels 1 and 2. Nonrecurring fair value measurements are those that are required or permitted in the statement of financial position in particular circumstances.", "label": "Fair Value Measurements, Recurring and Nonrecurring [Table Text Block]", "verboseLabel": "Schedule of assets and liabilities that are measured at fair value on a recurring basis" } } }, "localname": "FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.shapeways.com/role/FairValueMeasurementsTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Fair Value Measurement Inputs and Valuation Techniques [Line Items]" } } }, "localname": "FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.shapeways.com/role/FairValueMeasurementsInitialMeasurementDetails", "http://www.shapeways.com/role/FairValueMeasurementsSubsequentMeasurementDetails" ], "xbrltype": "stringItemType" }, "us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTable": { "auth_ref": [ "r467" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of information about input and valuation technique used to measure fair value and change in valuation approach and technique for each separate class of asset and liability measured on recurring and nonrecurring basis.", "label": "Fair Value Measurement Inputs and Valuation Techniques [Table]" } } }, "localname": "FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTable", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.shapeways.com/role/FairValueMeasurementsInitialMeasurementDetails", "http://www.shapeways.com/role/FairValueMeasurementsSubsequentMeasurementDetails" ], "xbrltype": "stringItemType" }, "us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock": { "auth_ref": [ "r467" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of input and valuation technique used to measure fair value and change in valuation approach and technique for each separate class of asset and liability measured on recurring and nonrecurring basis.", "label": "Fair Value Measurement Inputs and Valuation Techniques [Table Text Block]", "verboseLabel": "Schedule of key inputs" } } }, "localname": "FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.shapeways.com/role/FairValueMeasurementsTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_FairValueByFairValueHierarchyLevelAxis": { "auth_ref": [ "r295", "r310", "r311", "r373", "r374", "r375", "r376", "r377", "r378", "r379", "r381", "r465", "r533", "r534", "r535" ], "lang": { "en-us": { "role": { "documentation": "Information by level within fair value hierarchy and fair value measured at net asset value per share as practical expedient.", "label": "Fair Value Hierarchy and NAV [Axis]" } } }, "localname": "FairValueByFairValueHierarchyLevelAxis", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.shapeways.com/role/FairValueMeasurementsDetails", "http://www.shapeways.com/role/FairValueMeasurementsInitialMeasurementDetails", "http://www.shapeways.com/role/FairValueMeasurementsSubsequentMeasurementDetails" ], "xbrltype": "stringItemType" }, "us-gaap_FairValueByLiabilityClassAxis": { "auth_ref": [ "r472", "r474" ], "lang": { "en-us": { "role": { "documentation": "Information by class of liability.", "label": "Liability Class [Axis]" } } }, "localname": "FairValueByLiabilityClassAxis", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.shapeways.com/role/ReverseRecapitalizationScheduleOfReconcilesTheElementsOfBusinessCombinationToTheUnauditedConsolidatedStatementOfChangesInStockholdersEquityDetails" ], "xbrltype": "stringItemType" }, "us-gaap_FairValueByMeasurementFrequencyAxis": { "auth_ref": [ "r464", "r465", "r468", "r469", "r475" ], "lang": { "en-us": { "role": { "documentation": "Information by measurement frequency.", "label": "Measurement Frequency [Axis]" } } }, "localname": "FairValueByMeasurementFrequencyAxis", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.shapeways.com/role/FairValueMeasurementsDetails" ], "xbrltype": "stringItemType" }, "us-gaap_FairValueDisclosuresAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Fair Value Disclosures [Abstract]" } } }, "localname": "FairValueDisclosuresAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "xbrltype": "stringItemType" }, "us-gaap_FairValueDisclosuresTextBlock": { "auth_ref": [ "r472" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for the fair value of financial instruments (as defined), including financial assets and financial liabilities (collectively, as defined), and the measurements of those instruments as well as disclosures related to the fair value of non-financial assets and liabilities. Such disclosures about the financial instruments, assets, and liabilities would include: (1) the fair value of the required items together with their carrying amounts (as appropriate); (2) for items for which it is not practicable to estimate fair value, disclosure would include: (a) information pertinent to estimating fair value (including, carrying amount, effective interest rate, and maturity, and (b) the reasons why it is not practicable to estimate fair value; (3) significant concentrations of credit risk including: (a) information about the activity, region, or economic characteristics identifying a concentration, (b) the maximum amount of loss the entity is exposed to based on the gross fair value of the related item, (c) policy for requiring collateral or other security and information as to accessing such collateral or security, and (d) the nature and brief description of such collateral or security; (4) quantitative information about market risks and how such risks are managed; (5) for items measured on both a recurring and nonrecurring basis information regarding the inputs used to develop the fair value measurement; and (6) for items presented in the financial statement for which fair value measurement is elected: (a) information necessary to understand the reasons for the election, (b) discussion of the effect of fair value changes on earnings, (c) a description of [similar groups] items for which the election is made and the relation thereof to the balance sheet, the aggregate carrying value of items included in the balance sheet that are not eligible for the election; (7) all other required (as defined) and desired information.", "label": "Fair Value Disclosures [Text Block]", "terseLabel": "Fair Value Measurements" } } }, "localname": "FairValueDisclosuresTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.shapeways.com/role/FairValueMeasurements" ], "xbrltype": "textBlockItemType" }, "us-gaap_FairValueInputsLevel3Member": { "auth_ref": [ "r295", "r310", "r311", "r373", "r374", "r375", "r376", "r377", "r378", "r379", "r381", "r465", "r535" ], "lang": { "en-us": { "role": { "documentation": "Unobservable inputs that reflect the entity's own assumption about the assumptions market participants would use in pricing.", "label": "Fair Value, Inputs, Level 3 [Member]", "terseLabel": "Level 3" } } }, "localname": "FairValueInputsLevel3Member", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.shapeways.com/role/FairValueMeasurementsDetails", "http://www.shapeways.com/role/FairValueMeasurementsInitialMeasurementDetails", "http://www.shapeways.com/role/FairValueMeasurementsSubsequentMeasurementDetails" ], "xbrltype": "domainItemType" }, "us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain": { "auth_ref": [ "r470" ], "lang": { "en-us": { "role": { "documentation": "Represents classes of liabilities measured and disclosed at fair value.", "label": "Fair Value by Liability Class [Domain]" } } }, "localname": "FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.shapeways.com/role/ReverseRecapitalizationScheduleOfReconcilesTheElementsOfBusinessCombinationToTheUnauditedConsolidatedStatementOfChangesInStockholdersEquityDetails" ], "xbrltype": "domainItemType" }, "us-gaap_FairValueMeasurementFrequencyDomain": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Measurement frequency.", "label": "Measurement Frequency [Domain]", "terseLabel": "Measurement Frequency [Domain]" } } }, "localname": "FairValueMeasurementFrequencyDomain", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.shapeways.com/role/FairValueMeasurementsDetails" ], "xbrltype": "domainItemType" }, "us-gaap_FairValueMeasurementsFairValueHierarchyDomain": { "auth_ref": [ "r295", "r310", "r311", "r373", "r374", "r375", "r376", "r377", "r378", "r379", "r381", "r533", "r534", "r535" ], "lang": { "en-us": { "role": { "documentation": "Categories used to prioritize the inputs to valuation techniques to measure fair value.", "label": "Fair Value Hierarchy and NAV [Domain]", "terseLabel": "Fair Value Hierarchy and NAV [Domain]" } } }, "localname": "FairValueMeasurementsFairValueHierarchyDomain", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.shapeways.com/role/FairValueMeasurementsDetails", "http://www.shapeways.com/role/FairValueMeasurementsInitialMeasurementDetails", "http://www.shapeways.com/role/FairValueMeasurementsSubsequentMeasurementDetails" ], "xbrltype": "domainItemType" }, "us-gaap_FairValueMeasurementsNonrecurringMember": { "auth_ref": [ "r464", "r465", "r468", "r469", "r471", "r475" ], "lang": { "en-us": { "role": { "documentation": "Infrequent fair value measurement. Includes, but is not limited to, fair value adjustment for impairment of asset, liability or equity, not frequently measured at fair value.", "label": "Fair Value, Nonrecurring [Member]", "terseLabel": "Nonrecurring" } } }, "localname": "FairValueMeasurementsNonrecurringMember", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.shapeways.com/role/FairValueMeasurementsDetails" ], "xbrltype": "domainItemType" }, "us-gaap_FairValueMeasurementsRecurringMember": { "auth_ref": [ "r472", "r475" ], "lang": { "en-us": { "role": { "documentation": "Frequent fair value measurement. Includes, but is not limited to, fair value adjustment for impairment of asset, liability or equity, frequently measured at fair value.", "label": "Fair Value, Recurring [Member]", "terseLabel": "Recurring" } } }, "localname": "FairValueMeasurementsRecurringMember", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.shapeways.com/role/FairValueMeasurementsDetails" ], "xbrltype": "domainItemType" }, "us-gaap_FairValueOfFinancialInstrumentsPolicy": { "auth_ref": [ "r476", "r477" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for determining the fair value of financial instruments.", "label": "Fair Value of Financial Instruments, Policy [Policy Text Block]", "terseLabel": "Fair Value Measurements" } } }, "localname": "FairValueOfFinancialInstrumentsPolicy", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.shapeways.com/role/SummaryOfSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_FinanceLeaseInterestExpense": { "auth_ref": [ "r499", "r504", "r513" ], "calculation": { "http://www.shapeways.com/role/CommitmentsAndContingenciesCompanysLeaseCostsDetails": { "order": 3.0, "parentTag": "us-gaap_LeaseCost", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of interest expense on finance lease liability.", "label": "Finance Lease, Interest Expense", "terseLabel": "Interest expense on finance lease liabilities" } } }, "localname": "FinanceLeaseInterestExpense", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.shapeways.com/role/CommitmentsAndContingenciesCompanysLeaseCostsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_FinanceLeaseInterestPaymentOnLiability": { "auth_ref": [ "r501", "r507" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of interest paid on finance lease liability.", "label": "Finance Lease, Interest Payment on Liability", "terseLabel": "Operating cash flows from finance leases" } } }, "localname": "FinanceLeaseInterestPaymentOnLiability", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.shapeways.com/role/CommitmentsAndContingenciesSupplementalCashFlowDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_FinanceLeasePrincipalPayments": { "auth_ref": [ "r500", "r507" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of cash outflow for principal payment on finance lease.", "label": "Finance Lease, Principal Payments", "terseLabel": "Financing cash flows from finance leases" } } }, "localname": "FinanceLeasePrincipalPayments", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.shapeways.com/role/CommitmentsAndContingenciesSupplementalCashFlowDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_FinanceLeaseRightOfUseAssetAmortization": { "auth_ref": [ "r499", "r504", "r513" ], "calculation": { "http://www.shapeways.com/role/CommitmentsAndContingenciesCompanysLeaseCostsDetails": { "order": 2.0, "parentTag": "us-gaap_LeaseCost", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of amortization expense attributable to right-of-use asset from finance lease.", "label": "Finance Lease, Right-of-Use Asset, Amortization", "terseLabel": "Finance lease expense" } } }, "localname": "FinanceLeaseRightOfUseAssetAmortization", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.shapeways.com/role/CommitmentsAndContingenciesCompanysLeaseCostsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_FinancialInstrumentAxis": { "auth_ref": [ "r218", "r219", "r221", "r222", "r223", "r228", "r229", "r230", "r231", "r232", "r233", "r234", "r235", "r236", "r306", "r335", "r457", "r530", "r531", "r532", "r533", "r534", "r535", "r536", "r537", "r538", "r539", "r540", "r541", "r542", "r543", "r544", "r545", "r546", "r547", "r548", "r549", "r550", "r551", "r552", "r553", "r554", "r555", "r556", "r557", "r558", "r559", "r657", "r658", "r659", "r660", "r661", "r662", "r663" ], "lang": { "en-us": { "role": { "documentation": "Information by type of financial instrument.", "label": "Financial Instrument [Axis]" } } }, "localname": "FinancialInstrumentAxis", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.shapeways.com/role/FairValueMeasurementsDetails" ], "xbrltype": "stringItemType" }, "us-gaap_FinancingReceivableImpairedLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Financing Receivable, Impaired [Line Items]" } } }, "localname": "FinancingReceivableImpairedLineItems", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.shapeways.com/role/SummaryOfSignificantAccountingPoliciesDetails" ], "xbrltype": "stringItemType" }, "us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock": { "auth_ref": [ "r490" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for (1) transactions denominated in a currency other than the reporting enterprise's functional currency, (2) translating foreign currency financial statements that are incorporated into the financial statements of the reporting enterprise by consolidation, combination, or the equity method of accounting, and (3) remeasurement of the financial statements of a foreign reporting enterprise in a hyperinflationary economy.", "label": "Foreign Currency Transactions and Translations Policy [Policy Text Block]", "terseLabel": "Functional Currency" } } }, "localname": "ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.shapeways.com/role/SummaryOfSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_FurnitureAndFixturesMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Equipment commonly used in offices and stores that have no permanent connection to the structure of a building or utilities. Examples include, but are not limited to, desks, chairs, tables, and bookcases.", "label": "Furniture and Fixtures [Member]", "terseLabel": "Furniture and fixtures" } } }, "localname": "FurnitureAndFixturesMember", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.shapeways.com/role/PropertyAndEquipmentNetDetails", "http://www.shapeways.com/role/SummaryOfSignificantAccountingPoliciesSummaryOfUsefulLivesOfPropertyPlantAndEquipmentDetails" ], "xbrltype": "domainItemType" }, "us-gaap_GainLossOnDispositionOfAssets1": { "auth_ref": [ "r108" ], "calculation": { "http://www.shapeways.com/role/CondensedConsolidatedStatementsOfCashFlows": { "order": 7.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": -1.0 }, "http://www.shapeways.com/role/CondensedConsolidatedStatementsOfOperationsAndComprehensiveLoss": { "order": 13.0, "parentTag": "us-gaap_NonoperatingIncomeExpense", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of gain (loss) on sale or disposal of assets, including but not limited to property plant and equipment, intangible assets and equity in securities of subsidiaries or equity method investee.", "label": "Gain (Loss) on Disposition of Assets", "negatedLabel": "Loss on disposal of assets", "terseLabel": "Loss on disposal of assets" } } }, "localname": "GainLossOnDispositionOfAssets1", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.shapeways.com/role/CondensedConsolidatedStatementsOfCashFlows", "http://www.shapeways.com/role/CondensedConsolidatedStatementsOfOperationsAndComprehensiveLoss" ], "xbrltype": "monetaryItemType" }, "us-gaap_Goodwill": { "auth_ref": [ "r244", "r246", "r525", "r578" ], "calculation": { "http://www.shapeways.com/role/CondensedConsolidatedBalanceSheets": { "order": 10.0, "parentTag": "us-gaap_Assets", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount after accumulated impairment loss of an asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.", "label": "Goodwill", "terseLabel": "Goodwill" } } }, "localname": "Goodwill", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.shapeways.com/role/CondensedConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_GoodwillAndIntangibleAssetsGoodwillPolicy": { "auth_ref": [ "r248" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for goodwill. This accounting policy also may address how an entity assesses and measures impairment of goodwill, how reporting units are determined, how goodwill is allocated to such units, and how the fair values of the reporting units are determined.", "label": "Goodwill and Intangible Assets, Goodwill, Policy [Policy Text Block]", "terseLabel": "Goodwill" } } }, "localname": "GoodwillAndIntangibleAssetsGoodwillPolicy", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.shapeways.com/role/SummaryOfSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_GoodwillAndIntangibleAssetsIntangibleAssetsIndefiniteLivedPolicy": { "auth_ref": [ "r250" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for indefinite-lived intangible assets (that is, those intangible assets not subject to amortization). This accounting policy also may address how the entity assesses whether events and circumstances continue to support an indefinite useful life and how the entity assesses and measures impairment of such assets.", "label": "Goodwill and Intangible Assets, Intangible Assets, Indefinite-Lived, Policy [Policy Text Block]", "terseLabel": "Long-Lived Assets, Including Definite-Lived Intangible Assets" } } }, "localname": "GoodwillAndIntangibleAssetsIntangibleAssetsIndefiniteLivedPolicy", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.shapeways.com/role/SummaryOfSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_GoodwillImpairmentLoss": { "auth_ref": [ "r108", "r245", "r247", "r249" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of loss from the write-down of an asset representing the future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.", "label": "Goodwill, Impairment Loss", "terseLabel": "Goodwill impairment loss" } } }, "localname": "GoodwillImpairmentLoss", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.shapeways.com/role/SummaryOfSignificantAccountingPoliciesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_GrossProfit": { "auth_ref": [ "r89", "r125", "r187", "r195", "r198", "r201", "r203", "r224", "r267", "r268", "r269", "r272", "r273", "r274", "r275", "r276", "r278", "r279", "r481" ], "calculation": { "http://www.shapeways.com/role/CondensedConsolidatedStatementsOfOperationsAndComprehensiveLoss": { "order": 5.0, "parentTag": "us-gaap_OperatingIncomeLoss", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Aggregate revenue less cost of goods and services sold or operating expenses directly attributable to the revenue generation activity.", "label": "Gross Profit", "totalLabel": "Gross profit" } } }, "localname": "GrossProfit", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.shapeways.com/role/CondensedConsolidatedStatementsOfOperationsAndComprehensiveLoss" ], "xbrltype": "monetaryItemType" }, "us-gaap_HeldToMaturitySecuritiesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Debt Securities, Held-to-Maturity, Fair Value to Amortized Cost, after Allowance for Credit Loss [Abstract]", "terseLabel": "Gross holding losses and fair value of held-to-maturity securities" } } }, "localname": "HeldToMaturitySecuritiesAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.shapeways.com/role/FairValueMeasurementsDetails" ], "xbrltype": "stringItemType" }, "us-gaap_IPOMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "First sale of stock by a private company to the public.", "label": "IPO [Member]", "verboseLabel": "IPO [Member]" } } }, "localname": "IPOMember", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.shapeways.com/role/SummaryOfSignificantAccountingPoliciesDetails" ], "xbrltype": "domainItemType" }, "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest": { "auth_ref": [ "r84", "r187", "r195", "r198", "r201", "r203", "r576", "r584", "r589", "r604" ], "calculation": { "http://www.shapeways.com/role/CondensedConsolidatedStatementsOfOperationsAndComprehensiveLoss": { "order": 15.0, "parentTag": "us-gaap_NetIncomeLoss", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of income (loss) from continuing operations, including income (loss) from equity method investments, before deduction of income tax expense (benefit), and income (loss) attributable to noncontrolling interest.", "label": "Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest", "terseLabel": "Income (loss) before income tax benefit" } } }, "localname": "IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.shapeways.com/role/CondensedConsolidatedStatementsOfOperationsAndComprehensiveLoss" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncomeStatementAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "CONSOLIDATED STATEMENTS OF OPERATIONS (Unaudited)" } } }, "localname": "IncomeStatementAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "xbrltype": "stringItemType" }, "us-gaap_IncomeStatementLocationAxis": { "auth_ref": [ "r257", "r259" ], "lang": { "en-us": { "role": { "documentation": "Information by location in the income statement.", "label": "Income Statement Location [Axis]" } } }, "localname": "IncomeStatementLocationAxis", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.shapeways.com/role/BorrowingArrangementsConvertiblePromissoryNotesDetails", "http://www.shapeways.com/role/BorrowingArrangementsPaycheckProtectionProgramLoanDetails" ], "xbrltype": "stringItemType" }, "us-gaap_IncomeStatementLocationDomain": { "auth_ref": [ "r259" ], "lang": { "en-us": { "role": { "documentation": "Location in the income statement.", "label": "Income Statement Location [Domain]" } } }, "localname": "IncomeStatementLocationDomain", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.shapeways.com/role/BorrowingArrangementsConvertiblePromissoryNotesDetails", "http://www.shapeways.com/role/BorrowingArrangementsPaycheckProtectionProgramLoanDetails" ], "xbrltype": "domainItemType" }, "us-gaap_IncomeTaxExpenseBenefit": { "auth_ref": [ "r126", "r144", "r145", "r186", "r423", "r431", "r432", "r605" ], "calculation": { "http://www.shapeways.com/role/CondensedConsolidatedStatementsOfOperationsAndComprehensiveLoss": { "order": 16.0, "parentTag": "us-gaap_NetIncomeLoss", "weight": -1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.", "label": "Income Tax Expense (Benefit)", "terseLabel": "Income tax benefit" } } }, "localname": "IncomeTaxExpenseBenefit", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.shapeways.com/role/CondensedConsolidatedStatementsOfOperationsAndComprehensiveLoss" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncomeTaxPolicyTextBlock": { "auth_ref": [ "r78", "r421", "r422", "r425", "r426", "r427", "r428" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for income taxes, which may include its accounting policies for recognizing and measuring deferred tax assets and liabilities and related valuation allowances, recognizing investment tax credits, operating loss carryforwards, tax credit carryforwards, and other carryforwards, methodologies for determining its effective income tax rate and the characterization of interest and penalties in the financial statements.", "label": "Income Tax, Policy [Policy Text Block]", "terseLabel": "Income Taxes" } } }, "localname": "IncomeTaxPolicyTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.shapeways.com/role/SummaryOfSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_IncreaseDecreaseInAccountsPayable": { "auth_ref": [ "r107" ], "calculation": { "http://www.shapeways.com/role/CondensedConsolidatedStatementsOfCashFlows": { "order": 15.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The increase (decrease) during the reporting period in the aggregate amount of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business.", "label": "Increase (Decrease) in Accounts Payable", "terseLabel": "Accounts payable" } } }, "localname": "IncreaseDecreaseInAccountsPayable", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.shapeways.com/role/CondensedConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncreaseDecreaseInAccountsReceivable": { "auth_ref": [ "r107" ], "calculation": { "http://www.shapeways.com/role/CondensedConsolidatedStatementsOfCashFlows": { "order": 12.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The increase (decrease) during the reporting period in amount due within one year (or one business cycle) from customers for the credit sale of goods and services.", "label": "Increase (Decrease) in Accounts Receivable", "negatedLabel": "Accounts receivable" } } }, "localname": "IncreaseDecreaseInAccountsReceivable", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.shapeways.com/role/CondensedConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncreaseDecreaseInAccruedLiabilities": { "auth_ref": [ "r107" ], "calculation": { "http://www.shapeways.com/role/CondensedConsolidatedStatementsOfCashFlows": { "order": 16.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The increase (decrease) during the reporting period in the aggregate amount of expenses incurred but not yet paid.", "label": "Increase (Decrease) in Accrued Liabilities", "terseLabel": "Accrued expenses and other liabilities" } } }, "localname": "IncreaseDecreaseInAccruedLiabilities", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.shapeways.com/role/CondensedConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncreaseDecreaseInDeferredRevenue": { "auth_ref": [ "r107" ], "calculation": { "http://www.shapeways.com/role/CondensedConsolidatedStatementsOfCashFlows": { "order": 18.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of increase (decrease) in deferred income and obligation to transfer product and service to customer for which consideration has been received or is receivable.", "label": "Increase (Decrease) in Deferred Revenue", "terseLabel": "Deferred revenue" } } }, "localname": "IncreaseDecreaseInDeferredRevenue", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.shapeways.com/role/CondensedConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncreaseDecreaseInInventories": { "auth_ref": [ "r107" ], "calculation": { "http://www.shapeways.com/role/CondensedConsolidatedStatementsOfCashFlows": { "order": 13.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The increase (decrease) during the reporting period in the aggregate value of all inventory held by the reporting entity, associated with underlying transactions that are classified as operating activities.", "label": "Increase (Decrease) in Inventories", "negatedLabel": "Inventory" } } }, "localname": "IncreaseDecreaseInInventories", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.shapeways.com/role/CondensedConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncreaseDecreaseInOperatingCapitalAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Increase (Decrease) in Operating Capital [Abstract]", "terseLabel": "Change in operating assets and liabilities:" } } }, "localname": "IncreaseDecreaseInOperatingCapitalAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.shapeways.com/role/CondensedConsolidatedStatementsOfCashFlows" ], "xbrltype": "stringItemType" }, "us-gaap_IncreaseDecreaseInPrepaidExpensesOther": { "auth_ref": [ "r107" ], "calculation": { "http://www.shapeways.com/role/CondensedConsolidatedStatementsOfCashFlows": { "order": 11.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of increase (decrease) of consideration paid in advance for other costs that provide economic benefits in future periods.", "label": "Increase (Decrease) in Prepaid Expenses, Other", "negatedLabel": "Prepaid expenses and other assets" } } }, "localname": "IncreaseDecreaseInPrepaidExpensesOther", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.shapeways.com/role/CondensedConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_InterestExpense": { "auth_ref": [ "r82", "r184", "r491", "r494", "r588" ], "calculation": { "http://www.shapeways.com/role/CondensedConsolidatedStatementsOfOperationsAndComprehensiveLoss": { "order": 9.0, "parentTag": "us-gaap_NonoperatingIncomeExpense", "weight": -1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of the cost of borrowed funds accounted for as interest expense.", "label": "Interest Expense", "negatedLabel": "Interest expense" } } }, "localname": "InterestExpense", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.shapeways.com/role/CondensedConsolidatedStatementsOfOperationsAndComprehensiveLoss" ], "xbrltype": "monetaryItemType" }, "us-gaap_InterestExpenseDebt": { "auth_ref": [ "r94", "r301", "r309", "r312", "r313" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of the cost of borrowed funds accounted for as interest expense for debt.", "label": "Interest Expense, Debt", "terseLabel": "Interest expense", "verboseLabel": "Interest expense" } } }, "localname": "InterestExpenseDebt", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.shapeways.com/role/BorrowingArrangementsConvertiblePromissoryNotesDetails", "http://www.shapeways.com/role/BorrowingArrangementsDutchLandlordLoanDetails", "http://www.shapeways.com/role/BorrowingArrangementsPaycheckProtectionProgramLoanDetails", "http://www.shapeways.com/role/BorrowingArrangementsTermLoanDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_InterestPaidNet": { "auth_ref": [ "r102", "r105", "r112" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of cash paid for interest, excluding capitalized interest, classified as operating activity. Includes, but is not limited to, payment to settle zero-coupon bond for accreted interest of debt discount and debt instrument with insignificant coupon interest rate in relation to effective interest rate of borrowing attributable to accreted interest of debt discount.", "label": "Interest Paid, Excluding Capitalized Interest, Operating Activities", "terseLabel": "Cash paid for interest" } } }, "localname": "InterestPaidNet", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.shapeways.com/role/CondensedConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_InterestPayableCurrent": { "auth_ref": [ "r15", "r16", "r55" ], "calculation": { "http://www.shapeways.com/role/AccruedExpensesAndOtherLiabilitiesDetails": { "order": 2.0, "parentTag": "shpw_AccruedAndOtherLiabilitiesCurrent", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Carrying value as of the balance sheet date of [accrued] interest payable on all forms of debt, including trade payables, that has been incurred and is unpaid. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).", "label": "Interest Payable, Current", "terseLabel": "Interest payable" } } }, "localname": "InterestPayableCurrent", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.shapeways.com/role/AccruedExpensesAndOtherLiabilitiesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_InventoryDisclosureAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Inventory Disclosure [Abstract]" } } }, "localname": "InventoryDisclosureAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "xbrltype": "stringItemType" }, "us-gaap_InventoryDisclosureTextBlock": { "auth_ref": [ "r240" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for inventory. Includes, but is not limited to, the basis of stating inventory, the method of determining inventory cost, the classes of inventory, and the nature of the cost elements included in inventory.", "label": "Inventory Disclosure [Text Block]", "terseLabel": "Inventory" } } }, "localname": "InventoryDisclosureTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.shapeways.com/role/Inventory" ], "xbrltype": "textBlockItemType" }, "us-gaap_InventoryFinishedGoodsNetOfReserves": { "auth_ref": [ "r38", "r239" ], "calculation": { "http://www.shapeways.com/role/InventoryDetails": { "order": 3.0, "parentTag": "us-gaap_InventoryNet", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Carrying amount, net of valuation reserves and adjustments, as of the balance sheet date of merchandise or goods held by the company that are readily available for sale.", "label": "Inventory, Finished Goods, Net of Reserves", "terseLabel": "Finished goods" } } }, "localname": "InventoryFinishedGoodsNetOfReserves", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.shapeways.com/role/InventoryDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_InventoryNet": { "auth_ref": [ "r6", "r65", "r525" ], "calculation": { "http://www.shapeways.com/role/CondensedConsolidatedBalanceSheets": { "order": 5.0, "parentTag": "us-gaap_AssetsCurrent", "weight": 1.0 }, "http://www.shapeways.com/role/InventoryDetails": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount after valuation and LIFO reserves of inventory expected to be sold, or consumed within one year or operating cycle, if longer.", "label": "Inventory, Net", "terseLabel": "Inventory", "totalLabel": "Total" } } }, "localname": "InventoryNet", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.shapeways.com/role/CondensedConsolidatedBalanceSheets", "http://www.shapeways.com/role/InventoryDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_InventoryNetItemsNetOfReserveAlternativeAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Inventory, Net, Items Net of Reserve Alternative [Abstract]" } } }, "localname": "InventoryNetItemsNetOfReserveAlternativeAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "xbrltype": "stringItemType" }, "us-gaap_InventoryPolicyTextBlock": { "auth_ref": [ "r17", "r66", "r118", "r163", "r237", "r238", "r240", "r561" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of inventory accounting policy for inventory classes, including, but not limited to, basis for determining inventory amounts, methods by which amounts are added and removed from inventory classes, loss recognition on impairment of inventories, and situations in which inventories are stated above cost.", "label": "Inventory, Policy [Policy Text Block]", "terseLabel": "Inventory" } } }, "localname": "InventoryPolicyTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.shapeways.com/role/SummaryOfSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_InventoryRawMaterialsNetOfReserves": { "auth_ref": [ "r40", "r239" ], "calculation": { "http://www.shapeways.com/role/InventoryDetails": { "order": 1.0, "parentTag": "us-gaap_InventoryNet", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Carrying amount, net of valuation reserves and adjustments, as of the balance sheet date of unprocessed items to be consumed in the manufacturing or production process.", "label": "Inventory, Raw Materials, Net of Reserves", "terseLabel": "Raw materials" } } }, "localname": "InventoryRawMaterialsNetOfReserves", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.shapeways.com/role/InventoryDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_InventoryWorkInProcessNetOfReserves": { "auth_ref": [ "r39", "r239" ], "calculation": { "http://www.shapeways.com/role/InventoryDetails": { "order": 2.0, "parentTag": "us-gaap_InventoryNet", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Carrying amount, net of reserves and adjustments, as of the balance sheet date of merchandise or goods which are partially completed. This inventory is generally comprised of raw materials, labor and factory overhead costs, which require further materials, labor and overhead to be converted into finished goods, and which generally require the use of estimates to determine percentage complete and pricing.", "label": "Inventory, Work in Process, Net of Reserves", "terseLabel": "Work-in-process" } } }, "localname": "InventoryWorkInProcessNetOfReserves", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.shapeways.com/role/InventoryDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_InvestmentIncomeInterest": { "auth_ref": [ "r92", "r183" ], "calculation": { "http://www.shapeways.com/role/CondensedConsolidatedStatementsOfOperationsAndComprehensiveLoss": { "order": 11.0, "parentTag": "us-gaap_NonoperatingIncomeExpense", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount before accretion (amortization) of purchase discount (premium) of interest income on nonoperating securities.", "label": "Investment Income, Interest", "verboseLabel": "Interest Income" } } }, "localname": "InvestmentIncomeInterest", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.shapeways.com/role/CondensedConsolidatedStatementsOfOperationsAndComprehensiveLoss" ], "xbrltype": "monetaryItemType" }, "us-gaap_InvestmentTypeAxis": { "auth_ref": [ "r629", "r630", "r631", "r632", "r633", "r634", "r635", "r636", "r637", "r638", "r639", "r640", "r641", "r642", "r643" ], "lang": { "en-us": { "role": { "documentation": "Information by type of investments.", "label": "Investment Type [Axis]" } } }, "localname": "InvestmentTypeAxis", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.shapeways.com/role/ReverseRecapitalizationScheduleOfCommonStockSharesIssuedFollowingTheConsummationOfBusinessCombinationDetails", "http://www.shapeways.com/role/ReverseRecapitalizationScheduleOfCommonStockSharesIssuedFollowingTheConsummationOfMergerDetails" ], "xbrltype": "stringItemType" }, "us-gaap_InvestmentTypeCategorizationMember": { "auth_ref": [ "r629", "r630", "r631", "r632", "r633", "r634", "r635", "r636", "r637", "r638", "r639", "r640", "r641", "r642", "r643" ], "lang": { "en-us": { "role": { "documentation": "Asset obtained to generate income or appreciate in value.", "label": "Investments [Domain]" } } }, "localname": "InvestmentTypeCategorizationMember", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.shapeways.com/role/ReverseRecapitalizationScheduleOfCommonStockSharesIssuedFollowingTheConsummationOfBusinessCombinationDetails", "http://www.shapeways.com/role/ReverseRecapitalizationScheduleOfCommonStockSharesIssuedFollowingTheConsummationOfMergerDetails" ], "xbrltype": "domainItemType" }, "us-gaap_LeaseCost": { "auth_ref": [ "r511", "r513" ], "calculation": { "http://www.shapeways.com/role/CommitmentsAndContingenciesCompanysLeaseCostsDetails": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of lease cost recognized by lessee for lease contract.", "label": "Lease, Cost", "totalLabel": "Total lease cost" } } }, "localname": "LeaseCost", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.shapeways.com/role/CommitmentsAndContingenciesCompanysLeaseCostsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_LeaseCostAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Lease, Cost [Abstract]", "terseLabel": "Certain information related to the Company's lease costs" } } }, "localname": "LeaseCostAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "xbrltype": "stringItemType" }, "us-gaap_LeaseCostTableTextBlock": { "auth_ref": [ "r511" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of lessee's lease cost. Includes, but is not limited to, interest expense for finance lease, amortization of right-of-use asset for finance lease, operating lease cost, short-term lease cost, variable lease cost and sublease income.", "label": "Lease, Cost [Table Text Block]", "terseLabel": "Summary of certain information related to the lease costs" } } }, "localname": "LeaseCostTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.shapeways.com/role/CommitmentsAndContingenciesTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_LeaseholdImprovementsMember": { "auth_ref": [ "r253" ], "lang": { "en-us": { "role": { "documentation": "Additions or improvements to assets held under a lease arrangement.", "label": "Leasehold Improvements [Member]", "terseLabel": "Leasehold improvements" } } }, "localname": "LeaseholdImprovementsMember", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.shapeways.com/role/PropertyAndEquipmentNetDetails", "http://www.shapeways.com/role/SummaryOfSignificantAccountingPoliciesSummaryOfUsefulLivesOfPropertyPlantAndEquipmentDetails" ], "xbrltype": "domainItemType" }, "us-gaap_LesseeLeasesPolicyTextBlock": { "auth_ref": [ "r503" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for leasing arrangement entered into by lessee.", "label": "Lessee, Leases [Policy Text Block]", "terseLabel": "Leases" } } }, "localname": "LesseeLeasesPolicyTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.shapeways.com/role/SummaryOfSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock": { "auth_ref": [ "r512" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of undiscounted cash flows of lessee's operating lease liability. Includes, but is not limited to, reconciliation of undiscounted cash flows to operating lease liability recognized in statement of financial position.", "label": "Lessee, Operating Lease, Liability, Maturity [Table Text Block]", "terseLabel": "Summary of future minimum lease payments required under operating leases" } } }, "localname": "LesseeOperatingLeaseLiabilityMaturityTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.shapeways.com/role/CommitmentsAndContingenciesTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue": { "auth_ref": [ "r512" ], "calculation": { "http://www.shapeways.com/role/CommitmentsAndContingenciesFutureMinimumLeasePaymentsDetails": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease.", "label": "Lessee, Operating Lease, Liability, to be Paid", "totalLabel": "Total minimum lease payments" } } }, "localname": "LesseeOperatingLeaseLiabilityPaymentsDue", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.shapeways.com/role/CommitmentsAndContingenciesFutureMinimumLeasePaymentsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths": { "auth_ref": [ "r512" ], "calculation": { "http://www.shapeways.com/role/CommitmentsAndContingenciesFutureMinimumLeasePaymentsDetails": { "order": 2.0, "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).", "label": "Lessee, Operating Lease, Liability, to be Paid, Year One", "terseLabel": "2022" } } }, "localname": "LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.shapeways.com/role/CommitmentsAndContingenciesFutureMinimumLeasePaymentsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour": { "auth_ref": [ "r512" ], "calculation": { "http://www.shapeways.com/role/CommitmentsAndContingenciesFutureMinimumLeasePaymentsDetails": { "order": 5.0, "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in fourth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).", "label": "Lessee, Operating Lease, Liability, to be Paid, Year Four", "terseLabel": "2025" } } }, "localname": "LesseeOperatingLeaseLiabilityPaymentsDueYearFour", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.shapeways.com/role/CommitmentsAndContingenciesFutureMinimumLeasePaymentsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree": { "auth_ref": [ "r512" ], "calculation": { "http://www.shapeways.com/role/CommitmentsAndContingenciesFutureMinimumLeasePaymentsDetails": { "order": 4.0, "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in third fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).", "label": "Lessee, Operating Lease, Liability, to be Paid, Year Three", "terseLabel": "2024" } } }, "localname": "LesseeOperatingLeaseLiabilityPaymentsDueYearThree", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.shapeways.com/role/CommitmentsAndContingenciesFutureMinimumLeasePaymentsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo": { "auth_ref": [ "r512" ], "calculation": { "http://www.shapeways.com/role/CommitmentsAndContingenciesFutureMinimumLeasePaymentsDetails": { "order": 3.0, "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in second fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).", "label": "Lessee, Operating Lease, Liability, to be Paid, Year Two", "terseLabel": "2023" } } }, "localname": "LesseeOperatingLeaseLiabilityPaymentsDueYearTwo", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.shapeways.com/role/CommitmentsAndContingenciesFutureMinimumLeasePaymentsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear": { "auth_ref": [ "r512" ], "calculation": { "http://www.shapeways.com/role/CommitmentsAndContingenciesFutureMinimumLeasePaymentsDetails": { "order": 1.0, "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease having initial or remaining lease term in excess of one year to be paid in remainder of current fiscal year.", "label": "Lessee, Operating Lease, Liability, to be Paid, Remainder of Fiscal Year", "terseLabel": "Rest of 2021" } } }, "localname": "LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.shapeways.com/role/CommitmentsAndContingenciesFutureMinimumLeasePaymentsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount": { "auth_ref": [ "r512" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of lessee's undiscounted obligation for lease payments in excess of discounted obligation for lease payments for operating lease.", "label": "Lessee, Operating Lease, Liability, Undiscounted Excess Amount", "negatedLabel": "Less effects of discounting" } } }, "localname": "LesseeOperatingLeaseLiabilityUndiscountedExcessAmount", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.shapeways.com/role/CommitmentsAndContingenciesFutureMinimumLeasePaymentsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_Liabilities": { "auth_ref": [ "r54", "r125", "r197", "r224", "r267", "r268", "r269", "r272", "r273", "r274", "r275", "r276", "r278", "r279", "r446", "r451", "r452", "r481", "r523", "r524" ], "calculation": { "http://www.shapeways.com/role/CondensedConsolidatedBalanceSheets": { "order": 18.0, "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Sum of the carrying amounts as of the balance sheet date of all liabilities that are recognized. Liabilities are probable future sacrifices of economic benefits arising from present obligations of an entity to transfer assets or provide services to other entities in the future.", "label": "Liabilities", "totalLabel": "Total liabilities" } } }, "localname": "Liabilities", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.shapeways.com/role/CondensedConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_LiabilitiesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Liabilities [Abstract]", "terseLabel": "LIABILITIES" } } }, "localname": "LiabilitiesAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.shapeways.com/role/CondensedConsolidatedBalanceSheets" ], "xbrltype": "stringItemType" }, "us-gaap_LiabilitiesAndStockholdersEquity": { "auth_ref": [ "r36", "r125", "r224", "r481", "r525", "r582", "r598" ], "calculation": { "http://www.shapeways.com/role/CondensedConsolidatedBalanceSheets": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of liabilities and equity items, including the portion of equity attributable to noncontrolling interests, if any.", "label": "Liabilities and Equity", "totalLabel": "Total liabilities and stockholders' equity (deficit)" } } }, "localname": "LiabilitiesAndStockholdersEquity", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.shapeways.com/role/CondensedConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_LiabilitiesAndStockholdersEquityAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Liabilities and Equity [Abstract]", "terseLabel": "LIABILITIES AND SHAREHOLDERS' EQUITY" } } }, "localname": "LiabilitiesAndStockholdersEquityAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.shapeways.com/role/CondensedConsolidatedBalanceSheets" ], "xbrltype": "stringItemType" }, "us-gaap_LiabilitiesCurrent": { "auth_ref": [ "r56", "r125", "r224", "r267", "r268", "r269", "r272", "r273", "r274", "r275", "r276", "r278", "r279", "r446", "r451", "r452", "r481", "r523", "r524", "r525" ], "calculation": { "http://www.shapeways.com/role/CondensedConsolidatedBalanceSheets": { "order": 19.0, "parentTag": "us-gaap_Liabilities", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Total obligations incurred as part of normal operations that are expected to be paid during the following twelve months or within one business cycle, if longer.", "label": "Liabilities, Current", "totalLabel": "Total current liabilities" } } }, "localname": "LiabilitiesCurrent", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.shapeways.com/role/CondensedConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_LiabilitiesFairValueDisclosureAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Liabilities, Fair Value Disclosure [Abstract]", "verboseLabel": "Liabilities:" } } }, "localname": "LiabilitiesFairValueDisclosureAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.shapeways.com/role/FairValueMeasurementsDetails" ], "xbrltype": "stringItemType" }, "us-gaap_LongTermDebt": { "auth_ref": [ "r25", "r294", "r308", "r310", "r311", "r581", "r594" ], "calculation": { "http://www.shapeways.com/role/BorrowingArrangementsOutstandingDebtObligationsDetails": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount, after unamortized (discount) premium and debt issuance costs, of long-term debt. Includes, but not limited to, notes payable, bonds payable, debentures, mortgage loans and commercial paper. Excludes capital lease obligations.", "label": "Long-term Debt", "totalLabel": "Long-term debt, including current portion" } } }, "localname": "LongTermDebt", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.shapeways.com/role/BorrowingArrangementsOutstandingDebtObligationsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_LongTermDebtCurrent": { "auth_ref": [ "r53" ], "calculation": { "http://www.shapeways.com/role/BorrowingArrangementsOutstandingDebtObligationsDetails": { "order": 1.0, "parentTag": "us-gaap_LongTermDebt", "weight": 1.0 }, "http://www.shapeways.com/role/CondensedConsolidatedBalanceSheets": { "order": 22.0, "parentTag": "us-gaap_LiabilitiesCurrent", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount, after unamortized (discount) premium and debt issuance costs, of long-term debt, classified as current. Includes, but not limited to, notes payable, bonds payable, debentures, mortgage loans and commercial paper. Excludes capital lease obligations.", "label": "Long-term Debt, Current Maturities", "negatedLabel": "Less: current portion", "terseLabel": "Current portion of long-term debt" } } }, "localname": "LongTermDebtCurrent", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.shapeways.com/role/BorrowingArrangementsOutstandingDebtObligationsDetails", "http://www.shapeways.com/role/CondensedConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_LongTermDebtNoncurrent": { "auth_ref": [ "r60" ], "calculation": { "http://www.shapeways.com/role/BorrowingArrangementsOutstandingDebtObligationsDetails": { "order": 2.0, "parentTag": "us-gaap_LongTermDebt", "weight": 1.0 }, "http://www.shapeways.com/role/CondensedConsolidatedBalanceSheets": { "order": 27.0, "parentTag": "us-gaap_Liabilities", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount after unamortized (discount) premium and debt issuance costs of long-term debt classified as noncurrent and excluding amounts to be repaid within one year or the normal operating cycle, if longer. Includes, but not limited to, notes payable, bonds payable, debentures, mortgage loans and commercial paper. Excludes capital lease obligations.", "label": "Long-term Debt, Excluding Current Maturities", "terseLabel": "Long-term debt", "verboseLabel": "Long-term debt" } } }, "localname": "LongTermDebtNoncurrent", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.shapeways.com/role/BorrowingArrangementsOutstandingDebtObligationsDetails", "http://www.shapeways.com/role/CondensedConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_LongTermPurchaseCommitmentAmount": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The minimum amount the entity agreed to spend under the long-term purchase commitment.", "label": "Long-term Purchase Commitment, Amount", "verboseLabel": "Long-term Purchase Commitment, Amount" } } }, "localname": "LongTermPurchaseCommitmentAmount", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.shapeways.com/role/CommitmentsAndContingenciesAdditionalInformationDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_LongtermDebtTypeAxis": { "auth_ref": [ "r60" ], "lang": { "en-us": { "role": { "documentation": "Information by type of long-term debt.", "label": "Long-term Debt, Type [Axis]" } } }, "localname": "LongtermDebtTypeAxis", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.shapeways.com/role/BorrowingArrangementsConvertiblePromissoryNotesDetails", "http://www.shapeways.com/role/BorrowingArrangementsDutchLandlordLoanDetails", "http://www.shapeways.com/role/BorrowingArrangementsOutstandingDebtObligationsDetails", "http://www.shapeways.com/role/BorrowingArrangementsPaycheckProtectionProgramLoanDetails", "http://www.shapeways.com/role/BorrowingArrangementsTermLoanDetails" ], "xbrltype": "stringItemType" }, "us-gaap_LongtermDebtTypeDomain": { "auth_ref": [ "r60", "r266" ], "lang": { "en-us": { "role": { "documentation": "Type of long-term debt arrangement, such as notes, line of credit, commercial paper, asset-based financing, project financing, letter of credit financing. These are debt arrangements that originally required repayment more than twelve months after issuance or greater than the normal operating cycle of the company, if longer.", "label": "Long-term Debt, Type [Domain]" } } }, "localname": "LongtermDebtTypeDomain", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.shapeways.com/role/BorrowingArrangementsConvertiblePromissoryNotesDetails", "http://www.shapeways.com/role/BorrowingArrangementsDutchLandlordLoanDetails", "http://www.shapeways.com/role/BorrowingArrangementsOutstandingDebtObligationsDetails", "http://www.shapeways.com/role/BorrowingArrangementsPaycheckProtectionProgramLoanDetails", "http://www.shapeways.com/role/BorrowingArrangementsTermLoanDetails" ], "xbrltype": "domainItemType" }, "us-gaap_MachineryAndEquipmentMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Tangible personal property used to produce goods and services, including, but is not limited to, tools, dies and molds, computer and office equipment.", "label": "Machinery and Equipment [Member]", "terseLabel": "Machinery and Equipment [Member]", "verboseLabel": "Machinery and equipment" } } }, "localname": "MachineryAndEquipmentMember", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.shapeways.com/role/PropertyAndEquipmentNetDetails", "http://www.shapeways.com/role/SummaryOfSignificantAccountingPoliciesSummaryOfUsefulLivesOfPropertyPlantAndEquipmentDetails" ], "xbrltype": "domainItemType" }, "us-gaap_MeasurementInputExercisePriceMember": { "auth_ref": [ "r467" ], "lang": { "en-us": { "role": { "documentation": "Measurement input using agreed upon price for exchange of underlying asset.", "label": "Measurement Input, Exercise Price [Member]", "terseLabel": "Exercise price per share" } } }, "localname": "MeasurementInputExercisePriceMember", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.shapeways.com/role/FairValueMeasurementsInitialMeasurementDetails" ], "xbrltype": "domainItemType" }, "us-gaap_MeasurementInputExpectedDividendRateMember": { "auth_ref": [ "r467" ], "lang": { "en-us": { "role": { "documentation": "Measurement input using expected dividend rate to be paid to holder of share per year.", "label": "Measurement Input, Expected Dividend Rate [Member]", "terseLabel": "Dividend yield" } } }, "localname": "MeasurementInputExpectedDividendRateMember", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.shapeways.com/role/FairValueMeasurementsInitialMeasurementDetails" ], "xbrltype": "domainItemType" }, "us-gaap_MeasurementInputExpectedTermMember": { "auth_ref": [ "r467" ], "lang": { "en-us": { "role": { "documentation": "Measurement input using period financial instrument is expected to be outstanding. Excludes maturity date.", "label": "Measurement Input, Expected Term [Member]", "terseLabel": "Expected life" } } }, "localname": "MeasurementInputExpectedTermMember", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.shapeways.com/role/FairValueMeasurementsInitialMeasurementDetails" ], "xbrltype": "domainItemType" }, "us-gaap_MeasurementInputPriceVolatilityMember": { "auth_ref": [ "r467" ], "lang": { "en-us": { "role": { "documentation": "Measurement input using rate at which price of security will increase (decrease) for given set of returns.", "label": "Measurement Input, Price Volatility [Member]", "terseLabel": "Volatility" } } }, "localname": "MeasurementInputPriceVolatilityMember", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.shapeways.com/role/FairValueMeasurementsInitialMeasurementDetails" ], "xbrltype": "domainItemType" }, "us-gaap_MeasurementInputSharePriceMember": { "auth_ref": [ "r467" ], "lang": { "en-us": { "role": { "documentation": "Measurement input using share price of saleable stock.", "label": "Measurement Input, Share Price [Member]", "terseLabel": "Stock price on valuation date" } } }, "localname": "MeasurementInputSharePriceMember", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.shapeways.com/role/FairValueMeasurementsInitialMeasurementDetails" ], "xbrltype": "domainItemType" }, "us-gaap_MeasurementInputTypeAxis": { "auth_ref": [ "r467" ], "lang": { "en-us": { "role": { "documentation": "Information by type of measurement input used to determine value of asset and liability.", "label": "Measurement Input Type [Axis]" } } }, "localname": "MeasurementInputTypeAxis", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.shapeways.com/role/FairValueMeasurementsInitialMeasurementDetails" ], "xbrltype": "stringItemType" }, "us-gaap_MeasurementInputTypeDomain": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Measurement input used to determine value of asset and liability.", "label": "Measurement Input Type [Domain]", "terseLabel": "Measurement Input Type [Domain]" } } }, "localname": "MeasurementInputTypeDomain", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.shapeways.com/role/FairValueMeasurementsInitialMeasurementDetails" ], "xbrltype": "domainItemType" }, "us-gaap_NetCashProvidedByUsedInFinancingActivities": { "auth_ref": [ "r104" ], "calculation": { "http://www.shapeways.com/role/CondensedConsolidatedStatementsOfCashFlows": { "order": 20.0, "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.", "label": "Net Cash Provided by (Used in) Financing Activities", "totalLabel": "Net cash provided by financing activities" } } }, "localname": "NetCashProvidedByUsedInFinancingActivities", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.shapeways.com/role/CondensedConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Net Cash Provided by (Used in) Financing Activities [Abstract]", "terseLabel": "Cash flows from financing activities:" } } }, "localname": "NetCashProvidedByUsedInFinancingActivitiesAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.shapeways.com/role/CondensedConsolidatedStatementsOfCashFlows" ], "xbrltype": "stringItemType" }, "us-gaap_NetCashProvidedByUsedInInvestingActivities": { "auth_ref": [ "r104" ], "calculation": { "http://www.shapeways.com/role/CondensedConsolidatedStatementsOfCashFlows": { "order": 1.0, "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of cash inflow (outflow) from investing activities, including discontinued operations. Investing activity cash flows include making and collecting loans and acquiring and disposing of debt or equity instruments and property, plant, and equipment and other productive assets.", "label": "Net Cash Provided by (Used in) Investing Activities", "totalLabel": "Net cash used in investing activities" } } }, "localname": "NetCashProvidedByUsedInInvestingActivities", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.shapeways.com/role/CondensedConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Net Cash Provided by (Used in) Investing Activities [Abstract]", "terseLabel": "Cash flows from investing activities:" } } }, "localname": "NetCashProvidedByUsedInInvestingActivitiesAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.shapeways.com/role/CondensedConsolidatedStatementsOfCashFlows" ], "xbrltype": "stringItemType" }, "us-gaap_NetCashProvidedByUsedInOperatingActivities": { "auth_ref": [ "r104", "r106", "r109" ], "calculation": { "http://www.shapeways.com/role/CondensedConsolidatedStatementsOfCashFlows": { "order": 3.0, "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect", "weight": 1.0 } }, "lang": { "en-us": { "role": { "documentation": "Amount of cash inflow (outflow) from operating activities, including discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities.", "label": "Net Cash Provided by (Used in) Operating Activities", "totalLabel": "Net cash used in operating activities" } } }, "localname": "NetCashProvidedByUsedInOperatingActivities", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.shapeways.com/role/CondensedConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Net Cash Provided by (Used in) Operating Activities [Abstract]", "terseLabel": "Cash Flows from Operating Activities:" } } }, "localname": "NetCashProvidedByUsedInOperatingActivitiesAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.shapeways.com/role/CondensedConsolidatedStatementsOfCashFlows" ], "xbrltype": "stringItemType" }, "us-gaap_NetIncomeLoss": { "auth_ref": [ "r3", "r73", "r75", "r81", "r85", "r109", "r125", "r134", "r136", "r137", "r139", "r140", "r144", "r145", "r153", "r187", "r195", "r198", "r201", "r203", "r224", "r267", "r268", "r269", "r272", "r273", "r274", "r275", "r276", "r278", "r279", "r463", "r481", "r585", "r601" ], "calculation": { "http://www.shapeways.com/role/CondensedConsolidatedStatementsOfOperationsAndComprehensiveLoss": { "order": 14.0, "parentTag": "us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.", "label": "Net Income (Loss) Attributable to Parent", "terseLabel": "Net loss", "totalLabel": "Net income (loss)" } } }, "localname": "NetIncomeLoss", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.shapeways.com/role/CondensedConsolidatedStatementsOfChangesInStockholdersEquityDeficit", "http://www.shapeways.com/role/CondensedConsolidatedStatementsOfOperationsAndComprehensiveLoss" ], "xbrltype": "monetaryItemType" }, "us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic": { "auth_ref": [ "r136", "r137", "r139", "r140", "r147", "r148", "r154", "r157", "r187", "r195", "r198", "r201", "r203" ], "calculation": { "http://www.shapeways.com/role/CondensedConsolidatedStatementsOfOperationsAndComprehensiveLoss": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount, after deduction of tax, noncontrolling interests, dividends on preferred stock and participating securities; of income (loss) available to common shareholders.", "label": "Net Income (Loss) Available to Common Stockholders, Basic", "totalLabel": "Net loss attributable to common stockholders" } } }, "localname": "NetIncomeLossAvailableToCommonStockholdersBasic", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.shapeways.com/role/CondensedConsolidatedStatementsOfOperationsAndComprehensiveLoss" ], "xbrltype": "monetaryItemType" }, "us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy pertaining to new accounting pronouncements that may impact the entity's financial reporting. Includes, but is not limited to, quantification of the expected or actual impact.", "label": "New Accounting Pronouncements, Policy [Policy Text Block]", "terseLabel": "Recent Accounting Standards" } } }, "localname": "NewAccountingPronouncementsPolicyPolicyTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.shapeways.com/role/SummaryOfSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_NonoperatingIncomeExpense": { "auth_ref": [ "r93" ], "calculation": { "http://www.shapeways.com/role/CondensedConsolidatedStatementsOfOperationsAndComprehensiveLoss": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The aggregate amount of income or expense from ancillary business-related activities (that is to say, excluding major activities considered part of the normal operations of the business).", "label": "Nonoperating Income (Expense)", "totalLabel": "Total other income (expense), net" } } }, "localname": "NonoperatingIncomeExpense", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.shapeways.com/role/CondensedConsolidatedStatementsOfOperationsAndComprehensiveLoss" ], "xbrltype": "monetaryItemType" }, "us-gaap_NonoperatingIncomeExpenseAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Nonoperating Income (Expense) [Abstract]", "verboseLabel": "Other income (expense)" } } }, "localname": "NonoperatingIncomeExpenseAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.shapeways.com/role/CondensedConsolidatedStatementsOfOperationsAndComprehensiveLoss" ], "xbrltype": "stringItemType" }, "us-gaap_OperatingExpenses": { "auth_ref": [], "calculation": { "http://www.shapeways.com/role/CondensedConsolidatedStatementsOfOperationsAndComprehensiveLoss": { "order": 1.0, "parentTag": "us-gaap_OperatingIncomeLoss", "weight": -1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Generally recurring costs associated with normal operations except for the portion of these expenses which can be clearly related to production and included in cost of sales or services. Includes selling, general and administrative expense.", "label": "Operating Expenses", "totalLabel": "Total operating expenses" } } }, "localname": "OperatingExpenses", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.shapeways.com/role/CondensedConsolidatedStatementsOfOperationsAndComprehensiveLoss" ], "xbrltype": "monetaryItemType" }, "us-gaap_OperatingExpensesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Operating Expenses [Abstract]", "terseLabel": "Operating expenses" } } }, "localname": "OperatingExpensesAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.shapeways.com/role/CondensedConsolidatedStatementsOfOperationsAndComprehensiveLoss" ], "xbrltype": "stringItemType" }, "us-gaap_OperatingIncomeLoss": { "auth_ref": [ "r187", "r195", "r198", "r201", "r203" ], "calculation": { "http://www.shapeways.com/role/CondensedConsolidatedStatementsOfOperationsAndComprehensiveLoss": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The net result for the period of deducting operating expenses from operating revenues.", "label": "Operating Income (Loss)", "totalLabel": "Loss from operations" } } }, "localname": "OperatingIncomeLoss", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.shapeways.com/role/CondensedConsolidatedStatementsOfOperationsAndComprehensiveLoss" ], "xbrltype": "monetaryItemType" }, "us-gaap_OperatingLeaseCost": { "auth_ref": [ "r505", "r513" ], "calculation": { "http://www.shapeways.com/role/CommitmentsAndContingenciesCompanysLeaseCostsDetails": { "order": 1.0, "parentTag": "us-gaap_LeaseCost", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of single lease cost, calculated by allocation of remaining cost of lease over remaining lease term. Includes, but is not limited to, single lease cost, after impairment of right-of-use asset, calculated by amortization of remaining right-of-use asset and accretion of lease liability.", "label": "Operating Lease, Cost", "terseLabel": "Operating lease expense" } } }, "localname": "OperatingLeaseCost", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.shapeways.com/role/CommitmentsAndContingenciesCompanysLeaseCostsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Lessee, Operating Lease, Liability, Payment, Due [Abstract]", "terseLabel": "Future minimum lease payments required under operating leases" } } }, "localname": "OperatingLeaseLiabilitiesPaymentsDueAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "xbrltype": "stringItemType" }, "us-gaap_OperatingLeaseLiability": { "auth_ref": [ "r498" ], "calculation": { "http://www.shapeways.com/role/CommitmentsAndContingenciesRightOfUseAssetsAndLeaseLiabilitiesForOperatingLeasesDetails": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Present value of lessee's discounted obligation for lease payments from operating lease.", "label": "Operating Lease, Liability", "terseLabel": "Present value of future minimum lease payments", "totalLabel": "Total lease liability" } } }, "localname": "OperatingLeaseLiability", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.shapeways.com/role/CommitmentsAndContingenciesFutureMinimumLeasePaymentsDetails", "http://www.shapeways.com/role/CommitmentsAndContingenciesRightOfUseAssetsAndLeaseLiabilitiesForOperatingLeasesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_OperatingLeaseLiabilityAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Operating Lease, Liability [Abstract]", "terseLabel": "Liabilities:" } } }, "localname": "OperatingLeaseLiabilityAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.shapeways.com/role/CommitmentsAndContingenciesRightOfUseAssetsAndLeaseLiabilitiesForOperatingLeasesDetails" ], "xbrltype": "stringItemType" }, "us-gaap_OperatingLeaseLiabilityCurrent": { "auth_ref": [ "r498" ], "calculation": { "http://www.shapeways.com/role/CommitmentsAndContingenciesRightOfUseAssetsAndLeaseLiabilitiesForOperatingLeasesDetails": { "order": 2.0, "parentTag": "us-gaap_OperatingLeaseLiability", "weight": 1.0 }, "http://www.shapeways.com/role/CondensedConsolidatedBalanceSheets": { "order": 23.0, "parentTag": "us-gaap_LiabilitiesCurrent", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Present value of lessee's discounted obligation for lease payments from operating lease, classified as current.", "label": "Operating Lease, Liability, Current", "terseLabel": "Operating lease liabilities, current", "verboseLabel": "Operating lease liabilities, current" } } }, "localname": "OperatingLeaseLiabilityCurrent", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.shapeways.com/role/CommitmentsAndContingenciesRightOfUseAssetsAndLeaseLiabilitiesForOperatingLeasesDetails", "http://www.shapeways.com/role/CondensedConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_OperatingLeaseLiabilityNoncurrent": { "auth_ref": [ "r498" ], "calculation": { "http://www.shapeways.com/role/CommitmentsAndContingenciesRightOfUseAssetsAndLeaseLiabilitiesForOperatingLeasesDetails": { "order": 3.0, "parentTag": "us-gaap_OperatingLeaseLiability", "weight": 1.0 }, "http://www.shapeways.com/role/CondensedConsolidatedBalanceSheets": { "order": 25.0, "parentTag": "us-gaap_Liabilities", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Present value of lessee's discounted obligation for lease payments from operating lease, classified as noncurrent.", "label": "Operating Lease, Liability, Noncurrent", "terseLabel": "Operating lease liabilities, net of current portion", "verboseLabel": "Non-current liabilities: Operating lease liabilities, net of current portion" } } }, "localname": "OperatingLeaseLiabilityNoncurrent", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.shapeways.com/role/CommitmentsAndContingenciesRightOfUseAssetsAndLeaseLiabilitiesForOperatingLeasesDetails", "http://www.shapeways.com/role/CondensedConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_OperatingLeasePayments": { "auth_ref": [ "r502", "r507" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of cash outflow from operating lease, excluding payments to bring another asset to condition and location necessary for its intended use.", "label": "Operating Lease, Payments", "terseLabel": "Operating cash flows from operating leases" } } }, "localname": "OperatingLeasePayments", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.shapeways.com/role/CommitmentsAndContingenciesSupplementalCashFlowDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_OperatingLeaseRightOfUseAsset": { "auth_ref": [ "r497" ], "calculation": { "http://www.shapeways.com/role/CommitmentsAndContingenciesRightOfUseAssetsAndLeaseLiabilitiesForOperatingLeasesDetails": { "order": 1.0, "parentTag": "shpw_AssetsOnLease", "weight": 1.0 }, "http://www.shapeways.com/role/CondensedConsolidatedBalanceSheets": { "order": 9.0, "parentTag": "us-gaap_Assets", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of lessee's right to use underlying asset under operating lease.", "label": "Operating Lease, Right-of-Use Asset", "terseLabel": "Right-of-use assets, net", "verboseLabel": "Right-of-use\u00a0assets, net" } } }, "localname": "OperatingLeaseRightOfUseAsset", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.shapeways.com/role/CommitmentsAndContingenciesRightOfUseAssetsAndLeaseLiabilitiesForOperatingLeasesDetails", "http://www.shapeways.com/role/CondensedConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent": { "auth_ref": [ "r510", "r513" ], "lang": { "en-us": { "role": { "documentation": "Weighted average discount rate for operating lease calculated at point in time.", "label": "Operating Lease, Weighted Average Discount Rate, Percent", "verboseLabel": "Weighted-average incremental borrowing rate" } } }, "localname": "OperatingLeaseWeightedAverageDiscountRatePercent", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.shapeways.com/role/CommitmentsAndContingenciesWeightedAverageDetails" ], "xbrltype": "percentItemType" }, "us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1": { "auth_ref": [ "r509", "r513" ], "lang": { "en-us": { "role": { "documentation": "Weighted average remaining lease term for operating lease, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.", "label": "Operating Lease, Weighted Average Remaining Lease Term", "verboseLabel": "Weighted-average remaining lease term for operating leases" } } }, "localname": "OperatingLeaseWeightedAverageRemainingLeaseTerm1", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.shapeways.com/role/CommitmentsAndContingenciesWeightedAverageDetails" ], "xbrltype": "durationItemType" }, "us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Organization" } } }, "localname": "OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "xbrltype": "stringItemType" }, "us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock": { "auth_ref": [ "r4", "r455" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for organization, consolidation and basis of presentation of financial statements disclosure.", "label": "Organization, Consolidation and Presentation of Financial Statements Disclosure [Text Block]", "terseLabel": "Organization" } } }, "localname": "OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.shapeways.com/role/Organization" ], "xbrltype": "textBlockItemType" }, "us-gaap_OtherAssetsCurrent": { "auth_ref": [ "r67", "r525" ], "calculation": { "http://www.shapeways.com/role/PrepaidExpensesAndOtherCurrentAssetsDetails": { "order": 4.0, "parentTag": "us-gaap_PrepaidExpenseAndOtherAssetsCurrent", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of current assets classified as other.", "label": "Other Assets, Current", "terseLabel": "Other current assets" } } }, "localname": "OtherAssetsCurrent", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.shapeways.com/role/PrepaidExpensesAndOtherCurrentAssetsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_OtherCommitmentsAxis": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Information by type of other commitment.", "label": "Other Commitments [Axis]" } } }, "localname": "OtherCommitmentsAxis", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.shapeways.com/role/CommitmentsAndContingenciesAdditionalInformationDetails" ], "xbrltype": "stringItemType" }, "us-gaap_OtherCommitmentsDomain": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Other future obligation.", "label": "Other Commitments [Domain]", "terseLabel": "Other Commitments [Domain]" } } }, "localname": "OtherCommitmentsDomain", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.shapeways.com/role/CommitmentsAndContingenciesAdditionalInformationDetails" ], "xbrltype": "domainItemType" }, "us-gaap_OtherCommitmentsLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Other Commitments [Line Items]" } } }, "localname": "OtherCommitmentsLineItems", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.shapeways.com/role/CommitmentsAndContingenciesAdditionalInformationDetails" ], "xbrltype": "stringItemType" }, "us-gaap_OtherCommitmentsTable": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Disclosure of information about obligations resulting from other commitments.", "label": "Other Commitments [Table]" } } }, "localname": "OtherCommitmentsTable", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.shapeways.com/role/CommitmentsAndContingenciesAdditionalInformationDetails" ], "xbrltype": "stringItemType" }, "us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent": { "auth_ref": [ "r443", "r444", "r449" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount after tax and reclassification adjustments of gain (loss) on foreign currency translation adjustments, foreign currency transactions designated and effective as economic hedges of a net investment in a foreign entity and intra-entity foreign currency transactions that are of a long-term-investment nature, attributable to parent entity.", "label": "Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Adjustment, Net of Tax, Portion Attributable to Parent", "terseLabel": "Foreign currency translation adjustment" } } }, "localname": "OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.shapeways.com/role/CondensedConsolidatedStatementsOfOperationsAndComprehensiveLoss" ], "xbrltype": "monetaryItemType" }, "us-gaap_OtherCustomerMember": { "auth_ref": [ "r606", "r608", "r610", "r611", "r615", "r626" ], "lang": { "en-us": { "role": { "documentation": "Customer classified as other.", "label": "Other Customer [Member]" } } }, "localname": "OtherCustomerMember", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.shapeways.com/role/SignificantConcentrationsDetails" ], "xbrltype": "domainItemType" }, "us-gaap_OtherIncomeMember": { "auth_ref": [ "r456" ], "lang": { "en-us": { "role": { "documentation": "Primary financial statement caption encompassing other revenue.", "label": "Other Income [Member]" } } }, "localname": "OtherIncomeMember", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.shapeways.com/role/BorrowingArrangementsPaycheckProtectionProgramLoanDetails" ], "xbrltype": "domainItemType" }, "us-gaap_OtherLiabilitiesCurrent": { "auth_ref": [ "r13", "r14", "r55", "r525" ], "calculation": { "http://www.shapeways.com/role/AccruedExpensesAndOtherLiabilitiesDetails": { "order": 5.0, "parentTag": "shpw_AccruedAndOtherLiabilitiesCurrent", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of liabilities classified as other, due within one year or the normal operating cycle, if longer.", "label": "Other Liabilities, Current", "terseLabel": "Other" } } }, "localname": "OtherLiabilitiesCurrent", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.shapeways.com/role/AccruedExpensesAndOtherLiabilitiesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_OtherNonoperatingIncomeExpense": { "auth_ref": [ "r95" ], "calculation": { "http://www.shapeways.com/role/CondensedConsolidatedStatementsOfOperationsAndComprehensiveLoss": { "order": 12.0, "parentTag": "us-gaap_NonoperatingIncomeExpense", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of income (expense) related to nonoperating activities, classified as other.", "label": "Other Nonoperating Income (Expense)", "terseLabel": "Other income" } } }, "localname": "OtherNonoperatingIncomeExpense", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.shapeways.com/role/CondensedConsolidatedStatementsOfOperationsAndComprehensiveLoss" ], "xbrltype": "monetaryItemType" }, "us-gaap_PaymentsOfMergerRelatedCostsFinancingActivities": { "auth_ref": [ "r101" ], "calculation": { "http://www.shapeways.com/role/ReverseRecapitalizationScheduleOfCommonStockSharesIssuedFollowingTheConsummationOfMergerDetails": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The cash outflow for financing costs associated with business combinations.", "label": "Payments of Merger Related Costs, Financing Activities", "totalLabel": "Effect of Merger, net of redemption, transaction costs and advisory costs" } } }, "localname": "PaymentsOfMergerRelatedCostsFinancingActivities", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.shapeways.com/role/ReverseRecapitalizationScheduleOfCommonStockSharesIssuedFollowingTheConsummationOfMergerDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_PaymentsToAcquireBusinessesGross": { "auth_ref": [ "r96", "r440" ], "calculation": { "http://www.shapeways.com/role/ReverseRecapitalizationScheduleOfCommonStockSharesIssuedFollowingTheConsummationOfMergerDetails": { "order": 1.0, "parentTag": "us-gaap_PaymentsOfMergerRelatedCostsFinancingActivities", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The cash outflow associated with the acquisition of business during the period. The cash portion only of the acquisition price.", "label": "Payments to Acquire Businesses, Gross", "terseLabel": "Payments to Acquire Businesses, Gross", "verboseLabel": "Cash - Galileo trust and cash, net of redemption" } } }, "localname": "PaymentsToAcquireBusinessesGross", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.shapeways.com/role/ReverseRecapitalizationScheduleOfCommonStockSharesIssuedFollowingTheConsummationOfMergerDetails", "http://www.shapeways.com/role/ReverseRecapitalizationScheduleOfReconcilesTheElementsOfBusinessCombinationToTheUnauditedConsolidatedStatementOfChangesInStockholdersEquityDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_PaymentsToAcquireOtherPropertyPlantAndEquipment": { "auth_ref": [ "r97" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of cash outflow from the acquisition of or improvements to long-lived, physical assets used to produce goods and services and not intended for resale, classified as other.", "label": "Payments to Acquire Other Property, Plant, and Equipment", "verboseLabel": "Payments to Acquire desktop metal" } } }, "localname": "PaymentsToAcquireOtherPropertyPlantAndEquipment", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.shapeways.com/role/CommitmentsAndContingenciesAdditionalInformationDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_PaymentsToAcquirePropertyPlantAndEquipment": { "auth_ref": [ "r97" ], "calculation": { "http://www.shapeways.com/role/CondensedConsolidatedStatementsOfCashFlows": { "order": 2.0, "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The cash outflow associated with the acquisition of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale; includes cash outflows to pay for construction of self-constructed assets.", "label": "Payments to Acquire Property, Plant, and Equipment", "negatedLabel": "Purchases of property and equipment" } } }, "localname": "PaymentsToAcquirePropertyPlantAndEquipment", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.shapeways.com/role/CondensedConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_PlanNameAxis": { "auth_ref": [ "r389", "r410" ], "lang": { "en-us": { "role": { "documentation": "Information by plan name for share-based payment arrangement.", "label": "Plan Name [Axis]" } } }, "localname": "PlanNameAxis", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.shapeways.com/role/ReverseRecapitalizationDetails", "http://www.shapeways.com/role/StockBasedCompensationDetails" ], "xbrltype": "stringItemType" }, "us-gaap_PlanNameDomain": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Plan name for share-based payment arrangement.", "label": "Plan Name [Domain]" } } }, "localname": "PlanNameDomain", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.shapeways.com/role/ReverseRecapitalizationDetails", "http://www.shapeways.com/role/StockBasedCompensationDetails" ], "xbrltype": "domainItemType" }, "us-gaap_PreferredStockDividendsAndOtherAdjustments": { "auth_ref": [ "r148", "r158" ], "calculation": { "http://www.shapeways.com/role/CondensedConsolidatedStatementsOfOperationsAndComprehensiveLoss": { "order": 17.0, "parentTag": "us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic", "weight": -1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The aggregate value of preferred stock dividends and other adjustments necessary to derive net income apportioned to common stockholders.", "label": "Preferred Stock Dividends and Other Adjustments", "negatedLabel": "Deemed dividend - Earnout Shares" } } }, "localname": "PreferredStockDividendsAndOtherAdjustments", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.shapeways.com/role/CondensedConsolidatedStatementsOfOperationsAndComprehensiveLoss" ], "xbrltype": "monetaryItemType" }, "us-gaap_PreferredStockMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Preferred shares may provide a preferential dividend to the dividend on common stock and may take precedence over common stock in the event of a liquidation. Preferred shares typically represent an ownership interest in the company.", "label": "Preferred Stock [Member]", "terseLabel": "Preferred Stock" } } }, "localname": "PreferredStockMember", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.shapeways.com/role/CondensedConsolidatedStatementsOfChangesInStockholdersEquityDeficit" ], "xbrltype": "domainItemType" }, "us-gaap_PreferredStockParOrStatedValuePerShare": { "auth_ref": [ "r27", "r320" ], "lang": { "en-us": { "role": { "documentation": "Face amount or stated value per share of preferred stock nonredeemable or redeemable solely at the option of the issuer.", "label": "Preferred Stock, Par or Stated Value Per Share", "terseLabel": "Preferred stock, par value" } } }, "localname": "PreferredStockParOrStatedValuePerShare", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.shapeways.com/role/CondensedConsolidatedBalanceSheetsParenthetical" ], "xbrltype": "perShareItemType" }, "us-gaap_PreferredStockSharesAuthorized": { "auth_ref": [ "r27" ], "lang": { "en-us": { "role": { "documentation": "The maximum number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) permitted to be issued by an entity's charter and bylaws.", "label": "Preferred Stock, Shares Authorized", "terseLabel": "Preferred stock, shares authorized" } } }, "localname": "PreferredStockSharesAuthorized", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.shapeways.com/role/CondensedConsolidatedBalanceSheetsParenthetical" ], "xbrltype": "sharesItemType" }, "us-gaap_PreferredStockSharesIssued": { "auth_ref": [ "r27", "r320" ], "lang": { "en-us": { "role": { "documentation": "Total number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) issued to shareholders (includes related preferred shares that were issued, repurchased, and remain in the treasury). May be all or portion of the number of preferred shares authorized. Excludes preferred shares that are classified as debt.", "label": "Preferred Stock, Shares Issued", "terseLabel": "Preferred stock, shares issued" } } }, "localname": "PreferredStockSharesIssued", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.shapeways.com/role/CondensedConsolidatedBalanceSheetsParenthetical" ], "xbrltype": "sharesItemType" }, "us-gaap_PreferredStockSharesOutstanding": { "auth_ref": [ "r27" ], "lang": { "en-us": { "role": { "documentation": "Aggregate share number for all nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer) held by stockholders. Does not include preferred shares that have been repurchased.", "label": "Preferred Stock, Shares Outstanding", "terseLabel": "Preferred stock, shares outstanding" } } }, "localname": "PreferredStockSharesOutstanding", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.shapeways.com/role/CondensedConsolidatedBalanceSheetsParenthetical" ], "xbrltype": "sharesItemType" }, "us-gaap_PreferredStockValue": { "auth_ref": [ "r27", "r525" ], "calculation": { "http://www.shapeways.com/role/CondensedConsolidatedBalanceSheets": { "order": 13.0, "parentTag": "us-gaap_StockholdersEquity", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Aggregate par or stated value of issued nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable preferred shares, par value and other disclosure concepts are in another section within stockholders' equity.", "label": "Preferred Stock, Value, Issued", "terseLabel": "Preferred stock ($0.0001 par value; 10,000,000 shares authorized; none issued and outstanding as of September 30, 2021 and December 31, 2020, respectively)" } } }, "localname": "PreferredStockValue", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.shapeways.com/role/CondensedConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_PrepaidExpenseAndOtherAssetsCurrent": { "auth_ref": [ "r10", "r44", "r45" ], "calculation": { "http://www.shapeways.com/role/CondensedConsolidatedBalanceSheets": { "order": 7.0, "parentTag": "us-gaap_AssetsCurrent", "weight": 1.0 }, "http://www.shapeways.com/role/PrepaidExpensesAndOtherCurrentAssetsDetails": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "debit", "lang": { "en-us": { "role": { "definitionGuidance": "Prepaid expenses and other current assets", "documentation": "Amount of asset related to consideration paid in advance for costs that provide economic benefits in future periods, and amount of other assets that are expected to be realized or consumed within one year or the normal operating cycle, if longer.", "label": "Prepaid Expense and Other Assets, Current", "totalLabel": "Total" } } }, "localname": "PrepaidExpenseAndOtherAssetsCurrent", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.shapeways.com/role/CondensedConsolidatedBalanceSheets", "http://www.shapeways.com/role/PrepaidExpensesAndOtherCurrentAssetsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_PrepaidExpenseAndOtherAssetsCurrentAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Prepaid Expense and Other Assets, Current [Abstract]" } } }, "localname": "PrepaidExpenseAndOtherAssetsCurrentAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "xbrltype": "stringItemType" }, "us-gaap_PrepaidExpenseCurrent": { "auth_ref": [ "r9", "r11", "r241", "r242" ], "calculation": { "http://www.shapeways.com/role/PrepaidExpensesAndOtherCurrentAssetsDetails": { "order": 1.0, "parentTag": "us-gaap_PrepaidExpenseAndOtherAssetsCurrent", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of asset related to consideration paid in advance for costs that provide economic benefits within a future period of one year or the normal operating cycle, if longer.", "label": "Prepaid Expense, Current", "verboseLabel": "Prepaid expenses" } } }, "localname": "PrepaidExpenseCurrent", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.shapeways.com/role/PrepaidExpensesAndOtherCurrentAssetsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_PrimeRateMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Interest rate charged by financial institutions to their most creditworthy borrowers.", "label": "Prime Rate [Member]" } } }, "localname": "PrimeRateMember", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.shapeways.com/role/BorrowingArrangementsTermLoanDetails" ], "xbrltype": "domainItemType" }, "us-gaap_PrivatePlacementMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "A private placement is a direct offering of securities to a limited number of sophisticated investors such as insurance companies, pension funds, mezzanine funds, stock funds and trusts.", "label": "Private Placement [Member]", "terseLabel": "Private Placement [Member]" } } }, "localname": "PrivatePlacementMember", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.shapeways.com/role/SummaryOfSignificantAccountingPoliciesDetails" ], "xbrltype": "domainItemType" }, "us-gaap_ProceedsFromIssuanceOfCommonStock": { "auth_ref": [ "r98" ], "calculation": { "http://www.shapeways.com/role/CondensedConsolidatedStatementsOfCashFlows": { "order": 22.0, "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The cash inflow from the additional capital contribution to the entity.", "label": "Proceeds from Issuance of Common Stock", "terseLabel": "Proceeds from issuance of common stock" } } }, "localname": "ProceedsFromIssuanceOfCommonStock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.shapeways.com/role/CondensedConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_ProceedsFromIssuanceOfPreferredStockAndPreferenceStock": { "auth_ref": [ "r98" ], "calculation": { "http://www.shapeways.com/role/CondensedConsolidatedStatementsOfCashFlows": { "order": 23.0, "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Proceeds from issuance of capital stock which provides for a specific dividend that is paid to the shareholders before any dividends to common stockholders and which takes precedence over common stockholders in the event of liquidation.", "label": "Proceeds from Issuance of Preferred Stock and Preference Stock", "terseLabel": "Proceeds received from exercise of preferred stock warrants" } } }, "localname": "ProceedsFromIssuanceOfPreferredStockAndPreferenceStock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.shapeways.com/role/CondensedConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_ProceedsFromLinesOfCredit": { "auth_ref": [ "r99", "r124" ], "calculation": { "http://www.shapeways.com/role/CondensedConsolidatedStatementsOfCashFlows": { "order": 25.0, "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of cash inflow from contractual arrangement with the lender, including but not limited to, letter of credit, standby letter of credit and revolving credit arrangements.", "label": "Proceeds from Lines of Credit", "terseLabel": "Proceeds from loans payable" } } }, "localname": "ProceedsFromLinesOfCredit", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.shapeways.com/role/CondensedConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_ProceedsFromNotesPayable": { "auth_ref": [ "r99" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The cash inflow from a borrowing supported by a written promise to pay an obligation.", "label": "Proceeds from Notes Payable", "terseLabel": "Amount of loan received" } } }, "localname": "ProceedsFromNotesPayable", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.shapeways.com/role/BorrowingArrangementsPaycheckProtectionProgramLoanDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_ProfitLoss": { "auth_ref": [ "r3", "r73", "r75", "r81", "r103", "r125", "r134", "r144", "r145", "r187", "r195", "r198", "r201", "r203", "r224", "r267", "r268", "r269", "r272", "r273", "r274", "r275", "r276", "r278", "r279", "r443", "r447", "r448", "r453", "r454", "r463", "r481", "r589" ], "calculation": { "http://www.shapeways.com/role/CondensedConsolidatedStatementsOfCashFlows": { "order": 4.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The consolidated profit or loss for the period, net of income taxes, including the portion attributable to the noncontrolling interest.", "label": "Net Income (Loss), Including Portion Attributable to Noncontrolling Interest", "verboseLabel": "Net income (loss)" } } }, "localname": "ProfitLoss", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.shapeways.com/role/CondensedConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_PropertyPlantAndEquipmentAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Property, Plant and Equipment [Abstract]" } } }, "localname": "PropertyPlantAndEquipmentAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "xbrltype": "stringItemType" }, "us-gaap_PropertyPlantAndEquipmentByTypeAxis": { "auth_ref": [ "r49", "r255" ], "lang": { "en-us": { "role": { "documentation": "Information by type of long-lived, physical assets used to produce goods and services and not intended for resale.", "label": "Long-Lived Tangible Asset [Axis]" } } }, "localname": "PropertyPlantAndEquipmentByTypeAxis", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.shapeways.com/role/CommitmentsAndContingenciesAdditionalInformationDetails", "http://www.shapeways.com/role/PropertyAndEquipmentNetDetails", "http://www.shapeways.com/role/SummaryOfSignificantAccountingPoliciesSummaryOfUsefulLivesOfPropertyPlantAndEquipmentDetails" ], "xbrltype": "stringItemType" }, "us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock": { "auth_ref": [ "r258", "r646", "r647", "r648" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for long-lived, physical asset used in normal conduct of business and not intended for resale. Includes, but is not limited to, work of art, historical treasure, and similar asset classified as collections.", "label": "Property, Plant and Equipment Disclosure [Text Block]", "terseLabel": "Property and Equipment, net" } } }, "localname": "PropertyPlantAndEquipmentDisclosureTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.shapeways.com/role/PropertyAndEquipmentNet" ], "xbrltype": "textBlockItemType" }, "us-gaap_PropertyPlantAndEquipmentGross": { "auth_ref": [ "r48", "r253" ], "calculation": { "http://www.shapeways.com/role/PropertyAndEquipmentNetDetails": { "order": 1.0, "parentTag": "us-gaap_PropertyPlantAndEquipmentNet", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount before accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.", "label": "Property, Plant and Equipment, Gross", "verboseLabel": "Property and equipment, gross" } } }, "localname": "PropertyPlantAndEquipmentGross", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.shapeways.com/role/PropertyAndEquipmentNetDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_PropertyPlantAndEquipmentLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Property, Plant and Equipment [Line Items]" } } }, "localname": "PropertyPlantAndEquipmentLineItems", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.shapeways.com/role/PropertyAndEquipmentNetDetails", "http://www.shapeways.com/role/SummaryOfSignificantAccountingPoliciesSummaryOfUsefulLivesOfPropertyPlantAndEquipmentDetails" ], "xbrltype": "stringItemType" }, "us-gaap_PropertyPlantAndEquipmentNet": { "auth_ref": [ "r21", "r22", "r255", "r525", "r590", "r599" ], "calculation": { "http://www.shapeways.com/role/CondensedConsolidatedBalanceSheets": { "order": 8.0, "parentTag": "us-gaap_Assets", "weight": 1.0 }, "http://www.shapeways.com/role/PropertyAndEquipmentNetDetails": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount after accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business to produce goods and services and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.", "label": "Property, Plant and Equipment, Net", "terseLabel": "Property and equipment, net", "totalLabel": "Property and equipment, net" } } }, "localname": "PropertyPlantAndEquipmentNet", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.shapeways.com/role/CondensedConsolidatedBalanceSheets", "http://www.shapeways.com/role/PropertyAndEquipmentNetDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_PropertyPlantAndEquipmentNetAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Property, Plant and Equipment, Net [Abstract]" } } }, "localname": "PropertyPlantAndEquipmentNetAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "xbrltype": "stringItemType" }, "us-gaap_PropertyPlantAndEquipmentPolicyTextBlock": { "auth_ref": [ "r47", "r255", "r646", "r647" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for long-lived, physical asset used in normal conduct of business and not intended for resale. Includes, but is not limited to, work of art, historical treasure, and similar asset classified as collections.", "label": "Property, Plant and Equipment, Policy [Policy Text Block]", "terseLabel": "Property and Equipment, net" } } }, "localname": "PropertyPlantAndEquipmentPolicyTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.shapeways.com/role/SummaryOfSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_PropertyPlantAndEquipmentTextBlock": { "auth_ref": [ "r21", "r255" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of physical assets used in the normal conduct of business and not intended for resale. Includes, but is not limited to, balances by class of assets, depreciation and depletion expense and method used, including composite depreciation, and accumulated deprecation.", "label": "Property, Plant and Equipment [Table Text Block]", "terseLabel": "Summary of property and equipment" } } }, "localname": "PropertyPlantAndEquipmentTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.shapeways.com/role/PropertyAndEquipmentNetTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_PropertyPlantAndEquipmentTypeDomain": { "auth_ref": [ "r21", "r253" ], "lang": { "en-us": { "role": { "documentation": "Listing of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale. Examples include land, buildings, machinery and equipment, and other types of furniture and equipment including, but not limited to, office equipment, furniture and fixtures, and computer equipment and software.", "label": "Long-Lived Tangible Asset [Domain]" } } }, "localname": "PropertyPlantAndEquipmentTypeDomain", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.shapeways.com/role/CommitmentsAndContingenciesAdditionalInformationDetails", "http://www.shapeways.com/role/PropertyAndEquipmentNetDetails", "http://www.shapeways.com/role/SummaryOfSignificantAccountingPoliciesSummaryOfUsefulLivesOfPropertyPlantAndEquipmentDetails" ], "xbrltype": "domainItemType" }, "us-gaap_PropertyPlantAndEquipmentUsefulLife": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Useful life of long lived, physical assets used in the normal conduct of business and not intended for resale, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days. Examples include, but not limited to, land, buildings, machinery and equipment, office equipment, furniture and fixtures, and computer equipment.", "label": "Property, Plant and Equipment, Useful Life", "terseLabel": "Property, Plant and Equipment, Useful Life" } } }, "localname": "PropertyPlantAndEquipmentUsefulLife", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.shapeways.com/role/SummaryOfSignificantAccountingPoliciesSummaryOfUsefulLivesOfPropertyPlantAndEquipmentDetails" ], "xbrltype": "durationItemType" }, "us-gaap_PurchaseObligation": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Minimum amount of purchase arrangement in which the entity has agreed to expend funds to procure goods or services from a supplier.", "label": "Purchase Obligation", "verboseLabel": "Purchase obligation" } } }, "localname": "PurchaseObligation", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.shapeways.com/role/CommitmentsAndContingenciesAdditionalInformationDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_RelatedPartyDomain": { "auth_ref": [ "r380", "r516", "r517" ], "lang": { "en-us": { "role": { "documentation": "Related parties include affiliates; other entities for which investments are accounted for by the equity method by the entity; trusts for benefit of employees; and principal owners, management, and members of immediate families. It also may include other parties with which the entity may control or can significantly influence the management or operating policies of the other to an extent that one of the transacting parties might be prevented from fully pursuing its own separate interests.", "label": "Related Party [Domain]" } } }, "localname": "RelatedPartyDomain", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.shapeways.com/role/RelatedPartyTransactionsDetails", "http://www.shapeways.com/role/ReverseRecapitalizationDetails" ], "xbrltype": "domainItemType" }, "us-gaap_RelatedPartyTransactionAxis": { "auth_ref": [ "r380", "r516", "r517", "r520" ], "lang": { "en-us": { "role": { "documentation": "Information by type of related party transaction.", "label": "Related Party Transaction [Axis]" } } }, "localname": "RelatedPartyTransactionAxis", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.shapeways.com/role/RelatedPartyTransactionsDetails" ], "xbrltype": "stringItemType" }, "us-gaap_RelatedPartyTransactionDomain": { "auth_ref": [ "r380" ], "lang": { "en-us": { "role": { "documentation": "Transaction between related party.", "label": "Related Party Transaction [Domain]", "terseLabel": "Related Party Transaction [Domain]" } } }, "localname": "RelatedPartyTransactionDomain", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.shapeways.com/role/RelatedPartyTransactionsDetails" ], "xbrltype": "domainItemType" }, "us-gaap_RelatedPartyTransactionLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Related Party Transaction [Line Items]" } } }, "localname": "RelatedPartyTransactionLineItems", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.shapeways.com/role/RelatedPartyTransactionsDetails" ], "xbrltype": "stringItemType" }, "us-gaap_RelatedPartyTransactionsAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Related Party Transactions [Abstract]" } } }, "localname": "RelatedPartyTransactionsAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "xbrltype": "stringItemType" }, "us-gaap_RelatedPartyTransactionsByRelatedPartyAxis": { "auth_ref": [ "r380", "r516", "r520", "r564", "r565", "r566", "r567", "r568", "r569", "r570", "r571", "r572", "r573", "r574", "r575" ], "lang": { "en-us": { "role": { "documentation": "Information by type of related party. Related parties include, but not limited to, affiliates; other entities for which investments are accounted for by the equity method by the entity; trusts for benefit of employees; and principal owners, management, and members of immediate families. It also may include other parties with which the entity may control or can significantly influence the management or operating policies of the other to an extent that one of the transacting parties might be prevented from fully pursuing its own separate interests.", "label": "Related Party [Axis]" } } }, "localname": "RelatedPartyTransactionsByRelatedPartyAxis", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.shapeways.com/role/RelatedPartyTransactionsDetails", "http://www.shapeways.com/role/ReverseRecapitalizationDetails" ], "xbrltype": "stringItemType" }, "us-gaap_RelatedPartyTransactionsDisclosureTextBlock": { "auth_ref": [ "r514", "r515", "r517", "r521", "r522" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for related party transactions. Examples of related party transactions include transactions between (a) a parent company and its subsidiary; (b) subsidiaries of a common parent; (c) and entity and its principal owners; and (d) affiliates.", "label": "Related Party Transactions Disclosure [Text Block]", "terseLabel": "Related Party Transactions" } } }, "localname": "RelatedPartyTransactionsDisclosureTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.shapeways.com/role/RelatedPartyTransactions" ], "xbrltype": "textBlockItemType" }, "us-gaap_RepaymentsOfLinesOfCredit": { "auth_ref": [ "r100", "r124" ], "calculation": { "http://www.shapeways.com/role/CondensedConsolidatedStatementsOfCashFlows": { "order": 24.0, "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of cash outflow for payment of an obligation from a lender, including but not limited to, letter of credit, standby letter of credit and revolving credit arrangements.", "label": "Repayments of Lines of Credit", "negatedLabel": "Repayments of loans payable" } } }, "localname": "RepaymentsOfLinesOfCredit", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.shapeways.com/role/CondensedConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_ResearchAndDevelopmentExpense": { "auth_ref": [ "r420", "r562", "r651" ], "calculation": { "http://www.shapeways.com/role/CondensedConsolidatedStatementsOfOperationsAndComprehensiveLoss": { "order": 3.0, "parentTag": "us-gaap_OperatingExpenses", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The aggregate costs incurred (1) in a planned search or critical investigation aimed at discovery of new knowledge with the hope that such knowledge will be useful in developing a new product or service, a new process or technique, or in bringing about a significant improvement to an existing product or process; or (2) to translate research findings or other knowledge into a plan or design for a new product or process or for a significant improvement to an existing product or process whether intended for sale or the entity's use, during the reporting period charged to research and development projects, including the costs of developing computer software up to the point in time of achieving technological feasibility, and costs allocated in accounting for a business combination to in-process projects deemed to have no alternative future use.", "label": "Research and Development Expense", "terseLabel": "Research and development", "verboseLabel": "Research and development expense" } } }, "localname": "ResearchAndDevelopmentExpense", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.shapeways.com/role/CondensedConsolidatedStatementsOfOperationsAndComprehensiveLoss", "http://www.shapeways.com/role/SummaryOfSignificantAccountingPoliciesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_ResearchAndDevelopmentExpensePolicy": { "auth_ref": [ "r420" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for costs it has incurred (1) in a planned search or critical investigation aimed at discovery of new knowledge with the hope that such knowledge will be useful in developing a new product or service, a new process or technique, or in bringing about a significant improvement to an existing product or process; or (2) to translate research findings or other knowledge into a plan or design for a new product or process or for a significant improvement to an existing product or process.", "label": "Research and Development Expense, Policy [Policy Text Block]", "terseLabel": "Research and Development Costs" } } }, "localname": "ResearchAndDevelopmentExpensePolicy", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.shapeways.com/role/SummaryOfSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_RestrictedCash": { "auth_ref": [ "r116", "r577", "r595" ], "calculation": { "http://www.shapeways.com/role/SummaryOfSignificantAccountingPoliciesSummaryOfReconciliationOfCashAndCashEquivalentsDetails": { "order": 2.0, "parentTag": "us-gaap_RestrictedCashAndCashEquivalentsAtCarryingValue", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of cash restricted as to withdrawal or usage. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits.", "label": "Restricted Cash", "terseLabel": "Restricted cash" } } }, "localname": "RestrictedCash", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.shapeways.com/role/SummaryOfSignificantAccountingPoliciesSummaryOfReconciliationOfCashAndCashEquivalentsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_RestrictedCashAndCashEquivalentsAtCarryingValue": { "auth_ref": [ "r5", "r19", "r110", "r116" ], "calculation": { "http://www.shapeways.com/role/SummaryOfSignificantAccountingPoliciesSummaryOfReconciliationOfCashAndCashEquivalentsDetails": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of cash and cash equivalents restricted as to withdrawal or usage, classified as current. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.", "label": "Restricted Cash and Cash Equivalents, Current", "totalLabel": "Total" } } }, "localname": "RestrictedCashAndCashEquivalentsAtCarryingValue", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.shapeways.com/role/SummaryOfSignificantAccountingPoliciesSummaryOfReconciliationOfCashAndCashEquivalentsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_RestrictedCashCurrent": { "auth_ref": [ "r5", "r19", "r116" ], "calculation": { "http://www.shapeways.com/role/CondensedConsolidatedBalanceSheets": { "order": 3.0, "parentTag": "us-gaap_AssetsCurrent", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of cash restricted as to withdrawal or usage, classified as current. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits.", "label": "Restricted Cash, Current", "terseLabel": "Restricted cash" } } }, "localname": "RestrictedCashCurrent", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.shapeways.com/role/CondensedConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_RetainedEarningsAccumulatedDeficit": { "auth_ref": [ "r32", "r345", "r414", "r525", "r597", "r620", "r625" ], "calculation": { "http://www.shapeways.com/role/CondensedConsolidatedBalanceSheets": { "order": 16.0, "parentTag": "us-gaap_StockholdersEquity", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The cumulative amount of the reporting entity's undistributed earnings or deficit.", "label": "Retained Earnings (Accumulated Deficit)", "terseLabel": "Accumulated deficit" } } }, "localname": "RetainedEarningsAccumulatedDeficit", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.shapeways.com/role/CondensedConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_RetainedEarningsMember": { "auth_ref": [ "r0", "r130", "r131", "r132", "r135", "r142", "r145", "r225", "r411", "r412", "r413", "r429", "r430", "r461", "r616", "r618" ], "lang": { "en-us": { "role": { "documentation": "The cumulative amount of the reporting entity's undistributed earnings or deficit.", "label": "Retained Earnings [Member]", "terseLabel": "Accumulated Deficit" } } }, "localname": "RetainedEarningsMember", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.shapeways.com/role/CondensedConsolidatedStatementsOfChangesInStockholdersEquityDeficit" ], "xbrltype": "domainItemType" }, "us-gaap_RevenueFromContractWithCustomerAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Revenue from Contract with Customer [Abstract]" } } }, "localname": "RevenueFromContractWithCustomerAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "xbrltype": "stringItemType" }, "us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax": { "auth_ref": [ "r181", "r182", "r194", "r199", "r200", "r204", "r205", "r206", "r359", "r360", "r563" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount, excluding tax collected from customer, of revenue from satisfaction of performance obligation by transferring promised good or service to customer. Tax collected from customer is tax assessed by governmental authority that is both imposed on and concurrent with specific revenue-producing transaction, including, but not limited to, sales, use, value added and excise.", "label": "Revenue from Contract with Customer, Excluding Assessed Tax", "verboseLabel": "Total revenue" } } }, "localname": "RevenueFromContractWithCustomerExcludingAssessedTax", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.shapeways.com/role/RevenueRecognitionDisaggregationOfRevenuesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_RevenueFromContractWithCustomerTextBlock": { "auth_ref": [ "r350", "r351", "r352", "r353", "r354", "r355", "r356", "r357", "r363", "r371" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure of revenue from contract with customer to transfer good or service and to transfer nonfinancial asset. Includes, but is not limited to, disaggregation of revenue, credit loss recognized from contract with customer, judgment and change in judgment related to contract with customer, and asset recognized from cost incurred to obtain or fulfill contract with customer. Excludes insurance and lease contracts.", "label": "Revenue from Contract with Customer [Text Block]", "terseLabel": "Revenue Recognition" } } }, "localname": "RevenueFromContractWithCustomerTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.shapeways.com/role/RevenueRecognition" ], "xbrltype": "textBlockItemType" }, "us-gaap_RevenuePracticalExpedientIncrementalCostOfObtainingContract": { "auth_ref": [ "r243", "r358" ], "lang": { "en-us": { "role": { "documentation": "Indicates (true false) whether practical expedient was elected to recognize incremental cost of obtaining contract as expense when incurred if amortization period would have been one year or less.", "label": "Revenue, Practical Expedient, Incremental Cost of Obtaining Contract [true false]", "terseLabel": "Practical Expedients, incremental costs of obtaining a contract" } } }, "localname": "RevenuePracticalExpedientIncrementalCostOfObtainingContract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.shapeways.com/role/RevenueRecognitionPracticalExpedientsAndExemptionsDetails" ], "xbrltype": "booleanItemType" }, "us-gaap_RevenueRecognitionPolicyTextBlock": { "auth_ref": [ "r119", "r120" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for revenue. Includes revenue from contract with customer and from other sources.", "label": "Revenue [Policy Text Block]", "terseLabel": "Revenue Recognition" } } }, "localname": "RevenueRecognitionPolicyTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.shapeways.com/role/SummaryOfSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_Revenues": { "auth_ref": [ "r83", "r125", "r181", "r182", "r194", "r199", "r200", "r204", "r205", "r206", "r224", "r267", "r268", "r269", "r272", "r273", "r274", "r275", "r276", "r278", "r279", "r481", "r589" ], "calculation": { "http://www.shapeways.com/role/CondensedConsolidatedStatementsOfOperationsAndComprehensiveLoss": { "order": 6.0, "parentTag": "us-gaap_GrossProfit", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of revenue recognized from goods sold, services rendered, insurance premiums, or other activities that constitute an earning process. Includes, but is not limited to, investment and interest income before deduction of interest expense when recognized as a component of revenue, and sales and trading gain (loss).", "label": "Revenues", "terseLabel": "Revenue, net" } } }, "localname": "Revenues", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.shapeways.com/role/CondensedConsolidatedStatementsOfOperationsAndComprehensiveLoss" ], "xbrltype": "monetaryItemType" }, "us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability": { "auth_ref": [ "r508", "r513" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of increase in right-of-use asset obtained in exchange for operating lease liability.", "label": "Right-of-Use Asset Obtained in Exchange for Operating Lease Liability", "terseLabel": "Lease liabilities arising from obtaining\u00a0right-of-use\u00a0assets" } } }, "localname": "RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.shapeways.com/role/CommitmentsAndContingenciesSupplementalCashFlowDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_RisksAndUncertaintiesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Risks and Uncertainties [Abstract]" } } }, "localname": "RisksAndUncertaintiesAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "xbrltype": "stringItemType" }, "us-gaap_SaleOfStockNameOfTransactionDomain": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Sale of the entity's stock, including, but not limited to, initial public offering (IPO) and private placement.", "label": "Sale of Stock [Domain]", "terseLabel": "Sale of Stock [Domain]", "verboseLabel": "IPO [Member]" } } }, "localname": "SaleOfStockNameOfTransactionDomain", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.shapeways.com/role/OrganizationDetails", "http://www.shapeways.com/role/SummaryOfSignificantAccountingPoliciesDetails" ], "xbrltype": "domainItemType" }, "us-gaap_SaleOfStockPricePerShare": { "auth_ref": [], "lang": { "en-us": { "role": { "disclosureGuidance": "Sale of stock price per share", "documentation": "Per share amount received by subsidiary or equity investee for each share of common stock issued or sold in the stock transaction.", "label": "Sale of Stock, Price Per Share", "verboseLabel": "Purchase price per share" } } }, "localname": "SaleOfStockPricePerShare", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.shapeways.com/role/ReverseRecapitalizationDetails", "http://www.shapeways.com/role/SummaryOfSignificantAccountingPoliciesDetails" ], "xbrltype": "perShareItemType" }, "us-gaap_SalesRevenueNetMember": { "auth_ref": [ "r174", "r206" ], "lang": { "en-us": { "role": { "documentation": "Revenue from sale of product and rendering of service and other sources of income, when it serves as benchmark in concentration of risk calculation.", "label": "Revenue Benchmark [Member]" } } }, "localname": "SalesRevenueNetMember", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.shapeways.com/role/SignificantConcentrationsDetails" ], "xbrltype": "domainItemType" }, "us-gaap_ScheduleOfCashAndCashEquivalentsTableTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of the components of cash and cash equivalents.", "label": "Schedule of Cash and Cash Equivalents [Table Text Block]", "terseLabel": "Summary Of Reconciliation Of Cash And Cash Equivalents" } } }, "localname": "ScheduleOfCashAndCashEquivalentsTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.shapeways.com/role/SummaryOfSignificantAccountingPoliciesTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfCommonStockOutstandingRollForwardTableTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of the change in common stock outstanding.", "label": "Schedule of Common Stock Outstanding Roll Forward [Table Text Block]", "terseLabel": "Summary Of Common Stock equivalents Outstanding Were Excluded From Computation Of Diluted Net Loss Per Share" } } }, "localname": "ScheduleOfCommonStockOutstandingRollForwardTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.shapeways.com/role/SummaryOfSignificantAccountingPoliciesTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfDebtTableTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of information pertaining to short-term and long-debt instruments or arrangements, including but not limited to identification of terms, features, collateral requirements and other information necessary to a fair presentation.", "label": "Schedule of Debt [Table Text Block]", "terseLabel": "Summary of outstanding debt obligation" } } }, "localname": "ScheduleOfDebtTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.shapeways.com/role/BorrowingArrangementsTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable": { "auth_ref": [ "r388", "r407", "r416" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of information about amount recognized for award under share-based payment arrangement. Includes, but is not limited to, amount expensed in statement of income or comprehensive income, amount capitalized in statement of financial position, and corresponding reporting line item in financial statements.", "label": "Share-based Payment Arrangement, Expensed and Capitalized, Amount [Table]" } } }, "localname": "ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.shapeways.com/role/StockBasedCompensationDetails" ], "xbrltype": "stringItemType" }, "us-gaap_ScheduleOfHeldToMaturitySecuritiesLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Schedule of Held-to-maturity Securities [Line Items]" } } }, "localname": "ScheduleOfHeldToMaturitySecuritiesLineItems", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.shapeways.com/role/FairValueMeasurementsDetails" ], "xbrltype": "stringItemType" }, "us-gaap_ScheduleOfHeldToMaturitySecuritiesTable": { "auth_ref": [ "r218", "r219", "r220" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of information about investment in debt security measured at amortized cost (held-to-maturity).", "label": "Debt Securities, Held-to-maturity [Table]" } } }, "localname": "ScheduleOfHeldToMaturitySecuritiesTable", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.shapeways.com/role/FairValueMeasurementsDetails" ], "xbrltype": "stringItemType" }, "us-gaap_ScheduleOfImpairedFinancingReceivableTable": { "auth_ref": [ "r213" ], "lang": { "en-us": { "role": { "documentation": "Schedule of the recorded investment, unpaid principal balance, associated allowance, average recorded investment, accounting policies, and interest income recognized on the accrual and cash basis for impaired financing receivables by class of financing receivable.", "label": "Schedule of Impaired Financing Receivable [Table]" } } }, "localname": "ScheduleOfImpairedFinancingReceivableTable", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.shapeways.com/role/SummaryOfSignificantAccountingPoliciesDetails" ], "xbrltype": "stringItemType" }, "us-gaap_ScheduleOfInventoryCurrentTableTextBlock": { "auth_ref": [ "r17", "r41", "r42", "r43" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of the carrying amount as of the balance sheet date of merchandise, goods, commodities, or supplies held for future sale or to be used in manufacturing, servicing or production process.", "label": "Schedule of Inventory, Current [Table Text Block]", "terseLabel": "Summary of components of inventory" } } }, "localname": "ScheduleOfInventoryCurrentTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.shapeways.com/role/InventoryTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfPropertyPlantAndEquipmentTable": { "auth_ref": [ "r49", "r255" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of information about physical assets used in the normal conduct of business and not intended for resale. Includes, but is not limited to, balances by class of assets, depreciation and depletion expense and method used, including composite depreciation, and accumulated deprecation.", "label": "Property, Plant and Equipment [Table]" } } }, "localname": "ScheduleOfPropertyPlantAndEquipmentTable", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.shapeways.com/role/PropertyAndEquipmentNetDetails", "http://www.shapeways.com/role/SummaryOfSignificantAccountingPoliciesSummaryOfUsefulLivesOfPropertyPlantAndEquipmentDetails" ], "xbrltype": "stringItemType" }, "us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable": { "auth_ref": [ "r518", "r520" ], "lang": { "en-us": { "role": { "documentation": "Schedule of quantitative and qualitative information pertaining to related party transactions. Examples of related party transactions include transactions between (a) a parent company and its subsidiary; (b) subsidiaries of a common parent; (c) and entity and its principal owners; and (d) affiliates.", "label": "Schedule of Related Party Transactions, by Related Party [Table]" } } }, "localname": "ScheduleOfRelatedPartyTransactionsByRelatedPartyTable", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.shapeways.com/role/RelatedPartyTransactionsDetails" ], "xbrltype": "stringItemType" }, "us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable": { "auth_ref": [ "r389", "r410" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of information about share-based payment arrangement.", "label": "Schedule of Share-based Compensation Arrangements by Share-based Payment Award [Table]" } } }, "localname": "ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.shapeways.com/role/StockBasedCompensationFairValueOfStockBasedCompensationDetails", "http://www.shapeways.com/role/StockBasedCompensationStockOptionPlanDetails" ], "xbrltype": "stringItemType" }, "us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock": { "auth_ref": [ "r393", "r399", "r401" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure for stock option plans. Includes, but is not limited to, outstanding awards at beginning and end of year, grants, exercises, forfeitures, and weighted-average grant date fair value.", "label": "Share-based Payment Arrangement, Option, Activity [Table Text Block]", "terseLabel": "Summary of stock option plan and the activity" } } }, "localname": "ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.shapeways.com/role/StockBasedCompensationTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock": { "auth_ref": [ "r404" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of the significant assumptions used during the year to estimate the fair value of stock options, including, but not limited to: (a) expected term of share options and similar instruments, (b) expected volatility of the entity's shares, (c) expected dividends, (d) risk-free rate(s), and (e) discount for post-vesting restrictions.", "label": "Schedule of Share-based Payment Award, Stock Options, Valuation Assumptions [Table Text Block]", "terseLabel": "Summary of assumptions used to determine the fair value of the stock options" } } }, "localname": "ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.shapeways.com/role/StockBasedCompensationTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfStockByClassTable": { "auth_ref": [ "r62", "r122", "r165", "r166", "r317", "r318", "r319", "r320", "r321", "r322", "r323", "r325", "r329", "r335", "r338", "r339", "r340", "r342", "r343", "r344", "r345" ], "lang": { "en-us": { "role": { "documentation": "Schedule detailing information related to equity by class of stock. Class of stock includes common, convertible, and preferred stocks which are not redeemable or redeemable solely at the option of the issuer. It also includes preferred stock with redemption features that are solely within the control of the issuer and mandatorily redeemable stock if redemption is required to occur only upon liquidation or termination of the reporting entity.", "label": "Schedule of Stock by Class [Table]" } } }, "localname": "ScheduleOfStockByClassTable", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.shapeways.com/role/StockholdersEquityDeficitDetails" ], "xbrltype": "stringItemType" }, "us-gaap_SegmentReportingPolicyPolicyTextBlock": { "auth_ref": [ "r188", "r189", "r190", "r191", "r192", "r193", "r205" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for segment reporting.", "label": "Segment Reporting, Policy [Policy Text Block]", "terseLabel": "Segment Information" } } }, "localname": "SegmentReportingPolicyPolicyTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.shapeways.com/role/SummaryOfSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_SellingGeneralAndAdministrativeExpense": { "auth_ref": [ "r91" ], "calculation": { "http://www.shapeways.com/role/CondensedConsolidatedStatementsOfOperationsAndComprehensiveLoss": { "order": 2.0, "parentTag": "us-gaap_OperatingExpenses", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The aggregate total costs related to selling a firm's product and services, as well as all other general and administrative expenses. Direct selling expenses (for example, credit, warranty, and advertising) are expenses that can be directly linked to the sale of specific products. Indirect selling expenses are expenses that cannot be directly linked to the sale of specific products, for example telephone expenses, Internet, and postal charges. General and administrative expenses include salaries of non-sales personnel, rent, utilities, communication, etc.", "label": "Selling, General and Administrative Expense", "terseLabel": "Selling, general and administrative" } } }, "localname": "SellingGeneralAndAdministrativeExpense", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.shapeways.com/role/CondensedConsolidatedStatementsOfOperationsAndComprehensiveLoss" ], "xbrltype": "monetaryItemType" }, "us-gaap_SeriesDPreferredStockMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Outstanding nonredeemable series D preferred stock or outstanding series D preferred stock. Classified within stockholders' equity if nonredeemable or redeemable solely at the option of the issuer. Classified within temporary equity if redemption is outside the control of the issuer.", "label": "Series D Preferred Stock [Member]" } } }, "localname": "SeriesDPreferredStockMember", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.shapeways.com/role/CondensedConsolidatedStatementsOfChangesInStockholdersEquityDeficit" ], "xbrltype": "domainItemType" }, "us-gaap_ShareBasedCompensation": { "auth_ref": [ "r107" ], "calculation": { "http://www.shapeways.com/role/CondensedConsolidatedStatementsOfCashFlows": { "order": 8.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of noncash expense for share-based payment arrangement.", "label": "Share-based Payment Arrangement, Noncash Expense", "terseLabel": "Stock-based compensation expense" } } }, "localname": "ShareBasedCompensation", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.shapeways.com/role/CondensedConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod": { "auth_ref": [ "r398" ], "lang": { "en-us": { "role": { "documentation": "The number of grants made during the period on other than stock (or unit) option plans (for example, phantom stock or unit plan, stock or unit appreciation rights plan, performance target plan).", "label": "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period", "terseLabel": "Number of restricted stock units granted" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.shapeways.com/role/ReverseRecapitalizationDetails" ], "xbrltype": "sharesItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate": { "auth_ref": [ "r406" ], "lang": { "en-us": { "role": { "documentation": "The estimated dividend rate (a percentage of the share price) to be paid (expected dividends) to holders of the underlying shares over the option's term.", "label": "Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Dividend Rate", "terseLabel": "Dividend yield" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.shapeways.com/role/StockBasedCompensationFairValueOfStockBasedCompensationDetails" ], "xbrltype": "percentItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The estimated measure of the maximum percentage by which a share price is expected to fluctuate during a period. Volatility also may be defined as a probability-weighted measure of the dispersion of returns about the mean. The volatility of a share price is the standard deviation of the continuously compounded rates of return on the share over a specified period. That is the same as the standard deviation of the differences in the natural logarithms of the stock prices plus dividends, if any, over the period.", "label": "Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Volatility Rate, Maximum", "terseLabel": "Expected volatility , maximum" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.shapeways.com/role/StockBasedCompensationFairValueOfStockBasedCompensationDetails" ], "xbrltype": "percentItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The estimated measure of the minimum percentage by which a share price is expected to fluctuate during a period. Volatility also may be defined as a probability-weighted measure of the dispersion of returns about the mean. The volatility of a share price is the standard deviation of the continuously compounded rates of return on the share over a specified period. That is the same as the standard deviation of the differences in the natural logarithms of the stock prices plus dividends, if any, over the period.", "label": "Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Volatility Rate, Minimum", "terseLabel": "Expected volatility , minimum" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.shapeways.com/role/StockBasedCompensationFairValueOfStockBasedCompensationDetails" ], "xbrltype": "percentItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The maximum risk-free interest rate assumption that is used in valuing an option on its own shares.", "label": "Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate, Maximum", "terseLabel": "Risk-free interest rate , maximum" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.shapeways.com/role/StockBasedCompensationFairValueOfStockBasedCompensationDetails" ], "xbrltype": "percentItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The minimum risk-free interest rate assumption that is used in valuing an option on its own shares.", "label": "Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate, Minimum", "terseLabel": "Risk-free interest rate , mininum" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.shapeways.com/role/StockBasedCompensationFairValueOfStockBasedCompensationDetails" ], "xbrltype": "percentItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Share-based Compensation Arrangement by Share-based Payment Award [Line Items]" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.shapeways.com/role/StockBasedCompensationFairValueOfStockBasedCompensationDetails", "http://www.shapeways.com/role/StockBasedCompensationStockOptionPlanDetails" ], "xbrltype": "stringItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized": { "auth_ref": [ "r390" ], "lang": { "en-us": { "role": { "documentation": "Number of shares authorized for issuance under share-based payment arrangement.", "label": "Share-based Compensation Arrangement by Share-based Payment Award, Number of Shares Authorized", "terseLabel": "Maximum number of shares authorized for issuance" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.shapeways.com/role/StockBasedCompensationDetails" ], "xbrltype": "sharesItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant": { "auth_ref": [ "r410" ], "lang": { "en-us": { "role": { "documentation": "The difference between the maximum number of shares (or other type of equity) authorized for issuance under the plan (including the effects of amendments and adjustments), and the sum of: 1) the number of shares (or other type of equity) already issued upon exercise of options or other equity-based awards under the plan; and 2) shares (or other type of equity) reserved for issuance on granting of outstanding awards, net of cancellations and forfeitures, if applicable.", "label": "Share-based Compensation Arrangement by Share-based Payment Award, Number of Shares Available for Grant", "terseLabel": "Number of shares remain available for issuance" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.shapeways.com/role/StockBasedCompensationDetails" ], "xbrltype": "sharesItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Additional Disclosures [Abstract]", "terseLabel": "Weighted Average Remaining Contractual Term (in years)" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.shapeways.com/role/StockBasedCompensationStockOptionPlanDetails" ], "xbrltype": "stringItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod": { "auth_ref": [ "r397" ], "lang": { "en-us": { "role": { "documentation": "The number of shares under options that were cancelled during the reporting period as a result of occurrence of a terminating event specified in contractual agreements pertaining to the stock option plan.", "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures in Period", "negatedLabel": "Forfeited" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.shapeways.com/role/StockBasedCompensationStockOptionPlanDetails" ], "xbrltype": "sharesItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Gross number of share options (or share units) granted during the period.", "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross", "terseLabel": "Granted", "verboseLabel": "Number of shares awarded" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.shapeways.com/role/StockBasedCompensationDetails", "http://www.shapeways.com/role/StockBasedCompensationStockOptionPlanDetails" ], "xbrltype": "sharesItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue": { "auth_ref": [ "r400" ], "lang": { "en-us": { "role": { "documentation": "The weighted average grant-date fair value of options granted during the reporting period as calculated by applying the disclosed option pricing methodology.", "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Weighted Average Grant Date Fair Value", "terseLabel": "Weighted-average grant-date fair value per stock option granted" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.shapeways.com/role/StockBasedCompensationDetails" ], "xbrltype": "perShareItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber": { "auth_ref": [ "r395", "r410" ], "lang": { "en-us": { "role": { "documentation": "Number of options outstanding, including both vested and non-vested options.", "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Number", "periodEndLabel": "Outstanding at ending", "periodStartLabel": "Outstanding at beginning" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.shapeways.com/role/StockBasedCompensationStockOptionPlanDetails" ], "xbrltype": "sharesItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.", "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding [Roll Forward]", "terseLabel": "Shares Underlying Options" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.shapeways.com/role/StockBasedCompensationStockOptionPlanDetails" ], "xbrltype": "stringItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice": { "auth_ref": [ "r394" ], "lang": { "en-us": { "role": { "documentation": "Weighted average price at which grantees can acquire the shares reserved for issuance under the stock option plan.", "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price", "periodEndLabel": "Outstanding at ending (in dollars per share)", "periodStartLabel": "Outstanding at beginning (in dollars per share)", "terseLabel": "Average exercise price per share" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.shapeways.com/role/StockBasedCompensationDetails", "http://www.shapeways.com/role/StockBasedCompensationStockOptionPlanDetails" ], "xbrltype": "perShareItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue": { "auth_ref": [ "r403" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount by which current fair value of underlying stock exceeds exercise price of fully vested and expected to vest exercisable or convertible options. Includes, but is not limited to, unvested options for which requisite service period has not been rendered but that are expected to vest based on achievement of performance condition, if forfeitures are recognized when they occur.", "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Exercisable, Aggregate Intrinsic Value", "terseLabel": "Exercisable at the end (in dollars)" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.shapeways.com/role/StockBasedCompensationStockOptionPlanDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber": { "auth_ref": [ "r403" ], "lang": { "en-us": { "role": { "documentation": "Number of fully vested and expected to vest exercisable options that may be converted into shares under option plan. Includes, but is not limited to, unvested options for which requisite service period has not been rendered but that are expected to vest based on achievement of performance condition, if forfeitures are recognized when they occur.", "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Exercisable, Number", "terseLabel": "Exercisable" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.shapeways.com/role/StockBasedCompensationStockOptionPlanDetails" ], "xbrltype": "sharesItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice": { "auth_ref": [ "r403" ], "lang": { "en-us": { "role": { "documentation": "Weighted-average exercise price, at which grantee can acquire shares reserved for issuance, for fully vested and expected to vest exercisable or convertible options. Includes, but is not limited to, unvested options for which requisite service period has not been rendered but that are expected to vest based on achievement of performance condition, if forfeitures are recognized when they occur.", "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Exercisable, Weighted Average Exercise Price", "terseLabel": "Exercisable (in dollars per share)" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.shapeways.com/role/StockBasedCompensationStockOptionPlanDetails" ], "xbrltype": "perShareItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesPurchasedForAward": { "auth_ref": [ "r387", "r410" ], "lang": { "en-us": { "role": { "documentation": "Number of shares purchased for issuance under share-based payment arrangement.", "label": "Share-based Compensation Arrangement by Share-based Payment Award, Shares Purchased for Award", "terseLabel": "Number of shares purchased" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesPurchasedForAward", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.shapeways.com/role/StockBasedCompensationDetails" ], "xbrltype": "sharesItemType" }, "us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain": { "auth_ref": [ "r387", "r391" ], "lang": { "en-us": { "role": { "documentation": "Award under share-based payment arrangement.", "label": "Award Type [Domain]" } } }, "localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.shapeways.com/role/ReverseRecapitalizationDetails", "http://www.shapeways.com/role/StockBasedCompensationDetails" ], "xbrltype": "domainItemType" }, "us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Weighted average price at which option holders acquired shares when converting their stock options into shares.", "label": "Share-based Compensation Arrangements by Share-based Payment Award, Options, Exercises in Period, Weighted Average Exercise Price", "terseLabel": "Exercised (in dollars per share)" } } }, "localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.shapeways.com/role/StockBasedCompensationStockOptionPlanDetails" ], "xbrltype": "perShareItemType" }, "us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Weighted average price at which grantees could have acquired the underlying shares with respect to stock options that were terminated.", "label": "Share-based Compensation Arrangements by Share-based Payment Award, Options, Forfeitures in Period, Weighted Average Exercise Price", "terseLabel": "Forfeited (in dollars per share)" } } }, "localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.shapeways.com/role/StockBasedCompensationStockOptionPlanDetails" ], "xbrltype": "perShareItemType" }, "us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Weighted average per share amount at which grantees can acquire shares of common stock by exercise of options.", "label": "Share-based Compensation Arrangements by Share-based Payment Award, Options, Grants in Period, Weighted Average Exercise Price", "terseLabel": "Granted (in dollars per share)" } } }, "localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.shapeways.com/role/StockBasedCompensationStockOptionPlanDetails" ], "xbrltype": "perShareItemType" }, "us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy": { "auth_ref": [ "r389", "r392" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for award under share-based payment arrangement. Includes, but is not limited to, methodology and assumption used in measuring cost.", "label": "Share-based Payment Arrangement [Policy Text Block]", "terseLabel": "Stock-based Compensation" } } }, "localname": "ShareBasedCompensationOptionAndIncentivePlansPolicy", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.shapeways.com/role/SummaryOfSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_ShareBasedGoodsAndNonemployeeServicesTransactionBySupplierAxis": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Information by supplier.", "label": "Supplier [Axis]" } } }, "localname": "ShareBasedGoodsAndNonemployeeServicesTransactionBySupplierAxis", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.shapeways.com/role/SignificantConcentrationsDetails" ], "xbrltype": "stringItemType" }, "us-gaap_ShareBasedGoodsAndNonemployeeServicesTransactionSupplierDomain": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Specific identification or general nature of (for example, a construction contractor, a consulting firm) the party from whom the goods or services were or are to be received.", "label": "Supplier [Domain]" } } }, "localname": "ShareBasedGoodsAndNonemployeeServicesTransactionSupplierDomain", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.shapeways.com/role/SignificantConcentrationsDetails" ], "xbrltype": "domainItemType" }, "us-gaap_SharePrice": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Price of a single share of a number of saleable stocks of a company.", "label": "Share Price", "terseLabel": "Share price" } } }, "localname": "SharePrice", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.shapeways.com/role/FairValueMeasurementsDetails", "http://www.shapeways.com/role/StockBasedCompensationFairValueOfStockBasedCompensationDetails" ], "xbrltype": "perShareItemType" }, "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1": { "auth_ref": [ "r405", "r415" ], "lang": { "en-us": { "role": { "documentation": "Expected term of award under share-based payment arrangement, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.", "label": "Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Term", "terseLabel": "Expected term (in years)" } } }, "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.shapeways.com/role/StockBasedCompensationFairValueOfStockBasedCompensationDetails" ], "xbrltype": "durationItemType" }, "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2": { "auth_ref": [ "r402" ], "lang": { "en-us": { "role": { "documentation": "Weighted average remaining contractual term for option awards outstanding, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.", "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Remaining Contractual Term", "terseLabel": "Outstanding (in years)" } } }, "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.shapeways.com/role/StockBasedCompensationStockOptionPlanDetails" ], "xbrltype": "durationItemType" }, "us-gaap_SharesSubjectToMandatoryRedemptionSettlementTermsFairValueOfShares": { "auth_ref": [ "r316" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The fair value of shares that would be issued, determined under the conditions specified in the contract if the settlement were to occur at the reporting date.", "label": "Financial Instruments Subject to Mandatory Redemption, Settlement Terms, Fair Value of Shares", "periodEndLabel": "Fair value, End period", "periodStartLabel": "Fair value, Beginning period", "terseLabel": "Warrant liability" } } }, "localname": "SharesSubjectToMandatoryRedemptionSettlementTermsFairValueOfShares", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.shapeways.com/role/FairValueMeasurementsDetails", "http://www.shapeways.com/role/FairValueMeasurementsSubsequentMeasurementDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_ShortTermDebtTypeAxis": { "auth_ref": [ "r52" ], "lang": { "en-us": { "role": { "documentation": "Information by type of short-term debt arrangement.", "label": "Short-term Debt, Type [Axis]" } } }, "localname": "ShortTermDebtTypeAxis", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.shapeways.com/role/RelatedPartyTransactionsDetails" ], "xbrltype": "stringItemType" }, "us-gaap_ShortTermDebtTypeDomain": { "auth_ref": [ "r51" ], "lang": { "en-us": { "role": { "documentation": "Type of short-term debt arrangement, such as notes, line of credit, commercial paper, asset-based financing, project financing, letter of credit financing.", "label": "Short-term Debt, Type [Domain]", "terseLabel": "Short-term Debt, Type [Domain]" } } }, "localname": "ShortTermDebtTypeDomain", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.shapeways.com/role/RelatedPartyTransactionsDetails" ], "xbrltype": "domainItemType" }, "us-gaap_ShortTermLeaseCost": { "auth_ref": [ "r506", "r513" ], "calculation": { "http://www.shapeways.com/role/CommitmentsAndContingenciesCompanysLeaseCostsDetails": { "order": 4.0, "parentTag": "us-gaap_LeaseCost", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of short-term lease cost, excluding expense for lease with term of one month or less.", "label": "Short-term Lease, Cost", "terseLabel": "Short-term lease expense" } } }, "localname": "ShortTermLeaseCost", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.shapeways.com/role/CommitmentsAndContingenciesCompanysLeaseCostsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_SignificantAccountingPoliciesTextBlock": { "auth_ref": [ "r117", "r129" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for all significant accounting policies of the reporting entity.", "label": "Significant Accounting Policies [Text Block]", "terseLabel": "Summary of Significant Accounting Policies" } } }, "localname": "SignificantAccountingPoliciesTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.shapeways.com/role/SummaryOfSignificantAccountingPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_SoftwareAndSoftwareDevelopmentCostsMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Purchased software applications and internally developed software for sale, licensing or long-term internal use.", "label": "Software and Software Development Costs [Member]", "terseLabel": "Software" } } }, "localname": "SoftwareAndSoftwareDevelopmentCostsMember", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.shapeways.com/role/RevenueRecognitionDisaggregationOfRevenuesDetails" ], "xbrltype": "domainItemType" }, "us-gaap_StatementClassOfStockAxis": { "auth_ref": [ "r26", "r27", "r28", "r122", "r125", "r150", "r151", "r152", "r155", "r157", "r165", "r166", "r167", "r224", "r267", "r272", "r273", "r274", "r278", "r279", "r320", "r321", "r325", "r329", "r337", "r481", "r657" ], "lang": { "en-us": { "role": { "documentation": "Information by the different classes of stock of the entity.", "label": "Class of Stock [Axis]" } } }, "localname": "StatementClassOfStockAxis", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.shapeways.com/role/CondensedConsolidatedStatementsOfChangesInStockholdersEquityDeficit", "http://www.shapeways.com/role/CondensedConsolidatedStatementsOfOperationsAndComprehensiveLoss", "http://www.shapeways.com/role/CoverPage", "http://www.shapeways.com/role/OrganizationDetails", "http://www.shapeways.com/role/StockholdersEquityDeficitDetails" ], "xbrltype": "stringItemType" }, "us-gaap_StatementEquityComponentsAxis": { "auth_ref": [ "r0", "r64", "r79", "r80", "r81", "r130", "r131", "r132", "r135", "r142", "r145", "r164", "r225", "r337", "r345", "r411", "r412", "r413", "r429", "r430", "r461", "r483", "r484", "r485", "r486", "r487", "r488", "r616", "r617", "r618", "r668" ], "lang": { "en-us": { "role": { "documentation": "Information by component of equity.", "label": "Equity Components [Axis]" } } }, "localname": "StatementEquityComponentsAxis", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.shapeways.com/role/BorrowingArrangementsConvertiblePromissoryNotesDetails", "http://www.shapeways.com/role/CondensedConsolidatedStatementsOfChangesInStockholdersEquityDeficit", "http://www.shapeways.com/role/CoverPage", "http://www.shapeways.com/role/FairValueMeasurementsDetails", "http://www.shapeways.com/role/RelatedPartyTransactionsDetails", "http://www.shapeways.com/role/ReverseRecapitalizationDetails", "http://www.shapeways.com/role/ReverseRecapitalizationScheduleOfCommonStockSharesIssuedFollowingTheConsummationOfBusinessCombinationDetails", "http://www.shapeways.com/role/StockholdersEquityDeficitDetails" ], "xbrltype": "stringItemType" }, "us-gaap_StatementLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Statement [Line Items]" } } }, "localname": "StatementLineItems", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.shapeways.com/role/CondensedConsolidatedStatementsOfChangesInStockholdersEquityDeficit", "http://www.shapeways.com/role/CondensedConsolidatedStatementsOfOperationsAndComprehensiveLoss" ], "xbrltype": "stringItemType" }, "us-gaap_StatementOfCashFlowsAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Statement of Cash Flows [Abstract]" } } }, "localname": "StatementOfCashFlowsAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "xbrltype": "stringItemType" }, "us-gaap_StatementOfFinancialPositionAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "CONSOLIDATED BALANCE SHEETS" } } }, "localname": "StatementOfFinancialPositionAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "xbrltype": "stringItemType" }, "us-gaap_StatementOfStockholdersEquityAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "CONSOLIDATED STATEMENTS OF CHANGES IN SHAREHOLDERS' EQUITY (Unaudited)" } } }, "localname": "StatementOfStockholdersEquityAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "xbrltype": "stringItemType" }, "us-gaap_StatementTable": { "auth_ref": [ "r130", "r131", "r132", "r164", "r563" ], "lang": { "en-us": { "role": { "documentation": "Schedule reflecting a Statement of Income, Statement of Cash Flows, Statement of Financial Position, Statement of Shareholders' Equity and Other Comprehensive Income, or other statement as needed.", "label": "Statement [Table]" } } }, "localname": "StatementTable", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.shapeways.com/role/CondensedConsolidatedStatementsOfChangesInStockholdersEquityDeficit", "http://www.shapeways.com/role/CondensedConsolidatedStatementsOfOperationsAndComprehensiveLoss" ], "xbrltype": "stringItemType" }, "us-gaap_StockIssuedDuringPeriodSharesAcquisitions": { "auth_ref": [ "r27", "r28", "r345" ], "lang": { "en-us": { "role": { "documentation": "Number of shares of stock issued during the period pursuant to acquisitions.", "label": "Stock Issued During Period, Shares, Acquisitions", "terseLabel": "Effect of Merger and recapitalization, net of redemptions and issuance costs (shares)" } } }, "localname": "StockIssuedDuringPeriodSharesAcquisitions", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.shapeways.com/role/CondensedConsolidatedStatementsOfChangesInStockholdersEquityDeficit" ], "xbrltype": "sharesItemType" }, "us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities": { "auth_ref": [ "r63", "r298", "r337", "r338", "r345" ], "lang": { "en-us": { "role": { "documentation": "Number of shares issued during the period as a result of the conversion of convertible securities.", "label": "Stock Issued During Period, Shares, Conversion of Convertible Securities", "terseLabel": "Issuance of Legacy Shapeways common stock upon conversion of convertible notes (shares)" } } }, "localname": "StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.shapeways.com/role/CondensedConsolidatedStatementsOfChangesInStockholdersEquityDeficit" ], "xbrltype": "sharesItemType" }, "us-gaap_StockIssuedDuringPeriodSharesConversionOfUnits": { "auth_ref": [ "r27", "r28", "r337", "r338", "r345" ], "lang": { "en-us": { "role": { "documentation": "The number of shares issued during the period upon the conversion of units. An example of a convertible unit is an umbrella partnership real estate investment trust unit (UPREIT unit).", "label": "Stock Issued During Period, Shares, Conversion of Units", "terseLabel": "Issuance of Legacy Shapeways convertible Series\u00a0preferred stock resulting from exercise of warrants (shares)" } } }, "localname": "StockIssuedDuringPeriodSharesConversionOfUnits", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.shapeways.com/role/CondensedConsolidatedStatementsOfChangesInStockholdersEquityDeficit" ], "xbrltype": "sharesItemType" }, "us-gaap_StockIssuedDuringPeriodSharesNewIssues": { "auth_ref": [ "r27", "r28", "r337", "r345" ], "lang": { "en-us": { "role": { "documentation": "Number of new stock issued during the period.", "label": "Stock Issued During Period, Shares, New Issues", "terseLabel": "Stock issued during period new shares issued" } } }, "localname": "StockIssuedDuringPeriodSharesNewIssues", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.shapeways.com/role/ReverseRecapitalizationDetails", "http://www.shapeways.com/role/ReverseRecapitalizationScheduleOfCommonStockSharesIssuedFollowingTheConsummationOfBusinessCombinationDetails", "http://www.shapeways.com/role/SummaryOfSignificantAccountingPoliciesDetails" ], "xbrltype": "sharesItemType" }, "us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised": { "auth_ref": [ "r27", "r28", "r337", "r345", "r396" ], "lang": { "en-us": { "role": { "documentation": "Number of share options (or share units) exercised during the current period.", "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period", "negatedLabel": "Exercised", "terseLabel": "Issuance of Legacy Shapeways common stock upon exercise of stock options (Shares)" } } }, "localname": "StockIssuedDuringPeriodSharesStockOptionsExercised", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.shapeways.com/role/CondensedConsolidatedStatementsOfChangesInStockholdersEquityDeficit", "http://www.shapeways.com/role/StockBasedCompensationStockOptionPlanDetails" ], "xbrltype": "sharesItemType" }, "us-gaap_StockIssuedDuringPeriodValueAcquisitions": { "auth_ref": [ "r64", "r337", "r345" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Value of stock issued pursuant to acquisitions during the period.", "label": "Stock Issued During Period, Value, Acquisitions", "terseLabel": "Effect of Merger and recapitalization, net of redemptions and issuance costs" } } }, "localname": "StockIssuedDuringPeriodValueAcquisitions", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.shapeways.com/role/CondensedConsolidatedStatementsOfChangesInStockholdersEquityDeficit" ], "xbrltype": "monetaryItemType" }, "us-gaap_StockIssuedDuringPeriodValueConversionOfConvertibleSecuritiesNetOfAdjustments": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The net amount of stock issued during the period upon the conversion of convertible securities, net of adjustments (for example, to additional paid in capital) including the write-off of an equity component recognized to record the convertible debt instrument as two separate components - a debt component and an equity component. This item is meant to disclose the value of shares issued on conversion of convertible securities that were recorded as two separate (debt and equity) components.", "label": "Stock Issued During Period, Value, Conversion of Convertible Securities, Net of Adjustments", "terseLabel": "Issuance of Legacy Shapeways common stock upon conversion of convertible notes" } } }, "localname": "StockIssuedDuringPeriodValueConversionOfConvertibleSecuritiesNetOfAdjustments", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.shapeways.com/role/CondensedConsolidatedStatementsOfChangesInStockholdersEquityDeficit" ], "xbrltype": "monetaryItemType" }, "us-gaap_StockIssuedDuringPeriodValueConversionOfUnits": { "auth_ref": [ "r64", "r337", "r345" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Value of stock issued during the period upon the conversion of units. An example of a convertible unit is an umbrella partnership real estate investment trust unit (UPREIT unit).", "label": "Stock Issued During Period, Value, Conversion of Units", "terseLabel": "Issuance of Legacy Shapeways convertible Series preferred stock resulting from exercise of warrants" } } }, "localname": "StockIssuedDuringPeriodValueConversionOfUnits", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.shapeways.com/role/CondensedConsolidatedStatementsOfChangesInStockholdersEquityDeficit" ], "xbrltype": "monetaryItemType" }, "us-gaap_StockIssuedDuringPeriodValueNewIssues": { "auth_ref": [ "r27", "r28", "r337", "r345" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Equity impact of the value of new stock issued during the period. Includes shares issued in an initial public offering or a secondary public offering.", "label": "Stock Issued During Period, Value, New Issues", "terseLabel": "Shared issued value" } } }, "localname": "StockIssuedDuringPeriodValueNewIssues", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.shapeways.com/role/ReverseRecapitalizationDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised": { "auth_ref": [ "r64", "r337", "r345" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Value of stock issued as a result of the exercise of stock options.", "label": "Stock Issued During Period, Value, Stock Options Exercised", "terseLabel": "Issuance of Legacy Shapeways common stock upon exercise of stock options" } } }, "localname": "StockIssuedDuringPeriodValueStockOptionsExercised", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.shapeways.com/role/CondensedConsolidatedStatementsOfChangesInStockholdersEquityDeficit" ], "xbrltype": "monetaryItemType" }, "us-gaap_StockRedeemedOrCalledDuringPeriodShares": { "auth_ref": [ "r337" ], "lang": { "en-us": { "role": { "documentation": "Number of stock bought back by the entity at the exercise price or redemption price.", "label": "Stock Redeemed or Called During Period, Shares", "negatedTerseLabel": "Less: redemption of Galileo shares" } } }, "localname": "StockRedeemedOrCalledDuringPeriodShares", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.shapeways.com/role/ReverseRecapitalizationScheduleOfCommonStockSharesIssuedFollowingTheConsummationOfBusinessCombinationDetails" ], "xbrltype": "sharesItemType" }, "us-gaap_StockRepurchasedDuringPeriodShares": { "auth_ref": [ "r27", "r28", "r337", "r345" ], "lang": { "en-us": { "role": { "documentation": "Number of shares that have been repurchased during the period and have not been retired and are not held in treasury. Some state laws may govern the circumstances under which an entity may acquire its own stock and prescribe the accounting treatment therefore. This element is used when state law does not recognize treasury stock.", "label": "Stock Repurchased During Period, Shares", "terseLabel": "Stock repurchased during period shares", "verboseLabel": "Repurchase of Legacy Shapeways common stock (shares)" } } }, "localname": "StockRepurchasedDuringPeriodShares", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.shapeways.com/role/CondensedConsolidatedStatementsOfChangesInStockholdersEquityDeficit", "http://www.shapeways.com/role/RelatedPartyTransactionsDetails" ], "xbrltype": "sharesItemType" }, "us-gaap_StockRepurchasedDuringPeriodValue": { "auth_ref": [ "r27", "r28", "r337", "r345" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Equity impact of the value of stock that has been repurchased during the period and has not been retired and is not held in treasury. Some state laws may mandate the circumstances under which an entity may acquire its own stock and prescribe the accounting treatment therefore. This element is used when state law does not recognize treasury stock.", "label": "Stock Repurchased During Period, Value", "negatedLabel": "Repurchase of Legacy Shapeways common stock" } } }, "localname": "StockRepurchasedDuringPeriodValue", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.shapeways.com/role/CondensedConsolidatedStatementsOfChangesInStockholdersEquityDeficit" ], "xbrltype": "monetaryItemType" }, "us-gaap_StockholdersEquity": { "auth_ref": [ "r28", "r34", "r35", "r125", "r216", "r224", "r481", "r525" ], "calculation": { "http://www.shapeways.com/role/CondensedConsolidatedBalanceSheets": { "order": 12.0, "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which are attributable to the parent. The amount of the economic entity's stockholders' equity attributable to the parent excludes the amount of stockholders' equity which is allocable to that ownership interest in subsidiary equity which is not attributable to the parent (noncontrolling interest, minority interest). This excludes temporary equity and is sometimes called permanent equity.", "label": "Stockholders' Equity Attributable to Parent", "periodEndLabel": "Ending Balance", "periodStartLabel": "Beginning Balance", "totalLabel": "Total stockholders' equity (deficit)" } } }, "localname": "StockholdersEquity", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.shapeways.com/role/CondensedConsolidatedBalanceSheets", "http://www.shapeways.com/role/CondensedConsolidatedStatementsOfChangesInStockholdersEquityDeficit" ], "xbrltype": "monetaryItemType" }, "us-gaap_StockholdersEquityNoteAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Stockholders' Equity Note [Abstract]", "terseLabel": "Stockholders' Equity (Deficit)" } } }, "localname": "StockholdersEquityNoteAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "xbrltype": "stringItemType" }, "us-gaap_StockholdersEquityNoteDisclosureTextBlock": { "auth_ref": [ "r123", "r321", "r324", "r325", "r326", "r327", "r328", "r329", "r330", "r331", "r333", "r334", "r336", "r345", "r347" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for shareholders' equity comprised of portions attributable to the parent entity and noncontrolling interest, including other comprehensive income. Includes, but is not limited to, balances of common stock, preferred stock, additional paid-in capital, other capital and retained earnings, accumulated balance for each classification of other comprehensive income and amount of comprehensive income.", "label": "Stockholders' Equity Note Disclosure [Text Block]", "terseLabel": "Stockholders' Equity (Deficit)" } } }, "localname": "StockholdersEquityNoteDisclosureTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.shapeways.com/role/StockholdersEquityDeficit" ], "xbrltype": "textBlockItemType" }, "us-gaap_StockholdersEquityNumberOfSharesParValueAndOtherDisclosuresAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Stockholders' Equity, Number of Shares, Par Value and Other Disclosures [Abstract]", "terseLabel": "Shareholders' Equity" } } }, "localname": "StockholdersEquityNumberOfSharesParValueAndOtherDisclosuresAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.shapeways.com/role/CondensedConsolidatedBalanceSheets" ], "xbrltype": "stringItemType" }, "us-gaap_SubsequentEventMember": { "auth_ref": [ "r489", "r527" ], "lang": { "en-us": { "role": { "documentation": "Identifies event that occurred after the balance sheet date but before financial statements are issued or available to be issued.", "label": "Subsequent Event [Member]" } } }, "localname": "SubsequentEventMember", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.shapeways.com/role/CommitmentsAndContingenciesAdditionalInformationDetails" ], "xbrltype": "domainItemType" }, "us-gaap_SubsequentEventTypeAxis": { "auth_ref": [ "r489", "r527" ], "lang": { "en-us": { "role": { "documentation": "Information by event that occurred after the balance sheet date but before financial statements are issued or available to be issued.", "label": "Subsequent Event Type [Axis]" } } }, "localname": "SubsequentEventTypeAxis", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.shapeways.com/role/CommitmentsAndContingenciesAdditionalInformationDetails" ], "xbrltype": "stringItemType" }, "us-gaap_SubsequentEventTypeDomain": { "auth_ref": [ "r489", "r527" ], "lang": { "en-us": { "role": { "documentation": "Event that occurred after the balance sheet date but before financial statements are issued or available to be issued.", "label": "Subsequent Event Type [Domain]" } } }, "localname": "SubsequentEventTypeDomain", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.shapeways.com/role/CommitmentsAndContingenciesAdditionalInformationDetails" ], "xbrltype": "domainItemType" }, "us-gaap_SubsequentEventsAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Subsequent Events [Abstract]" } } }, "localname": "SubsequentEventsAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "xbrltype": "stringItemType" }, "us-gaap_SubsequentEventsTextBlock": { "auth_ref": [ "r526", "r529" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for significant events or transactions that occurred after the balance sheet date through the date the financial statements were issued or the date the financial statements were available to be issued. Examples include: the sale of a capital stock issue, purchase of a business, settlement of litigation, catastrophic loss, significant foreign exchange rate changes, loans to insiders or affiliates, and transactions not in the ordinary course of business.", "label": "Subsequent Events [Text Block]", "terseLabel": "Subsequent Events" } } }, "localname": "SubsequentEventsTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.shapeways.com/role/SubsequentEvents" ], "xbrltype": "textBlockItemType" }, "us-gaap_SubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Different names of stock transactions and the different attributes of each transaction.", "label": "Subsidiary or Equity Method Investee, Sale of Stock by Subsidiary or Equity Investee [Table]" } } }, "localname": "SubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.shapeways.com/role/OrganizationDetails" ], "xbrltype": "stringItemType" }, "us-gaap_SubsidiarySaleOfStockAxis": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Information by type of sale of the entity's stock.", "label": "Sale of Stock [Axis]" } } }, "localname": "SubsidiarySaleOfStockAxis", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.shapeways.com/role/OrganizationDetails", "http://www.shapeways.com/role/SummaryOfSignificantAccountingPoliciesDetails" ], "xbrltype": "stringItemType" }, "us-gaap_SubsidiarySaleOfStockLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Subsidiary, Sale of Stock [Line Items]" } } }, "localname": "SubsidiarySaleOfStockLineItems", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.shapeways.com/role/OrganizationDetails" ], "xbrltype": "stringItemType" }, "us-gaap_SupplementalCashFlowInformationAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Supplemental Cash Flow Information [Abstract]", "terseLabel": "Supplemental disclosure of cash and non-cash transactions:" } } }, "localname": "SupplementalCashFlowInformationAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.shapeways.com/role/CondensedConsolidatedStatementsOfCashFlows" ], "xbrltype": "stringItemType" }, "us-gaap_SupplementalIncomeStatementElementsAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Supplemental Income Statement Elements [Abstract]", "terseLabel": "Other comprehensive (loss) income" } } }, "localname": "SupplementalIncomeStatementElementsAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.shapeways.com/role/CondensedConsolidatedStatementsOfOperationsAndComprehensiveLoss" ], "xbrltype": "stringItemType" }, "us-gaap_SupplierConcentrationRiskMember": { "auth_ref": [ "r173" ], "lang": { "en-us": { "role": { "documentation": "Reflects the percentage that purchases in the period from one or more significant suppliers is to cost of goods or services, as defined by the entity, such as total cost of sales or services, product line cost of sales or services, segment cost of sales or services. Risk is the materially adverse effects of loss of a material supplier or a supplier of critically needed goods or services.", "label": "Supplier Concentration Risk [Member]" } } }, "localname": "SupplierConcentrationRiskMember", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.shapeways.com/role/SignificantConcentrationsDetails" ], "xbrltype": "domainItemType" }, "us-gaap_TangibleAssetImpairmentCharges": { "auth_ref": [ "r2", "r256" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The charge against earnings resulting from the aggregate write down of tangible assets from their carrying value to their fair value.", "label": "Tangible Asset Impairment Charges", "verboseLabel": "Tangible asset impairment charges" } } }, "localname": "TangibleAssetImpairmentCharges", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.shapeways.com/role/SummaryOfSignificantAccountingPoliciesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_TaxesPayableCurrent": { "auth_ref": [ "r53" ], "calculation": { "http://www.shapeways.com/role/AccruedExpensesAndOtherLiabilitiesDetails": { "order": 3.0, "parentTag": "shpw_AccruedAndOtherLiabilitiesCurrent", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Carrying value as of the balance sheet date of obligations incurred and payable for statutory income, sales, use, payroll, excise, real, property and other taxes. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).", "label": "Taxes Payable, Current", "terseLabel": "Taxes payable" } } }, "localname": "TaxesPayableCurrent", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.shapeways.com/role/AccruedExpensesAndOtherLiabilitiesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_TemporaryEquityForeignCurrencyTranslationAdjustments": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Adjustments to temporary equity resulting from foreign currency translation adjustments.", "label": "Temporary Equity, Foreign Currency Translation Adjustments", "terseLabel": "Foreign currency translation" } } }, "localname": "TemporaryEquityForeignCurrencyTranslationAdjustments", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.shapeways.com/role/CondensedConsolidatedStatementsOfChangesInStockholdersEquityDeficit" ], "xbrltype": "monetaryItemType" }, "us-gaap_TimingOfTransferOfGoodOrServiceAxis": { "auth_ref": [ "r360", "r369" ], "lang": { "en-us": { "role": { "documentation": "Information by timing of transfer of good or service to customer.", "label": "Timing of Transfer of Good or Service [Axis]" } } }, "localname": "TimingOfTransferOfGoodOrServiceAxis", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.shapeways.com/role/RevenueRecognitionDisaggregationOfRevenuesDetails" ], "xbrltype": "stringItemType" }, "us-gaap_TimingOfTransferOfGoodOrServiceDomain": { "auth_ref": [ "r360", "r369" ], "lang": { "en-us": { "role": { "documentation": "Timing of transfer of good or service to customer. Includes, but is not limited to, at point in time or over time.", "label": "Timing of Transfer of Good or Service [Domain]" } } }, "localname": "TimingOfTransferOfGoodOrServiceDomain", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.shapeways.com/role/RevenueRecognitionDisaggregationOfRevenuesDetails" ], "xbrltype": "domainItemType" }, "us-gaap_TradeAndOtherAccountsReceivablePolicy": { "auth_ref": [ "r210", "r211", "r212", "r214", "r215", "r217" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for accounts receivable.", "label": "Accounts Receivable [Policy Text Block]", "terseLabel": "Accounts Receivable" } } }, "localname": "TradeAndOtherAccountsReceivablePolicy", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.shapeways.com/role/SummaryOfSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_TransferredAtPointInTimeMember": { "auth_ref": [ "r369" ], "lang": { "en-us": { "role": { "documentation": "Contract with customer in which good or service is transferred at point in time.", "label": "Transferred at Point in Time [Member]", "terseLabel": "Products transferred at a point in time" } } }, "localname": "TransferredAtPointInTimeMember", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.shapeways.com/role/RevenueRecognitionDisaggregationOfRevenuesDetails" ], "xbrltype": "domainItemType" }, "us-gaap_TransferredOverTimeMember": { "auth_ref": [ "r369" ], "lang": { "en-us": { "role": { "documentation": "Contract with customer in which good or service is transferred over time.", "label": "Transferred over Time [Member]", "terseLabel": "Products and services transferred over time" } } }, "localname": "TransferredOverTimeMember", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.shapeways.com/role/RevenueRecognitionDisaggregationOfRevenuesDetails" ], "xbrltype": "domainItemType" }, "us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain": { "auth_ref": [ "r218", "r219", "r221", "r222", "r223", "r306", "r335", "r457", "r530", "r531", "r532", "r533", "r534", "r535", "r536", "r537", "r538", "r539", "r540", "r541", "r542", "r543", "r544", "r545", "r546", "r547", "r548", "r549", "r550", "r551", "r552", "r553", "r554", "r555", "r556", "r557", "r558", "r559", "r657", "r658", "r659", "r660", "r661", "r662", "r663" ], "lang": { "en-us": { "role": { "documentation": "Instrument or contract that imposes a contractual obligation to deliver cash or another financial instrument or to exchange other financial instruments on potentially unfavorable terms and conveys a contractual right to receive cash or another financial instrument or to exchange other financial instruments on potentially favorable terms.", "label": "Financial Instruments [Domain]", "terseLabel": "Financial Instruments [Domain]" } } }, "localname": "TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.shapeways.com/role/FairValueMeasurementsDetails" ], "xbrltype": "domainItemType" }, "us-gaap_TypeOfArrangementAxis": { "auth_ref": [ "r442" ], "lang": { "en-us": { "role": { "documentation": "Information by collaborative arrangement and arrangement other than collaborative applicable to revenue-generating activity or operations.", "label": "Collaborative Arrangement and Arrangement Other than Collaborative [Axis]" } } }, "localname": "TypeOfArrangementAxis", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.shapeways.com/role/ReverseRecapitalizationDetails" ], "xbrltype": "stringItemType" }, "us-gaap_UseOfEstimates": { "auth_ref": [ "r168", "r169", "r170", "r171", "r177", "r178", "r179" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for the use of estimates in the preparation of financial statements in conformity with generally accepted accounting principles.", "label": "Use of Estimates, Policy [Policy Text Block]", "terseLabel": "Use of Estimates" } } }, "localname": "UseOfEstimates", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.shapeways.com/role/SummaryOfSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_ValueAddedTaxReceivableCurrent": { "auth_ref": [ "r67" ], "calculation": { "http://www.shapeways.com/role/PrepaidExpensesAndOtherCurrentAssetsDetails": { "order": 3.0, "parentTag": "us-gaap_PrepaidExpenseAndOtherAssetsCurrent", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Carrying amount as of the balance sheet date of value added taxes due either from customers arising from sales on credit terms, or as previously overpaid to tax authorities. For classified balance sheets, represents the current amount receivable, that is amounts expected to be collected within one year or the normal operating cycle, if longer.", "label": "Value Added Tax Receivable, Current", "terseLabel": "VAT receivable" } } }, "localname": "ValueAddedTaxReceivableCurrent", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.shapeways.com/role/PrepaidExpensesAndOtherCurrentAssetsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_VariableRateAxis": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Information by type of variable rate.", "label": "Variable Rate [Axis]" } } }, "localname": "VariableRateAxis", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.shapeways.com/role/BorrowingArrangementsTermLoanDetails" ], "xbrltype": "stringItemType" }, "us-gaap_VariableRateDomain": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Interest rate that fluctuates over time as a result of an underlying benchmark interest rate or index.", "label": "Variable Rate [Domain]" } } }, "localname": "VariableRateDomain", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.shapeways.com/role/BorrowingArrangementsTermLoanDetails" ], "xbrltype": "domainItemType" }, "us-gaap_WarrantMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Security that gives the holder the right to purchase shares of stock in accordance with the terms of the instrument, usually upon payment of a specified amount.", "label": "Warrant [Member]" } } }, "localname": "WarrantMember", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.shapeways.com/role/CoverPage" ], "xbrltype": "domainItemType" }, "us-gaap_WarrantsAndRightsOutstandingMeasurementInput": { "auth_ref": [ "r469" ], "lang": { "en-us": { "role": { "documentation": "Value of input used to measure outstanding warrant and right embodying unconditional obligation requiring redemption by transferring asset at specified or determinable date or upon event certain to occur.", "label": "Warrants and Rights Outstanding, Measurement Input", "verboseLabel": "Warrants measurement input" } } }, "localname": "WarrantsAndRightsOutstandingMeasurementInput", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.shapeways.com/role/FairValueMeasurementsInitialMeasurementDetails" ], "xbrltype": "decimalItemType" }, "us-gaap_WarrantsAndRightsOutstandingTerm": { "auth_ref": [ "r469" ], "lang": { "en-us": { "role": { "documentation": "Period between issuance and expiration of outstanding warrant and right embodying unconditional obligation requiring redemption by transferring asset at specified or determinable date or upon event certain to occur, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.", "label": "Warrants and Rights Outstanding, Term", "terseLabel": "Warrants expiry term" } } }, "localname": "WarrantsAndRightsOutstandingTerm", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.shapeways.com/role/StockholdersEquityDeficitDetails" ], "xbrltype": "durationItemType" }, "us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment": { "auth_ref": [ "r157" ], "lang": { "en-us": { "role": { "documentation": "The sum of dilutive potential common shares or units used in the calculation of the diluted per-share or per-unit computation.", "label": "Weighted Average Number Diluted Shares Outstanding Adjustment", "terseLabel": "Weighted average shares included in computation of earning per share" } } }, "localname": "WeightedAverageNumberDilutedSharesOutstandingAdjustment", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.shapeways.com/role/SummaryOfSignificantAccountingPoliciesDetails" ], "xbrltype": "sharesItemType" }, "us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding": { "auth_ref": [ "r149", "r157" ], "lang": { "en-us": { "role": { "documentation": "The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.", "label": "Weighted Average Number of Shares Outstanding, Diluted", "verboseLabel": "Diluted" } } }, "localname": "WeightedAverageNumberOfDilutedSharesOutstanding", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.shapeways.com/role/CondensedConsolidatedStatementsOfOperationsAndComprehensiveLoss" ], "xbrltype": "sharesItemType" }, "us-gaap_WeightedAverageNumberOfSharesOutstandingBasic": { "auth_ref": [ "r147", "r157" ], "lang": { "en-us": { "role": { "documentation": "Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.", "label": "Weighted Average Number of Shares Outstanding, Basic", "terseLabel": "Basic" } } }, "localname": "WeightedAverageNumberOfSharesOutstandingBasic", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.shapeways.com/role/CondensedConsolidatedStatementsOfOperationsAndComprehensiveLoss" ], "xbrltype": "sharesItemType" } }, "unitCount": 17 } }, "std_ref": { "r0": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "105", "URI": "http://asc.fasb.org/extlink&oid=124434974&loc=SL124442142-165695" }, "r1": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "105", "URI": "http://asc.fasb.org/extlink&oid=124434974&loc=SL124442142-165695" }, "r10": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=124098289&loc=d3e6676-107765" }, "r100": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3291-108585" }, "r101": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3291-108585" }, "r102": { "Name": "Accounting Standards Codification", "Paragraph": "17", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3367-108585" }, "r103": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3000-108585" }, "r104": { "Name": "Accounting Standards Codification", "Paragraph": "24", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3521-108585" }, "r105": { "Name": "Accounting Standards Codification", "Paragraph": "25", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(e)", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3536-108585" }, "r106": { "Name": "Accounting Standards Codification", "Paragraph": "25", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3536-108585" }, "r107": { "Name": "Accounting Standards Codification", "Paragraph": "28", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3602-108585" }, "r108": { "Name": "Accounting Standards Codification", "Paragraph": "28", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3602-108585" }, "r109": { "Name": "Accounting Standards Codification", "Paragraph": "28", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3602-108585" }, "r11": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=124098289&loc=d3e6787-107765" }, "r110": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3044-108585" }, "r111": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=123431023&loc=d3e4273-108586" }, "r112": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=123431023&loc=d3e4297-108586" }, "r113": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=123431023&loc=d3e4304-108586" }, "r114": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=123431023&loc=d3e4313-108586" }, "r115": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=123431023&loc=d3e4332-108586" }, "r116": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=123431023&loc=SL98516268-108586" }, "r117": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "235", "URI": "http://asc.fasb.org/extlink&oid=123372394&loc=d3e18726-107790" }, "r118": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "235", "URI": "http://asc.fasb.org/extlink&oid=123372394&loc=d3e18823-107790" }, "r119": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(e)", "Topic": "235", "URI": "http://asc.fasb.org/extlink&oid=123372394&loc=d3e18823-107790" }, "r12": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=124098289&loc=d3e6801-107765" }, "r120": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)", "Topic": "235", "URI": "http://asc.fasb.org/extlink&oid=123372394&loc=d3e18823-107790" }, "r121": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.4-08(c))", "Topic": "235", "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690" }, "r122": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.4-08(d))", "Topic": "235", "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690" }, "r123": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.4-08(e)(1))", "Topic": "235", "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690" }, "r124": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.4-08(f))", "Topic": "235", "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690" }, "r125": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.4-08(g)(1)(ii))", "Topic": "235", "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690" }, "r126": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.4-08(h))", "Topic": "235", "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690" }, "r127": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.4-08(k)(1))", "Topic": "235", "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690" }, "r128": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.12-04(a))", "Topic": "235", "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e24072-122690" }, "r129": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "235", "URI": "http://asc.fasb.org/topic&trid=2122369" }, "r13": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=124098289&loc=d3e6904-107765" }, "r130": { "Name": "Accounting Standards Codification", "Paragraph": "23", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "250", "URI": "http://asc.fasb.org/extlink&oid=124436220&loc=d3e21914-107793" }, "r131": { "Name": "Accounting Standards Codification", "Paragraph": "24", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "250", "URI": "http://asc.fasb.org/extlink&oid=124436220&loc=d3e21930-107793" }, "r132": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "250", "URI": "http://asc.fasb.org/extlink&oid=124436220&loc=d3e21711-107793" }, "r133": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "250", "URI": "http://asc.fasb.org/extlink&oid=124436220&loc=d3e21728-107793" }, "r134": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)(2)", "Topic": "250", "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22499-107794" }, "r135": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)(3)", "Topic": "250", "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22499-107794" }, "r136": { "Name": "Accounting Standards Codification", "Paragraph": "11", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "250", "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22694-107794" }, "r137": { "Name": "Accounting Standards Codification", "Paragraph": "11", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "250", "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22694-107794" }, "r138": { "Name": "Accounting Standards Codification", "Paragraph": "12", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "250", "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=SL124452830-107794" }, "r139": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "250", "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22583-107794" }, "r14": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=124098289&loc=d3e6911-107765" }, "r140": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "250", "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22595-107794" }, "r141": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "250", "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22644-107794" }, "r142": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "250", "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22644-107794" }, "r143": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "250", "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22644-107794" }, "r144": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "250", "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22658-107794" }, "r145": { "Name": "Accounting Standards Codification", "Paragraph": "9", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "250", "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22663-107794" }, "r146": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB Topic 11.M.Q2)", "Topic": "250", "URI": "http://asc.fasb.org/extlink&oid=122038215&loc=d3e31137-122693" }, "r147": { "Name": "Accounting Standards Codification", "Paragraph": "10", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "260", "URI": "http://asc.fasb.org/extlink&oid=125511455&loc=d3e1448-109256" }, "r148": { "Name": "Accounting Standards Codification", "Paragraph": "11", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "260", "URI": "http://asc.fasb.org/extlink&oid=125511455&loc=d3e1377-109256" }, "r149": { "Name": "Accounting Standards Codification", "Paragraph": "16", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "260", "URI": "http://asc.fasb.org/extlink&oid=125511455&loc=d3e1505-109256" }, "r15": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=124098289&loc=d3e6935-107765" }, "r150": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "260", "URI": "http://asc.fasb.org/extlink&oid=125511455&loc=d3e1252-109256" }, "r151": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "260", "URI": "http://asc.fasb.org/extlink&oid=125511455&loc=d3e1278-109256" }, "r152": { "Name": "Accounting Standards Codification", "Paragraph": "55", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "260", "URI": "http://asc.fasb.org/extlink&oid=125511455&loc=d3e2626-109256" }, "r153": { "Name": "Accounting Standards Codification", "Paragraph": "60B", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "260", "URI": "http://asc.fasb.org/extlink&oid=125511455&loc=SL5780133-109256" }, "r154": { "Name": "Accounting Standards Codification", "Paragraph": "60B", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "260", "URI": "http://asc.fasb.org/extlink&oid=125511455&loc=SL5780133-109256" }, "r155": { "Name": "Accounting Standards Codification", "Paragraph": "60B", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "260", "URI": "http://asc.fasb.org/extlink&oid=125511455&loc=SL5780133-109256" }, "r156": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "260", "URI": "http://asc.fasb.org/extlink&oid=125511455&loc=d3e1337-109256" }, "r157": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "260", "URI": "http://asc.fasb.org/extlink&oid=124432515&loc=d3e3550-109257" }, "r158": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "260", "URI": "http://asc.fasb.org/extlink&oid=124432515&loc=d3e3550-109257" }, "r159": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "260", "URI": "http://asc.fasb.org/extlink&oid=124432515&loc=d3e3550-109257" }, "r16": { "Name": "Accounting Standards Codification", "Paragraph": "9", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=124098289&loc=d3e7018-107765" }, "r160": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "260", "URI": "http://asc.fasb.org/extlink&oid=124432515&loc=d3e3630-109257" }, "r161": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Topic": "260", "URI": "http://asc.fasb.org/extlink&oid=125512782&loc=d3e3842-109258" }, "r162": { "Name": "Accounting Standards Codification", "Paragraph": "52", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Topic": "260", "URI": "http://asc.fasb.org/extlink&oid=125512782&loc=d3e4984-109258" }, "r163": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "270", "URI": "http://asc.fasb.org/extlink&oid=124437754&loc=d3e543-108305" }, "r164": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "272", "URI": "http://asc.fasb.org/extlink&oid=125520817&loc=d3e70191-108054" }, "r165": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "272", "URI": "http://asc.fasb.org/extlink&oid=125520817&loc=d3e70229-108054" }, "r166": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "272", "URI": "http://asc.fasb.org/extlink&oid=6373374&loc=d3e70434-108055" }, "r167": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "272", "URI": "http://asc.fasb.org/extlink&oid=6373374&loc=d3e70478-108055" }, "r168": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "275", "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e5967-108592" }, "r169": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "275", "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e5967-108592" }, "r17": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=6361739&loc=d3e7789-107766" }, "r170": { "Name": "Accounting Standards Codification", "Paragraph": "11", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "275", "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e6161-108592" }, "r171": { "Name": "Accounting Standards Codification", "Paragraph": "12", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "275", "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e6191-108592" }, "r172": { "Name": "Accounting Standards Codification", "Paragraph": "16", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "275", "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e6327-108592" }, "r173": { "Name": "Accounting Standards Codification", "Paragraph": "18", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "275", "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e6351-108592" }, "r174": { "Name": "Accounting Standards Codification", "Paragraph": "18", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "275", "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e6351-108592" }, "r175": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "275", "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e6404-108592" }, "r176": { "Name": "Accounting Standards Codification", "Paragraph": "21", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "275", "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e6442-108592" }, "r177": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "275", "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e6061-108592" }, "r178": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "275", "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e6132-108592" }, "r179": { "Name": "Accounting Standards Codification", "Paragraph": "9", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "275", "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e6143-108592" }, "r18": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(19)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r180": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "275", "URI": "http://asc.fasb.org/topic&trid=2134479" }, "r181": { "Name": "Accounting Standards Codification", "Paragraph": "22", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8736-108599" }, "r182": { "Name": "Accounting Standards Codification", "Paragraph": "22", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8736-108599" }, "r183": { "Name": "Accounting Standards Codification", "Paragraph": "22", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8736-108599" }, "r184": { "Name": "Accounting Standards Codification", "Paragraph": "22", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8736-108599" }, "r185": { "Name": "Accounting Standards Codification", "Paragraph": "22", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(e)", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8736-108599" }, "r186": { "Name": "Accounting Standards Codification", "Paragraph": "22", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(h)", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8736-108599" }, "r187": { "Name": "Accounting Standards Codification", "Paragraph": "22", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8736-108599" }, "r188": { "Name": "Accounting Standards Codification", "Paragraph": "29", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8864-108599" }, "r189": { "Name": "Accounting Standards Codification", "Paragraph": "29", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8864-108599" }, "r19": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(1))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r190": { "Name": "Accounting Standards Codification", "Paragraph": "29", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8864-108599" }, "r191": { "Name": "Accounting Standards Codification", "Paragraph": "29", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8864-108599" }, "r192": { "Name": "Accounting Standards Codification", "Paragraph": "29", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(e)", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8864-108599" }, "r193": { "Name": "Accounting Standards Codification", "Paragraph": "29", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8864-108599" }, "r194": { "Name": "Accounting Standards Codification", "Paragraph": "30", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8906-108599" }, "r195": { "Name": "Accounting Standards Codification", "Paragraph": "30", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8906-108599" }, "r196": { "Name": "Accounting Standards Codification", "Paragraph": "30", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8906-108599" }, "r197": { "Name": "Accounting Standards Codification", "Paragraph": "30", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8906-108599" }, "r198": { "Name": "Accounting Standards Codification", "Paragraph": "31", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8924-108599" }, "r199": { "Name": "Accounting Standards Codification", "Paragraph": "32", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8933-108599" }, "r2": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "205", "URI": "http://asc.fasb.org/extlink&oid=109222650&loc=d3e1361-107760" }, "r20": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(11))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r200": { "Name": "Accounting Standards Codification", "Paragraph": "32", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8933-108599" }, "r201": { "Name": "Accounting Standards Codification", "Paragraph": "32", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8933-108599" }, "r202": { "Name": "Accounting Standards Codification", "Paragraph": "32", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8933-108599" }, "r203": { "Name": "Accounting Standards Codification", "Paragraph": "32", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8933-108599" }, "r204": { "Name": "Accounting Standards Codification", "Paragraph": "40", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e9031-108599" }, "r205": { "Name": "Accounting Standards Codification", "Paragraph": "41", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e9038-108599" }, "r206": { "Name": "Accounting Standards Codification", "Paragraph": "42", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e9054-108599" }, "r207": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "310", "URI": "http://asc.fasb.org/extlink&oid=124259787&loc=d3e4647-111522" }, "r208": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "310", "URI": "http://asc.fasb.org/extlink&oid=124259787&loc=d3e4428-111522" }, "r209": { "Name": "Accounting Standards Codification", "Paragraph": "9", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "310", "URI": "http://asc.fasb.org/extlink&oid=124259787&loc=d3e4531-111522" }, "r21": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(13))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r210": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "310", "URI": "http://asc.fasb.org/extlink&oid=123577603&loc=d3e4975-111524" }, "r211": { "Name": "Accounting Standards Codification", "Paragraph": "11B", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "310", "URI": "http://asc.fasb.org/extlink&oid=123577603&loc=SL6953423-111524" }, "r212": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "310", "URI": "http://asc.fasb.org/extlink&oid=123577603&loc=d3e5212-111524" }, "r213": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "310", "URI": "http://asc.fasb.org/extlink&oid=123577603&loc=d3e5212-111524" }, "r214": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "310", "URI": "http://asc.fasb.org/extlink&oid=123577603&loc=d3e5033-111524" }, "r215": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "310", "URI": "http://asc.fasb.org/extlink&oid=123577603&loc=d3e5093-111524" }, "r216": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB Topic 4.E)", "Topic": "310", "URI": "http://asc.fasb.org/extlink&oid=122038336&loc=d3e74512-122707" }, "r217": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "310", "URI": "http://asc.fasb.org/extlink&oid=84159169&loc=d3e10133-111534" }, "r218": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "320", "URI": "http://asc.fasb.org/extlink&oid=123581744&loc=d3e27232-111563" }, "r219": { "Name": "Accounting Standards Codification", "Paragraph": "5A", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "320", "URI": "http://asc.fasb.org/extlink&oid=123581744&loc=SL120269820-111563" }, "r22": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(14))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r220": { "Name": "Accounting Standards Codification", "Paragraph": "5B", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "320", "URI": "http://asc.fasb.org/extlink&oid=123581744&loc=SL120269825-111563" }, "r221": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "321", "URI": "http://asc.fasb.org/extlink&oid=123583765&loc=SL75117539-209714" }, "r222": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "321", "URI": "http://asc.fasb.org/extlink&oid=123583765&loc=SL75117539-209714" }, "r223": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "321", "URI": "http://asc.fasb.org/extlink&oid=123583765&loc=SL75117539-209714" }, "r224": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "323", "URI": "http://asc.fasb.org/extlink&oid=114001798&loc=d3e33918-111571" }, "r225": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "326", "URI": "http://asc.fasb.org/extlink&oid=122640432&loc=SL121648383-210437" }, "r226": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(e)(3)", "Topic": "326", "URI": "http://asc.fasb.org/extlink&oid=122640432&loc=SL121648383-210437" }, "r227": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(e)(4)", "Topic": "326", "URI": "http://asc.fasb.org/extlink&oid=122640432&loc=SL121648383-210437" }, "r228": { "Name": "Accounting Standards Codification", "Paragraph": "11", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "326", "URI": "http://asc.fasb.org/extlink&oid=124255953&loc=SL82919244-210447" }, "r229": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "326", "URI": "http://asc.fasb.org/extlink&oid=124255953&loc=SL82919249-210447" }, "r23": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(19))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r230": { "Name": "Accounting Standards Codification", "Paragraph": "14", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "326", "URI": "http://asc.fasb.org/extlink&oid=124255953&loc=SL82919253-210447" }, "r231": { "Name": "Accounting Standards Codification", "Paragraph": "16", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "326", "URI": "http://asc.fasb.org/extlink&oid=124255953&loc=SL82919258-210447" }, "r232": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "326", "URI": "http://asc.fasb.org/extlink&oid=124255953&loc=SL82919230-210447" }, "r233": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Topic": "326", "URI": "http://asc.fasb.org/extlink&oid=124269663&loc=SL82922888-210455" }, "r234": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Topic": "326", "URI": "http://asc.fasb.org/extlink&oid=124269663&loc=SL82922895-210455" }, "r235": { "Name": "Accounting Standards Codification", "Paragraph": "9", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Topic": "326", "URI": "http://asc.fasb.org/extlink&oid=124269663&loc=SL82922900-210455" }, "r236": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "55", "SubTopic": "30", "Topic": "326", "URI": "http://asc.fasb.org/extlink&oid=121590138&loc=SL82922954-210456" }, "r237": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "330", "URI": "http://asc.fasb.org/extlink&oid=116847112&loc=d3e4492-108314" }, "r238": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "330", "URI": "http://asc.fasb.org/extlink&oid=116847112&loc=d3e4556-108314" }, "r239": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB Topic 5.BB)", "Topic": "330", "URI": "http://asc.fasb.org/extlink&oid=27011343&loc=d3e100047-122729" }, "r24": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(20))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r240": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "330", "URI": "http://asc.fasb.org/topic&trid=2126998" }, "r241": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "05", "SubTopic": "10", "Topic": "340", "URI": "http://asc.fasb.org/extlink&oid=123349782&loc=d3e5879-108316" }, "r242": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "340", "URI": "http://asc.fasb.org/extlink&oid=6387103&loc=d3e6435-108320" }, "r243": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "40", "Topic": "340", "URI": "http://asc.fasb.org/extlink&oid=123353750&loc=SL51790836-203054" }, "r244": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "20", "Topic": "350", "URI": "http://asc.fasb.org/extlink&oid=99380562&loc=d3e13770-109266" }, "r245": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "45", "SubTopic": "20", "Topic": "350", "URI": "http://asc.fasb.org/extlink&oid=99380562&loc=d3e13777-109266" }, "r246": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "45", "SubTopic": "20", "Topic": "350", "URI": "http://asc.fasb.org/extlink&oid=120320667&loc=SL49117168-202975" }, "r247": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(e)", "Topic": "350", "URI": "http://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267" }, "r248": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "350", "URI": "http://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267" }, "r249": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "350", "URI": "http://asc.fasb.org/extlink&oid=121556970&loc=d3e13854-109267" }, "r25": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(22))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r250": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "(b)", "Topic": "350", "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275" }, "r251": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "360", "URI": "http://asc.fasb.org/extlink&oid=123351718&loc=d3e2420-110228" }, "r252": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "360", "URI": "http://asc.fasb.org/extlink&oid=6391035&loc=d3e2868-110229" }, "r253": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "360", "URI": "http://asc.fasb.org/extlink&oid=6391035&loc=d3e2868-110229" }, "r254": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "360", "URI": "http://asc.fasb.org/extlink&oid=6391035&loc=d3e2868-110229" }, "r255": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "360", "URI": "http://asc.fasb.org/extlink&oid=6391035&loc=d3e2868-110229" }, "r256": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "360", "URI": "http://asc.fasb.org/extlink&oid=109226691&loc=d3e2921-110230" }, "r257": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "360", "URI": "http://asc.fasb.org/extlink&oid=109226691&loc=d3e2941-110230" }, "r258": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "360", "URI": "http://asc.fasb.org/topic&trid=2155823" }, "r259": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "420", "URI": "http://asc.fasb.org/extlink&oid=6394359&loc=d3e17939-110869" }, "r26": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(27))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r260": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "440", "URI": "http://asc.fasb.org/extlink&oid=123406679&loc=d3e25336-109308" }, "r261": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "440", "URI": "http://asc.fasb.org/extlink&oid=123406679&loc=d3e25336-109308" }, "r262": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "440", "URI": "http://asc.fasb.org/topic&trid=2144648" }, "r263": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "450", "URI": "http://asc.fasb.org/extlink&oid=121557415&loc=d3e14326-108349" }, "r264": { "Name": "Accounting Standards Codification", "Paragraph": "10", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "450", "URI": "http://asc.fasb.org/extlink&oid=121557415&loc=d3e14615-108349" }, "r265": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "450", "URI": "http://asc.fasb.org/topic&trid=2127136" }, "r266": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=123465755&loc=SL6230698-112601" }, "r267": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-01(a)(4)(i))", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442526-122756" }, "r268": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-01(a)(4)(ii))", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442526-122756" }, "r269": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-01(a)(4)(iii)(A))", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442526-122756" }, "r27": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(28))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r270": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-01(a)(4)(iii)(B))", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442526-122756" }, "r271": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-01(a)(4)(iii))", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442526-122756" }, "r272": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-01(a)(4)(iv))", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442526-122756" }, "r273": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-01(a)(5))", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442526-122756" }, "r274": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-02(a)(4)(i))", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442552-122756" }, "r275": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-02(a)(4)(iii)(A))", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442552-122756" }, "r276": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-02(a)(4)(iii)(B))", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442552-122756" }, "r277": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-02(a)(4)(iii)(C))", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442552-122756" }, "r278": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-02(a)(4)(iv))", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442552-122756" }, "r279": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-02(a)(5))", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442552-122756" }, "r28": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(29))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r280": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611" }, "r281": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611" }, "r282": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(c)", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611" }, "r283": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611" }, "r284": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(e)", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611" }, "r285": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(f)", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611" }, "r286": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(g)", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611" }, "r287": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(h)", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611" }, "r288": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(i)", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611" }, "r289": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611" }, "r29": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(3)(a)(2))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r290": { "Name": "Accounting Standards Codification", "Paragraph": "1C", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495334-112611" }, "r291": { "Name": "Accounting Standards Codification", "Paragraph": "1C", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495334-112611" }, "r292": { "Name": "Accounting Standards Codification", "Paragraph": "1C", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(c)", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495334-112611" }, "r293": { "Name": "Accounting Standards Codification", "Paragraph": "1D", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495340-112611" }, "r294": { "Name": "Accounting Standards Codification", "Paragraph": "1D", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495340-112611" }, "r295": { "Name": "Accounting Standards Codification", "Paragraph": "1D", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(c)", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495340-112611" }, "r296": { "Name": "Accounting Standards Codification", "Paragraph": "1E", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495348-112611" }, "r297": { "Name": "Accounting Standards Codification", "Paragraph": "1E", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495348-112611" }, "r298": { "Name": "Accounting Standards Codification", "Paragraph": "1E", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(c)", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495348-112611" }, "r299": { "Name": "Accounting Standards Codification", "Paragraph": "1E", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495348-112611" }, "r3": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "205", "URI": "http://asc.fasb.org/extlink&oid=109222650&loc=SL51721683-107760" }, "r30": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(3))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r300": { "Name": "Accounting Standards Codification", "Paragraph": "1F", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495355-112611" }, "r301": { "Name": "Accounting Standards Codification", "Paragraph": "1F", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495355-112611" }, "r302": { "Name": "Accounting Standards Codification", "Paragraph": "1F", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)(1)", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495355-112611" }, "r303": { "Name": "Accounting Standards Codification", "Paragraph": "1F", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)(2)", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495355-112611" }, "r304": { "Name": "Accounting Standards Codification", "Paragraph": "1I", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495371-112611" }, "r305": { "Name": "Accounting Standards Codification", "Paragraph": "1I", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495371-112611" }, "r306": { "Name": "Accounting Standards Codification", "Paragraph": "1I", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(c)", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495371-112611" }, "r307": { "Name": "Accounting Standards Codification", "Paragraph": "1I", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495371-112611" }, "r308": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)(3)", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=123466204&loc=SL6031897-161870" }, "r309": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=123466204&loc=SL6036836-161870" }, "r31": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(30)(a)(1))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r310": { "Name": "Accounting Standards Codification", "Paragraph": "69B", "Publisher": "FASB", "Section": "55", "SubTopic": "20", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=123466577&loc=SL123495735-112612" }, "r311": { "Name": "Accounting Standards Codification", "Paragraph": "69C", "Publisher": "FASB", "Section": "55", "SubTopic": "20", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=123466577&loc=SL123495737-112612" }, "r312": { "Name": "Accounting Standards Codification", "Paragraph": "69E", "Publisher": "FASB", "Section": "55", "SubTopic": "20", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=123466577&loc=SL123495743-112612" }, "r313": { "Name": "Accounting Standards Codification", "Paragraph": "69F", "Publisher": "FASB", "Section": "55", "SubTopic": "20", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=123466577&loc=SL123495745-112612" }, "r314": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "470", "URI": "http://asc.fasb.org/topic&trid=2208564" }, "r315": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "25", "SubTopic": "10", "Topic": "480", "URI": "http://asc.fasb.org/extlink&oid=109262497&loc=d3e20148-110875" }, "r316": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "480", "URI": "http://asc.fasb.org/extlink&oid=109262807&loc=d3e22047-110879" }, "r317": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(CFRR 211.02)", "Topic": "480", "URI": "http://asc.fasb.org/extlink&oid=122040564&loc=d3e177068-122764" }, "r318": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "505", "URI": "http://asc.fasb.org/extlink&oid=65888546&loc=d3e21300-112643" }, "r319": { "Name": "Accounting Standards Codification", "Paragraph": "10", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "505", "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=d3e21553-112644" }, "r32": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(30)(a)(3))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r320": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "505", "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496158-112644" }, "r321": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "505", "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496158-112644" }, "r322": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "505", "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496158-112644" }, "r323": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(e)", "Topic": "505", "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496158-112644" }, "r324": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(g)", "Topic": "505", "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496158-112644" }, "r325": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(h)", "Topic": "505", "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496158-112644" }, "r326": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(i)", "Topic": "505", "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496158-112644" }, "r327": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "505", "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496158-112644" }, "r328": { "Name": "Accounting Standards Codification", "Paragraph": "14", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "505", "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496171-112644" }, "r329": { "Name": "Accounting Standards Codification", "Paragraph": "14", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "505", "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496171-112644" }, "r33": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(30)(a)(4))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r330": { "Name": "Accounting Standards Codification", "Paragraph": "14", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "505", "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496171-112644" }, "r331": { "Name": "Accounting Standards Codification", "Paragraph": "16", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "505", "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496180-112644" }, "r332": { "Name": "Accounting Standards Codification", "Paragraph": "16", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "505", "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496180-112644" }, "r333": { "Name": "Accounting Standards Codification", "Paragraph": "18", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "505", "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496189-112644" }, "r334": { "Name": "Accounting Standards Codification", "Paragraph": "18", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "505", "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496189-112644" }, "r335": { "Name": "Accounting Standards Codification", "Paragraph": "18", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "505", "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496189-112644" }, "r336": { "Name": "Accounting Standards Codification", "Paragraph": "18", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "505", "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496189-112644" }, "r337": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "505", "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=d3e21463-112644" }, "r338": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "505", "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=d3e21475-112644" }, "r339": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "505", "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=d3e21484-112644" }, "r34": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(30))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r340": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "505", "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=d3e21488-112644" }, "r341": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "505", "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=d3e21506-112644" }, "r342": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "505", "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=d3e21506-112644" }, "r343": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "505", "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=d3e21521-112644" }, "r344": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "505", "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=d3e21538-112644" }, "r345": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.3-04)", "Topic": "505", "URI": "http://asc.fasb.org/extlink&oid=120397183&loc=d3e187085-122770" }, "r346": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "50", "Topic": "505", "URI": "http://asc.fasb.org/extlink&oid=6784392&loc=d3e188667-122775" }, "r347": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "505", "URI": "http://asc.fasb.org/topic&trid=2208762" }, "r348": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "606", "URI": "http://asc.fasb.org/extlink&oid=123360276&loc=SL49130531-203044" }, "r349": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "606", "URI": "http://asc.fasb.org/extlink&oid=123360276&loc=SL49130532-203044" }, "r35": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(31))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r350": { "Name": "Accounting Standards Codification", "Paragraph": "10", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "606", "URI": "http://asc.fasb.org/extlink&oid=123351226&loc=SL49130551-203045" }, "r351": { "Name": "Accounting Standards Codification", "Paragraph": "12", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "606", "URI": "http://asc.fasb.org/extlink&oid=123351226&loc=SL49130554-203045" }, "r352": { "Name": "Accounting Standards Codification", "Paragraph": "12", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "606", "URI": "http://asc.fasb.org/extlink&oid=123351226&loc=SL49130554-203045" }, "r353": { "Name": "Accounting Standards Codification", "Paragraph": "12", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "606", "URI": "http://asc.fasb.org/extlink&oid=123351226&loc=SL49130554-203045" }, "r354": { "Name": "Accounting Standards Codification", "Paragraph": "12", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "606", "URI": "http://asc.fasb.org/extlink&oid=123351226&loc=SL49130554-203045" }, "r355": { "Name": "Accounting Standards Codification", "Paragraph": "12", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(e)", "Topic": "606", "URI": "http://asc.fasb.org/extlink&oid=123351226&loc=SL49130554-203045" }, "r356": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)(2)", "Topic": "606", "URI": "http://asc.fasb.org/extlink&oid=123351226&loc=SL49130556-203045" }, "r357": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "606", "URI": "http://asc.fasb.org/extlink&oid=123351226&loc=SL49130558-203045" }, "r358": { "Name": "Accounting Standards Codification", "Paragraph": "22", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "606", "URI": "http://asc.fasb.org/extlink&oid=123351226&loc=SL49130569-203045" }, "r359": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "606", "URI": "http://asc.fasb.org/extlink&oid=123351226&loc=SL49130543-203045" }, "r36": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(32))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r360": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "606", "URI": "http://asc.fasb.org/extlink&oid=123351226&loc=SL49130545-203045" }, "r361": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "606", "URI": "http://asc.fasb.org/extlink&oid=123351226&loc=SL49130549-203045" }, "r362": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "606", "URI": "http://asc.fasb.org/extlink&oid=123351226&loc=SL49130549-203045" }, "r363": { "Name": "Accounting Standards Codification", "Paragraph": "9", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "606", "URI": "http://asc.fasb.org/extlink&oid=123351226&loc=SL49130550-203045" }, "r364": { "Name": "Accounting Standards Codification", "Paragraph": "91", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "606", "URI": "http://asc.fasb.org/extlink&oid=123410239&loc=SL49130690-203046-203046" }, "r365": { "Name": "Accounting Standards Codification", "Paragraph": "91", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "606", "URI": "http://asc.fasb.org/extlink&oid=123410239&loc=SL49130690-203046-203046" }, "r366": { "Name": "Accounting Standards Codification", "Paragraph": "91", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "606", "URI": "http://asc.fasb.org/extlink&oid=123410239&loc=SL49130690-203046-203046" }, "r367": { "Name": "Accounting Standards Codification", "Paragraph": "91", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "606", "URI": "http://asc.fasb.org/extlink&oid=123410239&loc=SL49130690-203046-203046" }, "r368": { "Name": "Accounting Standards Codification", "Paragraph": "91", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Subparagraph": "(e)", "Topic": "606", "URI": "http://asc.fasb.org/extlink&oid=123410239&loc=SL49130690-203046-203046" }, "r369": { "Name": "Accounting Standards Codification", "Paragraph": "91", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Subparagraph": "(f)", "Topic": "606", "URI": "http://asc.fasb.org/extlink&oid=123410239&loc=SL49130690-203046-203046" }, "r37": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(5))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r370": { "Name": "Accounting Standards Codification", "Paragraph": "91", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Subparagraph": "(g)", "Topic": "606", "URI": "http://asc.fasb.org/extlink&oid=123410239&loc=SL49130690-203046-203046" }, "r371": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "606", "URI": "http://asc.fasb.org/topic&trid=49130388" }, "r372": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)(i)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920" }, "r373": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)(ii)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920" }, "r374": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)(iv)(01)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920" }, "r375": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)(iv)(02)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920" }, "r376": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)(iv)(02)(A)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920" }, "r377": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)(iv)(02)(B)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920" }, "r378": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)(iv)(02)(C)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920" }, "r379": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)(iv)(03)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920" }, "r38": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(6)(a)(1))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r380": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(n)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920" }, "r381": { "Name": "Accounting Standards Codification", "Paragraph": "17", "Publisher": "FASB", "Section": "55", "SubTopic": "20", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=123450688&loc=d3e4179-114921" }, "r382": { "Name": "Accounting Standards Codification", "Paragraph": "11", "Publisher": "FASB", "Section": "50", "SubTopic": "80", "Subparagraph": "(a)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=65877416&loc=SL14450702-114947" }, "r383": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "80", "Subparagraph": "(d)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=65877416&loc=SL14450657-114947" }, "r384": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "80", "Subparagraph": "(f)(3)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=65877416&loc=SL14450657-114947" }, "r385": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "80", "Subparagraph": "(a)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=65877416&loc=SL14450673-114947" }, "r386": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "55", "SubTopic": "80", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=35742348&loc=SL14450788-114948" }, "r387": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5047-113901" }, "r388": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5047-113901" }, "r389": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5047-113901" }, "r39": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(6)(a)(3))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r390": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)(3)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901" }, "r391": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a),(g)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901" }, "r392": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b),(f)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901" }, "r393": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901" }, "r394": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)(i)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901" }, "r395": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)(i)-(ii)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901" }, "r396": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)(iv)(2)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901" }, "r397": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)(iv)(3)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901" }, "r398": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(2)(iii)(1)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901" }, "r399": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901" }, "r4": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "205", "URI": "http://asc.fasb.org/topic&trid=2122149" }, "r40": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(6)(a)(4))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r400": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)(1)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901" }, "r401": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(e)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901" }, "r402": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(e)(1)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901" }, "r403": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(e)(2)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901" }, "r404": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)(2)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901" }, "r405": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)(2)(i)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901" }, "r406": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)(2)(iii)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901" }, "r407": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(h)(1)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901" }, "r408": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(h)(1)(i)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901" }, "r409": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(i)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901" }, "r41": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(6)(a))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r410": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901" }, "r411": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(e)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=121322162&loc=SL121327923-165333" }, "r412": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(f)(1)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=121322162&loc=SL121327923-165333" }, "r413": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(f)(2)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=121322162&loc=SL121327923-165333" }, "r414": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(g)(2)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=121322162&loc=SL121327923-165333" }, "r415": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB Topic 14.D.2)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=122041274&loc=d3e301413-122809" }, "r416": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB Topic 14.F)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=122041274&loc=d3e301413-122809" }, "r417": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "718", "URI": "http://asc.fasb.org/topic&trid=2228938" }, "r418": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "35", "Subparagraph": "(a)", "Topic": "720", "URI": "http://asc.fasb.org/extlink&oid=6420018&loc=d3e36677-107848" }, "r419": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "35", "Subparagraph": "(b)", "Topic": "720", "URI": "http://asc.fasb.org/extlink&oid=6420018&loc=d3e36677-107848" }, "r42": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(6)(b))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r420": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "730", "URI": "http://asc.fasb.org/extlink&oid=6420194&loc=d3e21568-108373" }, "r421": { "Name": "Accounting Standards Codification", "Paragraph": "25", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=123427490&loc=d3e32247-109318" }, "r422": { "Name": "Accounting Standards Codification", "Paragraph": "28", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=123427490&loc=d3e32280-109318" }, "r423": { "Name": "Accounting Standards Codification", "Paragraph": "10", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=d3e32672-109319" }, "r424": { "Name": "Accounting Standards Codification", "Paragraph": "12", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=d3e32687-109319" }, "r425": { "Name": "Accounting Standards Codification", "Paragraph": "17", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=d3e32809-109319" }, "r426": { "Name": "Accounting Standards Codification", "Paragraph": "19", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=d3e32840-109319" }, "r427": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=d3e32847-109319" }, "r428": { "Name": "Accounting Standards Codification", "Paragraph": "9", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=d3e32639-109319" }, "r429": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(d)(2)", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=123459177&loc=SL121830611-158277" }, "r43": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(6)(c))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r430": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(d)(3)", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=123459177&loc=SL121830611-158277" }, "r431": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB TOPIC 6.I.7)", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=122134291&loc=d3e330036-122817" }, "r432": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "45", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=123586238&loc=d3e38679-109324" }, "r433": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "805", "URI": "http://asc.fasb.org/extlink&oid=79982066&loc=d3e1392-128463" }, "r434": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "805", "URI": "http://asc.fasb.org/extlink&oid=79982066&loc=d3e1486-128463" }, "r435": { "Name": "Accounting Standards Codification", "Paragraph": "37", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Topic": "805", "URI": "http://asc.fasb.org/extlink&oid=123455525&loc=d3e2207-128464" }, "r436": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(c)", "Topic": "805", "URI": "http://asc.fasb.org/extlink&oid=123413009&loc=d3e4845-128472" }, "r437": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "30", "SubTopic": "30", "Topic": "805", "URI": "http://asc.fasb.org/extlink&oid=116859721&loc=d3e6578-128477" }, "r438": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "30", "SubTopic": "30", "Topic": "805", "URI": "http://asc.fasb.org/extlink&oid=116859721&loc=d3e6613-128477" }, "r439": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "(b)", "Topic": "805", "URI": "http://asc.fasb.org/extlink&oid=120321790&loc=d3e6927-128479" }, "r44": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(7))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r440": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "(b)(1)", "Topic": "805", "URI": "http://asc.fasb.org/extlink&oid=120321790&loc=d3e6927-128479" }, "r441": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "(b)(4)", "Topic": "805", "URI": "http://asc.fasb.org/extlink&oid=120321790&loc=d3e6927-128479" }, "r442": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "808", "URI": "http://asc.fasb.org/extlink&oid=6931272&loc=SL5834143-161434" }, "r443": { "Name": "Accounting Standards Codification", "Paragraph": "19", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "810", "URI": "http://asc.fasb.org/extlink&oid=123454820&loc=SL4569616-111683" }, "r444": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "810", "URI": "http://asc.fasb.org/extlink&oid=123454820&loc=SL4569643-111683" }, "r445": { "Name": "Accounting Standards Codification", "Paragraph": "25", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "810", "URI": "http://asc.fasb.org/extlink&oid=116870748&loc=SL6758485-165988" }, "r446": { "Name": "Accounting Standards Codification", "Paragraph": "25", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "810", "URI": "http://asc.fasb.org/extlink&oid=116870748&loc=SL6758485-165988" }, "r447": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)(1)", "Topic": "810", "URI": "http://asc.fasb.org/extlink&oid=109239629&loc=SL4573702-111684" }, "r448": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)", "Topic": "810", "URI": "http://asc.fasb.org/extlink&oid=109239629&loc=SL4573702-111684" }, "r449": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(3)", "Topic": "810", "URI": "http://asc.fasb.org/extlink&oid=109239629&loc=SL4573702-111684" }, "r45": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(8))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r450": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c),(3)", "Topic": "810", "URI": "http://asc.fasb.org/extlink&oid=109239629&loc=SL4573702-111684" }, "r451": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(bb)", "Topic": "810", "URI": "http://asc.fasb.org/extlink&oid=123419778&loc=d3e5710-111685" }, "r452": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "810", "URI": "http://asc.fasb.org/extlink&oid=123419778&loc=d3e5710-111685" }, "r453": { "Name": "Accounting Standards Codification", "Paragraph": "4J", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Topic": "810", "URI": "http://asc.fasb.org/extlink&oid=120409616&loc=SL4591551-111686" }, "r454": { "Name": "Accounting Standards Codification", "Paragraph": "4K", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Topic": "810", "URI": "http://asc.fasb.org/extlink&oid=120409616&loc=SL4591552-111686" }, "r455": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "810", "URI": "http://asc.fasb.org/topic&trid=2197479" }, "r456": { "Name": "Accounting Standards Codification", "Paragraph": "4F", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "815", "URI": "http://asc.fasb.org/extlink&oid=125515794&loc=SL5624186-113959" }, "r457": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "40", "Subparagraph": "(f)", "Topic": "815", "URI": "http://asc.fasb.org/extlink&oid=123477628&loc=d3e90205-114008" }, "r458": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(b)(1)", "Topic": "815", "URI": "http://asc.fasb.org/extlink&oid=123482062&loc=SL123482106-238011" }, "r459": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(b)(2)", "Topic": "815", "URI": "http://asc.fasb.org/extlink&oid=123482062&loc=SL123482106-238011" }, "r46": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.1)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r460": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(d)", "Topic": "815", "URI": "http://asc.fasb.org/extlink&oid=123482062&loc=SL123482106-238011" }, "r461": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(e)(3)", "Topic": "815", "URI": "http://asc.fasb.org/extlink&oid=123482062&loc=SL123482106-238011" }, "r462": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(e)(4)", "Topic": "815", "URI": "http://asc.fasb.org/extlink&oid=123482062&loc=SL123482106-238011" }, "r463": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(f)", "Topic": "815", "URI": "http://asc.fasb.org/extlink&oid=123482062&loc=SL123482106-238011" }, "r464": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "820", "URI": "http://asc.fasb.org/extlink&oid=123874694&loc=d3e19207-110258" }, "r465": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "820", "URI": "http://asc.fasb.org/extlink&oid=123874694&loc=d3e19207-110258" }, "r466": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(bb)", "Topic": "820", "URI": "http://asc.fasb.org/extlink&oid=123874694&loc=d3e19207-110258" }, "r467": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(bbb)", "Topic": "820", "URI": "http://asc.fasb.org/extlink&oid=123874694&loc=d3e19207-110258" }, "r468": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(bbb)(1)", "Topic": "820", "URI": "http://asc.fasb.org/extlink&oid=123874694&loc=d3e19207-110258" }, "r469": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(bbb)(2)", "Topic": "820", "URI": "http://asc.fasb.org/extlink&oid=123874694&loc=d3e19207-110258" }, "r47": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.13(a))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r470": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "820", "URI": "http://asc.fasb.org/extlink&oid=123874694&loc=d3e19207-110258" }, "r471": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(h)", "Topic": "820", "URI": "http://asc.fasb.org/extlink&oid=123874694&loc=d3e19207-110258" }, "r472": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "820", "URI": "http://asc.fasb.org/extlink&oid=123874694&loc=d3e19207-110258" }, "r473": { "Name": "Accounting Standards Codification", "Paragraph": "2C", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "820", "URI": "http://asc.fasb.org/extlink&oid=123874694&loc=SL7498348-110258" }, "r474": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "820", "URI": "http://asc.fasb.org/extlink&oid=123874694&loc=d3e19279-110258" }, "r475": { "Name": "Accounting Standards Codification", "Paragraph": "6A", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "820", "URI": "http://asc.fasb.org/extlink&oid=123874694&loc=SL6742756-110258" }, "r476": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "60", "SubTopic": "10", "Topic": "820", "URI": "http://asc.fasb.org/extlink&oid=7493716&loc=d3e21868-110260" }, "r477": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "825", "URI": "http://asc.fasb.org/extlink&oid=123594938&loc=d3e13279-108611" }, "r478": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "825", "URI": "http://asc.fasb.org/extlink&oid=123594938&loc=d3e13531-108611" }, "r479": { "Name": "Accounting Standards Codification", "Paragraph": "21", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "825", "URI": "http://asc.fasb.org/extlink&oid=123594938&loc=d3e13537-108611" }, "r48": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.13)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r480": { "Name": "Accounting Standards Codification", "Paragraph": "21", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "825", "URI": "http://asc.fasb.org/extlink&oid=123594938&loc=d3e13537-108611" }, "r481": { "Name": "Accounting Standards Codification", "Paragraph": "28", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)", "Topic": "825", "URI": "http://asc.fasb.org/extlink&oid=123596393&loc=d3e14064-108612" }, "r482": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "230", "Topic": "830", "URI": "http://asc.fasb.org/extlink&oid=123444420&loc=d3e33268-110906" }, "r483": { "Name": "Accounting Standards Codification", "Paragraph": "17", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Topic": "830", "URI": "http://asc.fasb.org/extlink&oid=118261656&loc=d3e32136-110900" }, "r484": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Subparagraph": "(a)", "Topic": "830", "URI": "http://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900" }, "r485": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Subparagraph": "(b)", "Topic": "830", "URI": "http://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900" }, "r486": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Subparagraph": "(c)", "Topic": "830", "URI": "http://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900" }, "r487": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Subparagraph": "(d)", "Topic": "830", "URI": "http://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900" }, "r488": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Topic": "830", "URI": "http://asc.fasb.org/extlink&oid=6450520&loc=d3e32583-110901" }, "r489": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Topic": "830", "URI": "http://asc.fasb.org/extlink&oid=6450520&loc=d3e32618-110901" }, "r49": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.14)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r490": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "830", "URI": "http://asc.fasb.org/topic&trid=2175825" }, "r491": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "835", "URI": "http://asc.fasb.org/extlink&oid=6450988&loc=d3e26243-108391" }, "r492": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Topic": "835", "URI": "http://asc.fasb.org/extlink&oid=124435984&loc=d3e28541-108399" }, "r493": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Topic": "835", "URI": "http://asc.fasb.org/extlink&oid=124435984&loc=d3e28551-108399" }, "r494": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Topic": "835", "URI": "http://asc.fasb.org/extlink&oid=124435984&loc=d3e28555-108399" }, "r495": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Topic": "835", "URI": "http://asc.fasb.org/extlink&oid=124429444&loc=SL124452920-239629" }, "r496": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "55", "SubTopic": "30", "Topic": "835", "URI": "http://asc.fasb.org/extlink&oid=114775985&loc=d3e28878-108400" }, "r497": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "842", "URI": "http://asc.fasb.org/extlink&oid=123391704&loc=SL77918627-209977" }, "r498": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "842", "URI": "http://asc.fasb.org/extlink&oid=123391704&loc=SL77918627-209977" }, "r499": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "45", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "842", "URI": "http://asc.fasb.org/extlink&oid=123391704&loc=SL77918638-209977" }, "r5": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=124098289&loc=d3e6676-107765" }, "r50": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.17)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r500": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "45", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "842", "URI": "http://asc.fasb.org/extlink&oid=123391704&loc=SL77918643-209977" }, "r501": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "45", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "842", "URI": "http://asc.fasb.org/extlink&oid=123391704&loc=SL77918643-209977" }, "r502": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "45", "SubTopic": "20", "Subparagraph": "(c)", "Topic": "842", "URI": "http://asc.fasb.org/extlink&oid=123391704&loc=SL77918643-209977" }, "r503": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "842", "URI": "http://asc.fasb.org/extlink&oid=123408670&loc=SL77918666-209980" }, "r504": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "842", "URI": "http://asc.fasb.org/extlink&oid=123408670&loc=SL77918686-209980" }, "r505": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "842", "URI": "http://asc.fasb.org/extlink&oid=123408670&loc=SL77918686-209980" }, "r506": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(c)", "Topic": "842", "URI": "http://asc.fasb.org/extlink&oid=123408670&loc=SL77918686-209980" }, "r507": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(g)(1)", "Topic": "842", "URI": "http://asc.fasb.org/extlink&oid=123408670&loc=SL77918686-209980" }, "r508": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(g)(2)", "Topic": "842", "URI": "http://asc.fasb.org/extlink&oid=123408670&loc=SL77918686-209980" }, "r509": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(g)(3)", "Topic": "842", "URI": "http://asc.fasb.org/extlink&oid=123408670&loc=SL77918686-209980" }, "r51": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.19(a))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r510": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(g)(4)", "Topic": "842", "URI": "http://asc.fasb.org/extlink&oid=123408670&loc=SL77918686-209980" }, "r511": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "842", "URI": "http://asc.fasb.org/extlink&oid=123408670&loc=SL77918686-209980" }, "r512": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "842", "URI": "http://asc.fasb.org/extlink&oid=123408670&loc=SL77918701-209980" }, "r513": { "Name": "Accounting Standards Codification", "Paragraph": "53", "Publisher": "FASB", "Section": "55", "SubTopic": "20", "Topic": "842", "URI": "http://asc.fasb.org/extlink&oid=123414884&loc=SL77918982-209971" }, "r514": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "850", "URI": "http://asc.fasb.org/extlink&oid=6457730&loc=d3e39549-107864" }, "r515": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "850", "URI": "http://asc.fasb.org/extlink&oid=6457730&loc=d3e39549-107864" }, "r516": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "850", "URI": "http://asc.fasb.org/extlink&oid=6457730&loc=d3e39549-107864" }, "r517": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "850", "URI": "http://asc.fasb.org/extlink&oid=6457730&loc=d3e39549-107864" }, "r518": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "850", "URI": "http://asc.fasb.org/extlink&oid=6457730&loc=d3e39549-107864" }, "r519": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "850", "URI": "http://asc.fasb.org/extlink&oid=6457730&loc=d3e39599-107864" }, "r52": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.19)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r520": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "850", "URI": "http://asc.fasb.org/extlink&oid=6457730&loc=d3e39603-107864" }, "r521": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "850", "URI": "http://asc.fasb.org/extlink&oid=6457730&loc=d3e39691-107864" }, "r522": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "850", "URI": "http://asc.fasb.org/topic&trid=2122745" }, "r523": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "852", "URI": "http://asc.fasb.org/extlink&oid=124433192&loc=SL2890621-112765" }, "r524": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "852", "URI": "http://asc.fasb.org/extlink&oid=124433192&loc=SL2890621-112765" }, "r525": { "Name": "Accounting Standards Codification", "Paragraph": "10", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Topic": "852", "URI": "http://asc.fasb.org/extlink&oid=84165509&loc=d3e56426-112766" }, "r526": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "855", "URI": "http://asc.fasb.org/extlink&oid=6842918&loc=SL6314017-165662" }, "r527": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "855", "URI": "http://asc.fasb.org/extlink&oid=6842918&loc=SL6314017-165662" }, "r528": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "855", "URI": "http://asc.fasb.org/extlink&oid=6842918&loc=SL6314020-165662" }, "r529": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "855", "URI": "http://asc.fasb.org/topic&trid=2122774" }, "r53": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.19,20)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r530": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)(2)(i)", "Topic": "860", "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719" }, "r531": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)(2)(ii)", "Topic": "860", "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719" }, "r532": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)(3)", "Topic": "860", "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719" }, "r533": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(bb)(1)", "Topic": "860", "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719" }, "r534": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(bb)(2)", "Topic": "860", "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719" }, "r535": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(bb)(3)", "Topic": "860", "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719" }, "r536": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(c)(1)", "Topic": "860", "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719" }, "r537": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(c)(2)", "Topic": "860", "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719" }, "r538": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(c)(3)", "Topic": "860", "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719" }, "r539": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)(1)", "Topic": "860", "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107314-111719" }, "r54": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.19-26)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r540": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)(2)", "Topic": "860", "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107314-111719" }, "r541": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)(3)", "Topic": "860", "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107314-111719" }, "r542": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(c)", "Topic": "860", "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107314-111719" }, "r543": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Topic": "860", "URI": "http://asc.fasb.org/extlink&oid=66007379&loc=d3e113888-111728" }, "r544": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "(a)", "Topic": "860", "URI": "http://asc.fasb.org/extlink&oid=109249958&loc=SL34722452-111729" }, "r545": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "50", "Subparagraph": "(a)(1)", "Topic": "860", "URI": "http://asc.fasb.org/extlink&oid=125521744&loc=d3e122625-111746" }, "r546": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "50", "Subparagraph": "(a)(2)", "Topic": "860", "URI": "http://asc.fasb.org/extlink&oid=125521744&loc=d3e122625-111746" }, "r547": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "50", "Subparagraph": "(a)(3)", "Topic": "860", "URI": "http://asc.fasb.org/extlink&oid=125521744&loc=d3e122625-111746" }, "r548": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "50", "Subparagraph": "(a)(4)(i)", "Topic": "860", "URI": "http://asc.fasb.org/extlink&oid=125521744&loc=d3e122625-111746" }, "r549": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "50", "Subparagraph": "(a)(1)", "Topic": "860", "URI": "http://asc.fasb.org/extlink&oid=125521744&loc=d3e122739-111746" }, "r55": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.20)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r550": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "50", "Subparagraph": "(a)(2)", "Topic": "860", "URI": "http://asc.fasb.org/extlink&oid=125521744&loc=d3e122739-111746" }, "r551": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "50", "Subparagraph": "(a)(3)", "Topic": "860", "URI": "http://asc.fasb.org/extlink&oid=125521744&loc=d3e122739-111746" }, "r552": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "50", "Subparagraph": "(a)(4)", "Topic": "860", "URI": "http://asc.fasb.org/extlink&oid=125521744&loc=d3e122739-111746" }, "r553": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "50", "Subparagraph": "(a)(5)", "Topic": "860", "URI": "http://asc.fasb.org/extlink&oid=125521744&loc=d3e122739-111746" }, "r554": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "50", "Subparagraph": "(a)(6)", "Topic": "860", "URI": "http://asc.fasb.org/extlink&oid=125521744&loc=d3e122739-111746" }, "r555": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "50", "Subparagraph": "(a)(7)", "Topic": "860", "URI": "http://asc.fasb.org/extlink&oid=125521744&loc=d3e122739-111746" }, "r556": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "50", "Subparagraph": "(b)", "Topic": "860", "URI": "http://asc.fasb.org/extlink&oid=125521744&loc=d3e122739-111746" }, "r557": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "50", "Subparagraph": "(e)(1)", "Topic": "860", "URI": "http://asc.fasb.org/extlink&oid=125521744&loc=d3e122739-111746" }, "r558": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "50", "Subparagraph": "(e)(2)", "Topic": "860", "URI": "http://asc.fasb.org/extlink&oid=125521744&loc=d3e122739-111746" }, "r559": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "50", "Subparagraph": "(e)(3)", "Topic": "860", "URI": "http://asc.fasb.org/extlink&oid=125521744&loc=d3e122739-111746" }, "r56": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.21)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r560": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "910", "URI": "http://asc.fasb.org/extlink&oid=123353855&loc=SL119991595-234733" }, "r561": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "330", "Topic": "912", "URI": "http://asc.fasb.org/extlink&oid=6471895&loc=d3e55923-109411" }, "r562": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "25", "SubTopic": "730", "Topic": "912", "URI": "http://asc.fasb.org/extlink&oid=6472174&loc=d3e58812-109433" }, "r563": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB Topic 11.L)", "Topic": "924", "URI": "http://asc.fasb.org/extlink&oid=6472922&loc=d3e499488-122856" }, "r564": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "50", "SubTopic": "235", "Subparagraph": "(a)", "Topic": "932", "URI": "http://asc.fasb.org/extlink&oid=123377692&loc=d3e61929-109447" }, "r565": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "50", "SubTopic": "235", "Subparagraph": "(b)", "Topic": "932", "URI": "http://asc.fasb.org/extlink&oid=123377692&loc=d3e61929-109447" }, "r566": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "50", "SubTopic": "235", "Subparagraph": "(a)", "Topic": "932", "URI": "http://asc.fasb.org/extlink&oid=123377692&loc=d3e62059-109447" }, "r567": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "50", "SubTopic": "235", "Subparagraph": "(b)", "Topic": "932", "URI": "http://asc.fasb.org/extlink&oid=123377692&loc=d3e62059-109447" }, "r568": { "Name": "Accounting Standards Codification", "Paragraph": "28", "Publisher": "FASB", "Section": "50", "SubTopic": "235", "Subparagraph": "(a)", "Topic": "932", "URI": "http://asc.fasb.org/extlink&oid=123377692&loc=d3e62395-109447" }, "r569": { "Name": "Accounting Standards Codification", "Paragraph": "28", "Publisher": "FASB", "Section": "50", "SubTopic": "235", "Subparagraph": "(b)", "Topic": "932", "URI": "http://asc.fasb.org/extlink&oid=123377692&loc=d3e62395-109447" }, "r57": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.22(a)(1))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r570": { "Name": "Accounting Standards Codification", "Paragraph": "33", "Publisher": "FASB", "Section": "50", "SubTopic": "235", "Subparagraph": "(a)", "Topic": "932", "URI": "http://asc.fasb.org/extlink&oid=123377692&loc=d3e62479-109447" }, "r571": { "Name": "Accounting Standards Codification", "Paragraph": "33", "Publisher": "FASB", "Section": "50", "SubTopic": "235", "Subparagraph": "(b)", "Topic": "932", "URI": "http://asc.fasb.org/extlink&oid=123377692&loc=d3e62479-109447" }, "r572": { "Name": "Accounting Standards Codification", "Paragraph": "35A", "Publisher": "FASB", "Section": "50", "SubTopic": "235", "Subparagraph": "(a)", "Topic": "932", "URI": "http://asc.fasb.org/extlink&oid=123377692&loc=SL6807758-109447" }, "r573": { "Name": "Accounting Standards Codification", "Paragraph": "35A", "Publisher": "FASB", "Section": "50", "SubTopic": "235", "Subparagraph": "(b)", "Topic": "932", "URI": "http://asc.fasb.org/extlink&oid=123377692&loc=SL6807758-109447" }, "r574": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "50", "SubTopic": "235", "Subparagraph": "(c)(1)", "Topic": "932", "URI": "http://asc.fasb.org/extlink&oid=123377692&loc=d3e61872-109447" }, "r575": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "50", "SubTopic": "235", "Subparagraph": "(c)(2)", "Topic": "932", "URI": "http://asc.fasb.org/extlink&oid=123377692&loc=d3e61872-109447" }, "r576": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "25", "SubTopic": "20", "Topic": "940", "URI": "http://asc.fasb.org/extlink&oid=123384075&loc=d3e41242-110953" }, "r577": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.9-03(1)(a))", "Topic": "942", "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878" }, "r578": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.9-03(10)(1))", "Topic": "942", "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878" }, "r579": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.9-03(11))", "Topic": "942", "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878" }, "r58": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.22(a)(2))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r580": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.9-03(13))", "Topic": "942", "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878" }, "r581": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.9-03(16))", "Topic": "942", "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878" }, "r582": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.9-03(23))", "Topic": "942", "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878" }, "r583": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.9-03.17)", "Topic": "942", "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878" }, "r584": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.9-04(15))", "Topic": "942", "URI": "http://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260" }, "r585": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.9-04(22))", "Topic": "942", "URI": "http://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260" }, "r586": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.9-04(26))", "Topic": "942", "URI": "http://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260" }, "r587": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.9-04(27))", "Topic": "942", "URI": "http://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260" }, "r588": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.9-04.9)", "Topic": "942", "URI": "http://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260" }, "r589": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "235", "Subparagraph": "(SX 210.9-05(b)(2))", "Topic": "942", "URI": "http://asc.fasb.org/extlink&oid=120399901&loc=d3e537907-122884" }, "r59": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.22(b))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r590": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "360", "Topic": "942", "URI": "http://asc.fasb.org/extlink&oid=124429447&loc=SL124453093-239630" }, "r591": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "470", "Topic": "942", "URI": "http://asc.fasb.org/extlink&oid=123599511&loc=d3e64711-112823" }, "r592": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03(16))", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910" }, "r593": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03(a)(12))", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910" }, "r594": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03(a)(16))", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910" }, "r595": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03(a)(2))", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910" }, "r596": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03(a)(23)(a)(3))", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910" }, "r597": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03(a)(23)(a)(4))", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910" }, "r598": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03(a)(25))", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910" }, "r599": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03(a)(8))", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910" }, "r6": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=124098289&loc=d3e6676-107765" }, "r60": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.22)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r600": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03.(a),19)", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910" }, "r601": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.7-04(18))", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263" }, "r602": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.7-04(22))", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263" }, "r603": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.7-04(23))", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263" }, "r604": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.7-04(8))", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263" }, "r605": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.7-04(9))", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263" }, "r606": { "Name": "Accounting Standards Codification", "Paragraph": "2B", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=124505477&loc=SL117422543-158416" }, "r607": { "Name": "Accounting Standards Codification", "Paragraph": "4H", "Publisher": "FASB", "Section": "50", "SubTopic": "40", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=116884468&loc=SL65671331-158438" }, "r608": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "40", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=124506351&loc=d3e14931-158439" }, "r609": { "Name": "Accounting Standards Codification", "Paragraph": "7A", "Publisher": "FASB", "Section": "50", "SubTopic": "40", "Subparagraph": "(d)", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=124506351&loc=SL117782755-158439" }, "r61": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.25)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r610": { "Name": "Accounting Standards Codification", "Paragraph": "7A", "Publisher": "FASB", "Section": "50", "SubTopic": "40", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=124506351&loc=SL117782755-158439" }, "r611": { "Name": "Accounting Standards Codification", "Paragraph": "7B", "Publisher": "FASB", "Section": "50", "SubTopic": "40", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=124506351&loc=SL117782768-158439" }, "r612": { "Name": "Accounting Standards Codification", "Paragraph": "13H", "Publisher": "FASB", "Section": "55", "SubTopic": "40", "Subparagraph": "(a)", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=124504033&loc=SL117783719-158441" }, "r613": { "Name": "Accounting Standards Codification", "Paragraph": "13H", "Publisher": "FASB", "Section": "55", "SubTopic": "40", "Subparagraph": "(c)", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=124504033&loc=SL117783719-158441" }, "r614": { "Name": "Accounting Standards Codification", "Paragraph": "29F", "Publisher": "FASB", "Section": "55", "SubTopic": "40", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=124504033&loc=SL117819544-158441" }, "r615": { "Name": "Accounting Standards Codification", "Paragraph": "9C", "Publisher": "FASB", "Section": "55", "SubTopic": "40", "Subparagraph": "(d)", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=122147696&loc=SL65671395-207642" }, "r616": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(e)", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641" }, "r617": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(f)(1)", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641" }, "r618": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(f)(2)", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641" }, "r619": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(g)(1)", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641" }, "r62": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.28,29)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r620": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(g)(2)(i)", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641" }, "r621": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(g)(2)(ii)", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641" }, "r622": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(g)(2)(iii)", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641" }, "r623": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(g)(2)(iv)", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641" }, "r624": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(h)(1)", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641" }, "r625": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(h)(2)", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641" }, "r626": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "80", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=124508989&loc=SL117422267-158473" }, "r627": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "50", "SubTopic": "825", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=123600520&loc=SL75241803-196195" }, "r628": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.6-04(13))", "Topic": "946", "URI": "http://asc.fasb.org/extlink&oid=120401414&loc=d3e603758-122996" }, "r629": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "S99", "SubTopic": "320", "Subparagraph": "(SX 210.12-12B(Column B)(Footnote 1))", "Topic": "946", "URI": "http://asc.fasb.org/extlink&oid=122147990&loc=d3e611197-123010" }, "r63": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.29-30)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r630": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "S99", "SubTopic": "320", "Subparagraph": "(SX 210.12-12B(Column B)(Footnote 6))", "Topic": "946", "URI": "http://asc.fasb.org/extlink&oid=122147990&loc=d3e611197-123010" }, "r631": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "S99", "SubTopic": "320", "Subparagraph": "(SX 210.12-12B(Column B)(Footnote 7))", "Topic": "946", "URI": "http://asc.fasb.org/extlink&oid=122147990&loc=d3e611197-123010" }, "r632": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "S99", "SubTopic": "320", "Subparagraph": "(SX 210.12-12B(Column C)(Footnote 1))", "Topic": "946", "URI": "http://asc.fasb.org/extlink&oid=122147990&loc=d3e611197-123010" }, "r633": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "S99", "SubTopic": "320", "Subparagraph": "(SX 210.12-12B(Column C)(Footnote 6))", "Topic": "946", "URI": "http://asc.fasb.org/extlink&oid=122147990&loc=d3e611197-123010" }, "r634": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "S99", "SubTopic": "320", "Subparagraph": "(SX 210.12-12B(Column C)(Footnote 7))", "Topic": "946", "URI": "http://asc.fasb.org/extlink&oid=122147990&loc=d3e611197-123010" }, "r635": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "S99", "SubTopic": "320", "Subparagraph": "(SX 210.12-12B(Column D)(Footnote 1))", "Topic": "946", "URI": "http://asc.fasb.org/extlink&oid=122147990&loc=d3e611197-123010" }, "r636": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "S99", "SubTopic": "320", "Subparagraph": "(SX 210.12-12B(Column D)(Footnote 6))", "Topic": "946", "URI": "http://asc.fasb.org/extlink&oid=122147990&loc=d3e611197-123010" }, "r637": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "S99", "SubTopic": "320", "Subparagraph": "(SX 210.12-12B(Column D)(Footnote 7))", "Topic": "946", "URI": "http://asc.fasb.org/extlink&oid=122147990&loc=d3e611197-123010" }, "r638": { "Name": "Accounting Standards Codification", "Paragraph": "5D", "Publisher": "FASB", "Section": "S99", "SubTopic": "320", "Subparagraph": "(SX 210.12-13D(Column B)(Footnote 2))", "Topic": "946", "URI": "http://asc.fasb.org/extlink&oid=122147990&loc=SL120429264-123010" }, "r639": { "Name": "Accounting Standards Codification", "Paragraph": "5D", "Publisher": "FASB", "Section": "S99", "SubTopic": "320", "Subparagraph": "(SX 210.12-13D(Column C)(Footnote 2))", "Topic": "946", "URI": "http://asc.fasb.org/extlink&oid=122147990&loc=SL120429264-123010" }, "r64": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.29-31)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r640": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "S99", "SubTopic": "320", "Subparagraph": "(SX 210.12-15(Column A))", "Topic": "946", "URI": "http://asc.fasb.org/extlink&oid=122147990&loc=d3e611379-123010" }, "r641": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "S99", "SubTopic": "320", "Subparagraph": "(SX 210.12-15(Column B))", "Topic": "946", "URI": "http://asc.fasb.org/extlink&oid=122147990&loc=d3e611379-123010" }, "r642": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "S99", "SubTopic": "320", "Subparagraph": "(SX 210.12-15(Column C))", "Topic": "946", "URI": "http://asc.fasb.org/extlink&oid=122147990&loc=d3e611379-123010" }, "r643": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "S99", "SubTopic": "320", "Subparagraph": "(SX 210.12-15(Column D))", "Topic": "946", "URI": "http://asc.fasb.org/extlink&oid=122147990&loc=d3e611379-123010" }, "r644": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "310", "Topic": "954", "URI": "http://asc.fasb.org/extlink&oid=123364037&loc=d3e3115-115594" }, "r645": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "440", "Subparagraph": "(a)", "Topic": "954", "URI": "http://asc.fasb.org/extlink&oid=6491277&loc=d3e6429-115629" }, "r646": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "360", "Subparagraph": "(d)", "Topic": "958", "URI": "http://asc.fasb.org/extlink&oid=120429125&loc=d3e99779-112916" }, "r647": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "360", "Topic": "958", "URI": "http://asc.fasb.org/extlink&oid=120429125&loc=d3e99893-112916" }, "r648": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "50", "SubTopic": "360", "Topic": "958", "URI": "http://asc.fasb.org/extlink&oid=120429125&loc=SL120174063-112916" }, "r649": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "310", "Subparagraph": "(c)", "Topic": "976", "URI": "http://asc.fasb.org/extlink&oid=6497875&loc=d3e22274-108663" }, "r65": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.6(a))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r650": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "310", "Subparagraph": "(b)", "Topic": "978", "URI": "http://asc.fasb.org/extlink&oid=123360121&loc=d3e27327-108691" }, "r651": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "985", "URI": "http://asc.fasb.org/extlink&oid=6501960&loc=d3e128462-111756" }, "r652": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "b" }, "r653": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "d1-1" }, "r654": { "Name": "Form 10-Q", "Number": "240", "Publisher": "SEC", "Section": "308", "Subsection": "a" }, "r655": { "Name": "Forms 10-K, 10-Q, 20-F", "Number": "240", "Publisher": "SEC", "Section": "13", "Subsection": "a-1" }, "r656": { "Name": "Regulation 12B", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "b-2" }, "r657": { "Name": "Regulation S-K (SK)", "Number": "229", "Paragraph": "(a)", "Publisher": "SEC", "Section": "1402" }, "r658": { "Name": "Regulation S-K (SK)", "Number": "229", "Paragraph": "(b)", "Publisher": "SEC", "Section": "1402", "Subparagraph": "(1)" }, "r659": { "Name": "Regulation S-K (SK)", "Number": "229", "Paragraph": "(b)", "Publisher": "SEC", "Section": "1402", "Subparagraph": "(2)" }, "r66": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.6(b))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r660": { "Name": "Regulation S-K (SK)", "Number": "229", "Paragraph": "(b)", "Publisher": "SEC", "Section": "1402", "Subparagraph": "(3)" }, "r661": { "Name": "Regulation S-K (SK)", "Number": "229", "Paragraph": "(c)", "Publisher": "SEC", "Section": "1402", "Subparagraph": "(2)(i)" }, "r662": { "Name": "Regulation S-K (SK)", "Number": "229", "Paragraph": "(c)", "Publisher": "SEC", "Section": "1402", "Subparagraph": "(2)(ii)" }, "r663": { "Name": "Regulation S-K (SK)", "Number": "229", "Paragraph": "(c)", "Publisher": "SEC", "Section": "1402", "Subparagraph": "(2)(iii)" }, "r664": { "Name": "Regulation S-T", "Number": "232", "Publisher": "SEC", "Section": "405" }, "r665": { "Name": "Securities Act", "Number": "7A", "Publisher": "SEC", "Section": "B", "Subsection": "2" }, "r666": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(a)(2)", "Topic": "848" }, "r667": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(a)(3)(iii)(01)", "Topic": "848" }, "r668": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(a)(3)(iii)(03)", "Topic": "848" }, "r67": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.8)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r68": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.9)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r69": { "Name": "Accounting Standards Codification", "Paragraph": "10A", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=124509347&loc=SL7669646-108580" }, "r7": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=124098289&loc=d3e6676-107765" }, "r70": { "Name": "Accounting Standards Codification", "Paragraph": "11", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=124509347&loc=d3e637-108580" }, "r71": { "Name": "Accounting Standards Codification", "Paragraph": "14", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=124509347&loc=d3e681-108580" }, "r72": { "Name": "Accounting Standards Codification", "Paragraph": "14A", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=124509347&loc=SL7669686-108580" }, "r73": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=124509347&loc=SL7669619-108580" }, "r74": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=124509347&loc=SL7669619-108580" }, "r75": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=124509347&loc=SL7669625-108580" }, "r76": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=124509347&loc=SL7669625-108580" }, "r77": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=124509347&loc=d3e557-108580" }, "r78": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=124431353&loc=SL116659661-227067" }, "r79": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=124431353&loc=SL124442407-227067" }, "r8": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=124098289&loc=d3e6676-107765" }, "r80": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=124431353&loc=SL124442411-227067" }, "r81": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=124431353&loc=SL124452729-227067" }, "r82": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(210.5-03(11))", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227" }, "r83": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03(1))", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227" }, "r84": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03(10))", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227" }, "r85": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03(20))", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227" }, "r86": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03(24))", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227" }, "r87": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03(25))", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227" }, "r88": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03(b)(2))", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227" }, "r89": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03.1,2)", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227" }, "r9": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(g)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=124098289&loc=d3e6676-107765" }, "r90": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03.2)", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227" }, "r91": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03.4)", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227" }, "r92": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03.7(b))", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227" }, "r93": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03.7)", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227" }, "r94": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03.8)", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227" }, "r95": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03.9)", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227" }, "r96": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3213-108585" }, "r97": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3213-108585" }, "r98": { "Name": "Accounting Standards Codification", "Paragraph": "14", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3255-108585" }, "r99": { "Name": "Accounting Standards Codification", "Paragraph": "14", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3255-108585" } }, "version": "2.1" } ZIP 92 0001193125-21-329998-xbrl.zip IDEA: XBRL DOCUMENT begin 644 0001193125-21-329998-xbrl.zip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